
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-10501-10800*
  '("A+P" "A-172" "A-43" "A-498" "A-C" "A-D" "A-GVGD" "A-allele" "A-deficiency"
    "A-deficient" "A-loop" "A-type" "A1" "A1-treated" "A1257T" "A1315T" "A1k"
    "A20-1" "A20-2" "A20-2-resistant" "A20-OTUmt" "A20-ZnF5-7" "A20-ΔOTU"
    "A20-ΔZnF" "A2λ" "A366T" "A431-P" "A491ins" "A549P" "A750P" "A750del"
    "A840T" "AAACAAT" "AAV1" "AAV1-tTA" "AAV1-tTA-IRES-zsGreen" "ABC-DLBCLs"
    "ABIPrism" "ABNOVA" "ABPA" "ABPs" "ABT-869" "ACAs" "ACS" "ACT-1" "ACY"
    "ACY-738" "ADRr" "ADRrE2" "AEC" "AECs" "AET" "AEW541" "AFU" "AG1204"
    "AG1478-treatment" "AG538" "AGCACGCGAGGTTCC" "AGGTCA" "AI-S"
    "AIDS-infected" "AIEC" "AIIB2" "AJ289875.1" "AJCC" "AJK" "AKI" "AKTi-1"
    "ALMS1" "AMBRA" "AMs" "ANRASSF1" "AP-1-like" "AP-23573" "AP12816a" "AP2γ"
    "AP4+RAS" "APOD-mRNA" "APPPPS1" "APPPS1" "APRs" "APSMs" "APV" "AQOA"
    "AQOA-A" "AQQAA" "AR-N" "AR-enhanced" "AR-gene" "AR-mediated" "AR-miR-21"
    "ARACNE" "ARD527" "ARE-luciferase" "ARHGEF33" "ARIC" "ARKO" "ARMS–Scorpion"
    "ARMS–scorpion" "ARN" "ARN-509" "ARRY" "ARRY-438162" "ARTPs" "ASANWTIQYND"
    "ASC-J9" "ASCA" "ASC–J9" "ATCC" "ATM-and-Rad53-like" "ATM-pathway" "ATMi"
    "ATN2" "ATR-dependent" "ATR-serine15" "ATRO" "ATS" "ATTG" "AY034471"
    "AY326428.1" "Ab708" "Abcam" "Abcl2" "Abdulghani" "Abr" "Ac-Lys" "Ac-TDG"
    "Aceto" "Achilles" "ActB" "Actinomicyn" "Ad-GFP" "Ad-IκB" "Ad-PTEN"
    "Ad-Skp2" "Ad-ZBP-89" "Ad-β-Gal" "AdCARas" "AdCASrc" "AdCre" "AdDNSrc"
    "AdDUSP4" "AdJLB1" "AdLacZ" "AdSpry4" "Adam" "Adank" "Addison" "Affymetrix"
    "Africa" "African" "African-American" "African-Americans" "Africans" "Ag"
    "Ahel" "Ahn" "Aida" "Aidaroos" "Aiden" "Aims" "Akt-fibroblast"
    "Akt1promoted" "Alagille" "Alaskan" "Alb-cre" "Aldoa" "Alex" "Alexa"
    "Alexa488" "Alexander" "Allagile" "Alleva" "Alltech" "Alltima" "Alstrom"
    "Alström" "AluSx" "Alzheimer" "Alzheimer's" "Alzheimer’s" "Alzihamer"
    "Amaravadi" "Ameri" "America" "American" "Americans" "Amgen" "Amicon"
    "Aminoethyl" "Ammirante" "Amo" "Amot" "Amot-Yap" "Amot-p130N" "Amots"
    "Amsh" "Amsterdam" "Anderson" "Andres" "Ann" "Ant-D-loop" "Antennapedia"
    "Antony" "Apennine" "Api" "Api5" "Aptamer" "Arf-null" "Arg-Val-Leu"
    "Arg-rich" "Arg194Trp" "Arg399Cln" "Arg399Gln" "Arizona" "Arp2" "ArrayScan"
    "Arsani" "Asian" "Asians" "Atox-1" "Atrophins" "Autoantigen-1" "Azare"
    "A + " "Aβo–PrP" "Aβ–PrP" "Aγ" "Aδ" "A–C" "A–S1C" "A–S4D" "A–S6E" "A→C"
    "A→G" "B-ATF" "B-D" "B-acute" "B-binding" "B-boxes" "B-depleted" "B-family"
    "B-inhibited" "B-lymphoid" "B-type" "B16-luc" "B3" "B5" "B6" "BACH1-FBXL17"
    "BAEC" "BAK1del" "BAK1mut" "BAK1wt" "BAPTA-AM" "BBLF2" "BCL-xl" "BCL11A-XL"
    "BCL2-immunoreactivity" "BCL2-like" "BCL2-negative" "BCL2-positive"
    "BCR-ABL1" "BCSCs" "BDCA3" "BEMAD" "BH-only" "BH3-mimetic" "BH3-mimetics"
    "BH3-only" "BHA2.1" "BHT" "BILAG" "BIR2" "BIR3" "BJ" "BLAT" "BLBCs" "BM73"
    "BME" "BMI≤24" "BML" "BML-1" "BML-11" "BML-5" "BML-7" "BML281" "BMPRs"
    "BOADICEA" "BOLERO2" "BRAF+PTCs" "BRAF-AA" "BRAF-ED" "BRCA2and" "BRCACX"
    "BRID" "BSCL1" "BSCL1-4" "BSCL3" "BSCL4" "BSE" "BTB474" "BUZ" "BZ"
    "BZ-9000" "Background" "Bak-independent" "Baldus" "Barbano" "Barrett"
    "Barry" "Barry-Hamilton" "Basal" "Basel" "Bcl" "Bcl-2-antagonist" "Bcl-xl"
    "Bcl2" "Bead-bound" "BeadChips" "Beamline" "Begg" "Begg's" "Begger"
    "Begger’s" "Begg’s" "Behcet" "Behrends" "Beighton" "Belfast" "Benjamini"
    "Benjamini-Hochberg" "Bennett" "Benvenuti" "Berghe" "Bessette" "Beva"
    "Bgl3" "Bi-transgenic" "BibiServ" "Billerica" "Bio" "Bio-Rad" "BioGRID"
    "BioRad" "Biocarta" "Biomol" "Biosystems" "BirA-tag" "Bix" "Black" "Blake"
    "Blood-borne" "Bmi1-miRNAs" "Bmi1-self" "Bmi1-targeting-shRNA" "Bolero-2"
    "Bonferroni" "Bookland" "Borbera" "Boroumand" "Boroumand-Noughabi" "Boston"
    "Boudot" "Boyden" "Bp65" "Br426" "Br731" "Brabletz" "Brachyury" "Bradford"
    "Brandwein" "Brandwein-Gensler" "BrdU-label" "BrdUrd" "Break-Induced"
    "Breslow" "Bridgman" "Bristol" "Brognard" "Brookhaven" "Brystol" "Btz"
    "Bullinger" "Burkitt" "Burris" "Bx" "Byers" "B–2D" "B–C" "B–D" "B–H" "C-C"
    "C-G" "C-NHEJ" "C-NHEJ-dependent" "C-NHEJ-mediated" "C-TADs" "C-allele"
    "C-allelecontaining" "C-eta" "C-helix" "C-lobe" "C-lobes" "C-mass"
    "C-region" "C-sections" "C-src" "C-terminally" "C-treated" "C-type" "C1"
    "C1-mediated" "C10orf26" "C139A" "C147A" "C18LL" "C1orf24" "C2" "C2-CH"
    "C2-domain" "C28" "C3" "C4" "C450ins" "C472S" "C540ins" "C56BL6J" "C57BL6"
    "C6" "C6orf47" "C779A" "C782A" "CAAG" "CAAX" "CACACA" "CACGTG" "CAIS"
    "CALHM2" "CALHM3" "CALR3" "CAP8AP2" "CASrc" "CAWG" "CBCS" "CC+GC" "CCAAT"
    "CCCG" "CCFR" "CCG-1423" "CCL-20" "CCL2ab" "CCR2S" "CCR2atg"
    "CD-associated" "CD11cCre" "CD28-induced" "CD28RE" "CD44+" "CD44S" "CD44V"
    "CD44V6" "CD8-Nef" "CDK4-6" "CDK6R31C" "CE" "CEC" "CELSR1" "CEP128" "CEP6"
    "CEU" "CFTR-172" "CFTR-172-induced" "CG-E" "CGAG" "CGH-microarrays"
    "CH99021" "CHME3" "CI1040" "CIAO" "CICs" "CINII" "CL" "CLB-Ga" "CLB-Re"
    "CLGN" "CLIA" "CM5-postive" "CNNM2" "CNQX" "COBRA" "COUP-TF" "COUP-TFs"
    "COUPTF" "COUPTF-II" "COUPTFII" "COX-2-765" "CPSCs" "CR-1" "CR-2" "CRAC"
    "CRCC" "CRL-5872" "CRS-PCR" "CRs" "CSA" "CSC-like" "CSPCs" "CT+CC" "CT+TT"
    "CTCs" "CTG" "CTNNA3" "CTTG" "CTTNB1" "CVB3" "CVs" "CW" "CWH" "CWWG" "CXCL"
    "CXH" "CYP2C19*2" "CaCl" "Cai" "Calbiochem" "Calcusyn" "Caliper"
    "Calphostin" "CamKII-tTA" "CamKIIα-tTA" "Cambridgeshire" "Campenot"
    "Canada" "Canu" "Carlo" "Carney" "Cartegni" "Case1" "Case2" "Caucasians"
    "Cavin" "Cd12" "Cdk1" "Cdk2" "Cdk4" "Cdk6R31C" "Cdk7" "Celgene" "Cen"
    "ChIP" "ChIP-PCR" "ChIP-on-Chip" "ChIP-qPCR" "ChIP-reChIP" "Chan" "Chang"
    "Chau" "Chemically-engineered" "Cherney" "Cheung" "Chi-square"
    "Chi-squares" "Chie" "Chng" "Circos" "Clark" "Class-I" "Classical-EMT"
    "Clinico-pathological" "Cmax" "CoM" "CoMCont" "CoMTb" "CoRNR" "CoRNR1and"
    "CoRNR2" "Coburg" "Cochrane" "ColE1" "Collins" "Colorado" "Commiphora"
    "Como" "CompPASS" "Conclusion" "Conclusions" "Congo" "Cookson" "Coomassie"
    "Coradini" "Corticosteroids" "Cortot" "CovalAb" "Cox-regression"
    "Coxsackievirus" "CpG-dense" "CpG-island" "Cr" "Cr-fragment" "Crc" "Cre"
    "Cre-driver" "Cre-negative" "Creutzfeld" "Creutzfeld-Jacob" "Crohn"
    "Crohn's" "Crohn’s" "Cross-regulation" "Crowden" "Crumb3" "Crus" "Cruz"
    "Cs" "CtIP-mediated" "Ct∼12" "Cu" "Cufflinks" "Cul1-Skp1-Fbw7"
    "Cullin-RING" "Cullin-Ring" "CyclinD1and" "CyclinD1as" "Cys-LT"
    "Cys-LT-mediated" "Cys-LTs" "Cys-X2-4-Cys-X35-50-Cys-X2-His" "CysLTR"
    "Cysteine-to-alanine" "Cysteinyl" "Cytobank" "Córdova" "Cα" "C–E" "C→A"
    "C→G" "C→T" "D-SZ" "D-box" "D-motif" "D-type" "D146N" "D1R" "D1R-GFP" "D2"
    "D2-GFP" "D3" "D4" "D4GDI" "D4Z4" "D5" "D5F3" "D770GY" "DA-like" "DALS"
    "DAVID" "DBN-S647" "DBSs" "DCIS-like" "DCP-LA" "DDGNDVpSP" "DDK" "DEF-A"
    "DFCI" "DGV" "DHX30" "DIPGs" "DK4" "DK6" "DM-W" "DM24h" "DMEM" "DMTs"
    "DNA-DNA" "DNA-DSB" "DNA-TDG-p300" "DNA-mismatch-repair" "DNA-protein"
    "DNA–protein" "DNCsk" "DNP-HSA" "DNSrc" "DO1" "DOI" "DOPAC" "DOX" "DPQ"
    "DPYD-MIR137" "DQ™-Red" "DR-4" "DR5-like" "DSB-R" "DSBs" "DSD" "DSGX"
    "DSGxxS" "DSTYK" "DU145Kd" "DUF1669" "DUX4-fl" "DUX4-s" "Dako" "Daniele"
    "Danish" "Danvers" "Dawson" "De-repressing" "Defazio" "Defazio-Eli"
    "Deficiens" "Dekken" "Dendra-tau" "Denis" "Denmark" "Denmeade" "Deshaies"
    "Design" "Detlef" "Dhand" "Dharmacon" "DiYF" "DiYF-knockin" "Diaz"
    "Dictyostelium" "Diego" "Diermeier" "Dieter" "Discrepant" "Discs" "Doebele"
    "Dohner" "Double-strand" "Down-modulation" "Down-stream" "Doxo" "Doxy"
    "DsRed-Monomer-tagged" "Dulbecco" "Dulbecco’s" "Duplan" "Duval" "Duve"
    "DyLight" "D–5G" "D–E" "D–S1F" "E-CMF" "E-GFP" "E-MTAB-37" "E-T-CMF"
    "E-box" "E-boxes" "E-cadheirn" "E-cadherin" "E-cadherin-expressing"
    "E-cadherin-negative" "E-guggulsterone" "E-value" "E-x-x-x-x-C" "E10a"
    "E10del" "E10del2" "E17b" "E2-promoter" "E2A-HLF" "E2F-7" "E2F-7-bound"
    "E2F-7-depleted" "E2F-8" "E2F1-8" "E2F1-dependent" "E2F1-induced"
    "E2F1-inducing" "E2F1-mediated" "E2F1-negative" "E2F1-positive"
    "E2F1-target" "E2F3a" "E2F3b" "E2F6-dependent" "E2F6-depleted" "E2F7a"
    "E3-ligase" "E3-ligase-like" "E3RS" "E5" "E572A" "E64c" "E6L50G" "E6a"
    "E7-immortalized" "E709A+G719C" "E7del" "E8" "E8.0" "E8.75" "E9.5" "EBPa"
    "EBPb" "EBPd" "EC1-4" "EC50" "ECFP" "ECM+C" "ECM-adhesion" "ECOG" "EEAs"
    "EEG" "EFGR" "EGF-R" "EGF-R-Shc-1-Grb2" "EGF-like" "EGFP-tag"
    "EGFR-MEK-dependent" "EGFR-P" "EGFR-PI3K-dependent" "EGFR-dependently"
    "EGFRwt" "EGFRwt-EGFRvIII-RIP1" "EIIIB" "EL11-26" "EL12-15" "EL12-58"
    "ELISAs" "ELREA" "EMT-TF-induced" "EMT-TFs" "EMT-like" "EMT-mRNA"
    "EMT-phenotype" "EMT-targeting" "EMVs" "ENST00000527240" "ER+" "ER++"
    "ER+positive" "ER+ve" "ER-E2F1" "ER-E2F1cells" "ER-coactivaton"
    "ER-negativity" "ER-positivity" "ER-signalling" "ER-status" "ER-to-Golgi"
    "ER-ve" "ER0" "ERAP1a" "ERAP1b" "EREs" "ERFR" "ERK-independent" "ERS"
    "ESCRT" "ESE" "ET-CMF" "EU" "EUFA" "EUFA-423" "EURTAC" "EV-C2" "EV-C4"
    "EVCT" "EVCTs" "EVH1" "EX-EGFP-M02" "EX-EGFP-M02-vector" "East-Asian"
    "Eckert" "Edinburgh" "EdnrA" "Eferl" "Egger" "Egger's" "Egger’s"
    "Eighty-nine" "Eighty-one" "Eighty-seven" "Eighty-six" "Eilers" "Ejlertsen"
    "Ellison" "Elo" "Elston" "Eluates" "EnSCs" "EndoPredict" "England"
    "EphA2-CAV1" "EphA2-kd" "Epithelial-Mesenchymal" "Epithelial-mesenchymal"
    "Epithelial-to-Mesenchymal" "ErB3" "Erb2-driven" "ErbB2-only"
    "Erk1-negative" "Erk1-positive" "Erkanli" "ErlR" "Erlangen" "Erythrocytes"
    "Eskimo" "Esposito" "Etienne" "Etude" "Europe" "European"
    "European-descent" "Evans" "Ex5-MBNL1" "Eμ-myc" "E–6G" "E–S2H" "F-BAR"
    "F-BAR–FX" "F-SNP" "F1" "F12" "F2" "F4" "FAD" "FAM83" "FAM83D" "FBCs"
    "FBLX20" "FBP-1" "FBS-replete" "FBXL11" "FBXL6" "FBXL7" "FBXO" "FBXW"
    "FBXW7α" "FBXWα" "FEF" "FEM1" "FEV1" "FFI" "FFLs" "FGF" "FGFR-2-III-b"
    "FGFR-2-IIIb" "FGFR-2-IIIb-specific" "FGFR-2-IIIc" "FGFR-invariant"
    "FGFR2b" "FGFR3K" "FGR2b" "FICZ" "FIGO" "FISH" "FKBP12-rapamycin" "FKSG30"
    "FLA9500" "FLAG" "FLAG-BCL11A-XL" "FLAG-DBN" "FLAG-LMW-E" "FLAG-hSIRT1-FL"
    "FLAG-hSIRT1-NT" "FLAG-tag" "FLICE-like" "FLJ36031-PIK3CG" "FLT3-ITD"
    "FLT3-ITD-driven" "FLT3-ITD-induced" "FLU-inducedγ-H2AX" "FLX-treated"
    "FN-null" "FNAB" "FOLFIRINOX" "FOLFOX6" "FOPFlash" "FOSL" "FOXO" "FOXO4a"
    "FRA1-WT-BS" "FRA1-wild-type-binding" "FRA16D" "FRA2C" "FRA2Ccen"
    "FRA2Ctel" "FRCn" "FREEC" "FRG1" "FRG2" "FRMP" "FSHD-1" "FSHD-2" "FSXLLXML"
    "FSXXLXXL" "FTIR" "FTS-1" "FVG" "FVIIa" "FXRXLRXL" "FXXLL" "FXXXLXXL"
    "FadA" "FadAc" "Fagerli" "FancD" "FancD2-mUb" "Fbw" "Fbw7-directed" "FcϵRI"
    "Fe" "Fernandes" "Ferraros" "Ferreira" "Ferrone" "Fi" "Fiala" "Fifty-six"
    "Filho" "Fine-mapping" "Finkel" "Finnish" "Fiordalisi" "Fischer" "Fish-oil"
    "Five-fluorouracil" "Flag" "Flag-DBN" "Flag-HA-tagged" "Flag-M2"
    "Flag-Polκ" "Flag-REV1-expressed" "Flag-Ubi" "Flag-Yap" "Flag-tag"
    "Flotilin-1" "Flow-cytometric" "Fluc" "Fluor-488-conjugated" "Fn" "FoSTeS"
    "Follow-up" "Fonseca" "Forster" "Forty-eight" "Forty-three" "Fourier"
    "Fourier-transform" "Foxo33" "Foxo3a-high" "Foxo3a-low" "Foxp" "France"
    "Francisco" "Fraumeni" "Frebel" "French" "Frey" "Frezza" "Friedl"
    "Friedrichs" "Frizzleds" "Fs" "Fu" "Fuhrman" "Functional" "Fura-2-AM"
    "FusionSeq" "F–S6H" "G-486T" "G-6-Pc" "G-C" "G-DNA" "G-KAP1" "G-LISA"
    "G-YL" "G-allele" "G-ratios" "G-substate" "G-substates" "G-substrates" "G0"
    "G0-G1" "G0-like" "G1" "G1-G3" "G1-to-S" "G2" "G2-irradiated" "G242fs"
    "G2E" "G2–M" "G719A" "G719X" "G724fs" "G770GY" "GADD45α"
    "GAL4-PNR-mediated" "GAS-like" "GBCs" "GBM12" "GBM13" "GBM9-NS" "GBM95"
    "GCCGGAG" "GCHM" "GDK" "GDZ" "GDZK" "GEF-dead" "GEF40" "GENOPTIX"
    "GENOSEARCH" "GEO2R" "GEO45130" "GFP-Exo70-induced" "GFP-Exo70-positive"
    "GFP-FRMD7-transfected" "GFP-PTENΔD" "GFP-RNF38ΔRING" "GFP-lifetimes"
    "GFP-mut3" "GFP-tag" "GFPRNF38" "GFRs" "GGCA" "GGGAGGTGGGG" "GGGGGCAGGGG"
    "GH-hPrlR" "GIVM" "GLATEKSRWSG" "GLOBOCAN" "GRC-1" "GRE" "GREs" "GRR"
    "GSCs-by" "GSE1159" "GSE12417" "GSE15434" "GSE19784" "GSE6365" "GSE6477"
    "GSE6891" "GST-A20-ZnF5-7" "GST-A20-ZnF5-7mt" "GST-EC5" "GST-Homer1c"
    "GST-LBD" "GST-RASSF5-SARAH" "GST-RNA" "GST-ZO-1-K253A" "GST-cIAP"
    "GST-hSIRT1-NT" "GST-pull" "GT-1" "GTCAGGA" "GTIC" "GTICs" "GTIIC" "GUVs"
    "GVGD" "GWAS-PheWAS" "GWASs" "GX15-070" "GXP" "GYJ" "GYJ-A" "GZBDK" "GZBDZ"
    "GaQ3-treatment" "Gaidzik" "Gain" "Gain-of-Function" "Gain-of-function"
    "Gandara" "Garcia" "Gautam" "GdmCl" "GenBank" "Gene-knockout" "GeneChip"
    "GeneXplain" "Genentech" "Genomatix" "Genome-wide" "Genomes"
    "Genotype-NSAID" "Genotype-phenotype" "Gensini" "Gensler" "German"
    "Germany" "Gerota" "Gerota’s" "Giemsa" "Girard" "Glasgow" "Gleason"
    "Gln+Gln" "Glomus" "Glostrup" "Glutathione-Sepharose" "Gly1121ValfsX3"
    "GoldenGate" "Goosecoid" "Gorbatyuk" "Graviola" "Grp78" "Guinier" "Guiorzo"
    "Gulley" "Gupta" "Gy" "Gγ" "G–A" "G–C" "G–T" "G→A" "G→C" "G→T" "H&E"
    "H-14-3-3zeta" "H-2Kb-tsA58" "H-E" "H-L" "H-MADD3A-YFP" "H-Ras-GTP"
    "H-WtMADD-YFP" "H1" "H113A" "H115A" "H179Y" "H1975" "H1993" "H1H1" "H1N1"
    "H2" "H2H2" "H3" "H37Ra" "H3K27" "H3K36" "H3K9Ac" "H4" "H4Lys12" "H538A"
    "HA-E2F1" "HA-Ub" "HA-Ub-K63-only" "HA-Ubi" "HA-tagged-USF2" "HADDOCK"
    "HAEC" "HAECs" "HAFoxp3" "HAOEC" "HAOSMC" "HAdV" "HAdV-C5" "HB-239" "HBCI"
    "HBII-239" "HBS+STAT3" "HBSs" "HCB" "HCIP" "HCIPs" "HCT116Bax" "HCT116KRAS"
    "HDFs" "HDMECs" "HEC-50" "HECD-1" "HELQ-1" "HELQ-BCDX2" "HELQ-defective"
    "HER-1–4" "HER-2+" "HER-2-low" "HER-family" "HER1-3" "HER1-4" "HER1–4"
    "HER2-negative" "HER2-normal" "HER2Bi-ATC" "HER2Bi-Ab" "HER2Bi-armed"
    "HER3-HRG" "HER3phosphorylation" "HERi" "HERi-HERj" "HERj" "HFY" "HG-U133"
    "HGGs" "HGMD" "HGS-OvCa" "HGVS" "HHE" "HIBECs" "HIF1+USF2" "HIF1α+STAT3C"
    "HIF1α+USF2" "HIF1α-C" "HIF1α-N" "HIF1αDPA" "HIF1αTM" "HIF1αTM+STAT3C"
    "HIF1αTM+USF2" "HIF2+USF2" "HIF2α-C" "HIF2α-N" "HIF2αDPA" "HIF2αTM"
    "HIF2αTM+STAT3C" "HIF2αTM+USF2" "HIFα" "HIFα112" "HIFα122" "HIFα211"
    "HIFα221" "HIV+IVDU" "HIV+IVDUs" "HIV-Tat" "HKC" "HKL" "HLA-DRB9" "HLH"
    "HMDECs" "HMLE-Slug" "HMLE-Snail" "HMLE-Twist" "HMSC" "HMSCs" "HNPC"
    "HOXA6" "HP-1" "HPASMC" "HPASMCs" "HPFS" "HPrE" "HR-HPV" "HR231" "HR=0.47"
    "HR=1.44" "HR=1.51" "HR=1.53" "HR=1.54" "HSM" "HSP70-Cluc" "HSV-1" "HT12"
    "HTB175" "HTKO" "HWE" "HYX" "Haas-Kogan" "Habashy" "HaemAtlas" "Haenszel"
    "Halotag-p62" "Hamilton" "HapMap" "HapMap3" "Hardy-Weinberg"
    "Hardy-Zuckerman" "Hardy–Weinberg" "Harinck" "Harris" "Harvard" "Harvey"
    "Hawaiian" "Hayashi" "Hb" "Hct" "HeCOG" "HeLa-OCT4" "HePTPP"
    "Helicase-like" "Hematoxylin–eosin" "Heme" "Hetero-oligomerization" "Hi-C"
    "Hieronymus" "High-grade" "High-risk" "Hildebrandt" "Hilden" "Hipple"
    "Hipple–Lindau" "Hippo-Salvador" "Hippo-Yap" "Hippo-responsive" "His-E1"
    "His-Flag-Ubi" "His-Hsp70" "His-Plk1" "His-Stub1" "His-Ubc5Hb" "His-hTDG"
    "Hiscott" "Hispanic" "HistoQuest" "Histofine" "Histoscores" "Hnf" "Hnf-3α"
    "Hnf-4α" "Hochberg" "Hocheberg" "Hodges" "Hodgkin" "Hodgkin’s" "Hoechst"
    "Hofstatter" "Holliday" "Holst" "Homer1a" "Homer1b" "HomerEVH1" "Homma"
    "Homo-or" "Homozygotes" "Hong" "Hopkins" "Horlings" "Horowitz"
    "Hsa-miR-105" "Hscore" "Huang" "Huggins" "Hui" "Humain" "Human610K"
    "Huntington" "Hwang" "HxKxxxKxxxD" "HxKxxxxD" "Hydropro" "I+II" "I-BAR"
    "I-III" "I-OMe-AG538" "I-Tfn" "I-map" "I-transferrin" "I2" "I230A" "I8V"
    "IAA" "IASLC" "IAV" "IB4-immunoreactive" "IBD-U" "IBDU" "IC-NST" "IC90"
    "ICBP50" "ICCs" "ICOS-L-mIgFc" "ICP6" "IDBC" "IDBCs" "IDCs" "IFN-ɣ" "IFN-λ"
    "IFN-λR" "IGF-1-induced" "IGF-1R-activated" "IGF-1was" "IGFR-1R-mediated"
    "IHGGK" "IIA" "III+IV" "III-map" "IIICS" "III–IV" "IIa" "IIiopoulos"
    "II–IV" "IKK-ε" "IL-1R-dependently" "IL-36γ" "IL-6-receptor-mediated"
    "IL12-p40-κB" "IL2-κB" "IL2-κB–DNA–protein" "IL4production" "ILBCs"
    "INF-α-induced" "INGI" "INGI-FVG" "INGI-VB" "INK" "IP-WB" "IP-kinase"
    "IPQA" "IPS" "IQ" "IQR" "IR-A" "IR-A-mediated" "IR-A–pcDNA3.1" "IRES"
    "IRES2" "IR–B" "ISG" "ISGF3γ" "ISGs" "ISI" "ISceI" "ITC" "IVDUs" "IVIG"
    "IVIS" "IVIS-100" "IVS" "IVS17+1G" "IVa2" "Ibadan" "Ichinose" "Ig-κB"
    "IgAλ" "IgGk" "IgGλ" "IgVH" "Igf1rβ" "Igs" "IkappaA" "IkappaA-kinase"
    "Ikegami" "Illumina" "Ilumina" "ImageJ" "ImageQuant" "Imetesltat"
    "Imetlestat" "Immuno-cytochemical" "Immuno-isolation" "Immunoglobulin"
    "Immunotherapies" "Improta" "InChianti" "Inab" "Indian" "Ink4a"
    "Inter-observer" "Intra-aortic" "Invitrogen" "Irt-like" "Isc" "Ishii"
    "Iwig" "IĸB" "IĸBα" "I–III" "I–IV" "I–VI" "I∼II" "J82-bladder" "JAH"
    "JAK2V617F" "JBZ" "JCF" "JCL" "JEP" "JFH1" "JH1" "JLR" "JPT" "JS-31" "JSF"
    "JWF" "JZ" "Jacob" "Jacobs" "Jak-STAT3" "Jak1and" "Jancelewicz" "Japanese"
    "Jasin" "Jedi-1" "Jeghers" "Ji" "Jiang" "Joazeiro" "Johnson" "Johnston"
    "Ju-Seog" "Julia" "Junicho" "J–S2L" "K-I" "K120" "K164" "K23V" "K259" "K2R"
    "K370" "K4E" "K540A" "K567X" "K571A" "K5E" "K5N" "K63" "K63R" "K72H" "K777"
    "KAP-1-depleted" "KCGS" "KCl-pretreatment" "KEGG" "KG" "KGGRSRLPLPPLPPPG"
    "KIGS" "KIM-PTP" "KIM-peptide" "KIMKIS" "KJC" "KRAB-ZFP-associated" "KV"
    "KXGS" "KY" "KYL" "Kadowaki" "Kagan" "Kalac" "Kaler" "Kalikaki" "Kanei"
    "Kanei-Ishii" "Kaplan-Meier" "Kaplan–Meier" "Karim" "Kasper" "Katakami"
    "Kenny" "Kenyan" "Kerr" "Ki-67" "Ki-67-positive" "Kiel" "Kim" "Kirsten"
    "Kitamura" "Knock-down" "Knock-in" "Knocking-down" "Knudson" "Knudson's"
    "Ko" "Kogan" "Komander" "Korah" "Korea" "Korean" "KpnI" "Kruppel" "Krüppel"
    "Ku-hTR" "Kuijper" "Kumar" "Kung" "Kunstman" "Kunz" "Kuriyan" "Kwon"
    "Kwon’s" "Kyoto" "Kyprianou" "K–M" "K–S2P" "L-Dopa-induced" "L-PHA"
    "L-X-L-X-φ" "L-type" "L1" "L1-5" "L1-RTP" "L1-RTP-inducing" "L19F" "L2"
    "L262-Q264" "L269fs" "L2K" "L2K+pcDNA3.1" "L2K+pcDNA3.1-miR-124" "L3"
    "L319A" "L38I" "L4" "L4-100K" "L4P" "L5" "L56Br-1" "L747-S751" "L747-S752"
    "L858R" "LC3-I" "LC3-punctae" "LCDD-LCs" "LCL" "LCLs" "LE" "LEF-Luc"
    "LERGEpSIEP" "LETF" "LETFs" "LEUTX" "LF82" "LFL" "LGR" "LGRs" "LIFRβ"
    "LINE-1" "LISA" "LLL12" "LMW" "LMW-E" "LMW-E-expressing"
    "LMW-E-overexpressing" "LMW-E–expressing" "LNGFR" "LNGFR-BirA-tag" "LNT14"
    "LOC10013023" "LOC84989" "LOVD" "LOX-wt-UTR" "LPMf" "LPR"
    "LPS-Stub1-induced" "LPTY" "LPV" "LPxY" "LPxY-PPxY" "LQQLL" "LR" "LR-Test"
    "LRRTM" "LRT" "LTD" "LTE" "LTGCs" "LTRs" "LTβR-stimulation-induced" "LUVs"
    "LUX-Lung" "LV-Stub1" "LXRα" "LXXML" "LXXXLXXXI" "LacCer" "Laemmli" "Lai"
    "Lang" "Langerhans" "Laptenko" "Larger-scale" "Larsen" "Lasmezas" "Laster"
    "Latino" "Lats1" "Lats1-Yap" "Lauren" "Lauren’s" "Layton" "Leica" "Leid"
    "Lemmers" "Leo" "Let-7a" "Let-7c" "Leu858→Arg" "Levis" "Lewy" "LexA-RID2"
    "Lgl" "Lgl3SA" "Li" "Li-Fraumeni" "Liang" "Liboi" "Licht" "Lieberman"
    "Lieberman-Aiden" "Lifeact" "Lifeline-basal" "Lindau" "LipidTOX"
    "Littleton" "Liu" "Live-dead" "Li–Fraumeni" "Li–Fraumeni-Like"
    "Li–Fraumeni-like" "Loberg" "Loeb" "Lokuge" "Long-range" "Loosdregt"
    "Lopez" "Lopez-Andres" "Lopez-Vicente" "Loss-of-function" "Low-dose"
    "Lowenberg" "Lu" "Luminex" "Lunardi" "Luo" "Luo’s" "Lv-MEK" "LxxLL" "Lysm"
    "Lyz2" "L–S6O" "M-IgVH" "M14" "M1k" "M1λ" "M2-like" "M227A" "M2λ"
    "MADS-box" "MAPK-pathway" "MAPK-pathways" "MAPK4K" "MAPKK-like" "MAPLE"
    "MAR" "MARTINI" "MB-435S" "MBCs" "MBII" "MBII-239" "MCBCS"
    "MCF-7-MEK5-ERK5-shRNA" "MCF10ADCIS" "MCF7-Cd" "MCF7-Cd2" "MCF7breast"
    "MCa" "MCo" "MDA-MB" "MDA-MB-231-D3H2-LN" "MDA-MB-231-PELP1-shRNA"
    "MDA-MB-231-PELP1shRNA" "MDAMD-231-PELP1shRNA" "MEBGEN" "MEDLINE" "MEGS"
    "MEM" "MHCCLM3" "MHCs" "MIAME" "MILE" "MIR" "MIR-106B-25" "MIR-17–92"
    "MIR106A" "MIR106B" "MIR1296" "MIR137" "MIR143-NOTCH" "MIR143-NOTCH2"
    "MIR143-fusion" "MIR93" "MK-571" "MKK3b" "MKLP" "ML-120B" "MLNs" "MM1S"
    "MM231-LN" "MMTV-PyMT" "MMTVcre" "MMTVneu" "MO7e" "MODELLER" "MONO-MAC6"
    "MOPC-141" "MPMQ" "MRAPs" "MRCKβ" "MREC" "MRLCs" "MRTF" "MRTF-B" "MRTFs"
    "MSCV" "MSFM" "MSH2-null" "MSI-H" "MSigDB" "MT-1A" "MT-1E" "MT-2A" "MT-3"
    "MTEP" "MTF-1" "MTGhi" "MTKs" "MTS" "MUC5AC-negative" "MV-1" "MVs"
    "MYC+RAS" "Maacke" "Mackay" "Mal-PEGylation" "Malay" "Manchester" "Manders"
    "Mantel-Cox" "Mantel-Haenszel" "Maoa" "Map" "Mapper" "Maryland"
    "Massachusetts" "Materials" "Mathworks" "Matias-guiu" "Matlab" "Matsukawa"
    "McCoy" "McGill" "Mdm2-null" "Medimmune" "Meier" "Mellitus" "Meso"
    "Methodology" "Methods" "Methyladenin" "Metzeler" "Mexico" "Mg" "Mi-2a"
    "MiR-192" "MiR-200" "MiR-200b" "MiR-21" "MiR-376c" "MiR-433" "MiRNA-125b"
    "MiRNA-768-3p" "MiRNAs-886-5p" "MiRanda" "Mia-PaCa2" "Michael" "Michelucci"
    "MicroRNA-21" "Microb" "Microsystems" "Middle-South" "Millipore"
    "MiniSOG-mCherry" "Mirlet7e" "Mixl" "Mizuki" "Mizutani" "Mn" "ModFit"
    "Moderate-to-strong" "Moelans" "Mollicutes" "MommeR1" "Monocyte-microglial"
    "Monte" "Morel" "Morgera" "Morgillo" "Moroni" "Morris" "Moses" "Motin"
    "Motokura" "Mps" "Mst" "Mt-p53" "Mu" "Mu-PACK" "Mulholland" "Muller"
    "Multicentre" "Multipathway" "Murakami" "Mus301" "Myc-53" "Myc-A20-WT"
    "Myc-I" "Myers" "MyosinII" "N-R" "N-TAD" "N-TADs" "N-arginine"
    "N-glycosylation" "N-labeled" "N-lobe" "N-methyl-N" "N-nitrosamines" "N4–6"
    "NA" "NADH-dehydrogenase" "NAM-sensitivity" "NAMEC-RAS" "NAMEC-RAS-Tom"
    "NAMEC-Tom" "NAMEC-Tom-RAS" "NAMEC11" "NAMEC8" "NB1141" "NB1142" "NB27"
    "NBRA" "NBRA-A" "NBRE-A" "NBRE-A-mediated" "NBRE-B" "NBRE-C" "NBRE-like"
    "NCBI" "NCBI's" "NCBI36" "NCI" "NCI-H295R" "NCI-H322" "NCSLC" "NC_000019.9"
    "NE-GOF" "NEJ002" "NES-like" "NES=2.05" "NEs" "NF-B" "NF-H" "NF-ĸB" "NF-Κb"
    "NF-κB–DNA" "NF1-patient" "NFT" "NFTs" "NGF-axon" "NGF-treatment" "NGFβ"
    "NHGRI" "NHWs" "NID+L" "NIDs" "NK-κB" "NKI" "NL" "NLS-SYFP-DBD"
    "NLS-SYFP-tagged" "NLS2" "NLSs" "NLStradamus" "NM_006297.2" "NNA" "NO"
    "NOD-SCID" "NOD-like" "NOTCH1-3" "NPIM" "NPM-ALK-Driven" "NPM-ALK-driven"
    "NPM-ALK-negative" "NP_006288.2" "NPxY" "NR-coregulator" "NR-coregulators"
    "NR2E" "NR2F" "NR4R" "NRF2-ARE" "NRF2-ARE-activation" "NRF2-ARE-mediated"
    "NRG1s" "NRI" "NSD" "NSLCs" "NSPCs" "NSTEMI" "Naidu" "Nakao" "Nd"
    "Necrostatin-7" "Nef-PI3K-PAK" "Nelson" "Nernst" "Nes8Cre" "Nestin-BrdU"
    "NetNES" "Netea" "Neubauer" "Nichirei" "Nickoloff" "Nielsen" "Niemann"
    "Niemann-Pick" "Nigeria" "Nigericine" "Nikaido" "Nikulenkov" "Ninety-eight"
    "Nissl" "Niu" "Nkx" "Nkx-2" "No" "Noonan" "North-East" "Notch-Akt"
    "Notch-PTEN-Akt" "Notch1ICD" "Notch2ICD" "Notch3-ICD-binding"
    "Notch3-ICD-transfected" "Notch3ICD" "NotchICD" "Noughabi" "Novocastra"
    "Novus" "Nowroozi" "Nox" "Nr" "Nr-ferm" "Nrf" "Nrf2-ARE" "Nrf2-dependence"
    "Nrf2-null" "Nu" "NuRD" "Nuc-pYStat5" "Nuc-pYStat5-positive" "Nucleo"
    "Nur77–reportedly" "NurRE" "Nurr1-knockout" "Nurr1a" "Nurr1b" "Nurr77"
    "N = 7" "O-GlcNAcylated" "O-GlcNAcylation" "O-GlcNAcylation–dependent"
    "O-GlcNAcylation–independent" "O-linked" "O-methylated" "OATS" "OB-1"
    "OCI-ly19" "OCM-1" "OCTT2" "OD490" "ODC-1" "ODE" "OH" "OHdG" "OMIM"
    "OR=0.47" "OR=0.49" "OR=0.60" "OR=0.70" "ORR" "ORs" "OTB" "OTUmt" "Oas1g"
    "Oc" "Oct4A" "Odgerel" "Oellers" "Off-rate" "Ohse" "Oiso" "Okada" "Okumura"
    "Oliveira" "Oliveras" "Oliveras-Ferraros" "Oncology" "Oncomine" "One-third"
    "One-way" "Ooi" "Orbitrap" "Os" "Oshima" "Ottawa" "Ottini"
    "Over-activation" "Overhauser" "Overholtzer" "Ovis" "P+1" "P1" "P1-P3"
    "P17L" "P256fs" "P442HfsX9" "P6" "P9" "P=3E-16" "PAHS012" "PANC410"
    "PANC420" "PANTHER" "PARD3L" "PARPi" "PAS" "PASMC" "PASMCs" "PAb240"
    "PAb240-positive" "PBB" "PBTs" "PBZ" "PBZ-motif" "PC-3" "PC-3AR" "PC-3AR9"
    "PC12-conditional" "PCNA-mUb-dependent" "PCNA-mUb-independent" "PCNAK164R"
    "PCR-RFLP" "PC−3" "PDCD" "PDD" "PDGFR-IV" "PDGFRBB" "PDGFRα" "PDGFβR"
    "PDZ1-3" "PDZ2-domain" "PDZ3" "PDZ4" "PELP1-miR" "PELP1-miR200a"
    "PELP1-shRNA-mediated" "PEST" "PFS=3" "PGK" "PGNase-F" "PGVPVP"
    "PI3K-AKT-mediated" "PI3KCA" "PI3P" "PIKK" "PIXα" "PJV" "PKCβII" "PKCη"
    "PKCλ" "PKM1" "PLCδ" "PLQPVP" "PNGaseF" "POLδ" "POLη" "POLι" "POLκ"
    "POU-homeodomain" "POUNDS" "PP30" "PPAA" "PPATSDA" "PPLPKRP" "PPXXF" "PPxY"
    "PQ" "PR-619" "PR-negative" "PR-positive" "PRF5" "PRICKLE" "PRMs" "PRTF"
    "PS" "PS1xMTEP" "PS647-DBN" "PSA-promoter" "PSChimera" "PSEDP" "PTEN-DBN"
    "PTEN-activity" "PTEN-exosomes" "PTEN-null" "PTENC2" "PTENs" "PTENΔD"
    "PTPSL-like" "PTRF-Cavin" "PVTT" "PY1" "PY2" "PY20" "PY3" "PYD" "Pab"
    "Pab240" "Pab240-positive" "PacMetUT1" "Pacific" "Paik" "Paired-end" "Pak"
    "Palakurthy" "Pam3Cys4" "PanINs" "Par-4" "Pardee" "Parker" "Parkin-SY5Y"
    "Parkinson" "Parkinson's" "Pasteur" "PathScan" "Patients" "Payne" "PbA"
    "Pbx-1" "Pearson" "Pearson's" "Pearson’s" "Peifer" "Pena" "Pena-Diaz"
    "Peng" "Penicillin-Streptomycin" "PeproTech" "Peptidylprolyl" "Perez"
    "Perlis" "Perou" "Peterlongo" "Peutz" "Peutz-Jeghers" "PgR0" "PgRSDF-1"
    "Phase-contrast" "PheWAS" "Philadelphia" "Phillip" "PhophoSitePlus"
    "PhosphoATM" "Pita" "Pitstop2" "Pledger" "Plex" "Plus2" "Poitiers"
    "Polo-Box" "Poly-ADP" "Poly-ADP-ribose" "PolyI" "PolyPhen" "Polymorphisme"
    "Polη" "Polι" "Polκ-UBZ" "Portuguese" "Post-Synaptic" "Potula" "PrP-His"
    "Prasad" "Preso1" "PriGO7A" "PriGO8A" "PriGO9A" "Primer3" "Primo"
    "Principal" "Principle" "Prives" "Pro-IL-1β" "Pro-inflammatory" "ProLabel"
    "Profiler" "Prognosis-Based" "Promega" "Protein-DNA" "ProtoArray"
    "Prusiner" "PtdBuOH" "Ptdins-3,4" "Puerto" "Pulikkan" "Pull-down" "PvuII"
    "PyMol" "P = 0.001" "P = 0.0001" "P = 0.006" "P = 0.020" "P = 0.036"
    "P = 0.045" "P = 0.49" "P≤0.05" "Q-Q" "Q-test" "Q2" "QKI-5" "QQ" "QUE-NL"
    "QUE-NL-exposed" "QUE-NL-induced" "QUE-NL-treated" "QUE-NLs"
    "QUE-NLs-induced" "QZ" "QcALL" "Qiagen" "Qian" "Qu" "Quantile-quantile"
    "Quantitle-quantile" "R-2HA2Flag-Api5" "R-2HA2flag-Api5" "R-CHOP"
    "R-SMAD-co-SMAD" "R-squared" "R110-YVAD" "R11EE" "R12" "R171X" "R282W"
    "R335X" "R4A" "R5" "R748-S752" "RAB8B" "RABBGTB" "RACE-PCR"
    "RAD51-foci-negative" "RAD51-foci-positive" "RAD51share" "RARβ2"
    "RAS-G12V-transformed" "RAS-association" "RAS-induced" "RAS-mediated"
    "RASFF1B" "RASFF1C" "RASSF1A-cytoskeletal" "RASSF1A-microtubule" "RASSF1C"
    "RB-expressing" "RB-positive" "RCC4T" "REX2a" "RFLP" "RFP-Ruby-tagged"
    "RGQ" "RID1-like" "RIG-I-like" "RING-finger" "RL95-2-IR-A" "RL95-2–IR-A"
    "RMSE" "RMSEs" "RNA-DNA" "RNA22" "RNAPII" "RNAhybrid" "RNPC1a" "RNPC1b"
    "RNU24" "RNU6" "RNU6-2" "RNU6B" "ROC-AUC" "ROCK-induced" "ROCK-mediated"
    "ROCK∆3-expressing" "ROR-1" "RORβ" "ROSA26" "RPH" "RPWE" "RR-only"
    "RRRCWWGYYY" "RRXCXXGXYX" "RRXCXXGXYX-XRXCXXGXYY" "RSMADs" "RT-Profiler"
    "RT-qPCR" "RTI" "RTK" "RTK-invariant" "RTqPCR" "RV16" "RV1b" "RVL" "RWPE"
    "Rab-like" "Rac-GTP" "Rac1" "Rac1-RhoGDIα" "Rac2-null" "RacGAP" "RacGAPs"
    "Racial" "Rad3-related" "Rad51-ssDNA" "Rad51C-like" "Radhakrishnan"
    "Radiation-and" "Radio-TLC" "Radio-high-performance" "Ran-GTP" "Rangatia"
    "Rap-specific" "Ras-Association" "Ras-association" "RasGRP-CAT" "RasPRG1"
    "Ras•GDP" "Ras•GTP" "Rb-MI" "Re-ChIP" "Re-expression" "Re-internalized"
    "Re-introduction" "Re-probing" "Reaccumulates" "Reactome" "Red-labeled"
    "Regensburg" "Regulatory-Sma" "Reis" "Reis-Filho" "Remarks" "Results"
    "Ret-CoR" "Rett" "Reul" "Rev-erbβ" "Rf" "Rho-GDP" "Rho-Rock"
    "Rho-Rock-driven" "Rho-family" "Rho-kinase" "Rho-like" "RhoA-signaling"
    "RhoGDI-FLAG-tagged" "RhoGDI1" "RhoGDI2L" "RhoGDIs" "RhoGDIɑ" "Rican"
    "Rico" "Rictor" "Rictor-depleted" "Rictor-mediated" "Rictor-specific"
    "Rictor–independent" "Riemann" "Rij" "Rini" "Riplet-3A" "Riplet-C21A"
    "Risk-dependent" "Ro-32-0432" "Robinia" "Robinson" "Roche"
    "Roche-Genentech" "Rockova" "Rockville" "Romano" "Rong" "Roose" "Rotterdam"
    "Royds" "Rs10497968" "Rs1978873" "Rs845552" "Rubicon" "Rubin" "Ruzzo" "RxS"
    "R→H" "S-Methionine-labeled" "S-XL" "S-labeled" "S-methionine"
    "S-nitroso-glutathione" "S-nitrosocysteine" "S-radiolabeled" "S1" "S12"
    "S138A" "S146A" "S146A-Cdh1" "S14A" "S14B" "S15B" "S19A" "S19B" "S19C"
    "S19D" "S19E" "S1C" "S1E" "S1F" "S1c" "S1d" "S1–S5" "S208-A209" "S235"
    "S2A" "S2B" "S2B–C" "S2C" "S2D" "S2J" "S2K" "S2L" "S3" "S3C" "S3E" "S473"
    "S4A" "S4B" "S4C" "S5A" "S5D" "S5F" "S6" "S647-DBN" "S6RP" "S7" "S7A" "S7B"
    "S7C" "S7F" "S8" "S807" "S8A" "S8D" "S8E" "S8F" "S9" "SA-β-galactosidade"
    "SAHA" "SAKK" "SAKK19" "SAM208-210LEA" "SANT" "SARAH" "SARMS" "SATURN"
    "SCC-R" "SCC-S" "SCEs" "SCF-FBXL" "SCID-Beige" "SCOPUS" "SDF" "SDF-α"
    "SDS-page" "SDS-polyacrylamide" "SDS–polyacrylamide" "SD≥6" "SD≥6months"
    "SELEX" "SERT-LPR" "SERTLPR" "SES-CD" "SFB-LMW-E" "SFD2" "SFFVp"
    "SH2-phospho-tyrosine" "SHIV" "SHJ" "SIFT" "SILAC" "SIRE" "SIRT1-7"
    "SIRT1-FL" "SIRT1-NT" "SIRT1-defective" "SIRT1expression" "SISH"
    "SIVmac239" "SK-EV-C1" "SK-EV-C3" "SK-EV-C4" "SK-β1-C1" "SKL"
    "SKP1-CUL1-F-box" "SM-actin" "SMAD-1" "SMAD-responsive" "SMHS" "SNO-parkin"
    "SNOC" "SNP-Nexus" "SNP-heritability" "SNPexp" "SOCS1-7" "SOD1transgenic"
    "SOMAmer" "SOMAmers" "SOS-CAT" "SOTOS" "SPE" "SPE-7" "SPSS" "SREBP-1or-2"
    "SRF-dependent" "SRF-mediated" "SRF-null" "SRGP-1" "SRS" "SSSTPPSV" "SSZ"
    "STAT#1" "STAT3-C" "STAT3-independent" "STAT3C" "STAT3F" "STE20-like"
    "STEMI" "STEP-like" "STGC" "STGCs" "SUM-44" "SVDetect" "SWI353" "SXLXXML"
    "SXXLXX" "SY" "SYBR" "SYBR-green" "SYFP" "SYPRO" "SYPRO-Ruby" "SZ"
    "Salomon" "Samstag" "Sanger" "Sarcoma" "Sardinia" "Sardinian" "Schar"
    "Schizosaccharomyces" "Schwann" "Scotland" "Segat" "Segat's" "Seidel"
    "Self-renewal" "Self-reported" "Semi-quantitative" "Sendai" "Seog" "Ser12"
    "Ser12-specific" "Ser15" "Ser19" "Ser235" "Ser2448" "Ser807" "Sertoli"
    "Sertoli-cell" "Seventy-seven" "Seventy-two" "Shaefer" "Shalizi" "Shanxi"
    "Sherbrooke" "Shien" "Sholl" "Sholl-plug" "Short-term" "SiHa-OCT4" "Sica"
    "Sidak" "Siegel" "Sigma-Aldrich" "Significance" "Significances" "Silybum"
    "SinceGrm5" "Sindbis" "Sip1" "Sixty-six" "Sixty-three" "Sjögren"
    "Sjögren’s" "Skp1-Cullin1-F-box" "Slater" "Slit-Robo" "Sloan" "SmGM"
    "Smad1" "Snail" "Soft-tissue" "Solfolubus" "Sordella" "Sourbier" "Soussi"
    "Spanish" "Spearman" "Spearman’s" "Spiekermann" "SpiroMeta"
    "Sponge-induced" "Sponge-mediated" "Sponge-reduced" "Springer"
    "Springer-Bio" "Spritz" "Sprouty4" "Spry4-null" "Spry4f" "Spuler" "Squibb"
    "Src-family" "Ssk2p" "Sskp2" "Stadler" "Stanley" "Stellp" "Sternberg"
    "Stockholm" "Strep-Tactin" "Streptavidine" "Stress-induced"
    "Stub1-IRES-dsRed2" "Sturm" "Sub-group" "Suda" "SupF" "Super-resolution"
    "Superarray" "Supernatants" "Suplem" "Supp" "Supple­mental" "Sweden-PGC"
    "Swedish" "Swiss" "Switzerland" "T-77C" "T-LAK" "T-Lymphoid"
    "T-Lymphotropic" "T-P-X-R" "T-S" "T-STAT3" "T-allele" "T-binding" "T-cell"
    "T-lymphoid" "T-rich" "T-vector" "T1" "T1-T3" "T174A" "T180" "T180A" "T1D"
    "T1G2.2" "T1G3.1" "T1G4.2" "T2DM" "T3" "T306D" "T308" "T36" "T37" "T5"
    "T599dup" "T6" "T790M" "T85" "T88" "TA-r" "TACE-dependently" "TAEC"
    "TAMRAD" "TAP-A20-containing" "TAP-A20-overexpressing" "TAPBPL" "TAPI"
    "TAPI-1" "TATA" "TATA-less" "TAZ-mediated" "TBS" "TBS-soluble" "TBSA≥20%"
    "TC-10" "TCF-4-driven" "TCF-4-mediated" "TDCs" "TDG1" "TDLUs" "TEA" "TEFb"
    "TEFb-dependent" "TEMEPAI" "TEV-GFP-10" "TF-N" "TFN-α" "TGAGTA" "TGAGTCA"
    "TGCGTCA" "TGCcaCA" "TGF-β-induced" "TGFβ1-blockade" "TGTCAGG" "TH-A"
    "TH-B" "TH-C" "THAB" "THAB-S2" "THAP" "THAP-S2" "THAP1-S1" "THAP1-S2"
    "THAP1-induced" "THAP1-regulated" "TI" "TITAN" "TKI-resistance"
    "TKI-treated" "TKKK" "TM+MM" "TM+TT" "TMPRSS4-negative" "TMPRSS4-positive"
    "TMRM" "TNBCs" "TNF-superfamily" "TNFR-2" "TOPFlash" "TRA-1-60" "TRAF31P2"
    "TRAF3IP2-_rs33980500" "TRAF3IP2_rs33980500" "TRCP" "TRCP2" "TROSY"
    "TROSY-HSQC" "TRPC6-p53-RE" "TRPC6-p53RE" "TRUS" "TRα" "TSEs" "TSST"
    "TT29201" "TTCN" "TTF-1-negative" "TTF=6.1" "TTF=7.4" "TTGTTTAC" "TTN5AA"
    "TTSP" "TTSPs" "TUJ1" "TURP" "TY" "TYK" "TZ" "Table2" "Tactin" "Taelman"
    "Tailless" "Taiwan" "Taiwanese" "Takahashi" "Takahashi’s" "Takata"
    "Take-home" "Tanay" "TaqMan" "Target-Scan" "TargetScan" "TargetScanS" "Tat"
    "Tat-TAR" "Tat-induced" "Tat-inhibitory" "Tat-mediated" "Taz" "Tead"
    "Teads" "Teff" "Teffector-like" "Tert-butanol" "Tet-o-MYC"
    "TetP-α-synuclein" "Teyssier" "Tfn" "Tg" "Tg6799" "Th-2" "Th17" "Th2"
    "Thakran" "Thakur" "TheErbB2" "TheraScreen" "Therascreen" "Thermo"
    "Thirty-eight" "Thirty-five" "Thirty-four" "Thirty-nine" "Thodeti" "Thomas"
    "Thr18" "Thr218" "Thr308" "Thr37" "Three-dimensional" "Thymoquinon" "Tiel"
    "Tiffen" "Time-course" "Time-lapse" "Tischkowitz" "Tokyo" "Toll-like"
    "Tomita" "Topoisomerase-IIA" "Topo–DNA" "TrF" "TrF-pathway" "TrFs" "TrF’s"
    "Trans-Activator" "Trans-membrane" "Translocated" "Transwell"
    "Transwell-invasion" "Tris-EDTA" "Tris-HCl" "Tris–HCl" "Trizma"
    "TrkA-immunoreactive" "Trp53" "Tsai" "Tsuneoka" "Tsuyada" "Tuj-1"
    "Tuj-1-postive" "Tukey" "Tukey’s" "Turkish" "Turnera" "Tweedie" "Tween"
    "Tween-20" "Twenty-five" "Twenty-four" "Twenty-nine" "Twenty-one"
    "Twenty-three" "Twenty-two" "Two-variant" "Tyr-572" "Tyr-742" "Tyr1007"
    "Tyr220" "Tyr551Stop" "T→A" "T→G" "U-IgVH" "U-rich" "U1" "U133" "U133A"
    "U1control" "U1wt" "U21459" "U23674" "U251" "U251-vIII" "U251vIII"
    "U251vIIIwt" "U2932" "U3" "U373" "U73122" "UA" "UACR" "UBMs" "UBZ" "UBZs"
    "UGI" "UGT2B15*2" "UK-Pan-1" "UM-UC-9" "USA" "USB" "USF2+HBS" "USF2∆basic"
    "USF81" "UTRMUT" "UTRs" "UV-irradiation" "UV-radiation" "UVB" "UVC"
    "Ub-K63-specific" "UbcH2" "UniProtKB" "Utah" "V-FITC" "V-Ki-ras2" "V3b"
    "V5" "V5-tagged" "V544ins" "V6" "VATS" "VB" "VBM" "VDG" "VDQ" "VDQ-002"
    "VE-cad-Cre" "VE1" "VEGRR" "VENUS" "VMC" "VPS34-dependent" "VSV-G"
    "VSV-G-ts45" "VU0155056" "VU0359595" "VXXXWLXXY" "VYSXWLXXY" "Value"
    "Vancouver" "Vastus" "Vectibix" "Vector" "Vegf-A" "VeraTag" "Verhaak"
    "Verma" "Vicente" "Vietnamese" "Villeurbanne" "Vincent-Salomon" "Vitamine"
    "Vpr-treated" "Vysis" "W515K" "W659A" "WBC" "WJC" "WJTOG3405" "WM" "WST"
    "WST-1" "WST-8" "WT-Cdh1" "WT-Cdh1-expressing" "WT-Vpr"
    "WT1-shRNA3repressed" "WT1enhanced" "WZ" "Waals" "Wach" "Wagner" "Wald"
    "Waldenstrom" "Waldenstrom’s" "Wallander" "Wallis" "Warburg" "Warth"
    "Webster" "Weigel" "Weinberg" "Weisberg" "Weiss" "Weri-Rb1" "Werner"
    "Western-blot" "White" "Whitney" "Whole-cell" "Wiernik" "Wiese" "Wilcoxon"
    "Wingender" "Wright-Giemsa" "Wsh" "Wt-p53" "Wu" "Wuerzburg" "Wv" "X-11787"
    "X-DL" "X-inactivation" "X-irradiation" "X-ray" "X100" "X4" "X9A" "XAip1"
    "XBY" "XL-ICN" "XLF-defective" "XRCC" "XRXCXXGXYY" "XTT" "XW" "XY" "Xavier"
    "Xenogen" "Xenogene" "Xia" "Xrcc3-like" "Xu" "Y-family" "Y201X" "Y229E"
    "Y229F" "Y233E" "Y233F" "Y2H" "Y352" "Y352E" "Y352F" "Y647F" "Y648F"
    "Y656A" "YAP-IHC" "YCK" "YFP-DBN" "YI" "YPet" "YRI" "YS" "YSPTSPS"
    "YSXXLXXL" "YVAD" "YVMA" "YVO4" "YXXM" "YXXXLXXY" "Yaffe" "Yamanaka"
    "Yamaoka" "Yang" "Yao" "Yap" "Yap-Amot-p130" "Yap-Tead-mediated"
    "Yap-Tead–dependent" "Yap-Tead–mediated" "Yasuda" "Ye" "Yes"
    "Yes-associated" "Yilmaz" "Yorkie" "Yoruba" "Yusada" "Z-guggulsterone"
    "ZAL4" "ZBKR1" "ZFN" "ZFNs" "ZIP6-M" "ZIP6-Y" "ZIP6-mediated" "ZIPB" "ZO"
    "ZO-1-PDZ2" "ZO-1-S168A-Flag" "ZO-1-S168D-Flag" "ZO-1-WT-Flag" "ZR-75"
    "ZR-PELP1" "ZR-PELP1-141-mimetic" "ZR-PELP1-200a-mimetic"
    "ZR-PELP1-GFP-Luc" "ZR75" "ZR75-PELP1-shRNA" "ZR75PELP1-shRNA" "ZRS" "ZVAD"
    "ZZ" "Zeb1-positive" "Zeng" "Zetterberg" "Zetterberg’s" "Zetterburg"
    "Zhang" "Zhao" "Zhou" "Zhu" "Zinc-finger-leucine" "Zn" "Zn-finger" "ZnF"
    "ZnFs" "ZnPP" "Zou" "Zrt" "Zuckerman" "Zunyi" "Zöller" "aCGH" "aK" "aPI3K"
    "aPKCs" "aUPID" "aUV" "above-noted" "ac-KIGS" "ac-Lys" "accound"
    "accumbens" "acetyl-lysine" "acetylaiton" "acetylated-KXGS"
    "acetylated-lysine" "acetylation-deacetylation" "acetylation-mimetic"
    "achaete" "achaete-schute" "acid-locked" "acinar-predominant"
    "acquired-resistance" "acral" "actin-cytoskeleton" "actin-like"
    "actinomyosin" "activation-loop" "activators" "actively-transcribed"
    "adSIRT1" "adduct" "adducts" "adeno" "adenocarcinoms" "adenoid"
    "adenomatoid" "adherent-invasive" "adhesiveness" "adipose-related"
    "advanced-stage" "advancements" "adverse-effect" "aeruginosa"
    "affinity-purify" "aflatoxin-B1" "aganosists" "agar" "age≤69" "agonism"
    "agreed-upon" "air-liquid" "air–medium" "algorithm" "algorithms" "all-atom"
    "all-time" "allele-A" "allele-C" "allele-G" "allele-T" "alleles"
    "allodynia" "allograft" "alpha-helical" "alveoli" "amines" "amino-acid"
    "amino-terminal" "aminoacids" "aminoactinomycin" "aminoethanethiol"
    "amoeboid" "amplicon" "amplicons" "amplification-driven" "amurensin"
    "amygdala" "amyloid-like" "amyloids" "anaerobe" "anchorage-independence"
    "and-761" "andA2λ" "andBrca1" "andErbB2" "andGrm5" "andPyMT" "andTP53"
    "andp21" "andp27" "aneuploid" "aneuploidy" "aneurysm" "aneurysms"
    "angiogenic-related" "angiomotin-like" "anilino"
    "anilino-monoindolylmaleimide" "anisotropy" "anoikis-resistance" "anorexia"
    "antagomir" "antagomirs" "ante-phase" "antibodies" "antineutrophil"
    "antiparallel" "antitumour" "anucleate" "aorta-derived" "ap" "ap-proach"
    "apical-basal" "apoE-null" "apoptosis-functional" "apoptosis-relevant"
    "apoptotic-proliferation" "aptamers" "apture" "arallel" "arcade-like"
    "arginin" "arginine-rich" "arginine-to-leucine" "aries" "arisen"
    "arrest-defective" "arterioles" "as-yet-unidentified" "asshown" "astroglia"
    "at-risk" "atand" "atches" "atomic-level" "atypy" "authors"
    "auto-activation" "auto-antibodies" "auto-inhibited" "auto-inhibitory"
    "auto-regulatory" "autophagy-lysosome" "autoradiography" "autoregulates"
    "avg" "awhich" "a–d" "b-actin" "b-d" "b0+Σ" "bHLH+PAS" "back-to-back"
    "back-up" "background-to-target" "bafilomycin" "bare-decorated"
    "barrier-permeable" "basal-like" "base-long" "base-pair" "baseline-like"
    "basic-leucine" "bead-microarrays" "beclomethasone" "begun" "benzo"
    "benzyl" "better-known" "between-765G" "between-766" "between-study"
    "bevacizumab-erlotinib" "bi" "bi-orientation" "bi-partite" "bi-phasic"
    "bi-weekly" "bifida" "bilayer" "bilayers" "bilirubinate" "biliverdin"
    "bio-energetic" "bio-photonic" "biologically-independent" "biologicals"
    "biomacromolecules" "bioresource" "bisphosphate" "bisphosphoglycerate"
    "bivariate" "blasticidine" "blockers" "blood-based" "blood-brain"
    "blood-brain-barrier" "blood-derived" "blood–brain" "blue-shifted"
    "body-associated" "bolus" "bone-like" "bone-marrow-derived" "bone-tropic"
    "bothEts2" "bothPyMT" "bothp21" "boundary-severing" "box-and-whisker" "bp"
    "brainstem" "branchings" "break-apart" "break-induced" "breakpoint"
    "breakpoints" "breast-like" "broad-acting" "broad-ranging" "broader"
    "bromoanilino" "bronchoconstrictors" "bulge-loop" "bundle-like" "butanol"
    "by-product" "by-products" "by16" "byTP53" "byp27" "b–d" "b–j" "c-MycER"
    "c-NHEJ" "c-SRC" "c-Src-dependent" "c-Src-induced" "c-Src-mediated" "c-e"
    "c-mediated" "c-src-phalloidin" "cFN" "cJUN" "caAkt" "caC" "caSTAT3"
    "cadheirn" "cadmium-induced" "café" "calcium-bilirubinate" "calorimetry"
    "cancer-like" "cancer-predisposition" "caner" "capillaries"
    "capillary-like" "carbazole" "carbon-oxygen" "carbon-sulfur" "carbonyl"
    "carboplatin-gemcitabine" "carboplatin-paclitaxel" "carboplatin-pemetrexed"
    "carboplatin-vinorelbine" "carboxyl" "carboxyl-terminal"
    "carboxyl-terminus" "carboxylcytosine" "carcinogen-DNA" "carcinogens"
    "cardia" "cardiotoxictiy" "cardiotrophin-like" "caregivers" "carnitine"
    "carotid" "carry-over" "cartilage-like" "case-by-case" "casepase9"
    "caspase-1-dependent" "caspase-like" "castration-induced"
    "castration-mediated" "castration-sensitive" "castration-sensitivity"
    "catalytic-domain" "catechol-O-methyl" "catenin-membrane-positive" "catnin"
    "caudate" "cause-and-effect" "caveolae-like" "cavin-3-GFP-expressing"
    "cavin-GFP" "cavin-MiniSOG" "ccRCC" "ccRCCs" "cel-miR-67" "celiac"
    "cell-autonomous" "cell-cycle-related" "cell-extracellular-matrix"
    "cell-in-cell" "cell-intrinsic" "cell-like" "cell-malignant"
    "cell-permeable" "cell-polarity" "cell-to-cell" "cell-to-medium"
    "cell-type-specific" "cells" "cellular-movement" "centromere" "cerebellum"
    "cermide" "cetuximab-naïve" "cetuximab-treatment" "cfDNA" "cg08008233"
    "cg12215675" "chain-mimetics" "chaperone--a" "charcoal-stripped"
    "checkpoint-compromised" "checkpoint-insensitive" "chelate"
    "chemically-engineered" "chemically-induced" "chemically-synthesized"
    "chemo" "chemo-protective" "chemo-radiation" "chemo-resistance"
    "chemo-responsiveness" "chemo-sensitivity" "chemo-sensitizers"
    "chemo-therapeutics" "chemo-therapies" "chemoattractant" "chemopreventer"
    "chemoresistance" "chemoresistant" "chemotherapeutically-induced"
    "chemotherapy-naïve" "chi-square" "chi-squared" "childhood-onset"
    "chlorouracil" "cholesterol-induced" "cholesterolemia" "choline" "chordate"
    "choroid" "chosen" "chr10" "chr3∶196,792,172" "chrX" "chromatid"
    "chromatids" "chromatin-RNA" "chromatin-remodeling" "chromophobe"
    "chromosome-specific" "circletail" "circuitry" "cis-elements"
    "cis-regulatory" "cisplatin-docetaxel" "cisplatin-gemcitabine"
    "cisplatin-pemetrexed" "cisplatin-vinorelbine"
    "cisplatin-vinorelbine-gemcitabine" "cistrome" "cistron" "clarifications"
    "class-1" "class-I" "classifier" "clearer" "clinic-pathological"
    "clinically-approved" "clinically-relevant" "clinicaltrials" "clinicians"
    "clinico" "clinico-pathological" "clone-11" "close-by" "cluster-like"
    "coactivaton" "coactivator-3" "coarse-grained" "cobblestone-like"
    "cocaine-Tat" "codon" "codon-12" "codons" "cof" "cofilactin" "coli"
    "collagen-1A2" "collectives" "collision-induced" "colony-forming"
    "combination-induced" "combinations" "combined-cocaine"
    "commercially-available" "commonest" "commonly-occurring" "compacta"
    "complex-the" "components" "concentration-dependence" "conditionalEts2"
    "conditionalParkin" "conductance" "conductances" "conformer" "conformers"
    "confounder" "consecutively-collected" "consensus-binding" "conshRNA"
    "contact-inhibited" "containingPyMT" "context-specificity" "continuum"
    "controlPyMT" "control±S" "contrst" "cooperativity-dependently"
    "cooperativity-independent" "cooperativity-reducing" "copy-number"
    "corneum" "cortico" "cortico-striatal" "corticosteroid" "cost-effective"
    "cost-effectiveness" "costimulation-induced" "counter-intuitive"
    "counter-productive" "covariables" "covariate" "covariates" "coworkers"
    "cpms" "craniorachischis" "crescent-shaped" "cribriform" "cromatography"
    "cross-activate" "cross-activation" "cross-binding" "cross-breeding"
    "cross-complementing" "cross-complementing-1" "cross-contamination"
    "cross-inhibited" "cross-inhibition" "cross-linker" "cross-reactivity"
    "cross-section" "cross-sectional" "cross-study" "cross-validate"
    "cross-validation" "cross-β" "crossover" "crossways" "cryobiopsies"
    "crypt-villus" "crypts-villus" "cullin-RING" "current-smokers"
    "current-to-voltage" "curvature-inducing" "cut-off" "cutpoint" "cy"
    "cy-totoxicity" "cyan" "cyanol" "cycleave" "cyclin-A-mediated"
    "cyclin-B-mediated" "cyclin-D3" "cyclin-E-dependent"
    "cyclin-depended-kinase" "cyclinAsubstrate" "cyclobutane–pyrimidine"
    "cycteine" "cypridina" "cys-LT-activated" "cys-LT-dependent"
    "cys-LT-induced" "cys-LT-mediated" "cys-LT-responsive" "cys-LTs" "cyto"
    "cyto-construction" "cyto-protective" "cytochome" "cytochromes"
    "cytokine-treatment" "cytology" "cytometer" "cytomorphology" "cytoplasma"
    "cytosole" "cytospin" "cytotoxicty" "c–e" "dG" "dHL-60" "dHPLC" "dPLB"
    "dPLB-985" "dRASSF" "damage-induced" "damage-inducible" "damage-inducing"
    "damage-regulated" "damage-related" "damage-responsive" "damiana"
    "database-TargetScan" "database-identified" "databases" "datas" "dataset"
    "datasets" "day-to-day" "dbSNP" "de-activated" "de-aggregated"
    "de-aggregation" "de-condensation" "de-differentiated" "de-novo"
    "de-regulate" "de-regulated" "de-regulation" "de-represses" "de-repression"
    "de-repressive" "de2-7" "deacetylase-defective" "decamers" "deconvolve"
    "deep-sequence" "deeper" "degron" "degrons" "dehydrogenase-5" "del11"
    "del11q" "del126-133" "del17" "del17p" "del19" "delL747-E749"
    "deleted-loop" "delins" "dendrite" "dendritic-like" "deoxycitidine"
    "deoxynucleotidyl" "deoxyuridine" "dependent-RNA" "dependent-manner"
    "depolarization-induced" "der" "desmocollin-1" "desmocollins" "desmogleins"
    "destabilizers" "detergent-insoluble" "di-arginine" "di-substituted"
    "diabetes-associated" "diabetes-increased" "diabetes-induced"
    "diabetes–increased" "diabetes–induced" "diacylglcyerol" "diaminobenzidine"
    "dichroism" "dideoxy" "dieback" "diet-fed" "diet–genotype"
    "differentiated-like" "diffusa" "diglucuronide" "dihydrochloride"
    "dihydroxy" "dimer-level" "dimerizers" "dimorphism" "dimorphisms"
    "dinucleotides" "dione" "dipeptidyl" "diphosphate" "diphosphates" "diploid"
    "diplotype" "dipropionate" "directlyfrom" "discoideum" "discriminant"
    "disease-relevant" "dithiobis" "divider" "dnSTAT3" "doi"
    "dominant-negative" "donor-to-donor" "donorsTo" "dormancy"
    "dosage-sensitive" "dose-and" "dose-based" "dose-dependency"
    "dose-dependently" "dose-response" "dose–response" "dot-like"
    "double-block" "double-membrane" "double-minute" "double-negative"
    "double-proline" "double-strand" "down-expressed" "down-modulated"
    "down-modulating" "down-modulation" "down-stream" "down-weights"
    "downstrem" "doxycyline" "drawn" "driven-tumors" "droplet" "ds" "dsDNA"
    "du" "dual-function" "dual-label" "dual-phosphorylation" "dual-reporter"
    "dual-specific" "dual-tilt" "duct-lobular" "duplexes" "duration=7.4"
    "dwarfism" "dying-back" "dyscrasia" "dyscrasias" "dyskinesia"
    "dyslipidemia" "dysphagia" "dysplasia" "d–f" "eEF2-56T" "eHELQ" "eLife"
    "eQTL" "eXRCC2" "early-late" "early-onset" "early-phase" "early-region"
    "ebpα" "echinoderm" "ectodomain" "ectodomains" "ectopically-expressed"
    "edema" "effecter" "effector-like" "egg-shell" "egion" "el"
    "electron-dense" "element-1" "element-variable" "element–driven" "eluate"
    "embryopathy" "en-bloc" "encephalomyelitis" "end-product" "end-resection"
    "end-stage" "endfeet" "endocrinology" "endoderm" "endometrioid"
    "endometrium" "endometrium-like" "endoplasmic-reticulum-located"
    "endothelia" "endothelial-independent" "endothelial-like"
    "endothelial-marker" "endothelial-specific" "endpoint" "endpoints"
    "energy-modulated" "enhancer" "enhancer-binding" "eno" "enriched-phenotype"
    "environmental-genetic" "enzyme-DNA" "enzyme-E2" "enzyme-substrate"
    "enzyme–DNA" "eosin" "eosinophil" "eosinophils" "epeat" "epidermoid"
    "epigenome" "epileptiform" "epiphyses" "epithelia" "epithelial-cell"
    "epithelial-derived" "epithelial-like" "epithelial-mesenchymal"
    "epithelial-sensitive" "epithelial-specific" "epithelial-stromal"
    "epithelial-to-mesenchymal" "epithelial-type" "epithelial–mesenchymal"
    "epithelium" "epitope-tag-specific" "epsilon-amino" "eptide"
    "erlotinib-naïve" "erlotinib-resistance" "error-containing" "ertotinib"
    "erythema" "erythematodes" "erythematosus" "erythoid" "erythroid-2-related"
    "erythroleukaemia" "esophagectomy" "et" "etablish" "ethnic-specific"
    "ethoxyphenyl" "ethynylthymidine" "ever-smoker" "ever-smokers" "ex"
    "ex-smokers" "ex-vivo" "examinedGrm5" "exanthema" "exoenzyme"
    "exogenously-expressed" "exome" "exon-level" "exon17" "exon19" "exon21"
    "exon9" "exons" "exosome" "exportin-cargo" "exposed-breast" "expressers"
    "expressors" "extension–retraction" "extra-cell" "extra-genital"
    "extra-oral" "extra-synaptic" "extract-induced" "extrapolations" "exudates"
    "e–f" "fC" "factor-1" "factor-4" "fagilis" "failure-to-thrive" "falciparum"
    "fatpad" "feed-back" "feedback-regulatory" "feedforward" "female-specific"
    "fermentans" "fetal-specific" "fibrinoid" "fibroblast-like" "fide"
    "fifty-seven" "filled-in" "filopodia-like" "fine-tune" "fine-tuned"
    "fine-tunes" "fine-tuning" "first-degree" "first-generation" "fish-oil"
    "five-stranded" "five-year" "flask-like" "flexibly-tethered" "flow-driven"
    "flow-intensity" "flow-thru" "fluoracil"
    "fluorescence-in-situ-hybridization" "fluorescence-lifetime" "fluorophore"
    "fluorophores" "fluorouracit" "flux–it" "fms-like" "focus-forming" "fodrin"
    "foliaceus" "folic" "follow-up" "followed-up" "footpad" "footpads"
    "force-stimulated" "forebrain" "forexample" "former-smokers" "formers"
    "formyl" "formyl-Met-Leu-Phe" "formyl-peptides" "formylcytosine"
    "formylindolo" "four-and-a-half" "four-color" "four-point-one"
    "frame-by-frame" "frame-shift" "frameshift" "freeze-substitution"
    "freeze-thaw" "fresh-frozen" "fromErbB2" "fromErrfi1" "fromEts2" "fromGrm5"
    "fromHomer1" "fromHomer1a" "fromPin1" "fromPyMT" "frozen" "frt" "fs"
    "full-site" "full-text" "function-2" "furocoumarins" "fusiform" "fwd"
    "g-ratios" "gC" "gDNA" "gabazine" "gain-of-function" "gallbladder" "gastro"
    "gastro-intestinal" "gastrocnemius" "gastrula" "gel-filtration" "gel-shift"
    "gene-aspirin" "gene-by-environment" "gene-disease" "gene-environment"
    "gene-gene" "gene-phenotype" "gene-therapy" "gene-wise" "geneset"
    "genetically-engineered" "genetically-susceptibility" "gene–diet"
    "gene–disease" "gene–environmental" "gene–gene" "genic" "genitalia"
    "genitals" "genome-wide" "genotype-disease" "genotype-phenotype"
    "genotype-selectable" "genotype–diet" "germinal-center" "germline" "glia"
    "glomeruli" "glomeruloid" "glomerulonephritis" "glucopyranosylidene"
    "glutamssine" "glutathione-sepharose" "glycerophosphate" "goat-anti-human"
    "goat-anti-mouse" "goes" "gonadectomies" "gonadectomy" "gone" "gp-120"
    "gradients" "gradings" "grainyhead-like" "granular-shaped" "greater"
    "greatest" "guiu" "g–i" "g–j" "hBRCA1" "hCD45" "hESC" "hESCs" "hEnSC"
    "hEnSCs" "hGH" "hGHR" "hIgG" "hMCM7" "hNSC" "hNSCs" "hSIRT1-FL" "hSIRT1-NT"
    "hScribble" "hTH-3174" "hTH-3174-luc" "hTH-NBRE-A" "hTR-Imetelstat"
    "half-a-million" "half-dozen" "half-life" "half-lives" "half-maximal"
    "half-saturated" "half-saturating" "half-saturation" "half-site"
    "half-sites" "half-stoichiometric" "hand-containing" "hand-foot" "hands-on"
    "haplotype" "haplotypes" "head-to-tail" "health-related" "healthy-state"
    "healthycontrols" "heat-inactivated" "heat-shock" "heatmap"
    "helical-domain" "helices" "helix" "helix-loop-helix" "helix–loop–helix"
    "helq-1" "hemangiopericytoma-like" "hemato" "hemato-endothelial"
    "hematocrit" "hematoxilin" "hematoxilin-eosin" "hematoxylin-eosin" "hemi"
    "hepato" "hepato-carcinogenesis" "hepatoid" "hepatotoxin" "heptamer"
    "heptapeptide" "hetero" "hetero-dimer" "hetero-dimers"
    "hetero-oligomerises" "hetero-tetramers" "heterodimerizaiton"
    "heterogeneous-mutated" "heterotetramer" "heterotetramers" "heterozygote"
    "hexamer" "hexamethylene-bis-acetamide" "hg18" "hg19" "hidden"
    "high-DNA-flexibility" "high-MW" "high-affinity"
    "high-blood-flow-dependent" "high-concentration" "high-concentrations"
    "high-confidence" "high-content" "high-density" "high-dose"
    "high-frequency" "high-glucose-induced" "high-grade" "high-invasive"
    "high-levels" "high-molecular-mass" "high-molecular-weight" "high-order"
    "high-penetrance" "high-performance" "high-pressure" "high-quality"
    "high-resolution" "high-risk" "high-stage" "high-stress" "high-tumour"
    "high-value" "higher-molecular-mass" "higher-order" "highly-prevalent"
    "highrisk" "hindlimb" "hindpaw" "histochemistry" "histologies" "histology"
    "histopathologies" "histopathology" "histoscore" "histotype" "histotypes"
    "hnRNPs" "hnRP" "holo-complex" "holo-receptor" "home-made" "homeodomain"
    "homo-oligomerization" "homo-or" "homogenates" "homolog" "homologies"
    "homologs" "homologue-1" "homology-2" "homozygote" "homozygousEts2"
    "honoraria" "hormone-independence" "hot-spot" "hotspot" "hotspots"
    "hour-time" "hr" "hsa-miR-125b-1" "hsa-miR-125b-2" "hydoxychloroquine"
    "hydroperoxyleucines" "hydroxy" "hydroxyl" "hydroxylase-positive"
    "hydroxymethylcytosine" "hyper-IgE" "hyper-cholesterolemia"
    "hyper-proliferative" "hyperdiploid" "hyperdiploidy" "hyperinsulinemia"
    "hyperinsulinism" "hyperoxia" "hyperresponsiveness" "hypersensitiviy"
    "hypo-acetylation" "hypo-phosphorylated" "hypocomplementemia"
    "hypoglycemia" "hypomagnesemia" "hypophos" "h " "h–t9" "iRBC" "iRBC’s"
    "identity-by-state" "ie" "ii" "ii-iv" "iii" "ii–iv" "ileocolitis"
    "ill-defined" "imager" "imidazole" "iminoglycinuria" "immediate-early"
    "immune-complex" "immune-compromised" "immune-mediated" "immune-reactivity"
    "immuno-electron" "immuno-fluorescence" "immuno-fluorescent"
    "immuno-histochemistry" "immuno-isolates" "immuno-isolation"
    "immuno-precipitant" "immuno-precipitate" "immuno-precipitation"
    "immunoassay" "immunoassays" "immunobead" "immunochemotherapy"
    "immunocomplexes" "immunocytochemistry" "immunoglobulin-like"
    "immunohistochemicals" "immunohistochemistry" "immunoisolates"
    "immunophenotype" "immunophenotypes" "immunoprecipitaiton"
    "immunoprecipitants" "immunoprecipitatedwith" "immunoprecipitations"
    "immunoprecipite" "immunoreactivty" "immunoreceptors" "immunosurveillance"
    "immunotherapy" "impedance" "in-activation" "in-between" "in-depth"
    "in-flow" "in-frame" "in-silico" "in-situ" "in-stent" "in-vitro" "in-vivo"
    "inErbB2" "inErrfi1" "inGrm5" "inHomer1" "inHomer1a" "inKras" "inMCF"
    "inMCF-7" "inPARP1" "inParkin" "inPyMT" "inTP53" "independently-generated"
    "indictors" "induced-apoptosis" "induced-entosis" "inevery"
    "inflammation-associated" "inflammation-induced" "inflammation-mediated"
    "inflammation-related" "infra-red" "inhibitor-5" "inhibitor-IV"
    "inhibitor-IV-treated" "inhibitor-anthracycline" "inhibitor-α" "inhibitors"
    "initio" "inp21" "insula" "insulin-like" "insulin-receptor-related"
    "integrators" "inter-cell" "inter-chromosomal" "inter-class" "inter-genic"
    "inter-group" "inter-helix" "inter-individual" "inter-kinetochore"
    "inter-observer" "inter-relationships" "inter-tumor" "interac"
    "interactome" "interdomain" "interferon-κ" "interlobe" "intermediate-like"
    "intermediate-risk" "intersister" "interstitium" "interstrand" "interwoven"
    "intra-aortic" "intra-chromosomal" "intra-individual" "intra-protein"
    "intra-renal" "intra-tumor" "intra-tumour" "intra-vascular" "intracardiac"
    "intratumour" "intron-exon" "inva" "inva-siveness" "invadepodia"
    "invadopoda" "invaginations" "invasion-inhibitory" "invasion-metastasis"
    "invasion-suppressive" "inverse-BAR" "iodoani" "iodoani-lino" "ionic"
    "ippo" "irradiation-induced" "ischaemia" "ischemia-reperfusion" "isobutyl"
    "isodisomy" "isoform-selective" "isoformA" "isomers" "isoprostanes"
    "isotopomer" "isotype" "isozyme" "isozymes" "iv" "k-MTs" "kDWW" "kappa-B"
    "karyotype" "kbp" "kcal" "kg" "kinase-defective" "kinase-interaction"
    "kinase-specificity" "kinase1" "kinases" "knock-down" "knock-down-induced"
    "knock-downs" "knock-in" "knockdwon" "knocked-down" "knockin"
    "knocking-down" "knocking-out" "ku11ees" "ku12es" "kymography" "laevis"
    "lambda" "lamellipodia-like" "lamina" "lammilopodia" "lane3" "large-cell"
    "large-cohort-based" "large-diameter" "large-flat" "large-scale"
    "large-size" "laser-capture" "late-G1" "late-acting" "late-phase"
    "late-recurring" "late-stage" "lateralis" "lattice-like" "lavage"
    "leading-edge" "leakiness" "leave-one-out" "left-shifted" "leftover"
    "lements" "lengh" "lentiviral-mediated" "lentivirues"
    "lepidic-non-mucinous" "let-7a" "let-7g" "lethal-7a" "leucine-zipper"
    "leucoderma" "leukemia-2" "leukoderma" "leukoencephalopathy"
    "life-expectancy" "lifecycle" "lifespan" "light-chain" "limiting-dilution"
    "limulus" "lincRNA-p21" "line-widths" "lineage-specific"
    "lipid-phosphatase" "lipoatrophy" "lipofectamine2000" "lipopolysaccharide"
    "lipoproteins" "littermate" "littermates" "lncRNA" "lo" "lobar" "lobule"
    "lobules" "localizations" "location-dependence" "location-specific"
    "locus-specific" "log-phase" "logrank" "long-acting" "long-axis"
    "long-lasting" "long-lived" "long-range" "long-standing" "long-tract"
    "longer-term" "looser" "loss-of" "loss-of-function" "lot-to-lot" "low-MW"
    "low-activity" "low-affinity" "low-cost" "low-density" "low-dosage"
    "low-dose" "low-frequency" "low-grade" "low-intensity" "low-level"
    "low-molecular-weight" "low-penetrance" "low-power" "low-risk" "low-scale"
    "low-serum" "low-throughput" "loxP" "lpr" "lrBM" "lumens" "luminal-like"
    "lupus-like" "lymph-node" "lymph-node-positive" "lymphadenopathy"
    "lymphoblastoid" "lymphoblasts" "lymphoma-like" "lymphotoxin" "lysis"
    "lysosome-mediated" "lystates" "lκBα" "mCherry-DBN" "mCherry-LC3"
    "mCherry-Lifeact" "mFadA" "mGlu" "mGluR5-pS" "mGluR5FR" "mGluR5TSAA"
    "mGluRs" "mIgFc" "mL " "mMDDC" "mNBRE-A1" "mNBRE-A2" "mPrE" "mRID1" "mSB"
    "mSIN3A" "mSIN3a" "mSin3A" "mTOCR2" "mTORC1-p70S6K-mediated" "mU" "mYap"
    "macrophage-like" "macrosattelite" "macules" "main-effect"
    "malarial-induced" "male-specific" "male-to-female" "malignant-dampening"
    "mammography" "mammoplasty" "mammosphere" "mammospheres" "mammospohere"
    "map-2" "marianum" "mastectomy" "master-switch" "matrix-remodeling"
    "maturity-onset" "mcg" "mdDA" "mdm2-antagonist" "mean±s" "mean ± "
    "mechano" "mechano-sensitivity" "mediated-sensitization" "medulla"
    "melanin" "melanocortin" "melanocortin-1" "melanogaster"
    "membrane-deformation" "membrane-depolarization" "membrane-non-binding"
    "memory-resting" "menhaden" "mercapoethanol" "meric" "meromyosin"
    "mesangium" "mesencephalon" "mesenchymal-epithelial" "mesenchymal-like"
    "mesenchymal-refractory" "mesenchymal-specific" "mesenchymal-to-epithelial"
    "mesenchyme" "mesenchymoangioblast-like" "mesendoderm" "mesentery"
    "mesh-like" "meshwork" "meshworks" "mesoderm" "mesoscale" "meta-analytic"
    "meta-regression" "meta-static" "metabolically-stressed" "metabolizer"
    "metabolome" "metal-binding" "metal-bound" "metal-response"
    "metalloestrogen" "metalloestrogens" "metalloproteinase-1" "metastamir"
    "metastamirs" "metastasis-related" "methanesulfonate" "methyl-guanosine"
    "methyladenine" "methylcytosine" "methylene" "methylmethanesulfonate"
    "methylome" "methylomes" "methyltransferas" "miR-100" "miR-101" "miR-103"
    "miR-105" "miR-105-specific" "miR-106" "miR-107" "miR-122" "miR-122KO"
    "miR-124" "miR-124-based" "miR-124-induced" "miR-124-mediated" "miR-124a"
    "miR-125b-1" "miR-125b-sponge-transfected" "miR-128" "miR-129" "miR-130b"
    "miR-137" "miR-138" "miR-141" "miR-143" "miR-143-based" "miR-145"
    "miR-146a" "miR-15" "miR-15a" "miR-16" "miR-17-92" "miR-192" "miR-193a"
    "miR-195" "miR-197" "miR-19a" "miR-19b" "miR-200" "miR-200-independent"
    "miR-200-promoter-Luc" "miR-200b" "miR-203" "miR-205" "miR-21" "miR-21-AR"
    "miR-21-controlled" "miR-21-forced" "miR-21-induced" "miR-21-liposomal"
    "miR-21-mediated" "miR-21-regulated" "miR-21-targeted" "miR-214" "miR-215"
    "miR-22" "miR-221" "miR-221-222" "miR-25" "miR-26a" "miR-27a" "miR-27a*-IH"
    "miR-27a-SL" "miR-27b" "miR-27b-3p" "miR-27b-5p" "miR-29" "miR-34"
    "miR-34-dependent" "miR-34-mediated" "miR-34-regulated" "miR-34b" "miR-34c"
    "miR-34c-depleted" "miR-34c-expressing" "miR-368" "miR-376" "miR-376a"
    "miR-376b" "miR-376c" "miR-376c-3p" "miR-376c-transfected" "miR-429"
    "miR-433" "miR-433-binding" "miR-449a" "miR-503" "miR-503-binding"
    "miR-503-regulated" "miR-503-suppressed" "miR-503-transfected" "miR-768-3p"
    "miR-768-5p" "miR-9" "miR-93" "miR-US4-1" "miR-negative" "miR141" "miR145"
    "miR200" "miR200a" "miR200b-200a-429" "miR200b-independent" "miR200c-141"
    "miR768-3p" "miRCURY" "miRNA-125b" "miRNA-125b-1" "miRNA-141" "miRNA-143"
    "miRNA-200a" "miRNA-200c" "miRNA-21" "miRNA-576" "miRNA-767" "miRNA-768"
    "miRNA-768-3p" "miRNA-768-5p" "miRNA-886-5p" "miRNA200b-200a-429"
    "miRNA200c" "miRNA768-3p" "miRNAs" "miRtarget2" "miScript" "micro-PET"
    "micro-aggregates" "micro-biosensor" "micro-dissection" "micro-homologies"
    "micro-lesions" "micro-molar" "microM" "microPET" "microRNA-124"
    "microRNA-204" "microRNA-21" "microRNA-503" "microbiota"
    "microcalcifications" "microcarcinomas" "microdomains" "microelectrode"
    "microenvironment-mediated" "microglobulin" "micrograph" "micrographs"
    "microhomologies" "microhomology" "micrometastases" "micromilieu"
    "micropipette" "microrarrys" "microsatellite" "microtiter"
    "microtubule-associated" "microvasculature" "microvesicles" "microvessel"
    "microvessels" "mid-G1" "mid-gestation" "mid-late" "mid-plane" "midbrain"
    "midzone" "military-related" "minP" "minP≤0.05" "minichromosome" "mir-143"
    "mir200c" "mis-localization" "mis-localize" "mis-segregate"
    "mis-segregation" "mis-sense" "misclassifications" "misincorporate"
    "mismastch" "misrepair" "missense" "mmBrca2" "mmpTRPC" "mmpTRPC63p-luc2"
    "mneo" "moDCs" "mock-transfected" "mock-treated" "moderate-strong"
    "moderate-to-severe" "modifications" "moesinezrin"
    "moesinezrin-radixin–like" "molecules" "molten" "mono-O-GlcNAcylated"
    "mono-cultured" "mono-exponential" "mono-lobed" "mono-therapy"
    "mono-treatment" "mono-treatments" "mono-ubiquitin" "monoadducts"
    "monoculture" "monocultures" "monocyte-derived" "monocyte-driven"
    "monocyte-endothelial" "monocyte-lineage" "monocyte-microglial"
    "monoindolylmaleimide" "monolayer" "monomer-oligomer" "monotherapy"
    "months" "more-than-10-fold" "morpholino" "morpholino-IPQA" "morphometry"
    "mortem" "motile" "motogen" "mouthwash" "mtp53" "mucoepidermoid" "mucosa"
    "mucosae" "mukkul" "multi-SNPs" "multi-center" "multi-colour" "multi-copy"
    "multi-drug" "multi-factorial" "multi-functional" "multi-genetic"
    "multi-institutional" "multi-meric" "multi-modality" "multi-resistance"
    "multi-stage" "multi-step" "multi-subunit" "multi-variate"
    "multi-vesicular" "multiangle" "multidomain" "multigene" "multimers"
    "multinucleotide" "multiorgan" "multiphoton" "multiple-target"
    "multiple-testing" "multiprotein" "multisite" "multistage" "multisubunit"
    "multivariate" "muscle-invasive" "muscle-specific" "muscleblind-like-1"
    "muscularis" "mut1" "mut2" "mutant-NSCLC" "mutations" "mutationsNotch2"
    "mutp53" "mycophenolate" "myocardium" "myocyte-specific" "myocytes"
    "myoepithelium" "myofiber" "myofibroblast-like" "myoid" "myonuclei"
    "myosin-II" "myotonia" "myotonic-dystrophy-like" "myristate" "n-6" "n-fold"
    "n=1" "n=118" "n=195" "n=2" "n=20" "n=3" "n=36" "n=4" "n=5" "n=6" "n=7"
    "n=9" "nPG" "nRNP" "nano" "nano-biosensor" "nanogold" "nanoliposome"
    "nanoliposomes" "nanotubules" "naphthyl" "naïve" "ncMMR" "ncomms3338"
    "ncomms3359" "near-complete" "near-endogenous" "near-field" "near-infrared"
    "near-saturating" "near-significance" "near-stoichiometric" "nearMECP2"
    "nearest" "necropsy" "necrostatin" "necrostatin-5" "necrostatins"
    "negative-curvature" "negative-feedback" "neo-RSK4" "neo-adjuvant"
    "neoadjuvant" "neocortex" "neointima" "neovasculature" "nephritis-like"
    "nephropathy" "nerves" "network-level" "neu-positive" "neurite" "neuroAIDS"
    "neuroendocrine" "neuroepithelium" "neuroglia" "neuron-like"
    "neuronal-enriched" "neuropathology" "neuropharmacology" "neurosphere"
    "neurospheres" "neurosurgery" "neurotropin" "neutrophil-like"
    "never-smokers" "never-smoking" "new-onset" "newly-generated"
    "next-generation" "nick-end" "nifedipine" "nigricans" "nitroflavone"
    "nitrosocysteine" "nitrosoguanidine" "nitrosoureas" "no-flow" "no-smoking"
    "node-negative" "node-positive" "noncardia" "noncarriers" "noncrossover"
    "nonfat" "nonmuscle" "nonrandom" "nonreceipt" "nonredundant"
    "nonsense-mediated" "nonsmall" "nontarget" "not-yet" "nt" "ntRNA"
    "ntisense" "nts" "nucleases" "nucleates" "nucleatum" "nucleotieds"
    "nucleus-positive" "nutrient-proficient" "nutrient-replete"
    "nutrient-response" "nystagmus" "n = 6" "n = 7" "n = 1" "n = 2" "n = 20"
    "n = 3" "n = 4" "n = 5" "n = 6" "oGTT" "oHSV" "occludens-1" "occludes"
    "octyl" "octyl-glucoside" "oestrogen" "oestrogens" "of4EBP1" "ofCdk6"
    "ofKras" "ofMBNL1" "ofPyMT" "off-target" "off-the-shelf" "ofp21" "ofp27"
    "of≤24" "oil-derived" "oldPyMT" "oleic" "oligo" "oligoadenylate"
    "oligodendroglial-predominant" "oligodeoxyribonucleotides" "oligomerises"
    "oligonucleosomes" "oligos" "omology" "on-column" "on-going" "on-site"
    "onGrm1" "oncologists" "oncology" "oncomir" "oncomirs" "oncongene"
    "one-copy" "one-ended" "one-fifth" "one-half" "one-third" "one-thousand"
    "one-way" "ones" "oocytes" "open-label" "orGrm5" "orHomer1" "orPyMT"
    "orchidectomy" "organelle" "organelles" "organoids" "oriLyt" "oropharynx"
    "ortholog" "orthologue" "orthologues" "osteoblasts" "otitis"
    "outcome–namely" "over-activate" "over-activated" "over-activation"
    "over-interpreted" "over-phosphorylation" "over-treatment" "overabundance"
    "overview" "oxygenase-1" "p110a" "p120-catnin" "p125luc" "p16+" "p160s"
    "p21WAF1" "p21waf1" "p27SJ" "p27kip" "p38CKO" "p38MAPK" "p38SJ"
    "p38α-dependence" "p38β" "p4EBP1" "p50α" "p53-RE" "p53-defective"
    "p53-dependent" "p53-minimal" "p53-null" "p53-promoter" "p53-reporter"
    "p53C" "p53CKO" "p53ER" "p53MH" "p53R175H" "p53R273H" "p53R280K" "p53REs"
    "p53WT" "p55α" "p62ΔTB" "p85α" "p=0.00001" "p=0.0001" "p=0.0002"
    "p=0.00022" "p=0.001" "p=0.002" "p=0.004" "p=0.0048" "p=0.006" "p=0.007"
    "p=0.009" "p=0.01" "p=0.012" "p=0.015" "p=0.017" "p=0.019" "p=0.02"
    "p=0.020" "p=0.023" "p=0.0247" "p=0.029" "p=0.03" "p=0.036" "p=0.037"
    "p=0.04" "p=0.043" "p=0.045" "p=0.05" "p=0.095" "p=0.17" "p=0.21" "p=0.26"
    "p=0.27" "p=0.40" "p=0.49" "p=0.59" "p=0.71" "p=1.0" "p=1.1×10" "p=1.4×10"
    "p=1.6×10" "p=2.1×10" "p=2.7×10" "p=3.6×10" "p=3.9×10" "p=5.9×10" "p=6.7"
    "p=6.7×10" "p=6×10" "p=7.5×10" "pA" "pAB240" "pAKT1" "pANCA" "pAP1-SEAP"
    "pAb1801" "pAb421" "pAkt1" "pBABE" "pBAD" "pCAG-myc-treated" "pCDNA-ING4"
    "pCEP4" "pCMV" "pCMV-5" "pCMV-Flag-MSH2" "pCdk5" "pEBG" "pECE" "pEF06R"
    "pEGFR" "pEZ-AMO1" "pEZ-MT01" "pEZ-MT01-derived" "pFPV25.1" "pF±0.5"
    "pGL-2" "pGL3-208" "pGL3-275" "pGL3-Basic" "pGL3-CCAR1-P1" "pGL3-basic"
    "pGL3-promoter" "pGL3M" "pGL3M-ROCK1-3" "pGSK3β" "pHDAC2" "pINDUCER-DUSP4"
    "pJAK2" "pJak1" "pJak2" "pKAP-1" "pLL3.7-GFP" "pLL3.7-WT1"
    "pLL3.7-WT1-shRNA" "pM" "pMADD" "pMIR-GRB2mt" "pMIR-TGFBR2" "pMMP3"
    "pMSCV-puro-based" "pPDGFRβ" "pRBC" "pRBCs" "pRTR" "pRTR-pri-miR-34a"
    "pS-P" "pS1126-P" "pS262" "pS32" "pS396" "pS473-AKT" "pS536" "pS647-DBN"
    "pS647-Drebrin" "pS6RP" "pSIN-Fluc" "pSTAT" "pSTAT1" "pSTAT3"
    "pSilencer2.1-U6-miR-203" "pSrc-416" "pStat-3" "pSupFG1" "pSuper"
    "pSuper-27a" "pSuper-empty" "pT" "pT180" "pT3-4" "pT72" "pTRPC"
    "pTRPC6p-luc1" "pTRPC6p-luc2" "pTstage" "pY1092" "pY1289" "pY317"
    "pack-year" "pack-years" "paired-end" "pairwise" "pan-HDACi" "pan-SIRT"
    "pan-phosphotyrosine" "pancreatitis" "para-aminosalicyclic" "paracrine"
    "paralog" "paralogues" "parenchyma" "parental-506" "paresthesia"
    "parkin-Pp53" "parkinsonism" "parotid" "parthanatos" "partite" "partum"
    "pathogen-associated" "pathogen-recognition" "pathophysiology" "pathways"
    "pathways-homologous" "patient-tumor" "pcDNA1" "pcDNA3-Par-4"
    "pcDNA3-THAP1" "pcDNA3.1" "pcDNA3.1-E2F1" "pcDNA3.1-EGFP"
    "pcDNA3.1-EGFP-NLK" "pcDNA3.1-HA-E2F1" "pcDNA3.1-c-Jun" "pcDNA3.1-miR-124"
    "pcDNA3.1-myc-HisA" "pediatric-specific" "penetrance" "penile"
    "pentanucleotide" "penton" "peptide-mimic" "per-allele" "perception-linked"
    "peri-cancer" "peri-nuclear" "peri-tumor" "permeant" "pes-ARKO–TRAMP"
    "pf11ees" "pf12" "pf21" "pf21s" "pf22s" "pfEMP-1" "phTH-3174-Luc"
    "pharmacophore" "pharmacotherapy" "phase-contrast" "phase-specific"
    "phenethyl" "phenome" "phenome-associations" "phenome-wide"
    "phenotype-genotype" "phenyl" "phenylcarbamate" "phenylethynyl"
    "phos-phorylation" "phosphatase-kinase" "phosphatidylbutanol"
    "phosphatidylbutanol-d" "phosphatidylinositol-3-phosphate" "phospho-Ets2"
    "phospho-SFK" "phosphoHER3" "phosphoHER4" "phosphoJAK" "phosphoTyr317"
    "phosphodiester" "phosphoenol" "phosphoepitope" "phosphoinositides"
    "phosphokinases" "phosphopeptide" "phosphopeptides" "phosphor-Igf1rβ"
    "phosphor-array" "phosphor-arrays" "phosphorimage" "phosphorodiamidate"
    "phosphorylation-SFKs-Syk" "phosphosites" "phosphosphorylate"
    "phosphostain" "phosphotyrosines" "phosphotyrosyl" "photo-switchable"
    "photo-switching" "photoacceptors" "photoadduct" "photonuclear-specific"
    "photoproduct" "photoproducts" "photoreceptors" "phyllodes"
    "physical-induction" "pi3k1" "picoseconds" "pifithrin-α" "pixel" "pixels"
    "place-cell" "plakophilin-1" "plakophilins" "plasma-membrane-located"
    "plasmacells" "plasmacytoid" "plasmon" "platinum-DNA" "ploidy"
    "plug-weight" "pluripotency-associated" "pmaxGFP" "point-mutated"
    "point-mutation" "pol-defective" "pola" "polarise" "pola­rization"
    "poleward" "polo-box" "poly-ubiquination" "polyADP" "polyI"
    "polychemotherapy" "polymerase-1" "polymerase-η" "polymorphims"
    "polymorphism" "polymorphisms" "polynucleotides" "polyphenol" "polypurine"
    "polypyrimidine" "pombe" "pons" "pontine" "poorer" "poorly-differentiated"
    "pore-forming" "position-765" "positive-control" "positron" "post-GWAS"
    "post-MI" "post-UV" "post-adjuvant" "post-erlotinib-treated" "post-hoc"
    "post-implantation" "post-incubation" "post-infection" "post-injection"
    "post-intracarotid" "post-irradiation" "post-ischemic" "post-menopausal"
    "post-mitosis" "post-mitotic" "post-mortem" "post-natal" "post-partum"
    "post-pristane" "post-procedure" "post-replicative" "post-small"
    "post-sort" "post-synaptic" "post-transcriptional" "post-transcriptionally"
    "post-transcriptomic" "post-transfection" "post-translational"
    "post-translationally" "post-treatment" "postmortem" "postpartum"
    "potentiatethe" "potentiators" "power=0.8" "pph" "pphPASMC" "precipitant"
    "predicted-to-be-deleterious" "predictve" "prenyl" "pressure-induced"
    "preterm" "pretest" "pri-miR-122" "pri-miR-125b-1" "pri-miR-125b-2"
    "pri-miR-34a" "primary-NSCLC" "primitive-NSCLC" "prion-like" "prionoid"
    "priori" "pro-angiogenic" "pro-apoptosis" "pro-arrest" "pro-carcinogenic"
    "pro-death" "pro-differentiation" "pro-fibrotic" "pro-growth"
    "pro-inflammation" "pro-inflammatory" "pro-inflammatory-secretory"
    "pro-invasive" "pro-ligand" "pro-ligands" "pro-metastatic" "pro-migratory"
    "pro-proliferative" "pro-senescence" "pro-survival" "pro-tumor"
    "pro-tumorigenic" "pro-tumour" "pro-tumourigenic" "proMMP" "proMMP-9"
    "proach" "proband" "probands" "probeset" "probeset-by-probeset" "probesets"
    "procaspase-3" "procollagen" "prodrome" "proenzyme" "progenies"
    "progenitors" "progeny" "progesterone-receptor-negative"
    "prognosis-associated" "prognosticators" "prolactin-acidosis"
    "proliferator-activated" "promoter-reporter" "promoterless" "promyeloid"
    "proof-of-concept" "proof-of-principal" "proof-of-principle" "proplatelet"
    "propositus" "propria" "prostaglandins" "prostatectomy" "prostectomy"
    "proteasome-mediated" "protectins" "protein-2" "protein-DNA"
    "protein-coding" "protein-like" "protein-like-4" "protein-lipid"
    "protein-membrane" "protein-only" "proteins" "protein–DNA" "proteome"
    "proteosome" "protocol-quality" "protofibrils" "proton-induced"
    "protooncogene" "protrusion–retraction" "proven" "proximity-based"
    "pseudo-aggregates" "pseudo-hypertrophy" "pseudo-kinase" "pseudoacacia"
    "pseudogene" "pseudogenes" "pseudovirus" "psiCHECK2" "pull-down"
    "pull-downs" "pulldown" "pulldowns" "pupal" "puparium" "purine-pyrimidine"
    "puromcyin" "pyelonephritis" "pyridine" "pyroglutamine" "p = 0.001"
    "p = 0.002" "p = 0.004" "p = 0.007" "p = 0.009" "p = 0.01" "p = 0.029"
    "p = 0.03" "p = 0.04" "qBiomarker" "qChIP" "qPCR" "qRT"
    "quality-controlled" "quasi" "quasi-insufficiency" "quinazolin-6-yl"
    "quinoxaline" "quintiles" "r=-0.542" "r=-0.556" "r=-0.625" "r=-0.633"
    "r=-0.769" "r=0.410" "r=0.525" "r=0.606" "r=0.707" "rIL-12" "rIL-27"
    "rIL-4" "rIL-6" "rIL-6-stimulated" "rQNestin34.5" "rRNA" "rTg4510" "rVista"
    "rVpr" "race-based" "radi" "radiation-induced" "radiation-mediated"
    "radio-HPLC" "radio-therapeutic" "radioresistance" "radioresistant"
    "radioresponse" "radiosensitizes" "radiosurgery" "radiotracer"
    "random-effect" "random-effects" "rapalog" "rapalogs" "rapidly-dividing"
    "rare-cutting" "rarer" "re-ChIP" "re-ChIPed" "re-added" "re-addition"
    "re-analyzed" "re-annealing" "re-attach" "re-biopsied" "re-biopsy"
    "re-characterization" "re-consider" "re-constituted" "re-counted"
    "re-distributed" "re-distributing" "re-distribution" "re-engineering"
    "re-enter" "re-entry" "re-establish" "re-establishment" "re-examine"
    "re-examined" "re-expressed" "re-expression" "re-fashioned" "re-feeding"
    "re-grow" "re-growth" "re-initiate" "re-internalized" "re-introduction"
    "re-localization" "re-organisation" "re-organization" "re-plated"
    "re-quantified" "re-synthesis" "re-tested" "re-treatment" "re-uptaking"
    "re-using" "reaction-restriction" "reaction–restriction" "read-out"
    "readout" "readouts" "realtime" "rebiopsy" "receptor-2" "receptor-SMAD2"
    "receptor-chain" "receptor-ligand" "receptor-like" "receptor-proximal"
    "receptors-negative" "red-colored" "red-emitting" "reenter"
    "refractoriness" "regrown" "regrowth" "regs" "regulators"
    "regulatory-associated" "reinitiate" "renarrows" "renilla" "replicons"
    "reponse" "reporter-gene" "repressors" "repressors–including" "repressp15"
    "reroute" "research-use" "resistant-cellular" "respiratory-related"
    "responders" "resting-state" "resting-states" "retrotranspose" "retrovirus"
    "reumatoid" "reuptake" "rhLOXL2" "rhabdoid" "rhamnolipids"
    "rhodamine-phalloidin" "ribooligonucleotides" "ribose" "ribose-5-phosphate"
    "ring-like" "risk-associated" "risk-stratification" "risk-stratify" "rmsd"
    "rod-like" "rotarod" "roteins" "round-like" "roziglitazone" "rs1006737"
    "rs1018119" "rs10306135" "rs1034528" "rs10463316" "rs10497968" "rs10506328"
    "rs10860757" "rs10914144" "rs11065987" "rs11077947" "rs11238349"
    "rs11249433" "rs11255458" "rs1136201" "rs1137070" "rs1155865" "rs115939516"
    "rs11602954" "rs11658698" "rs1198588" "rs12089041" "rs12146808"
    "rs12212067" "rs12450046" "rs12602885" "rs12680762" "rs12845396"
    "rs13190932" "rs13190932_A + " "rs13190932_G" "rs13190932_G " "rs13196377"
    "rs13196377_A + " "rs13196377_G" "rs13196377_G " "rs13210247"
    "rs13210247_A" "rs13210247_G" "rs13538" "rs1354034" "rs1382566" "rs1471384"
    "rs1522813" "rs152524" "rs1566819" "rs1596776" "rs16260" "rs16430"
    "rs1668873" "rs16847082" "rs16847416" "rs17036508" "rs17099156"
    "rs17408757" "rs17586365" "rs17691888" "rs1800954" "rs1801200" "rs1810132"
    "rs182123615" "rs1836721" "rs1846522" "rs1883965" "rs1887582" "rs1902023"
    "rs1960669" "rs1978873" "rs1982346" "rs20417" "rs20424" "rs2075112"
    "rs2077647" "rs2180748" "rs2233678" "rs2233679" "rs2234693" "rs2247128"
    "rs2290257" "rs2295080" "rs240943" "rs2436389" "rs250092" "rs250108"
    "rs2536" "rs25405" "rs25406" "rs2628476" "rs265155" "rs2736340"
    "rs2736340-located" "rs2745557" "rs28362491" "rs2943641"
    "rs2943641T-allele" "rs2950390" "rs2981582" "rs308379" "rs308382"
    "rs308435" "rs3087386" "rs3184504" "rs334558" "rs334558 " "rs33980500"
    "rs33980500_T" "rs33980500_T " "rs342240" "rs35220450" "rs36228499"
    "rs3729558" "rs3730668" "rs3755557" "rs3755557 " "rs3755557–rs334558"
    "rs3789587" "rs3792136" "rs3806317" "rs381299" "rs3819299" "rs3842787"
    "rs385893" "rs4006531" "rs4244285" "rs4252596" "rs4379723" "rs458017"
    "rs462779" "rs465646" "rs4680" "rs4746554" "rs4821877" "rs4895441"
    "rs4912868" "rs4912876" "rs5029748" "rs5744533" "rs5744533-rs5744724"
    "rs5744720" "rs5744724" "rs6001512" "rs6065" "rs6314" "rs6478565"
    "rs653178" "rs6534365" "rs6538998" "rs6546857" "rs6895139" "rs6941583"
    "rs6954351" "rs6993775" "rs6995402" "rs7101" "rs712829" "rs712830"
    "rs71372224" "rs7149242" "rs7216812" "rs7308665" "rs739496" "rs7543272"
    "rs7700205" "rs78190160" "rs7961894" "rs8074277" "rs8305" "rs845552"
    "rs869190" "rs879500" "rs9324889" "rs9399137" "rs9622978" "rs9660992"
    "rs9788973" "rs9900280" "rtTA" "ruboxistaurine" "rythroid"
    "s00403-013-1407-9" "s13402-013-0143-7" "sCD40L" "sPDGFr" "saline-treated"
    "same-patient" "sanitizes" "sapien" "scatterplot" "scavage" "schute"
    "score≤7" "score≥7" "scorpion-amplified" "scratch-wound"
    "second-generation" "second-passage" "second-site" "secondaries"
    "secosterol" "seed-sequence-dependent" "seeding-nucleation" "seizure-like"
    "selectinand" "self-administration" "self-aggregation" "self-assembly"
    "self-associate" "self-association" "self-cleavage" "self-cleavages"
    "self-defense" "self-digestion" "self-interaction" "self-limited"
    "self-multimerize" "self-oligomerizes" "self-peptide-MHC-I" "self-reactive"
    "self-regulated" "self-renew" "self-renewal" "self-renewal-related"
    "self-reported" "self-tolerance" "self-tolerant" "self-ubiquitination"
    "semi" "semi-quantitative" "semi-solid" "semimature"
    "senescence-associated-β-galactosidase" "sensitizer" "sensitizers"
    "sepharose-Ac-TDG-peptide" "seq" "sequelae" "sequence-based"
    "sequence-independent" "sequence-specific" "sequestome1" "serology"
    "serotype" "set-point" "set-up" "several-year" "severely-affected"
    "sex-associated" "sex-determining" "sex-differences" "sex-linked"
    "sex-specific" "sh-Amot" "shApi5" "shCdh" "shCdh1-treated" "shControl"
    "shDUSP4" "shEmpty" "shFOXO" "shGFP" "shHbo1-4" "shHbo1-5" "shHbo1-5R"
    "shNC" "shNT" "shRIP" "shRIP-1-L11" "shRIP1" "shRIP1-L11" "shRNA-XPC"
    "shRNA-empty" "shRNA1" "shRPN" "shRPN2-UTR" "shRPN2-site2" "shRSK4"
    "shRSK4-GRC-1" "shSCR" "shSTAT3" "shTRAF6" "sham-treatment" "shape-induced"
    "sheet-like" "short-range" "short-term" "shrunken" "shut-off" "shβ-TRCP"
    "si-p53-1" "si-p53-2" "siAR" "siApi5" "siCON" "siCONTROL" "siDUSP4"
    "siE2F1" "siE2F6" "siEGFR" "siFBXL17" "siGRB2" "siGRB2-1" "siGRB2-2"
    "siGRB2s" "siMBNL" "siMBNL1-Ex5" "siMMP3" "siMSH2" "siNotch1" "siNotch2"
    "siNotch3" "siPTEN" "siRNA-1" "siRNA-2" "siRNA-2-treated" "siRNA-ATR"
    "siRNA-Neg" "siSTAT3" "siTPEN" "siTiam1" "sib-pair" "sibling-control"
    "side-by-side" "side-effect" "side-population" "sidechain" "sidechains"
    "signaling-to-protrusion" "signficance" "signiﬁcant" "silencing-mediated"
    "silico" "silybin" "sim" "similark" "simpler" "simplest" "single-cell"
    "single-cell-based" "single-drug" "single-gene" "single-locus"
    "single-nucleotide" "single-regimen" "single-strand" "single-target"
    "singleEts2" "sino" "sino-nasal" "sirtuin" "site-PCR" "site-specific"
    "sites" "situ" "siveness" "siβ-TRCP" "slow-moving" "slower-migrating"
    "slowly-progressive" "smLRP1" "small-angle" "small-cell"
    "small-hairpin-RNA" "small-interfering" "small-interfering-RNA"
    "small-molecule" "smartpool" "smoker-related" "smokers" "smoothes" "socio"
    "socio-economic" "sodium-induced" "soft-agar" "soft-tissue" "solfataricus"
    "sorbitol" "spacer" "spacers" "spatio" "spatio-microenvironmental"
    "spatio-temporal" "spec-trometry" "specifc" "speciﬁc" "speck-like"
    "sphere-formation" "sphere-like" "spheroid-like" "sphingosine" "spike-like"
    "spiked-in" "spina" "spindle-like" "spindle-shape" "spirometry"
    "spliced-in" "spliceopathy" "splicings" "spn-A" "spn-B" "spn-C" "spn-D"
    "spondylopathies" "spongiform" "spot-like" "squamous-cell"
    "square-discriminant" "srGAP" "srGAPs" "ss" "stainer" "stand-alone"
    "start-sites" "starved-cells" "steady-state" "stem-cell" "stem-cell-based"
    "stem-cells" "stem-like" "stem-loop" "stemness" "step-by-step" "step-wise"
    "stepwise" "strep" "streptavidin–biotin" "stress-activated"
    "stress-induced" "stress-mediated" "stress-specific" "stressful"
    "stressors" "stress–activated" "stress–responsive" "striations"
    "stromal-epithelial" "stromal-specific" "stromal–epithelial"
    "structure-function" "structure-wise" "structureunder" "structure–function"
    "sub-G1" "sub-analysis" "sub-cellular" "sub-class" "sub-cortical"
    "sub-divided" "sub-domains" "sub-endothelial" "sub-epithelial" "sub-family"
    "sub-group" "sub-kilobase" "sub-lines" "sub-localization" "sub-population"
    "sub-region" "sub-regions" "sub-set" "sub-stoichiometric" "sub-threshold"
    "sub-toxic" "sub-types" "sub-zero" "subG1" "subclass" "subclasses"
    "subcomplex" "subcomplexes" "subdiploid" "subdomain" "suberoylanilide"
    "sublines" "subphenotypes" "subset" "subsets" "subsites" "substate"
    "substates" "substratesp70" "substudy" "subtilisin-like" "subtype"
    "succinimidylpropionate" "sulforphane" "summa" "super-repressor"
    "super-shift" "supernatant" "superprotein" "suppressor-like" "suppressp70"
    "sural" "surrogacy" "survival-concentration" "switch-like" "switching-off"
    "synapse" "synapses" "synergism" "synthesizer" "tSNPs" "tagSNP" "tagSNPs"
    "tail-vein" "tamaxifen" "tamoxifen-resistance" "tamoxifin" "tamxifenin"
    "tandem-affinity" "target-cell" "tau–microtubule" "tdTomato"
    "temporal-specific" "ten-eleven" "tenofovir"
    "terminal-deoxynucleotidyl-transferase" "tert" "tert-butanol"
    "test-threshold" "tet-off" "tet-transactivator" "tetrahydrochloride"
    "tetraploid" "tetrazolium" "thatp27" "the-765" "theFoxO3a" "theGrm1"
    "thePDGFRA" "theRAS" "theRosa26" "thep27" "therapy-based" "therapy-naïve"
    "therapy-resistance" "therapy-resistant-MCL" "therapy-treated" "thinner"
    "thio" "thio-phosphoramidate" "thioflavin" "thioglycolate" "third-highest"
    "third-most-changed" "thirty-nine" "three-component" "three-dimensional"
    "three-gene" "three-pathway" "three-quarter-sites" "three-stranded"
    "three-way" "threoine" "thrombi" "thrombocytes" "thrombocythemia"
    "through-out" "thru" "thymine–thymine" "thymocytes" "thyroidectomies"
    "time-course" "time-dependant" "time-lapse" "time-point" "time-points"
    "time-to-progression" "time-to-recurrence" "timecourse" "timeframe"
    "tissue-dependant" "titer" "titers" "titre" "titres" "tk" "toEx"
    "toEx5-MBNL1" "toTRAF6" "toll-like" "toluidine" "tomograms" "top-down"
    "top-right" "topoisomerases" "topology" "toremifene" "toses" "tosis" "toto"
    "toxicants" "trachomatis" "trait-associated" "trans-bronchial"
    "trans-dominant" "trans-genes" "trans-membrane" "trans-phosphorlyation"
    "transactivaton" "transcript-inductions" "transcription-3"
    "transcription-PCR" "transcription-competent" "transcription-quantitative"
    "transcriptome" "transcriptome-wide" "transcriptomes" "transdifferentiate"
    "transducer" "transfectedHomer1" "transfections" "transferase-mediated"
    "transformants" "transgenes" "transgenic-immunodeficient" "translocase-1"
    "traztuzumab" "treatment-naive" "treatment-naïve" "triphosphate"
    "triple-negative" "trisomies" "trisomy" "trisphosphate" "triton-insoluble"
    "trometry" "trophoblasts" "trypsin-like" "tryptamino" "tubastatin"
    "tuberculomas" "tubule" "tubules" "tubulingenes" "tubulo"
    "tubulo-interstitial" "tumor-angiogenesis" "tumor-like" "tumor-promotive"
    "tumor-suppressive" "tumor-to-background" "tumor-to-blood"
    "tumor-to-muscle" "tumor-to-vector" "tumorgrafts" "tumors" "turboRFP"
    "twenty-two" "two-ended" "two-hit" "two-hour" "two-hybrid" "two-pronged"
    "two-tailed" "two-thirds" "two-tiered" "two-to-four" "two-way" "two-year"
    "twofold-higher" "type-1" "type-2-diabetes"
    "tyrosine-phosphorylation-dependent" "tyrosine-to-phenylalanine" "tyrosyl"
    "uHL" "uHL-60" "ubiqitin" "ubiquitin-and" "ubiquitin-chain"
    "ubiquitin-proteasomal" "ubiquitination-defective" "ubiquitine"
    "ubiquitins" "ubiquitin–proteasome-mediated" "ubiquity-lation" "ug"
    "ultrastructure" "ultrathin" "uman" "un" "un-surgery" "under-ridding"
    "undergoes" "undergone" "undertaken" "uni" "univariate" "unmet"
    "unresponsiveness" "upto" "urea" "users" "usingHomer1" "uteri" "utero"
    "uveal" "v-Ki-ras2" "v-erb-b2" "v-ets" "v-ki-ras2" "vIII" "vacuoles"
    "values" "variants" "variate" "vascular-like" "veh" "vehicle-treated"
    "vena" "verage" "vessels" "vi" "villi" "villus" "vimentin-null"
    "vinclocolin" "viral-induced" "viral-infected" "virally-encoded"
    "virally-transduced" "viremia" "virotherapy" "virus-1" "vitro" "vivo"
    "vorinostat-epirubicin" "vorinsotat" "voxel" "vs.12" "vs.ErbB2" "vs.Ets2"
    "vs.PyMT" "vt" "vulgaris" "wasI" "water-soluble" "web-based" "webserver"
    "websites" "wednesday" "weight-loss" "well-annotated" "well-being"
    "well-characterised" "well-circumscribed" "well-conserved"
    "well-coordinated" "well-defined" "well-demarcated" "well-designed"
    "well-differentiated" "well-documented" "well-powered" "well-recognized"
    "well-regulated" "well-resolved" "well-separated" "well-studied"
    "well-tolerated" "wellknown" "whole-brain" "whole-cell" "whole-tumor"
    "widefield" "wildtype" "withEts2" "withPARP1" "within-family" "withk"
    "withr" "wk" "workers" "world-wide" "wortmanin" "wtMADD" "wtSTAT3" "wtp53"
    "x100" "xMAP" "xenotransplant" "xenotransplants" "y-axis" "year-old"
    "yet-to-be-identified" "yl" "z-guggulsterone" "zinc-mediated" "zipper-like"
    "zona" "zsGreen" "zymography" "×1" "×10" "×100" "×3" "×His" "×MOG" "× 10"
    "× 10 " "× 10" "× 100" "ĸB" "Δ1" "Δ175–244" "Δ1–75" "Δ23-111" "Δ3" "Δ349"
    "Δ369" "Δ393–414" "Δ4" "Δ40p53" "Δ40p53-dependent" "Δ40p53-encoding"
    "Δ40p53-infected" "Δ40p53-transduced" "Δ40p53V" "Δ40p53V-transduced"
    "Δ628–630" "Δ746-750" "Δ8" "ΔC" "ΔC-box-Cdh1" "ΔC12" "ΔCore" "ΔCt" "ΔCtBP"
    "ΔCt " "ΔD" "ΔDBD2" "ΔE9" "ΔEF1" "ΔEGFR" "ΔEx3" "ΔEx5-MBNL" "ΔEx5-MBNL1"
    "ΔF" "ΔFHA" "ΔFizzy-Cdh1" "ΔG" "ΔL" "ΔMADSMEF2" "ΔN" "ΔRING" "ΔS1" "ΔTB"
    "Δcysteine" "Δcysteine-rich" "ΔΔCt" "ΔΔCt " "ΔΨ" "ΔΨm" "α--like" "α-1"
    "α-6" "α-ARNT1" "α-Ac" "α-AhR" "α-BACH1" "α-EGFP" "α-ERα" "α-GFP" "α-Mst2"
    "α-aquaporin-1" "α-globin-like" "α-helical" "α-helices" "α-phalloidin"
    "α-receptor" "α-related" "α-subunits" "α0" "α2β1" "α3β1" "α4" "α4β1"
    "α5-integrin" "α5PPAA" "α5WT" "α6β4" "α=5×10" "αC" "αD" "αD–αE" "αE" "αG"
    "αV" "ανβ3" "β-ME" "β-TRCP" "β-TRCP-dependent" "β-TRCP-depletion-mediated"
    "β-TRCP-mediated" "β-TRCP-recognizable" "β-TRCP1" "β-TRCP2" "β-activated"
    "β-catenin-non-response" "β-catenin-response" "β-chemotactic"
    "β-elimination" "β-fodrin" "β-globin-like" "β-mercapoethanol" "β-oxidation"
    "β-peptide" "β-sheet" "β-sheet-rich" "β-sheets" "β-sodium" "β-subunit"
    "β-subunits" "β-transducing" "β1-6" "β1-6-branching" "β1-integrins" "β3"
    "β3-null" "β4–β7" "β7–β8" "β8" "βI" "βII" "βc" "βic" "β–activated" "γ-GCS"
    "γ-GCSh" "γ-globins" "γ-glutamyl-cysteine" "γ-irradiated" "γ-irradiation"
    "γ-phosphate" "γ-radiation" "γ2" "γδ-intergenic" "δ-elimination" "εC"
    "ζ-zeta" "ι-involved" "ι-mediated" "ι-related" "μg" "μg " "μl" "μmol"
    "μmoles" "π-cation" "χ2" "χ²" "ψKxE" "ψKxExxSP" "ϕ-x" "ϵRI" "‘TIRF’"
    "‘widefield’" "”m" "€overruled" "↑G1" "∆11" "∆3" "∆C-TAD" "∆GAP" "∆IH"
    "∆N-TAD" "∆PAS" "∆bHLH" "∆basic" "〈2" "ﬁber" "（p"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-10501-10800*
  '("knockdwon" "Renilla" "nucleotieds" "100mg/L" "#shRNA" "BCSCs" "reinitiate"
    "Fu" "WTp53" "mean±" "approximately 22.5±6.7%" "15.6±2.8%" "HMDECs"
    "HDMECs" "Homolog" "EdnrA" "approximately 29.2±3%" "∼24%" "reenter"
    "47.2±8.7%" "20.2±1.7%" "45.1±4.0%" "59.4±4.4%" "68.8±3.4%" "±0.4"
    "this period practically no biopsies" "a treatment-naive biopsy" "SATURN"
    "E709A+G719C" "rarer" "the EGFR gene several exonic probesets" "2–7"
    "Kirsten rat sarcoma viral oncogene homolog (KRAS)" "probeset"
    "the exonic probesets" "probeset-by-probeset" "probesets" "del19"
    "substudy" "SAKK 19/05" "SAKK"
    "V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)"
    "homolog (KRAS)" "non-responders" "V-Ki-ras2" "monoindolylmaleimide"
    "sCD40L" "adhesiveness" "×100" "the exact breakpoint"
    "immunohistochemicals" "AluSx" "47672050-47680329del8280" "non-allelic"
    "47694636-47697106del2471" "LTRs" "Clinico" "_47694485" "AAACAAT" "2p21"
    "×1" "microrarrys" "Amsterdam" "LGR" "Probands" "LGRs" "Hg19" "bolus"
    "5-fluoro-uracil" "E64c" "CPSCs" "BIO" "S/G2/M" "SDF1 caused CSPCs"
    "adenomatous polyposis coli (APC)" "coli (APC)" "SKL" "CSPCs"
    "casein kinase 1α" "stromal cell derived factor 1α" "stem/progenitors"
    "S/G2" "K120/164R" "K2R" "K120/164"
    "a p53 conditional knockout (p53CKO) hESCs" "p53CKO" "mock-treated hESCs"
    "mesodermal marker Brachyury (BRA)" "Brachyury (BRA)" "Brachyury" "Tert"
    "TRA-1-60" "primitive endoderm/mesoderm" "hESC"
    "p53 conditional knockout (p53CKO) hESCs" "hESCs" "UV photoproducts" "UVB"
    "FancD" "non-polyposis" "ncMMR" "methylmethanesulfonate"
    "UV radiation-induced adducts" "Diaz" "Pena" "UBZ" "UV adducts" "siMSH2"
    "mismastch" "UBMs" "UBZs" "C1orf24" "Polι" "dG" "benzo" "Polη"
    "photoproducts" "Polκ" "caAkt" "The exogenous wtMADD" "Billerica" "WtMADD"
    "phosphorylatable wtMADD" "wtMADD" "Non-pMADD" "non-pMADD" "to 14-3-3" "Le"
    "pMADD" "LETF" "renilla" "~40%" "TFDP" "KO" "C/ebpα" "Hnf"
    "immunoprecipitaiton" "rVista" "Aldoa" "FVBN" "Tet-o-MYC" "Tet-o-"
    "double-negative" "tet-o-" "LETFs" "~30%" "RNA22" "RNU6B" "non-AR"
    "prostectomy" "miScript" "BPH-1/C" "BPH-1/AR" "pMIR-" "PacMetUT1" "Smad2/3"
    "pAb421" "p53/Δ40p53" "Δ40p53-transduced" "9-hours" "7Gy"
    "non-infected (NI)" "subdiploid" "Δ40p53-infected" "HR231" "Δ40p53V" "NI"
    "SFFVp" "exogenous Δ40p53" "Δ40p53" "3-hours" "non-irradiated" "3-hour"
    "DO1" "dominant-negative" "LERGEpSIEP" "Arsani" "pY1289" "j" "SWEHSC"
    "phosphoHER3" "4G10" "sorbitol" "YXXM" "MTKs" "ventricular heart explants"
    "Sskp2" "Ssk2p" "Stellp" "HER2/HER3" "LC–MS/MS" "8% ± 4"
    "HER3 phosphorylation" "minichromosome" "Netea" "Xavier" "MIR106A" "Kwon’s"
    "Kwon" "human intestinal epithelia" "the intestinal epithelia"
    "healthy mucosa" "Mucosae" "Intestinal epithelia" "mucosae" "GFP-mut3"
    "pFPV25.1" "LF82" "AIEC" "MIR93-" "miR93" "-UTR-MUT" "-UTRMUT" "UTRMUT"
    "-UTR-WT" "HCT116/GFP-LC3" "autophagosome/autolysosome" "multiprotein"
    "intestinal epithelia" "MIR93" "16L1" "MIR106B" "Table 2" "4 h"
    "CD-associated" "leftover" "mono-ubiquitin" "ubiquitins" "H113A/H115A"
    "Amsh" "Tubastatin" "de-aggregated" "de-aggregation" "BUZ" "actinomyosin-"
    "actinomyosin" "~ 70%" "sicontrol" "Fe" "~10-fold" "ΔF" "FAM83D"
    "lements ( MARE )" "lements" "RABBGTB" "CLGN" "HCIP" "CIAO" "FBXL7" "CAAX"
    "prenyl" "Overview" "only 1 or 2 APSMs" "the two biological replicates"
    "Class A HCIPs" "both biological replicates" "FBXW7α"
    "technical replicates" "atches" "eptide" "verage" "APSMs" "erythoid"
    "omology" "Btz" "HCIPs" "CompPASS" "apture" "arallel" "FBXO" "FBXL" "FBXW"
    "partite" "meric" "Komander" "Joazeiro" "Deshaies" "Behrends" "FBXL17"
    "FBXLs" "~3-fold" "~2-fold" "FAM83" "protein/lipid" "re-examined"
    "Vietnamese" "Kenyan" "Africa" "Larsen" "oligonucleosomes" "MONO-MAC6"
    "minor and major allele homozygotes" "Reaccumulates" "I:C" "Pam3Cys4"
    "bioresource" "rs12212067" "Biocarta" "KEGG" "sequelae" "n = 2" "n = 1"
    "3 × 10" "10 ng/ml" "= 8" "1 × 10" "monocytes/macrophages" "Foxo3a  +"
    "4 hr" "toll-like" "= 0.88" "= 2.1 " "= 668" "NSLCs" "hydoxychloroquine"
    "Other previously described anti-tumor" "Y229F/Y233F/Y352F" "EEE/Rubicon"
    "EEE/EGFR" "FFF" "recombinant active EGFR L858R/T790M" "L858R/T790M"
    "H1975/GFP-LC3" "HCC827/GFP-LC3" "Δ746-750" "EGFR/Beclin 1" "multisite"
    "Co-immunoprecipitations" "de-differentiated" "Non-Small" "F/Y" "ER0/PgR"
    "ER++/PgR" "ER+/PgR+" "ER+/PgR" "Kagan" "Inab" "Erkanli" "Mackay"
    "oestrogens" "atypy" "guiu" "Crowden" "Wallis" "ER+/PgR0" "ER0/PgR0"
    "ER++/PgR0" "accound" "predictve" "genitals" "commonest" "ΔΔCt" "= 14"
    "10q23" "AFU/μg" "Corticosteroid" "AFU" "eno" "non-PS" "dipropionate"
    "beclomethasone" "expression/activity" "BALF" "non-passive" "AMs" "pAkt1"
    "= 0.59" "= 0.71" "VMC" "infected cardiac myocytes" "CVB3" "Coxsackievirus"
    "mean±S" "μ l" "μ g/ml" "of 4EBP1" "loss/suppression"
    "the most aggressive subtype" "Rasal2/Trp53" "logrank" "normal breast-like"
    "Parker" "MMTVneu" "K567X" "roteins" "C57BL6" "shRNA1" "p =0.006"
    "non-expressing" "p =0.04" "p =0.05" "p =0.007" "EL12-58" "EL11-26"
    "EL12-15" "TNBCs" "typically hormone receptors-negative"
    "receptors-negative" "DMFS" "triple - negative" "triple-negative"
    "heterodimeric activator protein-1" "PDGFRα/β" "theRAS" "and 1/463783"
    "approximately 1/2314" "Tom" "NAMEC" "mesenchymal NAMECs" "NAMECs" "HMLE"
    "PR −" "- negative" "ER + /PR +" "p-MEK1/2" "luminal-like" "re-tested"
    "GFP +" "non-tumorigenic" "C α" "TAEC" "diglucuronide"
    "bilirubin crystal and deciduous epithelium" "bilirubinate"
    "MUC5AC-negative" "mucoepidermoid" "HIBECs" "pEGFR" "DMEM/F12"
    "radiosensitizes" "Nelson" "Hieronymus" "ARN-509" "ARN" "radioresponse"
    "gonadectomy" "gonadectomies" "timing/onset" "Oas1g" "oligoadenylate"
    "Maoa" "non-sex-specific" "H37Ra (MTB)" "Thioglycolate" "thioglycolate"
    "2×MOG" "Cre-negative" "fl/fl" "p38CKO" "×MOG" "Huang" "sex-specific DMTs"
    "such sexual dimorphisms" "DMTs" "macrophages/myeloid cells"
    "this sexual dimorphism" "encephalomyelitis (EAE)" "encephalomyelitis"
    "the sexual dimorphism" "monocytes/" "co-stimulatory" "ug/mL" "LIVE/DEAD"
    "RPH3A–" "RPH" "FLJ36031" "proplatelet" "/pinocytosis" "lifecycle" "celiac"
    "Addison" "rs3819299" "1368=3.6E-5" "HaemAtlas" "Reactome" "PANTHER"
    "rs9399137" "spondylopathies" "The most significant SNP rs7961894"
    "rs7961894" "=−4.94" "=1E-9" "12q24.1" "12q13.13" "10q21.2"
    "An intronic SNP rs10914144" "rs10914144" "rs2180748" "1q24.3" "rs9660992"
    "DSTYK" "1q32.1" "rs342240" "7q22.3" "rs1354034" "9p24.1" "6q23.3"
    "rs11602954" "11p" "=5E-12" "11p15.5" "PLT/MPV" "rs653178" "rs3184504"
    "eosinophil" "12q24.12" "3p14.3" "thrombocytes" "PheWAS" "phenome" "EMR"
    "n =4" "=13" "=48" "Córdova" "Moroni" "Takahashi’s" "Takahashi" "lpr"
    "MOPC-141-" "sulforphane" "UACR" "Nrf2 +/+" "purpuric nephropathy"
    "acute proliferative glomerulonephritis" "fibrinoid" "mesangium"
    "the nephritogenic monoclonal antibody R4A" "R4A" "Nrf2+/+" "glomeruli"
    "lupus-like" "MRL/ lpr" "JWF" "KV" "BxPC3/Vector" "BxPC3/shSTAT3" "Pan-1"
    "FOLFIRINOX" "Burris" "10 ng/mL" "μg/mL " "five-year" "Wiese" "Frebel"
    "neuropharmacology" "Oliveira" "-tubulingenes" "tubulingenes" "Dendrite"
    "hEnSCs" "EnSCs" "wellknown" "hEnSC" "6 h" "4,5-dimethylthiazol-2-yl"
    "12 h" "XRXCXXGXYY" "RRXCXXGXYX" "andp21" "mSIN3A" "CCCG" "CGAG" "+6"
    "tamaxifen" "p53ER" "Doxo" "MO7e" "even metastatic ccRCC" "ccRCC (MAVI)"
    "vena" "signiﬁcant" "Gerota’s" "Gerota" "Barrett" "Seog" "gone"
    "51.97±1.66%" "pcDNA3.1-E2F1"
    "the normal renal proximal tubular cell line HKC" "HKC" "pTstage"
    "crossways" "Lindau" "Hipple" "chromophobe" "MAVI" "p =0.023" "±1" "=0.011"
    "p =0.001" "non-migrating" "and 1×10" "Anti-sense"
    "Conclusions/Significance" "PDGFRBB" "synergism" "motogen" "co-activation"
    "nonrandom" "S 1 C" "p44/42" "TEMEPAI"
    "always normal female external genitalia" "etablish" "methylome"
    "phenotypic normal male external genitalia" "human external genitalia"
    "X-inactivation" "shaping sexual dimorphisms" "epigenome"
    "genitalia (PAIS)" "normal female external genitalia" "CAIS" "XY" "DSD"
    "vinclocolin" "coworkers" "Sertoli" "human sexual dimorphisms" "Sjögren’s"
    "erythematodes" "Sjögren" "sexual dimorphisms"
    "the most evident sexual dimorphism" "genitalia" "phenotypic dimorphisms"
    "dimorphisms" "sexual dimorphism" "AIS" "n = 2" "= 0.56" "= 0.37" "Egger’s"
    "Begger’s" "Begger" "the χ 2 -based Q-test" "co-dominant" "MEDLINE"
    "polymorphism (SNP)" "= 0.36" "P = 0.04" "= 0.91" "P = 0.01" "95% CI = 1"
    "vs. GG" "Turkish" "Yilmaz" "Tsai" "= 0.17-0.85" "rs16260" "pyelonephritis"
    "= 0.14" "= 0.37" "= 0.57" "= 0.56" "OR = 0.47" "= 0.17" "pharmacotherapy"
    "FEV1/FVC" "Kumar" "CTNNA3" "C-region" "myosin binding protein C1"
    "rs879500" "FEV 1 /FVC" "SpiroMeta" "rs10860757" "genic" "1.0 ×10"
    "Quantitle-quantile" "spirometry" "specifically FEV 1 /FVC" "/FVC" "FEV 1"
    "FEV1" "FEF" "FVC" "P-value" "Coradini" "E-cadherin-negative"
    "the normal mammary epithelium" "BCL2-negative" "-negative" "IDBCs"
    "MDA-MB-435/M14" "TDLUs" "non-obligate" "IDBC"
    "a special breast cancer subtype" "Ferreira" "ILBCs" "SUM-44" "ILBC"
    "-eQTL" "rs2736340-located" "northern and western Europe (CEU)" "Nigeria"
    "eQTL" "SNPexp" "rs1382566" "rs6993775" "Asian-" "BeadChips" "wasI"
    "1.354–1.657" "Korean-" "intravenous immunoglobulin (IVIG)" "IVIG"
    "cervical lymphadenopathy" "erythema" "rs2736340" "endothelial-like"
    "transdifferentiate" "mesenchymoangioblast-like" "vascular-like"
    "dipeptidyl" "± 0.4-fold" "Mixl" "Mesendoderm" "± 0.3-fold" "5-day" "Oct4A"
    "chordate" "hemato" "mesendoderm" "mesenchymal stromal/stem cells"
    "capillary-like" "1.7 ± " "± 0.15" "1.8 ± 0.1-fold" "± 0.4" "± 0.3"
    "spheroid-like" "Rho-kinase" "rs2745557" "rs3842787" "Rotterdam" "NHWs"
    "non-users" "rs6478565" "rs10306135" "P17L" "minP" "LRT" "rs20417"
    "anucleate" "prostaglandins" "PTGS" "CCFR" "DALS" "1–3 µ" "p=0.05"
    "amurensin" "SIRT1 expression" "≥ 60" "= 0.021" "P  =  0. 006" "= 0.035"
    "P  = 0.017" "= 0.033" "= 0.018" "= 0.026" "P  = 0.006" "P  = 0.029"
    "= 0.032" "P  = 0.019" "fresh tissue biopsy" "de-condensation" "Spuler"
    "healthycontrols" "myonuclei" "Homma" "−ΔΔCt " "ΔΔCt " "LEUTX" "FRG2"
    "FRG1" "translocase-1" "Lemmers" "D4Z4" "macrosattelite" "KpnI" "FSHD-1"
    "lateralis" "Vastus" "FSHD" "non-affected" "n = 5" "=  3" "=  9" "ΔCt "
    "CTTNB1" "G→A" "nonreceipt" "Anderson" "=0.181" "3-year" "n=5" "=0.022"
    "P =0.037" "BTB474" "hexamethylene-bis-acetamide" "bis"
    "further combination immunotherapy" "co-injected" "（p" "HER2Bi" "ng/10"
    "HER2Bi-Ab" "Tiffen" "IVIS" "Xenogene" "3.7cmvBirA" "uveal" "HER2/neu"
    "HER2/" "Immunotherapies" "E/T" "HER2Bi-armed" "effector/target" "Bi"
    "co-transduced" "1 μg /ml" "HER2 +" "CD8 +" "Boudot" "Teyssier" "-Cd12"
    "re-ChIPed" "re-ChIP" "Fi" "Ji" "Cd-cell lines" "metalloestrogen" "Cd12"
    "Superarray" "Cd" "metalloestrogens–" "metalloestrogens" "10X" "-5-"
    "methylene" "ethoxyphenyl" "Aminoethyl" "GCS" "Semi" "hyperoxia" "GCHM"
    "otitis" "rhamnolipids" "aeruginosa (PA)"
    "the respiratory pathogen Pseudomonas aeruginosa" "aeruginosa"
    "anti-Rabbit" "BME" "∼25%" "HYD" "ECFP/FRET" "glycerophosphate" "Vitamine"
    "DEX" "YPet" "ECFP" "cyan" "co-regulate" "HMSC" "HMSCs" "−7" "∼45%" "∼15%"
    "∼35%" "non-receptor protein" "co-inhibition" "inKras" "-5-trisphosphate"
    "ofKras" "mouse intestinal epithelium" "transcription-3" "mesentery"
    "BrdUrd" "Fluc" "the closely related atypical PKCι isozyme" "isozyme"
    "Anti-Rabbit" "GG/CG" "Malay" "wild GG genotype" "CNKI" "CC/CG" "= 0.07"
    "rs2233678" "G/C" "characteristic flask-shaped invaginations" "subdomain"
    "larger multimers" "multimers" "Ultrastructure"
    "Correlative electron micrographs" "polarise" "nanogold" "immunoisolates"
    "Subcomplexes" "Sypro" "5–7" "co-localised" "×His"
    "all caveolar proteins co-purified" "Eluates" "co-fractionation"
    "co-fractionated" "co-fractionate" "w/v" "octyl" "ultrathin" "striations"
    "co-localise" "oligomerises" "nonmuscle" "tomograms" "MiniSOG" "Cavins"
    "cavin" "mechano" "cavins" "lattice-like" "–7" "Horowitz" "3AB" "non-live"
    "starting 1.5 hr" "Topoisomerases" "topology" "OH" "phosphodiester"
    "tyrosyl" "topoisomerases" "LPMf" "Mollicutes" "fermentans" "to 2×10"
    "patients heterozygous forBRCA2 D2723H" "≤60kDa" "ArrayScan" "EUFA" "pixel"
    "hs" "BRCA2 and" "Ran-GTP" "-x-ϕ" "1-3" "NetNES" "picoseconds"
    "fluorophore" "Forster" "fluorophores" "SYFP" "-double-strand" "dsDNA"
    "nucleates" "ds" "+ 2" "2 D" "A-deficiency" "Poleward" "non-k-MT"
    "poleward" "aneuploid" "non-activated" "-171" "non-degradable" "Rs3087386"
    "POLδ" "1.06-1.97" "rs25406-" "rs5744533-rs5744724" "rs5744533" "OR=0.49"
    "OR=0.47" "rs3729558" "=0.60" "HCB" "rs1018119" "POL ι" "rs8305" "SMHS"
    "POLη" "rs3792136" "rs3087386" "POLι" "GLOBOCAN" "POLκ" "rs25406"
    "rs5744724" "=0.70" "= 0.49" "= 0.98" "= 1.0" "=0.47" "= 0.40" "Y-family"
    "= 0.47" "95% confidence" "activation/inactivation" "Autoradiography"
    "Δcysteine" "aminoacids" "Streptavidine" "its PBZ-motif" "PBZ-motif" "PBZ"
    "polyADP" "12 h" "72 h" "1 μg/ml" "Ectodomain" "Frizzleds" "MRAPs"
    "melanocortin" "accessory ectodomains" "ectodomains" "FRMP" "/G" "3XTg"
    "APP/PS1xMTEP" "memory 24-hours" "EEG" "ΔE9" "FAD" "mGlu" "smoothes" "CNQX"
    "chelate" "6D11" "Δ23-111" "conductances" "21DIV" "MPMQ" "MTEP" "LRRTM"
    "epileptiform" "oocytes" "Aβo"
    "Soluble Amyloid-β oligomers (Aβo) trigger Alzheimer’s"
    "Soluble Amyloid-β oligomers (Aβo) trigger Alzheimer" "Non-canonical"
    "24-hours" "-56" "anti-Aβ" "EC50" "BOLERO2" "TAMRAD"
    "a large public gene expression dataset" "GFRs" "Co-targeting" "Prives"
    "Laptenko" "both normal and neoplastic intestinal epithelium" "Organoids"
    "organoids" "normal intestinal epithelium"
    "normal and neoplastic intestinal epithelium"
    "Normal Intestinal Epithelium" "Epithelium" "Soussi" "muscularis"
    "intestinal epithelium" "Wnt/β-catenin" "Zöller" "Plus 2" "anti-sense"
    "active procaspase-3" "Chemoresistance" "Procaspase-3" "procaspase-3"
    "fodrin" "proenzyme" "Gallbladder" "GBCs" "GBC" "gallbladder" "0.36–1.92"
    "GA/AA" "JPT" "Tokyo" "YRI" "Ibadan" "Yoruba" "Humain" "Polymorphisme" "du"
    "Etude" "the previously investigated genetic variant rs2943641" "POUNDS"
    "a 2-year" "dyslipidemia" "2-year" "A-allele" "noncarriers" "rs2943641"
    "rs1522813" "= 0.08" "= 0.07" "= 0.12" "= 0.004" "P = 0.27" "P = 0.002"
    "mutations/inhibition" "targetSCAN" "gastrointestinal stromal tumors/GIST"
    "Friedrichs" "or/and" "Yusada" "antagomiR" "pRTR"
    "epithelial-mesenchymal transition (EMT)/metastasis" "/metastasis" "IPS"
    "miR-193a" "Zuckerman" "an important mediator/initiator" "p ≤ 0.05"
    "autocrine/paracrine" "multiorgan" "is/are" "BIR3" "Tactin" "Strep"
    "A20-ZnF5-7" "GST-A20-ZnF5-7mt" "GST-A20-ZnF5-7" "OTUmt" "ΔZnF" "ΔOTU"
    "ZnFs" "LTα 1" "Retrovirus" "A20-1" "strep" "ZnF" "LUBAC" "cIAP1/2"
    "Anti-mouse" "Pab240" "Pab" "p≤0.05" "Littleton" "Novus" "Danvers"
    "SMAD2/3" "co-SMAD4" "pphPASMC" "-7" "pph" "HIV+ IVDU" "HIV+IVDU"
    "non-drug" "R-SMAD-co-SMAD" "mono-treatment" "HPASMC" "-1B" "HPASMCs"
    "mono-treatments" "PASMC" "RSMADs" "BMPRs" "PASMCs" "non-infectious"
    "HRPAH" "HIV+IVDUs" "IVDUs (IVDU)" "non-IVDUs (HIV)" "IVDU" "IVDUs" "-1A"
    "anti- proliferative" "SY" "KY" "TY" "1.5–1.7" "Mu" "GENOSEARCH" "MEBGEN"
    "QIAGEN" "xMAP" "Luminex" "P = 0.001" "P  = 0.006" "exon 9" "≥20 " "VENUS"
    "∆3" "kymography" "RacGAP" "RacGAPs" "srGAPs" "srGAP" "dimerizers" "pola"
    "PIXα" "S7B" "S7A" "dPLB" "S1E" "micropipette" "nontarget" "mTOR-" "mTOR"
    "formyl-Met-Leu-Phe" "uHL" "neutrophil-like" "discoideum" "Dictyostelium"
    "chemoattractants" "∼10%" "S7C" "∼20%" "S1F" "S1D" "± 0.7%" "± 1"
    "The intronic variant rs869190" "rs869190" "Kiel" "Finnish" "Julia"
    "rs458017" "Rs 13190932" "Rs13190932" "Rs33980500" "~twofold"
    "rs13190932_A + " "rs13196377_A + " "rs33980500_T " "rs13210247_G"
    "rs13190932_G " "rs13196377_G " "rs13210247_A" "rs13210247" "rs13196377"
    "TRAF3IP2_rs33980500" "_rs33980500" "mutations/polymorphisms" "17q25"
    "TRAF31P2" "clinically relevant subphenotypes" "subphenotypes" "rs13190932"
    "_A" "_G" "_T " "_A + " "_G " "rs33980500" "= 3.3 × 10" "= 1.4" "= 5"
    "= 1.6" "× 10 " "= 0.96" "= 0.88" "= 1.1" "= 0.003" "= 0.024" "95 % CI"
    "2–3 " "= 1.2" "= 0.0008" "= 1" "A + " "= 0.0054" "= 2" "= 2.5"
    "10.1038/ncomms3338" "Takata" "A common intronic polymorphism" "HELQ-1"
    "noncrossover" "the two RAD51 paralog subcomplexes, BCDX2" "monoadducts"
    "aUV" "and 2G9" "5G6" "intersister" "polynucleotides" "eXRCC2" "subcomplex"
    "BCDX2" "eHELQ" "ZFN" "10H3" "ZFNs" "RAD51B/C/D" "solfataricus"
    "Solfolubus" "subcomplexes" "nitrosoureas" "photoactivatable furocoumarins"
    "furocoumarins" "interstrand" "Non-Targeting" "5B" "2.4 × 10" "JLR" "JCF"
    "respiratory epithelium" "Jancelewicz"
    "the fetal lung mesenchyme and airway epithelium"
    "both the bronchial and bronchiolar epithelium"
    "the bronchial and bronchiolar epithelium" "alveoli"
    "primitive lung mesenchyme" "PBB" "FGFR2b" "CCAM" "adenomatoid" "AJK" "JAH"
    "CL" "promyeloid" "imidazole" "interstitium" "microelectrode" "IDCs" "hGHR"
    "hPrlR" "pYStat5" "signal transducer and activator of transcription-5a"
    "signal transducer and activator of transcription-5b" "Pasteur"
    "xenotransplants" "anti-angiogenesis" "n  = 9" "p  = 0.01" "= 1.9"
    "= 0.013" "p =  0.009" "mean ± " "n  = 3" "5 × 10" "Jak1 and"
    "nucleic acid aptamers" "oligomeric and fibrillar amyloids" "Antony"
    "molten" "a typical prionoid" "prionoid" "Hetero" "folding/unfolding"
    "GdmCl" "secosterol" "co-aggregation" "APRs" "immunoassay" "Fourier" "FTIR"
    "-tetrazolium" "tetrazolium" "amyloids" "prion-like" "Prusiner" "Stanley"
    "Huntington" "Parkinson's" "Parkinson" "protofibrils" "Muller" "Como"
    "paralogues" "oestrogen-" "Leo" "amyloid-like" "p53C" "PR−"
    "non-transformed" "anti-oncogenic" "arisen" "readouts"
    "a transcriptionally active Yap-Tead–" "Chan"
    "its normal functions/localizations" "Taz" "Amots" "Amot/Yap" "GTIIC"
    "mYap" "LY1/PY2" "Amot-p130N" "PY2" "PY1" "LPTY" "weight/body" "DKO" "Amo"
    "a porphyrinogenic hepatotoxin"
    "3,5-diethoxycarbonyl-l,4-dihydrocollidine (DDC)" "hepatotoxin"
    "cre -negative littermate" "Mps" "kDWW" "moesinezrin" "Tead" "hypophos"
    "Mst" "Motin" "TEA" "Teads" "LPxY" "PPxY" "Δ C" "+ 1" "co-occurrence"
    "C139A/C147A" "structureunder" "Synapse" "Micromilieu" "Gorbatyuk" "PBTs"
    "BMRB" "IAA" "trisphosphate" "Samstag" "mature immune synapses"
    "micromilieu" "live/dead" "Nkx" "⩾65" "German" "mucinous adenocarcinoms"
    "gradings" "adenocarcinoms" "non-mucinous" "The histological subtype"
    "_A750deletion" "delins" "Wuerzburg" "Regensburg" "Erlangen" "Coburg"
    "daily routine histopathology" "Histology" "Southern Germany" "multicentre"
    "P- value" "Non-smokers" "~ 2-fold" "caspase-like" "trypsin-like"
    "epidermoid" "family 1A" "-deoxycitidine" "deoxycitidine" "0.5-1" "1μg/ml"
    "Beighton" "Spritz" "II:1" "successfully four polymorphisms" "melanin"
    "1-year-old" "propositus" "Murakami" "TKA"
    "homogeneous variant co-segregated" "co-segregated" "III:2" "II:3" "II:4"
    "IVS" "III:1" "leucoderma" "2484+1G" "Oiso" "macules" "café"
    "congenital leukoderma" "leukoderma" "exon 17" "year-old" "intron/exon"
    "/ μ L" "1-year" "PKM1" "bisphosphoglycerate" "Warburg" "nano" "Greater"
    "isotopomer" "Harvey-" "centromere" "1p13.1-1p12" "arm 1p"
    "acquired uniparental isodisomy" "aUPID" "isodisomy" "non-recurrent"
    "intracranial aneurysms" "Alagille" "aneurysms" "leukoencephalopathy"
    "utero" "mir" "cistron" "a previously published sarcoma dataset" "NOTCH1-3"
    "myofibroma/tosis" "Subtypes" "acral" "non-acral" "fwd" "Suplem" "CEP128"
    "glomus" "a histologic continuum" "myoid" "MIR143" "myofibroma/toses"
    "sino" "in 1p13" "5q32" "FusionSeq" "Glomus" "T-rich" "9/15" "hg19"
    "GENOPTIX" "the mucinous histotype" "p=0.020" "p=0.023" "=0.095"
    "histotypes" "=195" "a mucinous tumor histotype" "mucinous histotype"
    "a mucinous histotype" "histotype" "Rican" "Rico" "Puerto" "=0.020"
    "=0.023" "Race/ethnicity" "IFN-λR" "RV1b-" "systemically 16 h"
    "Viral titers" "RV1b" "RV16" "IAV-" "nPG" "IAV" "Nox" "AEC" "AECs"
    "decreased viral titers" "viral titers" "P-values" "50 mg/kg"
    "EMT/CSC-like" "Shien" "Morgillo" "silybin" "marianum" "Silybum"
    "surrogacy" "delL747-E749" "Suda" "Yao" "initio" "H1975"
    "IGF-1R-driven EMT-like" "AG1204" "re-localization" "PC-9/TGFβ1"
    "goosecoid ( GSC )" "goosecoid" "focal adhesion-like" "μmol/L-" "μmol/L"
    "AG538" "PC-9/ErlR" "Profiler" "Proteome" "qBiomarker"
    "gefitinib/erlotinib" "multinucleotide" "refractoriness" "≥ 3" "3 × 10"
    "48 h" "fibroblast-like" "24 h" "72 h" "10 ng/mL" "EMT-like" "~5%"
    "erlotinib/gefitinib" "laevis" "58bp" "∼80%" "Nickoloff" "Jasin" "GCs"
    "at least 331 bp" "STGCs" "two-ended DSBs" "6/21" "15/21" "9/23" "14/23"
    "x" "the maximum LTGC:total HR ratio being ∼60%" "ROSA26" "SMARTpool"
    "non-crossover" "28/29" "and 1/29" "4/65" "58/65" "∼2-fold" "fl/ mut"
    "11CO/47T" "gDNA" "fl/mut" "LTGCs" "two artificial exons" "non-invading"
    "paralogs" "misrepair" "STGC/LTGC" "LTGC" "STGC" "EXON21" "Primer 3"
    "the recently developed AR degradation enhancer" "os" "Kung" "Jiang"
    "methyladenine" "Duve" "AR+" "Frezza" "proteins/kinases" "Laster"
    "oncology" "non-apoptosis" "Overholtzer" "PC-3AR" "el" "Kadowaki"
    "AGCACGCGAGGTTCC" "Bix" "bio" "Kerr" "NCCD" "rat urogenital mesenchyme"
    "mesenchyme" "stromal-epithelial co-culture" "mPrE" "HPrE" "CK5+/CK8+"
    "CK8+" "CK5+" "anti-androgen/AR" "re-establishment" "non-genetic" "PC−3"
    "Stem/progenitor" "Denmeade" "≥ 8" "T308/S473" "PSMA+" "PSA+" "Bp65" "≥8"
    "1/50" "microcalcifications" "mammography" "´-kinase" "MAPLE" "Johnston"
    "=-0.542" "=-0.769" "=-0.625" "=-0.556" "=-0.633" "=0.707" "=0.525"
    "=0.017" "intratumour" "=0.606" "=0.005" "=0.030" "P =0.009" "P =0.012"
    "P -values" "1/10" "= 42" "non-amplified" "P =0.020" "P =0.006" "=0.044"
    "P =0.004" "fluorouracit" "T36/45" "S235/236" "p70S6 ribosomal kinase 1"
    "Ser235/236" "FTS-1" "posttranscriptional modifications/degradation" "GDZK"
    "GDKZ" "GDZ" "GDK" "approximately 2 h" "GZBDK-" "GZBDZ" "GZBDK" "GZB"
    "HeLa cells significantly increases cell migration/invasion" "B-boxes"
    "oriLyt" "CTRD" "micrometastases" "14 d" "and 1 × 10" "=0.015"
    "Treg/Th17 cells" "Cytobank" "NSTEMI" "STEMI" "UA" "Gensini" "Th17/Treg"
    "immunobead" "ACS" "Anti-inflammatory" "= 0.0051" "= 51" "= 0.39"
    "STAT3/HBS" "normoxia-active HIFα" "HIF2+USF2" "HIF1+USF2" "HIF1α+STAT3C"
    "-1096" "+25" "-506" "2USF2V1/Luc" "the parental CA9/Luc" "2HBS/Luc" "∆IH"
    "∆N-TAD" "∆C-TAD" "∆PAS" "HA-tagged constitutively active STAT3C" "HIFα211"
    "HIFα221" "bHLH+PAS" "HIF2αDPA" "HIFα122" "HIFα112" "CA9/Luc" "RCC4T"
    "HIF1α+USF2" "HBSs" "HIF2αTM" "HIF1αTM" "∆basic" "PGK1/Luc" "PAI1/Luc"
    "CANNTG" "HIFα" "HBS" "unique subsets" "/enhancers" "inMCF" "tamoxifin"
    "tamxifenin" "hour-time" "boyden" "indictors" "6-weeks" "=0.037" "p =0.02"
    "=36" "3×10" "4 hr" "n= 3" "1× 10" "U133" "non-chromothrispsis"
    "polypyrimidine" "polypurine" "MMBIR" "FoSTeS" "2p24.3" "tetraploid" "2p23"
    "deleted/duplicated/inverted exons" "NB1142" "S/MAR" "non-chromothripsis"
    "Microhomology" "Breakpoint" "and 2p24" "NB1141" "12q24.33"
    "12q21.33–12q24.33" "12q" "BLAT" "and 3p" "DGV" "11q" "FREEC" "SVDetect"
    "Ga" "microhomology" "breakpoint" "17q" "1p" "ploidy" "microhomologies"
    "breakpoints" "= 1.4" "n = 1" "n = 7" "3p" "GT-1" "OA" "anti-motility"
    "non-nuclear" "A-type" "p27kip" "T37/46"
    "cyclin-dependent kinase inhibitor 1B" "siRNA-1" "B-type" "8p12"
    "EndoPredict" "multigene" "triple negative/basal-like" "P  = 0.04"
    "P  = 0.001" "Conclusion/Significance" "Diermeier" "Paik" "cardiotoxictiy"
    "SK-EV-C1" "P -value" "N-glycosylation" "mesenchymal SK-β1-C1" "SK- β1-C1"
    "SK-EV-C4" "mammospohere" "SK-β1-C1" "SK-EV-C3" "SKBR-3/β1" "SKBR-3/EV"
    "Ferraros" "Oliveras" "basal/mesenchymal" "TZR" "HER-2+" "72h" "P  = 0.043"
    "= 0.05" "De-novo" "de-novo" "CD44+" "Clark" "proMMP" "invadopoda"
    "regulators/components" "invadepodia" "regulator/component"
    "metastasis/invasion" "non-receptor tyrosine kinase" "Qu" "co-amplified"
    "sarcomatous tumour cell histologies" "188/254" "glomeruloid" "170/324"
    "79/302" "306/341" "41/49" "8/41"
    "robust phenotypic conclusions being drawn" "2/23" "46/52" "90/169"
    "196/341" "56/332" "5/341" "/7" "8/154" "9/154" "24/154" "1/9" "56/236"
    "49/235" "26/190" "63/283" "54/233" "3/13" "gastro" "cells/foci" "74/463"
    "histologies" "4q12" "= 0.0012" "14/37" "= 0.068" "11/43" "4/30" "= 0.054"
    "6/37" "= 276" "unresponsiveness" "biologicals" "SOMAmers"
    "absolute EGFR levels approximately 10/ng/mL" "CVs" "synthesizer"
    "isobutyl" "tryptamino" "naphthyl" "benzyl" "Aptamers" "SELEX" "aptamer"
    "SOMAmer" "Aptamer" "non-EGFR" "PEYLNTVQ" "TYK"
    "the biochemical mechanism/s" "+3" "+2" "phosphopeptides" "pY317" "B/C"
    "Elo" "phosphoTyr317" "pY1092" "Orbitrap" "egion" "region/s" "JH1" "Δ349"
    "Δ369" "mSB" "phosphotyrosines" "phosphotyrosyl" "JIR" "mechanism/s"
    "co-variants" "misclassifications" "Improta" "CT+CC" "Arg399Gln" "399Gln"
    "DBSs" "non-parametric" "Tweedie" "Duval" "= 0.71–0.90" "0.79–1.00"
    "0.81–1.00" "= 0.78–0.89" "h " "h  " "DSBR" "anti-tumour" "= 0.520" "= 6.3"
    "= 13" "= 16" "= 0.042" "= 0.009" "= 36" "= 0.71" "= 0.78" "HOXA6" "/DNA"
    "lncRNA/DNA" "the unspliced intronic ANRASSF1" "the intronic ANRASSF1"
    "Palakurthy" "non-cross" "Neubauer" "RNAPII" "the public array datasets"
    "Cufflinks" "ATTAAA" "ntisense" "RASSF1C" "ANRASSF1" "H3K27"
    "HER3phosphorylation" "VeraTag" "Francisco" "Defazio" "extrapolations"
    "ADRrE2" "receptors/cell" "pf21s" "pf12" "pf11ees" "pf21" "_ji" "ADRr"
    "S19C" "molecules/cell" "HER2−3+" "∼90%" "HER2+3+" "2C4" "EGFR/HER1" "HERj"
    "HERi" "Rij" "RMSEs" "RMSE" "HER1-3" "uman" "∼60%" "S2A" "24H" "rapalogs"
    "non-isogenic" "antitumour" "wortmanin" "sites/proteins" "bisphosphate"
    "72 h" "S6RP" "PI3KCA" "mean±s"
    "eukaryotic translation initiation factor 2α" "load/fluid" "non-loaded"
    "C28/I2" "NGFβ" "the ovarian epithelium" "33/75" "25/25" "51/75" "9/25"
    "only 25% ~ 30%" "EOC" "FIGO" "Pearson’s" "= 0.032" "P  = 0.036" "= 0.011"
    "P  = 0.009" "= 0.021" "P  = 0.043" "= 0.015" "= 0.027" "~ 30%" "VDG" "MCa"
    "MCo" "Brystol" "honoraria" "Medimmune" "Celgene" "Amgen" "Genentech"
    "Roche" "Squibb" "Myers" "Bristol" "109/120" "37/40" "19/24" "37/52"
    "atand" "109/178" "114/273" "2/105" "44/207" "339/528" "376/749" "80/528"
    "34/216" "46/312" "153/298" "223/451" "non-Sardinian" "Breslow" "354/513"
    "Sardinia" "the different biological subset" "secondaries" "AJCC" "5/38"
    "/100" "3-like-1" "procollagen" "FRCn" "Naïve" "IĸBα" "IĸB" "GREs" "GRE"
    "ɣ" "PTD" "mMDDC" "SHIV" "SDF" "Nef-associated serine kinase Pak" "Pak"
    "microdomains" "27kDa" "CD8+" "exanthema" "lymphadenopathy"
    "the intestinal lumina propria" "propria" "CCR5+"
    "infectious DC/T-cell synapses" "ĸB" "non-dividing" "non-classical" "HGVS"
    "LOVD" "HGMD" "pretest" "JAK2V617F" "JAK2 V617F" "approximately 2–3"
    "W515K/L" "BCR-ABL1" "515K/L" "essential thrombocythemia (ET)"
    "thrombocythemia" "S-nitrosocysteine" "-nitro-L-Arginine" "heptamer"
    "GCCGGAG" "Duplan" "ILBD" "3-Br-7-NI"
    "the relatively neuronal specific NOS inhibitor 3-bromo-7-nitroindazole"
    "3-bromo-7-nitroindazole" "-nitro-l-arginine (NNA)" "NNA" "PQ/MB" "PQ"
    "200 μM ‘old’ SNOC" "Pp53" "SNOC" "nitrosocysteine"
    "S-nitroso-glutathione (GSNO)" "pcDNA1" "stressors" "T-allele" "GC/GG"
    "CC/GC" "TT/CT" "C-allele" "418Ser" "glutamssine"
    "approximately 500.000–1 " "1.23–1.70" "1.24–1.97" "1.25–1.73" "1.20–1.86"
    "1.05–1.67" "1.61–3.28" "P = 0.012" "= 13" "= 16" "= 20" "NP_006288.2"
    "χ  2" "μ L" "NC_000019.9" "NM_006297.2" "Arg194Trp" "194Trp" "χ 2" "AG/AA"
    "GG/AG" "_006297.2" "non-synonymous" "_006288.2" "_000019.9" "1.06-1.66"
    "1.18-1.83" "1.21-3.31" "genotypes/alleles" "= 0.027" "= 0.014" "P = 0.036"
    "= 0.0048" "= 0.0145" "= 0.0030" "the most clinically relevant endpoints"
    "socio" "quintiles" "microvessels" "NRI" "0.98-3.2" "HPFS" "Harvard"
    "underwent radical prostatectomy" "= 0.0129" "P = 0.04" "= 0.002" "= 0.049"
    "= 0.06" "= 0.03" "= 0.04" "Cai" "Rubin" "Denis" "lymphotoxin" "Tsuyada"
    "Brabletz" "Kyprianou" "increasing PCa cell migration/invasion" "ARKO"
    "Rini" "Garcia" "the orthotopic TRAMP-C1 siAR tumours + CCR2atg" "veh"
    "WT/TRAMP" "Junicho" "Potula" "CCR2atg" "Cherney" "CCL2ab" "monoculture"
    "mono-cultured" "Azare" "Abdulghani" "Alexander" "Friedl" "Sica" "M2-like"
    "migration/invasiveness" "Qian" "Mizutani" "Alleva" "Kaler" "siAR"
    "Ammirante" "progression/metastasis" "growth/metastasis" "Loberg" "Zhu"
    "Lai" "Niu" "Mulholland" "Yamaoka" "Cookson" "Kasper" "Harris" "Gulley"
    "Hodges" "Huggins" "Siegel" "cell migration/invasion" "= 4" "= 2" "n = 9"
    "migration/invasion" "= 0.003" "cermide" "C1q/tumor necrosis factor"
    "its pharmacological inhibition further increases LPS anti-apoptotic"
    "lipopolysaccharide (LPS)" "p38 MAPKs" "6 h" "non-apoptotic" "1 × 10"
    "× 10" "Eμ-myc" "Kalac" "germinal center B cell-like (GCB)"
    "B cell-like (GCB)" "complete/partial" "Annexin V/propidium" "B cell-like"
    "regs" "anti-CD28–inducible IL2-κB–DNA–protein" "CD28RE"
    "mono-O-GlcNAcylated" "5-kD" "amino- N -phenylcarbamate" "-phenylcarbamate"
    "phenylcarbamate" "-glucopyranosylidene" "glucopyranosylidene" "AET"
    "aminoethanethiol" "Michael" "BEMAD" "κB"
    "maternal diabetes–induced embryopathy" "Mouse diabetic embryopathy" "L/L"
    "E8.75" "diabetic mellitus" "diabetic embryopathy" "embryopathy"
    "neuroepithelium" "8-week" "C57BL/6J" "± 1.9%" "LFL" "pupal" "puparium"
    "pseudogenes" "the proband’s" "ELREA" "P53 WT" "Sourbier" "geneset"
    "`hyper" "a unique `hyper" "quasi" "P-REX2a" "ubiquitine" "hetero"
    "diabetic nephropathy" "glomerulonephritis" "kidney proximal tubules"
    "siTPEN" "siPTEN" "3p25" "Mean ±" "JSF" "LR" "SIRE" "cerebral ischaemia"
    "ischaemia" "CoM" "CoMCont" "tuberculomas" "endfeet" "Tukey’s" "Tukey"
    "ELISAs" "CoMTb" "serine/threonine" "two-hour" "p38 MAPK" "neuropathology"
    "phosphorylation/dephosphorylation" "sphingosine" "LacCer" "+PKCε" "oleic"
    "E/L" "Niemann" "PKCβII" "~20-fold" "PKC βII" "Zetterberg’s" "Pledger"
    "Zetterberg" "Zetterburg" "MCF7 breast" "S807/811" "7hr" "11 hr" "of4EBP1"
    "approximately 16 hr" "BJ" "Pardee"
    "mammalian/mechanistic target of rapamycin" "EEAs" "Ser807/811" "re-enter"
    "only 2 h" "non-CF" "TAPI" "approximately one-half" "ie"
    "approximately 12 h" "TAPI-1" "Perez" "NHBE" "0 h" "covariates" "∼2%"
    "Begg’s" "1.08–1.18" "1.06–1.12" "Thomas" "GWA" "Caucasians" "Africans"
    "Cochrane" "ISI" "SCOPUS" "rs11249433" "1p11" "PR+" "PR-negative"
    "PR-positive" "P = 0.49" "= 0.06" "=  1" "P  =  0.002" "P  =  0.05" "rRNA"
    "TRM" "H538A/K540A" "phosphopeptide" "TAR" "YSPTSPS" "heptapeptide"
    "pseudovirus" "LTR" "TEFb" "12/14" "The subsequent FGFR-2 re-expression"
    "endocrinology" "IIIc" "=  0.07" "= 0.14" "1–3 " "Barbano" "Maacke"
    "= 0.011" "= 0.034" "P  = 0.036" "insertion/deletion" "Riemann"
    "the homozygous insertion genotype" "del/del" "rs28362491" "ins/del" "4q24"
    "UCC" "ATTG" "homozygous insertion genotype" "= 0.025" "= 3" "95% CI  "
    "CysLTR" "βI" "βII" "cys-LT-mediated c-fos phosphorylation/expression"
    "phosphorylation/expression" "CRAC" "GFX" "Thodeti"
    "atypical (ξ, λ) isozymes" "At least eleven closely related PKC isozymes"
    "isozymes" "cysteinyl" "lavage" "hyperresponsiveness (AHR)"
    "hyperresponsiveness" "eosinophils" "LTE" "potentiators"
    "bronchoconstrictors" "LTs" "Cysteinyl" "mean ±" "serine/" "Oshima"
    "co-opts" "McGill" "Stockholm" "NKI" "containingPyMT" "db/  loxP" "9-week"
    "16-week" "oncongene" "specifc" "pT72" "mammary glands fromErbB2"
    "fromErbB2" "inErbB2" "mammary glands fromPyMT" "oldPyMT" "fromPyMT"
    "the respective Cre transgenes" "transgenes" "LoxP" "ofPyMT" "orPyMT"
    "inPyMT" "db/loxP" "controlPyMT" "andPyMT" "bothPyMT" "conditionalEts2"
    "transcriptomes" "Transcriptome" "ets" "PyMT" "= 0.00004" "Jacobs" "CRs"
    "neuron-like" "NBRA" "subclass" "Romano" "CR-1" "nucleo" "Nucleo" "vb"
    "Ichinose" "DA-like" "-tk" "tk" "mNBRE" "NBRE-like" "DR5-like" "NurRE"
    "hNSCs" "mesencephalon" "mdDA" "hNSC" "NBRE" "co-regulators" "TFN" "vitro"
    "mmpTRPC63p-luc2" "the mutant minimal mmpTRPC63p-luc2" "mmpTRPC"
    "the minimal pTRPC6p-luc2" "seq" "pTRPC6p-luc1" "pTRPC" "sim" "genomatix"
    "_193240" "Genomatix" "+1" "Mt" "Wt" "p53 RE" "Segat's" "co-infected"
    "Alzihamer" "19p13" "Egger's" "Begg's" "Begg" "Egger" "CC+GC"
    "Heterozygote" "HWE" "RFLP" "Naidu" "Segat" "Ser/Thr-Pro" "ORs" "Genotype"
    "Peptidylprolyl" "= 0.015" "p = 0.006" "95% CIs" "coactivaton"
    "ER+positive" "methyltransferases" "Xenogen" "ZR-PELP1-GFP-Luc" "ZR-PELP1-"
    "Non-targeting-" "the active histone mark H3K9Ac" "H3K9Ac" "+83"
    "miR200b-200a-429" "miRNA200b-200a-429" "200b-200a-429" "non-genomic"
    "MDA-MB-231-PELP1shRNA" "conshRNA" "miRCURY" "ZR75" "coactivator-3"
    "paralog" "metastasis-suppressing metastamirs"
    "The metastasis-promoting metastamir" "metastamirs" "metastamir" "MiRs"
    "decreased PELP1 driven migration/invasion" "miRs" "= 5" "6-week-old"
    "1 μg/mL" "Non-targeting" "miR200c" "miR 200c" "200a" "Br731" "let-7g"
    "MiR-200b" "Hmga2 -/-"
    "five major microRNA-target pair prediction programs/databases"
    "programs/databases" "TargetScanS" "BMS" "Hochberg"
    "another important effecter" "effecter" "miR-200b" "2 +" "ZEB1/2" "ΔEx3"
    "Par-4/THAP1" "Par-4/THAP" "SFD2" "ribooligonucleotides" "GGTCTGAG"
    "TGAGTA" "GTCAGGA" "TGTCAGG" "ESE" "2.5-kb" "-pulldown" "THAP1/91-213aa"
    "THAP1/1-90aa" "reChIP" "THAB" "pcDNA3" "GGCA" "Immuno" "pGL3-CCAR1-P1"
    "_018273.2" "co-transformed" "5-kb" "Lane 3" "NR/cofactor" "pulldown"
    "auto-inhibited" "BCL11A/B" "LXXVI" "atrophins" "Atrophins" "SXLXXML"
    "FSXLLXML" "LXXML" "FXXLL" "NID+L" "NR1F2/RORβ" "NIDs" "RID1-like"
    "803-FXXLL-807" "SOTOS" "FXRXLRXL" "COUP-TFI/II" "LXXL" "ATRO" "SANT"
    "YXXXLXXY" "FXXXLXXL" "VXXXWLXXY" "Helix" "NR2E" "NR4A1/Nurr77" "BioGRID"
    "transformants" "Y2H" "RID1/2" "COUP-TFII/DNA" "supershifts" "COUPTFII"
    "erythroleukaemia" "COUPTF" "Bgl3" "NR2E/Fs" "RARβ2" "roziglitazone" "NR2F"
    "SXXLXX" "VYSXWLXXY" "LBD" "Leid" "NuRD" "Krüppel" "Moses" "CoRNR" "LBDs"
    "LXXLL" "FSXXLXXL" "YSXXLXXL" "Tailless/TLX" "RID2" "COUP" "NR2E/F"
    "co-regulated" "×3" "C57BL/6 J" "μl Protein" "∼26%" "co-recruitment" "∼11%"
    "∼12%" "PDSM" "L269fs" "P256fs" "G242fs" "Frameshift" "Y201X" "R171X"
    "adenylate" "FSK" "co-repressive" "co-repression" "L38I" "K4E" "PyMol"
    "tRFP+" "turboRFP" "U2932" "ARACNe" "Circos" "HBCI" "Interactome"
    "Deficiens" "immunochemotherapy" "non-Hodgkin’s" "72H" "n = 3" "= 47" "A/T"
    "co-activators" "co-repressors" "prodrome" "deeper" "Danish" "ABPA"
    "HapMap3" "rs1198588" "Collins" "C10orf26" "MIR137" "pseudogene" "NHGRI"
    "Perlis" "non-response" "nifedipine" "L-type" "multiple possible signals
nearMECP2"
    "nearMECP2" "Rett" "chrX" "=0.1" "ISC" "Sweden" "∼8,300" "Swedish" "N=20"
    "P =1.1×10" "=1.3×10" "=5" "re-analyzed" "ARS" "serotype" "AAV1" "inPARP1"
    "Postmortem" "Nissl-" "a functional behavioral readout" "immunoreactivty"
    "conditionalParkin" "AAV1-tTA-IRES-zsGreen" "zsGreen" "tTA" "adeno"
    "-nitrosoguanidine" "nitrosoguanidine" "DPQ" "ZVAD" "doxycyline" "DOPAC"
    "rotarod" "VTA" "compacta" "zona" "Nissl" "medulla" "pons"
    "the ventral midbrain" "parthanatos" "mortem" "inParkin" "midbrain" "Lewy"
    "1-methyl-4-phenyl-1,2" "polymerase-1" "= 0.05" "= 3" "Anti-FLAG" "± 1.0"
    "± 0.4" "mean ± s" "clearer" "ruboxistaurine" "lystates" "formyl"
    "phosphostain" "phosphorimage" "SYPRO" "Promega"
    "oligodeoxyribonucleotides" "monocyte/macrophages" "1000 g" "mg/ mL"
    "μg/ mL" "non-transcriptional" "efficiently repair DSBs" "Isc" "ISceI"
    "non-lethal" "#3" "72 h" "1 μg/ml" "co-repressor" "6 h" "G 0 /G 1"
    "aberrant COX-2/PGE 2" "GEF40" "SILAC" "element binding protein-1" "± 2"
    "± 0.3" "pEBG" "GFP-RNF38ΔRING" "ΔRING" "NLSs" "NLStradamus" "Mapper"
    "AP12816a" "Lunardi" "pcDNA 3.1" "Loosdregt" "drawn" "co-transfer" ":1×10"
    "co-transferred" "non-Treg" "Teff" "His-Ubc5Hb" "co-purified" "Foxp" "Ubi"
    "UniProtKB" "Foxp3 +" "T cell-like" "Th17" "Toll-like" "D-box" "interwoven"
    "ODE" "EV" "S138A/S146A" "shCdh" "shGFP" "A/Cdk2" "degrons" "D/E"
    "DDGNDVpSP" "DSGxxS" "RVL" "Cdk2/cyclinAsubstrate" "degron" "DSGX" "TRCP2"
    "ΔFizzy-Cdh1" "TRCP" "β-TRCP1" "multisubunit" "life/death" "asshown"
    "inevery" "realtime" "directlyfrom" "U1wt" "immunoprecipite" "shRIP1"
    "shRIP" "=15.47" "χ²" "puromcyin" "U251vIII" "GBM9" "vIII" "ubiqitin"
    "co-exist" "cIAPs" "cIAP" "EGFRwt" "10ng/ml" "PcDNA3.1"
    "a lethal skeletal dysplasia" "P+1" "Waals" "der" "carbonyl" "phenyl"
    "Webster" "hinge/interlobe" "hydroxyl" "A-Loop" "LPV" "FGFR3K" "Nowroozi"
    "readout" "Liboi" "invariant" "A-loop" "dwarfism" "Dysplasia" "Auto-"
    "ΔL/D146N" "ΔL" "H/" "pT180" "the kinase-inactive Mst2 KD/D146N" "aK"
    "the catalytically inactive Mst2 KD/D146N" "KD/D146N" "Undergoes" "αC"
    "dRASSF" "ippo" "circuitry" "= 19" "S-labeled" "Lats1/2" "Bp" "Algorithm"
    "FBCs" "Michelucci" "non- BRCA2" "hormonal dimorphism" "dimorphism"
    "micropapillary histology" "Ottini" "a considerably higher penetrance"
    "Benvenuti" "sporadic MBCs" "Dawson" "0/6" "and 2/6" "5/6" "11/30"
    "tumour histological subtype" "BRCACX" "ribose" "FBC" "p4EBP1" "MBCs"
    "P = 0.009" "μL" "BRCA1 / 2" "BRCA1 /2" "= 0.035" "P = 0.006" "= 0.024"
    "= 0.030" "a previously published dataset" "Kenny" "Aceto" "hIgG-" "hIgG"
    "a classic ring-like" "ring-like" "rhLOXL2" "control acini formed lumens"
    "pBABE" "lumens" "lobule" "lobules" "intracardiac" "Hamilton" "Barry"
    "a previously published breast cancer patient dataset" "DSGA" "traztuzumab"
    "P ≤ 0.05" "= 51" "STAT3F" "STAT1/3" "Jak-STAT3" "± 0.15" "Tuj-1" "NB27"
    "NPIM" "neurosphere"
    "proneural basic helix-loop-helix (bHLH) transcription factors mammalian achaete-schute homologue-1"
    "NSPCs" "SVZ" "homologue-1" "schute" "achaete" "at least 2-3" "000/year"
    "/100 " "histological subtype" "36/90" "54/90" "59/90" "Wnt/" "CD44V6"
    "5/20" "non-brainstem pediatric HGG" "neocortex" "2/43" "13/90" "astroglia"
    "histopathology" "UHC" "EGFRvIII-driven murine HGGs"
    "PDGFR-driven murine HGGs" "PDGFRα-driven murine HGGs"
    "anaplastic oligoastrocytoma histology" "anaplastic astrocytoma histology"
    "E10del" "DWE" "IC90" "V544ins" "XTT" "thePDGFRA" "Δ8"
    "83 non-brainstem pediatric HGGs" "E7del" "E10del2" "90 pediatric HGGs"
    "Pediatric HGGs" "pediatric and adult HGGs" "histopathologies"
    "pediatric HGG" "83 non-brainstem pediatric HGG" "non-brainstem"
    "non-brainstem pediatric HGGs" "pediatric HGGs" "DIPGs" "HGGs" "brainstem"
    "DIPG" "pontine" "HGG" "44/70" "1/6" "=0.26" "=0.068" "Anti-rabbit"
    "two-year" "KJC" "XBY" "HYX" "WZ" "SSZ" "MHCCLM3" "PVTT" "multistage"
    "portal vein tumor thrombi" "thrombi" "p = 0.029" "p = 0.012" "× 100"
    "24 h" "48 h" "anti-phospho" "neurotropin" "Etienne" "RhoGDI2L" "RhoGDIs"
    "idiopathic congenital nystagmus" "ﬁber" "Cr" "ferm" "Nr" "RhoGDIɑ"
    "spinal motor neuron subtypes"
    "the X-linked idiopathic congenital nystagmus (ICN)" "RhoGDIα" "FRMD7"
    "the X-linked disorder idiopathic congenital nystagmus (ICN)" "nystagmus"
    "FERM" "RhoGDI1" "+/515A" "Lang" "chemoresistant"
    "various tumor-associated mutp53" "21/47" "26/47" "19/55" "36/55" "12/56"
    "22/58" "a mutational hotspot" "Hotspot" "Mutp53" "mutational hotspots"
    "hotspots" "mutp53" "OvCa" "p =0.002" "× 100" "=0.035" "=0.054" "phenethyl"
    "p53 R280K" "p53 R175H" "Dox" "Perou" "aggressive molecular subtypes"
    "p21WAF1" "hypoglycemia" "TTGTTTAC" "±0.3" "Lasmezas" "IGF-1 was" "NEs"
    "aries" "Ovis" "+134" "GenBank" "co-treated" "1.7±" "IGF-1-induced"
    "IGF-1was" "Cu" "FFI" "Jacob" "Creutzfeld" "BSE" "forkhead box O3a" "TSEs"
    "spongiform" "8H" "entry/arrest" "myofiber" "re-added" "Nernst"
    "re-addition" "2EF" "2AB" "pA/pF" "siEGFR" "95.7±4.9%" "profiler"
    "proteome" "Enhancer" "n = 4" "= 5" "neuroendocrine" "HBEC"
    "two public SCLC datasets" "bronchial epithelia" "copies/function" "Byers"
    "Peifer" "anti-differentiation" "= 0.0013" "= 4" "= 2" "= 14" "ug/ml"
    "acetylaiton" "homeodomain (PHD)" "E6 L50G" "E6L50G" "immunocomplexes"
    "Coomassie" "pCDNA" "12p13" "hScribble" "p21 WAF1" "responders"
    "lipopolysaccharide" "monocultures" "BAEC" "neuroglia" "microvasculature"
    "selectinand" "CSA" "90–115kDa" "cerebral endothelia" "endothelia" "siMMP3"
    "–d" "dnSTAT3" "caSTAT3" "wtSTAT3" "GAS-like" "siSTAT3" "luc" "pMMP3" "PbA"
    "C/EBPb" "MBVEC" "mouse endothelial and primary HBVEC" "CXCL10-" "CXCL"
    "biliverdin" "glia" "pRBCs" "iRBC’s" "postmortem" "iRBC" "pRBC"
    "erythrocytes" "falciparum" "HBVEC" "1×10" "n = 3" "Dekken"
    "human colonic biopsies" "Behcet" "pANCA" "antineutrophil" "ASCA" "≥24%"
    "The Spearman's" "paraffin-embedded colonic biopsies" "50-year" "28-year"
    "IBDU" "Thr 821/836" "Ser 807/811" "Sturm" "clinicians" "Crohn's" "UC"
    "anti-phosphorylated" "Habashy" "the mammary epithelium" "Elston"
    "21.04±15.77%" "43.75±16.49%" "LI" "Zou" "EREs" "toremifene" "P = 0.006"
    "= 0.038" "P = 0.002" "ZO-1-" "ZO" "non-parallel" "Calphostin" "PDZ1-3"
    "PPATSDA" "α5 WT" "Phosphoinositides" "‘widefield’" "widefield" "‘TIRF’"
    "TIRF" "PPAA" "spatio" "aneuploidy" "PDZ2" "Anti-Mouse"
    "genes revealed several miRNAs" "weak p53 REs" "decamers" "CTTG" "CAAG"
    "non-CATG" "CAWG" "the more rigid non-CATG" "heterotetramers" "GeneXplain"
    "Supp" "hypersensitiviy" "a polymorphic pentanucleotide microsatellite"
    "pentanucleotide" "RTqPCR" "Nikulenkov" "MSigDB" "spacers" "Fraumeni"
    "the inflexible CWWG" "the other possible CWWG" "CWWG" "an optional spacer"
    "RRRCWWGYYY" "spacer" "cistrome" "P ≤0.05" "p53 REs" "non-canonical"
    "expression/phosphorylation" "neovasculature"
    "their respective FN fibril meshworks" "splicings" "Canada" "Sherbrooke"
    "Placental explants" "amplicons" "Caliper" "amplicon" "IIICS" "Endometrium"
    "Laemmli" "trophoblastic villi" "villus" "placental villi" "C-sections"
    "wk" "meshworks" "the placental villi" "villi" "EVCTs"
    "the maternal endometrium" "cFN" "EDA+" "A+" "human placental explants"
    "EVCT" "explants" "** p" "≤ 0.05" "* p" "= 14" "n = 4" "= 0.015"
    "p = 0.036" "8 h" "α5" "48 h" "Royds" "penton" "promoterless" "ΔCore"
    "viral progeny" "progeny" "nascent viral genomes" "genomes" "IVa2" "HAdV"
    "L4P" "MLTU" "by 16" "1 × 10" "12 h" "Morel"
    "the contralateral mammary fatpad" "the left mammary fatpad" "fatpad"
    "co-administered" "mesenchymal BLBCs" "DOX" "rtTA" "pINDUCER" "CI1040"
    "siDUSP4" "siCONTROL" "#73" "luminal/androgen receptor" "ICBP50" "hemi-"
    "hemi" "TCGA" "aggressive breast cancer subtypes" "CSC-like" "CD44 +"
    "highly aggressive BLBCs" "BLBCs" "BLBC" "10 ng/mL" "mg/mL" "nu/nu"
    "Basal-like" "FFLs" "goes" "FFL" "E2F1-induced" "ER-E2F1 cells"
    "expressors" "Wilcoxon" "several publicly available expression datasets"
    "ER-E2F1cells" "shFOXO" "ER-E2F1" "OHT" "Achilles" "E2F1/FOXO"
    "yet-to-be-identified" "American/Alaskan" "Black/African" "Thep27"
    "facial burns and burn size ≥20% TBSA" "caregivers" "andp27"
    "percent TBSA burn ≥20" "≥20" "heterozygotes" "7.7±2.1" "7±2" "≥20%"
    "percent TBSA" "Sidak" "race/ethnicity" "Alaskan" "±2"
    "Median percent TBSA" "Tiel" "rs36228499" "Indian/Alaskan" "thep27" "TBSA"
    "VSS" "Vancouver" "P =0.002" "=0.16" "P =0.04" "P=0.03" "P=0.04" "P=0.02"
    "10.1038/ncomms3359" "doi" "ERAP1 as" "ERAP1b" "ERAP1a" "si-p53-1" "p53WT"
    "any possible p53REs" "p53REs" "heatmap" "iv" "TAPBPL" "ProLabel" "p53RE"
    "H1N1" "30 h" "24 h" "μg " "48 h" "sensitivity/resistance"
    "timing/schedule" "Haenszel" "p=0.17" "=0.49" "p=0.71" "=0.21" "=0.40"
    "p=0.006" "mastectomy" "NCCTG" "copies/nucleus" "co-amplification" "NSABP"
    "MYC+" "=0.17" "p=0.02" "=0.71" "smaller arterioles" "arterioles"
    "non-overlapping" "Allagile" "lamina" "co-staining"
    "the sub-endothelial neointima" "non-proliferative" "4000vp/cell"
    "~2000vp/cell" "~70%" "8h" "NotchICD" "siNotch3" "siNotch2" "siNotch1"
    "48h" "15h" "12h" "0h" "30h" "SmGM" "Notch2ICD" "the last 6h" "6h"
    "-deoxyuridine" "deoxyuridine" "qRT" "ntRNA" "si" "Carotid" "SM" "24h"
    "non-targeting" "non-proliferating" "anti-lymphoma" "NK-κB" "Gautam"
    "Radhakrishnan" "proteosome" "necropsy" "cell growth/proliferation"
    "downstrem" "cytomorphology" "Giemsa" "GRR" "growth/proliferation" "urea"
    "quinoxaline" "N=7" "Anti-tumor" "N=3" "2–3" "TTF = 6.1" "Fiala" "FLEX"
    "had squamous histology" "n=3" "n=4" "=9" "=3" "n=2" "#10" "n=1" "13.7+"
    "#15" "6.3+" "SD≥6 months" "24.2+" "#2" "7.7+" "SD≥6" "#17" "=2" "anorexia"
    "hypomagnesemia" "GY" "mg/m 2" "squamous histology" "months/PR" "ertotinib"
    "CLIA" "n=20" "n=6" "3 +" "≤3" "mg/dL" "≥6" "re-introduction" "pSuper-27a"
    "17B cells" "pSuper" "22B-pSuper-27a" "miR-27a*-IH" "*-IH" "*-inhibitor"
    "subsites" "27b" "miR-27a" "n=7" "similarly employ non-transgenic mice"
    "non-transgenic mice" "rTg4510" "Rockville" "Meso" "ng/g" "K259/353Q"
    "12E8" "oligomeric Aβ" "4KQ" "4KR" "BML281" "ACY-738" "tubastatin" "ACY"
    "thioflavin" "KCGS" "KIGS" "NFT" "parkinsonism" "KXGS" "NFTs" "lane 3"
    "scavage" "CIDE" "A549P" "rapalog" "MTS" "pCMV" "× 3" "24 h" "≥3"
    "Katakami" "dysphagia" "Yang" "P = 0.007" "P = 0.001" "co-chaperones"
    "2DICAL" "Cluc" "cypridina" "CH99021" "shRPN2" "shNC" "shRPN" "MM231"
    "del126-133" "Mtp53" "wtp53" "LOF" "mtp53" "non-obese" "Alexa 488"
    "glycogen synthase kinase-3β" "mono/combinations" "Brognard" "Sordella"
    "autoradiography" "-6,7-dimethoxyquinazoline" "bromoanilino" "Langerhans"
    "Ko" "PanINs" "ID/g" "activity/expression" "MicroPET" "Alltima" "Alltech"
    "Rf" "3-morpholin-4-yl-propyl" "-amide-" "yl" "iodoani" "pharmacophore"
    "anilino" "positron" "EFGR" "Leu858→Arg" "Taiwanese" "Nonsmall"
    "Morpholino-" "Morpholino" "noninvasive microPET" "microPET" "radiotracer"
    "IPQA" "morpholino-" "nonsmall" "≥90%" "5 × 10" "μ g/mL" "-6-" "exon 21"
    "A750 del" "osteoblasts" "αV" "AdCre" "AdLacZ" "Spry4f/f"
    "exogenous integrin β3" "DNCsk" "c-Src-mediated" "DNSrc" "AdDNSrc" "HAEC"
    "CASrc" "co-transduction" "AdCASrc" "Boyden" "AdSpry4" "AdCARas"
    "littermates" "c-Src-dependent" "VE-cad-Cre" "hindlimb" "knockin" "DiYF"
    "β3" "Sprouty4" "f/f" "regrowth" "Gupta" "Calcusyn" "HTSA" "non-CSC"
    "shEmpty" "shHbo1-5" "shControl" "significantly more mammospheres"
    "ProtoArray" "non-CSCs" "significantly more secondary mammospheres"
    "/CD24 lo cells and forms robust mammospheres" "larger mammospheres"
    "mammospheres" "T1G4.2" "T1G3.1" "T1G2.2" "76NE6" "the 76NE6-LMW-E" "TDCs"
    "76NE6-EL" "76NE6-V" "76NE6-LMW-E" "mammoplasty" "Fbw" "mammosphere" "LMW"
    "S/T-P" "= 72" "=118" "non-SCCs" "p38MAPK" "phosphokinases" "Cheung"
    "Shalizi" "re-growth" "Microb" "neuroAIDS" "pCdk5" "cytosole" "branchings"
    "Sholl" "scratch/wound" "Bookland" "p27SJ/p38SJ" "Zhao" "Okumura" "fide"
    "sensitizers" "sensitizer" "cytochome"
    "apoptotic protease-activating factor-1" "Hoechst" "cells/"
    "Anti-apoptotic" "even much greater" "non-detectable" "Co-IP" "GGGAGGTGGGG"
    "GGGGGCAGGGG" "lysine 9/14" "hepato" "methyltransferas" "Kruppel" "pombe"
    "Schizosaccharomyces" "Doxy"
    "doxycycline-inducible wild-type E2F6 or E2F6 12/52" "12/52" "S12/52A"
    "siE2F6" "HU" "auto-regulatory" "immunoreceptors" "Jedi-1" "thinner" "PY20"
    "melanogaster" "Co-expression" "anti-V5" "EGF-like" "McCoy" "fagilis" "=19"
    "=16" "FOPFlash" "TOPFlash" "cytoplasma" "non-E-cadherin-expressing"
    "ASANWTIQYND" "USF81" "HECD-1" "EC5" "non-CRC" "FadAc" "mFadA" "Ikegami"
    "XW" "preterm" "an opportunistic commensal anaerobe" "anaerobe"
    "overabundance" "microbiota" "Fn" "nucleatum" "CO-IP" "mg/ml"
    "non-permeabilized" "Kunz" "acetylation/deacetylation"
    "cross-complementing-1" "methanesulfonate (MMS)" "methanesulfonate"
    "lifespan" "substate" "non-enzyme" "substates" "immunoprecipitants"
    "Amicon" "Biomol" "Hopkins" "Phillip" "Maryland" "Alex" "ImageQuant"
    "imager" "FLA 9500" "cyanol" "fC/G-" "T/G-" "μg/ml" "μl" "fC" "FU/G"
    "FLA9500" "precipitant" "anti-rabbit" "Plex" "USB" "nonfat" "Tween"
    "mercapoethanol" "v/v" "Finkel" "DMEM" "MEM" "Bradford" "pECE" "thru"
    "Switzerland" "Basel" "Schar" "Primo" "ABNOVA" "Thermo" "DyLight" "BioRad"
    "Invitrogen" "Calbiochem" "Millipore" "Aldrich" "caC/G" "fC/G" "sanitizes"
    "relocalizes" "sirtuins" "sirtuin" "non-specifically" "U/G" "caC"
    "hydroxymethylcytosine" "chlorouracil" "carboxylcytosine" "formylcytosine"
    "T/G" "methylcytosine" "1  +" "non-histone" "still almost 2.5-times" "vt"
    "amplification/gain" "overview" "vt/vt" "wt/vt" "wt/*2" "rs1902023"
    "rs2234693" "healthy donors 1±0.05" "1±0.05" "and 1.17±0.47" "*2/*2"
    "UGT2B15 *2/*2" "UGT2B15*2" "metabolizer" "CYP2C19*2" "Polymorphism" "Os"
    "UGT2B15 *2" "*2" "PvuII" "P =0.02" "=0.0003" "=0.07" "=0.06" "P =0.01"
    "mg/day" "=0.08" "P =0.03" "both Alzheimer’s" "lobar" "Canu" "Crus"
    "caudate" "insula" "Diplotype" "signficance" "= 0.037–0.128" "BRID" "OATS"
    "Pbx-1" "rs334558 " "rs3755557 " "ICV" "VBM" "morphometry" "voxel"
    "Glycogen synthase kinase-3β" "H1/H2" "diplotype" "rs334558" "rs3755557"
    "= 0.96" "= 0.039" "p  = 0.004" "= 6" "= 0.037" "GIVM" "P≤0.05" "≤0.05"
    "chemoattractant" "n = 20" "B-binding" "MIR" "IQ" "exoenzyme" "and 1P-MRLC"
    "Wu" "diphosphorylate" "diphosphorylates" "B-depleted" "MKLP1-" "MKLP"
    "Midzone" "4F12" "B-inhibited" "heterotetramer" "MHCs" "hexamer"
    "meromyosin" "to 2P-MRLC" "and 2P-MRLC" "midzone" "MRLCs" "Thr18/Ser19"
    "non-tumors" "radioresistance" "formers" "α2β1-"
    "The function-blocking antibody BHA2.1" "BHA2.1" "α4β1" "AIIB2" "α3β1"
    "extracellular signal-regulated kinase-1/2" "α2β1" "2D" "non-sensitive"
    "Wallander" "ZAL4" "Novocastra" "5A4" "Nichirei" "Histofine" "IHC2+"
    "12/100" "Taiwan" "28/37" "4/5" "co-existing" "non-SCC" "IHC3+" "IHC 3+"
    "IHC 2+" "clinico" "ADSC" "Vysis" "3a+3b" "Echinoderm"
    "6-diamidino-2- phenylindole" "=0.0002" "IHC 1+" "non-smoker" "23/44"
    "gut/GALT" "a more activated immunophenotype" "immunophenotype" "MLNs"
    "Th1/Th2" "a lifelong ileocolitis" "ileocolitis" "pSTAT" "cells/µ" "CD1c+"
    "BDCA3+" "-α-" "Transducers" "semimature" "plasmacytoid" "phosphoepitope"
    "Crohn’s" "Crohn" "N = 7" "P  = 0.020" "pg/ml" "=  0.006" "=  0.013"
    "the Alzheimer’s" "photoreceptors" "cytochromes" "photoacceptors" "112±21%"
    "137±36%" "soluble Aβ" "PTENs" "reumatoid" "ICN" "Alzheimer's" "BZ" "CW"
    "Design/Materials" "LLI" "Wach et al., whereby prostate tumour epithelium"
    "Wach" "RPWE" "Shaefer" "RWPE" "endpoints" "Targetscan" "GeneChip" "ModFit"
    "number/viability" "Dharmacon" "Affymetrix" "oncomirs" "449a" "aptamers"
    "myosinII" "MyosinII" "re-organisation" "the SYBR-green based qPCR"
    "the SYBR-green" "SYBR-green" "SYBR" "PDCD" "1-like" "BCL2-like" "sapien"
    "Homo sapiens microtubule-associated protein 1B" "MIAME" "Hocheberg"
    "Benjamini" "DAVID" "siTiam1" "ImageJ" "microglobulin" "choroid"
    "diphosphate" "IRSWG" "LipofectAMINE 2000" "non-invasive" "AP2γ"
    "MCF-7-MEK5-" "MCF-7-MEK5-ERK5-shRNA" "Goosecoid" "Kyoto" "ZR-75" "ZR"
    "Thr218/Tyr220" "phospho-ERK5" "histochemistry" "ERE" "≥2" "= 0.5"
    "speciﬁc" "datas" "xenotransplant" "phospho-ERK1/2" "OD490" "cells/well"
    "carboxyl" "1receptor" "T2DM" "endometrium" "isoformA" "pg/mL" "Hiscott"
    "JFH1" "C21A" "Riplet-3A" "Oc" "replicons" "5KR" "non-ubiquitinated"
    "biotin" "Pearson's" "p125luc" "Sendai" "Reul" "-triphosphate"
    "lipofectamine 2000" "pCDNA3.1" "/A" "Co-localization" "polyI:C"
    "auto-activation" "expression/localization" "∆/"
    "237 invasive breast cancer samples using immunohistochemistry (IHC)"
    "mouse mammary epithelium" "myoepithelium" "∆11/co" "MMTVcre" "Mst1/2"
    "Yorkie" "Yes" "= 0.024" "p  = 0.002" "X100" "BCL" "NOD/SCID" "MYC+RAS"
    "AP4+RAS" "an AP4-encoding retrovirus"
    "diabetic/severe combined immunodeficiency" "pathways/functions"
    "retroviruses" "Lu" "a 3T3" "∼4.5 " "HDFs" "kbp" "qChIP" "E-boxes" "frt"
    "loxP" "CACGTG" "E-box" "Eilers" "G 1 /S" "organelle" "virus-1"
    "Δ Ex5-MBNL" "spliceopathy" "ofMBNL1" "siMBNL" "15-day-differentiated"
    "PRM/SH3 domain" "Manders" "=4" "vi" "KGGRSRLPLPPLPPPG" "PPLPKRP" "PGVPVP"
    "PLQPVP" "PRMs" "anti-P9" "Anti-P9" "autoregulates" "3isoforms" "ΔEx5-MBNL"
    "Ex5" "inclusion/exclusion" "CUG" "myotonic-dystrophy-like" "myotonia"
    "toEx" "muscleblind-like-1" "CTG" "Myotonic dystrophy type-1" "co-workers"
    "Chau" "the VP-16-induced autophagic vacuoles" "U373" "deoxynucleotidyl"
    "non-silenced" "Neg" "∼70%" "GBM95" "ATCC" "chemo-" "Kogan" "fluoracil"
    "Non-adherent" "kinase 1" "DK6" "DK4" "INK" "NPM-ALK-" "nonredundant"
    "ChIP/Re-ChIP" "D-type" "BCR-ABL  +" "+Cdk6 cells" "Supernatant"
    "− / −tumors" "CDK6R31C" "HistoQuest" "Cdk6R31C" "pMSCV-puro-based" "S2L"
    "p185 BCR-ABL -transformed Cdk6 − / −cells" "− / −cells"
    "p185 BCR-ABL -transformed Cdk6 − / −cell lines" "− / −cell lines"
    "BCR-ABL+" "+Cdk6cells" "+Cdk6" "leukemia/lymphoma" "− / −mouse" "5 × 10"
    "Nu/Nu" "ALK +" "ALK  +" "S2B" "and 1D" "S1C" "Morgera" "rod-like" "holo"
    "Bridgman" "ultrastructure" "Mathworks" "Matlab" "FWHM" "Lifeact"
    "micrograph" "/a" "=σ" "Carlo" "Monte" "Mesoscale"
    "the associated lipid bilayer" "anti-parallel" "anisotropy" "fs" "MARTINI"
    "bilayer" "MODELLER" "CGMD" "bilayers" "K571A/E572A" "Δ1–75" "GUVs"
    "the tubular invaginations" "tubular invaginations" "LUVs" "mesoscale"
    "tubules" "tubular membrane invaginations" "co-stained" "re-plated" "2 ps"
    "~20%" "=20" "non-physiological" "XL" "contrst" "MT-1A" "cycteine" "MTF-1"
    "MT-2A" "Zunyi" "Nuclear factor (erythroid-derived 2)-like" "Nrf" "Primer3"
    "TZ" "Nikaido" "phosphosphorylate" "Motokura" "11q13"
    "Miller tubular epithelium" "endometrial glandular epithelium" "=12.293"
    "non-metastatic" "uteri" "America" "Europe" "endometrioid" "= 0.005" "= 1"
    "anti-human" "proach" "ap" "Genomes" "rs78190160" "rs71372224" "1-Mb"
    "Tanay" "Yaffe" "Aiden" "Lieberman" "inactive ones" "orthologs" "ZRS"
    "Knudson's" "Knudson" "superprotein" "Bennett" "Germline"
    "approximately 1/3" "SPSS" "histoscores" "ICCC" "Histoscores" "Hscore"
    "Tunel" "anti-Ki-67" "Microsystems" "Leica" "stainer" "Denmark" "Glostrup"
    "DAKO" "Glasgow" "tetrahydrochloride" "diaminobenzidine" "A/S" "USA"
    "Cambridgeshire" "Abcam" "TBS" "Trizma" "un" "recognise" "non-retaining"
    "Villeurbanne" "CovalAb" "paraffin embedded TURP" "TURP" "TRUS"
    "aganosists" "Scotland" "Multicentre" "histoscore" "1.1–3.4" "IQR"
    "orchidectomy" "HNPC" "0.5–1" "HR = 1.9" "p = 0.04" "p = 0.02" "= 2.1"
    "p = 0.004" "ORR" "Missense" "original diagnostic biopsy" "Biosystems"
    "ABIPrism" "CMOCO" "PET/CT" "Manchester" "G719X" "2-3"
    "vessels/capillaries" "Ex" "~100%" "TCM" "damiana" "diffusa" "Turnera"
    "pseudoacacia" "Robinia" "dormancy" "Swiss" "pStat-3" "upto" "≤ 24"
    "5/group" "Univariate" "the histological subtype" "shRSK4" "pcDNA3.1/neo"
    "Cruz" "GRC-1" "variate" "=0.039" "CRCC" "ccRCC" "=0.021" "ccRCCs" "Thakur"
    "Vicente" "immunophenotypes" "Fuhrman" "anti-invasive" "=0.024" "μ g " "=1"
    "covariables" "the combined unfavorable genotypes" "age≤69"
    "adverse genotypes" "the mTOR rs2536 CT heterozygous genotype"
    "Hildebrandt" "Xu" "FRB" "1p36.2" "BMI≤24" "GT/GG" "possible haplotypes"
    "Haplotype" "the GG homozygous variant genotype" "I+II"
    "the TT homozygous variant genotype" "III+IV" "≤24"
    "their homozygous wild-type genotypes" "score≥7" "score≤7" "≤69" "3+4"
    "kg/m 2" "CG/CC" "1.07–1.55" "1.13–1.78"
    "their respective wild-type genotypes" "heterozygote" "≥7" "≤7" "≤10 ng/ml"
    "Gleason" "almost all the candidate SNPs" "GWASs" "IARC" "rs17036508"
    "two adverse genotypes" "more adverse genotypes"
    "their common homozygous genotypes" "rs2295080" "rs1034528" "rs2536"
    "=  0.014" "P  = 0.004" "=  0.003" "=  0.005" "= 0.019" "= 0.008"
    "P  = 0.012" "10 ng/ml" "P  = 0.007" "Conclusions/Significances"
    "de-repression" "gabazine" "HFS" "pS647-Drebrin" "dendrites" "PTENΔD"
    "anti-pS647-DBN" "pS647-DBN" "o" "anti-DBN" "dendrite" "Antennapedia"
    "permeant" "GFP-PTENΔD" "multiphoton" "PTENC2" "ΔD" "D-loop" "PTEN:DBN"
    "2 / 5" "non-phosphorylated" "Lipofectamine 2000" "co-IP" "Ahel" "Api5-"
    "Api" "siApi5" "HA-E2F1" "eluate" "Tata" "shSCR" "R-2HA2Flag-Api5" "shApi5"
    "E2F1-target cell" "h" "Berghe" "Morris" "subclasses"
    "Co-Immunoprecipitation" "non-transfected" "co-transfections"
    "Co-transfection" "Methodology/Principal" "exon 19" "exon21" "exon19"
    "Gandara" "OHdG" "ERFR" "Kalikaki" "and 3+" "delE746-A750" "WJTOG3405"
    "NEJ002" "P  = 0.045" "P = 0.045" "= 0.014" "= 0.027" "= 0.030" "= 0.024"
    "P = 0.036" "= 0.028" "P = 0.03" "P = 0.020" "MVs" "homogenates"
    "complete monoclonal immunoglobulin" "IgGk" "tubular cast nephropathy"
    "myocardium" "microvesicles/exosomes" "donorsTo" "SFM" "cromatography"
    "Whitney" "nanotubules" "co-incubation" "plasmacells" "EMVs/MVs"
    "exosomes/microvesicles" "Re-internalized" "M2λ" "A2λ" "A1k" "Congo" "M2 λ"
    "M1k" "IgGλ" "the proximal tubule" "tubule" "tubulo" "LCDD" "Waldenstrom’s"
    "Waldenstrom" "immunoglobulins" "SMM" "dyscrasia" "reroute"
    "re-internalized" "lambda" "dyscrasias" "*P" "X 100" "re-distribution"
    "** P" "* P" "foliaceus" "vulgaris" "Philadelphia" "ActB" "corneum"
    "GEF-dead" "CaCl" "LISA" "Abr" "MRTF" "MRTFs" "plakophilin-1"
    "plakophilins" "desmocollins" "desmogleins" "anti–mouse"
    "anti-phosphotyrosine" "C-terminally" "-3T3" "diphosphates" "vorinsotat"
    "HDAC1/2" "ortholog" "de-regulated" "IIa" "Zn" "stability/function" "MRN"
    "PIKK" "esophagectomy" "infiltrative histology" "the infiltrative subset"
    "regrown" "LNT14" "OCTT2" "fusiform" "amoeboid" "non-infiltrative"
    "Gensler" "Brandwein" "mesenchymal-like" "immunoassays" "JZ" "cyto" "ex"
    "Nrf2-asso-" "sphere-like" "quinone oxidoreductase1" "radi" "rythroid"
    "= 0.0009" "= 0.042" "n  = 6" "non-infected" "ISGs" "ISG" "virotherapy"
    "microM" "LLL12" "co-merged" "cytotoxicty" "MOI" "titer" "size/number"
    "shSTAT3" "gC" "titers" "pCR/CMV" "subsequent distribution/spread"
    "phosphorylation/activation" "rQNestin34.5" "oHSV"
    "the mesenchymal transcriptome" "=0.019" "anti-FLAG" "2 p" "class-1"
    "a dual lipid/protein kinase" "the exogenous substrate βic" "Dhand"
    "Layton" "undertaken" "class 1a" "p85α" "phosphoinositide 3-kinases" "Mn"
    "βic" "βc" "-kinases" "2+" "andTP53" "mut/+" "Ruzzo" "inTP53" "neoadjuvant"
    "HCT116KRAS" "let-7a" "Let-7a" "stepwise" "catnin" "cytoplasmic/nuclear"
    "cadheirn" "The stratified squamous epithelium" "P = 0.03" "= 0.39"
    "P = 0.01" "= 0.91" "rhabdoid" "cytometer" "Fernandes" "Hayashi" "vivo"
    "Case2" "Case1" "pLL3.7-WT1-shRNA" "WT1 enhanced" "WT1-shRNA3repressed"
    "**p" "*p" "WT1enhanced" "Rong" "non-cancer" "-kinase" "n = 6" "Loeb"
    "Exosome" "Exosomes" "PC-3" "exosomes" "exosome" "HPEC" "HAOSMC" "HAOEC"
    "DU145Kd" "unnecessary biopsies" "Harvey" "triphosphate" "non-cancerous"
    "Oellers" "invaginations" "ABPs" "websites" "cluster-like" "dot-like"
    "the miR-124-mediated anti-invasion" "miR-124-mediated anti-invasion" "Δ3"
    "anti-invasion" "meshwork" "looser" "shrunken"
    "polymerization/depolymerization" "kcal/mol" "BibiServ" "nts" "miRanda"
    "anti-migration" "L2K+pcDNA3.1" "pcDNA3.1" "Non-muscle" "= 20"
    "cholesterolemia" "Japanese" "adducts" "BHT" "ZnPP" "menhaden" "LC-MS/MS"
    "Intra" "isoprostanes" "protectins" "anti-inflammatory" "anti-atherogenic"
    "Eskimo" "HHE" "hydroxy" "oxygenase-1" "C57BL/6" "2P" "mg/kg"
    "A unique haplotype" "TATA" "C/T" "CACACA" "and 1B" "HapMap" "rs11255458"
    "InChianti" "FVG" "g/dl" "GG" "homozygotes" "rs1887582" "VB" "INGI"
    "Borbera" "Apennine" "Hct" "hematocrit" "Erythrocytes" "MCHC" "= 3.05"
    "Yasuda" "protooncogene" "adenoid" "Ishii" "Kanei" "Chie"
    "pcDNA3.1-EGFP-NLK" "pcDNA3.1-EGFP" "re-feeding" "expressers" "kinase1"
    "transforming growth factor β-activated kinase1" "P = 0.029" "tumorgrafts"
    "inErrfi1" "cutpoint" "1/16" "10/18" "PANC410" "PANC420" "BML-11" "BML-1"
    "BML" "blasticidine" "retrovirus" "MSCV" "Adam" "VEGRR" "re-using" "AKI"
    "P  = 0.002" "= 0.0002" "g/mL" "P  = 0.01" "Aida" "Andres" "Lopez"
    "human adult cardiac myocytes" "myocytes" "Weiss" "PeproTech" "limulus"
    "EU" "Immunocytochemistry" "heterodimerizaiton" "-1α" "1/2" "transducers"
    "zymography" "HAECs" "24 hrs" "IIiopoulos" "feedforward" "mir200c"
    "paracrine" "pS32" "Dieter" "Supershift" "pS536" "and 3D" "to 2D"
    "timeframe" "droplet" "timecourse" "NCSLC" "ZEB2/Sip1" "CICs"
    "stem/progenitor" "stem-like" "Cartegni" "dinucleotides" "orthologues"
    "Polyphen" "GVGD" "Peterlongo" "Hofstatter" "Harinck" "Guiorzo" "Adank"
    "Stadler" "CEU" "polymorphims" "the last codons" "breast/pancreatic" "IDC"
    "Gly1121ValfsX3" "a premature stop codon" "Tyr551Stop" "Slater" "Xia"
    "Tischkowitz" "BRCA1/2" "pancreatitis" "Jeghers" "Peutz" "germline"
    "penetrance" "breast/ovarian" "frameshift" "chromatids" "XRCC3-" "XRCC"
    "RAD51-foci-positive DSBs" "PARPi" "foci/chromatid" "SCEs" "ATMi" "ss"
    "pKAP-1" "PhosphoATM" "undergone" "euchromatic (EC) DSBs" "Holliday"
    "ssDNA" "chromatid" "KU70/80" "homologies" "non-homologous"
    "instead repair heterochromatic DSBs" "heterochromatic DSBs" "PR-619"
    "co-habitation" "trachomatis" "monocyte/macrophage" "Nigericine" "viremia"
    "cytology" "CINII" "cervical cancer biopsies" "ΔN" "ΔC" "re-constituted"
    "DQ™-Red" "™-Red" "Methyladenin" "bafilomycin" "punctae" "YVAD" "PYD"
    "immunosurveillance" "the antiviral defense interactome"
    "genome-wide transcriptome" "lysis" "penile" "interactome" "= 1" "= 8"
    "5×10" "co-activator" "non-malignant" "BMI" "hyperinsulinemia" "Alström"
    "hydroperoxyleucines" "iminoglycinuria" "Pyroglutamine"
    "the cumulative GRS" "a hypothetical gene LOC10013023" "LOC10013023"
    "rs4006531" "withr" "rs6546857" "rs13538" "ALMS1" "Alstrom" "rs10463316"
    "QQ" "metabolome" "GRS" "8q24" "2p13" "5q33" "ARIC" "dihydroxy"
    "pyroglutamine" "= 0.019" "= 6" "rebiopsy" "Warth" "covariate" "Girard"
    "Korea" "Portuguese" "EURTAC" "cycleave" "transthoracic needle biopsies"
    "3/218" "vs" "summa" "oncologists" "wednesday" "French" "Germany" "Hilden"
    "Qiagen" "RGQ" "Therascreen" "A750del" "Ellison" "dideoxy"
    "bronchial biopsies" "=0.27" "non-small" "autophagic vacuoles" "vacuoles"
    "MycER" "Tsuneoka" "Amaravadi" "PI3P" "Dendra" "Halotag" "ac" "OTB"
    "orthologue" "smartpool" "oligos" "morpholino" "phosphorodiamidate"
    "factor-1" "biomacromolecules" "ESCRT" "LE/MVB" "LE/MVBs" "Perhaps"
    "micrographs" "organelles" "siCon" "Tfn" "ligand:receptor" "anti-mouse"
    "Alexa488" "g/ml" "minimal co-localization" "Autoantigen-1" "EGFRs/cells"
    "siCON" "a dramatic re-distribution" "LE" "The acetylation-mimetic 3KQ"
    "LipidTOX" "and 3KR" "interac" "SIRTs" "546–554R" "3KR"
    "a half-life around 6 hr" "Ac" "anti-acetylated" "3KQ" "trometry" "SIRT"
    "~60%" "p38α nearly 6-times" "NSD" "Hydropro" "RMSD" "α4" "α-1" "α0"
    "CAT 2D" "PTPSL-like" "p38α:PSChimera" "PSChimera" "-p38α:800" "Guinier"
    "X9A" "Brookhaven" "Beamline" "KIMKIS" "a 2D" "~2-times" "β8" "HePTPP" "αE"
    "αD" "TROSY" "HADDOCK" "SAXS" "D-motif" "KIM" "amygdala" "Alzheimer’s"
    "Alzheimer" "auto-" "= 1" "~75%" "day-to-day" "unmet" "Asians"
    "Hispanic/Latino" "MSKCC" "Sloan" "45 pack-year" "=1.0" "0/21" "12/66"
    "1/3" "45 pack-years" "pack-years" "23/252" "71/207" "86/359"
    "Massachusetts" "Boston" "England"
    "v-ki-ras2 Kirsten rat sarcoma viral oncogene homolog ( KRAS )"
    "homolog ( KRAS )" "homolog" "45pack-year" "pack-year" "~10%" "~15%" "~35%"
    "=0.012" "microcarcinomas" "thyroidectomies" "biopsy (FNAB)" "FNAB" "7/8"
    "6/17" "8/25" "17/25" "≤2" "GLATEKSRWSG" "VE1" "Bio" "Springer" "BRAF+"
    "echinoderm microtubule-associated protein-like" "cerebellum" "non-Asian"
    "Cortot" "Daniele" "non-treated" "France" "neurosurgery" "YVMA" "codons"
    "Gy" "radioresistant" "stereotactic radiosurgery" "Poitiers" "protein-like"
    "n = 6" "co-authors" "QZ" "CWH" "PJV" "SZ" "WJC" "AQOA" "HFY" "JBZ" "JEP"
    "Hong" "Ferrone" "Dohner" "Gaidzik" "Bullinger" "Baldus" "Hwang" "Peng"
    "Fiordalisi" "Rangatia" "Pulikkan" "Fagerli" "Levis" "Verhaak" "GSE6891"
    "GSE 6891" "a publicly available dataset GSE12417" "GSE12417" "Metzeler"
    "hCD45+" "hCD45" "bi" "Li" "Wiernik" "80.5%/14.6%" "G1/S" "46.6%/41.1%"
    "69.7%/21.6%" "∼64.5%" "∼66.7%" "aminoactinomycin" "Eckert" "Hui" "Liu"
    "SEAP" "Wagner" "Eferl" "S1d" "Seidel" "TTCN" "Wingender" "Blake"
    "Spiekermann" "Robinson" "Odgerel"
    "publicly available AML patient datasets" "karyotype" "immunotherapy"
    "Matsukawa" "Liang" "Aidaroos" "Bessette" "Dataset" "suberoylanilide"
    "Zeng" "Weisberg" "Mizuki" "Nakao" "Rockova" "Licht" "Sternberg"
    "Lowenberg" "ITD" "n = 7" "pJAK2" "p = 0.007" "= 0.0004" "= 0.025"
    "= 0.028" "∼50%" "co-transfection" "p = 0.001" "even fewer miRNA" "parotid"
    "RNU6" "768-3p" "Let-7c" "886-5p" "wildtype" "pEZ-MT01-derived" "Luc"
    "predictive database algorithms" "Kirsten" "v" "antagomir" "768-5p"
    "antagomirs" "miRNA-886-5p" "200c" "HB-239" "MBII-239" "MBII" "C/D"
    "MiRNAs" "MiRNA" "co-cultured" "Co-culture" "miRNAs" "leakiness" "edema"
    "miRNA-768-3p" "miRNA" "re-establish" "miRNA-125b" "stem cell-like" "Kim"
    "Chang" "transactivaton" "MRE" "Zhou" "=0.0030" "miR-125b-1" "=0.042"
    "21q21" "11q24" "MiRNA-125b" "TUNEL" "universal primers GP5+/6+" "GP5+/6+"
    "=8" "human normal cervical (NC) epithelium" "mesoderm" "endoderm" "=0.036"
    "=0.0048" "Igf1rβ" "16/19" "~45%" "the orthotopic allograft"
    "compartment/cell membrane" "U21459" "gastrocnemius" "allograft" "0–1" "lo"
    "continuum" "U23674" "intra-" "1 +" "~50%" "≥0.5" "datasets" "awhich"
    "the most significant SNPs" "Rs16847082" "Rs1978873" "Rs10497968"
    "Rs845552" "rs2075112" "rs16847082" "probands" "the ERBB4 intronic SNPs"
    "the stringent Bonferroni" "rs1801200" "rs11238349"
    "previously unknown neighboring SNPs" "highrisk" "proband"
    "the previously identified functional common polymorphisms" "Ilumina"
    "tSNPs" "P = 0.05" "16 SNPs" "HKL" "JCL" "KYL" "SHJ" "YCK" "CTCs" "dHPLC"
    "Taqman" "Sanger" "non-smokers" "10/60"
    "The most common histological subtype" "cfDNA" "SARMS" "IPASS" "KMLCG"
    "Korean" "Johnson" "= 0.054" "polychemotherapy" "low MYC IHC scores ≤10%"
    "≤10%" "WBC" "= 0.0009" "= 2.34" "= 1.90" "non-blastic" "Spearman’s"
    "benign lymph node/tonsil" "blastic histology" "/μL" "Ann" "Burkitt" "ECOG"
    "MIPI" "intra" "= 0.012" "= 0.034" "p = 0.03" "p =0.009" "≥ 2" "p =0.03"
    "Bioinformatic algorithms" "ARACNE" "algorithms" "a TrF’s" "co-occurring"
    "dataset" "TRANSFAC" "co-targeting" "GSE6477" "scatterplot" "TrF’s" "Chng"
    "the TrF’s" "TrFs" "TrF" "trisomy" "hyperdiploidy" "14q32" "immunoglobulin"
    "trisomies" "non-hyperdiploid" "TrF-pathway" "NHMM" "hyperdiploid" "Zhang"
    "Ag" "STAT#1" "#1" "IL-6/STAT3C" "+20" "STAT3C" "nt" "mIgFc" "co-cultures"
    "pSTAT3" "co-culture" "TSST" "Igs" "moDCs" "isotype"
    "a possible confounder" "uni-" "uni" "confounder" "CEP6"
    "a manual scoring algorithm" "Holst" "Tomita" "Nielsen" "Ejlertsen" "Ooi"
    "Filho" "Reis" "Horlings" "Moelans" "Salomon" "aCGH" "6q25.1"
    "amplification/overexpression" "normal/No" "gain/Functional"
    "normal/Functional" "Gain/No" "tumoral ESR1/CEP6 gene ratio ≤1" "≤1" "Wald"
    "weak/moderate" "invasive ductal histology" "invasive lobular histology"
    "histological grade I/II" "I/II" "IIA" "ΔCt" "algorithm"
    "No statistically significant DFS" "Oncology" "discrepant" "DFS"
    "gain/amplification" "ESR1/CEP6" "favorable prognosticators"
    "prognosticators" "HeCOG" "Discrepant" "p = 0.04" "95% CI " "= 0.012"
    "p = 0.009" "p = 0.002" "Kaplan–Meier" "p = 0.029" "non-functional" "G0/G1"
    "cpms" "L56Brc1cell line" "WST-1" "wt" "the larger genome" "™-vector"
    "pmaxGFP" "EX-EGFP-M02" "destabilizers" "p = 0.001" "Kaplan-Meier" "EGFR/"
    "Taelman" "co-localizes" "neointima" "co-localize"
    "virtually no co-localization" "succinimidylpropionate" "dithiobis"
    "the soluble ectodomain" "sPDGFr" "pPDGFRβ" "ectodomain" "plasmon"
    "microtiter" "NPXY" "NPxY" "smLRP1" "aneurysm" "lipoproteins" "renarrows"
    "= 7" "Imetesltat" "Imetlestat" "FLU-induced γ-H2AX" "pM" "lengh" "del11"
    "del17" "Cmax" "del11q" "del17p" "clinicaltrials" "thio" "DSB" "DSBs"
    "potentiatethe" "IgVH" "Ku70/80" "oligo" "Ku" "p = 0.004" "p = 0.0001"
    "p = 0.03" "= 0.036" "p = 0.01" "= 1.6" "p = 0.007" "= 0.003" "TITAN"
    "Doebele" "cryobiopsies" "bronchoscopic or transthoracic core biopsies"
    "_T710" "D770GY" "ERS" "ATS" "IASLC" "non-squamous" "hotspot" "Biopsies"
    "p  = 0.05" "p  = 0.04" "p  = 0.03" "p  = 0.01" "non-squamous cell"
    "non-small-cell" "FVIIa" "Meier" "histology" "Multivariate" "non-tumor"
    "Non-tumor" "Mucosa" "TTSP" "TTSPs" "Lauren’s" "Lauren"
    "Immunohistochemistry" "P = 0.0001" "= 0.005" "Kitamura" "LXRα" "carnitine"
    "Thakran" "pulldowns" "phosphoenol" "G-6-Pc" "Subset" "co-precipitation"
    "AGGTCA" "the predominant TR subtype" "active LXRα" "coactivator 1α"
    "co-regulator" "β1" "Anti-Flag" "anti-Flag" "pathophysiology"
    "GRB2 -targeted miR-376c" "trophoblasts" "siGRB2s" "receptor-like" "Ye" "b"
    "siGRB2" "siGRB2-2" "siGRB2-1" "mt" "pMIR" "the online software TargetScan"
    "MiR-376c" "IHGGK" "TKKK" "ICCs" "homeodomain" "miR-376c" "C→G" "C→A"
    "photoadduct" "misincorporate" "SupF" "industrial aromatic amines" "amines"
    "J/m 2" "UVC" "adduct" "supershift" "pcDNA" "+63MU" "TGCcaCA" "AP-1-like"
    "+63" "TGAGTCA" "TGCGTCA" "−275" "exome" "non-PCP"
    "the previously published SCRIB mutation p" "PDZ3" "Homozygotes"
    "craniorachischis" "A1315T" "SIFT" "predicted-to-be-deleterious" "A366T"
    "dbSNP" "non-craniorachischisis" "PRICKLE" "Celsr1 D1040G" "folic" "Spina"
    "complete low spinal closure causes spina bifida" "PolyPhen" "missense"
    "Crc" "circletail" "bifida" "spina" "OMIM" "co-precipitates"
    "ALK1 and D5F3 IHC" "ALK1+" "the ALK1 IHC" "3a/b" "E6a" "E6a/b" "E17b"
    "3a/3b" "ALK1 IHC" "repeated IHC" "the D5F3 IHC" "only 4 IHC 3+" "and 2+"
    "1+" "E10a/b" "hepatoid" "p  " "ALK IHC" "2p" "echinoderm" "D5F3" "Dako"
    "cribriform" "situ" "= 0.006" "= 0.013" "p  = 0.59" "= 0.83"
    "6-diamidino-2-phenylindole" "the repressive effect miR-34c"
    "the benign epithelium" "the benign and malignant epithelium" "epithelium"
    "transcriptome" "miRtarget2" "RNAhybrid" "Pita" "Miranda" "NCBI's" "NCBI"
    "characterise" "forexample" "CRPC" "prostatectomy" "miR-34c" "stemness" "c"
    "=0.032" "=0.0008" "P =0.05" "=0.034" "P =0.001" "=0.006" "=0.003" "μ g"
    "CAP8AP2" "P = 0.020" "gastrointestinal mucosa" "mucosa" "IkappaA"
    "subtypes" "2q32-q33" "= 0.011" "95% CI" "= 0.96" "reponse" "subtype"
    "Noughabi" "Boroumand" "rs5029748" "95%CI" "= 6.3E-03" "serology" "=0.96"
    "rs7543272" "rs12089041" "rs3789587" "rs1846522" "rs7216812" "rs9788973"
    "Bonferroni" "their most significant SNPs" "UGI" "hoc" "Shanxi" "GNCA"
    "noncardia" "cardia" "= 0.8" "P = 0.004" "= 0.020" "= 0.013"
    "non-significant" "= 0.005" "non-coding" "P = 0.02" "= 6.3" "RTK/ligand"
    "immuno" "priori" "multipathway" "Multipathway" "deconvolve" "PCA"
    "nearly all downstream phosphosites" "phosphosites" "cy" "simpler"
    "Spearman" "classifier"
    "the IGF1R (insulin-like growth factor 1 receptor)-targeted drug AEW541"
    "AEW541" "SVM" "bivariate" "Pairwise" "CCLE" "siveness" "inva" "mol/L"
    "E-guggulsterone" "Verma" "Ahn" "motile" "re-organization" "xl" "Bcl"
    "diploid" "progenies" "chemoresistance" "Graviola" "Thymoquinon"
    "cytoskeletal re-organization" "non-receptor protein-tyrosine kinase"
    "lammilopodia" "Co-immunoprecipitation" "pBAD" "14-3-3ζ" "HNSCC" "p=0.001"
    "Alexa" "mukkul" "Commiphora" "exudates" "polyphenol" "dione" "non-toxic"
    "chemo" "CD18/HPAF" "anti-proliferative" "GS" "mg /kg" "P= 0.002" "=0.001"
    "5-year" "anti-tumor" "gastrula" "coverslips" "non-adherent" "PNGaseF"
    "SSSTPPSV" "PEST" "GSK-3α/β" "immunocytochemistry" "control±S" "Oncomine"
    "oestrogen" "ZIPB" "Zrt-" "Zrt" "monolayers" "P =0.007" "collectives" "WM"
    "epiphyses" "FOSL" "C/EBPs" "C/EBP" "hnRNPs" "HnRPs" "UV" "hnRP"
    "nucleases" "A definite endpoint" "endpoint" "mU/l" "oGTT" "mg/dl" "BSCL4"
    "BSCL3/caveolin-1" "BSCL1/AGPAT2" "lipoatrophy" "protein/DNA" "Cavin"
    "BSCL1-4" "hyperinsulinism" "nigricans" "non-redundant" "PDD" "reuptake"
    "partum" "Spanish" "introns" "broader" "Genotypes" "LPR" "epeat" "SERTLPR"
    "univariate" "rs6314" "=0.02" "rs4680" "=0.05" "=3.05" "p=0.04" "rs2077647"
    "EPDS" "approximately six haplotype" "Weinberg"
    "eleven strong candidate polymorphisms" "Payne" "Lokuge" "Postpartum"
    "Edinburgh" "microsatellite" "postpartum" "p=0.002" "biopsy" "p16/Rb"
    "inactive Rb" "strong Rb" "−9p" "13q14" "9p21" "Esposito" "Karim" "Kuijper"
    "basal-like" "oropharynx" "p16+/low" "weak Rb" "3/14" "4/14"
    "phyllodes (BLP)" "benign phyllodes (BP)" "9p" "immunohistochemistry (IHC)"
    "Phyllodes" "benign phyllodes" "Rb+" "p16+" "diffuse strong Rb"
    "Twenty-nine percent (4/14) malignant phyllodes" "p16−" "p" "Rb−" "Rb"
    "phyllodes" "GYJ" "Dulbecco’s" "Dulbecco" "dihydrochloride" "Actinomicyn"
    "myristate" "Immunoglobulin" "SPE" "non-specific" "supernatant" "H&E"
    "C57BL6/J" "Beva" "toluidine" "hematoxilin" "Wv" "Non-specific" "IRES"
    "stressful" "CXH" "CHX" "cytospin" "°C" "supernatants" "BFA" "Supernatants"
    "microvessel" "biopsies" "FcϵRI" "ϵRI" "Wsh" "non-Hodgkin" "KG" "Luo’s"
    "Luo" "approximately 260 μg/L" "μg/L" "anti-oncomir" "MiRanda" "TargetScan"
    "rs16430" "-UTRs" "UTRs" "Three functionally important polymorphisms" "iii"
    "WST" "silico" "YI" "RTIs" "TI" "YS" "2-amino-1-methyl-6-phenylimidazo"
    "de-regulation" "the viral titres" "copies/mL" "the viral titre" "titre"
    "L1-RTP-inducing" "ΔC12" "exogenous FICZ" "open reading frame-1" "AQQAA"
    "carbazole (FICZ)" "photoproduct" "FICZ" "carbazole" "formylindolo"
    "siRNAs" "-nitroflavone" "nitroflavone" "LQQLL" "LxxLL" "COBRA" "L1-5" "μg"
    "μmoles" "RTI" "-ethynylthymidine" "ethynylthymidine" "tenofovir" "WB"
    "8D1" "TaqMan" "pEF06R" "bp" "I/ColE1" "mneo"
    "HIV-1-associated nephropathy (HIVAN)" "nephropathy" "Americans"
    "retrotranspose" "low viral titres" "titres" "Tg" "rVpr" "element-1"
    "type-1" "× 10" "Ohse" "Prasad" "FFPE" "Fonseca" "Ameri" "Kunstman" "Korah"
    "benign ACAs" "co-localized" "sporadic co-localization" "transwell"
    "re-expression" "co-localization" "re-expressed" "SW-13/V" "SW-13/AM"
    "SW-13/A" "RASSF1A/A133S" "ACT-1" "NCI" "frozen" "methylomes" "SARAH"
    "Family 1A" "Carney" "exons" "ACAs" "U/mL" "&E" "Re-expression" "n = 6"
    "n = 7" "naïve" "±0.3%" "necrostatin" "necrostatins" "±0.7%" "=0.029"
    "=0.59" "±1.9%" "±1.1" "±1.0" "p=0.045" "=0.045" "=2.7×10" "9.8±2.7 %"
    "mycophenolate" "Fischer" "blockers" "=0.043" "12.7±0.7%" "MTGhi" "=3.6×10"
    "=0.0001" "=0.0015" "=0.0247" "12.7±0.7 %" "21.8±0.7 %" "U/ml" "p=3.9×10"
    "≥ 4" "MFI" "p=1.6×10" "=0.410" "=0.00001" "=−0.316" "=0.00022" "=1.6"
    "co-stimulation" "=0.00003" "=0.254" "Anti-DNA" "=1.4" "BILAG" "Pearson"
    "× 10" "pS6RP" "ΔΨ m" "1–3" "p=6.7" "p=1.1×10" "=3.9×10" "=1.1" "=5.9×10"
    "subsets" "TMRM" "ΔΨ" "/CD4 +" "hypocomplementemia" "anti-DNA" "MHP" "≥4"
    "×10" "discriminant" "SLEDAI" "p=0.009" "= 7" "p=0.007" "=2.1" "transducer"
    "Pre" "hyper" "monotherapy" "co-treatment" "PathScan" "gavage"
    "mono-therapy" "leakier" "Evans" "monolayer"
    "an electric cell-substrate impedance" "ECIS" "impedance" "intracarotid"
    "tdTomato" "Transwell" "immunohistochemistry" "sublines" "IHC" "carotid"
    "CNS" "BBB" "non-receptor tyrosine kinases" "TNBC" "HER2+"
    "stereotactic radiosurgery (SRS)" "SRS" "radiosurgery" "WBRT" "_through"
    "parenchyma" "p = 0.002" "=0.008" "3+" "replicate" "important SNPs" "MCBCS"
    "HRs" "African" "poorer" "rs250108" "Cen" "rs152524" "rs17099156"
    "rs1596776" "rs4252596" "rs1810132" "homozygote" "rs308435" "rs6001512"
    "rs4912868" "rs9622978" "greater" "PR-" "ER+" "rs9324889" "rs265155"
    "ARTPs" "rs2436389" "SEER" "Arizona" "Colorado" "Utah" "CBCS" "Mexico" "132
blinded internal replicates"
    "replicates" "Diego" "Illumina" "GoldenGate" "European" "=0.8" "codon"
    "TagSNPs" "tagSNP" "Genome" "mouthwash" "multi" "non-Hispanic" "rs1136201"
    "GWAS" "ER+/PR+" "rs2981582" "NA" "American" "NHW" "p
= 0.03"
    "=0.04" "= 0.007" "U-rich" "RNPC1b" "RNPC1a" "CRAF-" "CRAF" "MEGS"
    "lentivirues" "co-precipitate" "DUF1669" "co-precipitated" "PhophoSitePlus"
    "lrBM" "shRNAs" "soft agar" "tert" "agar" "VU0155056" "butanol" "PtdBuOH"
    "d" "phosphatidylbutanol" "HxKxxxxD" "HxKxxxKxxxD" "proven" "VDQ" "ARRY"
    "the Vpr-induced mechanical allodynia" "Aβ" "mellitus" "Mellitus" "dieback"
    "Aδ" "ii" "agonism" "μg/mL" "non-significantly" "pGSK3β" "pre" "Axons"
    "divider" "neurites" "Campenot" "footpad" "=6" "=7" "sural"
    "significant mechanical allodynia" "Frey" "hindpaw" "footpads"
    "smaller caliber axons" "Schwann" "axons" "display mechanical allodynia"
    "concurrent HAART" "paresthesia" "HAART" "axon" "neurite" "littermate"
    "mechanical allodynia" "allodynia" "AMBRA" "PKCλ/ι" "shTRAF6" "siRNA"
    "RING" "pixels" "ΔTB" "PXEXX" "PSEDP" "shNT" "aPKCs" "Cs" "begun" "K63R"
    "XAip1" "Okada" "cofilactin" "= 0.5" "=0.9" "a longer L  avg"
    "the shortest observed L  avg" "greatest" "avg" "=0.5" "~0.5" "cof"
    "nearest" "mGluRs" "L-Dopa-induced dyskinesia" "dyskinesia" "cortico"
    "conformers" "conformer" "an unusual IEG" "intron" "D1R"
    "the corticostriatal synapse" "and 1c" "Homer1b/c" "fromGrm5" "fromHomer1"
    "hrs" "hr" "LTD" "Corticostriatal synapses" "mGluR5TSAA" "accumbens"
    "similark" "withk" "ZZ" "/pS" "isomers" "inGrm5" "mGluR5FR" "R/R" "Sindbis"
    "inHomer1" "conductance" "APV" "2-Methyl-6-" "pyridine" "phenylethynyl"
    "HTKO" "forebrain" "Homer1c" "pT" "IEG" "pS" "co-functional" "TPPSPF"
    "EVH1" "Homer1a" "PPXXF" "mGluR1/5" "Preso1" "corticostriatal synapses"
    "synapse" "synapses" "= 0.01" "et" "Roose" "RasPRG1" "clarifications"
    "Kuriyan" "toto" "Weigel" "Detlef" "Noonan" "perhaps" "diacylglcyerol"
    "undergoes" "Overhauser" "∼10.5" "dichroism" "sidechain" "HSQC" "CE"
    "isothermal titration calorimetry (ITC)" "calorimetry (ITC)" "ITC"
    "calorimetry" "∼15-fold" "choline" "∼300-fold" "multiangle" "helix"
    "sidechains" "ionic" "webserver" "rmsd" "occludes" "antiparallel" "helices"
    "CC" "CEC" "coli" "simplest" "phosphoinositides" "Ras•GTP" "erythematosus"
    "•GTP" "•GDP" "DOI" "Iwig" "‘fresh’ ones" "ones" "eLife" "hidden"
    "interdomain" "corticosteroid" "Asian" "enhancers" "enhancer"
    "corticosteroids" "=0.002" "QcALL" "SNPs" "p=0.03" "LCLs" "LCL"
    "lymphoblastoid" "semi" "arginin" "genotype" "p=0.01" "= 1.9" "=0.03"
    "DFCI" "haplotype" "*1" "=6.3" "=0.004" "=0.009" "TT29201" "=0.007" "=0.01"
    "≥5%" "haplotypes" "tagSNPs" "pairwise" "Polymorphisms" "lymphoblasts"
    "genotypes" "polymorphism" "multivariate" "polymorphisms" "genome"
    "Corticosteroids" "anti-apoptotic" "HA-Ub-K63-only" "co-transfected" "ED"
    "anti-Ub-K63-specific" "Ub" "homologs" "suppressor-like" "PriGO7A"
    "PriGO9A" "TUJ1" "neurospheres" "PriGO8A" "chosen" "GTIC" "Ottawa"
    "duplexes" "Lgl3SA" "Yamanaka" "non-muscle" "dysplasia" "epithelia"
    "non-phosphorylatable" "GTICs" "subset" "U251" "shRNA" "arrest/death"
    "anti-cancer" "Nanoliposomes" "multidomain" "ELISA" "eosin" "nanoliposome"
    "QUE-NL-induced" "a potential chemopreventer" "chemopreventer"
    "advancements" "NLs" "NL" "QUE" "nanoliposomes"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-10501-10800*
  '(("mutational p53" . SPARSER::PROTEIN)
    ("Bmi1 and wild-type p53 protein" . SPARSER::COLLECTION)
    ("both miR-200c and miR-203" . SPARSER::COLLECTION)
    ("caspase 9 and caspase 7" . SPARSER::COLLECTION)
    ("posses mutational p53" . SPARSER::PROTEIN)
    ("pEGFP-N1-p53" . SPARSER::COLLECTION) ("pRL-TK" . SPARSER::COLLECTION)
    ("pRL" . SPARSER::PROTEIN) ("miR-200c or miR-203" . SPARSER::COLLECTION)
    ("pMir-Bmi1-Mut" . SPARSER::COLLECTION)
    ("pMir-Bmi1-Wt" . SPARSER::COLLECTION) ("pMir" . SPARSER::PROTEIN)
    ("miR-200c and miR-203 expression" . SPARSER::COLLECTION)
    ("a legitimate target" . SPARSER::TARGET-PROTEIN)
    ("critically conserved nucleotides" . SPARSER::NUCLEOTIDE)
    ("miR-203 maybe target Bmi1" . SPARSER::PROTEIN)
    ("Bmi1 and Bax" . SPARSER::COLLECTION)
    ("Bmi1 enriched breast cancer stem cell CD44 + /CD24"
     . SPARSER::COLLECTION)
    ("Bmi1, gain-of-function and loss-of-function" . SPARSER::COLLECTION)
    ("p16INK4a and p19ARF" . SPARSER::COLLECTION)
    ("hedgehog" . SPARSER::PROTEIN) ("Polycomb" . SPARSER::PROTEIN)
    ("CSTs" . SPARSER::PROTEIN) ("TICs" . SPARSER::PROTEIN)
    ("p53, and Bmi1" . SPARSER::COLLECTION)
    ("miR-200c and miR-203" . SPARSER::COLLECTION)
    ("Bmi1 and miR-200c" . SPARSER::COLLECTION)
    ("caspase 7" . SPARSER::PROTEIN) ("type 3" . SPARSER::PROTEIN)
    ("caspase9" . SPARSER::PROTEIN) ("caspase7" . SPARSER::PROTEIN)
    ("p14ARF" . SPARSER::PROTEIN) ("p16INK4a" . SPARSER::PROTEIN)
    ("Angptl4, Cxcl12 and Mdk" . SPARSER::COLLECTION)
    ("Mdk and TGF-β" . SPARSER::COLLECTION)
    ("second-wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Myc and Tnfsf15" . SPARSER::COLLECTION)
    ("inhibitor (VEGI)" . SPARSER::INHIBITOR) ("VEGI" . SPARSER::PROTEIN)
    ("inflammatory cytokines and adhesion molecules" . SPARSER::COLLECTION)
    ("/Sca1" . SPARSER::COLLECTION) ("Sdf-1" . SPARSER::PROTEIN)
    ("integrins and adhesion molecules" . SPARSER::COLLECTION)
    ("Angptl4, Mdk, Cxcl12, Tgfb2 and Tnfsf15" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines and adhesion molecules" . SPARSER::COLLECTION)
    ("p21 and p15" . SPARSER::COLLECTION)
    ("Cdc25A and Cyclin B1" . SPARSER::COLLECTION)
    ("p19 and p21" . SPARSER::COLLECTION)
    ("p15, p16 and p21" . SPARSER::COLLECTION)
    ("Tgfb2 and Vcam1" . SPARSER::COLLECTION)
    ("Angptl4 and Tgfb2" . SPARSER::COLLECTION) ("Stat1" . SPARSER::PROTEIN)
    ("Tnfsf15, Angptl4, Tgfb2 and Vcam1" . SPARSER::COLLECTION)
    ("Mdk and Tgfb2" . SPARSER::COLLECTION)
    ("Cell cycle inhibitor genes Cdkn1a (p21) and Cdkn2d (p19)"
     . SPARSER::COLLECTION)
    ("the cell cycle activators Ccnb1 (Cyclin B1) and Cdc25A (Cell Division Cycle Homolog 25A)"
     . SPARSER::COLLECTION)
    ("Ccnb1" . SPARSER::PROTEIN) ("Cdkn2d" . SPARSER::PROTEIN)
    ("Edn1" . SPARSER::PROTEIN) ("endothelin" . SPARSER::PROTEIN)
    ("chemokines Cxcl2 (3.83-fold) and Cxcl12 (6.32-fold)"
     . SPARSER::COLLECTION)
    ("cell adhesion molecules Icam1 (4.07-fold) and Vcam1 (4.27-fold)"
     . SPARSER::COLLECTION)
    ("Icam1" . SPARSER::PROTEIN) ("Icam" . SPARSER::PROTEIN-FAMILY)
    ("extracellular-matrix proteins and adhesion molecules"
     . SPARSER::COLLECTION)
    ("several growth factors, cytokines, extracellular-matrix proteins and adhesion molecules"
     . SPARSER::COLLECTION)
    ("extracellular-matrix (ECM)/adhesion molecules and cell cycle regulation genes"
     . SPARSER::COLLECTION)
    ("possible downstream targets" . SPARSER::TARGET-PROTEIN)
    ("-β-galactosidase" . SPARSER::COLLECTION)
    ("complete media" . SPARSER::PROTEIN)
    ("protein and RNA" . SPARSER::COLLECTION)
    ("c-Myc (KD) or non-silencing shRNA (NS)" . SPARSER::COLLECTION)
    ("shRNA (NS)" . SPARSER::PROTEIN)
    ("growth factors and chemokines" . SPARSER::COLLECTION)
    ("E2f1, Id1 and Myb" . SPARSER::COLLECTION)
    ("RelB, Stat1, Stat2 and Stat4" . SPARSER::COLLECTION)
    ("Angptl4, Cxcl12, Mdk, Tgfb2 and Tnfsf15" . SPARSER::COLLECTION)
    ("Tnfsf15" . SPARSER::PROTEIN) ("Cxcl12" . SPARSER::PROTEIN)
    ("Angptl4" . SPARSER::PROTEIN)
    ("extracellular-matrix" . SPARSER::COLLECTION) ("Mdk" . SPARSER::PROTEIN)
    ("Cdkn2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Angiotensin converting enzyme" . SPARSER::PROTEIN)
    ("Cxcl2" . SPARSER::PROTEIN) ("Vcam1" . SPARSER::PROTEIN)
    ("GAG-Pol" . SPARSER::PROTEIN) ("Stat2" . SPARSER::PROTEIN)
    ("Tgfb2" . SPARSER::PROTEIN)
    ("a potential predictive biomarker" . SPARSER::MOLECULE)
    ("erlotinib and bevacizumab" . SPARSER::COLLECTION)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("TKIs or TKIs" . SPARSER::COLLECTION)
    ("a significantly shorter PFS" . SPARSER::PROTEIN)
    ("TS12 and exon" . SPARSER::COLLECTION)
    ("EGFR, KRAS and VEGFA" . SPARSER::COLLECTION)
    ("either TS12 ( xref , central and right panels) or the other investigated endpoints"
     . SPARSER::COLLECTION)
    ("KRAS and VEGFA" . SPARSER::COLLECTION)
    ("TS12 and TTP" . SPARSER::COLLECTION)
    ("Epidermal growth factor-receptor" . SPARSER::COLLECTION)
    ("PR or CR" . SPARSER::COLLECTION) ("TTP" . SPARSER::PROTEIN)
    ("recent biomarker" . SPARSER::MOLECULE)
    ("a TKI or a TKI" . SPARSER::COLLECTION)
    ("a relevant predictive biomarker" . SPARSER::MOLECULE)
    ("bevacizumab and erlotinib" . SPARSER::COLLECTION)
    ("VEGFA" . SPARSER::PROTEIN)
    ("additional relevant biomarkers" . SPARSER::MOLECULE)
    ("TS12" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("Our observations shed new light" . SPARSER::PROTEIN)
    ("calcium and second messenger diacylglycerol" . SPARSER::COLLECTION)
    ("a family of serine- and threonine-specific protein kinases that can be activated by calcium"
     . SPARSER::COLLECTION)
    ("being given CD40L" . SPARSER::PROTEIN) ("BL6" . SPARSER::PROTEIN)
    ("these subcellular fractions" . SPARSER::COMPONENT)
    ("PKCβ-DN" . SPARSER::COLLECTION)
    ("IκBα, an inhibitor of NF-κB, and nuclear translocation of NF-κB p65"
     . SPARSER::COLLECTION)
    ("CD40L-" . SPARSER::PROTEIN) ("calcein" . SPARSER::MOLECULE)
    ("human peripheral monocytes" . SPARSER::PROTEIN)
    ("the cell-associated form" . SPARSER::FORM)
    ("CD40 and CD40L" . SPARSER::COLLECTION)
    ("CD40-CD40L" . SPARSER::COLLECTION)
    ("the tumor necrosis factor (TNF) and TNF-receptor (TNFR) family"
     . SPARSER::COLLECTION)
    ("the multipotent immunomodulator CD40L" . SPARSER::PROTEIN)
    ("tumor necrosis factor (TNF)" . SPARSER::PROTEIN)
    ("CD40 and CD40 ligand" . SPARSER::COLLECTION)
    ("CD40L or CD154" . SPARSER::COLLECTION)
    ("TNF-receptor" . SPARSER::COLLECTION)
    ("selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1"
     . SPARSER::COLLECTION)
    ("selectins" . SPARSER::PROTEIN) ("PKCβ and NF-κB" . SPARSER::COLLECTION)
    ("CD40 and its ligand CD40L" . SPARSER::COLLECTION)
    ("Iκ-Bα" . SPARSER::PROTEIN) ("Anti–" . SPARSER::ANTIBODY)
    ("CD154" . SPARSER::PROTEIN) ("CD40 ligand" . SPARSER::PROTEIN)
    ("meiotic" . SPARSER::DRUG)
    ("the proximal and distal Alu" . SPARSER::PROTEIN)
    ("Alu-Alu" . SPARSER::COLLECTION) ("NAHR" . SPARSER::PROTEIN)
    ("gene and exons" . SPARSER::COLLECTION)
    ("Families" . SPARSER::PROTEIN-FAMILY)
    ("MLH1 and MSH2" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin E and Cdc25A" . SPARSER::COLLECTION)
    ("p16 and p19ARF" . SPARSER::COLLECTION)
    ("the predominant factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CKIs, p21 Cip1 , p27 Kip1 , and p57" . SPARSER::COLLECTION)
    ("p16 and p19ARF and cyclin D1" . SPARSER::COLLECTION)
    ("p19ARF and cyclin D1" . SPARSER::COLLECTION)
    ("Ink4a-ARF" . SPARSER::COLLECTION)
    ("a CK1α-associated protein" . SPARSER::PROTEIN)
    ("β-catenin and GSK3β" . SPARSER::COLLECTION)
    ("AKT, GSK3β and β-catenin" . SPARSER::COLLECTION)
    ("our previous studies SDF1" . SPARSER::PROTEIN)
    ("MAPKs, ERK, JNK, and p38, and AKT" . SPARSER::COLLECTION)
    ("p38, and AKT" . SPARSER::COLLECTION)
    ("chronic ischemia" . SPARSER::PROTEIN)
    ("a healthy state" . SPARSER::BIO-STATE) ("ring" . SPARSER::PROTEIN)
    ("p27 Kip1 or p57" . SPARSER::COLLECTION)
    ("p21 Cip1 , p27 Kip1 , and p57" . SPARSER::COLLECTION)
    ("Kip1 , and Bmi-1" . SPARSER::COLLECTION)
    ("CK1α and β-catenin" . SPARSER::COLLECTION)
    ("active β-catenin (unphosphorylated, stable) and total β-catenin"
     . SPARSER::COLLECTION)
    ("the proteasomal inhibitor" . SPARSER::INHIBITOR)
    ("lactacystin" . SPARSER::DRUG) ("CK1α and GSK3β" . SPARSER::COLLECTION)
    ("SDF1 and CK1α" . SPARSER::COLLECTION)
    ("a β-catenin" . SPARSER::COLLECTION) ("LEF-Luc" . SPARSER::PROTEIN-PAIR)
    ("CK1α and S33" . SPARSER::COLLECTION)
    ("GSK3β and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and CK1α" . SPARSER::COLLECTION)
    ("chronic AMD3100" . SPARSER::DRUG) ("Axin" . SPARSER::PROTEIN)
    ("Flt3-LSK" . SPARSER::COLLECTION) ("LSK" . SPARSER::PROTEIN)
    ("SDF1-CXCR4" . SPARSER::COLLECTION) ("Delta" . SPARSER::PROTEIN)
    ("Bmi-1 and cyclin D1" . SPARSER::COLLECTION)
    ("TCF/LEF" . SPARSER::COLLECTION) ("CSPC" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN) ("Cdc25A" . SPARSER::PROTEIN)
    ("p57 Kip2" . SPARSER::PROTEIN) ("p19ARF" . SPARSER::PROTEIN)
    ("Wnt3a" . SPARSER::PROTEIN) ("a β" . SPARSER::PROTEIN)
    ("β catenin" . SPARSER::PROTEIN) ("β2 microglobulin" . SPARSER::PROTEIN)
    ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CKIα" . SPARSER::PROTEIN)
    ("S33" . SPARSER::PROTEIN) ("GSK-3 β" . SPARSER::PROTEIN)
    ("Flt3" . SPARSER::PROTEIN) ("Sca1" . SPARSER::PROTEIN)
    ("Bmi-1" . SPARSER::PROTEIN) ("CK1α" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN)
    ("stromal cell derived factor 1" . SPARSER::PROTEIN)
    ("Oct4-Sirt1-p53" . SPARSER::COLLECTION)
    ("Sirt1 and p53" . SPARSER::COLLECTION)
    ("Oct4 and p53" . SPARSER::COLLECTION)
    ("pluripotent state" . SPARSER::BIO-STATE)
    ("Nanog and Sox2" . SPARSER::COLLECTION)
    ("pluripotency genes and various lineage-specific genes ( xref )"
     . SPARSER::COLLECTION)
    ("pluripotency genes and the increased expression of various lineage-specific genes ( xref )"
     . SPARSER::COLLECTION)
    ("various lineage-specific genes" . SPARSER::GENE)
    ("p53 and its E3 ligase Mdm2" . SPARSER::COLLECTION)
    ("Cripto and Tert" . SPARSER::COLLECTION)
    ("the Oct4- and p53-depleted hESCs" . SPARSER::COLLECTION)
    ("Nanog, FoxD3, and Rex1" . SPARSER::COLLECTION)
    ("Oct4-" . SPARSER::PROTEIN)
    ("the pluripotency genes and lineage-specific genes" . SPARSER::COLLECTION)
    ("p53 and Oct4" . SPARSER::COLLECTION)
    ("ectodermal marker Cdx2 and left-right determination factor 1"
     . SPARSER::COLLECTION)
    ("endodermal marker GATA6 and Osteopontin (OPN)" . SPARSER::COLLECTION)
    ("GATA6 and Osteopontin (OPN)" . SPARSER::COLLECTION)
    ("lineage-specific genes" . SPARSER::GENE)
    ("Nanog, FoxD3, Rex1, Cripto and Tert" . SPARSER::COLLECTION)
    ("GATA6 and Osteopontin" . SPARSER::COLLECTION)
    ("Cdx2 and left-right determination factor 1" . SPARSER::COLLECTION)
    ("Lefty" . SPARSER::PROTEIN) ("BRA" . SPARSER::PROTEIN)
    ("Osteopontin" . SPARSER::PROTEIN) ("Cripto" . SPARSER::PROTEIN)
    ("TRA" . SPARSER::PROTEIN) ("p53 and Sirt1" . SPARSER::COLLECTION)
    ("Tip60 and CBP" . SPARSER::COLLECTION)
    ("Oct4 and Sox2" . SPARSER::COLLECTION)
    ("the pluripotent state" . SPARSER::BIO-STATE)
    ("Oct4, Sox2 and Nanog" . SPARSER::COLLECTION)
    ("left-right determination factor 1" . SPARSER::PROTEIN)
    ("Cdx2" . SPARSER::PROTEIN) ("GATA6" . SPARSER::PROTEIN)
    ("Rex1" . SPARSER::PROTEIN) ("FoxD3" . SPARSER::PROTEIN)
    ("SSEA3" . SPARSER::MOLECULE) ("Micrococcal Nuclease" . SPARSER::PROTEIN)
    ("Oct3" . SPARSER::PROTEIN) ("β–mercaptoethanol" . SPARSER::MOLECULE)
    ("NAD+" . SPARSER::MOLECULE) ("Tip60" . SPARSER::PROTEIN)
    ("post-UV chromatin" . SPARSER::PROTEIN)
    ("optimal UV-induced chromatin" . SPARSER::PROTEIN)
    ("MLH1/PMS2" . SPARSER::COLLECTION)
    ("UV-induced PCNA-mUb" . SPARSER::COLLECTION)
    ("canonical MMR" . SPARSER::PROTEIN) ("MSH2-MSH6" . SPARSER::COLLECTION)
    ("MSH6 or MSH3" . SPARSER::COLLECTION) ("normal MMR" . SPARSER::PROTEIN)
    ("UV radiation-induced TLS" . SPARSER::PROTEIN)
    ("MSH2 and Polκ or REV1" . SPARSER::COLLECTION)
    ("Polκ or REV1" . SPARSER::COLLECTION)
    ("exogenous MSH2" . SPARSER::PROTEIN)
    ("exogenous MSH2 protein" . SPARSER::PROTEIN)
    ("UV-induced REV1-UBM" . SPARSER::COLLECTION)
    ("REV1-UBM" . SPARSER::COLLECTION) ("MSH2-Flag" . SPARSER::COLLECTION)
    ("MSH2 and GFP-REV1-UBM" . SPARSER::COLLECTION)
    ("UV-induced RPA foci" . SPARSER::PROTEIN)
    ("Rad18 and RPA" . SPARSER::COLLECTION)
    ("post-UV PCNA-mUb" . SPARSER::COLLECTION)
    ("defective MMR" . SPARSER::PROTEIN) ("UV light" . SPARSER::PROTEIN)
    ("UV radiation-induced PCNA-mUb" . SPARSER::COLLECTION)
    ("mUb-PCNA" . SPARSER::COLLECTION)
    ("MSH2, pCMV-Flag-MSH2 and pEGFP-Polκ" . SPARSER::COLLECTION)
    ("pEGFP-Polκ" . SPARSER::COLLECTION) ("siNC" . SPARSER::DRUG)
    ("MSH2/Polκ" . SPARSER::COLLECTION) ("Polκ and REV1" . SPARSER::COLLECTION)
    ("Flag-REV1" . SPARSER::COLLECTION) ("GFP-REV1-UBM" . SPARSER::COLLECTION)
    ("UBM" . SPARSER::PROTEIN) ("GFP-REV1" . SPARSER::COLLECTION)
    ("REV1 and MSH2" . SPARSER::COLLECTION)
    ("Polκ and MSH2" . SPARSER::COLLECTION)
    ("peptide (PIP)" . SPARSER::PEPTIDE) ("PIP" . SPARSER::PROTEIN)
    ("GFP-Polκ" . SPARSER::COLLECTION) ("Flag-MSH2" . SPARSER::COLLECTION)
    ("FLAG-Polκ" . SPARSER::COLLECTION) ("Polκ" . SPARSER::PROTEIN)
    ("the triton-insoluble fraction" . SPARSER::COMPONENT)
    ("Flag-Polκ" . SPARSER::PROTEIN-PAIR) ("triton" . SPARSER::MOLECULE)
    ("CPD" . SPARSER::PROTEIN) ("MMR" . SPARSER::PROTEIN)
    ("optimal TLS" . SPARSER::PROTEIN)
    ("mUb and TLS in normal cells" . SPARSER::COLLECTION)
    ("replication protein A (RPA)-coated single-stranded DNA" . SPARSER::DNA)
    ("PCNA-mUb" . SPARSER::COLLECTION) ("mUb" . SPARSER::PROTEIN)
    ("the ubiquitin-conjugating enzyme Rad6 and its cognate ubiquitin ligase Rad18 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("solar ultraviolet (UV) radiation-induced cis–syn thymine–thymine cyclobutane–pyrimidine dimers"
     . SPARSER::DIMER)
    ("cis–syn" . SPARSER::COLLECTION) ("CPDs" . SPARSER::PROTEIN)
    ("syn" . SPARSER::PROTEIN) ("epoxide" . SPARSER::MOLECULE)
    ("diol" . SPARSER::MOLECULE) ("eta (Polη) and REV1" . SPARSER::COLLECTION)
    ("exonuclease activity and replicate" . SPARSER::COLLECTION)
    ("endonuclease activity" . SPARSER::PROTEIN) ("MSH3" . SPARSER::PROTEIN)
    ("RPA32" . SPARSER::PROTEIN) ("Rad6" . SPARSER::PROTEIN)
    ("exonuclease activity" . SPARSER::PROTEIN) ("Rad18" . SPARSER::PROTEIN)
    ("mismatch repair protein" . SPARSER::PROTEIN)
    ("DNA polymerase kappa" . SPARSER::PROTEIN)
    ("PTEN-MADD" . SPARSER::COLLECTION) ("the intact MADD" . SPARSER::PROTEIN)
    ("Bax/14-3-3" . SPARSER::COLLECTION)
    ("Some pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("oligomers and causes cytochrome-c release from mitochondria into cytosol"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic protein Bad" . SPARSER::PROTEIN)
    ("PTEN-PI3K-Akt" . SPARSER::COLLECTION)
    ("Akt and PTEN" . SPARSER::COLLECTION) ("Bax-14-3-3" . SPARSER::COLLECTION)
    ("Bax and 14-3-3" . SPARSER::COLLECTION)
    ("MADD and 14-3-3" . SPARSER::COLLECTION) ("EMD" . SPARSER::PROTEIN)
    ("PI3K or Akt" . SPARSER::COLLECTION) ("DRs" . SPARSER::PROTEIN)
    ("b-MADD3A-GST" . SPARSER::COLLECTION) ("b-MADD-GST" . SPARSER::COLLECTION)
    ("MADD3A and 14-3-3" . SPARSER::COLLECTION)
    ("14-3-3 and non-phosphorylatable" . SPARSER::COLLECTION)
    ("a PI3K inhibitor or a dominant negative Akt (DN-Akt)"
     . SPARSER::COLLECTION)
    ("DN-Akt" . SPARSER::COLLECTION)
    ("Similarly cells expressing PTEN" . SPARSER::PROTEIN)
    ("expressing PTEN" . SPARSER::PROTEIN)
    ("exogenous PTEN" . SPARSER::PROTEIN)
    ("pAkt and pMADD" . SPARSER::COLLECTION)
    ("Akt, MADD and PTEN" . SPARSER::COLLECTION)
    ("Bax and Bad" . SPARSER::COLLECTION) ("IAPs" . SPARSER::PROTEIN)
    ("Apaf-1 and procaspase-9" . SPARSER::COLLECTION)
    ("mitochondrial pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Smac/Diablo" . SPARSER::COLLECTION) ("Diablo" . SPARSER::PROTEIN)
    ("Smac" . SPARSER::PROTEIN) ("Akt and MADD" . SPARSER::COLLECTION)
    ("exogenous MADD" . SPARSER::PROTEIN) ("protein (MADD)" . SPARSER::PROTEIN)
    ("14-3-3 associated Bax" . SPARSER::PROTEIN)
    ("tumor necrosis factor α-related apoptosis-inducing ligand (TRAIL)"
     . SPARSER::MOLECULE)
    ("ligand (TRAIL)" . SPARSER::MOLECULE)
    ("a pro-apoptotic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MADD" . SPARSER::PROTEIN) ("Mitogen" . SPARSER::MITOGEN)
    ("NH2" . SPARSER::MOLECULE) ("core protein" . SPARSER::PROTEIN)
    ("DR4" . SPARSER::PROTEIN) ("Apaf-1" . SPARSER::PROTEIN)
    ("Protein kinase B" . SPARSER::PROTEIN)
    ("E2f1 (in mouse) and its dimerization partner Tfdp2 (both in mouse and human)"
     . SPARSER::COLLECTION)
    ("our Northern blot" . SPARSER::PROTEIN)
    ("Iqgap1, Mapre1 and Pkm2" . SPARSER::COLLECTION)
    ("a noncanonical poly(A) polymerase" . SPARSER::PROTEIN)
    ("spontaneous HCCs" . SPARSER::PROTEIN)
    ("the pleiotropic oncogene c-Myc" . SPARSER::PROTEIN)
    ("the activator (E2f1) and co-activator (Tfdp2)" . SPARSER::COLLECTION)
    ("PRF" . SPARSER::PROTEIN) ("c-MYC and TFDP2" . SPARSER::COLLECTION)
    ("Tfdp2 or E2f1" . SPARSER::COLLECTION)
    ("E2f1 and Tfdp2" . SPARSER::COLLECTION)
    ("hepatocytes, Tfdp2 and E2f1" . SPARSER::COLLECTION)
    ("a complex and trans-activate c-Myc promoter" . SPARSER::COLLECTION)
    ("mRNA and hnRNA" . SPARSER::COLLECTION)
    ("Hepa and KO" . SPARSER::COLLECTION)
    ("Hnf6 ( xref ) as well as C/ebpα ( xref )" . SPARSER::COLLECTION)
    ("Hnf6" . SPARSER::PROTEIN) ("ebp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNA polymerase II (Pol II) and histone H3K9Ac" . SPARSER::COLLECTION)
    ("its immediate upstream promoter" . SPARSER::PROMOTER)
    ("Hepa" . SPARSER::PROTEIN) ("Pkm2" . SPARSER::PROTEIN)
    ("Iqgap1 and Mapre1" . SPARSER::COLLECTION)
    ("Adam10, Agpat1, Ccng1, Ndrg3, Aldoa, Iqgap1 and Mapre1"
     . SPARSER::COLLECTION)
    ("Mapre1" . SPARSER::PROTEIN) ("Iqgap1" . SPARSER::PROTEIN)
    ("Ccng1" . SPARSER::PROTEIN) ("Iqgap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ndrg" . SPARSER::PROTEIN-FAMILY) ("mature miR" . SPARSER::MICRO-RNA)
    ("the Northern blot" . SPARSER::PROTEIN)
    ("a tetracycline (tet)-repressible MYC transgene (tet-o- MYC ) and a transgene"
     . SPARSER::COLLECTION)
    ("promoter (LAP)" . SPARSER::PROMOTER)
    ("a tetracycline (tet)-repressible MYC transgene" . SPARSER::PROTEIN)
    ("LAP-tTA" . SPARSER::COLLECTION) ("Tfdp2 and E2f1" . SPARSER::COLLECTION)
    ("transcriptional activator E2f1 and coactivator Tfdp2"
     . SPARSER::COLLECTION)
    ("E2f1" . SPARSER::PROTEIN)
    ("RNA polymerase II and histone" . SPARSER::COLLECTION)
    ("HCCs" . SPARSER::PROTEIN) ("HNF3β" . SPARSER::PROTEIN)
    ("pri-miRNA" . SPARSER::RNA) ("Hnf3β" . SPARSER::PROTEIN)
    ("TFDP2" . SPARSER::PROTEIN) ("Hnf-1α" . SPARSER::PROTEIN)
    ("Agpat1" . SPARSER::PROTEIN) ("Adam10" . SPARSER::PROTEIN)
    ("Myc-interacting zinc finger protein 1" . SPARSER::PROTEIN)
    ("Tfdp2" . SPARSER::PROTEIN) ("Hnf-3β" . SPARSER::PROTEIN)
    ("a novel prognostic biomarker" . SPARSER::MOLECULE)
    ("PTEN and AR" . SPARSER::COLLECTION)
    ("the ventral lobe" . SPARSER::PROTEIN)
    ("an anti-miR-21-liposomal complex" . SPARSER::BIO-COMPLEX)
    ("p-Smad2" . SPARSER::COLLECTION)
    ("Androgen receptor and miR-21" . SPARSER::COLLECTION)
    ("TGFBR2-3" . SPARSER::COLLECTION) ("pMIR" . SPARSER::PROTEIN)
    ("pMIR-TGFBR2" . SPARSER::COLLECTION) ("MicroRNA's" . SPARSER::MICRO-RNA)
    ("Aza" . SPARSER::DRUG) ("TGFBR1 and TGFBR2" . SPARSER::COLLECTION)
    ("low TGFBR2 and high AR ( xref )" . SPARSER::COLLECTION)
    ("AR and TGFBR2" . SPARSER::COLLECTION)
    ("Bcl-xL and cyclin D" . SPARSER::COLLECTION)
    ("Smad2 and Smad3" . SPARSER::COLLECTION)
    ("serine (GS)" . SPARSER::AMINO-ACID)
    ("the constitutively active dimeric TGFBR2" . SPARSER::PROTEIN)
    ("receptors, TGFBR1 and TGFBR2" . SPARSER::COLLECTION)
    ("AR and miR-21" . SPARSER::COLLECTION)
    ("AR or miR-21" . SPARSER::COLLECTION) ("UTR and AR" . SPARSER::COLLECTION)
    ("β-Gal" . SPARSER::PROTEIN) ("TGFβs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smad-3" . SPARSER::PROTEIN) ("2'-deoxycytidine" . SPARSER::MOLECULE)
    ("TGFBR1" . SPARSER::PROTEIN) ("its 3" . SPARSER::PROTEIN)
    ("TGFBR2" . SPARSER::PROTEIN)
    ("the only consistently expressed p53 isoform" . SPARSER::ISOFORM)
    ("expressed p53 isoform" . SPARSER::ISOFORM)
    ("using serine 15 phosphorylated p53, pAb421, and 9282 antibodies"
     . SPARSER::COLLECTION)
    ("p53, pAb421, and 9282 antibodies" . SPARSER::COLLECTION)
    ("LRDD and CDKN1A" . SPARSER::COLLECTION)
    ("PIDD and p21" . SPARSER::COLLECTION)
    ("approximately 100kD" . SPARSER::PROTEIN)
    ("p53 and Δ40p53" . SPARSER::COLLECTION)
    ("p21 and PIDD" . SPARSER::COLLECTION)
    ("PIDD, PCBP4, APAF1, and Bax" . SPARSER::COLLECTION)
    ("p21 and GADD45" . SPARSER::COLLECTION)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("pAb" . SPARSER::PROTEIN) ("-polymerase" . SPARSER::COLLECTION)
    ("fewer adherent A375 melanoma" . SPARSER::PROTEIN)
    ("full-length p53 and its isoforms ( xref )" . SPARSER::COLLECTION)
    ("‘mutant’" . SPARSER::MUTANT)
    ("the first forty N-terminal amino acids of the full-length protein"
     . SPARSER::PROTEIN)
    ("Cyclin B1" . SPARSER::PROTEIN) ("CDK5" . SPARSER::PROTEIN)
    ("p70 S6K" . SPARSER::PROTEIN) ("p-RSK" . SPARSER::PROTEIN)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY) ("100kD" . SPARSER::PROTEIN)
    ("50kD" . SPARSER::PROTEIN) ("150kD" . SPARSER::PROTEIN)
    ("NP62" . SPARSER::PROTEIN) ("PCBP4" . SPARSER::PROTEIN)
    ("CGK733" . SPARSER::DRUG) ("CM1" . SPARSER::PROTEIN)
    ("a desirable molecular target" . SPARSER::TARGET-PROTEIN)
    ("matrix metalloproteinases or other enzymes" . SPARSER::COLLECTION)
    ("MEKK4 and actin" . SPARSER::COLLECTION)
    ("HER2 and effectively inhibited HER3 phosphorylation"
     . SPARSER::COLLECTION)
    ("lapatinib, EGFR and HER2" . SPARSER::COLLECTION)
    ("EGFR, HER2 and HER4" . SPARSER::COLLECTION)
    ("MTK1 and insulin" . SPARSER::COLLECTION)
    ("MTK1 and IRS-1" . SPARSER::COLLECTION)
    ("HER3 and IRS-1 strongly links MTK1" . SPARSER::PROTEIN)
    ("HER3 and IRS-1" . SPARSER::COLLECTION)
    ("kDa or greater" . SPARSER::COLLECTION)
    ("HER3 [ xref ] and these proteins" . SPARSER::COLLECTION)
    ("Shc, PI3K, and Grb7" . SPARSER::COLLECTION)
    ("MTK1 and phosphoHER3" . SPARSER::COLLECTION)
    ("siRNA or NS" . SPARSER::COLLECTION)
    ("siRNA, and non-transfected" . SPARSER::COLLECTION)
    ("MTK1 and NS" . SPARSER::COLLECTION)
    ("HER2 and MTK1" . SPARSER::COLLECTION)
    ("siRNA and non-transfected" . SPARSER::COLLECTION)
    ("specifically targets MTK1 and non-specific (NS) siRNA"
     . SPARSER::PROTEIN)
    ("MTK1 and non-specific" . SPARSER::COLLECTION)
    ("Media" . SPARSER::PROTEIN) ("HRG or EGF" . SPARSER::COLLECTION)
    ("HRG or sorbitol" . SPARSER::COLLECTION)
    ("MTK1 and pY1289" . SPARSER::COLLECTION)
    ("possible inducers" . SPARSER::MOLECULE)
    ("MTK1-actin" . SPARSER::COLLECTION)
    ("Flag-tagged wild-type MEKK4 and flag-tagged AIR MEKK4"
     . SPARSER::COLLECTION)
    ("proteins and 25/40" . SPARSER::COLLECTION)
    ("MEKK4/MTK1" . SPARSER::COLLECTION)
    ("Human MTK1 and the mouse homolog" . SPARSER::COLLECTION)
    ("estrogen receptor, progesterone receptor or HER2" . SPARSER::COLLECTION)
    ("HER3-MTK1" . SPARSER::COLLECTION)
    ("HER2/HER3 and HER3/HER4 heterodimers" . SPARSER::COLLECTION)
    ("HER3/HER4" . SPARSER::COLLECTION)
    ("HER2, HER3 and HER4" . SPARSER::COLLECTION)
    ("HER3/MTK1" . SPARSER::COLLECTION)
    ("HRG, EGF, insulin and sorbitol" . SPARSER::COLLECTION)
    ("neither EGFR nor HER2" . SPARSER::COLLECTION)
    ("EGF, sorbitol or vehicle" . SPARSER::COLLECTION)
    ("approximately 150 kDa" . SPARSER::PROTEIN)
    ("EGF or insulin" . SPARSER::COLLECTION)
    ("tryptic peptides" . SPARSER::PEPTIDE)
    ("HER3 and MTK1" . SPARSER::COLLECTION)
    ("MTK1, and MTK1" . SPARSER::COLLECTION)
    ("antibody and HER3" . SPARSER::COLLECTION)
    ("immunoblotted HER3" . SPARSER::PROTEIN) ("b and c" . SPARSER::COLLECTION)
    ("nitrocellulose" . SPARSER::MOLECULE) ("β1 (HRG)" . SPARSER::PROTEIN)
    ("MTK1 and HER3" . SPARSER::COLLECTION)
    ("the IFNγ cytokine receptor [ xref ] and the GPCR" . SPARSER::COLLECTION)
    ("Heregulin" . SPARSER::PROTEIN) ("MTK1 and actin" . SPARSER::COLLECTION)
    ("which links HER3" . SPARSER::PROTEIN)
    ("globular actin" . SPARSER::PROTEIN) ("g-actin" . SPARSER::COLLECTION)
    ("HER2 and downstream signaling proteins [ xref ]" . SPARSER::COLLECTION)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("HER2/HER3" . SPARSER::PROTEIN)
    ("EGFR, HER2 or HER4" . SPARSER::COLLECTION)
    ("EGFR, HER3 or HER4" . SPARSER::COLLECTION)
    ("epidermal growth factor receptors (HER)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Receptor tyrosine kinases (RTK’s) and the growth factors"
     . SPARSER::COLLECTION)
    ("Human MAP3K4 (MTK1) and the mouse homolog (MEKK4)" . SPARSER::COLLECTION)
    ("skeletal malformations" . SPARSER::PROTEIN)
    ("MEKK4 and MTK1" . SPARSER::COLLECTION) ("MEKK" . SPARSER::PROTEIN)
    ("MEKs and MEKs" . SPARSER::COLLECTION) ("MEKKs" . SPARSER::PROTEIN)
    ("HER2/HER3-HRG" . SPARSER::PROTEIN-PAIR)
    ("MTK1/HER3" . SPARSER::COLLECTION) ("beta1 (HRG)" . SPARSER::PROTEIN)
    ("-heregulin" . SPARSER::COLLECTION) ("Grb7" . SPARSER::PROTEIN)
    ("PI3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cytochalasin D" . SPARSER::DRUG) ("f-actin" . SPARSER::BIO-COMPLEX)
    ("phosphoinositide kinase" . SPARSER::PROTEIN) ("MEK4" . SPARSER::PROTEIN)
    ("Ssk2" . SPARSER::PROTEIN) ("Ste11" . SPARSER::PROTEIN)
    ("Mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytochalasin D" . SPARSER::DRUG) ("beta1" . SPARSER::PROTEIN)
    ("MTK1" . SPARSER::PROTEIN)
    ("the minichromosome maintenance protein 7 (MCM7 ) gene, which is transcriptionally regulated by c-Myc"
     . SPARSER::PROTEIN)
    ("ATG16L1 and p21" . SPARSER::COLLECTION)
    ("bacterial components" . SPARSER::COMPONENT)
    ("ATG16L1 and the risk variant ATG16L1 T300A" . SPARSER::COLLECTION)
    ("a selective autophagy substrate and a mediator" . SPARSER::COLLECTION)
    ("ATG16L1, MIR106B and MIR93" . SPARSER::COLLECTION)
    ("a likely pathogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NOD2 and IRGM1" . SPARSER::COLLECTION)
    ("ATG16L1 and active" . SPARSER::COLLECTION)
    ("ATGs and fine tune autophagy" . SPARSER::COLLECTION)
    ("ATG16L1 and ATG9" . SPARSER::COLLECTION)
    ("p21 and ATG16L1" . SPARSER::COLLECTION)
    ("mCherry-LC3" . SPARSER::PROTEIN-PAIR)
    ("CD-associated AIEC strain LF82" . SPARSER::PROTEIN)
    ("ileal" . SPARSER::PROTEIN) ("FLAG-ATG16L1" . SPARSER::COLLECTION)
    ("pmir-GLO-ATG16L1-3" . SPARSER::COLLECTION)
    ("pmir-GLO" . SPARSER::COLLECTION) ("MUT" . SPARSER::PROTEIN)
    ("GLO" . SPARSER::PROTEIN) ("p21 and LC3-II" . SPARSER::COLLECTION)
    ("ATG5–ATG12" . SPARSER::COLLECTION)
    ("SW480/GFP-LC3" . SPARSER::COLLECTION)
    ("PITA, and miRanda" . SPARSER::COLLECTION)
    ("ATG1, ATG9A, and ATG16L1" . SPARSER::COLLECTION)
    ("ATGs and Autophagosome Formation" . SPARSER::COLLECTION)
    ("ATGs" . SPARSER::DRUG) ("Dicer" . SPARSER::PROTEIN)
    ("the risk-associated allele" . SPARSER::ALLELE)
    ("the complementary mRNAs" . SPARSER::PROTEIN)
    ("gene (ATG)" . SPARSER::PROTEIN) ("Apg16L" . SPARSER::PROTEIN)
    ("ATG5-ATG12" . SPARSER::COLLECTION) ("CMYC" . SPARSER::PROTEIN)
    ("LF" . SPARSER::PROTEIN) ("AIMS" . SPARSER::PROTEIN)
    ("MCM7" . SPARSER::PROTEIN) ("NOD2" . SPARSER::PROTEIN)
    ("ATG9A" . SPARSER::PROTEIN) ("ATG1" . SPARSER::PROTEIN)
    ("ATG9" . SPARSER::PROTEIN) ("IRGM1" . SPARSER::PROTEIN)
    ("M protein" . SPARSER::PROTEIN) ("ATG8" . SPARSER::PROTEIN)
    ("Dicer 1" . SPARSER::PROTEIN) ("ATG16L1" . SPARSER::PROTEIN)
    ("micro-RNAs" . SPARSER::MICRO-RNA)
    ("these unusual substrates" . SPARSER::SUBSTRATE)
    ("a new ubiquitin" . SPARSER::PROTEIN)
    ("RIG-1 and TAK1" . SPARSER::COLLECTION) ("QC" . SPARSER::PROTEIN)
    ("endo-protease" . SPARSER::COLLECTION) ("endo" . SPARSER::PROTEIN)
    ("proteasomal Poh1" . SPARSER::PROTEIN)
    ("the proteasomal deubiquitinating enzyme" . SPARSER::PROTEIN)
    ("proteasome-associated Poh1" . SPARSER::PROTEIN)
    ("myosin 9 (IIA)" . SPARSER::PROTEIN) ("IIB" . SPARSER::PROTEIN)
    ("HDAC6- and cortactin-dependent F-actin" . SPARSER::COLLECTION)
    ("HDAC6-" . SPARSER::PROTEIN) ("Poh1 and HDAC6" . SPARSER::COLLECTION)
    ("an accessory factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("filter-trap" . SPARSER::PROTEIN)
    ("HDAC6-associated unanchored ubiquitin" . SPARSER::PROTEIN)
    ("IsoT" . SPARSER::PROTEIN)
    ("Both K63- and K48-linked ubiquitin" . SPARSER::COLLECTION)
    ("either K63- or K48- linked free ubiquitin" . SPARSER::COLLECTION)
    ("detergent-insoluble protein" . SPARSER::PROTEIN)
    ("K63-" . SPARSER::PROTEIN) ("exogenous free ubiquitin" . SPARSER::PROTEIN)
    ("a stoichiometric subunit" . SPARSER::FRAGMENT)
    ("proteasomal deubiquitinating enzymes Usp14 and Uch37"
     . SPARSER::COLLECTION)
    ("enzymes, Amsh and Brcc36" . SPARSER::COLLECTION)
    ("Usp14 and Uch37" . SPARSER::COLLECTION) ("Usp14" . SPARSER::PROTEIN)
    ("Uch" . SPARSER::PROTEIN) ("Usp" . SPARSER::PROTEIN)
    ("JAMM/MPN" . SPARSER::COLLECTION) ("JAMM" . SPARSER::PROTEIN-FAMILY)
    ("the proteasomal deubiquitinating enzyme Poh1" . SPARSER::PROTEIN)
    ("Butyrate" . SPARSER::PROTEIN)
    ("p62 and α-synuclein" . SPARSER::COLLECTION)
    ("inclusion body-associated proteasomes" . SPARSER::PROTEIN)
    ("Gly-Gly" . SPARSER::COLLECTION)
    ("these inclusion body-associated proteasomes" . SPARSER::PROTEIN)
    ("toxic protein" . SPARSER::PROTEIN)
    ("ubiquitinated proteins and releases ubiquitin" . SPARSER::COLLECTION)
    ("a proteasomal deubiquitinating enzyme" . SPARSER::PROTEIN)
    ("NK2" . SPARSER::PROTEIN) ("RIG-1" . SPARSER::PROTEIN)
    ("ataxin 3" . SPARSER::PROTEIN) ("myosin 10" . SPARSER::PROTEIN)
    ("myosin 9" . SPARSER::PROTEIN) ("isopeptidase T" . SPARSER::PROTEIN)
    ("Brcc36" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RPN11" . SPARSER::PROTEIN)
    ("Poh1" . SPARSER::PROTEIN)
    ("FBXL17 and BTB proteins" . SPARSER::COLLECTION)
    ("ZNF238/ZBTB22" . SPARSER::COLLECTION)
    ("BACH1-MAFG" . SPARSER::COLLECTION) ("FBXL17-BACH1" . SPARSER::COLLECTION)
    ("HOIP" . SPARSER::PROTEIN)
    ("SCF FBXL17 and its target BACH1" . SPARSER::COLLECTION)
    ("validatable targets" . SPARSER::TARGET-PROTEIN)
    ("IPP, ITPR3 and SLC7A11" . SPARSER::COLLECTION) ("IPP" . SPARSER::PROTEIN)
    ("FAM96B, IREB2, MED6, HDAC6, ZNF238, PRAME, ITPR1, and NEURL4"
     . SPARSER::COLLECTION)
    ("GPS" . SPARSER::PROTEIN) ("FBXLs" . SPARSER::PROTEIN)
    ("substrates or regulatory proteins" . SPARSER::COLLECTION)
    ("possibly other E3s" . SPARSER::MOLECULE) ("leptomycin" . SPARSER::DRUG)
    ("MG132 and MLN4924" . SPARSER::COLLECTION) ("Hemin" . SPARSER::MOLECULE)
    ("FBXL17 and CUL3" . SPARSER::COLLECTION)
    ("residual BACH1" . SPARSER::PROTEIN)
    ("BACH1 and FBXL17" . SPARSER::COLLECTION)
    ("BACH1-associated MARE  HMOX1" . SPARSER::PROTEIN)
    ("NRF2-associated MARE  HMOX1" . SPARSER::PROTEIN)
    ("BACH1 and a 3-fold" . SPARSER::COLLECTION)
    ("NRF2 or BACH1" . SPARSER::COLLECTION)
    ("HMOX1, BACH1 and FBXL17" . SPARSER::COLLECTION)
    ("NRF2 and BACH1" . SPARSER::COLLECTION)
    ("FLAG-HA-BACH1" . SPARSER::COLLECTION)
    ("NRF2-HMOX1" . SPARSER::COLLECTION)
    ("FBXL17 and BACH1" . SPARSER::COLLECTION)
    ("FBXL17, CUL1, and SKP1" . SPARSER::COLLECTION)
    ("SUFU, KLHL25, and ZBTB10" . SPARSER::COLLECTION)
    ("SUFU" . SPARSER::PROTEIN) ("the repressive form" . SPARSER::FORM)
    ("the heterodimeric BACH1-MAF complex" . SPARSER::BIO-COMPLEX)
    ("HMMR or FAM83D" . SPARSER::COLLECTION)
    ("FLAG-HA-FBXL17" . SPARSER::COLLECTION)
    ("CUL1 and SKP1" . SPARSER::COLLECTION)
    ("the known BACH1-associated proteins MAFF, MAFG and MAFK, HMMR, and FAM83D"
     . SPARSER::COLLECTION)
    ("MAFF, MAFG and MAFK, HMMR, and FAM83D" . SPARSER::COLLECTION)
    ("MAFK, HMMR, and FAM83D" . SPARSER::COLLECTION)
    ("HMMR" . SPARSER::PROTEIN) ("BACH1-MAF" . SPARSER::COLLECTION)
    ("MARE" . SPARSER::PROTEIN) ("MAFF" . SPARSER::PROTEIN)
    ("MAFG" . SPARSER::PROTEIN) ("MAFK" . SPARSER::PROTEIN)
    ("basic region leucine zipper protein family" . SPARSER::PROTEIN-FAMILY)
    ("CNC-bZip" . SPARSER::COLLECTION) ("bZip" . SPARSER::PROTEIN-FAMILY)
    ("CNC" . SPARSER::PROTEIN)
    ("the previously unstudied adaptor FBXL17" . SPARSER::PROTEIN)
    ("FBXL" . SPARSER::PROTEIN) ("-BACH1" . SPARSER::COLLECTION)
    ("reciprocal AP-MS" . SPARSER::PROTEIN)
    ("candidate targets or regulatory proteins" . SPARSER::COLLECTION)
    ("SCF-FBXL" . SPARSER::COLLECTION) ("FBXL17" . SPARSER::PROTEIN)
    ("FBXL2, ERLEC1 and CLGN" . SPARSER::COLLECTION)
    ("FBXL4, and PRAME" . SPARSER::COLLECTION)
    ("FBXL19 and FBXW7α" . SPARSER::COLLECTION)
    ("Hemerythrin" . SPARSER::PROTEIN) ("complex (CIA)" . SPARSER::BIO-COMPLEX)
    ("CIA" . SPARSER::PROTEIN) ("USP1, USP46, and WDR20" . SPARSER::COLLECTION)
    ("WDR20 and WDR48" . SPARSER::COLLECTION)
    ("3 related deubiquitylating (Dub) enzymes (USP1, USP12 and USP46) as well as their regulatory components WDR20"
     . SPARSER::COLLECTION)
    ("USP1, USP12 and USP46" . SPARSER::COLLECTION)
    ("PARD3, PARD3L, and PARD6G" . SPARSER::COLLECTION)
    ("FBXL13, FBXL15, and FBXL16" . SPARSER::COLLECTION)
    ("CETN2, CEP97, and CEP164" . SPARSER::COLLECTION)
    ("BACH1-FBXL17" . SPARSER::PROTEIN-PAIR)
    ("KLHL25 and KLHL21" . SPARSER::COLLECTION)
    ("kinases, or protein phosphatases" . SPARSER::COLLECTION)
    ("FBXL12 and FBXL17" . SPARSER::COLLECTION) ("PRAME" . SPARSER::PROTEIN)
    ("the RAB geranylgeranyltransferase RABGGTB and the β-subunit"
     . SPARSER::COLLECTION)
    ("FBXL2 and FBXL20" . SPARSER::COLLECTION) ("RABGGTB" . SPARSER::PROTEIN)
    ("FBXL2, and IREB2" . SPARSER::COLLECTION)
    ("CCNA2-CDK2" . SPARSER::COLLECTION)
    ("Only 23 proteins" . SPARSER::PROTEIN)
    ("here form intact CRL" . SPARSER::PROTEIN)
    ("CUL1 or CSN" . SPARSER::COLLECTION)
    ("FBXL13 or FBXL16" . SPARSER::COLLECTION)
    ("KDM2A (FBXL11) or KDM2B (FBXL10)" . SPARSER::COLLECTION)
    ("CUL1 or COP9 Signalosome" . SPARSER::COLLECTION)
    ("FBXL13, FBLX20, and FBXL22" . SPARSER::COLLECTION)
    ("LRRs" . SPARSER::PROTEIN)
    ("systematically survey FBXL proteins" . SPARSER::PROTEIN)
    ("targets and regulators" . SPARSER::COLLECTION)
    ("the known substrates c-MYC ( xref ) and MED13 ( xref )"
     . SPARSER::COLLECTION)
    ("USP37 and USP47" . SPARSER::COLLECTION)
    ("proteasomal targets" . SPARSER::TARGET-PROTEIN)
    ("CUL1, SKP1, and components" . SPARSER::COLLECTION)
    ("CSN" . SPARSER::PROTEIN) ("stats" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FLAG-HA" . SPARSER::COLLECTION) ("BACH1 and NRF2" . SPARSER::COLLECTION)
    ("NRF2-MAF" . SPARSER::COLLECTION)
    ("CRL and proteasomal substrates" . SPARSER::COLLECTION)
    ("proteasomal substrates" . SPARSER::SUBSTRATE)
    ("the proteasome inhibitor Bortezomib (Btz) or CRL inhibitor MLN4924"
     . SPARSER::COLLECTION)
    ("SCFs" . SPARSER::PROTEIN) ("proteins and CRL" . SPARSER::COLLECTION)
    ("particular E3s" . SPARSER::MOLECULE)
    ("the relevant CRL-adaptor complex" . SPARSER::BIO-COMPLEX)
    ("SPOP" . SPARSER::PROTEIN) ("FBXW7, and FBXL1" . SPARSER::COLLECTION)
    ("unstable CRL" . SPARSER::PROTEIN) ("DCN1-RBX1" . SPARSER::COLLECTION)
    ("cullin-homology" . SPARSER::COLLECTION)
    ("protein (SCF)" . SPARSER::PROTEIN) ("the largest class" . CLASS)
    ("RBX1 and RBX2" . SPARSER::COLLECTION) ("RING-finger" . SPARSER::GENE)
    ("cullin" . SPARSER::PROTEIN-FAMILY) ("HECT and RBR" . SPARSER::COLLECTION)
    ("RBR" . SPARSER::PROTEIN) ("HECT" . SPARSER::PROTEIN)
    ("thioester-driven E1 ubiquitin" . SPARSER::PROTEIN)
    ("thioester" . SPARSER::MOLECULE) ("PAC" . SPARSER::PROTEIN)
    ("biologically relevant substrates" . SPARSER::SUBSTRATE)
    ("Modular Cullin-RING E3 ubiquitin ligases (CRLs) use substrate binding adaptor proteins"
     . SPARSER::PROTEIN)
    ("Cullin-RING" . SPARSER::PROTEIN-PAIR) ("CRLs" . SPARSER::PROTEIN)
    ("CM-H" . SPARSER::MOLECULE) ("MCM5" . SPARSER::PROTEIN)
    ("KLHL17" . SPARSER::PROTEIN) ("KLHL13" . SPARSER::PROTEIN)
    ("ZBTB22" . SPARSER::PROTEIN) ("SLC7A11" . SPARSER::PROTEIN)
    ("ITPR3" . SPARSER::PROTEIN) ("NEURL4" . SPARSER::PROTEIN)
    ("ITPR1" . SPARSER::PROTEIN) ("MED6" . SPARSER::PROTEIN)
    ("ZBTB33" . SPARSER::PROTEIN) ("ZBTB10" . SPARSER::PROTEIN)
    ("cap'n'collar" . SPARSER::PROTEIN) ("AHCYL1" . SPARSER::PROTEIN)
    ("FBXL4" . SPARSER::PROTEIN) ("ERLEC1" . SPARSER::PROTEIN)
    ("FBXL19" . SPARSER::PROTEIN) ("MIP18" . SPARSER::PROTEIN)
    ("FAM96B" . SPARSER::PROTEIN) ("MMS19" . SPARSER::PROTEIN)
    ("Fe-S" . SPARSER::PROTEIN)
    ("iron responsive element binding protein 2" . SPARSER::PROTEIN)
    ("WDR48" . SPARSER::PROTEIN) ("WDR20" . SPARSER::PROTEIN)
    ("USP46" . SPARSER::PROTEIN) ("USP12" . SPARSER::PROTEIN)
    ("USP1" . SPARSER::PROTEIN) ("par-6" . SPARSER::PROTEIN)
    ("PARD6G" . SPARSER::PROTEIN) ("PARD3" . SPARSER::PROTEIN)
    ("CEP164" . SPARSER::PROTEIN) ("CEP97" . SPARSER::PROTEIN)
    ("CETN2" . SPARSER::PROTEIN) ("FBXL15" . SPARSER::PROTEIN)
    ("inositol 1,4,5-trisphosphate receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FBXL14" . SPARSER::PROTEIN) ("KLHL21" . SPARSER::PROTEIN)
    ("KLHL25" . SPARSER::PROTEIN) ("ZBTB1" . SPARSER::PROTEIN)
    ("ZNF238" . SPARSER::PROTEIN)
    ("protein phosphatases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CUL2" . SPARSER::PROTEIN) ("FBXL12" . SPARSER::PROTEIN)
    ("FBXL20" . SPARSER::PROTEIN) ("PTAR1" . SPARSER::PROTEIN)
    ("FBXL5" . SPARSER::PROTEIN) ("IREB2" . SPARSER::PROTEIN)
    ("FBXL2" . SPARSER::PROTEIN) ("PIK3R2" . SPARSER::PROTEIN)
    ("CCNA2" . SPARSER::PROTEIN) ("Class C" . SPARSER::PROTEIN)
    ("Class B" . SPARSER::PROTEIN) ("FBXL16" . SPARSER::PROTEIN)
    ("FBXL10" . SPARSER::PROTEIN) ("KDM2B" . SPARSER::PROTEIN)
    ("KDM2A" . SPARSER::PROTEIN) ("COP9 Signalosome" . SPARSER::PROTEIN)
    ("FBXL22" . SPARSER::PROTEIN) ("FBXL13" . SPARSER::PROTEIN)
    ("FBXL8" . SPARSER::PROTEIN) ("FBXL21" . SPARSER::PROTEIN)
    ("MED13L" . SPARSER::PROTEIN) ("MED13" . SPARSER::PROTEIN)
    ("USP47" . SPARSER::PROTEIN) ("USP37" . SPARSER::PROTEIN)
    ("FBXO5" . SPARSER::PROTEIN) ("AP-MS" . SPARSER::PROTEIN)
    ("FBXW11" . SPARSER::PROTEIN) ("CUL3" . SPARSER::PROTEIN)
    ("FBXL1" . SPARSER::PROTEIN) ("FBXW7" . SPARSER::PROTEIN)
    ("FBXW1" . SPARSER::PROTEIN) ("MLN4924" . SPARSER::DRUG)
    ("DCN1" . SPARSER::PROTEIN) ("UBC12" . SPARSER::PROTEIN)
    ("NEDD8 conjugating enzyme" . SPARSER::PROTEIN)
    ("NEDD8" . SPARSER::PROTEIN) ("RBX2" . SPARSER::PROTEIN)
    ("RBX1" . SPARSER::PROTEIN) ("domain E" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzyme" . SPARSER::PROTEIN-FAMILY)
    ("HMOX1" . SPARSER::PROTEIN) ("NFR2" . SPARSER::PROTEIN)
    ("E3s" . SPARSER::MOLECULE) ("CUL1" . SPARSER::PROTEIN)
    ("SKP1" . SPARSER::PROTEIN)
    ("proinflammatory macrophages" . SPARSER::PROTEIN)
    ("the prognosis-associated variant" . SPARSER::VARIANT)
    ("Africa—proinflammatory cytokines" . SPARSER::PROTEIN)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("TNFα, IL-6, and IL-10" . SPARSER::COLLECTION)
    ("sodium sulfate (DSS)" . SPARSER::MOLECULE)
    ("stimulated monocytes produced less TNFα and more IL-10"
     . SPARSER::COLLECTION)
    ("Annexin V and 7-AAD" . SPARSER::COLLECTION) ("FOXO3-" . SPARSER::PROTEIN)
    ("less TNFα and more IL-10" . SPARSER::COLLECTION)
    ("exogenous TGFβ1" . SPARSER::PROTEIN)
    ("relatively more TGFβ1" . SPARSER::PROTEIN)
    ("nuclear, and TNFα" . SPARSER::COLLECTION)
    ("GM-CSF, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, and IL-12p40"
     . SPARSER::COLLECTION)
    ("IL-1β, IL-6, and IL-8" . SPARSER::COLLECTION)
    ("other proinflammatory cytokines" . SPARSER::PROTEIN)
    ("Flagellin" . SPARSER::PROTEIN) ("Pam" . SPARSER::PROTEIN)
    ("TNFα and IL-10" . SPARSER::COLLECTION)
    ("relatively more IL-10" . SPARSER::PROTEIN)
    ("the archetypal proinflammatory cytokine in CD ( xref ) and target"
     . SPARSER::COLLECTION)
    ("the archetypal proinflammatory cytokine" . SPARSER::PROTEIN)
    ("the minor or major allele" . SPARSER::ALLELE)
    ("external factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("allele or haplotype" . SPARSER::COLLECTION)
    ("complex disease-associated SNPs" . SPARSER::PROTEIN)
    ("any demonstrable LD" . SPARSER::PROTEIN)
    ("an intronic SNP" . SPARSER::PROTEIN)
    ("other disease-associated cytokines" . SPARSER::PROTEIN)
    ("IL-2 or IL-7" . SPARSER::COLLECTION)
    ("immunomodulators or intestinal resections" . SPARSER::COLLECTION)
    ("n " . SPARSER::PROTEIN)
    ("the indolent disease-associated allele" . SPARSER::ALLELE)
    ("the prognosis-associated SNP" . SPARSER::PROTEIN)
    ("FOXO1 and FOXO4" . SPARSER::COLLECTION)
    ("a disease-associated variant" . SPARSER::VARIANT)
    ("IL-2 and IL-7" . SPARSER::COLLECTION) ("CYB5" . SPARSER::PROTEIN)
    ("Foxo3" . SPARSER::PROTEIN) ("IL-12p40" . SPARSER::PROTEIN)
    ("TLR9" . SPARSER::PROTEIN) ("TLR5" . SPARSER::PROTEIN)
    ("TLR1" . SPARSER::PROTEIN) ("FOXO3A" . SPARSER::PROTEIN)
    ("a viral Bcl-2 autophagy inhibitor" . SPARSER::INHIBITOR)
    ("a viral Bcl-2 mutant" . SPARSER::MUTANT)
    ("chloroquine and hydoxychloroquine" . SPARSER::COLLECTION)
    ("a Beclin 1 tyrosine phosphomimetic mutant" . SPARSER::MUTANT)
    ("Bcl-2, VPS34, UVRAG, or ATG14" . SPARSER::COLLECTION)
    ("the EGFR family (e.g. HER2, HER3, HER4) and/or other oncogenic receptor tyrosine kinases"
     . SPARSER::COLLECTION)
    ("EGFR and the Beclin 1 autophagy protein" . SPARSER::COLLECTION)
    ("PI3K, Akt and mTOR" . SPARSER::COLLECTION)
    ("These findings directly link receptor tyrosine kinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("diverse cellular and viral autophagy stimulatory or inhibitory proteins"
     . SPARSER::PROTEIN)
    ("the viral Bcl-2 inhibitor" . SPARSER::INHIBITOR)
    ("the mutant viral Bcl-2 protein" . SPARSER::PROTEIN)
    ("a mutant viral Bcl-2 (M11 AAA) protein" . SPARSER::PROTEIN)
    ("either weak or undetectable TTF-1" . SPARSER::PROTEIN)
    ("strong TTF-1" . SPARSER::PROTEIN)
    ("TTF-1, p63, and cytokeratin 5" . SPARSER::COLLECTION)
    ("e-cadherin and vimentin" . SPARSER::COLLECTION)
    ("HCC/Flag-Beclin 1" . SPARSER::COLLECTION) ("FFF" . SPARSER::PROTEIN)
    ("the Beclin 1 tyrosine phosphomimetic mutant" . SPARSER::MUTANT)
    ("Flag-Beclin 1 FFF" . SPARSER::PROTEIN)
    ("Beclin 1, or Beclin 1" . SPARSER::COLLECTION)
    ("A Beclin 1 Tyrosine Phosphomimetic Mutant" . SPARSER::MUTANT)
    ("Perhaps" . SPARSER::PROTEIN)
    ("Beclin 1 or Beclin 1" . SPARSER::COLLECTION)
    ("the phosphomimetic Beclin 1 EEE mutant" . SPARSER::MUTANT)
    ("Rubicon and Bcl-2" . SPARSER::COLLECTION)
    ("active EGFR and its interactome" . SPARSER::COLLECTION)
    ("EEE" . SPARSER::MOLECULE)
    ("a phosphospecific antibody" . SPARSER::ANTIBODY)
    ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("mutationally active PDGFRα T674I and SRMS" . SPARSER::COLLECTION)
    ("PDGFRβ, mutationally active PDGFRα T674I and SRMS" . SPARSER::COLLECTION)
    ("SRMS" . SPARSER::PROTEIN) ("EGFR and Ligand" . SPARSER::COLLECTION)
    ("Bcl-2, ATG14, UVRAG, or VPS34" . SPARSER::COLLECTION)
    ("Beclin 1 and negative regulators" . SPARSER::COLLECTION)
    ("Bcl-2 and Rubicon" . SPARSER::COLLECTION)
    ("Beclin 1/Bcl-2" . SPARSER::COLLECTION)
    ("Beclin 1/VPS34" . SPARSER::COLLECTION)
    ("Beclin 1/Rubicon" . SPARSER::COLLECTION)
    ("Beclin 1/EGFR" . SPARSER::COLLECTION)
    ("Beclin 1 and VPS34" . SPARSER::COLLECTION)
    ("Beclin 1 and Rubicon" . SPARSER::COLLECTION)
    ("Beclin 1 and Bcl-2" . SPARSER::COLLECTION)
    ("Beclin 1 and ATG14 or Beclin 1 and UVRAG" . SPARSER::COLLECTION)
    ("ATG14 or Beclin 1 and UVRAG" . SPARSER::COLLECTION)
    ("Beclin 1 and UVRAG" . SPARSER::COLLECTION)
    ("Bcl-2, Rubicon, VPS34, UVRAG and ATG14" . SPARSER::COLLECTION)
    ("Bcl-2 (which binds to the Beclin 1 BH3 domain) and Rubicon (which binds to the Beclin 1 ECD)"
     . SPARSER::COLLECTION)
    ("Rubicon" . SPARSER::PROTEIN) ("at least two domains" . SPARSER::PROTEIN)
    ("Beclin 1 and EGFR" . SPARSER::COLLECTION)
    ("the active EGFR L858R mutant and Beclin 1 truncation mutants ( xref )"
     . SPARSER::COLLECTION)
    ("LAMP1 and Tom20" . SPARSER::COLLECTION)
    ("LAMP1 (a late endosome/lysosome marker) and Tom20" . SPARSER::COLLECTION)
    ("EEA1 (an early endosome marker), LAMP1 (a late endosome/lysosome marker) and Tom20"
     . SPARSER::COLLECTION)
    ("almost all EGFR" . SPARSER::PROTEIN)
    ("EGFR and Beclin 1" . SPARSER::COLLECTION)
    ("Flag-Beclin 1" . SPARSER::PROTEIN-PAIR)
    ("EGF and EGFR" . SPARSER::COLLECTION)
    ("normal or serum-free media" . SPARSER::PROTEIN)
    ("the Class III phosphatidylinositol 3-kinase (PI3K) (VPS34) autophagy-inducing complex"
     . SPARSER::BIO-COMPLEX)
    ("an autophagic substrate" . SPARSER::SUBSTRATE)
    ("the autophagosome-associated lipidated form" . SPARSER::FORM)
    ("LC3, and p62" . SPARSER::COLLECTION)
    ("a haploinsufficient tumor suppressor protein" . SPARSER::PROTEIN)
    ("the essential autophagy protein" . SPARSER::PROTEIN)
    ("PI3K, Akt, and mTOR" . SPARSER::COLLECTION)
    ("single-base" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a tyrosine phosphomimetic Beclin 1 mutant" . SPARSER::MUTANT)
    ("ATG7" . SPARSER::PROTEIN) ("cytokeratin 5" . SPARSER::PROTEIN)
    ("e-cadherin" . SPARSER::PROTEIN) ("ATG14" . SPARSER::PROTEIN)
    ("green fluorescent" . SPARSER::PROTEIN) ("Atg4C" . SPARSER::PROTEIN)
    ("Atg7" . SPARSER::PROTEIN)
    ("PI3K inhibitors and AKT inhibitors" . SPARSER::COLLECTION)
    ("e.g. mTOR inhibitors" . SPARSER::INHIBITOR)
    ("a predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K inhibitors (enzastaurin) and AKT inhibitors (triciribine)"
     . SPARSER::COLLECTION)
    ("triciribine" . SPARSER::MOLECULE) ("enzastaurin" . SPARSER::DRUG)
    ("everolimus (RAD001) and deforolimus (AP23573)" . SPARSER::COLLECTION)
    ("temsirolimus (CCI-779), everolimus (RAD001) and deforolimus (AP23573)"
     . SPARSER::COLLECTION)
    ("deforolimus" . SPARSER::DRUG)
    ("mTOR-AKT-PI3K-PTEN" . SPARSER::COLLECTION) ("Prat" . SPARSER::PROTEIN)
    ("loss of heterozygosity and promoter" . SPARSER::COLLECTION)
    ("PTEN and ER and PgR" . SPARSER::COLLECTION)
    ("receptors and gene" . SPARSER::COLLECTION)
    ("a more aggressive neoplasm type" . TYPE)
    ("PTEN-PI3K-AKT" . SPARSER::COLLECTION)
    ("Phosphatase and Tensin" . SPARSER::COLLECTION)
    ("Homologue" . SPARSER::PROTEIN) ("Tensin" . SPARSER::PROTEIN)
    ("Phosphatase" . SPARSER::PHOSPHATASE) ("ER and PgR" . SPARSER::COLLECTION)
    ("n  " . SPARSER::PROTEIN) ("gene and receptors" . SPARSER::COLLECTION)
    ("Loss of heterozygosity" . SPARSER::PROTEIN)
    ("ribonucleic acid" . SPARSER::RNA) ("ER 1" . SPARSER::PROTEIN)
    ("Progesterone Receptor" . SPARSER::PROTEIN)
    ("Anti-Human" . SPARSER::PROTEIN)
    ("an oxidative stress biomarker" . SPARSER::MOLECULE)
    ("the PS and the non-PS" . SPARSER::COLLECTION)
    ("the PS group or the non-PS group" . SPARSER::COLLECTION)
    ("IP-HDAC2" . SPARSER::COLLECTION) ("PS and non-PS" . SPARSER::COLLECTION)
    ("the PS and the non-PS group" . SPARSER::COLLECTION)
    ("cotinine" . SPARSER::DRUG) ("-adrenoceptor" . SPARSER::COLLECTION)
    ("adrenoceptor" . SPARSER::PROTEIN)
    ("relatively higher neutrophil" . SPARSER::PROTEIN)
    ("Akt1 and HDAC2" . SPARSER::COLLECTION)
    ("Akt/HDAC2" . SPARSER::COLLECTION)
    ("thiobarbituric acid" . SPARSER::MOLECULE)
    ("Thiobarbituric Acid" . SPARSER::MOLECULE)
    ("Nitric Oxide" . SPARSER::MOLECULE) ("PKBα" . SPARSER::PROTEIN)
    ("HDAC-1" . SPARSER::PROTEIN) ("PI3Kδ" . SPARSER::PROTEIN)
    ("Bax/Bak" . SPARSER::COLLECTION)
    ("the ER and the mitochondria and Bim" . SPARSER::COLLECTION)
    ("mitochondria and Bim" . SPARSER::COLLECTION) ("Bax-" . SPARSER::PROTEIN)
    ("Bax and Bim" . SPARSER::COLLECTION) ("BH" . SPARSER::PROTEIN)
    ("mTOR/p70S6K" . SPARSER::COLLECTION) ("mTOR/4EBP1" . SPARSER::COLLECTION)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TSC1-TSC2" . SPARSER::COLLECTION)
    ("4EBP1 and p70S6K" . SPARSER::COLLECTION)
    ("Bcl-2 and caspase" . SPARSER::COLLECTION)
    ("Akt1 or Akt2" . SPARSER::COLLECTION)
    ("p70S6K or Akt1" . SPARSER::COLLECTION)
    ("Bim and Akt" . SPARSER::COLLECTION) ("JNK and p38" . SPARSER::COLLECTION)
    ("viral mRNA" . SPARSER::RNA)
    ("LY294002 and rapamycin" . SPARSER::COLLECTION)
    ("p70S6K, Akt1 or Akt2" . SPARSER::COLLECTION)
    ("PI3K- and mTOR-signaling pathway" . SPARSER::COLLECTION)
    ("CPE" . SPARSER::PROTEIN) ("-Akt2" . SPARSER::COLLECTION)
    ("-Akt1" . SPARSER::COLLECTION) ("-p70S6K" . SPARSER::COLLECTION)
    ("-4EBP1" . SPARSER::COLLECTION) ("HisA" . SPARSER::PROTEIN)
    ("p70S6k" . SPARSER::PROTEIN)
    ("4EBP1, p70S6K, Akt1 and Akt2" . SPARSER::COLLECTION)
    ("the eIF4E-binding protein 1(4EBP1) and p70S6 kinase (S6K)"
     . SPARSER::COLLECTION)
    ("Akt1, Akt2 and Akt3" . SPARSER::COLLECTION)
    ("PI3K and phosphatase and tensin homolog" . SPARSER::COLLECTION)
    ("amino acid and oxygen availability" . SPARSER::COLLECTION)
    ("disparate downstream effectors" . SPARSER::EFFECTOR)
    ("PKB or Akt" . SPARSER::COLLECTION)
    ("kinases and protein kinase" . SPARSER::COLLECTION) ("GMP" . SPARSER::GMP)
    ("AGC" . SPARSER::PROTEIN) ("4EBP1, p70S6K and Akt" . SPARSER::COLLECTION)
    ("PI3K and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("BcL-2 and caspase" . SPARSER::COLLECTION)
    ("Bim, Bax and caspase-3" . SPARSER::COLLECTION)
    ("procaspase-9 and procaspase-3" . SPARSER::COLLECTION)
    ("Bim, Bax and caspase-9" . SPARSER::COLLECTION)
    ("Bim and Bax" . SPARSER::COLLECTION)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("viral capsid protein VP1" . SPARSER::PROTEIN)
    ("Bim, Bax, caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("Akt1 and Akt2" . SPARSER::COLLECTION)
    ("eIF4E-binding protein 1" . SPARSER::PROTEIN)
    ("P70S6K" . SPARSER::PROTEIN) ("mSOD1" . SPARSER::PROTEIN)
    ("Akt3" . SPARSER::PROTEIN) ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BcL-2" . SPARSER::PROTEIN) ("procaspase-9" . SPARSER::PROTEIN)
    ("VP1" . SPARSER::PROTEIN) ("capsid protein VP1" . SPARSER::PROTEIN)
    ("Akt2" . SPARSER::PROTEIN) ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("PTEN and INPP4B" . SPARSER::COLLECTION) ("/p53" . SPARSER::COLLECTION)
    ("Rasal2/p53" . SPARSER::COLLECTION)
    ("metastasis suppressor in breast and other cancers" . SPARSER::COLLECTION)
    ("functional Rasal2" . SPARSER::PROTEIN)
    ("spontaneously lost/suppressed Rasal2" . SPARSER::PROTEIN)
    ("phospho-ERK and phospho-AKT" . SPARSER::COLLECTION)
    ("phospho-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gene-trap" . SPARSER::PROTEIN) ("two distinct shRNAs" . SPARSER::PROTEIN)
    ("acutely inactivated RASAL2" . SPARSER::PROTEIN)
    ("HRAS or KRAS" . SPARSER::COLLECTION)
    ("KRAS or HRAS" . SPARSER::COLLECTION)
    ("K-Ras and H-Ras-GTP" . SPARSER::COLLECTION)
    ("a functional RasGAP" . SPARSER::PROTEIN)
    ("Ras-GTP and phospho-ERK" . SPARSER::COLLECTION)
    ("RASAL2, Ras-GTP and phospho-ERK" . SPARSER::COLLECTION)
    ("mature luminal" . SPARSER::DRUG) ("KRAS and HRAS" . SPARSER::COLLECTION)
    ("NF1 and DAB2IP" . SPARSER::COLLECTION) ("Dab2IP" . SPARSER::PROTEIN)
    ("a well-documented tumor suppressor gene" . SPARSER::PROTEIN)
    ("Rasal2" . SPARSER::PROTEIN) ("Dab2ip" . SPARSER::PROTEIN)
    ("Nf1" . SPARSER::PROTEIN) ("Rasal" . SPARSER::PROTEIN)
    ("Distinct shRNAs" . SPARSER::PROTEIN) ("TPase" . SPARSER::PROTEIN)
    ("RasGAPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RasGAP" . SPARSER::PROTEIN)
    ("Ras and ERK" . SPARSER::COLLECTION) ("PMA2" . SPARSER::PROTEIN)
    ("p120RasGAP" . SPARSER::PROTEIN) ("Erbb2" . SPARSER::PROTEIN)
    ("Phospho-ERK" . SPARSER::PROTEIN) ("Dab2" . SPARSER::PROTEIN)
    ("N-RAS" . SPARSER::PROTEIN) ("DAB2IP" . SPARSER::PROTEIN)
    ("Ras-GDP" . SPARSER::PROTEIN) ("RASAL2" . SPARSER::PROTEIN)
    ("phenotypic states" . SPARSER::BIO-STATE)
    ("mesenchymal MECs" . SPARSER::PROTEIN)
    ("inhibitor or vehicle" . SPARSER::COLLECTION)
    ("Moderate-to-strong nuclear FRA1" . SPARSER::PROTEIN)
    ("FOSL1 , PDGFRA and PDGFRB" . SPARSER::COLLECTION)
    ("PKCα and FOSL1" . SPARSER::COLLECTION)
    ("FOS or FOSB" . SPARSER::COLLECTION) ("FOSB" . SPARSER::PROTEIN)
    ("FRA1 and PKCα" . SPARSER::COLLECTION)
    ("expressed control shRNA" . SPARSER::PROTEIN)
    ("TWIST or SNAIL" . SPARSER::COLLECTION)
    ("a previously reported FRA1-bound gene promoter" . SPARSER::PROMOTER)
    ("FRA1-mut-BS" . SPARSER::COLLECTION)
    ("Twist or Snail" . SPARSER::COLLECTION)
    ("HMLE-Snail-ER" . SPARSER::COLLECTION)
    ("HMLE-Twist-ER" . SPARSER::COLLECTION)
    ("FOSL1 and FOS" . SPARSER::COLLECTION) ("/PROCR" . SPARSER::COLLECTION)
    ("FN1 (48x) and TWIST (6.6x)" . SPARSER::COLLECTION)
    ("MCF7-Ras" . SPARSER::COLLECTION)
    ("VIM , FN1 and CDH2" . SPARSER::COLLECTION)
    ("PKCα and ERK1/2" . SPARSER::COLLECTION)
    ("total FRA1 or p-c-JUN ( xref )" . SPARSER::COLLECTION)
    ("p-c-JUN" . SPARSER::COLLECTION) ("PDGFR and PKCα" . SPARSER::COLLECTION)
    ("p-c-RAF" . SPARSER::COLLECTION) ("RAS-RAF" . SPARSER::COLLECTION)
    ("c-RAF" . SPARSER::COLLECTION) ("c-Raf" . SPARSER::COLLECTION)
    ("E-cadherin and Crumb3" . SPARSER::COLLECTION)
    ("but not c-JUN, which was downregulated in the epithelial state ( xref )"
     . SPARSER::PROTEIN)
    ("c-JUN, JUNB and JUND" . SPARSER::COLLECTION) ("Tom" . SPARSER::PROTEIN)
    ("NAMEC-Tom" . SPARSER::COLLECTION) ("c-FOS-FRA1" . SPARSER::COLLECTION)
    ("JUNB and JUND" . SPARSER::COLLECTION) ("p-FRA1" . SPARSER::COLLECTION)
    ("JUN" . SPARSER::PROTEIN)
    ("the mesenchymal cell state" . SPARSER::BIO-STATE)
    ("c-FOS or FRA1" . SPARSER::COLLECTION)
    ("here cross-inhibited c-KIT- and VEGFR-associated tyrosine kinases"
     . SPARSER::COLLECTION)
    ("VEGFR-associated tyrosine kinases" . SPARSER::KINASE)
    ("here cross-inhibited c-KIT-" . SPARSER::PROTEIN)
    ("a pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("c-KIT-" . SPARSER::PROTEIN) ("PDGFR and PLCγ" . SPARSER::COLLECTION)
    ("p-PLCγ2" . SPARSER::COLLECTION) ("p-PLCγ1" . SPARSER::COLLECTION)
    ("PLCγ1 and PLCγ2" . SPARSER::COLLECTION)
    ("a PDGFR-neutralizing antibody or a PDGFR pharmacologic inhibitor"
     . SPARSER::COLLECTION)
    ("a PDGFR pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("NAMECs" . SPARSER::PROTEIN)
    ("PDGFRA , PDGFRB and PDGFC" . SPARSER::COLLECTION)
    ("total and phosphorylated PDGFRα/β proteins" . SPARSER::PROTEIN)
    ("PDGFA , PDGFB and PDGFD" . SPARSER::COLLECTION)
    ("PDGFD" . SPARSER::PROTEIN)
    ("PDGFRA (encoding PDGFRα) and PDGFRB" . SPARSER::COLLECTION)
    ("PDGFC" . SPARSER::PROTEIN) ("HMLE-RAS-GFP" . SPARSER::COLLECTION)
    ("GFP (HMLE-GFP-RAS) and re-tested" . SPARSER::COLLECTION)
    ("HMLE-GFP-RAS" . SPARSER::COLLECTION)
    ("PKCα and other kinase-encoding genes" . SPARSER::COLLECTION)
    ("NAMEC" . SPARSER::PROTEIN) ("HMLE-RAS" . SPARSER::COLLECTION)
    ("NAMEC-RAS" . SPARSER::COLLECTION)
    ("lentiviral shRNAs" . SPARSER::PROTEIN)
    ("paclitaxel and staurosporine" . SPARSER::COLLECTION)
    ("staurosporine, doxorubicin and paclitaxel" . SPARSER::COLLECTION)
    ("bisindolylmaleimide" . SPARSER::DRUG)
    ("total and phosphorylated PKCα" . SPARSER::PROTEIN)
    ("15 commercially available kinase inhibitors" . SPARSER::INHIBITOR)
    ("the tdTomato red fluorescent protein" . SPARSER::PROTEIN)
    ("HMLE-GFP" . SPARSER::COLLECTION)
    ("Twist, Snail, Slug and Zeb1" . SPARSER::COLLECTION)
    ("vimentin, N-cadherin and fibronectin" . SPARSER::COLLECTION)
    ("their phenotypic state" . SPARSER::BIO-STATE)
    ("a mesenchymal state" . SPARSER::BIO-STATE)
    ("EMT-TF" . SPARSER::COLLECTION)
    ("SGK1 , SPHK1 and CDK6" . SPARSER::COLLECTION)
    ("PRKCA" . SPARSER::PROTEIN) ("HMLE" . SPARSER::PROTEIN)
    ("HMLE-Twist, HMLE-Snail and HMLE-Slug" . SPARSER::COLLECTION)
    ("HMLE-Slug" . SPARSER::COLLECTION) ("HMLE-Snail" . SPARSER::COLLECTION)
    ("HMLE-Twist" . SPARSER::COLLECTION)
    ("the hTERT and SV40 early-region genes ( xref )" . SPARSER::COLLECTION)
    ("Twist, Snail and Slug" . SPARSER::COLLECTION)
    ("the mesenchymal state" . SPARSER::BIO-STATE)
    ("a distinctive CD44" . SPARSER::PROTEIN)
    ("mesenchymal traits" . SPARSER::PROTEIN) ("MECs" . SPARSER::PROTEIN)
    ("highly aggressive traits" . SPARSER::PROTEIN)
    ("the PKH26 lipophilic dye" . SPARSER::MOLECULE)
    ("PKCα and FRA1" . SPARSER::COLLECTION)
    ("c-FOS and FRA1" . SPARSER::COLLECTION) ("IL2R" . SPARSER::PROTEIN)
    ("OH-" . SPARSER::MOLECULE) ("protein C receptor" . SPARSER::PROTEIN)
    ("B-RAF" . SPARSER::PROTEIN) ("FOSL1" . SPARSER::PROTEIN)
    ("c-KIT" . SPARSER::PROTEIN) ("PLCγ2" . SPARSER::PROTEIN)
    ("bisindolylmaleimide I" . SPARSER::DRUG) ("Ro-31-8220" . SPARSER::DRUG)
    ("NME7" . SPARSER::PROTEIN) ("EPHA2" . SPARSER::PROTEIN)
    ("CLK1" . SPARSER::PROTEIN) ("PKH26" . SPARSER::DRUG)
    ("ALDH1" . SPARSER::PROTEIN) ("FRA1" . SPARSER::PROTEIN)
    ("western-blot" . SPARSER::PROTEIN)
    ("EGFR and MUC5AC" . SPARSER::COLLECTION)
    ("TACE or EGFR" . SPARSER::COLLECTION)
    ("EGFR or TACE" . SPARSER::COLLECTION)
    ("EGFR and TACE" . SPARSER::COLLECTION)
    ("disintegrin and metalloprotease" . SPARSER::COLLECTION)
    ("ADAM" . SPARSER::PROTEIN) ("disintegrin" . SPARSER::PROTEIN)
    ("The polymeric form and abundant O-linked oligosaccharides"
     . SPARSER::COLLECTION)
    ("The polymeric form" . SPARSER::FORM)
    ("oligosaccharides" . SPARSER::MOLECULE)
    ("MUC5AC and pEGFR" . SPARSER::COLLECTION)
    ("tumour necrosis factor-" . SPARSER::PROTEIN)
    ("Mucins" . SPARSER::PROTEIN) ("/EGFR" . SPARSER::COLLECTION)
    ("TACE/TGF- α" . SPARSER::COLLECTION)
    ("converting enzyme (TACE)" . SPARSER::PROTEIN)
    ("Transforming growth factor-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ADAM-17" . SPARSER::PROTEIN) ("β -glucuronidase" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("mucin 5AC" . SPARSER::PROTEIN) ("TGF- α" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mucin 5AC" . SPARSER::PROTEIN)
    ("nuclear hormone receptor/transcription factor" . SPARSER::COLLECTION)
    ("Androgens" . SPARSER::DRUG) ("gene, and GFP+" . SPARSER::COLLECTION)
    ("Amp and chloramphenicol" . SPARSER::COLLECTION)
    ("chloramphenicol" . SPARSER::DRUG) ("Amp" . SPARSER::PROTEIN)
    ("ampicillin" . SPARSER::DRUG) ("RAG1 and RAG2" . SPARSER::COLLECTION)
    ("post-IR" . SPARSER::COLLECTION)
    ("mock-treated cells demonstrated increased gamma-H2AX foci"
     . SPARSER::PROTEIN)
    ("IR and gamma-H2AX foci" . SPARSER::COLLECTION)
    ("AR-associated DNA repair genes" . SPARSER::GENE)
    ("LNCaP-AR" . SPARSER::COLLECTION) ("the basic biologic" . SPARSER::DRUG)
    ("antiandrogen" . SPARSER::DRUG) ("LIG4" . SPARSER::PROTEIN)
    ("LSM 5" . SPARSER::PROTEIN) ("Lig4" . SPARSER::PROTEIN)
    ("much needed female-specific DMT" . SPARSER::PROTEIN)
    ("DMT" . SPARSER::PROTEIN)
    ("proinflammatory cytokines and mediators" . SPARSER::COLLECTION)
    ("cytokines and mediators" . SPARSER::COLLECTION)
    ("an ancillary adjuvant" . SPARSER::DRUG)
    ("toxin (PTX)" . SPARSER::MOLECULE)
    ("somewhat counter-intuitive given reduced EAE" . SPARSER::PROTEIN)
    ("Sham" . SPARSER::DRUG)
    ("key p38α-controlled sex-specific genes" . SPARSER::GENE)
    ("Il10 and Oas1g" . SPARSER::COLLECTION) ("Il6" . SPARSER::PROTEIN)
    ("Tnfa" . SPARSER::PROTEIN) ("Il1b" . SPARSER::PROTEIN)
    ("Fcgr1, Ccr1 and Ccr5" . SPARSER::COLLECTION)
    ("IL-12 and IL-23" . SPARSER::COLLECTION) ("Il12b" . SPARSER::PROTEIN)
    ("an immunosuppressive cytokine" . SPARSER::PROTEIN)
    ("Il10" . SPARSER::PROTEIN) ("Ccr1" . SPARSER::PROTEIN)
    ("FCGR1a" . SPARSER::PROTEIN) ("Fcgr1" . SPARSER::PROTEIN)
    ("EAE or MS" . SPARSER::COLLECTION) ("Ccr5" . SPARSER::PROTEIN)
    ("Il1f9" . SPARSER::PROTEIN) ("EAE/MS" . SPARSER::COLLECTION)
    ("Serpinb2 (plasminogen activator inhibitor 2, PAI-2) and Mmp13 (matrix metalloproteinase 13, MMP-13)"
     . SPARSER::COLLECTION)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("the primary adjuvant" . SPARSER::DRUG) ("MTB" . SPARSER::PROTEIN)
    ("Macrophages" . SPARSER::PROTEIN) ("TNFα and IL-6" . SPARSER::COLLECTION)
    ("passive EAE" . SPARSER::PROTEIN)
    ("IFNγ, IL-17, and GM-CSF" . SPARSER::COLLECTION)
    ("macrophages and microglia" . SPARSER::COLLECTION)
    ("IFNγ, IL-17, or GM-CSF" . SPARSER::COLLECTION) ("CKO" . SPARSER::PROTEIN)
    ("Lck , Cd11c , or Lysm/Lyz2" . SPARSER::COLLECTION)
    ("Cd11c" . SPARSER::PROTEIN) ("EAE and MS" . SPARSER::COLLECTION)
    ("MS and EAE" . SPARSER::COLLECTION)
    ("a small molecule inhibitor of p38α and β" . SPARSER::COLLECTION)
    ("/CFA" . SPARSER::COLLECTION) ("CFA" . SPARSER::PROTEIN)
    ("MOG" . SPARSER::PROTEIN)
    ("the predominant p38 MAPK isoform" . SPARSER::ISOFORM)
    ("pathogenic IL-17" . SPARSER::PROTEIN) ("EAE" . SPARSER::PROTEIN)
    ("MAP kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MS or MS" . SPARSER::COLLECTION) ("B10" . SPARSER::PROTEIN)
    ("Il12" . SPARSER::PROTEIN-FAMILY) ("Fc receptor" . SPARSER::PROTEIN)
    ("FCGR1" . SPARSER::PROTEIN) ("MMP-13" . SPARSER::PROTEIN)
    ("Mmp13" . SPARSER::PROTEIN) ("PAI-2" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor 2" . SPARSER::PROTEIN)
    ("Serpinb2" . SPARSER::PROTEIN) ("Gene 2" . SPARSER::PROTEIN)
    ("delta-" . SPARSER::PROTEIN) ("Anti-mouse" . SPARSER::PROTEIN)
    ("Ly6G" . SPARSER::PROTEIN) ("Ly6C" . SPARSER::PROTEIN)
    ("CD11c" . SPARSER::PROTEIN) ("TCRβ" . SPARSER::PROTEIN)
    ("H37" . SPARSER::PROTEIN) ("Lyz2" . SPARSER::PROTEIN)
    ("apoptosis signal-regulating kinase 1" . SPARSER::PROTEIN)
    ("MAPK14" . SPARSER::PROTEIN)
    ("BAK1, CBL, HLA-B, PTPN11, MYB and TPM1" . SPARSER::COLLECTION)
    ("CBL" . SPARSER::PROTEIN)
    ("clinically relevant traits" . SPARSER::PROTEIN)
    ("multiple intergenic SNPs" . SPARSER::PROTEIN)
    ("CD9–VWF" . SPARSER::COLLECTION)
    ("FLJ36031-PIK3CG" . SPARSER::PROTEIN-PAIR)
    ("HBS1L-MYB" . SPARSER::COLLECTION) ("VWF" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase catalytic subunit gamma isoform ( PIK3CG ) and TAO kinase 1 gene ( TAOK1 ) encoding a microtubule affinity-regulating kinase that regulates"
     . SPARSER::COLLECTION)
    ("TAO" . SPARSER::DRUG) ("erythropoietin" . SPARSER::PROTEIN)
    ("medically important quantitative traits" . SPARSER::PROTEIN)
    ("PLT and/or MPV" . SPARSER::COLLECTION)
    ("platelet trait-associated genes" . SPARSER::GENE)
    ("gene ( PLEC )" . SPARSER::PROTEIN) ("PTGES3–BAZ2A" . SPARSER::COLLECTION)
    ("HBS1L–" . SPARSER::PROTEIN) ("PLEC" . SPARSER::PROTEIN)
    ("plectin" . SPARSER::PROTEIN) ("THPO" . SPARSER::PROTEIN)
    ("SIRPA" . SPARSER::PROTEIN)
    ("TMEM120B, SETD1B, PSMD9, and BCL7A" . SPARSER::COLLECTION)
    ("TAOK1 and one SNP" . SPARSER::COLLECTION)
    ("Three intronic SNPs" . SPARSER::PROTEIN)
    ("NRBF2, JMJD1C, MIR1296, LOC84989, and REEP3" . SPARSER::COLLECTION)
    ("Intronic SNPs" . SPARSER::PROTEIN)
    ("Another intronic SNP" . SPARSER::PROTEIN)
    ("CNTN2, TMEM81, DSTYK, TMCC2, and NUAK2" . SPARSER::COLLECTION)
    ("PIK3CG and rs342240" . SPARSER::COLLECTION)
    ("Another intergenic SNP" . SPARSER::PROTEIN)
    ("An intergenic SNP" . SPARSER::PROTEIN)
    ("HBS1L and MYB" . SPARSER::COLLECTION)
    ("BET1L and SIRT3" . SPARSER::COLLECTION)
    ("SCGB1C1, ODF3, RIC8A, BET1L, SIRT3, and PSMD13" . SPARSER::COLLECTION)
    ("an adjacent SNP" . SPARSER::PROTEIN)
    ("An intronic SNP" . SPARSER::PROTEIN) ("PLT or MPV" . SPARSER::COLLECTION)
    ("platelets and platelet-derived growth factors" . SPARSER::COLLECTION)
    ("influencing PLT and 22 SNPs" . SPARSER::COLLECTION)
    ("PLT and MPV" . SPARSER::COLLECTION) ("MPV and PLT" . SPARSER::COLLECTION)
    ("MPV" . SPARSER::MOLECULE) ("PLT" . SPARSER::PROTEIN)
    ("TPM1" . SPARSER::PROTEIN) ("CD9" . SPARSER::PROTEIN)
    ("RPH3A" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("catalytic subunit gamma" . SPARSER::PROTEIN)
    ("adenylate kinase 3" . SPARSER::PROTEIN)
    ("coat protein" . SPARSER::PROTEIN) ("lyase activity" . SPARSER::PROTEIN)
    ("BAZ2A" . SPARSER::PROTEIN) ("PTGES3" . SPARSER::PROTEIN)
    ("B12" . SPARSER::PROTEIN) ("DLK1" . SPARSER::PROTEIN)
    ("GP1BA" . SPARSER::PROTEIN) ("PTPN11" . SPARSER::PROTEIN)
    ("EHD3" . SPARSER::PROTEIN) ("CABLES1" . SPARSER::PROTEIN)
    ("RBBP5" . SPARSER::PROTEIN) ("COPZ1" . SPARSER::PROTEIN)
    ("AK3" . SPARSER::PROTEIN) ("BCL7A" . SPARSER::PROTEIN)
    ("PSMD9" . SPARSER::PROTEIN) ("SETD1B" . SPARSER::PROTEIN)
    ("TMEM120B" . SPARSER::PROTEIN) ("WDR66" . SPARSER::PROTEIN)
    ("NFE2" . SPARSER::PROTEIN) ("TAOK1" . SPARSER::PROTEIN)
    ("Chromosome 17" . SPARSER::PROTEIN) ("REEP3" . SPARSER::PROTEIN)
    ("JMJD1C" . SPARSER::PROTEIN) ("NRBF2" . SPARSER::PROTEIN)
    ("DNM3" . SPARSER::PROTEIN) ("NUAK2" . SPARSER::PROTEIN)
    ("TMCC2" . SPARSER::PROTEIN) ("TMEM81" . SPARSER::PROTEIN)
    ("CNTN2" . SPARSER::PROTEIN) ("PIK3CG" . SPARSER::PROTEIN)
    ("RCL1" . SPARSER::PROTEIN) ("HBS1L" . SPARSER::PROTEIN)
    ("PSMD13" . SPARSER::PROTEIN) ("BET1L" . SPARSER::PROTEIN)
    ("RIC8A" . SPARSER::PROTEIN) ("ODF3" . SPARSER::PROTEIN)
    ("SCGB1C1" . SPARSER::PROTEIN) ("ATXN2" . SPARSER::PROTEIN)
    ("SH2B3" . SPARSER::PROTEIN) ("ARHGEF3" . SPARSER::PROTEIN)
    ("Rho guanine nucleotide exchange factor 3" . SPARSER::PROTEIN)
    ("Nrf2 and NF-κB" . SPARSER::COLLECTION)
    ("Class I and Class V" . SPARSER::COLLECTION)
    ("p65 and IκB" . SPARSER::COLLECTION)
    ("either control-siRNA or Nrf2-siRNA ( xref )" . SPARSER::COLLECTION)
    ("Nrf2-siRNA" . SPARSER::COLLECTION) ("MOPC" . SPARSER::PROTEIN)
    ("TGFβ1, fibronectin, and iNOS" . SPARSER::COLLECTION)
    ("Nrf2 and NQO1" . SPARSER::COLLECTION) ("Sulforaphane" . SPARSER::PROTEIN)
    ("TGFβ1 and fibronectin" . SPARSER::COLLECTION)
    ("TGFβ1 and FN" . SPARSER::COLLECTION)
    ("transforming growth factor β1 (TGFβ1) and fibronectin"
     . SPARSER::COLLECTION)
    ("Anti-ssDNA, anti-nRNP, and anti-Histone Ig’s" . SPARSER::MOLECULE)
    ("Pristane" . SPARSER::DRUG) ("pristane" . SPARSER::DRUG)
    ("Nrf2, NQO1 and 8-Oxo-dG" . SPARSER::COLLECTION)
    ("Nrf2, NQO1, and 8-Oxo-dG" . SPARSER::COLLECTION)
    ("Solution" . SPARSER::MOLECULE) ("NF-κB and TGFβ1" . SPARSER::COLLECTION)
    ("iNOS, TGFβ1 and fibronectin" . SPARSER::COLLECTION)
    ("TGFβ1, fibronectin and iNOS" . SPARSER::COLLECTION)
    ("sulforaphane" . SPARSER::DRUG) ("anti-oxidant" . SPARSER::DRUG)
    ("Class V" . SPARSER::PROTEIN) ("B-F" . SPARSER::PROTEIN)
    ("PH, LC and QZ" . SPARSER::COLLECTION)
    ("LP, SZ and STN" . SPARSER::COLLECTION) ("STN" . SPARSER::PROTEIN)
    ("clinically relevant inhibitors" . SPARSER::INHIBITOR)
    ("AKT or ERKs" . SPARSER::COLLECTION)
    ("EGFR, AKT and ERKs" . SPARSER::COLLECTION)
    ("EGFR, ERKs and STAT3" . SPARSER::COLLECTION)
    ("gemcitabine and an EGFR inhibitor" . SPARSER::COLLECTION)
    ("STAT3 and Ki-67" . SPARSER::COLLECTION)
    ("expressing STAT3" . SPARSER::PROTEIN)
    ("STAT3-shRNA" . SPARSER::COLLECTION)
    ("AG1478 or gemcitabine" . SPARSER::COLLECTION)
    ("AG1478 and gemcitabine" . SPARSER::COLLECTION)
    ("Pan-1" . SPARSER::PROTEIN) ("RON" . SPARSER::PROTEIN)
    ("UK-Pan-1" . SPARSER::PROTEIN-PAIR)
    ("EGFR, STAT3, and ERKs" . SPARSER::COLLECTION)
    ("a relevant target" . SPARSER::TARGET-PROTEIN)
    ("the functional tumor suppressor gene" . SPARSER::PROTEIN)
    ("AKT and ERKs" . SPARSER::COLLECTION)
    ("gemcitabine or AG1478" . SPARSER::COLLECTION)
    ("Ki67 and STAT3" . SPARSER::COLLECTION) ("Smad4" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("DPC4" . SPARSER::PROTEIN)
    ("c-K-Ras" . SPARSER::PROTEIN) ("PI3/Akt" . SPARSER::COLLECTION)
    ("PI3-K/AKT" . SPARSER::COLLECTION)
    ("BrdU and Nestin" . SPARSER::COLLECTION) ("GSK3b" . SPARSER::PROTEIN)
    ("iPS" . SPARSER::PROTEIN) ("eag" . SPARSER::PROTEIN)
    ("SSRIs" . SPARSER::DRUG)
    ("Nonserotoninergic targets" . SPARSER::TARGET-PROTEIN)
    ("PI3k/Akt" . SPARSER::COLLECTION) ("antidepressant" . SPARSER::DRUG)
    ("neural fate" . SPARSER::PROTEIN)
    ("Neurotransmitters" . SPARSER::MOLECULE) ("fluoxetine" . SPARSER::DRUG)
    ("Nestin, MAP-2, and β -tubulin" . SPARSER::COLLECTION)
    ("fate and Akt1" . SPARSER::COLLECTION)
    ("selective serotonin reuptake inhibitor (SSRI)" . SPARSER::DRUG)
    ("SSRI" . SPARSER::DRUG) ("FLX" . SPARSER::PROTEIN)
    ("Fluoxetine" . SPARSER::DRUG) ("K 1" . SPARSER::PROTEIN)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("Anti- β" . SPARSER::PROTEIN) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("CD90" . SPARSER::PROTEIN) ("CD105" . SPARSER::PROTEIN)
    ("CD146" . SPARSER::PROTEIN) ("MAP-2" . SPARSER::PROTEIN)
    ("selective serotonin reuptake inhibitor" . SPARSER::DRUG)
    ("c-Myc , survivin , MAP4, Nanog and Arf" . SPARSER::COLLECTION)
    ("the repressive p53 RE" . SPARSER::PROTEIN)
    ("repressive p53 REs" . SPARSER::PROTEIN)
    ("The canonical p53 RE" . SPARSER::PROTEIN)
    ("pyrimidine and W" . SPARSER::COLLECTION)
    ("Gfi1 and c-Myc" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bcl-2 family members Bax" . SPARSER::PROTEIN)
    ("Bax, Bak and Bcl-2" . SPARSER::COLLECTION)
    ("expressed Gfi1" . SPARSER::PROTEIN) ("Cip1" . SPARSER::PROTEIN)
    ("Histone Deacetylases (HDACs) and p21 Cip1" . SPARSER::COLLECTION)
    ("Deacetylases" . SPARSER::PROTEIN)
    ("the potential repressive p53 RE" . SPARSER::PROTEIN)
    ("an anti-human p53 antibody or a species-matched control antibody"
     . SPARSER::COLLECTION)
    ("lacked functional p53" . SPARSER::PROTEIN)
    ("p53/estrogen receptor" . SPARSER::COLLECTION)
    ("response element (RE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("HLF" . SPARSER::PROTEIN) ("HSCs" . SPARSER::PROTEIN)
    ("HSC" . SPARSER::PROTEIN) ("atypical monocytes" . SPARSER::PROTEIN)
    ("Myeloid" . SPARSER::PROTEIN) ("ZF" . SPARSER::PROTEIN)
    ("a putative p53 repressive response element"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("a DNA binding-defective p53 mutant" . SPARSER::MUTANT)
    ("p53 REs" . SPARSER::PROTEIN) ("pro-B" . SPARSER::DRUG)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-3" . SPARSER::PROTEIN) ("Pro-B" . SPARSER::DRUG)
    ("Pim-1" . SPARSER::PROTEIN) ("Gfi1" . SPARSER::PROTEIN)
    ("GFI1" . SPARSER::PROTEIN)
    ("sorafenib and sunitinib" . SPARSER::COLLECTION)
    ("sorafenib" . SPARSER::DRUG)
    ("this versatile transcription factor" . SPARSER::PROTEIN)
    ("two Epithelial-to-Mesenchymal Transition (EMT) related genes"
     . SPARSER::GENE)
    ("vimentin and ZEB1" . SPARSER::COLLECTION) ("cava" . SPARSER::PROTEIN)
    ("E2F1 and its associated genes" . SPARSER::COLLECTION)
    ("its associated genes" . SPARSER::GENE)
    ("vascular wall degradation related genes" . SPARSER::GENE)
    ("potential elemental genes" . SPARSER::GENE)
    ("MMP2, MMP9, vimentin, and ZEB1" . SPARSER::COLLECTION)
    ("un-transfected group and pcDNA3.1-entry group" . SPARSER::COLLECTION)
    ("noncancerous tissue group" . SPARSER::MOLECULE)
    ("MMP2 and MMP9" . SPARSER::COLLECTION) ("von" . SPARSER::PROTEIN)
    ("1,10-phenanthroline" . SPARSER::MOLECULE)
    ("peptidylprolyl isomerase A" . SPARSER::PROTEIN)
    ("Transcription factor E2F1" . SPARSER::PROTEIN)
    ("CXCL12- and PDGFBB-induced chemotaxis" . SPARSER::COLLECTION)
    ("PDGF and CXCL12" . SPARSER::COLLECTION)
    ("receptors and GPCRs" . SPARSER::COLLECTION)
    ("S1PRs [ xref , xref ] and P2Y2 [ xref ]" . SPARSER::COLLECTION)
    ("EGF induced chemotaxis" . SPARSER::PROTEIN)
    ("EGFR and CXCR4" . SPARSER::COLLECTION)
    ("PDGF-induced chemotaxis and vice versa" . SPARSER::COLLECTION)
    ("PDGF/PDGFR" . SPARSER::COLLECTION)
    ("CXCR4, PDGFRα, PDGFRβ and c-kit" . SPARSER::COLLECTION)
    ("neither CXCL12- or PDGF-induced chemotaxis" . SPARSER::COLLECTION)
    ("possible common pathways src" . SPARSER::PROTEIN)
    ("CXCL12 or PDGF" . SPARSER::COLLECTION)
    ("kinases and c-Abl" . SPARSER::COLLECTION)
    ("-chelating agent" . SPARSER::MOLECULE)
    ("CXCR4 and PDGFRβ" . SPARSER::COLLECTION) ("CXCL12-" . SPARSER::PROTEIN)
    ("CXCL12, PDGF or CXCL12" . SPARSER::COLLECTION)
    ("CXCL12 and PDGF" . SPARSER::COLLECTION)
    ("CXCL12 and PDGFBB" . SPARSER::COLLECTION)
    ("PDGF and the two receptor inhibitors ( xref )" . SPARSER::COLLECTION)
    ("CXCL12, PDGF and the two receptor inhibitors ( xref )"
     . SPARSER::COLLECTION)
    ("expressed PDGFRβ, GBM12 and GBM13" . SPARSER::COLLECTION)
    ("PDGFRβ, GBM12 and GBM13" . SPARSER::COLLECTION)
    ("PDGFR and CXCR4" . SPARSER::COLLECTION) ("VII" . SPARSER::PROTEIN)
    ("PDGFBB and CXCL12" . SPARSER::COLLECTION)
    ("PDGFRα, PDGFRβ and c-kit" . SPARSER::COLLECTION)
    ("EGFR and PDGFR" . SPARSER::COLLECTION)
    ("PDGFRβ and CXCR4" . SPARSER::COLLECTION)
    ("particular PDGFRβ" . SPARSER::PROTEIN)
    ("RTKs and GPCRs" . SPARSER::COLLECTION)
    ("GPCRs and RTKs" . SPARSER::COLLECTION)
    ("PDGFBB ligand and phosphorylation of PDGFRβ [ xref ]"
     . SPARSER::COLLECTION)
    ("Platelet-derived growth factors (PDGFs) and their receptors"
     . SPARSER::COLLECTION)
    ("CXCR4 and abnormally activated RTKs" . SPARSER::COLLECTION)
    ("receptors, which are often over-expressed or constitutively active in GBM cells"
     . SPARSER::COLLECTION)
    ("HIF1 and VEGF" . SPARSER::COLLECTION)
    ("CXCL12 and its receptor" . SPARSER::COLLECTION)
    ("signals even more complex" . SPARSER::BIO-COMPLEX)
    ("chemokines and their receptors" . SPARSER::COLLECTION)
    ("Growth factors, cytokines, chemokines and their receptors"
     . SPARSER::COLLECTION)
    ("the most aggressive form" . SPARSER::FORM)
    ("CXCR4 and PDGFR" . SPARSER::COLLECTION)
    ("CXCL12/CXCR4" . SPARSER::COLLECTION) ("P2Y2" . SPARSER::PROTEIN)
    ("S1PRs" . SPARSER::PROTEIN-FAMILY) ("KCa3.1" . SPARSER::PROTEIN)
    ("src-like" . SPARSER::PROTEIN) ("AMD3100" . SPARSER::DRUG)
    ("AG1296" . SPARSER::DRUG)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AATF" . SPARSER::PROTEIN) ("TMEPAI" . SPARSER::PROTEIN)
    ("androgen−" . SPARSER::PROTEIN) ("ARD" . SPARSER::PROTEIN)
    ("response elements (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("only 6 genes" . SPARSER::GENE)
    ("an intact AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("APOD" . SPARSER::PROTEIN)
    ("The imprinted genes included GNAS" . SPARSER::PROTEIN)
    ("MEST" . SPARSER::PROTEIN) ("GNAS" . SPARSER::PROTEIN)
    ("RR " . SPARSER::PROTEIN)
    ("high CpG (HCP) and low CpG (LCP) promoter genes (34)"
     . SPARSER::COLLECTION)
    ("CpG (HCP)" . SPARSER::PROTEIN) ("LCP" . SPARSER::PROTEIN)
    ("HCP" . SPARSER::PROTEIN) ("intact AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAIS" . SPARSER::PROTEIN) ("transgenerational impact" . SPARSER::PROTEIN)
    ("Dnmt3A and Dnmt3L" . SPARSER::COLLECTION) ("Dnmt" . SPARSER::PROTEIN)
    ("extragenital health states and diseases" . SPARSER::COLLECTION)
    ("prenatal androgen" . SPARSER::PROTEIN)
    ("states and diseases" . SPARSER::COLLECTION)
    ("postnatal androgen" . SPARSER::PROTEIN)
    ("testosterone and dihydrotestosterone" . SPARSER::COLLECTION)
    ("-gene" . SPARSER::GENE) ("gonadal" . SPARSER::PROTEIN-FAMILY)
    ("SRY" . SPARSER::PROTEIN) ("behavioral traits" . SPARSER::PROTEIN)
    ("considerable impact" . SPARSER::PROTEIN)
    ("androgen target genes and low CpG content promoter genes"
     . SPARSER::COLLECTION)
    ("162 unique human genes" . SPARSER::GENE) ("HOXA5" . SPARSER::PROTEIN)
    ("Flavin-containing monooxygenase" . SPARSER::PROTEIN)
    ("FMO2" . SPARSER::PROTEIN) ("ALDH1A3" . SPARSER::PROTEIN)
    ("CDK11-p58" . SPARSER::PROTEIN) ("CDC2L2" . SPARSER::PROTEIN)
    ("O-6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("carbonic anhydrase II" . SPARSER::PROTEIN) ("CA2" . SPARSER::PROTEIN)
    ("CAMK4" . SPARSER::PROTEIN) ("chr3" . SPARSER::PROTEIN)
    ("Apolipoprotein D" . SPARSER::PROTEIN) ("PEG3" . SPARSER::PROTEIN)
    ("Dnmt3A" . SPARSER::PROTEIN)
    ("possible confounding factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type and ethnicity" . SPARSER::COLLECTION) ("FB" . SPARSER::PROTEIN)
    ("HNC" . SPARSER::PROTEIN)
    ("inflammation-associated molecules" . SPARSER::MOLECULE)
    ("type and race" . SPARSER::COLLECTION)
    ("Inflammation-associated genetic variants" . SPARSER::VARIANT)
    ("prostaglandin-endoperoxide synthase 2" . SPARSER::PROTEIN)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("a particular genotype" . SPARSER::PROTEIN)
    ("hospital-base" . SPARSER::PROTEIN)
    ("matrix Gla protein (MGP)" . SPARSER::PROTEIN)
    ("receptor ( CASR )" . SPARSER::RECEPTOR)
    ("receptor (VDR)" . SPARSER::RECEPTOR)
    ("androgen and estrogen" . SPARSER::COLLECTION) ("MGP" . SPARSER::PROTEIN)
    ("CASR" . SPARSER::PROTEIN) ("the A allele variant" . SPARSER::VARIANT)
    ("Hypercalciuria" . SPARSER::PROTEIN) ("The A allele" . SPARSER::ALLELE)
    ("oxalate" . SPARSER::MOLECULE) ("alkaline" . SPARSER::PROTEIN)
    ("hypercalciuria" . SPARSER::PROTEIN) ("FN 1" . SPARSER::PROTEIN)
    ("matrix Gla protein" . SPARSER::PROTEIN) ("vitamin D" . SPARSER::MOLECULE)
    ("protein expressed in" . SPARSER::PROTEIN)
    ("Cytoskeletal glycoproteins and cell-cell adhesion molecules"
     . SPARSER::COLLECTION)
    ("Cytoskeletal glycoproteins" . SPARSER::PROTEIN)
    ("both mechanical and environmental factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Several key glycoproteins" . SPARSER::PROTEIN)
    ("Glycoproteins" . SPARSER::PROTEIN)
    ("class and lung" . SPARSER::COLLECTION) ("NSCL" . SPARSER::PROTEIN)
    ("a myosin-associated slow skeletal muscle isoform" . SPARSER::ISOFORM)
    ("SNPs, rs10860757, rs6538998, rs7308665, and rs12146808"
     . SPARSER::COLLECTION)
    ("a calcium dependent transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("a vital component" . SPARSER::COMPONENT)
    ("two independent primarily adult cohorts" . SPARSER::MOLECULE)
    ("MYBPC1 and FEV1" . SPARSER::COLLECTION)
    ("smaller cohorts" . SPARSER::MOLECULE)
    ("the top 2,000 published SNPs and closest genes" . SPARSER::COLLECTION)
    ("the African American pediatric cohort" . SPARSER::MOLECULE)
    ("GSTCD" . SPARSER::PROTEIN) ("Two intronic SNPs" . SPARSER::PROTEIN)
    ("the Caucasian cohort" . SPARSER::MOLECULE) ("GIF" . SPARSER::PROTEIN)
    ("Caucasian cohorts" . SPARSER::MOLECULE)
    ("SNPs and 510k" . SPARSER::COLLECTION) ("MDS" . SPARSER::PROTEIN)
    ("a single Mendelian gene" . SPARSER::GENE) ("meta  " . SPARSER::PROTEIN)
    ("FEV" . SPARSER::PROTEIN) ("toluene diisocyanate" . SPARSER::MOLECULE)
    ("alpha 3" . SPARSER::PROTEIN)
    ("catenin (cadherin-associated protein)" . SPARSER::PROTEIN)
    ("MYBPC1" . SPARSER::PROTEIN)
    ("myosin binding protein C" . SPARSER::PROTEIN)
    ("INTS12" . SPARSER::PROTEIN) ("BCL2 and Notch-1" . SPARSER::COLLECTION)
    ("E-cadherin, Notch-1 and BCL2" . SPARSER::COLLECTION)
    ("E-cadherin and the anti-apoptotic oncoprotein BCL2"
     . SPARSER::COLLECTION)
    ("intra" . SPARSER::PROTEIN)
    ("typically lack E-cadherin" . SPARSER::PROTEIN)
    ("EGFP-tagged full-length wild-type E-cadherin (Ecad-EGFP) or EGFP"
     . SPARSER::COLLECTION)
    ("Ecad-EGFP" . SPARSER::COLLECTION) ("Ecad" . SPARSER::PROTEIN)
    ("Kaiso" . SPARSER::PROTEIN)
    ("tumor suppressor gene and CDH1" . SPARSER::COLLECTION)
    ("BCL2 and E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and BCL2" . SPARSER::COLLECTION)
    ("c-erbB2" . SPARSER::PROTEIN) ("c20" . SPARSER::PROTEIN)
    ("Notch-1" . SPARSER::PROTEIN) ("CD40-CD40 L" . SPARSER::COLLECTION)
    ("genotypes and BLK" . SPARSER::COLLECTION) ("Quad" . SPARSER::DRUG)
    ("SNPs, rs2736340, rs6993775, and rs1382566" . SPARSER::COLLECTION)
    ("KD-associated SNPs" . SPARSER::PROTEIN) ("acute KD" . SPARSER::PROTEIN)
    ("BLK and CD40" . SPARSER::COLLECTION) ("BLK" . SPARSER::PROTEIN)
    ("CD40 L" . SPARSER::PROTEIN) ("p42 MAPK" . SPARSER::PROTEIN)
    ("state and thence" . SPARSER::COLLECTION)
    ("the mesenchymal fate" . SPARSER::PROTEIN)
    ("a premesenchymal state" . SPARSER::BIO-STATE)
    ("PDGFRs or FN" . SPARSER::COLLECTION)
    ("profuse FN matrix" . SPARSER::PROTEIN-FAMILY)
    ("exogenous DNA" . SPARSER::DNA)
    ("the extracellular matrix molecule FN or the functionally linked PDGFR"
     . SPARSER::COLLECTION)
    ("FITC-dextran ( xref L)" . SPARSER::MOLECULE)
    ("FITC-dextran ( xref J)" . SPARSER::MOLECULE)
    ("FITC-dextran staining ( xref F)" . SPARSER::MOLECULE)
    ("FITC-dextran" . SPARSER::MOLECULE)
    ("distinctive PECAM-1" . SPARSER::PROTEIN)
    ("potent angiogenic-related proteins" . SPARSER::PROTEIN)
    ("leptin" . SPARSER::PROTEIN) ("vasohibin" . SPARSER::PROTEIN-FAMILY)
    ("endoglin" . SPARSER::PROTEIN)
    ("monocyte chemotactic protein-1, and thrombospondin-1"
     . SPARSER::COLLECTION)
    ("neurotrophic factor, IGFBP-1, IL-8, PlGF, and VEGF-C"
     . SPARSER::COLLECTION)
    ("protein-1, and thrombospondin-1" . SPARSER::COLLECTION)
    ("endostatin" . SPARSER::PROTEIN) ("adherent 2D MSCs" . SPARSER::PROTEIN)
    ("Angiogenic Factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VEGFR" . SPARSER::PROTEIN)
    ("displayed prominent PECAM-1" . SPARSER::PROTEIN)
    ("expressed both PECAM-1 and VE-cadherin protein" . SPARSER::COLLECTION)
    ("contained spindle-shaped MSCs, expressed both PECAM-1 and VE-cadherin protein"
     . SPARSER::COLLECTION)
    ("expressed both PECAM-1" . SPARSER::PROTEIN)
    ("expressed significantly increased PECAM-1" . SPARSER::PROTEIN)
    ("adherent MSCs" . SPARSER::PROTEIN)
    ("a more multipotent state" . SPARSER::BIO-STATE)
    ("Oct4, Nanog, and Sox2" . SPARSER::COLLECTION)
    ("Oct4, Nanog, and Sox2, and endoderm" . SPARSER::COLLECTION)
    ("Sox2, and endoderm" . SPARSER::COLLECTION)
    ("Sox17, AFP, Foxa2, and CDH1" . SPARSER::COLLECTION)
    ("significantly higher CDH1" . SPARSER::PROTEIN)
    ("Foxa2" . SPARSER::PROTEIN) ("adherent MSC" . SPARSER::PROTEIN)
    ("nuclear STAT3 (Y705) and STAT1 (Y701)" . SPARSER::COLLECTION)
    ("Nanog and Oct4A" . SPARSER::COLLECTION)
    ("untreated adherent MSCs" . SPARSER::PROTEIN)
    ("PDGFRs, and FN" . SPARSER::COLLECTION)
    ("filaments and FN" . SPARSER::COLLECTION)
    ("E-cadherin, Oct4A, and Nanog" . SPARSER::COLLECTION)
    ("-cadherin" . SPARSER::COLLECTION)
    ("EOMES, Foxh1, and Mixl1" . SPARSER::COLLECTION)
    ("EOMES" . SPARSER::PROTEIN)
    ("fibrillar matrices" . SPARSER::PROTEIN-FAMILY)
    ("FN/α5β1" . SPARSER::COLLECTION) ("RhoA/Rho kinase" . SPARSER::COLLECTION)
    ("PDGFRα or PDGF-A" . SPARSER::COLLECTION)
    ("receptors (PDGFR)" . SPARSER::RECEPTOR)
    ("mesenchymal regulators" . SPARSER::REGULATOR)
    ("mesenchymal fate" . SPARSER::PROTEIN)
    ("many angiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDGF receptors or depleting fibronectin" . SPARSER::COLLECTION)
    ("E-cadherin, and Janus" . SPARSER::COLLECTION)
    ("abundant smooth muscle α-actin filaments and fibronectin-rich matrix"
     . SPARSER::COLLECTION)
    ("the mesenchymal regulators" . SPARSER::REGULATOR)
    ("receptors or fibronectin" . SPARSER::COLLECTION)
    ("thrombospondin-1" . SPARSER::PROTEIN) ("FGF-7" . SPARSER::PROTEIN)
    ("angiopoietin-1" . SPARSER::PROTEIN) ("VEGF-C" . SPARSER::PROTEIN)
    ("IGFBP-1" . SPARSER::PROTEIN) ("FGF-1" . SPARSER::PROTEIN)
    ("ADAMTS-1" . SPARSER::PROTEIN) ("activin-A" . SPARSER::MOLECULE)
    ("Sox17" . SPARSER::PROTEIN) ("α-fetoprotein" . SPARSER::PROTEIN)
    ("Foxa1" . SPARSER::PROTEIN) ("Mixl1" . SPARSER::PROTEIN)
    ("Foxh1" . SPARSER::PROTEIN) ("neuropilin-1" . SPARSER::PROTEIN)
    ("endothelial differentiation" . SPARSER::PROTEIN)
    ("vascular endothelial-cadherin" . SPARSER::PROTEIN)
    ("platelet endothelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("increased urinary PGE 2 metabolites and biomarkers"
     . SPARSER::COLLECTION)
    ("metabolites and biomarkers" . SPARSER::COLLECTION)
    ("PGE 2 and PGD 2" . SPARSER::COLLECTION)
    ("prostanoids" . SPARSER::MOLECULE)
    ("colorectal cancer risk and rs20417 genotype" . SPARSER::PROTEIN)
    ("a global p" . SPARSER::PROTEIN)
    ("this rs20417 SNP, NSAID use, and rectal cancer risk"
     . SPARSER::COLLECTION)
    ("Genotype" . SPARSER::PROTEIN) ("sib" . SPARSER::DRUG)
    ("int" . SPARSER::PROTEIN) ("genotypes" . SPARSER::PROTEIN)
    ("genotype-NSAID" . SPARSER::COLLECTION)
    ("the homozygous variant CC genotype" . SPARSER::PROTEIN)
    ("the GC or CC genotype ( xref )" . SPARSER::COLLECTION)
    ("genotype" . SPARSER::PROTEIN) ("PTGS1 and PTGS2" . SPARSER::COLLECTION)
    ("PTGS" . SPARSER::PROTEIN)
    ("nonsteroidal anti-inflammatory drugs" . SPARSER::DRUG)
    ("PTGS2 and colon cancer" . SPARSER::COLLECTION)
    ("Genotype-NSAID" . SPARSER::COLLECTION)
    ("PTGS1 (COX-1) and PTGS2 (COX-2)" . SPARSER::COLLECTION)
    ("NSAID" . SPARSER::PROTEIN)
    ("Nonsteroidal anti-inflammatory drugs (NSAIDs) target"
     . SPARSER::TARGET-PROTEIN)
    ("synthase" . SPARSER::PROTEIN) ("NSAIDs" . SPARSER::DRUG)
    ("signal peptide" . SPARSER::PROTEIN) ("PGD 2" . SPARSER::PROTEIN)
    ("P17" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Colon cancer" . SPARSER::PROTEIN)
    ("PTGS1" . SPARSER::PROTEIN) ("SIRT1-DBC1" . SPARSER::COLLECTION)
    ("DBC1-SIRT1" . SPARSER::COLLECTION)
    ("β-catenin, cyclin D1, and P53" . SPARSER::COLLECTION)
    ("DBC1 and SIRT1" . SPARSER::COLLECTION)
    ("β-catenin or cyclin D1" . SPARSER::COLLECTION)
    ("SIRT1 and β-catenin" . SPARSER::COLLECTION)
    ("cyclin D1, and survivin" . SPARSER::COLLECTION)
    ("the destructive complex" . SPARSER::BIO-COMPLEX)
    ("SIRT1 and P53" . SPARSER::COLLECTION)
    ("P53 and FoxO3" . SPARSER::COLLECTION)
    ("c-Myc and N-Myc" . SPARSER::COLLECTION)
    ("SIRT3 and SIRT6" . SPARSER::COLLECTION)
    ("P53, β-catenin, and cyclin D1" . SPARSER::COLLECTION)
    ("SIRT1, DBC1, P53, β-catenin, and cyclin D1, and Ki67"
     . SPARSER::COLLECTION)
    ("cyclin D1, and Ki67" . SPARSER::COLLECTION)
    ("SIRT1, DBC1, P53, cyclin D1, and Ki67" . SPARSER::COLLECTION)
    ("β-catenin and cyclin D1" . SPARSER::COLLECTION)
    ("SIRT1 and DBC1" . SPARSER::COLLECTION)
    ("50 histological subtypes" . SPARSER::PROTEIN)
    ("c-Myc, β-catenin, cyclin D1, and survivin" . SPARSER::COLLECTION)
    ("SIRT1-" . SPARSER::PROTEIN)
    ("SIRT1, DBC1, P53, β-catenin, and cyclin D1" . SPARSER::COLLECTION)
    ("SIRT1, DBC1, P53, β-catenin, cyclin D1, and KI67" . SPARSER::COLLECTION)
    ("DBC1" . SPARSER::PROTEIN) ("Beta-Catenin" . SPARSER::PROTEIN)
    ("FoxO3" . SPARSER::PROTEIN) ("SIRT4" . SPARSER::PROTEIN)
    ("SIRT3" . SPARSER::PROTEIN) ("homolog 1" . SPARSER::PROTEIN)
    ("KI67" . SPARSER::PROTEIN) ("CAV3, DYSF and FHL1" . SPARSER::COLLECTION)
    ("a hypothetical protein" . SPARSER::PROTEIN)
    ("dystrophic" . SPARSER::PROTEIN)
    ("cyclin A1 and DUX4" . SPARSER::COLLECTION)
    ("primary myoblasts" . SPARSER::PROTEIN)
    ("CAV3, DYSF, and FHL1" . SPARSER::COLLECTION)
    ("Homeobox" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FDR " . SPARSER::PROTEIN)
    ("DYSF" . SPARSER::PROTEIN)
    ("CCND1, CCND2, CCND3, CCNA1 and CDK 4 and CDK6" . SPARSER::COLLECTION)
    ("CDK 4 and CDK6" . SPARSER::COLLECTION)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("a Ca 2+ -dependent protein and a component" . SPARSER::COLLECTION)
    ("regulator and FRG2" . SPARSER::COLLECTION) ("FRG" . SPARSER::PROTEIN)
    ("upper arms" . SPARSER::PROTEIN) ("DUX4" . SPARSER::PROTEIN)
    ("muscle)" . SPARSER::PROTEIN) ("β -tubulin" . SPARSER::PROTEIN)
    ("CAV3" . SPARSER::PROTEIN) ("creatine kinase" . SPARSER::PROTEIN)
    ("FHL1" . SPARSER::PROTEIN) ("CAV 3" . SPARSER::PROTEIN)
    ("CDKN1B" . SPARSER::PROTEIN) ("CDK 4" . SPARSER::PROTEIN)
    ("CCND2" . SPARSER::PROTEIN) ("CCNA1" . SPARSER::PROTEIN)
    ("ANT-1" . SPARSER::PROTEIN) ("SMCHD1" . SPARSER::PROTEIN)
    ("consequent insufficient DNA" . SPARSER::DNA)
    ("metachronous CLM" . SPARSER::PROTEIN) ("bilobar CLM" . SPARSER::PROTEIN)
    ("PIK3CA, BRAF, CTTNB1 , and AKT1" . SPARSER::COLLECTION)
    ("KRAS, NRAS, PIK3CA , and BRAF" . SPARSER::COLLECTION)
    ("the most common point-mutated genes" . SPARSER::GENE)
    ("RAS, BRAF , and PIK3CA" . SPARSER::COLLECTION)
    ("KRAS and NRAS" . SPARSER::COLLECTION) ("KRAS/NRAS" . SPARSER::COLLECTION)
    ("CLM" . SPARSER::PROTEIN) ("TNK2" . SPARSER::PROTEIN)
    ("PRKAG2" . SPARSER::PROTEIN) ("PRKAG1" . SPARSER::PROTEIN)
    ("PHLPP2" . SPARSER::PROTEIN) ("PDPK1" . SPARSER::PROTEIN)
    ("IDH2" . SPARSER::PROTEIN) ("HIF1A" . SPARSER::PROTEIN)
    ("DEAR1" . SPARSER::PROTEIN) ("AKT3" . SPARSER::PROTEIN)
    ("RAS family" . SPARSER::PROTEIN) ("VEGF and SDF-1" . SPARSER::COLLECTION)
    ("Intratumoural hypoxia" . SPARSER::PROTEIN)
    ("SDF-1 and CXCR4" . SPARSER::COLLECTION)
    ("VEGF, SDF-1 and CXCR4" . SPARSER::COLLECTION)
    ("HDAC1–MTA1" . SPARSER::COLLECTION)
    ("particular Spry2" . SPARSER::PROTEIN) ("PHD1–PHD3" . SPARSER::COLLECTION)
    ("PHD1, PHD2 and PHD3" . SPARSER::COLLECTION)
    ("PHD1 or PHD3" . SPARSER::COLLECTION)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("HEXIM1 and HEXIM1" . SPARSER::COLLECTION)
    ("HIF-1 α or HDAC1" . SPARSER::COLLECTION)
    ("CXCR4, SDF-1 and LOXL2" . SPARSER::COLLECTION)
    ("VEGF , SDF-1 , CXCR4 and LOXL2" . SPARSER::COLLECTION)
    ("CXCR4 and SDF1" . SPARSER::COLLECTION)
    ("HEXIM1 and HDAC1" . SPARSER::COLLECTION) ("–HDAC1" . SPARSER::COLLECTION)
    ("HDAC1 and ARD1" . SPARSER::COLLECTION)
    ("pVHL and HIF-1 α" . SPARSER::COLLECTION)
    ("HDAC1–HIF-1 α" . SPARSER::COLLECTION)
    ("PHD3 and HIF-1 α" . SPARSER::COLLECTION) ("PHDs" . SPARSER::PROTEIN)
    ("HIF-1 α and PHD3" . SPARSER::COLLECTION)
    ("MCF7 and BTB474" . SPARSER::COLLECTION)
    ("MCF7-HEXIM1" . SPARSER::COLLECTION)
    ("HEXIM1 and HIF-1 α" . SPARSER::COLLECTION)
    ("FLAG-HEXIM1" . SPARSER::COLLECTION) ("FLAG–HEXIM1" . SPARSER::COLLECTION)
    ("HIF-1 α target genes and HIF-1 α -induced cell invasion"
     . SPARSER::COLLECTION)
    ("ODD" . SPARSER::PROTEIN)
    ("redundant angiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prune" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteases and GLUT1" . SPARSER::COLLECTION) ("EMC" . SPARSER::PROTEIN)
    ("a heterodimeric transcription factor" . SPARSER::PROTEIN)
    ("-subunits" . SPARSER::COLLECTION)
    ("HIF-1 α and HEXIM1, and HEXIM1" . SPARSER::COLLECTION)
    ("HEXIM1, and HEXIM1" . SPARSER::COLLECTION) ("bis" . SPARSER::PROTEIN)
    ("HMBA" . SPARSER::DRUG) ("SDF-1 receptor" . SPARSER::PROTEIN)
    ("PHD1" . SPARSER::PROTEIN) ("PHD2" . SPARSER::PROTEIN)
    ("HSulf-1" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("sulfatase 1" . SPARSER::PROTEIN) ("HSulf1" . SPARSER::PROTEIN)
    ("polymerase II" . SPARSER::PROTEIN) ("HIF-2 α" . SPARSER::PROTEIN)
    ("derived factor" . SPARSER::PROTEIN)
    ("CXC chemokine receptor" . SPARSER::PROTEIN) ("ARD1" . SPARSER::PROTEIN)
    ("prolyl hydroxylase" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("histone deacetylase 1" . SPARSER::PROTEIN)
    ("prolyl hydroxylase 3" . SPARSER::PROTEIN) ("PHD3" . SPARSER::PROTEIN)
    ("von Hippel–Lindau protein" . SPARSER::PROTEIN)
    ("HIF-1 α" . SPARSER::PROTEIN)
    ("bispecific antibodies" . SPARSER::ANTIBODY)
    ("the HER2 tumor-associated antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FcR" . SPARSER::PROTEIN-FAMILY) ("TNF-α and IFN-γ" . SPARSER::COLLECTION)
    ("ADCC" . SPARSER::PROTEIN) ("a soluble truncated HER2" . SPARSER::PROTEIN)
    ("ATC or HER2Bi-ATC" . SPARSER::COLLECTION)
    ("HER2Bi-ATC" . SPARSER::PROTEIN-PAIR) ("luc" . SPARSER::PROTEIN)
    ("ell" . SPARSER::PROTEIN) ("B16-luc" . SPARSER::PROTEIN-PAIR)
    ("armed-ATC and unarmed-ATC" . SPARSER::COLLECTION)
    ("fresh medium containing CCK8 reagent" . SPARSER::MOLECULE)
    ("anti-human" . SPARSER::PROTEIN) ("goat-anti-human" . SPARSER::COLLECTION)
    ("anti-mouse" . SPARSER::PROTEIN) ("goat-anti-mouse" . SPARSER::COLLECTION)
    ("FITC" . SPARSER::MOLECULE)
    ("expressing both luciferase and LNGFR-BirA-tag" . SPARSER::COLLECTION)
    ("luciferase and LNGFR-BirA-tag" . SPARSER::COLLECTION)
    ("a firefly luciferase reporter gene and a BirA-tag" . SPARSER::COLLECTION)
    ("biotin" . SPARSER::PROTEIN) ("BirA" . SPARSER::PROTEIN)
    ("expressed firefly luciferase" . SPARSER::PROTEIN)
    ("OMM-1, Malme-3M, Mel624, Mel888, and SK Mel28" . SPARSER::PROTEIN)
    ("Mel" . SPARSER::PROTEIN) ("OCM" . SPARSER::PROTEIN)
    ("a 185-kDa transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("ipilimumab" . SPARSER::DRUG)
    ("antibodies and small molecules" . SPARSER::COLLECTION)
    ("Immunosuppressive molecule CD200 and immune checkpoint proteins"
     . SPARSER::COLLECTION)
    ("CTLA-4, PD-1 and CD40" . SPARSER::COLLECTION)
    ("MAGE family, BAGE, GAGE and gp75" . SPARSER::COLLECTION)
    ("GAGE" . SPARSER::PROTEIN-FAMILY) ("BAGE" . SPARSER::PROTEIN)
    ("tyrosinase" . SPARSER::PROTEIN) ("potentially dangerous type" . TYPE)
    ("ATC" . SPARSER::PROTEIN) ("Anti-HER2/neu" . SPARSER::COLLECTION)
    ("CCK8" . SPARSER::PROTEIN) ("Bispecific Antibody" . SPARSER::DRUG)
    ("pLP2" . SPARSER::PROTEIN)
    ("low-affinity nerve growth factor receptor" . SPARSER::PROTEIN)
    ("cerbB2" . SPARSER::PROTEIN) ("PD-1" . SPARSER::PROTEIN)
    ("CD200" . SPARSER::PROTEIN) ("gp75" . SPARSER::PROTEIN)
    ("MAGE family" . SPARSER::PROTEIN-FAMILY) ("gp100" . SPARSER::PROTEIN)
    ("MART-1" . SPARSER::PROTEIN) ("bispecific antibody" . SPARSER::DRUG)
    ("factors–" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D1 and c-myc–" . SPARSER::COLLECTION)
    ("c-myc–" . SPARSER::PROTEIN)
    ("SDF-1, cyclin D1, and c-myc" . SPARSER::COLLECTION)
    ("ERα/c-fos" . SPARSER::COLLECTION)
    ("c-jun or c-fos" . SPARSER::COLLECTION) ("SDF1-" . SPARSER::PROTEIN)
    ("parental MCF7" . SPARSER::PROTEIN) ("-Cd7" . SPARSER::COLLECTION)
    ("MCF7-Cd4" . SPARSER::COLLECTION) ("MCF7-Cd7" . SPARSER::COLLECTION)
    ("MCF7-Cd2" . SPARSER::COLLECTION) ("lab–" . SPARSER::PROTEIN)
    ("ERα and c-fos" . SPARSER::COLLECTION) ("triple-ChIP" . SPARSER::PROTEIN)
    ("ERα/c-jun" . SPARSER::COLLECTION)
    ("either ERα or rabbit IgG" . SPARSER::COLLECTION)
    ("SDF-1 and cyclin D1" . SPARSER::COLLECTION)
    ("ERα, c-jun, and c-fos" . SPARSER::COLLECTION)
    ("cyclin D1 and c-myc" . SPARSER::COLLECTION)
    ("either c-jun (Ji) or c-fos (Fi)" . SPARSER::COLLECTION)
    ("c-jun and c-fos" . SPARSER::COLLECTION)
    ("both parental MCF7" . SPARSER::PROTEIN)
    ("c-fos and c-jun" . SPARSER::COLLECTION) ("ERα–" . SPARSER::PROTEIN)
    ("β-catenin–" . SPARSER::PROTEIN)
    ("MCF7, Cd7 and Cd12" . SPARSER::COLLECTION)
    ("protein and gene" . SPARSER::COLLECTION)
    ("blot and semi-quantitative" . SPARSER::COLLECTION)
    ("MCF7, Cd4, Cd7 and Cd12" . SPARSER::COLLECTION)
    ("Cd7 and Cd12" . SPARSER::COLLECTION) ("Cd7" . SPARSER::PROTEIN)
    ("RT-Profiler" . SPARSER::PROTEIN-PAIR) ("Cd2" . SPARSER::PROTEIN)
    ("Cd" . SPARSER::PROTEIN) ("MCF7-Cd" . SPARSER::COLLECTION)
    ("c-jun/c-fos" . SPARSER::COLLECTION)
    ("ERα and c-jun" . SPARSER::COLLECTION)
    ("cyclin D1, c-myc, progesterone receptor, and cathepsin-D"
     . SPARSER::COLLECTION)
    ("antiestrogens" . SPARSER::DRUG)
    ("ERα, c-jun and c-fos" . SPARSER::COLLECTION) ("Cd-" . SPARSER::PROTEIN)
    ("SDF1" . SPARSER::PROTEIN) ("cycD1" . SPARSER::PROTEIN)
    ("derived factor-1" . SPARSER::PROTEIN) ("cyclin D 1" . SPARSER::PROTEIN)
    ("cathepsin-D" . SPARSER::PROTEIN) ("CdCl 2" . SPARSER::MOLECULE)
    ("NRF2:Keap1" . SPARSER::BIO-COMPLEX)
    ("PI3K, which phosphorylates AKT and MEK1/2-ERK1/2" . SPARSER::COLLECTION)
    ("AKT and MEK1/2-ERK1/2" . SPARSER::COLLECTION)
    ("EGFR and PI3K" . SPARSER::COLLECTION)
    ("NQO1 and γ-GCSh" . SPARSER::COLLECTION)
    ("EGFR, PI3K, AKT, MEK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("enzymes, NQO1 and γ-GCSh" . SPARSER::COLLECTION)
    ("the antioxidative genes γ GCSh and NQO1" . SPARSER::COLLECTION)
    ("GCSh and NQO1" . SPARSER::COLLECTION)
    ("the indirect activators" . SPARSER::ACTIVATOR)
    ("AKT and ERK" . SPARSER::COLLECTION)
    ("AG1478 and LY294002" . SPARSER::COLLECTION)
    ("-2,4-thiazolidinedione, and AKT" . SPARSER::COLLECTION)
    ("-2,4-thiazolidinedione" . SPARSER::DRUG) ("hydrate" . SPARSER::MOLECULE)
    ("trifluoroacetate" . SPARSER::MOLECULE) ("VIII" . SPARSER::PROTEIN)
    ("AKT and ERK1/2" . SPARSER::COLLECTION)
    ("PI3K-AKT/MEK1/2-ERK1/2" . SPARSER::COLLECTION)
    ("MUC5AC and MUC5B" . SPARSER::COLLECTION)
    ("the NRF2 inhibitor trigonelline and the antioxidant GSH"
     . SPARSER::COLLECTION)
    ("trigonelline" . SPARSER::DRUG) ("post-PCN" . SPARSER::COLLECTION)
    ("quinones and their derivatives" . SPARSER::COLLECTION)
    ("quinones" . SPARSER::MOLECULE) ("GCSh" . SPARSER::PROTEIN)
    ("antibody and DAPI" . SPARSER::COLLECTION) ("Trypan" . SPARSER::DRUG)
    ("NRF2-KEAP1" . SPARSER::COLLECTION) ("excessive ROS" . SPARSER::PROTEIN)
    (":quinone oxidoreductase" . SPARSER::BIO-COMPLEX)
    ("NADP" . SPARSER::MOLECULE)
    ("proteins and phospholipids" . SPARSER::COLLECTION)
    ("Superoxide" . SPARSER::MOLECULE)
    ("a blue redox-active secondary metabolite" . SPARSER::MOLECULE)
    ("phenazines" . SPARSER::DRUG) ("hemolysin" . SPARSER::PROTEIN)
    ("phospholipases" . SPARSER::PROTEIN) ("exoproteases" . SPARSER::PROTEIN)
    ("EGFR-PI3K-AKT/MEK1/2-ERK1/2" . SPARSER::COLLECTION)
    ("EGFR-PI3K" . SPARSER::COLLECTION)
    ("AKT and MEK1/2-ERK1/2 MAP kinases" . SPARSER::COLLECTION)
    ("MEK1/2-ERK1/2" . SPARSER::COLLECTION)
    ("EGFR-phosphoinositide-3-kinase" . SPARSER::COLLECTION)
    ("EGFR and its downstream signaling components" . SPARSER::COLLECTION)
    ("antioxidative enzymes" . SPARSER::ENZYME)
    ("enzymes and proteins" . SPARSER::COLLECTION)
    ("pyocyanin (PCN)" . SPARSER::MOLECULE) ("PCN" . SPARSER::PROTEIN)
    ("pyocyanin" . SPARSER::MOLECULE) ("FOXA2" . SPARSER::PROTEIN)
    ("p-MEK1" . SPARSER::PROTEIN) ("MUC5B" . SPARSER::PROTEIN)
    ("MUC5AC" . SPARSER::PROTEIN) ("2,4-thiazolidinedione" . SPARSER::DRUG)
    ("pERK1/2" . SPARSER::PROTEIN) ("pMEK1" . SPARSER::PROTEIN)
    ("KEAP1" . SPARSER::PROTEIN) ("Cap’n’Collar" . SPARSER::PROTEIN)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src/FAK" . SPARSER::COLLECTION)
    ("neurogenic reagents" . SPARSER::MOLECULE)
    ("the myoblastic induction reagents" . SPARSER::MOLECULE)
    ("osteogenic reagents" . SPARSER::MOLECULE) ("MSC" . SPARSER::PROTEIN)
    ("further activating FAK" . SPARSER::PROTEIN)
    ("FAK/Src kinase" . SPARSER::COLLECTION)
    ("the neural induction reagents" . SPARSER::MOLECULE)
    ("damped" . SPARSER::MOLECULE)
    ("the combined neural induction mixture" . SPARSER::MOLECULE)
    ("mixture and DMSO" . SPARSER::COLLECTION)
    ("The combined neural induction mixture and its individual components DMSO"
     . SPARSER::COLLECTION)
    ("The combined neural induction mixture" . SPARSER::MOLECULE)
    ("neural induction reagents" . SPARSER::MOLECULE)
    ("mercaptoethanol" . SPARSER::MOLECULE) ("MSCs" . SPARSER::PROTEIN)
    ("the combined myoblastic induction mixture" . SPARSER::MOLECULE)
    ("osteogenic induction reagents" . SPARSER::MOLECULE)
    ("the osteogenic reagent" . SPARSER::MOLECULE) ("HYD" . SPARSER::DRUG)
    ("Hydrocortisone (HYD) and DEX xref" . SPARSER::COLLECTION)
    ("Hydrocortisone" . SPARSER::DRUG) ("DEX or Vit" . SPARSER::COLLECTION)
    ("The osteogenic induction reagent" . SPARSER::MOLECULE)
    ("reagent, DEX, or Vit" . SPARSER::COLLECTION)
    ("the combined osteogenic mixture and its components"
     . SPARSER::COLLECTION)
    ("DEX and Vit" . SPARSER::COLLECTION) ("DEX" . SPARSER::PROTEIN)
    ("The combined osteogenic induction mixture" . SPARSER::MOLECULE)
    ("Vit" . SPARSER::PROTEIN) ("Dexamethasone" . SPARSER::PROTEIN)
    ("the combined osteogenic mixture" . SPARSER::MOLECULE)
    ("osteogenic induction reagent" . SPARSER::MOLECULE)
    ("KRas-Src" . SPARSER::COLLECTION) ("Lyn-FAK" . SPARSER::COLLECTION)
    ("Src or FAK" . SPARSER::COLLECTION) ("FAK or Src" . SPARSER::COLLECTION)
    ("an enhanced cyan fluorescent protein" . SPARSER::PROTEIN)
    ("focal adhesion kinase (FAK) and Src" . SPARSER::COLLECTION)
    ("FAK and Src kinase" . SPARSER::COLLECTION)
    ("cytokines, growth factors, or extracellular" . SPARSER::COLLECTION)
    ("osteogenic, myoblastic, or neural induction reagents"
     . SPARSER::MOLECULE)
    ("vitamin C" . SPARSER::MOLECULE) ("PF228" . SPARSER::DRUG)
    ("currently no clinically relevant inhibitors" . SPARSER::INHIBITOR)
    ("Src or EGFR" . SPARSER::COLLECTION) ("Ptdins" . SPARSER::PROTEIN)
    ("pSIN" . SPARSER::PROTEIN) ("esters" . SPARSER::MOLECULE)
    ("suppressor or tumor" . SPARSER::COLLECTION)
    ("tissue type" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("the genetic variant and the susceptibility" . SPARSER::COLLECTION)
    ("gene and cancer" . SPARSER::COLLECTION) ("PPIase" . SPARSER::PROTEIN)
    ("the variant CG (OR = 0.635, 95% CI: 0.548,0.735; P heterogeneity  = 0.240) and CG/CC (OR = 0.645, 95% CI: 0.559,0.744, Pheterogeneity = 0.258) genotypes"
     . SPARSER::COLLECTION)
    ("the variant CG (OR = 0.728, 95% CI: 0.585,0.906; P heterogeneity <0.01) and CG/CC (OR = 0.731, 95% CI: 0.602,0.888; P heterogeneity <0.01) genotypes"
     . SPARSER::COLLECTION)
    ("interleukin-8" . SPARSER::PROTEIN)
    ("Peptidyl-prolyl cis–trans isomerase NIMA-interacting 1"
     . SPARSER::PROTEIN)
    ("TEM" . SPARSER::PROTEIN) ("oxygen or DAB" . SPARSER::COLLECTION)
    ("oxygen and DAB" . SPARSER::COLLECTION)
    ("osmiophilic DAB polymer" . SPARSER::MOLECULE)
    ("apparently smaller cavin" . SPARSER::PROTEIN)
    ("relatively more cavin 2" . SPARSER::PROTEIN)
    ("cavin 2 or siRNA-mediated" . SPARSER::COLLECTION)
    ("cavin 2, and cavin 1" . SPARSER::COLLECTION)
    ("complex and vice" . SPARSER::COLLECTION)
    ("cavins and caveolin 1" . SPARSER::COLLECTION)
    ("an SDS-resistant oligomeric state" . SPARSER::BIO-STATE)
    ("a three-stranded coiled coil" . SPARSER::PROTEIN)
    ("cavin 2 or cavin 3" . SPARSER::COLLECTION) ("tilt" . SPARSER::DRUG)
    ("cavin-3-MiniSOG" . SPARSER::COLLECTION)
    ("cavin-2-MiniSOG" . SPARSER::COLLECTION)
    ("cavin-1-MiniSOG" . SPARSER::COLLECTION)
    ("complex labeled using cavin-MiniSOG" . SPARSER::COLLECTION)
    ("expressing cavin-MiniSOG" . SPARSER::COLLECTION)
    ("osmium" . SPARSER::MOLECULE) ("MiniSOG" . SPARSER::PROTEIN)
    ("glutaraldehyde" . SPARSER::MOLECULE) ("RPE" . SPARSER::PROTEIN)
    ("cavin-MiniSOG" . SPARSER::COLLECTION)
    ("MiniSOG-mCherry" . SPARSER::PROTEIN-PAIR)
    ("an osmiophilic electron-dense polymer" . SPARSER::MOLECULE)
    ("a relatively small (106 amino acids) fluorescent flavoprotein"
     . SPARSER::MOLECULE)
    ("flavoprotein" . SPARSER::MOLECULE) ("Oxygen" . SPARSER::MOLECULE)
    ("GFP-EHD2" . SPARSER::COLLECTION)
    ("anti-GFP antibodies and nanogold-conjugated secondary antibodies"
     . SPARSER::COLLECTION)
    ("nanogold-conjugated secondary antibodies" . SPARSER::ANTIBODY)
    ("were run" . SPARSER::PROTEIN) ("flotillin" . SPARSER::PROTEIN)
    ("Cavin 2, Cavin 3, and EHD2" . SPARSER::COLLECTION)
    ("cavin 1, and partial" . SPARSER::COLLECTION)
    ("cavin 1 and cavin 2" . SPARSER::COLLECTION)
    ("cavin 1 and cavin 3, and cavins" . SPARSER::COLLECTION)
    ("cavin 3, and cavins" . SPARSER::COLLECTION)
    ("a relatively stable oligomeric form" . SPARSER::FORM)
    ("trimer" . SPARSER::TRIMER) ("Monomeric cavin 1" . SPARSER::PROTEIN)
    ("the 350–400 kDa oligomeric form" . SPARSER::FORM)
    ("high molecular weight oligomeric forms" . SPARSER::FORM)
    ("monomers or dimers" . SPARSER::COLLECTION)
    ("cavin 1 or caveolin 1" . SPARSER::COLLECTION)
    ("mCherry or GFP" . SPARSER::COLLECTION)
    ("Cavin 1 and Caveolin 1" . SPARSER::COLLECTION)
    ("around 1 cavin 1∶4 caveolin molecules" . SPARSER::MOLECULE)
    ("cavin 1 and caveolin" . SPARSER::COLLECTION)
    ("cavins and caveolins" . SPARSER::COLLECTION)
    ("complex, and vice" . SPARSER::COLLECTION)
    ("caveolar puncta" . SPARSER::PROTEIN)
    ("cavin-2-mCherry" . SPARSER::COLLECTION)
    ("cavin 2 and cavin 3" . SPARSER::COLLECTION)
    ("cavin and caveolin" . SPARSER::COLLECTION)
    ("caveolin 1 and caveolin 2" . SPARSER::COLLECTION)
    ("exogenously expressed cavin-GFPs" . SPARSER::COLLECTION)
    ("expressed cavin-GFPs" . SPARSER::COLLECTION)
    ("cavin-GFPs" . SPARSER::COLLECTION) ("GFPs" . SPARSER::PROTEIN)
    ("Cavin-1-GFP" . SPARSER::COLLECTION)
    ("Cavin 2 and Cavin 3" . SPARSER::COLLECTION)
    ("this latter fusion protein" . SPARSER::PROTEIN)
    ("cavin 1, cavin 3, and caveolin 1" . SPARSER::COLLECTION)
    ("pacsin 2 and EHD2" . SPARSER::COLLECTION)
    ("cavin 1 and caveolin 1" . SPARSER::COLLECTION)
    ("cavin 3-mCherry" . SPARSER::COLLECTION)
    ("cavin-3-mCherry" . SPARSER::COLLECTION) ("cavins" . SPARSER::PROTEIN)
    ("Cavin-2-GFP" . SPARSER::COLLECTION)
    ("all cavin-GFP fusion proteins, endogenous cavin 1 and cavin 3, as well as caveolin 1 co-fractionated"
     . SPARSER::COLLECTION)
    ("cavin 1 and cavin 3" . SPARSER::COLLECTION) ("cavin" . SPARSER::PROTEIN)
    ("cavin-GFP" . SPARSER::COLLECTION) ("cavin-3-GFP" . SPARSER::COLLECTION)
    ("available antibodies" . SPARSER::ANTIBODY)
    ("cavin-2-GFP" . SPARSER::COLLECTION) ("cavin-1-GFP" . SPARSER::COLLECTION)
    ("stably expressing each protein" . SPARSER::PROTEIN)
    ("expressing each protein" . SPARSER::PROTEIN)
    ("-3-GFP" . SPARSER::COLLECTION)
    ("no further abundant protein components" . SPARSER::COMPONENT)
    ("cellular cavin 1" . SPARSER::PROTEIN)
    ("the most tryptic peptides" . SPARSER::PEPTIDE)
    ("cavin 1, cavin 3, and caveolins" . SPARSER::COLLECTION)
    ("Immuno" . SPARSER::PROTEIN) ("HMW" . SPARSER::PROTEIN)
    ("caveolin 1 or cavin 1" . SPARSER::COLLECTION)
    ("Caveolin-1-GFP" . SPARSER::COLLECTION)
    ("flotillin-2-GFP" . SPARSER::COLLECTION)
    ("60S ribosomal subunits" . SPARSER::PROTEIN)
    ("caveolin and cavin" . SPARSER::COLLECTION)
    ("ribosomes" . SPARSER::BIO-COMPLEX) ("glucoside" . SPARSER::MOLECULE)
    ("the membrane permeable and reversible cross-linker DSP"
     . SPARSER::PROTEIN)
    ("caveolin-1-GFP" . SPARSER::COLLECTION)
    ("Such oligomeric complexes" . SPARSER::BIO-COMPLEX)
    ("sphingolipids" . SPARSER::MOLECULE)
    ("Caveolins and Cavins" . SPARSER::COLLECTION)
    ("this unitary complex" . SPARSER::BIO-COMPLEX)
    ("immuno-EM" . SPARSER::COLLECTION)
    ("caveolins and cavins" . SPARSER::COLLECTION)
    ("Platinum and chromium coating" . SPARSER::COLLECTION)
    ("caveolins and/or cavins" . SPARSER::COLLECTION)
    ("the additional caveolar proteins EHD2 and pacsin 2"
     . SPARSER::COLLECTION)
    ("higher order oligomeric complexes" . SPARSER::BIO-COMPLEX)
    ("Oligomerisation" . SPARSER::PROTEIN-FAMILY)
    ("oligomerisation" . SPARSER::PROTEIN-FAMILY) ("SRBC" . SPARSER::PROTEIN)
    ("MURC" . SPARSER::PROTEIN) ("PRKCDBP" . SPARSER::PROTEIN)
    ("SDPR" . SPARSER::PROTEIN) ("caveolar components" . SPARSER::COMPONENT)
    ("Caveolins" . SPARSER::PROTEIN-FAMILY) ("scaffolds" . SPARSER::SCAFFOLD)
    ("caveolin 1, and hetero-oligomerises" . SPARSER::COLLECTION)
    ("two further caveolin proteins" . SPARSER::PROTEIN)
    ("the major integral membrane protein" . SPARSER::PROTEIN)
    ("two caveolar proteins, cavin 2 and cavin 3" . SPARSER::COLLECTION)
    ("proteins, cavin 2 and cavin 3" . SPARSER::COLLECTION)
    ("components, cavins and caveolins" . SPARSER::COLLECTION)
    ("a recently developed protein" . SPARSER::PROTEIN)
    ("caveolin 1 and cavin 1" . SPARSER::COLLECTION)
    ("cavin 2, cavin 3, and EHD2" . SPARSER::COLLECTION)
    ("complex, and form" . SPARSER::COLLECTION) ("trimers" . SPARSER::TRIMER)
    ("no further abundant components" . SPARSER::COMPONENT)
    ("a homogenous 80S complex" . SPARSER::BIO-COMPLEX)
    ("Caveolin and cavin" . SPARSER::COLLECTION)
    ("EHD2 and pacsin 2" . SPARSER::COLLECTION) ("Caveolin" . SPARSER::PROTEIN)
    ("caveolins" . SPARSER::PROTEIN-FAMILY) ("cavin3" . SPARSER::PROTEIN)
    ("flotillin 2" . SPARSER::PROTEIN) ("flotillin 1" . SPARSER::PROTEIN)
    ("Cavin1" . SPARSER::PROTEIN) ("flotillin-1" . SPARSER::PROTEIN)
    ("caveolin 2" . SPARSER::PROTEIN) ("Cavin-1" . SPARSER::PROTEIN)
    ("Cavin-2" . SPARSER::PROTEIN) ("cavin-3" . SPARSER::PROTEIN)
    ("cavin-2" . SPARSER::PROTEIN) ("cavin-1" . SPARSER::PROTEIN)
    ("Cavin 2" . SPARSER::PROTEIN) ("flotillin-2" . SPARSER::PROTEIN)
    ("caveolin 3" . SPARSER::PROTEIN) ("Cavin 3" . SPARSER::PROTEIN)
    ("Caveolin 3" . SPARSER::PROTEIN) ("Caveolin 2" . SPARSER::PROTEIN)
    ("Caveolin 1" . SPARSER::PROTEIN) ("cavin 3" . SPARSER::PROTEIN)
    ("cavin 2" . SPARSER::PROTEIN) ("cavin 1" . SPARSER::PROTEIN)
    ("caveolin 1" . SPARSER::PROTEIN) ("Cavin 1" . SPARSER::PROTEIN)
    ("pacsin 2" . SPARSER::PROTEIN) ("EHD2" . SPARSER::PROTEIN)
    ("essential cellular enzymes" . SPARSER::ENZYME)
    ("ERK2 and PARP-1" . SPARSER::COLLECTION) ("p-ERK" . SPARSER::COLLECTION)
    ("LAMP" . SPARSER::PROTEIN) ("DNA-enzyme" . SPARSER::DNA)
    ("proteins/glycoproteins" . SPARSER::COLLECTION)
    ("inhibitor (PD)" . SPARSER::INHIBITOR)
    ("the enzyme–DNA cleavable complexes" . SPARSER::BIO-COMPLEX)
    ("MCF7 and U251" . SPARSER::COLLECTION)
    ("p38, NF-kB, AP-1, and ERK 1/2" . SPARSER::COLLECTION)
    ("SAPK/JNK" . SPARSER::COLLECTION) ("poly-ADP" . SPARSER::PROTEIN)
    ("IB" . SPARSER::PROTEIN) ("the cleavable complex" . SPARSER::BIO-COMPLEX)
    ("TPT and CPT-11" . SPARSER::COLLECTION) ("TPT" . SPARSER::PROTEIN)
    ("Camptothecin" . SPARSER::DRUG)
    ("either type I (cleaves one strand of DNA) or type II (cleaves two strands of DNA)"
     . SPARSER::COLLECTION)
    ("the topological state" . SPARSER::BIO-STATE)
    ("essential nuclear enzymes" . SPARSER::ENZYME) ("CPTs" . SPARSER::PROTEIN)
    ("camptothecins" . SPARSER::DRUG) ("Topo" . SPARSER::PROTEIN)
    ("DNA Topoisomerase I" . SPARSER::PROTEIN) ("p-ERK 1/2" . SPARSER::PROTEIN)
    ("topoisomerase I" . SPARSER::PROTEIN)
    ("Topoisomerase I" . SPARSER::PROTEIN) ("Cl 2" . SPARSER::PROTEIN)
    ("SP4" . SPARSER::PROTEIN) ("K7" . SPARSER::PROTEIN)
    ("DNA topoisomerase I" . SPARSER::PROTEIN) ("CPT-11" . SPARSER::DRUG)
    ("PARP-1" . SPARSER::PROTEIN) ("DNA Topoisomerase" . SPARSER::PROTEIN)
    ("oligomers, or monomers" . SPARSER::COLLECTION)
    ("monomeric RAD51" . SPARSER::PROTEIN) ("37kDa" . SPARSER::PROTEIN)
    ("RAD52 or the BRC" . SPARSER::COLLECTION)
    ("BRCA2-DSS1-RAD51" . SPARSER::COLLECTION)
    ("BRCA2, DSS1 and RAD51" . SPARSER::COLLECTION)
    ("DSS1-BRCA2" . SPARSER::COLLECTION) ("Flag-BRCA2" . SPARSER::COLLECTION)
    ("BRCA2 or DSS1" . SPARSER::COLLECTION)
    ("Ku59848, hydroxyurea or aphidicolin" . SPARSER::COLLECTION)
    ("aphidicolin" . SPARSER::PROTEIN) ("genotoxins" . SPARSER::MOLECULE)
    ("etoposide and MMC" . SPARSER::COLLECTION)
    ("DSS1, and BRCA2 and" . SPARSER::COLLECTION)
    ("‘masking’" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAD51-SAM" . SPARSER::COLLECTION) ("LEA" . SPARSER::PROTEIN)
    ("the essential co-factor" . SPARSER::MOLECULE)
    ("this heterologous protein" . SPARSER::PROTEIN)
    ("exportin" . SPARSER::PROTEIN)
    ("exportins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("‘masks’" . SPARSER::PROTEIN)
    ("NLS-SYFP-tagged D2723H or W2725A mutants" . SPARSER::MUTANT)
    ("mCherry-DSS1" . SPARSER::COLLECTION)
    ("yellow fluorescent protein (SYFP)" . SPARSER::PROTEIN)
    ("the heterozygous state" . SPARSER::BIO-STATE)
    ("BRCA2 and RAD51" . SPARSER::COLLECTION)
    ("NES-masking" . SPARSER::COLLECTION) ("BRCA2-RAD51" . SPARSER::COLLECTION)
    ("BRCA2-DSS1" . SPARSER::COLLECTION) ("GTPγS" . SPARSER::PROTEIN)
    ("Leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("6-aminohexanoic acid" . SPARSER::DRUG) ("Rad 51" . SPARSER::PROTEIN)
    ("RAD 51" . SPARSER::PROTEIN) ("Not1" . SPARSER::PROTEIN)
    ("Brh2" . SPARSER::MOLECULE) ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("nuclear pores" . SPARSER::BIO-COMPLEX) ("RAD52" . SPARSER::PROTEIN)
    ("Rad53" . SPARSER::PROTEIN) ("CRM1" . SPARSER::PROTEIN)
    ("BRCA2 protein" . SPARSER::PROTEIN) ("DSS1" . SPARSER::PROTEIN)
    ("siRNA or protein" . SPARSER::COLLECTION) ("monastrol" . SPARSER::DRUG)
    ("unstable k-MT" . SPARSER::PROTEIN) ("nocodazole" . SPARSER::DRUG)
    ("aurora" . SPARSER::PROTEIN) ("astrin" . SPARSER::PROTEIN)
    ("Ammonium Chloride" . SPARSER::MOLECULE) ("k2" . SPARSER::PROTEIN)
    ("k1" . SPARSER::PROTEIN) ("pH3" . SPARSER::PROTEIN)
    ("Hec1" . SPARSER::PROTEIN) ("Cyclin A2" . SPARSER::PROTEIN)
    ("RPE1" . SPARSER::PROTEIN) ("Nuf2" . SPARSER::PROTEIN)
    ("K-MT" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("PtK1" . SPARSER::PROTEIN) ("k-MT" . SPARSER::PROTEIN)
    ("different histological types" . TYPE)
    ("protein, and rs3792136" . SPARSER::COLLECTION)
    ("POLη, POLι, REV3 and REV1 variants and lung cancer risk"
     . SPARSER::COLLECTION)
    ("et al. ( xref ) previously investigated 44 SNPs" . SPARSER::PROTEIN)
    ("PCNA and non-classical" . SPARSER::COLLECTION)
    ("GC and rs1018119" . SPARSER::COLLECTION)
    ("et al. ( xref ) previously investigated 70 genes" . SPARSER::GENE)
    ("histological types" . TYPE) ("A-G and A-C" . SPARSER::COLLECTION)
    ("SNPs, rs5744533 and rs5744724" . SPARSER::COLLECTION)
    ("SNPs, rs25406 and rs3729558" . SPARSER::COLLECTION)
    ("the POL ι gene (P HW =0.007) and rs1018119" . SPARSER::COLLECTION)
    ("PCNA (rs25406, rs3729558) and POLη (rs6941583) genes"
     . SPARSER::COLLECTION)
    ("ESTR" . SPARSER::PROTEIN)
    ("B-family DNA polymerases (REV3 and REV7) and PCNA ( xref )"
     . SPARSER::COLLECTION)
    ("the Y-family DNA polymerases (POLη, POLκ, POLι and REV1), B-family DNA polymerases (REV3 and REV7) and PCNA ( xref )"
     . SPARSER::COLLECTION)
    ("REV3 and REV7" . SPARSER::COLLECTION)
    ("nitrosamines" . SPARSER::MOLECULE) ("PAHs" . SPARSER::PROTEIN)
    ("Cigarette" . SPARSER::DRUG) ("POL" . SPARSER::PROTEIN)
    ("A-G" . SPARSER::PROTEIN) ("period 2" . SPARSER::PROTEIN)
    ("REV7" . SPARSER::PROTEIN) ("REV3" . SPARSER::PROTEIN)
    ("REV1" . SPARSER::PROTEIN) ("VP" . SPARSER::PROTEIN)
    ("CHFR, TOPK, PTEN and AKT" . SPARSER::COLLECTION)
    ("PTEN, and pAkt" . SPARSER::COLLECTION) ("GST–PTEN" . SPARSER::COLLECTION)
    ("PTEN–Akt" . SPARSER::COLLECTION) ("expressed CHFR" . SPARSER::PROTEIN)
    ("TOPK and TOPK" . SPARSER::COLLECTION)
    ("Nocodazole and phospho Histone H3" . SPARSER::COLLECTION)
    ("Aurora A and Kif22" . SPARSER::COLLECTION)
    ("new associated protein" . SPARSER::PROTEIN)
    ("FLAG–TOPK" . SPARSER::COLLECTION)
    ("CHFR, ΔFHA, and ΔRING" . SPARSER::COLLECTION)
    ("FHA" . SPARSER::PROTEIN-FAMILY)
    ("bacterially expressed recombinant GST–CHFR" . SPARSER::COLLECTION)
    ("expressed recombinant GST–CHFR" . SPARSER::COLLECTION)
    ("TOPK and CHFR" . SPARSER::COLLECTION) ("GST–CHFR" . SPARSER::COLLECTION)
    ("exogenously expressed Flag-tagged TOPK" . SPARSER::PROTEIN)
    ("expressed Flag-tagged TOPK" . SPARSER::PROTEIN)
    ("cdk1/cyclin" . SPARSER::COLLECTION) ("Threonine" . SPARSER::AMINO-ACID)
    ("LAK" . SPARSER::PROTEIN) ("lymphokine" . SPARSER::PROTEIN)
    ("SFB-CHFR" . SPARSER::COLLECTION)
    ("its proteosomal substrates" . SPARSER::SUBSTRATE)
    ("Aurora A, Plk1, Kif22 and PARP1" . SPARSER::COLLECTION)
    ("Kif22" . SPARSER::PROTEIN) ("TOPK and PTEN" . SPARSER::COLLECTION)
    ("kinase and PTEN" . SPARSER::COLLECTION)
    ("TOPK/PBK" . SPARSER::COLLECTION) ("PBK" . SPARSER::PROTEIN)
    ("TOPK" . SPARSER::PROTEIN)
    ("an E3 ubiquitin ligase and a checkpoint protein" . SPARSER::COLLECTION)
    ("CHFR" . SPARSER::PROTEIN) ("p 32" . SPARSER::PROTEIN)
    ("NaVO3" . SPARSER::MOLECULE) ("PTEN 2" . SPARSER::PROTEIN)
    ("cdk1" . SPARSER::PROTEIN)
    ("T-cell-originated protein kinase" . SPARSER::PROTEIN)
    ("S-protein" . SPARSER::PROTEIN) ("Aurora A" . SPARSER::PROTEIN)
    ("mitotic checkpoint protein" . SPARSER::PROTEIN)
    ("–mGluR5–Fyn" . SPARSER::COLLECTION)
    ("The only previously known endogenous ligand" . SPARSER::MOLECULE)
    ("Ectodomain accessory proteins" . SPARSER::PROTEIN)
    ("heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("Smoothened and Frizzleds" . SPARSER::COLLECTION)
    ("Patched and LRP5/6" . SPARSER::COLLECTION) ("Patched" . SPARSER::PROTEIN)
    ("Smoothened" . SPARSER::PROTEIN) ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Calcitonin and related receptors" . SPARSER::COLLECTION)
    ("transmembrane RAMPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAMPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Calcitonin" . SPARSER::PROTEIN)
    ("both melanocortin agonists and Agouti/AgRP antagonists"
     . SPARSER::COLLECTION)
    ("Agouti/AgRP" . SPARSER::COLLECTION) ("AgRP" . SPARSER::PROTEIN)
    ("Agouti" . SPARSER::PROTEIN-FAMILY)
    ("accessory subunits or co-receptors" . SPARSER::COLLECTION)
    ("subunits or co-receptors" . SPARSER::COLLECTION)
    ("metabotropic glutamate receptors" . SPARSER::RECEPTOR)
    ("Alternate ligands and accessory ectodomains" . SPARSER::COLLECTION)
    ("Alternate ligands" . SPARSER::LIGAND)
    ("metabotropic receptors" . SPARSER::PROTEIN)
    ("Fyn and PrP" . SPARSER::COLLECTION)
    ("audiogenic seizures" . SPARSER::PROTEIN)
    ("APP and PS1" . SPARSER::COLLECTION)
    ("receptor and eEF2K" . SPARSER::COLLECTION)
    ("Arc/Arg3.1" . SPARSER::COLLECTION) ("Src/Fyn" . SPARSER::COLLECTION)
    ("TRP" . SPARSER::PROTEIN) ("calcium and protein" . SPARSER::COLLECTION)
    ("presynaptic synaptophysin" . SPARSER::PROTEIN)
    ("synaptophysin" . SPARSER::PROTEIN)
    ("APP, PS1 and Tau" . SPARSER::COLLECTION) ("Tau" . SPARSER::PROTEIN)
    ("RM-ANOVA" . SPARSER::COLLECTION) ("APPswe/PS1" . SPARSER::COLLECTION)
    ("Antagonist" . SPARSER::MOLECULE) ("chronic DHPG" . SPARSER::DRUG)
    ("Prnp– and Fyn" . SPARSER::COLLECTION) ("Prnp–" . SPARSER::PROTEIN)
    ("myristoyl-GFP" . SPARSER::COLLECTION)
    ("Grm5 −/− and Prnp −/−" . SPARSER::COLLECTION)
    ("p-eEF2" . SPARSER::COLLECTION) ("Arc" . SPARSER::PROTEIN)
    ("Metabotropic GluRs" . SPARSER::PROTEIN) ("GluRs" . SPARSER::PROTEIN)
    ("Aβo and DHPG" . SPARSER::COLLECTION)
    ("relatively immobile complexes" . SPARSER::BIO-COMPLEX)
    ("Aβo and the group I mGlu receptor agonist" . SPARSER::COLLECTION)
    ("a cell impermeable reagent" . SPARSER::MOLECULE)
    ("HEK–mGluR5" . SPARSER::COLLECTION) ("Chronic Aβo" . SPARSER::PROTEIN)
    ("Fyn and calcium" . SPARSER::COLLECTION)
    ("Thapsigargin" . SPARSER::MOLECULE)
    ("MPEP and MTEP" . SPARSER::COLLECTION) ("PrP-Fc" . SPARSER::COLLECTION)
    ("monomeric Aβ" . SPARSER::PROTEIN)
    ("a calcium-sensitive fluorescent dye" . SPARSER::MOLECULE)
    ("Acute Aβo-Induced Calcium" . SPARSER::CALCIUM)
    ("BAPTA" . SPARSER::MOLECULE) ("subsequent Aβo" . SPARSER::PROTEIN)
    ("-mGluR5" . SPARSER::COLLECTION) ("mGluR5-PrP" . SPARSER::COLLECTION)
    ("mGluR1 or mGluR5" . SPARSER::COLLECTION)
    ("an easily detected transmembrane chloride channel" . SPARSER::PROTEIN)
    ("the heterotrimeric GTPases" . SPARSER::GTPASE)
    ("Punctate" . SPARSER::PROTEIN) ("mGluR1 or mGluR8" . SPARSER::COLLECTION)
    ("mGluR5–Fyn" . SPARSER::COLLECTION)
    ("mGluR8, NR2B or GluR1" . SPARSER::COLLECTION)
    ("neuronal mGluR5" . SPARSER::PROTEIN)
    ("EphB2 and Fyn" . SPARSER::COLLECTION)
    ("Aβo and Fyn" . SPARSER::COLLECTION)
    ("Aβo, mGluR1 or mGluR5" . SPARSER::COLLECTION) ("Aβ" . SPARSER::PROTEIN)
    ("APLP1 and APLP2" . SPARSER::COLLECTION) ("Aβo/PrP" . SPARSER::COLLECTION)
    ("Antagonists" . SPARSER::MOLECULE) ("neuronal Fyn" . SPARSER::PROTEIN)
    ("mGluR5 and PrP" . SPARSER::COLLECTION) ("PSDs" . SPARSER::PROTEIN)
    ("glycolipid" . SPARSER::MOLECULE) ("Post" . SPARSER::PROTEIN)
    ("Aβo and Aβ–PrP" . SPARSER::COLLECTION) ("Aβ–PrP" . SPARSER::PROTEIN-PAIR)
    ("APP/PS1" . SPARSER::COLLECTION) ("soluble oligomers" . SPARSER::PROTEIN)
    ("late onset AD" . SPARSER::PROTEIN) ("Biomarker" . SPARSER::MOLECULE)
    ("Amyloid-β Precursor Protein (APP) or Presenilin (PS1 or PS2)"
     . SPARSER::COLLECTION)
    ("Precursor Protein (APP)" . SPARSER::PROTEIN)
    ("PS1 or PS2" . SPARSER::COLLECTION) ("Presenilin" . SPARSER::PROTEIN)
    ("–mGluR5" . SPARSER::COLLECTION)
    ("the metabotropic glutamate receptor" . SPARSER::PROTEIN)
    ("Aβo" . SPARSER::PROTEIN) ("Aβo–PrP" . SPARSER::COLLECTION)
    ("Cellular Prion Protein" . SPARSER::PROTEIN) ("LRP5/6" . SPARSER::PROTEIN)
    ("co-receptors" . SPARSER::PROTEIN) ("NMDA-Rs" . SPARSER::PROTEIN)
    ("Homer family" . SPARSER::PROTEIN-FAMILY) ("Arg3.1" . SPARSER::PROTEIN)
    ("eEF2K" . SPARSER::PROTEIN) ("tyrosine kinase 2" . SPARSER::PROTEIN)
    ("eEF-2" . SPARSER::PROTEIN) ("co-receptor" . SPARSER::PROTEIN)
    ("eukaryotic elongation factor" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("NMDA-R" . SPARSER::PROTEIN) ("C –Fyn" . SPARSER::PROTEIN)
    ("chloride channel" . SPARSER::PROTEIN) ("IP3" . SPARSER::IP3)
    ("GluR1" . SPARSER::PROTEIN) ("mGluR8" . SPARSER::PROTEIN)
    ("EphB2" . SPARSER::PROTEIN) ("APLP2" . SPARSER::PROTEIN)
    ("APLP1" . SPARSER::PROTEIN) ("PS2" . SPARSER::PROTEIN)
    ("PS1" . SPARSER::PROTEIN) ("Precursor Protein" . SPARSER::PROTEIN)
    ("eEF2" . SPARSER::PROTEIN) ("Prion Protein" . SPARSER::PROTEIN)
    ("Amyloid-β" . SPARSER::MOLECULE) ("mTOR/MEK" . SPARSER::COLLECTION)
    ("letrozole" . SPARSER::DRUG)
    ("everolimus or tamoxifen" . SPARSER::COLLECTION)
    ("exemestane or tamoxifen" . SPARSER::COLLECTION)
    ("exemestane" . SPARSER::DRUG) ("AIs" . SPARSER::PROTEIN)
    ("PI3K and ER" . SPARSER::COLLECTION)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("mTORC1 and PI3K" . SPARSER::COLLECTION)
    ("SRC3 or NCoA3" . SPARSER::COLLECTION) ("NCoA" . SPARSER::PROTEIN)
    ("ER and p-ERK1/2" . SPARSER::COLLECTION)
    ("HER2, RAF, or MEK" . SPARSER::COLLECTION)
    ("PI3K or MAPK" . SPARSER::COLLECTION)
    ("PIK3CA, PTEN , and AKT" . SPARSER::COLLECTION)
    ("CMap" . SPARSER::PROTEIN) ("SERMs" . SPARSER::DRUG)
    ("AKT1, AKT2, and PDK1" . SPARSER::COLLECTION)
    ("ER and GFR" . SPARSER::COLLECTION) ("GFR" . SPARSER::PROTEIN)
    ("AKT and mTOR" . SPARSER::COLLECTION)
    ("RAS/RAF/MEK/MAPK" . SPARSER::COLLECTION) ("BEZ-235" . SPARSER::DRUG)
    ("insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SRC3" . SPARSER::PROTEIN)
    ("inositol polyphosphate-4-phosphatase" . SPARSER::PROTEIN)
    ("INPP4B" . SPARSER::PROTEIN) ("PIK3CB" . SPARSER::PROTEIN)
    ("which makes CD44" . SPARSER::PROTEIN)
    ("ASPP1, BRCA1 or PTEN" . SPARSER::COLLECTION)
    ("gene and p53" . SPARSER::COLLECTION) ("nutlin" . SPARSER::DRUG)
    ("NCS" . SPARSER::PROTEIN)
    ("Cdkn1a , Cd44 , and c-Myc" . SPARSER::COLLECTION)
    ("Cd44" . SPARSER::PROTEIN) ("Cdkn1a" . SPARSER::PROTEIN)
    ("p53, p21, and CD44" . SPARSER::COLLECTION)
    ("CDKN1A ( p21) and CD44" . SPARSER::COLLECTION)
    ("wild type APC and CTNNB1 genes and lack constitutive β-catenin/TCF-4-mediated transcription xref"
     . SPARSER::COLLECTION)
    ("APC and CTNNB1" . SPARSER::COLLECTION)
    ("p53 and K-Ras" . SPARSER::COLLECTION)
    ("p53 protein or nuclear" . SPARSER::COLLECTION)
    ("a strong nuclear" . SPARSER::PROTEIN)
    ("colon cancer and intestinal epithelium" . SPARSER::COLLECTION)
    ("p53 and CD44" . SPARSER::COLLECTION)
    ("90 localized primary CRCs" . SPARSER::PROTEIN)
    ("ASPP1" . SPARSER::PROTEIN) ("TCF-4" . SPARSER::PROTEIN)
    ("Colon Cancer" . SPARSER::PROTEIN) ("Log2" . SPARSER::PROTEIN)
    ("HER and ER" . SPARSER::COLLECTION)
    ("HER and estrogen receptor" . SPARSER::COLLECTION)
    ("a triple positive hormone receptor" . SPARSER::RECEPTOR)
    ("the apoptosis-functional protein caspase-3" . SPARSER::PROTEIN)
    ("neu-" . SPARSER::PROTEIN) ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("chromatin and DNA" . SPARSER::COLLECTION)
    ("taxanes, 5-fluorouracil, and doxorubicin" . SPARSER::COLLECTION)
    ("further effector caspases" . SPARSER::PROTEIN)
    ("estrogen and progesterone receptor" . SPARSER::COLLECTION)
    ("ER and HER/neu-positive GBCs" . SPARSER::COLLECTION)
    ("antipro-caspase-3" . SPARSER::COLLECTION)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dietary fat and carbohydrate" . SPARSER::COLLECTION)
    ("fat and carbohydrate" . SPARSER::COLLECTION)
    ("carbohydrate" . SPARSER::MOLECULE)
    ("low-fat and high-fat" . SPARSER::COLLECTION)
    ("the MetS or individual components" . SPARSER::COLLECTION)
    ("CHB" . SPARSER::PROTEIN)
    ("the MetS or other individual components" . SPARSER::COLLECTION)
    ("HDL" . SPARSER::PROTEIN) ("high-fat and low-fat" . SPARSER::COLLECTION)
    ("low-fat" . SPARSER::PROTEIN) ("high-fat" . SPARSER::PROTEIN)
    ("IRS1 , rs1522813 and rs2943641" . SPARSER::COLLECTION)
    ("macronutrient" . SPARSER::MOLECULE) ("MetS" . SPARSER::PROTEIN)
    ("Insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDGFR α, PDGFR β and c-Kit" . SPARSER::COLLECTION)
    ("Axl" . SPARSER::PROTEIN) ("Imatinib" . SPARSER::DRUG)
    ("the c-Kit receptor as well as its ligand" . SPARSER::COLLECTION)
    ("c- Kit and its published downstream effectors c-Fos and Oncostatin M"
     . SPARSER::COLLECTION)
    ("c-Kit or/and presumably factors regulating c-Kit" . SPARSER::PROTEIN)
    ("receptor and ligand" . SPARSER::COLLECTION)
    ("OLFM4, CD44, β-catenin, BMI-1 and Lgr5" . SPARSER::COLLECTION)
    ("c-Kit and stemness" . SPARSER::COLLECTION)
    ("CD44 and BMI-1" . SPARSER::COLLECTION)
    ("c-Fos and Oncostatin M" . SPARSER::COLLECTION)
    ("P8 , β-catenin , Sox2 , BMI-1 and OLFM4" . SPARSER::COLLECTION)
    ("Nanog" . SPARSER::PROTEIN)
    ("c- Fos and Oncostatin M" . SPARSER::COLLECTION)
    ("Vimentin , CDH1 , Occludin and Fibronectin" . SPARSER::COLLECTION)
    ("Occludin" . SPARSER::PROTEIN) ("SCF and miR-34a" . SPARSER::COLLECTION)
    ("SCF/c-Kit" . SPARSER::COLLECTION)
    ("5-FU and Doxorubicin" . SPARSER::COLLECTION)
    ("miR-34a and 5-FU" . SPARSER::COLLECTION)
    ("miR-34a or control oligos" . SPARSER::COLLECTION)
    ("the anti-metabolite 5-FU or the anthracycline antibiotic Doxorubicin"
     . SPARSER::COLLECTION)
    ("c-Kit, and SW480" . SPARSER::COLLECTION)
    ("miR-34a and c-Kit" . SPARSER::COLLECTION)
    ("doxycycline (DOX)" . SPARSER::MOLECULE) ("tet" . SPARSER::PROTEIN)
    ("ORF" . SPARSER::PROTEIN)
    ("OLFM4 , LGR5 , BMI-1 and CD44" . SPARSER::COLLECTION)
    ("SCF/stem cell factor" . SPARSER::COLLECTION)
    ("mast cell" . SPARSER::PROTEIN) ("Jak/Stat" . SPARSER::COLLECTION)
    ("v-" . SPARSER::PROTEIN)
    ("a type III receptor tyrosine kinase (RTK) and an important mediator/initiator"
     . SPARSER::COLLECTION)
    ("CD117 or stem cell factor receptor" . SPARSER::COLLECTION)
    ("a conditional miR-34a allele" . SPARSER::ALLELE)
    ("CD44 , Lgr5 and BMI-1" . SPARSER::COLLECTION)
    ("primary CRC" . SPARSER::PROTEIN)
    ("Lgr5 , CD44 , OLFM4 , BMI-1 and β-catenin" . SPARSER::COLLECTION)
    ("a conditional c- Kit allele" . SPARSER::ALLELE)
    ("c-Kit ligand/stem cell factor" . SPARSER::COLLECTION)
    ("interleukin-4" . SPARSER::PROTEIN) ("CCL22" . SPARSER::PROTEIN)
    ("PDGFR β" . SPARSER::PROTEIN) ("PDGFR α" . SPARSER::PROTEIN)
    ("STI571" . SPARSER::DRUG) ("c- Kit ligand" . SPARSER::PROTEIN)
    ("P8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("c- Fos" . SPARSER::PROTEIN)
    ("c -Kit" . SPARSER::PROTEIN) ("site 2" . SPARSER::PROTEIN)
    ("site 1" . SPARSER::PROTEIN) ("LGR5" . SPARSER::PROTEIN)
    ("PI-3" . SPARSER::PROTEIN) ("steel factor" . SPARSER::PROTEIN)
    ("stem cell factor receptor" . SPARSER::PROTEIN)
    ("MiR-34a" . SPARSER::MOLECULE) ("OLFM4" . SPARSER::PROTEIN)
    ("Lgr5" . SPARSER::PROTEIN) ("c-Kit ligand" . SPARSER::PROTEIN)
    ("c- Kit" . SPARSER::PROTEIN) ("the oligomerized LTβR" . SPARSER::PROTEIN)
    ("LTβR and NIK" . SPARSER::COLLECTION)
    ("TNFα or IL-1" . SPARSER::COLLECTION)
    ("A20 and TRAF2" . SPARSER::COLLECTION)
    ("either K63 or linear polyubiquitin" . SPARSER::COLLECTION)
    ("LTβR, Fn14, and RANK" . SPARSER::COLLECTION)
    ("TRAF2, TRAF3, and cIAP1/2" . SPARSER::COLLECTION)
    ("ZnF7 and cIAP1" . SPARSER::COLLECTION)
    ("cIAP and K63" . SPARSER::COLLECTION)
    ("polyubiquitin, and cIAP1" . SPARSER::COLLECTION)
    ("A20/cIAP1/TRAF2" . SPARSER::COLLECTION)
    ("the cIAP1 deletion mutants and GST-A20-ZnF5-7" . SPARSER::COLLECTION)
    ("TAP-tagged cIAP1 and its deletion mutants" . SPARSER::COLLECTION)
    ("cIAP1 and A20-ZnF5-7" . SPARSER::COLLECTION) ("cIAP" . SPARSER::PROTEIN)
    ("Bead-bound GST-cIAP1" . SPARSER::COLLECTION)
    ("GST-cIAP1" . SPARSER::COLLECTION) ("GST-cIAP" . SPARSER::PROTEIN-PAIR)
    ("K63 or linear polyubiquitin" . SPARSER::COLLECTION)
    ("A20 and cIAP" . SPARSER::COLLECTION)
    ("second mitochondria-derived activator of caspase (SMAC)"
     . SPARSER::PROTEIN)
    ("MV" . SPARSER::PROTEIN)
    ("A20 and the cIAP1/TRAF2 complex" . SPARSER::COLLECTION)
    ("cIAP1, TRAF2, and TRAF3" . SPARSER::COLLECTION)
    ("the NIK-associated proteins" . SPARSER::PROTEIN)
    ("TAP-NIK" . SPARSER::COLLECTION) ("Myc-A20-ZnF7mt" . SPARSER::COLLECTION)
    ("A20 and cIAP1/2" . SPARSER::COLLECTION)
    ("A20-ZnF7mt" . SPARSER::COLLECTION)
    ("the deubiquitinase nor the E3 ligase activity" . SPARSER::COLLECTION)
    ("which lacks E3 ligase activity" . SPARSER::PROTEIN)
    ("A20-ZnF4mt" . SPARSER::COLLECTION) ("mt" . SPARSER::PROTEIN)
    ("ΔZnF" . SPARSER::PROTEIN) ("ΔOTU" . SPARSER::PROTEIN)
    ("cIAP1/TRAF2" . SPARSER::COLLECTION) ("A20-ΔZnF" . SPARSER::COLLECTION)
    ("A20-ΔOTU" . SPARSER::COLLECTION)
    ("the OTU domain or an A20-ΔZnF mutant" . SPARSER::COLLECTION)
    ("A20-" . SPARSER::PROTEIN) ("TRAF3 or NIK" . SPARSER::COLLECTION)
    ("cIAP2 and TRAF3" . SPARSER::COLLECTION) ("TAP-A20" . SPARSER::COLLECTION)
    ("either A20-2 siRNA or control siRNA" . SPARSER::COLLECTION)
    ("ligand (RANKL)" . SPARSER::MOLECULE) ("RANKL" . SPARSER::PROTEIN)
    ("tumor necrosis factor-like weak inducer" . SPARSER::PROTEIN)
    ("TWEAK" . SPARSER::PROTEIN) ("TNFRSF" . SPARSER::PROTEIN)
    ("p52 and RelB" . SPARSER::COLLECTION)
    ("IKK and IκBα" . SPARSER::COLLECTION)
    ("two distinct siRNAs" . SPARSER::PROTEIN)
    ("cIAP1 and TRAF2" . SPARSER::COLLECTION)
    ("FLAG and double strep" . SPARSER::COLLECTION)
    ("deubiquitinase and ubiquitin ligase" . SPARSER::COLLECTION)
    ("OTU" . SPARSER::PROTEIN) ("TRAF2 and TRAF3" . SPARSER::COLLECTION)
    ("NIK and cIAP1/2" . SPARSER::COLLECTION)
    ("complex (LUBAC)" . SPARSER::BIO-COMPLEX)
    ("UBC5 and cIAP1" . SPARSER::COLLECTION)
    ("receptor (BAFFR)" . SPARSER::RECEPTOR) ("BAFFR" . SPARSER::PROTEIN)
    ("IKKα and IKKβ" . SPARSER::COLLECTION)
    ("NF-κB (IκB) family or a p100 protein" . SPARSER::COLLECTION)
    ("homodimers or heterodimers" . SPARSER::COLLECTION)
    ("p52/RelB" . SPARSER::COLLECTION) ("p50/RelA" . SPARSER::COLLECTION)
    ("the NFKB1 (p105/p50) and NFKB2 (p100/p52) genes" . SPARSER::COLLECTION)
    ("RelA, RelB, and c-Rel" . SPARSER::COLLECTION)
    ("p105/p50" . SPARSER::COLLECTION) ("TRAF2/TRAF3" . SPARSER::COLLECTION)
    ("TNF receptor-associated factor 2" . SPARSER::PROTEIN)
    ("k14" . SPARSER::PROTEIN) ("Map3" . SPARSER::PROTEIN)
    ("MAP3K14" . SPARSER::PROTEIN) ("MV1" . SPARSER::MOLECULE)
    ("BIR1" . SPARSER::PROTEIN) ("ZnF5" . SPARSER::PROTEIN)
    ("Glutathione-S-transferase" . SPARSER::PROTEIN)
    ("second mitochondria-derived activator of caspase" . SPARSER::PROTEIN)
    ("ZnF4" . SPARSER::PROTEIN) ("OTU domain" . SPARSER::PROTEIN)
    ("ZnF7" . SPARSER::PROTEIN) ("UBC5C" . SPARSER::PROTEIN)
    ("UBC13" . SPARSER::PROTEIN) ("TAB2" . SPARSER::PROTEIN)
    ("TAB3" . SPARSER::PROTEIN) ("UBC5" . SPARSER::PROTEIN)
    ("Fn14" . SPARSER::PROTEIN) ("LTβR" . SPARSER::PROTEIN)
    ("lymphotoxin-β" . SPARSER::PROTEIN) ("IκBs" . SPARSER::PROTEIN)
    ("inhibitor of apoptosis protein 1" . SPARSER::PROTEIN)
    ("Mdm2 and Slug" . SPARSER::COLLECTION)
    ("Slug and Mdm2" . SPARSER::COLLECTION)
    ("p53-Mdm2-Slug" . SPARSER::COLLECTION) ("pAB" . SPARSER::PROTEIN)
    ("Slug, and mutant" . SPARSER::COLLECTION)
    ("UVR-induced preneoplastic foci" . SPARSER::PROTEIN)
    ("p53-positive preneoplastic foci" . SPARSER::PROTEIN)
    ("these UVR-induced preneoplastic foci" . SPARSER::PROTEIN)
    ("neoplastic epithelial components and all spindle cell components"
     . SPARSER::COLLECTION)
    ("Pab240-positive foci" . SPARSER::PROTEIN)
    ("p53 and Slug" . SPARSER::COLLECTION)
    ("all applicable state" . SPARSER::BIO-STATE)
    ("Slug and p53" . SPARSER::COLLECTION) ("PAb" . SPARSER::PROTEIN)
    ("UVR and Slug" . SPARSER::COLLECTION) ("UVR" . SPARSER::PROTEIN)
    ("Snai2" . SPARSER::PROTEIN) ("PDGF and BMP" . SPARSER::COLLECTION)
    ("BMP and TGF" . SPARSER::COLLECTION) ("idiopathic PAH" . SPARSER::PROTEIN)
    ("TGF-β/ALK-5/Smad2" . SPARSER::COLLECTION)
    ("BMPR-2/Smad1" . SPARSER::COLLECTION)
    ("receptor-SMAD2" . SPARSER::PROTEIN-PAIR)
    ("receptors or kinase" . SPARSER::COLLECTION)
    ("BMP/SMAD" . SPARSER::COLLECTION)
    ("Smad-6, -7 or BAMBI" . SPARSER::COLLECTION) ("BAMBI" . SPARSER::PROTEIN)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BMP-2 and -7" . SPARSER::COLLECTION)
    ("type I/type II" . SPARSER::COLLECTION)
    ("BMPR-2,-1A and -1B" . SPARSER::COLLECTION)
    ("other viral proteins" . SPARSER::PROTEIN)
    ("monocrotaline" . SPARSER::MOLECULE)
    ("idiopathic or heritable PAH" . SPARSER::PROTEIN)
    ("type II and type I" . SPARSER::COLLECTION)
    ("BMPR-2 and -1A" . SPARSER::COLLECTION)
    ("BMPR-2, -1A and -1B" . SPARSER::COLLECTION)
    ("down-modulating BMPR" . SPARSER::PROTEIN)
    ("the arterial smooth muscle" . SPARSER::PROTEIN)
    ("group or normal controls" . SPARSER::COLLECTION)
    ("that cocaine and Tat" . SPARSER::COLLECTION)
    ("p-SMAD2" . SPARSER::PROTEIN-PAIR) ("p-SMAD1" . SPARSER::PROTEIN-PAIR)
    ("cocaine or Tat mono-treatment" . SPARSER::COLLECTION)
    ("this cocaine or Tat mono-treatment mediated attenuation of BMPR protein levels"
     . SPARSER::COLLECTION)
    ("BMPR-1A and -1B" . SPARSER::COLLECTION)
    ("heteromeric BMP receptor complex" . SPARSER::BIO-COMPLEX)
    ("either cocaine or Tat treatment" . SPARSER::COLLECTION)
    ("cocaine and Tat" . SPARSER::COLLECTION)
    ("simultaneous cocaine" . SPARSER::DRUG) ("BMP/BMPR" . SPARSER::COLLECTION)
    ("an angiogenic and oncogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heteromeric complexes" . SPARSER::BIO-COMPLEX)
    ("BMPR-1A or BMPR-1B" . SPARSER::COLLECTION) ("MAD" . SPARSER::PROTEIN)
    ("BMP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("viral proteins and growth factors" . SPARSER::COLLECTION)
    ("RNA or DNA" . SPARSER::COLLECTION)
    ("illicit drugs and HIV-infection" . SPARSER::COLLECTION)
    ("illicit drugs" . SPARSER::DRUG) ("dys" . SPARSER::PROTEIN)
    ("cocaine and other stimulants" . SPARSER::COLLECTION)
    ("stimulants" . SPARSER::DRUG) ("HRPAH" . SPARSER::PROTEIN)
    ("PAH (HRPAH)" . SPARSER::PROTEIN) ("PAH" . SPARSER::PROTEIN)
    ("viral protein(s) and cocaine" . SPARSER::COLLECTION)
    ("cocaine or HIV" . SPARSER::COLLECTION)
    ("cocaine and HIV" . SPARSER::COLLECTION)
    ("Activator" . SPARSER::ACTIVATOR) ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("receptor (BMPR)" . SPARSER::RECEPTOR)
    ("HIV-protein and cocaine" . SPARSER::COLLECTION)
    ("BMPR" . SPARSER::PROTEIN) ("Smad3" . SPARSER::PROTEIN)
    ("ALK-5" . SPARSER::PROTEIN) ("Smad2" . SPARSER::PROTEIN)
    ("sigma-1" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("SMAD2" . SPARSER::PROTEIN) ("SMAD-4" . SPARSER::PROTEIN)
    ("R-SMADs" . SPARSER::PROTEIN-FAMILY)
    ("bone morphogenetic proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BMP-2" . SPARSER::PROTEIN) ("SMAD4" . SPARSER::PROTEIN)
    ("SMAD-1" . SPARSER::PROTEIN) ("R-SMAD" . SPARSER::PROTEIN-FAMILY)
    ("BMPR-2" . SPARSER::PROTEIN) ("BMPR-1B" . SPARSER::PROTEIN)
    ("BMPR-1A" . SPARSER::PROTEIN)
    ("Bone morphogenetic protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Id1" . SPARSER::PROTEIN) ("SMAD1" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AO" . SPARSER::PROTEIN) ("SF" . SPARSER::PROTEIN)
    ("DCR" . SPARSER::PROTEIN) ("EGFR and BRAF" . SPARSER::COLLECTION)
    ("KRAS , BRAF , NRAS , and PIK3CA" . SPARSER::COLLECTION)
    ("NRAS , or PIK3CA" . SPARSER::COLLECTION)
    ("RRs and DCRs" . SPARSER::COLLECTION)
    ("DCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("whose genomic DNA" . SPARSER::DNA) ("MBL" . SPARSER::PROTEIN)
    ("BRAF , NRAS , or PIK3CA" . SPARSER::COLLECTION)
    ("KRAS, BRAF , NRAS , and PIK3CA" . SPARSER::COLLECTION)
    ("negative predictive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRAF , NRAS , and PIK3CA" . SPARSER::COLLECTION)
    ("6.3 " . SPARSER::PROTEIN) ("Rac1 and srGAP1" . SPARSER::COLLECTION)
    ("blebbistatin or Y27632" . SPARSER::COLLECTION)
    ("siRNA, and S16" . SPARSER::COLLECTION)
    ("actin and myosin II" . SPARSER::COLLECTION)
    ("blebbistatin and Y27632" . SPARSER::COLLECTION)
    ("S12 and S13" . SPARSER::COLLECTION) ("blebbistatin" . SPARSER::DRUG)
    ("the Rac1 dominant-negative mutant" . SPARSER::MUTANT)
    ("Fes" . SPARSER::PROTEIN)
    ("The N-terminal 500 amino acids of srGAP2 and srGAP3"
     . SPARSER::COLLECTION)
    ("GAP-deleted mutants" . SPARSER::MUTANT)
    ("Exogenous srGAP1" . SPARSER::PROTEIN) ("FX" . SPARSER::PROTEIN)
    ("Raichu-Rac1" . SPARSER::COLLECTION)
    ("srGAP2 and srGAP3" . SPARSER::COLLECTION)
    ("srGAP1 and srGAP2" . SPARSER::COLLECTION)
    ("srGAP1 and srGAP3" . SPARSER::COLLECTION)
    ("RhoA and Cdc42" . SPARSER::COLLECTION) ("HT1080" . SPARSER::PROTEIN)
    ("srGAP2, srGAP3, and ARHGAP4" . SPARSER::COLLECTION)
    ("ARHGAP4/p115" . SPARSER::COLLECTION) ("srGAP3/WRP" . SPARSER::COLLECTION)
    ("WRP" . SPARSER::PROTEIN) ("RhoGAP, and SH3—and" . SPARSER::COLLECTION)
    ("mDia" . SPARSER::PROTEIN) ("WAVE/Arp2/3" . SPARSER::COLLECTION)
    ("WAVE" . SPARSER::PROTEIN) ("Robo" . SPARSER::PROTEIN)
    ("Rac and Rho" . SPARSER::COLLECTION)
    ("Rac1 and RhoA" . SPARSER::COLLECTION) ("p34" . SPARSER::PROTEIN)
    ("myosin Light Chain 2" . SPARSER::PROTEIN) ("FBP17" . SPARSER::PROTEIN)
    ("MYL12B" . SPARSER::PROTEIN)
    ("myosin regulatory light chain" . SPARSER::PROTEIN)
    ("CED-10" . SPARSER::PROTEIN) ("p115" . SPARSER::PROTEIN)
    ("ARHGAP4" . SPARSER::PROTEIN) ("srGAP3" . SPARSER::PROTEIN)
    ("GAP 1" . SPARSER::PROTEIN) ("srGAP1" . SPARSER::PROTEIN)
    ("C5a and IL-8" . SPARSER::COLLECTION)
    ("RhoA-myosin" . SPARSER::COLLECTION)
    ("neutrophils and neutrophils" . SPARSER::COLLECTION)
    ("Rho and myosin" . SPARSER::COLLECTION)
    ("DOCK2 and PIXα" . SPARSER::COLLECTION)
    ("DOCK2, PIXα, and P-Rex1" . SPARSER::COLLECTION)
    ("PIX" . SPARSER::PROTEIN) ("AKTs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTORC2 and mTOR" . SPARSER::COLLECTION)
    ("regulators of actin dynamics and neutrophil chemotaxis"
     . SPARSER::COLLECTION)
    ("the neutrophil's" . SPARSER::PROTEIN)
    ("P3 and Rac" . SPARSER::COLLECTION) ("integrin–ECM" . SPARSER::COLLECTION)
    ("Rac and/or Cdc42" . SPARSER::COLLECTION)
    ("dominant-negative mutants" . SPARSER::MUTANT)
    ("dominant-negative Rac mutants" . SPARSER::MUTANT)
    ("S5, C and D" . SPARSER::COLLECTION) ("polymers" . SPARSER::MOLECULE)
    ("Rictor-depleted cells actin-YFP" . SPARSER::COLLECTION)
    ("actin-YFP" . SPARSER::COLLECTION)
    ("shRNA or Rictor-specific" . SPARSER::COLLECTION)
    ("actin–yellow fluorescent protein" . SPARSER::COLLECTION)
    ("fibrinogen" . SPARSER::PROTEIN) ("S6K1 and AKT" . SPARSER::COLLECTION)
    ("both phosphorylated S6K1 (at threonine 389) and AKT (by 84 and 88%, respectively; xref and Supplemental Figure S4, A and B)"
     . SPARSER::COLLECTION)
    ("human primary neutrophils" . SPARSER::PROTEIN)
    ("AKTi" . SPARSER::PROTEIN) ("PKBR1 and PKBA" . SPARSER::COLLECTION)
    ("PKBA" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ACG" . SPARSER::PROTEIN)
    ("an indispensable component" . SPARSER::COMPONENT)
    ("the exogenously expressed mRNAs" . SPARSER::PROTEIN)
    ("expressed mRNAs" . SPARSER::PROTEIN) ("S4 and S5" . SPARSER::COLLECTION)
    ("Raptor-" . SPARSER::PROTEIN) ("at least two shRNAs" . SPARSER::PROTEIN)
    ("protein (GFP)" . SPARSER::PROTEIN) ("fMLP" . SPARSER::PROTEIN)
    ("primary neutrophils" . SPARSER::PROTEIN)
    ("an essential regulator" . SPARSER::PROTEIN)
    ("chemotactic neutrophils" . SPARSER::PROTEIN)
    ("RhoA-ROCK-myosin" . SPARSER::COLLECTION)
    ("yeast Torc2" . SPARSER::PROTEIN-FAMILY)
    ("Torc" . SPARSER::PROTEIN-FAMILY) ("patatin" . SPARSER::PROTEIN)
    ("mTORC2- and mTOR" . SPARSER::COLLECTION) ("mTORC2-" . SPARSER::PROTEIN)
    ("chemoattractants" . SPARSER::PROTEIN) ("Raptor" . SPARSER::PROTEIN)
    ("Chemotaxis" . SPARSER::PROTEIN)
    ("Glutathione S -transferase" . SPARSER::PROTEIN)
    ("pCDNA3" . SPARSER::PROTEIN) ("mSin 1" . SPARSER::PROTEIN)
    ("FK506" . SPARSER::DRUG) ("PI3Kγ" . SPARSER::PROTEIN)
    ("P-Rex1" . SPARSER::PROTEIN) ("SGK1" . SPARSER::PROTEIN)
    ("latrunculin B" . SPARSER::DRUG) ("Rac2" . SPARSER::PROTEIN)
    ("S6K1" . SPARSER::PROTEIN) ("PKBR1" . SPARSER::PROTEIN)
    ("YPK2" . SPARSER::PROTEIN) ("TorC2" . SPARSER::PROTEIN)
    ("AKT/protein" . SPARSER::PROTEIN) ("TORC2" . SPARSER::PROTEIN)
    ("PLA2" . SPARSER::PROTEIN) ("phospholipase A2" . SPARSER::PROTEIN)
    ("pi3k" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("mSin1" . SPARSER::PROTEIN)
    ("TRAF3IP2-_rs33980500" . SPARSER::PROTEIN-PAIR)
    ("the only psoriasis susceptibility gene" . SPARSER::PROTEIN)
    ("common variants of this gene and their association with disease"
     . SPARSER::COLLECTION)
    ("TNF receptor-associated factors TRAF3 and TRAF6" . SPARSER::COLLECTION)
    ("TRAF3 and TRAF6" . SPARSER::COLLECTION)
    ("colony-stimulating factor (GMCSF)" . SPARSER::PROTEIN)
    ("matrix-metalloproteases" . SPARSER::COLLECTION)
    ("GMCSF" . SPARSER::PROTEIN) ("NFKB" . SPARSER::PROTEIN)
    ("two intronic variants (rs13210247, rs13196377) as well as one"
     . SPARSER::COLLECTION)
    ("two intronic variants" . SPARSER::VARIANT)
    ("TRAF31P2 gene and psoriasis vulgaris" . SPARSER::COLLECTION)
    ("more severe PASI" . SPARSER::PROTEIN) ("PASI" . SPARSER::PROTEIN)
    ("ZNF750 , Rptor and TRAF31P2" . SPARSER::COLLECTION)
    ("n  " . SPARSER::PROTEIN) ("Rptor" . SPARSER::PROTEIN)
    ("ZNF750 and RPTOR" . SPARSER::COLLECTION)
    ("ZNF750 (OMIM 610226) and RPTOR (OMIM 607130)" . SPARSER::COLLECTION)
    ("PsV" . SPARSER::PROTEIN) ("TRAF3IP2-" . SPARSER::PROTEIN)
    ("RPTOR and ZNF750" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("ZNF750 , RPTOR and TRAF31P2" . SPARSER::COLLECTION)
    ("TRAF" . SPARSER::PROTEIN-FAMILY) ("RPTOR" . SPARSER::PROTEIN)
    ("CARD 14" . SPARSER::PROTEIN) ("Act1" . SPARSER::PROTEIN)
    ("ICAM1" . SPARSER::PROTEIN) ("prostaglandin E2" . SPARSER::MOLECULE)
    ("interleukin 17 receptor" . SPARSER::PROTEIN) ("Act 1" . SPARSER::PROTEIN)
    ("ORs 1" . SPARSER::PROTEIN)
    ("Regulatory-associated protein of mTOR" . SPARSER::PROTEIN)
    ("CARD14" . SPARSER::PROTEIN) ("PSORS2" . SPARSER::PROTEIN)
    ("TRAF3IP2" . SPARSER::PROTEIN) ("ZNF750" . SPARSER::PROTEIN)
    ("HELQ and XRCC2" . SPARSER::COLLECTION)
    ("RAD51C and RAD51D" . SPARSER::COLLECTION)
    ("HELQ and the RAD51 paralogs" . SPARSER::COLLECTION)
    ("RAD17 and TOPBP1" . SPARSER::COLLECTION)
    ("SLX4 and FAN1" . SPARSER::COLLECTION) ("FANCP" . SPARSER::PROTEIN)
    ("FANC" . SPARSER::PROTEIN)
    ("The HELQ-associated protein RAD51C" . SPARSER::PROTEIN)
    ("FANCO" . SPARSER::PROTEIN) ("helq" . SPARSER::PROTEIN)
    ("spn" . SPARSER::PROTEIN) ("HELQ and RAD51" . SPARSER::COLLECTION)
    ("BCDX2 and CX3" . SPARSER::COLLECTION) ("only one DNA" . SPARSER::DNA)
    ("damage-induced SCE" . SPARSER::PROTEIN) ("Rad51d" . SPARSER::PROTEIN)
    ("ATR and XRCC2" . SPARSER::COLLECTION)
    ("GFP-tagged HELQ and Flag-tagged XRCC2" . SPARSER::COLLECTION)
    ("HELQ and DsRed-Monomer-tagged" . SPARSER::COLLECTION)
    ("ATR and DsRed-Monomer-tagged" . SPARSER::COLLECTION)
    ("DsRed-Monomer-tagged RAD51B and endogenous ATR" . SPARSER::COLLECTION)
    ("DsRed-Monomer-tagged RAD51B" . SPARSER::PROTEIN)
    ("Monomer" . SPARSER::MONOMER) ("DsRed" . SPARSER::PROTEIN)
    ("DNase/RNase" . SPARSER::COLLECTION)
    ("ATR and BCDX2" . SPARSER::COLLECTION) ("BCDX2" . SPARSER::PROTEIN)
    ("HELQ-ATR" . SPARSER::COLLECTION) ("HELQ-BCDX2" . SPARSER::PROTEIN-PAIR)
    ("RAD51, or DNA polymerase" . SPARSER::COLLECTION)
    ("RAD51B, RAD51C, RAD51D and HELQ" . SPARSER::COLLECTION)
    ("RAD51B (22) and RAD51C (18)" . SPARSER::COLLECTION)
    ("XRCC2 (25), HELQ (47), RAD51D (23), RAD51B (22) and RAD51C (18)"
     . SPARSER::COLLECTION)
    ("unique peptides" . SPARSER::PEPTIDE)
    ("RAD51C and XRCC3" . SPARSER::COLLECTION) ("POLN" . SPARSER::PROTEIN)
    ("Flag-HA" . SPARSER::COLLECTION)
    ("The DNA damage-responsive kinase ATR and its partner ATRIP"
     . SPARSER::COLLECTION)
    ("The DNA damage-responsive kinase ATR" . SPARSER::PROTEIN)
    ("ATRIP" . SPARSER::PROTEIN)
    ("RAD51B, RAD51C, RAD51D and XRCC2" . SPARSER::COLLECTION)
    ("Flag and HA" . SPARSER::COLLECTION)
    ("associated proteins" . SPARSER::PROTEIN)
    ("HELQ and FA" . SPARSER::COLLECTION)
    ("olaparib or UV irradiation ( xref and xref )" . SPARSER::COLLECTION)
    ("MMC and cisplatin" . SPARSER::COLLECTION) ("olaparib" . SPARSER::DRUG)
    ("a candidate ovarian cancer predisposition gene" . SPARSER::PROTEIN)
    ("subsequent factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("streptavidin–biotin" . SPARSER::PROTEIN-PAIR)
    ("BRIP1 (also known as FANCJ) and FANCM" . SPARSER::COLLECTION)
    ("FANCM" . SPARSER::PROTEIN) ("FANCJ" . SPARSER::PROTEIN)
    ("Helicase" . SPARSER::PROTEIN)
    ("RAD51B, RAD51C, RAD51D, XRCC2 and XRCC3" . SPARSER::COLLECTION)
    ("nitrogen mustards and derivatives (melphalan and chlorambucil) and nitrosoureas"
     . SPARSER::COLLECTION)
    ("derivatives (melphalan and chlorambucil) and nitrosoureas"
     . SPARSER::COLLECTION)
    ("melphalan and chlorambucil" . SPARSER::COLLECTION)
    ("chlorambucil" . SPARSER::DRUG) ("melphalan" . SPARSER::DRUG)
    ("mustards" . SPARSER::DRUG) ("psoralens" . SPARSER::DRUG)
    ("ATR and RAD51" . SPARSER::COLLECTION)
    ("a candidate ovarian cancer gene" . SPARSER::PROTEIN)
    ("the DNA damage-responsive kinase ATR" . SPARSER::PROTEIN)
    ("Fanconi" . SPARSER::PROTEIN-FAMILY) ("mitomycin C (MMC)" . SPARSER::DRUG)
    ("MMC" . SPARSER::PROTEIN) ("ICL" . SPARSER::PROTEIN)
    ("ICLs" . SPARSER::PROTEIN) ("HELQ" . SPARSER::PROTEIN)
    ("CA5" . SPARSER::PROTEIN) ("β -mercaptoethanol" . SPARSER::MOLECULE)
    ("TOPBP1" . SPARSER::PROTEIN) ("RAD17" . SPARSER::PROTEIN)
    ("FANCD2/FANCI-associated nuclease 1" . SPARSER::PROTEIN)
    ("FAN1" . SPARSER::PROTEIN) ("SLX4" . SPARSER::PROTEIN)
    ("RFS-1" . SPARSER::PROTEIN) ("Rad54" . SPARSER::PROTEIN)
    ("Xrcc3" . SPARSER::PROTEIN) ("CX3" . SPARSER::PROTEIN)
    ("FANCD2" . SPARSER::PROTEIN) ("HEL308" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN) ("RAD51D" . SPARSER::PROTEIN)
    ("RAD51C" . SPARSER::PROTEIN) ("RAD51B" . SPARSER::PROTEIN)
    ("MCC" . SPARSER::PROTEIN) ("AH" . SPARSER::MOLECULE)
    ("NKD" . SPARSER::PROTEIN) ("GL" . SPARSER::PROTEIN)
    ("FGR" . SPARSER::PROTEIN) ("FGF10 and FGFR2b" . SPARSER::COLLECTION)
    ("mesenchymal components" . SPARSER::COMPONENT)
    ("muscle-specific actin, cytokeratin, thyroid transcription factor 1, and S100 protein"
     . SPARSER::PROTEIN)
    ("actin, cytokeratin, thyroid transcription factor 1, and S100"
     . SPARSER::COLLECTION)
    ("myogenin" . SPARSER::PROTEIN)
    ("small mesenchymal foci" . SPARSER::PROTEIN) ("septa" . SPARSER::PROTEIN)
    ("desmin and Ki-67" . SPARSER::COLLECTION) ("desmin" . SPARSER::PROTEIN)
    ("Desmin and Ki-67" . SPARSER::COLLECTION) ("Desmin" . SPARSER::PROTEIN)
    ("nos" . SPARSER::PROTEIN) ("Sonic Hedgehog (SHH)" . SPARSER::PROTEIN)
    ("a diffusible factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a mesenchymal growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyst" . SPARSER::PROTEIN) ("type I or type II" . SPARSER::COLLECTION)
    ("FGF10, FGFR2b, or SHH" . SPARSER::COLLECTION)
    ("Type I and type II" . SPARSER::COLLECTION)
    ("FGF10, FGFR2b, and SHH" . SPARSER::COLLECTION)
    ("FGF10, its receptor FGFR2b, and its inhibitor sonic hedgehog (SHH)"
     . SPARSER::COLLECTION)
    ("sonic hedgehog (SHH)" . SPARSER::PROTEIN)
    ("Sonic hedgehog" . SPARSER::PROTEIN)
    ("Fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("FGF-10" . SPARSER::PROTEIN) ("FGF7" . SPARSER::PROTEIN)
    ("2b" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sonic Hedgehog" . SPARSER::PROTEIN) ("FGF10" . SPARSER::PROTEIN)
    ("32D-hPrlR and 32D-hGHR" . SPARSER::COLLECTION) ("MAG" . SPARSER::PROTEIN)
    ("THT" . SPARSER::MOLECULE) ("BF" . SPARSER::PROTEIN)
    ("ARP" . SPARSER::PROTEIN) ("hPrlR" . SPARSER::PROTEIN)
    ("pHe" . SPARSER::AMINO-ACID)
    ("prolactin-Jak2-Stat5" . SPARSER::COLLECTION) ("Prl" . SPARSER::PROTEIN)
    ("the full-length or ‘long’ PrlR" . SPARSER::COLLECTION)
    ("‘intermediate’ and ‘short’ PrlR isoforms" . SPARSER::ISOFORM)
    ("PrlRs and GHRs" . SPARSER::COLLECTION) ("GHRs" . SPARSER::PROTEIN)
    ("PrlRs" . SPARSER::PROTEIN) ("hPrlRs" . SPARSER::PROTEIN)
    ("prolactin and its cognate receptor" . SPARSER::COLLECTION)
    ("prolactin receptor and Stat5" . SPARSER::COLLECTION)
    ("heterogeneous GLUT1" . SPARSER::PROTEIN)
    ("regional hypoxia" . SPARSER::PROTEIN)
    ("generally homogenous GLUT1" . SPARSER::PROTEIN)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("epithelial GLUT1" . SPARSER::PROTEIN)
    ("pYStat5 and GLUT1" . SPARSER::COLLECTION)
    ("exogenous human prolactin" . SPARSER::PROTEIN)
    ("PrlR and Stat5" . SPARSER::COLLECTION)
    ("GLUT1 and the key glycolytic enzyme" . SPARSER::COLLECTION)
    ("Stat5a, Stat5b and PrlR" . SPARSER::COLLECTION)
    ("displayed reduced Nuc-pYStat5" . SPARSER::COLLECTION)
    ("pYStat5 or GLUT1" . SPARSER::COLLECTION) ("pYStat5" . SPARSER::PROTEIN)
    ("Nuc-pYStat5" . SPARSER::COLLECTION)
    ("pH e 7.4 or pH e 6.8" . SPARSER::COLLECTION)
    ("the alternate pH" . SPARSER::PROTEIN)
    ("Stat5, Jak2 and Erk" . SPARSER::COLLECTION)
    ("ligand-receptor" . SPARSER::PROTEIN)
    ("GHR and PrlR" . SPARSER::COLLECTION) ("GH-hPrlR" . SPARSER::PROTEIN-PAIR)
    ("GHR or hPrlR" . SPARSER::COLLECTION) ("GHR" . SPARSER::PROTEIN)
    ("growth hormone (GH)" . SPARSER::PROTEIN)
    ("pH e 7.4" . SPARSER::PROTEIN-FAMILY)
    ("c-jun and CISH" . SPARSER::COLLECTION)
    ("the proinflammatory cytokine" . SPARSER::PROTEIN)
    ("OSM" . SPARSER::PROTEIN) ("normal pH" . SPARSER::PROTEIN)
    ("Stat5, Erk and Akt" . SPARSER::COLLECTION)
    ("pH e 6.8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pH e 7.0" . SPARSER::PROTEIN-FAMILY)
    ("a pathophysiological pH" . SPARSER::PROTEIN)
    ("Stat5 and Erk" . SPARSER::COLLECTION)
    ("Stat3 and Erk" . SPARSER::COLLECTION) ("Stat5a" . SPARSER::PROTEIN)
    ("GLUT1 or Nuc-pYStat5" . SPARSER::COLLECTION) ("PrlR" . SPARSER::PROTEIN)
    ("AQUA" . SPARSER::MOLECULE) ("Stat5 and GLUT1" . SPARSER::COLLECTION)
    ("Prolactin" . SPARSER::PROTEIN) ("exogenous prolactin" . SPARSER::PROTEIN)
    ("receptors and Stat5" . SPARSER::COLLECTION)
    ("GLUT1 and Nuc-pYStat5" . SPARSER::COLLECTION)
    ("epidermal growth factor, oncostatin M, IGF1, FGF or growth hormone"
     . SPARSER::COLLECTION)
    ("quantitative immunofluorescence protein" . SPARSER::PROTEIN)
    ("prolactin-Stat5" . SPARSER::COLLECTION) ("antiestrogen" . SPARSER::DRUG)
    ("Nuc" . SPARSER::PROTEIN) ("prolactin" . SPARSER::PROTEIN)
    ("growth hormone receptor" . SPARSER::PROTEIN)
    ("Cathepsin D" . SPARSER::PROTEIN) ("cathepsin D" . SPARSER::PROTEIN)
    ("PTP1B" . SPARSER::PROTEIN) ("GH receptor" . SPARSER::PROTEIN)
    ("Prolactin receptor" . SPARSER::PROTEIN) ("e 7" . SPARSER::PROTEIN-FAMILY)
    ("signal transducer and activator of transcription-5" . SPARSER::PROTEIN)
    ("e 6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LDH5" . SPARSER::PROTEIN)
    ("1A2" . SPARSER::PROTEIN) ("MIB-1" . SPARSER::PROTEIN)
    ("1D" . SPARSER::PROTEIN) ("Stat5b" . SPARSER::PROTEIN)
    ("lactic acid" . SPARSER::MOLECULE) ("growth hormone" . SPARSER::PROTEIN)
    ("Stat5" . SPARSER::PROTEIN)
    ("mammalian functional homologues" . SPARSER::PROTEIN)
    ("conjugated ubiquitin and several cell cycle-regulating cyclins"
     . SPARSER::COLLECTION)
    ("p53–Hsp70–Mdm2" . SPARSER::COLLECTION)
    ("p53 and its paralogues, p63 and p73" . SPARSER::COLLECTION)
    ("up new possible targets" . SPARSER::TARGET-PROTEIN)
    ("sink" . SPARSER::PROTEIN) ("polyanions" . SPARSER::MOLECULE)
    ("p53 family, p63 and p73" . SPARSER::COLLECTION)
    ("intra-protein" . SPARSER::PROTEIN-PAIR)
    ("A11 and anti-p53" . SPARSER::COLLECTION) ("DO" . SPARSER::PROTEIN)
    ("diphenyl" . SPARSER::DRUG) ("AFM" . SPARSER::PROTEIN) ("types " . TYPE)
    ("tau and α-synuclein" . SPARSER::COLLECTION)
    ("sporadic prion" . SPARSER::PROTEIN-FAMILY)
    ("Oligomers" . SPARSER::PROTEIN) ("IAPP" . SPARSER::PROTEIN)
    ("huntingtin" . SPARSER::PROTEIN) ("ALS" . SPARSER::PROTEIN)
    ("HEC" . SPARSER::PROTEIN) ("/integrin" . SPARSER::COLLECTION)
    ("The last two classes" . CLASS) ("an aggressive class" . CLASS)
    ("ER−, PR− and HER2−" . SPARSER::COLLECTION)
    ("aflatoxin" . SPARSER::MOLECULE) ("Rb and BRCA1" . SPARSER::COLLECTION)
    ("A common ancestral gene" . SPARSER::GENE)
    ("TP53 , TP63 and TP73" . SPARSER::COLLECTION)
    ("an internal promoter" . SPARSER::PROMOTER)
    ("‘oncogene’" . SPARSER::ONCOGENE)
    ("sequestering WT p53 and other proteins" . SPARSER::COLLECTION)
    ("PMDs" . SPARSER::PROTEIN) ("proteasomes" . SPARSER::PROTEIN)
    ("a tetrameric nuclear phosphoprotein" . SPARSER::PROTEIN)
    ("p300 " . SPARSER::PROTEIN) ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-amyloid" . SPARSER::MOLECULE)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("islet amyloid polypeptide" . SPARSER::PROTEIN)
    ("Type 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p63 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("TP73" . SPARSER::PROTEIN)
    ("TP63" . SPARSER::PROTEIN) ("p53s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 " . SPARSER::PROTEIN) ("double minute 2" . SPARSER::PROTEIN)
    ("WW45/Sav1" . SPARSER::COLLECTION) ("perhaps" . SPARSER::PROTEIN)
    ("luciferase and ChIP" . SPARSER::COLLECTION)
    ("ApoE, AREG , and TGF β" . SPARSER::COLLECTION)
    ("a transcriptionally active nuclear complex" . SPARSER::BIO-COMPLEX)
    ("Patj/Mupp1" . SPARSER::COLLECTION)
    ("the junctional protein ZO2" . SPARSER::PROTEIN)
    ("Sequential ChIP" . SPARSER::PROTEIN)
    ("ApoE, AREG , and TGFB1" . SPARSER::COLLECTION)
    ("AREG (which encodes amphiregulin) and TGFB1 [which encodes transforming growth factor–β1 (TGFβ1)]"
     . SPARSER::COLLECTION)
    ("AREG" . SPARSER::PROTEIN)
    ("an Amot/Yap negatively co-regulated gene" . SPARSER::PROTEIN)
    ("ApoE" . SPARSER::PROTEIN) ("GTIIC-luciferase" . SPARSER::COLLECTION)
    ("top-ranked Amot-regulated genes and top-ranked Yap-regulated genes ( xref )"
     . SPARSER::COLLECTION)
    ("Amot-KD" . SPARSER::COLLECTION) ("sh-Amot" . SPARSER::PROTEIN-PAIR)
    ("Lats1 or Mst2" . SPARSER::COLLECTION)
    ("Amot-p80 and Amot-p130 in HEK293 cells" . SPARSER::COLLECTION)
    ("showed negligible Amot" . SPARSER::PROTEIN)
    ("the deleted Amot allele" . SPARSER::ALLELE) ("OPN" . SPARSER::PROTEIN)
    ("KO, and DKO" . SPARSER::COLLECTION)
    ("Nf2 and/or Amot" . SPARSER::COLLECTION)
    ("hepatocytes and BECs" . SPARSER::COLLECTION)
    ("Nf2 and Amot" . SPARSER::COLLECTION) ("Nf2:Amot" . SPARSER::BIO-COMPLEX)
    ("BEC" . SPARSER::MOLECULE) ("BECs" . SPARSER::MOLECULE)
    ("DDC" . SPARSER::PROTEIN) (":Amot" . SPARSER::BIO-COMPLEX)
    ("CTGF (which encodes connective tissue growth factor) and Cyr61 (which encodes cysteine-rich, angiogenic inducer, 61)"
     . SPARSER::COLLECTION)
    ("AmotL1, and AmotL2—but not" . SPARSER::COLLECTION)
    ("Amot-p80" . SPARSER::COLLECTION) ("MOB" . SPARSER::PROTEIN)
    ("Kibra" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Merlin" . SPARSER::PROTEIN)
    ("AmotL1 and AmotL2" . SPARSER::COLLECTION)
    ("tight junction proteins Patj [protein associated with lin seven 1 (PALS1)–associated tight junction protein] and Mupp1 (multiple PDZ domain protein 1)"
     . SPARSER::COLLECTION)
    ("lin" . SPARSER::PROTEIN) ("Patj" . SPARSER::PROTEIN)
    ("synectin" . SPARSER::PROTEIN) ("Syx" . SPARSER::PROTEIN)
    ("p80 and p130" . SPARSER::COLLECTION) ("angiostatin" . SPARSER::PROTEIN)
    ("Angiomotin" . SPARSER::PROTEIN) ("Amot-p130" . SPARSER::COLLECTION)
    ("Amot" . SPARSER::PROTEIN) ("angiomotin" . SPARSER::PROTEIN)
    ("KC1" . SPARSER::PROTEIN) ("TEAD2" . SPARSER::PROTEIN)
    ("TEAD3" . SPARSER::PROTEIN) ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Yap2" . SPARSER::PROTEIN) ("ZO2" . SPARSER::PROTEIN)
    ("transforming growth factor–β1" . SPARSER::PROTEIN)
    ("TGFB1" . SPARSER::PROTEIN) ("Tead4" . SPARSER::PROTEIN)
    ("Tead1" . SPARSER::PROTEIN) ("LY1" . SPARSER::PROTEIN)
    ("NF2" . SPARSER::PROTEIN) ("CK19" . SPARSER::PROTEIN)
    ("cytokeratin 19" . SPARSER::PROTEIN) ("Cyr61" . SPARSER::PROTEIN)
    ("activator 1" . SPARSER::PROTEIN) ("WW45" . SPARSER::PROTEIN)
    ("large tumor suppressor" . SPARSER::PROTEIN) ("STE20" . SPARSER::PROTEIN)
    ("Rich1" . SPARSER::PROTEIN) ("Mupp1" . SPARSER::PROTEIN)
    ("PALS1" . SPARSER::PROTEIN) ("member A" . SPARSER::PROTEIN)
    ("Ras homolog gene family" . SPARSER::PROTEIN) ("p80" . SPARSER::PROTEIN)
    ("AmotL2" . SPARSER::PROTEIN) ("AmotL1" . SPARSER::PROTEIN)
    ("Nf2" . SPARSER::PROTEIN) ("thiol" . SPARSER::MOLECULE)
    ("otherwise inhibited cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("active and inactive" . SPARSER::COLLECTION)
    ("proper chemotaxis" . SPARSER::PROTEIN)
    ("phospholipase C and LIM" . SPARSER::COLLECTION)
    ("quantitatively more active cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WT cofilin and the cysteine mutants" . SPARSER::COLLECTION)
    ("NMR and Mal-PEGylation" . SPARSER::COLLECTION)
    ("these oligomeric protein" . SPARSER::PROTEIN)
    ("reduced WT cofilin and the cofilin cysteine mutants"
     . SPARSER::COLLECTION)
    ("cofilin and CD3" . SPARSER::COLLECTION)
    ("F-actin and cofilin enrichment" . SPARSER::COLLECTION)
    ("even PIP 2 -bound cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DTT-treated cofilin" . SPARSER::PROTEIN) ("Da" . SPARSER::MOLECULE)
    ("anti-CD3/CD28" . SPARSER::COLLECTION) ("ME" . SPARSER::PROTEIN)
    ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mutants" . SPARSER::MUTANT)
    ("Cysteine" . SPARSER::AMINO-ACID)
    ("cofilin and cofilin" . SPARSER::COLLECTION)
    ("cofilin (PDB)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bank (BMRB)" . SPARSER::PROTEIN) ("Bank" . SPARSER::PROTEIN)
    ("Mal-PEG" . SPARSER::COLLECTION) ("Mal" . SPARSER::PROTEIN)
    ("PBT" . SPARSER::PROTEIN)
    ("IAA-treated recombinant cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cysteines" . SPARSER::AMINO-ACID) ("thiols" . SPARSER::MOLECULE)
    ("diacylglycerol and phosphatidylinositol" . SPARSER::COLLECTION)
    ("Amino acids" . SPARSER::AMINO-ACID)
    ("reducing agent" . SPARSER::MOLECULE)
    ("staphylococcal enterotoxin B" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("serine 3" . SPARSER::PROTEIN)
    ("Epithelial growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epithelial growth factor receptor (EGFR)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA-binding protein" . SPARSER::PROTEIN)
    ("thyroid transcription factor 1" . SPARSER::PROTEIN)
    ("PFS 1" . SPARSER::PROTEIN)
    ("Thyroid transcription factor 1" . SPARSER::PROTEIN)
    ("PB" . SPARSER::PROTEIN) ("possibly other DNMTs" . SPARSER::PROTEIN)
    ("trypsin- and caspase-like" . SPARSER::COLLECTION)
    ("trypsin-" . SPARSER::PROTEIN)
    ("selectively targets DNMT1 and DNMT3B" . SPARSER::COLLECTION)
    ("selectively target DNMT1 and DNMT3B" . SPARSER::COLLECTION)
    ("cytidine" . SPARSER::MOLECULE) ("PC3 or BPH1" . SPARSER::COLLECTION)
    ("DNMT and RASSF1A" . SPARSER::COLLECTION)
    ("androgen-receptor" . SPARSER::COLLECTION)
    ("DNMT1, DNMT3B and Akt" . SPARSER::COLLECTION)
    ("Phosphoinositide 3-kinase or PI3K" . SPARSER::COLLECTION)
    ("mahanine and MG132" . SPARSER::COLLECTION)
    ("chymotrypsin-like, trypsin-like, and caspase-like" . SPARSER::COLLECTION)
    ("LNCaP and PC3" . SPARSER::COLLECTION)
    ("LNCaP or PC3" . SPARSER::COLLECTION)
    ("DNMT1, DNMT3A and DNMT3B" . SPARSER::COLLECTION)
    ("methylated RASSF1A promoter" . SPARSER::PROMOTER)
    ("PC3 and LNCaP" . SPARSER::COLLECTION)
    ("neutral aqueous solution" . SPARSER::MOLECULE)
    ("azacytidine" . SPARSER::DRUG) ("azacitidine" . SPARSER::DRUG)
    ("hepatocellular, acute and chronic myelogenous leukemia"
     . SPARSER::PROTEIN)
    ("DNMT3A and DNMT3B" . SPARSER::COLLECTION) ("DNMTs" . SPARSER::PROTEIN)
    ("Mahanine" . SPARSER::DRUG) ("DNMT1 and DNMT3B" . SPARSER::COLLECTION)
    ("alkaloid" . SPARSER::MOLECULE) ("mahanine" . SPARSER::DRUG)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("penicillin G" . SPARSER::MOLECULE)
    ("Phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("chymotrypsin-like" . SPARSER::PROTEIN) ("S1B" . SPARSER::PROTEIN)
    ("BPH1" . SPARSER::PROTEIN) ("family 1" . SPARSER::PROTEIN)
    ("di-nucleotides" . SPARSER::MOLECULE) ("DNMT3A" . SPARSER::PROTEIN)
    ("deafness and KIT" . SPARSER::COLLECTION) ("severe form" . SPARSER::FORM)
    ("the homozygous variant p" . SPARSER::PROTEIN)
    ("the severe form" . SPARSER::FORM)
    ("the most severe forms" . SPARSER::FORM)
    ("relatively mild form" . SPARSER::FORM) ("KITLG" . SPARSER::PROTEIN)
    ("4 heterozygous variants" . SPARSER::VARIANT)
    ("deafness" . SPARSER::PROTEIN) ("obvious patch" . SPARSER::PROTEIN)
    ("XX" . SPARSER::PROTEIN) ("the homozygous p" . SPARSER::PROTEIN)
    ("a homozygous variant p" . SPARSER::PROTEIN) ("mild form" . SPARSER::FORM)
    ("KIT and MC1R" . SPARSER::COLLECTION)
    ("the homogeneous MC1R (a gene which is associated with the hair color) variant"
     . SPARSER::VARIANT)
    ("KIT ligand" . SPARSER::PROTEIN) ("TK2" . SPARSER::PROTEIN)
    ("TK1" . SPARSER::PROTEIN)
    ("stem cell growth factor receptor" . SPARSER::PROTEIN)
    ("MC1R" . SPARSER::PROTEIN) ("GLUT1 and HK2" . SPARSER::COLLECTION)
    ("PGK1, PKM1, and LDHA" . SPARSER::COLLECTION)
    ("HIF-1 and Myc" . SPARSER::COLLECTION)
    ("GLUT1, HK2, PGK1, LDHA, PDK1, and PK" . SPARSER::COLLECTION)
    ("the key enzyme PDH and its inhibitory kinase PDK1 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("-oncogene" . SPARSER::ONCOGENE) ("GLUT1 and SGLT1" . SPARSER::COLLECTION)
    ("GLUT1, HK2, PGK1, and PKM2" . SPARSER::COLLECTION)
    ("potentially increased nucleotides and NADPH synthesis"
     . SPARSER::COLLECTION)
    ("NADPH and ribose-5-phosphate" . SPARSER::COLLECTION)
    ("dehydrogenase (PDH)" . SPARSER::PROTEIN)
    ("acetyl-CoA and oxaloacetate" . SPARSER::COLLECTION)
    ("PDH" . SPARSER::PROTEIN) ("oxaloacetate" . SPARSER::MOLECULE)
    ("-glucose" . SPARSER::COLLECTION) ("kinase (PK)" . SPARSER::KINASE)
    ("PEP" . SPARSER::PROTEIN) ("phosphoenolpyruvate" . SPARSER::MOLECULE)
    ("PKM" . SPARSER::PROTEIN) ("Pyruvate" . SPARSER::PROTEIN)
    ("phosphoglycerate" . SPARSER::MOLECULE)
    ("glucose transporters and glycolytic inhibitors" . SPARSER::COLLECTION)
    ("other chemotherapeutic drugs" . SPARSER::DRUG)
    ("glucose transporters and glycolytic enzymes" . SPARSER::COLLECTION)
    ("NADPH" . SPARSER::PROTEIN) ("pentose" . SPARSER::MOLECULE)
    ("NMR, and gene" . SPARSER::COLLECTION) ("HIF-1" . SPARSER::PROTEIN)
    ("Complex I" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("G6PD" . SPARSER::PROTEIN)
    ("pyruvate dehydrogenase kinase 1" . SPARSER::PROTEIN)
    ("lactate dehydrogenase A" . SPARSER::PROTEIN)
    ("Phosphoglycerate kinase 1" . SPARSER::PROTEIN) ("HK2" . SPARSER::PROTEIN)
    ("hexokinase 2" . SPARSER::PROTEIN) ("SGLT1" . SPARSER::PROTEIN)
    ("H-ras" . SPARSER::PROTEIN) ("α-ketoglutarate" . SPARSER::MOLECULE)
    ("pyruvate carboxylase" . SPARSER::PROTEIN) ("M+6" . SPARSER::PROTEIN)
    ("M+2" . SPARSER::MOLECULE) ("K- ras" . SPARSER::PROTEIN)
    ("H- ras" . SPARSER::PROTEIN)
    ("the very strong MIR143 promoter" . SPARSER::PROMOTER)
    ("ALU" . SPARSER::PROTEIN)
    ("inherited glomuvenous malformations" . SPARSER::PROTEIN)
    ("SNP-chip" . SPARSER::COLLECTION) ("GVMs" . SPARSER::PROTEIN)
    ("NICD" . SPARSER::PROTEIN) ("NOTCH1 and NOTCH2" . SPARSER::COLLECTION)
    ("a strong promoter" . SPARSER::PROMOTER) ("calponin" . SPARSER::PROTEIN)
    ("GLMN" . SPARSER::PROTEIN) ("glomulin" . SPARSER::PROTEIN)
    ("p22" . SPARSER::PROTEIN) ("LMS" . SPARSER::PROTEIN)
    ("morphologic types" . TYPE) ("the Strong Promoter" . SPARSER::PROMOTER)
    ("Subtypes" . SPARSER::PROTEIN) ("NOTCH2 and NOTCH3" . SPARSER::COLLECTION)
    ("centromeric part" . SPARSER::COMPONENT)
    ("a benign GT component" . SPARSER::COMPONENT)
    ("a malignant GT" . SPARSER::PROTEIN)
    ("Only two NOTCH2-" . SPARSER::PROTEIN) ("NOTCH2-" . SPARSER::PROTEIN)
    ("a benign soft tissue GT" . SPARSER::PROTEIN)
    ("MIR143-NOTCH1" . SPARSER::COLLECTION)
    ("-GGAACAATCAATCGACCAACTCC-3" . SPARSER::COLLECTION)
    ("-CTGCTCCTCCCCACTTCC-3" . SPARSER::COLLECTION)
    ("NOTCH2-CEP128" . SPARSER::COLLECTION)
    ("NOTCH2 and MIR143" . SPARSER::COLLECTION) ("MIR143" . SPARSER::PROTEIN)
    ("a malignant gastrointestinal GT" . SPARSER::PROTEIN)
    ("MIR143-NOTCH2" . SPARSER::COLLECTION)
    ("NOTCH1 or NOTCH2" . SPARSER::COLLECTION)
    ("benign soft tissue GT" . SPARSER::PROTEIN)
    ("GT1 or NOTCH1" . SPARSER::COLLECTION) ("GT1" . SPARSER::PROTEIN)
    ("arm 1" . SPARSER::PROTEIN) ("SM-MHC" . SPARSER::PROTEIN)
    ("GLI1" . SPARSER::PROTEIN) ("Micro-RNA" . SPARSER::MICRO-RNA)
    ("GT1 as" . SPARSER::MOLECULE) ("NOTCH3" . SPARSER::PROTEIN)
    ("GT2" . SPARSER::PROTEIN)
    ("peritumoral lymphocytic inflammation and mutant K-RAS"
     . SPARSER::PROTEIN)
    ("ASP" . SPARSER::PROTEIN) ("IRF1 and EGFR" . SPARSER::COLLECTION)
    ("airway epithelial IRF1 and IFN-λ" . SPARSER::COLLECTION)
    ("IRF3 and IRF7" . SPARSER::COLLECTION)
    ("Gefitinib and IRF1" . SPARSER::COLLECTION)
    ("IFN-λ receptor (IFN-λR) and virus-induced IFN-λ" . SPARSER::COLLECTION)
    ("Abs" . SPARSER::PROTEIN) ("IFN-α or IFN-β" . SPARSER::COLLECTION)
    ("ROS and MP" . SPARSER::COLLECTION) ("EGFR-p" . SPARSER::COLLECTION)
    ("EGFR, and EGFR" . SPARSER::COLLECTION)
    ("IRF1, IRF3, and IRF7" . SPARSER::COLLECTION) ("IRFs" . SPARSER::PROTEIN)
    ("the primary IFN" . SPARSER::PROTEIN)
    ("metalloproteinase (MP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ErbB1/HER1" . SPARSER::COLLECTION)
    ("IRF1 and IFN-λ" . SPARSER::COLLECTION) ("IRF" . SPARSER::PROTEIN)
    ("Interferon" . SPARSER::PROTEIN)
    ("epithelial epidermal growth factor receptor (EGFR)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RV" . SPARSER::PROTEIN) ("IFN-λ1" . SPARSER::PROTEIN)
    ("IL-29" . SPARSER::PROTEIN) ("1B" . SPARSER::PROTEIN)
    ("IL-10R" . SPARSER::PROTEIN) ("IFN α" . SPARSER::PROTEIN)
    ("poly I:C" . SPARSER::MOLECULE) ("AG 1478" . SPARSER::DRUG)
    ("NADP +" . SPARSER::MOLECULE) ("IRF1" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase (ALDH)" . SPARSER::PROTEIN)
    ("a commercially used water-soluble form" . SPARSER::FORM)
    ("anti-IGF-1R/EMT" . SPARSER::COLLECTION) ("meglumine" . SPARSER::MOLECULE)
    ("Silibinin" . SPARSER::DRUG) ("silymarin" . SPARSER::DRUG)
    ("silibinin" . SPARSER::DRUG)
    ("exogenous TGFβ1 and erlotinib" . SPARSER::COLLECTION)
    ("TGFβ1 and erlotinib" . SPARSER::COLLECTION)
    ("TGFβ1 and IGF-1R" . SPARSER::COLLECTION)
    ("pro-apoptotic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SNAIL" . SPARSER::PROTEIN) ("figitumumab" . SPARSER::DRUG)
    ("IGFBP-3 and IGFBP-4" . SPARSER::COLLECTION)
    ("mutant-selective EGFR inhibitors and irreversible quinazoline EGFR inhibitors"
     . SPARSER::COLLECTION)
    ("MET-" . SPARSER::PROTEIN)
    ("the tight junctional protein E-cadherin" . SPARSER::PROTEIN)
    ("the mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("the mesenchymal adhesion protein vimentin" . SPARSER::PROTEIN)
    ("TGFβ1 and IGF1R" . SPARSER::COLLECTION) ("pro-EMT" . SPARSER::COLLECTION)
    ("the mesenchymal-specific marker vimentin" . SPARSER::PROTEIN)
    ("CDH1 and OCLN" . SPARSER::COLLECTION)
    ("occludin or zonula" . SPARSER::COLLECTION) ("zonula" . SPARSER::PROTEIN)
    ("occludin" . SPARSER::PROTEIN) ("OCLN" . SPARSER::PROTEIN)
    ("progressive EMT" . SPARSER::PROTEIN)
    ("SNAIL1 and SLUG" . SPARSER::COLLECTION)
    ("the cytoskeletal protein vinculin" . SPARSER::PROTEIN)
    ("the cytoskeletal protein F-actin" . SPARSER::BIO-COMPLEX)
    ("erlotinib and I-OMe-AG538" . SPARSER::COLLECTION)
    ("a cell-permeable analog of tyrphostin AG538 and potent inhibitor of the IGF-1R kinase activity"
     . SPARSER::COLLECTION)
    ("a cell-permeable analog" . SPARSER::ANALOG)
    ("tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and IGF-1R" . SPARSER::COLLECTION)
    ("delE746-A750" . SPARSER::PROTEIN) ("secondary BRAF" . SPARSER::PROTEIN)
    ("MET, AXL, and HER2" . SPARSER::COLLECTION) ("track" . SPARSER::PROTEIN)
    ("the selective EGFR TK inhibitors (TKIs) gefitinib (Iressa™) and erlotinib (Tarceva™) xref  xref  xref  xref"
     . SPARSER::COLLECTION)
    ("Tarceva" . SPARSER::DRUG) ("IGF-1R and EMT" . SPARSER::COLLECTION)
    ("the TGFβ1's" . SPARSER::PROTEIN) ("IGF-1R/EMT" . SPARSER::COLLECTION)
    ("FN1" . SPARSER::PROTEIN) ("TCF3" . SPARSER::PROTEIN)
    ("KRT19" . SPARSER::PROTEIN) ("KRT14" . SPARSER::PROTEIN)
    ("IGFR-1" . SPARSER::PROTEIN) ("IGFBP-4" . SPARSER::PROTEIN)
    ("IGFBP-3" . SPARSER::PROTEIN) ("PC9" . SPARSER::PROTEIN)
    ("SNAIL2" . SPARSER::PROTEIN) ("SNAIL1" . SPARSER::PROTEIN)
    ("AG1024" . SPARSER::DRUG) ("GAS6" . SPARSER::PROTEIN)
    ("TGFβ1" . SPARSER::PROTEIN)
    ("Transforming Growth Factor-beta1" . SPARSER::PROTEIN)
    ("Insulin-like Growth Factor-1" . SPARSER::PROTEIN)
    ("preferentially trigger BIR" . SPARSER::PROTEIN) ("avid" . SPARSER::DRUG)
    ("MM-BIR" . SPARSER::COLLECTION) ("BIR—perhaps" . SPARSER::PROTEIN-PAIR)
    ("A key trigger" . SPARSER::PROTEIN)
    ("the Mre11 nuclease and the CtIP homolog" . SPARSER::COLLECTION)
    ("Brca1, CtIP and Exo1" . SPARSER::COLLECTION)
    ("somatic HR" . SPARSER::PROTEIN) ("a key antagonist" . SPARSER::MOLECULE)
    ("STGC/LTGC" . SPARSER::PROTEIN)
    ("four independent one-ended RFP-SCR reporter Brca1  Δ/mut"
     . SPARSER::COLLECTION)
    ("Brca1/CtIP" . SPARSER::COLLECTION)
    ("BRCA1, BARD1 or CtIP" . SPARSER::COLLECTION)
    ("BRCA1/BARD1/CtIP" . SPARSER::COLLECTION)
    ("Luciferase, Bard1 or CtIP" . SPARSER::COLLECTION)
    ("a previously characterized dominant negative fragment"
     . SPARSER::FRAGMENT)
    ("exonuclease" . SPARSER::PROTEIN) ("BACH1 or Rap80" . SPARSER::COLLECTION)
    ("siRNA or SMARTpool" . SPARSER::COLLECTION)
    ("at least part of Bach1’s" . SPARSER::COMPONENT)
    ("Abraxas/Rap80" . SPARSER::COLLECTION)
    ("RAP80, BRCC36, BRCC45, and MERIT40" . SPARSER::COLLECTION)
    ("BACH1 and TopBP1" . SPARSER::COLLECTION)
    ("CCDC98/Abraxas" . SPARSER::COLLECTION)
    ("BRCA1-interactors" . SPARSER::COLLECTION)
    ("Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA1/BARD1" . SPARSER::COLLECTION)
    ("Brca1 or Bard1" . SPARSER::COLLECTION)
    ("BRCA1-BARD1" . SPARSER::COLLECTION)
    ("transiently co-transfected Brca1  Δ/mut" . SPARSER::COLLECTION)
    ("BRCA1 and I-SceI" . SPARSER::COLLECTION)
    ("four independent Cre-treated Brca1  Δ/mut" . SPARSER::COLLECTION)
    ("mut and Brca1" . SPARSER::COLLECTION)
    ("the functionally wt Brca1  fl allele" . SPARSER::ALLELE)
    ("Δ/mut" . SPARSER::COLLECTION) ("RFP-SCR" . SPARSER::COLLECTION)
    ("BRCA1 and CtIP" . SPARSER::COLLECTION)
    ("BRCA1 or CtIP" . SPARSER::COLLECTION) ("53bp1" . SPARSER::PROTEIN)
    ("BACH1/BRIP1" . SPARSER::COLLECTION)
    ("CtIP (C-terminus-binding protein of adenovirus E1A-interacting protein) and the Mre11/Rad50/NBS1 (MRN) complex"
     . SPARSER::COLLECTION)
    ("Mre11/Rad50/NBS1" . SPARSER::COLLECTION) ("ssDNA" . SPARSER::PROTEIN)
    ("Brca2" . SPARSER::PROTEIN)
    ("XRCC3, Rad51C or XRCC2" . SPARSER::COLLECTION)
    ("paralogs" . SPARSER::PROTEIN) ("Rad51-ssDNA" . SPARSER::PROTEIN-PAIR)
    ("nucleoprotein" . SPARSER::PROTEIN)
    ("The major hereditary breast/ovarian cancer predisposition genes"
     . SPARSER::GENE)
    ("SCR" . SPARSER::PROTEIN) ("BRCA1/CtIP" . SPARSER::COLLECTION)
    ("SDSA" . SPARSER::PROTEIN) ("bis-Tris" . SPARSER::MOLECULE)
    ("POL32" . SPARSER::PROTEIN) ("Sae2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Exo1" . SPARSER::PROTEIN) ("Sirt6" . SPARSER::PROTEIN)
    ("Bach1" . SPARSER::PROTEIN) ("Rap80" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TopBP1" . SPARSER::PROTEIN) ("MERIT40" . SPARSER::PROTEIN)
    ("BRCC45" . SPARSER::PROTEIN) ("BRCC36" . SPARSER::PROTEIN)
    ("CCDC98" . SPARSER::PROTEIN) ("Bard1" . SPARSER::PROTEIN)
    ("BARD1" . SPARSER::PROTEIN) ("RFP1" . SPARSER::PROTEIN)
    ("enhanced Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("RAP80" . SPARSER::PROTEIN) ("Nbs1" . SPARSER::PROTEIN)
    ("Rad51C" . SPARSER::PROTEIN) ("the anti-anoikis" . SPARSER::ANTIBODY)
    ("Platycodin" . SPARSER::DRUG)
    ("an apoptosis promoter instead of survival protector"
     . SPARSER::COLLECTION)
    ("BiP" . SPARSER::PROTEIN) ("Grp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AMBRA1, ATG5, ATG12 or beclin1" . SPARSER::COLLECTION)
    ("ACD" . SPARSER::PROTEIN)
    ("cisplatin and bortezomib" . SPARSER::COLLECTION)
    ("cisplatin and the proteasome inhibitor bortezomib" . SPARSER::COLLECTION)
    ("cyproterone" . SPARSER::DRUG) ("vasopressin" . SPARSER::PROTEIN)
    ("TNFR1 and TNFR2" . SPARSER::COLLECTION)
    ("TRAILR1 and TRAILR2" . SPARSER::COLLECTION)
    ("LMP and lysosomal" . SPARSER::COLLECTION)
    ("RIP3/RIPK3" . SPARSER::COLLECTION) ("RIP1/RIPK1" . SPARSER::COLLECTION)
    ("hydrolases" . SPARSER::PROTEIN) ("LMP" . SPARSER::PROTEIN)
    ("PCa and non-tumor" . SPARSER::COLLECTION) ("DHT" . SPARSER::PROTEIN)
    ("RhoA-ROCK" . SPARSER::COLLECTION) ("Par3-Lgl" . SPARSER::COLLECTION)
    ("caspase and Bcl-2" . SPARSER::COLLECTION)
    ("ROCK1/ROCK2" . SPARSER::COLLECTION) ("GTPase-RhoA" . SPARSER::COLLECTION)
    ("Anoikis" . SPARSER::PROTEIN)
    ("Bad, FasL and caspase-3" . SPARSER::COLLECTION)
    ("PI-3K/Akt/NF-kappaB" . SPARSER::COLLECTION) ("PDT" . SPARSER::PROTEIN)
    ("PIRH2-p53-p21" . SPARSER::COLLECTION)
    ("PIRH 2 and p53" . SPARSER::COLLECTION)
    ("light and staurosporine" . SPARSER::COLLECTION)
    ("Bortezomib and the AR antagonist Casodex" . SPARSER::COLLECTION)
    ("LNCaP and PC-3AR" . SPARSER::COLLECTION) ("Casodex" . SPARSER::DRUG)
    ("FUS/TLS" . SPARSER::COLLECTION) ("Fused" . SPARSER::PROTEIN)
    ("FUS" . SPARSER::PROTEIN) ("ERK-1 and ERK-2" . SPARSER::COLLECTION)
    ("the Bcl-2-associated death protein" . SPARSER::PROTEIN)
    ("Androgen/AR" . SPARSER::COLLECTION)
    ("PI3K and AKT1/AKT2" . SPARSER::COLLECTION)
    ("AKT1/AKT2" . SPARSER::COLLECTION) ("TNF-α/Fas" . SPARSER::COLLECTION)
    ("WAF1, CIP1, SDI1, or CAP20" . SPARSER::COLLECTION)
    ("roughly spherical or ovoid cytoplasmic fragments" . SPARSER::FRAGMENT)
    ("yet both anoikis" . SPARSER::PROTEIN) ("at least 5 types" . TYPE)
    ("stromal AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("strong promoter" . SPARSER::PROMOTER)
    ("CK5 and CK8" . SPARSER::COLLECTION) ("Rv" . SPARSER::MOLECULE)
    ("CK5−" . SPARSER::PROTEIN) ("CK8−, AR− and CK5+" . SPARSER::COLLECTION)
    ("AR−" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CK8−" . SPARSER::PROTEIN)
    ("Androgen/androgen receptor" . SPARSER::COLLECTION)
    ("beclin1" . SPARSER::PROTEIN) ("ATG12" . SPARSER::PROTEIN)
    ("ATG5" . SPARSER::PROTEIN) ("VPS34" . SPARSER::PROTEIN)
    ("RIPK3" . SPARSER::PROTEIN) ("RIP3" . SPARSER::PROTEIN)
    ("TRAILR2" . SPARSER::PROTEIN) ("TRAILR1" . SPARSER::PROTEIN)
    ("TNFR1" . SPARSER::PROTEIN) ("CD95" . SPARSER::PROTEIN)
    ("Par3" . SPARSER::PROTEIN) ("Metallothionein 2A" . SPARSER::PROTEIN)
    ("PIRH2" . SPARSER::PROTEIN) ("PIRH 2" . SPARSER::PROTEIN)
    ("caspase -3" . SPARSER::PROTEIN) ("AKT2" . SPARSER::PROTEIN)
    ("CAP20" . SPARSER::PROTEIN) ("SDI1" . SPARSER::PROTEIN)
    ("WAF1" . SPARSER::PROTEIN) ("caspase-2" . SPARSER::PROTEIN)
    ("CK18" . SPARSER::PROTEIN) ("CK8" . SPARSER::PROTEIN)
    ("anti-androgens" . SPARSER::DRUG) ("Raf-1/ERK" . SPARSER::COLLECTION)
    ("AR and/or androgen" . SPARSER::COLLECTION)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("NF- κ B, and Akt" . SPARSER::COLLECTION)
    ("RKIP and Akt" . SPARSER::COLLECTION) ("primary PC" . SPARSER::PROTEIN)
    ("BPH" . SPARSER::PROTEIN) ("PSMA and PSA" . SPARSER::COLLECTION)
    ("RKIP/NF- κ B" . SPARSER::COLLECTION) ("RKIP/ERK" . SPARSER::COLLECTION)
    ("Raf-1 and MEK" . SPARSER::COLLECTION)
    ("NIK and TAK1" . SPARSER::COLLECTION)
    ("ERK1/2 and p38" . SPARSER::COLLECTION) ("PC3-PSMA" . SPARSER::COLLECTION)
    ("RKIP/Raf-1/MEK/ERK" . SPARSER::COLLECTION)
    ("Raf-1 and RKIP" . SPARSER::COLLECTION)
    ("Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("RKIP, PSA and PSMA" . SPARSER::COLLECTION)
    ("RKIP and second group" . SPARSER::COLLECTION)
    ("p50 or NF-" . SPARSER::COLLECTION)
    ("Raf-1, MEK-1, ERK-1, and ERK-2" . SPARSER::COLLECTION)
    ("PSA, PSMA, and RKIP" . SPARSER::COLLECTION)
    ("kinase and NF- κ B" . SPARSER::COLLECTION)
    ("p50/p65" . SPARSER::COLLECTION)
    ("Ras/Raf-1/MEK/ERK" . SPARSER::COLLECTION)
    ("MAPKs, NF- κ B, and Akt" . SPARSER::COLLECTION)
    ("Prostate specific antigen (PSA) and prostate specific membrane antigen (PSMA)"
     . SPARSER::COLLECTION)
    ("PSA-PSMA" . SPARSER::COLLECTION) ("Raf-1/MEK/ERK" . SPARSER::COLLECTION)
    ("PSA and PSMA" . SPARSER::COLLECTION)
    ("p50, and NF-" . SPARSER::COLLECTION) ("NF-" . SPARSER::PROTEIN)
    ("PSMA" . SPARSER::PROTEIN) ("NFkBp50" . SPARSER::PROTEIN)
    ("prostate specific membrane antigen" . SPARSER::PROTEIN)
    ("Prostate specific antigen" . SPARSER::PROTEIN)
    ("ERK-2" . SPARSER::PROTEIN) ("ERK-1" . SPARSER::PROTEIN)
    ("estradiol and ER" . SPARSER::COLLECTION)
    ("ER and EGFR/HER1" . SPARSER::COLLECTION)
    ("HRG-beta" . SPARSER::COLLECTION) ("-Akt" . SPARSER::COLLECTION)
    ("HER-receptors" . SPARSER::COLLECTION)
    ("HER2 , HER3 and HER4" . SPARSER::COLLECTION)
    ("trastuzumab and either lapatinib [ xref ] or pertuzumab [ xref ]"
     . SPARSER::COLLECTION)
    ("either lapatinib [ xref ] or pertuzumab [ xref ]" . SPARSER::COLLECTION)
    ("particular HER2" . SPARSER::PROTEIN)
    ("ER and growth factors" . SPARSER::COLLECTION)
    ("elevated estradiol and suppression of EGFR/HER1" . SPARSER::COLLECTION)
    ("NRG1 and ESR1" . SPARSER::COLLECTION)
    ("estrogens in tissues and plasma" . SPARSER::COLLECTION)
    ("HER2 (r=0.525, P =0.044, xref ) and HER3 (r=0.707, P =0.003, xref )"
     . SPARSER::COLLECTION)
    ("HER3 and E2" . SPARSER::COLLECTION)
    ("HER3 ( P =0.004) and HER4 ( P =0.024)" . SPARSER::COLLECTION)
    ("both HER2 (r=0.547, P =0.001, data not shown) and HER4 (r=0.513, P =0.017)"
     . SPARSER::COLLECTION)
    ("HER2 ( P =0.042) as well as HER4 ( P =0.012)" . SPARSER::COLLECTION)
    ("HER3 ( P =0.030) and HER4 ( P =0.007)" . SPARSER::COLLECTION)
    ("HER2 (r=0.532, P =0.009) as well as HER4 (r=0.480, P =0.020)"
     . SPARSER::COLLECTION)
    ("receptors and NRG1" . SPARSER::COLLECTION)
    ("HER2 as well as other components" . SPARSER::COLLECTION)
    ("HER-receptor" . SPARSER::COLLECTION)
    ("trastuzumab or lapatinib" . SPARSER::COLLECTION)
    ("ER and HER2" . SPARSER::COLLECTION)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("Estradiol" . SPARSER::MOLECULE)
    ("estradiol and EGFR/HER1" . SPARSER::COLLECTION)
    ("HER3 as well as HER4" . SPARSER::COLLECTION)
    ("HER2 and HER4" . SPARSER::COLLECTION)
    ("receptor and neuregulin-1" . SPARSER::COLLECTION)
    ("E1S" . SPARSER::MOLECULE) ("plasma)" . SPARSER::PROTEIN)
    ("TATA-box binding protein" . SPARSER::PROTEIN) ("NRG1" . SPARSER::PROTEIN)
    ("neuregulin-1" . SPARSER::PROTEIN)
    ("capecitabine and oxaliplatin" . SPARSER::COLLECTION)
    ("capecitabine and irinotecan" . SPARSER::COLLECTION)
    ("irinotecan" . SPARSER::DRUG) ("capecitabine" . SPARSER::DRUG)
    ("leucovorin" . SPARSER::DRUG)
    ("erlotinib and PP242" . SPARSER::COLLECTION)
    ("PI3K and ERK" . SPARSER::COLLECTION)
    ("RICTOR, p70S6K, eIF4E and 4E-BP1" . SPARSER::COLLECTION)
    ("caspase-3, DFF45 and PARP" . SPARSER::COLLECTION)
    ("PP242 or erlotinib" . SPARSER::COLLECTION)
    ("PP242 (0.5 μM) or erlotinib (2 μM)" . SPARSER::COLLECTION)
    ("erlotinib (2 μM) and PP242 (0.5 μM)" . SPARSER::COLLECTION)
    ("EGFR and mTOR" . SPARSER::COLLECTION)
    ("PP242 ( xref ) and erlotinib ( xref )" . SPARSER::COLLECTION)
    ("EGFR (EGFR T1068 ) and mTORC1 substrates (S6 S235/236 ; 4E-BP1 T36/45 )"
     . SPARSER::COLLECTION)
    ("rapamycin or PP242" . SPARSER::COLLECTION)
    ("EGF-EGFR" . SPARSER::COLLECTION)
    ("rapamycin and PP242" . SPARSER::COLLECTION)
    ("rapamycin (0.1 μM) or PP242 (1 μM)" . SPARSER::COLLECTION)
    ("RICTOR, p70S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("p70S6K, 4E-BP1 and AKT" . SPARSER::COLLECTION) ("PP" . SPARSER::PROTEIN)
    ("adenosine triphosphate (ATP)" . SPARSER::MOLECULE)
    ("FK506 binding protein 12 (FKBP-12) and form" . SPARSER::COLLECTION)
    ("rapamycin and its analogs (known as rapalogs) such as everolimus (RAD001)"
     . SPARSER::COLLECTION)
    ("temsirolimus (CCI-779) and ridaforolimus (AP23573)"
     . SPARSER::COLLECTION)
    ("ridaforolimus" . SPARSER::DRUG) ("temsirolimus" . SPARSER::DRUG)
    ("substrate (IRS)" . SPARSER::SUBSTRATE)
    ("growth factor-mTORC1" . SPARSER::COLLECTION)
    ("the mTORC1 inhibitor TSC2 [ xref ] and RAPTOR [ xref ]"
     . SPARSER::COLLECTION)
    ("Ras-extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("tuberous sclerosis 2 (TSC2) and proline-rich AKT substrate 40 kDa (PRAS40)"
     . SPARSER::COLLECTION)
    ("PI3K and AKT and AKT" . SPARSER::COLLECTION)
    ("AKT and AKT" . SPARSER::COLLECTION)
    ("glucocorticoid-regulated kinase" . SPARSER::COLLECTION)
    ("ribosomal protein S6 and 4E-BP1" . SPARSER::COLLECTION)
    ("eIF4" . SPARSER::PROTEIN) ("p70S6K" . SPARSER::PROTEIN)
    ("the regulatory-associated protein" . SPARSER::PROTEIN)
    ("unique regulatory proteins" . SPARSER::PROTEIN)
    ("RICTOR" . SPARSER::PROTEIN) ("RAPTOR" . SPARSER::PROTEIN)
    ("a conservative serine/threonine (S/T) protein kinase" . SPARSER::PROTEIN)
    ("kinase and EGFR" . SPARSER::COLLECTION)
    ("PP242 and erlotinib" . SPARSER::COLLECTION) ("BKM120" . SPARSER::DRUG)
    ("PI3K inhibitor BKM120" . SPARSER::DRUG)
    ("p-nitrophenyl" . SPARSER::MOLECULE)
    ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("FKBP-12" . SPARSER::PROTEIN)
    ("FK506 binding protein 12" . SPARSER::PROTEIN)
    ("GRB10" . SPARSER::PROTEIN) ("tuberous sclerosis 2" . SPARSER::PROTEIN)
    ("Insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("regulated kinase" . SPARSER::PROTEIN) ("PP242" . SPARSER::DRUG)
    ("β-catenin-reptin" . SPARSER::COLLECTION) ("reptin" . SPARSER::PROTEIN)
    ("a proximal activator" . SPARSER::ACTIVATOR) ("RRM" . SPARSER::PROTEIN)
    ("KAP1 and FTS-1" . SPARSER::COLLECTION) ("FTS" . SPARSER::PROTEIN)
    ("CMV promoter-driven KAP1" . SPARSER::PROTEIN)
    ("ZBRK1/KAP1" . SPARSER::COLLECTION) ("that ZBRK1’s" . SPARSER::PROTEIN)
    ("ZBRK1/BRCA1" . SPARSER::COLLECTION)
    ("ZBRK1 and GZBDK" . SPARSER::COLLECTION) ("the KAP1’s" . SPARSER::PROTEIN)
    ("APP, CDH2, S100A6 and CLDN3" . SPARSER::COLLECTION)
    ("ODC1, VIM and NFE2L2" . SPARSER::COLLECTION)
    ("MMP9, SH3GLB2 and MAPK4K" . SPARSER::COLLECTION)
    ("ZBRK1 and BRCA1" . SPARSER::COLLECTION)
    ("the ZBRK1 (GZB) and KRAB-truncated ZBRK1 (GDK) transfectants"
     . SPARSER::COLLECTION)
    ("the CTRD-truncated ZBRK1 (GDZ) or the both KRAB- and CTRD-truncated ZBRK1 (GDKZ) transfectants ( xref  , left panel, and  xref )"
     . SPARSER::COLLECTION)
    ("the both KRAB- and CTRD-truncated ZBRK1 (GDKZ) transfectants ( xref  , left panel, and  xref )"
     . SPARSER::COLLECTION)
    ("ZBRK1 (GDZ)" . SPARSER::PROTEIN) ("KRAB-" . SPARSER::PROTEIN-FAMILY)
    ("GZB" . SPARSER::COLLECTION)
    ("ectopically expressed EGFP-ZBRK1" . SPARSER::COLLECTION)
    ("expressed EGFP-ZBRK1" . SPARSER::COLLECTION)
    ("EGFP-ZBRK1" . SPARSER::COLLECTION) ("pGL" . SPARSER::PROTEIN)
    ("GADD45 , ANG1 and p21" . SPARSER::COLLECTION)
    ("KRAB and CTRD" . SPARSER::COLLECTION) ("ZBRK1 (GZB)" . SPARSER::PROTEIN)
    ("ectopically expressing EGFP" . SPARSER::PROTEIN)
    ("expressing EGFP" . SPARSER::PROTEIN) ("EGFP-fused" . SPARSER::COLLECTION)
    ("KAP1 and BRCA1" . SPARSER::COLLECTION) ("RBCC" . SPARSER::PROTEIN)
    ("the ZBRK1’s" . SPARSER::PROTEIN)
    ("transcriptional corepressors, CtIP and BRCA1" . SPARSER::COLLECTION)
    ("corepressors, CtIP and BRCA1" . SPARSER::COLLECTION)
    ("KRAB-zinc finger" . SPARSER::COLLECTION)
    ("ZBRK1 and KAP1" . SPARSER::COLLECTION)
    ("BRCA1 and KAP1" . SPARSER::COLLECTION)
    ("breast cancer 1 (BRCA1) and KRAB-ZFP-associated protein 1 (KAP1)"
     . SPARSER::COLLECTION)
    ("KRAB" . SPARSER::PROTEIN-FAMILY)
    ("heterochromatin protein1" . SPARSER::PROTEIN) ("KAI1" . SPARSER::PROTEIN)
    ("CBF-A" . SPARSER::PROTEIN) ("MAPK4" . SPARSER::PROTEIN)
    ("SH3GLB2" . SPARSER::PROTEIN) ("NFE2L2" . SPARSER::PROTEIN)
    ("ODC1" . SPARSER::PROTEIN) ("CLDN3" . SPARSER::PROTEIN)
    ("S100A6" . SPARSER::PROTEIN) ("ANG1" . SPARSER::PROTEIN)
    ("heterochromatin protein 1" . SPARSER::PROTEIN)
    ("SETDB1" . SPARSER::PROTEIN) ("2/3" . SPARSER::PROTEIN)
    ("angiopoietin 1" . SPARSER::PROTEIN) ("C2H2" . SPARSER::MOLECULE)
    ("KAP1" . SPARSER::PROTEIN) ("ZBRK1" . SPARSER::PROTEIN)
    ("Biologics" . SPARSER::DRUG) ("TnI" . SPARSER::PROTEIN)
    ("other known prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C-reactive protein and statin" . SPARSER::COLLECTION)
    ("statin" . SPARSER::MOLECULE)
    ("IL-6 and anti-inflammatory" . SPARSER::COLLECTION)
    ("IL-10, IL-27 and IL-21" . SPARSER::COLLECTION)
    ("TNF-α or other cytokines and IL-6" . SPARSER::COLLECTION)
    ("IL-1β, TNF-α or other cytokines and IL-6" . SPARSER::COLLECTION)
    ("cytokines and IL-6" . SPARSER::COLLECTION)
    ("IL-1β, TNF-α and IL-17" . SPARSER::COLLECTION) ("NKT" . SPARSER::PROTEIN)
    ("a pathogenetic component" . SPARSER::COMPONENT)
    ("hIL-6 and TGF-β1" . SPARSER::COLLECTION) ("Sera" . SPARSER::PROTEIN)
    ("IL-6 and/or TGF-β1" . SPARSER::COLLECTION)
    ("the systemic inflammatory state" . SPARSER::BIO-STATE)
    ("MACS and co-cultured" . SPARSER::COLLECTION) ("MACS" . SPARSER::PROTEIN)
    ("The STAT3-regulated RORγt and its protein RORγt" . SPARSER::COLLECTION)
    ("TGF-β1, IL-6, IL-17 and IL-23" . SPARSER::COLLECTION)
    ("IL-1β and IL-23" . SPARSER::COLLECTION)
    ("IL-6, IFN-γ, IL-17 and IL-8" . SPARSER::COLLECTION)
    ("HDs" . SPARSER::PROTEIN) ("n  " . SPARSER::PROTEIN)
    ("CAD" . SPARSER::PROTEIN) ("HD" . SPARSER::PROTEIN)
    ("monocyte-derived pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-21 or IL-1β" . SPARSER::COLLECTION)
    ("IL-1β and IL-6" . SPARSER::COLLECTION)
    ("STAT3/RORγt" . SPARSER::COLLECTION)
    ("IL-17 and IFN-γ" . SPARSER::COLLECTION)
    ("IL-6-STAT3" . SPARSER::COLLECTION)
    ("22 inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6R" . SPARSER::PROTEIN) ("CD45RO" . SPARSER::PROTEIN)
    ("IgG2a" . SPARSER::PROTEIN) ("PC7" . SPARSER::PROTEIN)
    ("IL-13" . SPARSER::PROTEIN) ("IL-5" . SPARSER::PROTEIN)
    ("Troponin I" . SPARSER::PROTEIN) ("Lp(a)" . SPARSER::PROTEIN)
    ("IL-23" . SPARSER::PROTEIN) ("RORγt" . SPARSER::PROTEIN)
    ("only one HIF" . SPARSER::PROTEIN)
    ("transcriptionally active Pol II-containing complexes"
     . SPARSER::BIO-COMPLEX)
    ("ETS1, ELK and NEMO" . SPARSER::COLLECTION) ("ELK" . SPARSER::PROTEIN)
    ("HIF2 and USF2" . SPARSER::COLLECTION)
    ("HIF1 and USF2" . SPARSER::COLLECTION)
    ("HIF1 or USF2" . SPARSER::COLLECTION)
    ("HIF or USF2" . SPARSER::COLLECTION)
    ("their respective co-transcriptional activator proteins"
     . SPARSER::PROTEIN)
    ("CANNTG" . SPARSER::PROTEIN)
    ("STAT3 co-transfection only moderately increases HIF1’s"
     . SPARSER::PROTEIN)
    ("STAT3 co-transfection only moderately increases HIF1" . SPARSER::PROTEIN)
    ("HIF, STAT3 and USF2" . SPARSER::COLLECTION)
    ("HIF1 and HIF2, STAT3 and USF2" . SPARSER::COLLECTION)
    ("HIF2, STAT3 and USF2" . SPARSER::COLLECTION)
    ("unique and common target genes" . SPARSER::GENE)
    ("siRNA or shRNA" . SPARSER::COLLECTION)
    ("only one HIFα protein" . SPARSER::PROTEIN)
    ("traditional ChIP" . SPARSER::PROTEIN)
    ("ChIP/ReChIP" . SPARSER::COLLECTION) ("ReChIP" . SPARSER::PROTEIN)
    ("transcription-competent RNA polymerase II-containing complex"
     . SPARSER::BIO-COMPLEX)
    ("only one HIF subunit" . SPARSER::FRAGMENT)
    ("Pol II/HIF2α" . SPARSER::COLLECTION)
    ("Pol II/HIF1α" . SPARSER::COLLECTION)
    ("HIF1 (4.9 fold) or USF2" . SPARSER::COLLECTION)
    ("both HIF1 (30.2 fold with 7.2 times of increasing) and HIF2 (10.1 fold with 5.9 times of increasing)"
     . SPARSER::COLLECTION)
    ("HIF (4.2 fold by HIF1 and 1.7 fold by HIF2) or USF2 (no activation)"
     . SPARSER::COLLECTION)
    ("HIF1 and STAT3C" . SPARSER::COLLECTION)
    ("CA9 and PAI1" . SPARSER::COLLECTION)
    ("the artificial HIF target promoters" . SPARSER::PROMOTER)
    ("whose promoter" . SPARSER::PROMOTER)
    ("whose promoters" . SPARSER::PROMOTER)
    ("a weak activator" . SPARSER::ACTIVATOR)
    ("USF2 and USF2" . SPARSER::COLLECTION)
    ("HIF1α or USF2" . SPARSER::COLLECTION)
    ("IH or C-TAD" . SPARSER::COLLECTION)
    ("HIF2α-N protein" . SPARSER::COLLECTION)
    ("The Flag-tagged FL HIF2α or its deletion mutants" . SPARSER::COLLECTION)
    ("IH, and C-TAD" . SPARSER::COLLECTION)
    ("C-TAD and N-TAD" . SPARSER::COLLECTION)
    ("HIF2α/USF2" . SPARSER::COLLECTION) ("the HIF1α’s" . SPARSER::PROTEIN)
    ("HIF1α-N protein" . SPARSER::COLLECTION)
    ("IH and C-TAD" . SPARSER::COLLECTION) ("immuno" . SPARSER::PROTEIN)
    ("their respective transcription factor" . SPARSER::PROTEIN)
    ("HIF1α/STAT3" . SPARSER::COLLECTION) ("PAI" . SPARSER::PROTEIN)
    ("HIF2α and HIFα" . SPARSER::COLLECTION)
    ("HIF1α and HIFα" . SPARSER::COLLECTION)
    ("anti-HIF1α or anti-HIF2α" . SPARSER::COLLECTION)
    ("HIF1α and STAT3" . SPARSER::COLLECTION) ("DPA" . SPARSER::PROTEIN)
    ("PGK1 and VEGF" . SPARSER::COLLECTION)
    ("CA9, PGK1 and VEGF" . SPARSER::COLLECTION) ("Hypoxia" . SPARSER::PROTEIN)
    ("CA9 , PGK1 and VEGF" . SPARSER::COLLECTION)
    ("STAT3 and HIF1" . SPARSER::COLLECTION)
    ("PAI1 , OCT4 and PLAC8" . SPARSER::COLLECTION)
    ("LDHA , BNIP3 , and LPK" . SPARSER::COLLECTION)
    ("USF1/USF2" . SPARSER::COLLECTION) ("LPK" . SPARSER::PROTEIN)
    ("HIF2α and HIF1α" . SPARSER::COLLECTION) ("normoxia" . SPARSER::PROTEIN)
    ("HIF1α/HIF2α" . SPARSER::COLLECTION) ("STAT3/USF2" . SPARSER::COLLECTION)
    ("HIF2 [ xref ] and STAT3 and HIF1α" . SPARSER::COLLECTION)
    ("USF2 and HIF2α" . SPARSER::COLLECTION)
    ("STAT3 and HIF1α" . SPARSER::COLLECTION)
    ("HIF2 or HIF1" . SPARSER::COLLECTION)
    ("pre-immuno" . SPARSER::PROTEIN-PAIR)
    ("CA9 , PAI1 and VEGF" . SPARSER::COLLECTION)
    ("HIF1/HIF2" . SPARSER::COLLECTION) ("pVHL" . SPARSER::PROTEIN)
    ("EPO , PAI1 , OCT4 and PLAC8" . SPARSER::COLLECTION)
    ("PGK1 , GLUT1 , LDHA and CA9" . SPARSER::COLLECTION)
    ("LDHA" . SPARSER::PROTEIN)
    ("endogenous HIF1 or HIF2 target genes or known STAT3 target genes"
     . SPARSER::COLLECTION)
    ("VEGF and MYC" . SPARSER::COLLECTION) ("PGK" . SPARSER::PROTEIN)
    ("EPO/Luciferase" . SPARSER::COLLECTION)
    ("CA9/Luciferase" . SPARSER::COLLECTION)
    ("over-expressed STAT3 or USF2 activated promoters" . SPARSER::PROMOTER)
    ("two HIF1 target genes ( CA9 and PGK1 ) and two HIF2 target genes ( PAI1 and EPO )"
     . SPARSER::COLLECTION)
    ("USF2 ( CANNTG )" . SPARSER::PROTEIN)
    ("promoter and enhancer" . SPARSER::COLLECTION)
    ("CA9 and PGK1" . SPARSER::COLLECTION)
    ("STAT3 and USF2" . SPARSER::COLLECTION)
    ("p300 and CBP" . SPARSER::COLLECTION)
    ("STAT3 (Signal Transducer and Activator of Transcription 3) and USF2 (Upstream Stimulatory Factor 2)"
     . SPARSER::COLLECTION)
    ("other eukaryotic genes" . SPARSER::GENE)
    ("enhanceosome" . SPARSER::PROTEIN) ("PGK1 and CA9" . SPARSER::COLLECTION)
    ("PAI1 and EPO" . SPARSER::COLLECTION) ("EPO" . SPARSER::PROTEIN)
    ("HIFs" . SPARSER::PROTEIN)
    ("a constitutively expressed beta subunit called ARNT (Aryl Hydrocarbon Receptor Nuclear Translocator) or HIF1"
     . SPARSER::COLLECTION)
    ("a constitutively expressed beta subunit called ARNT" . SPARSER::PROTEIN)
    ("HIF1α and HIF2α" . SPARSER::COLLECTION)
    ("HIF2α/ARNT" . SPARSER::COLLECTION) ("HIF1α/ARNT" . SPARSER::COLLECTION)
    ("ARNT" . SPARSER::PROTEIN)
    ("inducible factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF1α or HIF2α" . SPARSER::COLLECTION)
    ("the promoter as well as its response to HIF2+USF2 activation"
     . SPARSER::COLLECTION)
    ("siRNA or inhibitor" . SPARSER::COLLECTION)
    ("STAT3 or USF2" . SPARSER::COLLECTION)
    ("HIF1 or HIF2" . SPARSER::COLLECTION)
    ("HIF1 and HIF2" . SPARSER::COLLECTION) ("HIF1-" . SPARSER::PROTEIN)
    ("RNA-polymerase" . SPARSER::PROTEIN) ("protein C" . SPARSER::PROTEIN)
    ("N protein" . SPARSER::PROTEIN) ("COS7" . SPARSER::PROTEIN)
    ("USF1" . SPARSER::PROTEIN) ("BNIP3" . SPARSER::PROTEIN)
    ("GLUT1" . SPARSER::PROTEIN) ("PLAC8" . SPARSER::PROTEIN)
    ("S3I-201" . SPARSER::MOLECULE) ("PRC3" . SPARSER::PROTEIN)
    ("Upstream Stimulatory Factor 2" . SPARSER::PROTEIN)
    ("Signal Transducer and Activator of Transcription 3" . SPARSER::PROTEIN)
    ("CA9" . SPARSER::PROTEIN) ("C-TAD" . SPARSER::PROTEIN)
    ("Aryl Hydrocarbon Receptor Nuclear Translocator" . SPARSER::PROTEIN)
    ("HIF2α" . SPARSER::PROTEIN) ("HIF1α" . SPARSER::PROTEIN)
    ("HIF2" . SPARSER::PROTEIN) ("HIF1" . SPARSER::PROTEIN)
    ("anti-angiogenic or anti-VEGF" . SPARSER::COLLECTION)
    ("HER2-" . SPARSER::PROTEIN)
    ("cyclin A1, ER-α and VEGF" . SPARSER::COLLECTION)
    ("E2 and cyclin A1" . SPARSER::COLLECTION)
    ("VEGF, ER-α and Ki-67" . SPARSER::COLLECTION)
    ("VEGF and VEGFR1" . SPARSER::COLLECTION)
    ("cyclin A1-pcDNA" . SPARSER::COLLECTION)
    ("expressed cyclin A1" . SPARSER::PROTEIN)
    ("cyclin A1 and ER-α" . SPARSER::COLLECTION)
    ("cyclin A1, estrogen and VEGF" . SPARSER::COLLECTION)
    ("E2 and ER-α" . SPARSER::COLLECTION)
    ("E2 and tamoxifen and cyclin A1" . SPARSER::COLLECTION)
    ("tamoxifen and cyclin A1" . SPARSER::COLLECTION)
    ("E2 and tamoxifin combination treatment" . SPARSER::COLLECTION)
    ("estrogen and tamxifenin" . SPARSER::COLLECTION)
    ("estrogen and ER-α" . SPARSER::COLLECTION)
    ("estrogen and cyclin A1" . SPARSER::COLLECTION)
    ("E2 or solvent" . SPARSER::COLLECTION)
    ("cyclin A1, ER and VEGF" . SPARSER::COLLECTION)
    ("cyclin A1 and estrogen" . SPARSER::COLLECTION)
    ("pCMS-EGFP" . SPARSER::COLLECTION)
    ("cyclin A1-pCMS-EGFP" . SPARSER::COLLECTION) ("pCMS" . SPARSER::PROTEIN)
    ("VEGF and cyclin A1" . SPARSER::COLLECTION)
    ("represented most aggressive type" . TYPE)
    ("VEGF and Ki67" . SPARSER::COLLECTION) ("vegf" . SPARSER::PROTEIN)
    ("VEGF and ER-α" . SPARSER::COLLECTION)
    ("VEGF and matrix" . SPARSER::COLLECTION)
    ("ER-α and VEGF" . SPARSER::COLLECTION)
    ("VEGF and its receptors" . SPARSER::COLLECTION)
    ("ER-α and its co-activator" . SPARSER::COLLECTION)
    ("VEGF, VEGFR1 and ER-α" . SPARSER::COLLECTION)
    ("cyclin A1 and estrogen receptor" . SPARSER::COLLECTION)
    ("cyclin A1 and VEGF" . SPARSER::COLLECTION)
    ("endocrine and vascular endothelial growth factors (VEGF)"
     . SPARSER::COLLECTION)
    ("endocrine and vascular endothelial growth factors" . SPARSER::COLLECTION)
    ("CD-31" . SPARSER::PROTEIN) ("G –3" . SPARSER::PROTEIN)
    ("CAT –3" . SPARSER::PROTEIN) ("VEGF-R2" . SPARSER::PROTEIN)
    ("Six1" . SPARSER::PROTEIN) ("homeobox protein" . SPARSER::PROTEIN)
    ("Cyclin A1" . SPARSER::PROTEIN) ("cyclin A1" . SPARSER::PROTEIN)
    ("vascular endothelial growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GC, polypurine and polypyrimidine" . SPARSER::COLLECTION)
    ("massive DNA" . SPARSER::DNA) ("BIR" . SPARSER::PROTEIN)
    ("gene and FRA2Ccen" . SPARSER::COLLECTION)
    ("KCNK2 and NBAS" . SPARSER::COLLECTION) ("WWOX" . SPARSER::PROTEIN)
    ("identified SVs targeted genes" . SPARSER::GENE)
    ("ARID1A and ARID1B" . SPARSER::COLLECTION)
    ("PTPRD and ODZ4" . SPARSER::COLLECTION) ("TPR" . SPARSER::PROTEIN)
    ("MITF" . SPARSER::PROTEIN)
    ("PDGFRB , FOXP1 and ABL2" . SPARSER::COLLECTION)
    ("PDGFRB , ATIC , EML4 , FOXP1 , MYCN and ABL2" . SPARSER::COLLECTION)
    ("ATIC" . SPARSER::PROTEIN) ("PDGFRB" . SPARSER::PROTEIN)
    ("NBAS , PTPRD and ODZ4" . SPARSER::COLLECTION)
    ("Several expressed chimeras involved genes" . SPARSER::GENE)
    ("introns" . SPARSER::PROTEIN) ("exon-exon" . SPARSER::COLLECTION)
    ("Scaffold/matrix" . SPARSER::COLLECTION) ("Scaffold" . SPARSER::SCAFFOLD)
    ("Fragments" . SPARSER::FRAGMENT) ("only two states" . SPARSER::BIO-STATE)
    ("der(4)t(4;17) and der(4)t(4;12)" . SPARSER::COLLECTION)
    ("LL-Ga" . SPARSER::COLLECTION) ("hg" . SPARSER::MOLECULE)
    ("PEM" . SPARSER::PROTEIN) ("SV" . SPARSER::MOLECULE)
    ("Ga" . SPARSER::PROTEIN) ("CLB-Ga and CLB-Re" . SPARSER::COLLECTION)
    ("CLB-Ga" . SPARSER::COLLECTION) ("SVs" . SPARSER::MOLECULE)
    ("CLB-Bar" . SPARSER::COLLECTION) ("Bar" . SPARSER::PROTEIN)
    ("CLB" . SPARSER::PROTEIN) ("constitutional DNA" . SPARSER::DNA)
    ("gene and base" . SPARSER::COLLECTION)
    ("genes and genes" . SPARSER::COLLECTION)
    ("ALK , NBAS , FHIT , PTPRD and ODZ4" . SPARSER::COLLECTION)
    ("PTPRD" . SPARSER::PROTEIN) ("FHIT" . SPARSER::PROTEIN)
    ("NBAS" . SPARSER::PROTEIN) ("L12" . SPARSER::PROTEIN)
    ("FRA2" . SPARSER::PROTEIN) ("KCNK2" . SPARSER::PROTEIN)
    ("FRA3B" . SPARSER::PROTEIN) ("ARID1B" . SPARSER::PROTEIN)
    ("ARID1A" . SPARSER::PROTEIN) ("ABL2" . SPARSER::PROTEIN)
    ("FOXP1" . SPARSER::PROTEIN) ("ARHGEF12" . SPARSER::PROTEIN)
    ("2p" . SPARSER::PROTEIN) ("ODZ4" . SPARSER::PROTEIN)
    ("TGF-β and non-TGF-β-induced" . SPARSER::COLLECTION)
    ("uPA/uPAR" . SPARSER::COLLECTION) ("eta" . SPARSER::PROTEIN)
    ("an important angiogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("two other mesenchymal related proteins, N-cadherin and Twist1"
     . SPARSER::COLLECTION)
    ("proteins, N-cadherin and Twist1" . SPARSER::COLLECTION)
    ("N-cadherin, Vimentin and Twist1" . SPARSER::COLLECTION)
    ("MEK (also MAPKK, mitogen activated protein kinase kinase) and ERK (extracellular regulated protein kinases)"
     . SPARSER::COLLECTION)
    ("mesenchymal cell markers N-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("N-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("E-cadherin, N-cadherin, Vimentin and Twist1" . SPARSER::COLLECTION)
    ("STAT3, JNK, Akt and NF-kappaB" . SPARSER::COLLECTION)
    ("Lv" . SPARSER::MOLECULE) ("OA" . SPARSER::MOLECULE)
    ("Mitogen-activated protein kinases/Extracellular signal-regulated kinase"
     . SPARSER::COLLECTION)
    ("PTPIP51" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("elongation factor 1" . SPARSER::PROTEIN) ("anti-ERK" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("oleanolic acid" . SPARSER::MOLECULE)
    ("Oleanolic acid" . SPARSER::MOLECULE)
    ("Extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER-1/HER-2" . SPARSER::COLLECTION) ("p27 and RB1" . SPARSER::COLLECTION)
    ("inhibitors (CDKI)" . SPARSER::INHIBITOR) ("CDKI" . SPARSER::DRUG)
    ("ERs and non-transcriptional" . SPARSER::COLLECTION)
    ("estrogen or tamoxifen" . SPARSER::COLLECTION)
    ("ER and its co-activators or co-repressors" . SPARSER::COLLECTION)
    ("HER-2, and insulin-like growth factor-1" . SPARSER::COLLECTION)
    ("Everolimus" . SPARSER::MOLECULE) ("p-ER" . SPARSER::COLLECTION)
    ("/Akt/mTOR" . SPARSER::COLLECTION) ("p-mTOR" . SPARSER::COLLECTION)
    ("both ERα ( P <0.05) and E-cadherin ( P <0.05)" . SPARSER::COLLECTION)
    ("MCF-10A" . SPARSER::PROTEIN)
    ("ERBB2 and cyclin D1" . SPARSER::COLLECTION)
    ("protein kinase B (PKB/Akt) or mammalian target of rapamycin (mTOR)"
     . SPARSER::COLLECTION)
    ("PKB/Akt" . SPARSER::COLLECTION) ("SERM" . SPARSER::DRUG)
    ("receptor (HER)" . SPARSER::RECEPTOR) ("Akt/mTOR" . SPARSER::COLLECTION)
    ("p12" . SPARSER::PROTEIN) ("sulforhodamine B" . SPARSER::MOLECULE)
    ("HER-1" . SPARSER::PROTEIN) ("HOXB7" . SPARSER::PROTEIN)
    ("LMTK3" . SPARSER::PROTEIN) ("CUEDC2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 4" . SPARSER::PROTEIN)
    ("IGF1-R" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("Zinc finger" . SPARSER::PROTEIN) ("ZNF703" . SPARSER::PROTEIN)
    ("biomarkers and therapeutic targets xref" . SPARSER::COLLECTION)
    ("ER and E-cadherin" . SPARSER::COLLECTION)
    ("ER and E-Cadherin" . SPARSER::COLLECTION)
    ("Cyclin-D1, and p27" . SPARSER::COLLECTION)
    ("receptors and ligands" . SPARSER::COLLECTION)
    ("mature isoform" . SPARSER::PROTEIN) ("EMT/CSC" . SPARSER::COLLECTION)
    ("ER and HER-2" . SPARSER::COLLECTION)
    ("EGFR and HER-2" . SPARSER::COLLECTION) ("Lapatinib" . SPARSER::DRUG)
    ("mature β1-integrin isoforms" . SPARSER::ISOFORM)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("HER-2 and β1-integrin" . SPARSER::COLLECTION)
    ("Cyclin-D1" . SPARSER::PROTEIN) ("p-FAK" . SPARSER::COLLECTION)
    ("several TZR-associated proteins" . SPARSER::PROTEIN)
    ("β1-integrin and EGFR" . SPARSER::COLLECTION)
    ("vimentin, and TWIST-1" . SPARSER::COLLECTION)
    ("-FAK" . SPARSER::COLLECTION) ("glycosyltransferase" . SPARSER::PROTEIN)
    ("MGAT" . SPARSER::PROTEIN) ("PHA" . SPARSER::PROTEIN)
    ("the 130 KDa ‘mature’ form" . SPARSER::FORM)
    ("EMT-inducer" . SPARSER::COLLECTION)
    ("IL-6 and TGF-β1" . SPARSER::COLLECTION)
    ("several soluble factor genes" . SPARSER::GENE)
    ("β1-integrin, vimentin and CK-18" . SPARSER::COLLECTION)
    ("mesenchymal marker protein" . SPARSER::PROTEIN)
    ("lamanin-alpha-4" . SPARSER::COLLECTION)
    ("vimentin (VIM)" . SPARSER::PROTEIN)
    ("WNT5B, and NOTCH4" . SPARSER::COLLECTION) ("Frizzled" . SPARSER::PROTEIN)
    ("EMT/SC" . SPARSER::COLLECTION)
    ("Interestingly SC related alpha6-integrin" . SPARSER::COLLECTION)
    ("alpha6-integrin" . SPARSER::COLLECTION)
    ("HER-2 and HER-3" . SPARSER::COLLECTION)
    ("expressed only low molecular weight β1-integrin" . SPARSER::PROTEIN)
    ("N-glycosylated β1-integrin and basal CSC" . SPARSER::COLLECTION)
    ("EMT, N-glycosylated β1-integrin and basal CSC" . SPARSER::COLLECTION)
    ("basal CSC" . SPARSER::PROTEIN) ("TWIST and SLUG" . SPARSER::COLLECTION)
    ("SLUG" . SPARSER::PROTEIN)
    ("a basal adhesion molecule" . SPARSER::PROTEIN)
    ("luminal and SC" . SPARSER::COLLECTION) ("Cyclin-D" . SPARSER::PROTEIN)
    ("N-glycan" . SPARSER::MOLECULE) ("TGF-β1" . SPARSER::PROTEIN)
    ("CK-18" . SPARSER::PROTEIN) ("claudin-3" . SPARSER::PROTEIN)
    ("alpha-4" . SPARSER::PROTEIN) ("collagen-1" . SPARSER::PROTEIN)
    ("CDH12" . SPARSER::PROTEIN) ("CDH2" . SPARSER::PROTEIN)
    ("ALDH7A1" . SPARSER::PROTEIN) ("ALDH4A1" . SPARSER::PROTEIN)
    ("ALDH1A2" . SPARSER::PROTEIN) ("NOTCH4" . SPARSER::PROTEIN)
    ("WNT5B" . SPARSER::PROTEIN) ("FZD 7" . SPARSER::PROTEIN)
    ("YBX1" . SPARSER::PROTEIN) ("HER-3" . SPARSER::PROTEIN)
    ("CS4" . SPARSER::PROTEIN) ("alpha6" . SPARSER::PROTEIN)
    ("alpha5" . SPARSER::PROTEIN) ("TWIST-1" . SPARSER::PROTEIN)
    ("Cytokeratin 8" . SPARSER::PROTEIN)
    ("Lapatinib Ditosylate" . SPARSER::DRUG)
    ("these two polyphenolic flavonoids" . SPARSER::MOLECULE)
    ("Snail, Slug, ZEB1, and ZEB2" . SPARSER::COLLECTION)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("cortactin, and MMP" . SPARSER::COLLECTION)
    ("an actin cytoskeletal regulator" . SPARSER::PROTEIN)
    ("MMP-2/MMP-9" . SPARSER::COLLECTION)
    ("MT1-MMP/MMP-2" . SPARSER::COLLECTION)
    ("MMP-2, MMP-9 and MT1-MMP" . SPARSER::COLLECTION)
    ("p-cortactin" . SPARSER::COLLECTION)
    ("Src kinase and its downstream cortactin" . SPARSER::COLLECTION)
    ("regulator and component" . SPARSER::COLLECTION)
    ("regulators and components" . SPARSER::COLLECTION)
    ("N-WASP, Nck1 and Dynamin2" . SPARSER::COLLECTION)
    ("Nck1" . SPARSER::PROTEIN) ("Nck" . SPARSER::PROTEIN)
    ("the possible impact" . SPARSER::PROTEIN)
    ("cortactin and Tks5" . SPARSER::COLLECTION)
    ("fibronectin, vimentin, Twist and Snail" . SPARSER::COLLECTION)
    ("luteolin or quercetin" . SPARSER::COLLECTION)
    ("MT1-MMP, TIMP1 and TIMP2" . SPARSER::COLLECTION)
    ("Src and cortactin" . SPARSER::COLLECTION)
    ("Luteolin and Quercetin" . SPARSER::COLLECTION)
    ("Luteolin" . SPARSER::DRUG) ("MT1-MMP and MMP-2" . SPARSER::COLLECTION)
    ("the key MMP" . SPARSER::PROTEIN)
    ("Src kinase and cortactin" . SPARSER::COLLECTION)
    ("regulator or component" . SPARSER::COLLECTION) ("Form" . SPARSER::FORM)
    ("flavonol" . SPARSER::MOLECULE) ("CTTN" . SPARSER::PROTEIN)
    ("cortical actin" . SPARSER::PROTEIN) ("Cortactin" . SPARSER::PROTEIN)
    ("AMAP1/ASAP1" . SPARSER::COLLECTION)
    ("MMPs, MMP-2, MMP-9 and MT1-MMP" . SPARSER::COLLECTION)
    ("cortactin, N-WASP, Arp2/3 and cofilin" . SPARSER::COLLECTION)
    ("v-src" . SPARSER::COLLECTION)
    ("luteolin (Lu) and quercetin (Qu)" . SPARSER::COLLECTION)
    ("two potent dietary flavonoids" . SPARSER::MOLECULE)
    ("luteolin" . SPARSER::DRUG) ("flavonoids" . SPARSER::MOLECULE)
    ("flavonoid" . SPARSER::MOLECULE) ("Flavonoids" . SPARSER::MOLECULE)
    ("cortactin and Src" . SPARSER::COLLECTION)
    ("cortactin" . SPARSER::PROTEIN)
    ("a highly invasive A431-III subline" . SPARSER::PROTEIN)
    ("p-Src" . SPARSER::PROTEIN) ("Dynamin2" . SPARSER::PROTEIN)
    ("Src Kinase" . SPARSER::PROTEIN) ("MMP14" . SPARSER::PROTEIN)
    ("TIMP2" . SPARSER::PROTEIN) ("GM6001" . SPARSER::DRUG)
    ("Anti-phospho" . SPARSER::PROTEIN) ("EMS1" . SPARSER::PROTEIN)
    ("ASAP1" . SPARSER::PROTEIN) ("AMAP1" . SPARSER::PROTEIN)
    ("dynamin2" . SPARSER::PROTEIN) ("Tks5" . SPARSER::PROTEIN)
    ("MT1-MMP" . SPARSER::PROTEIN) ("N-WASP" . SPARSER::PROTEIN)
    ("v-Src" . SPARSER::PROTEIN) ("KIT and VEGFR2" . SPARSER::COLLECTION)
    ("ligand or receptor" . SPARSER::COLLECTION)
    ("PDGFRA , KIT or VEGFR2" . SPARSER::COLLECTION)
    ("concurrent PDGFRA and KIT amplification fell" . SPARSER::PROTEIN)
    ("fell" . SPARSER::PROTEIN) ("gene or combination" . SPARSER::COLLECTION)
    ("PDGFRA , KIT and VEGFR2" . SPARSER::COLLECTION)
    ("PDGFRA, KIT and VEGFR2" . SPARSER::COLLECTION)
    ("stem cell factor (SCF)" . SPARSER::PROTEIN)
    ("the glioblastoma-associated vasculature" . SPARSER::PROTEIN)
    ("VEGF/VEGFR2" . SPARSER::COLLECTION)
    ("the receptor tyrosine kinases (RTKs) and drug targets PDGFRA , KIT , and KDR (VEGFR2)"
     . SPARSER::COLLECTION)
    ("PDGFRA , KIT , and KDR" . SPARSER::COLLECTION)
    ("KIT or VEGFR2" . SPARSER::COLLECTION)
    ("PDGFRA and KIT" . SPARSER::COLLECTION) ("MGMT" . SPARSER::PROTEIN)
    ("PDGFRA/KIT/VEGFR2" . SPARSER::COLLECTION)
    ("PDGFRA/KIT" . SPARSER::COLLECTION)
    ("types and patterns" . SPARSER::COLLECTION)
    ("PDGFRA , KIT , and VEGFR2" . SPARSER::COLLECTION)
    ("E19" . SPARSER::PROTEIN) ("D11" . SPARSER::PROTEIN)
    ("CD117" . SPARSER::PROTEIN) ("IDH1" . SPARSER::PROTEIN)
    ("taking cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("either the drug or the EGFR ECD xref" . SPARSER::COLLECTION)
    ("BRAF , PIK3CA , and PTEN" . SPARSER::COLLECTION)
    ("Cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("normal sera" . SPARSER::PROTEIN) ("infinite reagent" . SPARSER::MOLECULE)
    ("these EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("cetuximab and panitumumab-unbound fraction of EGFR"
     . SPARSER::COLLECTION)
    ("between-run" . SPARSER::PROTEIN) ("within-run" . SPARSER::PROTEIN)
    ("ErbB2, ErbB 3, and ErbB 4" . SPARSER::COLLECTION)
    ("spiked" . SPARSER::PROTEIN)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("commercial oligonucleotide" . SPARSER::MOLECULE)
    ("dUTPs" . SPARSER::MOLECULE) ("antibody or aptamer" . SPARSER::COLLECTION)
    ("EGFR and cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("gefitinib and progression-free survival xref" . SPARSER::COLLECTION)
    ("metastatic colon cancer, and cetuximab" . SPARSER::COLLECTION)
    ("colon cancer, and cetuximab" . SPARSER::COLLECTION)
    ("two monoclonal antibodies, cetuximab and panitumumab"
     . SPARSER::COLLECTION)
    ("antibodies, cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("HER-2/neu" . SPARSER::COLLECTION)
    ("transforming growth factor-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epigen" . SPARSER::PROTEIN) ("epiregulin" . SPARSER::PROTEIN)
    ("betacellulin" . SPARSER::PROTEIN) ("amphiregulin" . SPARSER::PROTEIN)
    ("Her-1 and ErbB1" . SPARSER::COLLECTION)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("using normal sera" . SPARSER::PROTEIN) ("ECD" . SPARSER::PROTEIN)
    ("One possible etiologic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cetuximab (Erbitux®) and panitumumab (Vectibix®)" . SPARSER::COLLECTION)
    ("Erbitux" . SPARSER::DRUG) ("ErbB 4" . SPARSER::PROTEIN)
    ("ErbB 3" . SPARSER::PROTEIN) ("erbB4" . SPARSER::PROTEIN)
    ("erbB3" . SPARSER::PROTEIN) ("erbB2" . SPARSER::PROTEIN)
    ("TGF-α" . SPARSER::PROTEIN) ("Her-1" . SPARSER::PROTEIN)
    ("insulin receptor, c-Met and M-CSF" . SPARSER::COLLECTION)
    ("GM-CSF and IL-3" . SPARSER::COLLECTION)
    ("Shc-1/Grb2" . SPARSER::COLLECTION)
    ("Ras and the downstream MAP kinases" . SPARSER::COLLECTION)
    ("Grb2 and Shc-1" . SPARSER::COLLECTION)
    ("Ras-mitogen activated protein kinase" . SPARSER::COLLECTION)
    ("SOCS3 and its physiological ligand" . SPARSER::COLLECTION)
    ("a biologically relevant target" . SPARSER::TARGET-PROTEIN)
    ("these two well-characterised JAK inhibitors" . SPARSER::INHIBITOR)
    ("SOCS1 or SOCS3" . SPARSER::COLLECTION)
    ("JAK1 and SOCS5" . SPARSER::COLLECTION)
    ("JAK1, JAK2, JAK3 and TYK" . SPARSER::COLLECTION)
    ("both JAK and the EGF-R" . SPARSER::COLLECTION)
    ("EGF and growth factor" . SPARSER::COLLECTION)
    ("Flag-tagged Shc-1 or Flag-tagged SOCS5" . SPARSER::COLLECTION)
    ("SOCS5-SH2" . SPARSER::COLLECTION)
    ("the JAK1(pY1033) and JAK2(pY1007) catalytic loop tyrosines ( K  D 17 and 78 µM, respectively)"
     . SPARSER::COLLECTION)
    ("GST-SOCS5-SH2" . SPARSER::COLLECTION) ("invariant" . SPARSER::PROTEIN)
    ("the relevant SOCS4" . SPARSER::PROTEIN)
    ("pervanadate and MG132" . SPARSER::COLLECTION)
    ("GST-SOCS4-SH2" . SPARSER::COLLECTION) ("pervanadate" . SPARSER::PROTEIN)
    ("JAK1 or JAK2" . SPARSER::COLLECTION)
    ("SOCS5 or SOCS5" . SPARSER::COLLECTION)
    ("JAK3 and TYK2" . SPARSER::COLLECTION)
    ("JAK2, JAK3, or TYK2" . SPARSER::COLLECTION) ("amine" . SPARSER::MOLECULE)
    ("JAK and SOCS" . SPARSER::COLLECTION) ("GST-JAK2" . SPARSER::COLLECTION)
    ("Flag-tagged JAK1 or Flag-tagged SOCS1, SOCS3 or SOCS5"
     . SPARSER::COLLECTION)
    ("SOCS1, SOCS3 or SOCS5" . SPARSER::COLLECTION)
    ("-ATP and phosphate" . SPARSER::COLLECTION)
    ("Flag-tagged JAK1 and either Flag-tagged SOCS1 or SOCS5"
     . SPARSER::COLLECTION)
    ("JAK-associated SOCS5" . SPARSER::PROTEIN)
    ("JAK1, JAK2, JAK3 and TYK2" . SPARSER::COLLECTION)
    ("a modest impact" . SPARSER::PROTEIN)
    ("antibody and JAK" . SPARSER::COLLECTION)
    ("JAK1, JAK2, JAK3, or TYK2" . SPARSER::COLLECTION)
    ("SOCS2, SOCS3, SOCS4 or SOCS6" . SPARSER::COLLECTION)
    ("SOCS1 or SOCS5" . SPARSER::COLLECTION)
    ("SOCS5 and JAK" . SPARSER::COLLECTION)
    ("SOCS1 and SOCS5" . SPARSER::COLLECTION)
    ("JAK and EGF-R" . SPARSER::COLLECTION)
    ("CIS, SOCS6 and SOCS7" . SPARSER::COLLECTION)
    ("SOCS1-3" . SPARSER::COLLECTION) ("SOCS4 and SOCS5" . SPARSER::COLLECTION)
    ("JAK1, JAK2 and TYK2" . SPARSER::COLLECTION)
    ("JAK/receptor/SOCS3" . SPARSER::COLLECTION) ("KIR" . SPARSER::PROTEIN)
    ("SOCS2 and CIS" . SPARSER::COLLECTION) ("elongins" . SPARSER::PROTEIN)
    ("protein (CIS)" . SPARSER::PROTEIN)
    ("proteins, SOCS1-7 and cytokine" . SPARSER::COLLECTION)
    ("JAK1-" . SPARSER::PROTEIN) ("apex" . SPARSER::PROTEIN)
    ("sit" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tyrosine and serine/threonine" . SPARSER::COLLECTION)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("SOCS1 and SOCS3" . SPARSER::COLLECTION)
    ("JAK1 and JAK2" . SPARSER::COLLECTION)
    ("JAK3 or TYK2" . SPARSER::COLLECTION) ("c-Met" . SPARSER::PROTEIN)
    ("Stat6" . SPARSER::PROTEIN) ("activation peptide" . SPARSER::PROTEIN)
    ("HSV-TK" . SPARSER::PROTEIN) ("hStat6" . SPARSER::PROTEIN)
    ("Gly-Ser" . SPARSER::MOLECULE) ("TM 4" . SPARSER::PROTEIN)
    ("D-1" . SPARSER::PROTEIN) ("mSH2" . SPARSER::PROTEIN)
    ("SOCS-5" . SPARSER::PROTEIN) ("IL-4R" . SPARSER::PROTEIN)
    ("SOCS7" . SPARSER::PROTEIN) ("SOCS6" . SPARSER::PROTEIN)
    ("SOCS2" . SPARSER::PROTEIN) ("Rbx2" . SPARSER::PROTEIN)
    ("Cullin5" . SPARSER::PROTEIN) ("Shc-1" . SPARSER::PROTEIN)
    ("SOCS1" . SPARSER::PROTEIN) ("TYK2" . SPARSER::PROTEIN)
    ("SOCS5" . SPARSER::PROTEIN)
    ("Suppressor of Cytokine Signaling" . SPARSER::PROTEIN)
    ("Sak" . SPARSER::PROTEIN) ("QR" . SPARSER::PROTEIN)
    ("oxaliplatin" . SPARSER::DRUG) ("Fluorouracil" . SPARSER::DRUG)
    ("Dai" . SPARSER::PROTEIN) ("b, and DNA ligase III" . SPARSER::COLLECTION)
    ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TT or Arg/Gln+Gln/Gln" . SPARSER::COLLECTION)
    ("Arg/Arg" . SPARSER::COLLECTION) ("TM" . SPARSER::PROTEIN)
    ("XRCC1 and XRCC3" . SPARSER::COLLECTION)
    ("these polymorphic genes" . SPARSER::GENE)
    ("at least 16 protein components" . SPARSER::COMPONENT)
    ("Hao" . SPARSER::PROTEIN) ("the cellular genome" . SPARSER::PROTEIN)
    ("DNA-repair" . SPARSER::DNA) ("DNA ligase III" . SPARSER::PROTEIN)
    ("XRCC 3" . SPARSER::PROTEIN) ("XRCC 1" . SPARSER::PROTEIN)
    ("TIN/PIN" . SPARSER::COLLECTION)
    ("these unspliced intronic lncRNAs" . SPARSER::RNA)
    ("TIN and PIN" . SPARSER::COLLECTION) ("PIN" . SPARSER::PROTEIN)
    ("TIN" . SPARSER::PROTEIN) ("the intergenic lncRNA" . SPARSER::RNA)
    ("HOXA" . SPARSER::PROTEIN)
    ("the repressive mark H3K27me3" . SPARSER::MOLECULE)
    ("the location-specific cis" . SPARSER::PROTEIN)
    ("intronic unspliced lncRNA" . SPARSER::RNA) ("Kcnq1" . SPARSER::PROTEIN)
    ("this intronic unspliced lncRNA" . SPARSER::RNA)
    ("intronic ncRNA" . SPARSER::RNA)
    ("an EZH2-bound intronic unspliced RNA" . SPARSER::RNA)
    ("intron" . SPARSER::PROTEIN) ("ncRNA" . SPARSER::RNA)
    ("many intronic RNA" . SPARSER::RNA) ("DNA-methyl" . SPARSER::DNA)
    ("the RASSF1C promoter and the promoters" . SPARSER::COLLECTION)
    ("H3K27me3 and PRC2" . SPARSER::COLLECTION)
    ("the well-studied intergenic lncRNAs" . SPARSER::RNA)
    ("an unspliced intronic lncRNA and a member of a poorly characterized class of RNAs"
     . SPARSER::COLLECTION)
    ("intronic unspliced RNAs" . SPARSER::RNA)
    ("an unspliced intronic lncRNA" . SPARSER::RNA)
    ("Kcnq1ot1 and Xist" . SPARSER::COLLECTION) ("Kcnq1ot1" . SPARSER::PROTEIN)
    ("Xist" . SPARSER::PROTEIN)
    ("ssRNA and RNA-DNA hybrids" . SPARSER::COLLECTION)
    ("ssRNA" . SPARSER::RNA) ("RASSF1A or RASSF1C" . SPARSER::COLLECTION)
    ("RNase-ChIP" . SPARSER::COLLECTION)
    ("RNase H or RNase" . SPARSER::COLLECTION)
    ("PRC2 and DNMT3B" . SPARSER::COLLECTION)
    ("promoter or DNA" . SPARSER::COLLECTION)
    ("anti-SUZ12 and anti-EZH2" . SPARSER::COLLECTION)
    ("MYC/PRC2" . SPARSER::COLLECTION)
    ("UVC light or the cytotoxic anti-cancer drug staurosporine"
     . SPARSER::COLLECTION)
    ("a bidirectional promoter" . SPARSER::PROMOTER)
    ("abundant intergenic lncRNAs" . SPARSER::RNA) ("SFPQ" . SPARSER::PROTEIN)
    ("HOTAIR" . SPARSER::PROTEIN) ("RASSF1 and Daxx" . SPARSER::COLLECTION)
    ("Daxx" . SPARSER::PROTEIN) ("ester and ionomycin" . SPARSER::COLLECTION)
    ("adenines" . SPARSER::NUCLEOBASE) ("ESTs" . SPARSER::PROTEIN)
    ("the repressive mark" . SPARSER::PROTEIN)
    ("a novel unspliced antisense intronic lncRNA" . SPARSER::RNA)
    ("Intergenic lncRNAs" . SPARSER::RNA)
    ("DNMT3B and the polycomb repressor complex 2 (PRC2)"
     . SPARSER::COLLECTION)
    ("only two isoforms" . SPARSER::ISOFORM)
    ("RASSF1A and RASSF1C" . SPARSER::COLLECTION)
    ("unspliced intronic lncRNAs" . SPARSER::RNA) ("lncRNAs" . SPARSER::RNA)
    ("MLL1" . SPARSER::PROTEIN) ("HOXA7" . SPARSER::PROTEIN)
    ("SMYD3" . SPARSER::PROTEIN) ("HOX3B" . SPARSER::PROTEIN)
    ("single-stranded RNA" . SPARSER::RNA) ("Alpha-tubulin" . SPARSER::PROTEIN)
    ("NPRL2" . SPARSER::PROTEIN) ("TUSC2" . SPARSER::PROTEIN)
    ("MALAT1" . SPARSER::PROTEIN) ("α-amanitin" . SPARSER::MOLECULE)
    ("RNA Polymerase II" . SPARSER::PROTEIN) ("SUZ12" . SPARSER::PROTEIN)
    ("MYC proto-oncogene protein" . SPARSER::PROTEIN)
    ("DNA methyltransferase" . SPARSER::PROTEIN) ("DNMT3B" . SPARSER::PROTEIN)
    ("HOXB3" . SPARSER::PROTEIN) ("family member 1" . SPARSER::PROTEIN)
    ("HER3-PI3K" . SPARSER::COLLECTION) ("expressed HER3" . SPARSER::PROTEIN)
    ("ku" . SPARSER::PROTEIN) ("active dimers" . SPARSER::DIMER)
    ("receptor type (EGFR)" . SPARSER::PROTEIN)
    ("the smaller R13 dimer" . SPARSER::DIMER)
    ("MAPK and Akt" . SPARSER::COLLECTION) ("Erk or Akt" . SPARSER::COLLECTION)
    ("pR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptors and HER" . SPARSER::COLLECTION)
    ("EGFR and HER3" . SPARSER::COLLECTION)
    ("expressed both EGFR and HER2" . SPARSER::COLLECTION)
    ("EGFR or HER3" . SPARSER::COLLECTION) ("HER2−" . SPARSER::PROTEIN)
    ("HER1, HER2, and HER3" . SPARSER::COLLECTION)
    ("S14, S15, and S16" . SPARSER::COLLECTION) ("Dimer" . SPARSER::DIMER)
    ("2C4-HER2" . SPARSER::PROTEIN-PAIR)
    ("the cellular HER2" . SPARSER::PROTEIN) ("Pertuzumab" . SPARSER::DRUG)
    ("HER1 and HER2" . SPARSER::COLLECTION)
    ("the R11 homodimer and the R12 heterodimer (in our notation Rij refers to the HERi-HERj dimer)"
     . SPARSER::COLLECTION)
    ("HRG, ligand-bound and unbound receptor monomers" . SPARSER::COLLECTION)
    ("Erk and Akt" . SPARSER::COLLECTION) ("HER1-3" . SPARSER::COLLECTION)
    ("HER1, HER2 and HER3" . SPARSER::COLLECTION)
    ("HER1, Erk and Akt" . SPARSER::COLLECTION)
    ("HER1, HER2, Erk and Akt" . SPARSER::COLLECTION)
    ("known ligand" . SPARSER::LIGAND)
    ("EGFR, HER2 and HER3" . SPARSER::COLLECTION)
    ("HER1 (EGFR)" . SPARSER::PROTEIN) ("HER3 and HER4" . SPARSER::COLLECTION)
    ("NEU" . SPARSER::PROTEIN) ("HER2-HER3" . SPARSER::COLLECTION)
    ("HER1-HER3" . SPARSER::COLLECTION) ("HER1-HER2" . SPARSER::COLLECTION)
    ("HER1-HER1" . SPARSER::COLLECTION) ("EGF and HRG" . SPARSER::COLLECTION)
    ("pertuzumab" . SPARSER::DRUG) ("HER/ErbB" . SPARSER::COLLECTION)
    ("pf22" . SPARSER::PROTEIN) ("S23" . SPARSER::PROTEIN)
    ("S25" . SPARSER::PROTEIN) ("S24" . SPARSER::PROTEIN)
    ("receptor type" . SPARSER::PROTEIN) ("S21" . SPARSER::PROTEIN)
    ("S19" . SPARSER::PROTEIN) ("S18" . SPARSER::PROTEIN)
    ("S17" . SPARSER::PROTEIN) ("S16" . SPARSER::PROTEIN)
    ("HER4" . SPARSER::PROTEIN) ("Akt and S6RP" . SPARSER::COLLECTION)
    ("rapamycin and wortmannin" . SPARSER::COLLECTION)
    ("Akt/GSK3" . SPARSER::COLLECTION)
    ("phospho-Ser2448 mTOR and phospho-Ser235/236 S6RP" . SPARSER::COLLECTION)
    ("phospho-Thr308 Akt, phospho-Ser2448 mTOR and phospho-Ser235/236 S6RP"
     . SPARSER::COLLECTION)
    ("Akt, mTOR and S6RP" . SPARSER::COLLECTION)
    ("mTOR/S6K" . SPARSER::COLLECTION)
    ("loss of heterozygosity or PTEN" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("mTOR and PI3K" . SPARSER::COLLECTION)
    ("the ribosomal protein S6 kinase (S6K) and the translational initiation factor eIF-4E-binding protein 1 (4EBP1)"
     . SPARSER::COLLECTION)
    ("the translational initiation factor eIF-4E-binding protein 1"
     . SPARSER::COLLECTION)
    ("eIF-4E-binding protein 1" . SPARSER::COLLECTION)
    ("/mammalian target of Rapamycin" . SPARSER::COLLECTION)
    ("functional PTEN" . SPARSER::PROTEIN)
    ("PTEN, and rapamycin" . SPARSER::COLLECTION)
    ("everolimus" . SPARSER::DRUG) ("TCC" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("Insulin Receptor Substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("4E-binding protein 1" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("Protein Kinase B" . SPARSER::PROTEIN)
    ("mammalian target of Rapamycin" . SPARSER::PROTEIN)
    ("-mRNA" . SPARSER::RNA) ("RhoA and cdc42" . SPARSER::COLLECTION)
    ("p-p38 and Rac1" . SPARSER::COLLECTION)
    ("NGF and p75" . SPARSER::COLLECTION) ("Pain" . SPARSER::PROTEIN)
    ("Salubrinal" . SPARSER::DRUG) ("Rac1 and siRNA" . SPARSER::COLLECTION)
    ("NGFβ mRNA (p=0.0014) and p75 mRNA (p=0.007)" . SPARSER::COLLECTION)
    ("NGF and receptor" . SPARSER::COLLECTION)
    ("NGF and its receptors" . SPARSER::COLLECTION) ("Trk" . SPARSER::PROTEIN)
    ("three major neurotrophins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("trophic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neurotrophins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a unique form" . SPARSER::FORM) ("dyn/cm 2" . SPARSER::COLLECTION)
    ("dyn" . SPARSER::PROTEIN) ("cm 2" . SPARSER::PROTEIN)
    ("p38-p" . SPARSER::COLLECTION) ("eIF2α" . SPARSER::PROTEIN)
    ("salubrinal" . SPARSER::DRUG)
    ("eukaryotic translation initiation factor 2" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("beta subunit" . SPARSER::PROTEIN) ("Plasminogen" . SPARSER::PROTEIN)
    ("tensin" . SPARSER::PROTEIN) ("the metastatic subline" . SPARSER::PROTEIN)
    ("correlative factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("clinical pathologic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("uPA/uPAR/PAI-1" . SPARSER::COLLECTION) ("uPAR" . SPARSER::PROTEIN)
    ("tPA and uPA" . SPARSER::COLLECTION) ("uPA" . SPARSER::PROTEIN)
    ("tPA" . SPARSER::PROTEIN) ("plasminogen" . SPARSER::PROTEIN)
    ("DLC1 and PAI-1" . SPARSER::COLLECTION)
    ("liver cancer 1 (DLC1) and plasminogen activator inhibitor 1 (PAI-1)"
     . SPARSER::COLLECTION)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("PAI1" . SPARSER::PROTEIN) ("plasminogen activator" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("DLC-1" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("DLC1" . SPARSER::PROTEIN) ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gene or pathway" . SPARSER::COLLECTION) ("v" . SPARSER::PROTEIN)
    ("the most preponderant BRAF variant" . SPARSER::VARIANT)
    ("BRAF or NRAS" . SPARSER::COLLECTION) ("available DNA" . SPARSER::DNA)
    ("Southern parts" . SPARSER::COMPONENT)
    ("intron-exon" . SPARSER::PROTEIN-PAIR) ("whose DNA" . SPARSER::DNA)
    ("BRAF-NRAS" . SPARSER::COLLECTION) ("sun" . SPARSER::PROTEIN)
    ("NRAS and BRAF" . SPARSER::COLLECTION)
    ("NRAS, BRAF, MEK1/2, and ERK1/2" . SPARSER::COLLECTION)
    ("immunostimulatory antibodies" . SPARSER::ANTIBODY)
    ("Melanoma" . SPARSER::PROTEIN) ("BRAF/NRAS" . SPARSER::COLLECTION)
    ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("the viral proteins" . SPARSER::PROTEIN)
    ("T-cell receptor and signaling molecules" . SPARSER::COLLECTION)
    ("replication competent HIV-1 genomes" . SPARSER::PROTEIN)
    ("CCR5 and low nucleotide" . SPARSER::COLLECTION)
    ("antiretroviral drugs" . SPARSER::DRUG) ("chitinase" . SPARSER::PROTEIN)
    ("available thymic DCs" . SPARSER::PROTEIN)
    ("Thymic DCs" . SPARSER::PROTEIN) ("TEC" . SPARSER::PROTEIN)
    ("TREC" . SPARSER::PROTEIN) ("CD4 or CD8" . SPARSER::COLLECTION)
    ("the complex soluble and cellular component" . SPARSER::COMPONENT)
    ("TNF-α and TNFR-2" . SPARSER::COLLECTION)
    ("macrophages and CD8+" . SPARSER::COLLECTION)
    ("macrophages and TNFR-2" . SPARSER::COLLECTION)
    ("TNF-α and TNF" . SPARSER::COLLECTION)
    ("CD4 and coreceptor" . SPARSER::COLLECTION)
    ("HIV-1 soluble envelope glycoproteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRAIL/DR5" . SPARSER::COLLECTION) ("Fas/FasL" . SPARSER::COLLECTION)
    ("TNF/TNFR superfamily" . SPARSER::COLLECTION)
    ("caspase-3 and caspase-1" . SPARSER::COLLECTION)
    ("Env and CXCR4" . SPARSER::COLLECTION) ("Env" . SPARSER::PROTEIN)
    ("gp120/gp41" . SPARSER::COLLECTION) ("AICD" . SPARSER::PROTEIN)
    ("Vpr and GR" . SPARSER::COLLECTION)
    ("the NF-ĸB inducible kinase (NIK) and cytokines" . SPARSER::COLLECTION)
    ("kinase (NIK)" . SPARSER::KINASE)
    ("IL-2, IL-12, TNF-α, IL-4, MIP-1α, MIP-1β and RANTES"
     . SPARSER::COLLECTION)
    ("RANTES" . SPARSER::PROTEIN) ("NIK" . SPARSER::PROTEIN)
    ("IL-12 and TGF-β" . SPARSER::COLLECTION)
    ("superantigens" . SPARSER::MOLECULE)
    ("the main costimulatory molecules" . SPARSER::MOLECULE)
    ("CD28 and CTLA-4" . SPARSER::COLLECTION)
    ("CD80 and CD86" . SPARSER::COLLECTION)
    ("various immunoregulatory molecules" . SPARSER::MOLECULE)
    ("ɣ" . SPARSER::PROTEIN)
    ("Bcl-xL, Bax and caspase 1" . SPARSER::COLLECTION)
    ("extracellular or soluble Vpr [ xref - xref ]" . SPARSER::COLLECTION)
    ("soluble Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA and SIV-Nef vaccination in vivo" . SPARSER::COLLECTION)
    ("IFN-ɣ" . SPARSER::COLLECTION) ("p300 and TFIIH" . SPARSER::COLLECTION)
    ("TFIIB and Vpr" . SPARSER::COLLECTION) ("TFIIB" . SPARSER::PROTEIN)
    ("NF-kB and Sp1" . SPARSER::COLLECTION)
    ("the cellular transcription factor Sp1" . SPARSER::PROTEIN)
    ("NFAT, GRE, NRF, NF-ĸB and Sp1" . SPARSER::COLLECTION)
    ("NRF" . SPARSER::PROTEIN)
    ("an essential HIV-1 protein" . SPARSER::PROTEIN)
    ("viral preintegration complex" . SPARSER::BIO-COMPLEX)
    ("IL-1 and IL-6" . SPARSER::COLLECTION)
    ("phosphatase, PTEN and PP2A" . SPARSER::COLLECTION)
    ("CD3 or CD28" . SPARSER::COLLECTION)
    ("fully glycosylated simian IL-7" . SPARSER::PROTEIN)
    ("The soluble Tat protein" . SPARSER::PROTEIN)
    ("CCR5 and CXCR4" . SPARSER::COLLECTION)
    ("TH1 and pro-inflammatory" . SPARSER::COLLECTION)
    ("TH1" . SPARSER::PROTEIN) ("integrin and chemokine" . SPARSER::COLLECTION)
    ("sulphate" . SPARSER::MOLECULE) ("The soluble form" . SPARSER::FORM)
    ("multifunctional protein" . SPARSER::PROTEIN)
    ("immunosuppressive cytokines" . SPARSER::PROTEIN)
    ("soluble gp120" . SPARSER::PROTEIN) ("gp120-CXCR4" . SPARSER::COLLECTION)
    ("a unique barrier" . SPARSER::PROTEIN)
    ("The static cortical actin" . SPARSER::PROTEIN)
    ("chemotaxis and T-cell" . SPARSER::COLLECTION)
    ("CD4/CXCR4" . SPARSER::COLLECTION)
    ("Erk-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CXCR4 or CCR5" . SPARSER::COLLECTION) ("coreceptor" . SPARSER::PROTEIN)
    ("receptors, CXCR4 and CCR5" . SPARSER::COLLECTION)
    ("Fas and TNFR" . SPARSER::COLLECTION) ("JNK/p38" . SPARSER::COLLECTION)
    ("MIP-1α and MIP-1β" . SPARSER::COLLECTION)
    ("immature DCs" . SPARSER::PROTEIN)
    ("macrophages or DCs" . SPARSER::COLLECTION)
    ("the viral promoter" . SPARSER::PROMOTER)
    ("NFAT and NF-ĸB" . SPARSER::COLLECTION)
    ("ATP and nuclear transcription factors [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vav and Vav2" . SPARSER::COLLECTION)
    ("Lck and Hck" . SPARSER::COLLECTION) ("Hck" . SPARSER::PROTEIN)
    ("a modular protein" . SPARSER::PROTEIN) ("polyproline" . SPARSER::PROTEIN)
    ("adaptor protein Vav [ xref ] and LAT [ xref ]" . SPARSER::COLLECTION)
    ("ERK1 and ERK2" . SPARSER::COLLECTION)
    ("DOCK2-ELMO1" . SPARSER::COLLECTION) ("Lck" . SPARSER::PROTEIN)
    ("Vav" . SPARSER::PROTEIN)
    ("both the T-cell receptor and its immediate downstream effectors"
     . SPARSER::COLLECTION)
    ("its immediate downstream effectors" . SPARSER::EFFECTOR)
    ("LAT and p42/44" . SPARSER::COLLECTION)
    ("MAP kinase and CD3" . SPARSER::COLLECTION) ("LAT" . SPARSER::PROTEIN)
    ("nef" . SPARSER::PROTEIN)
    ("the viral encoded proteins" . SPARSER::PROTEIN)
    ("Each viral protein" . SPARSER::PROTEIN)
    ("HIV-1 viral proteins" . SPARSER::PROTEIN)
    ("PROTEINS AND T-CELL" . SPARSER::COLLECTION)
    ("PROTEINS" . SPARSER::PROTEIN) ("memory T-cell" . SPARSER::PROTEIN)
    ("abnormal T-cell" . SPARSER::PROTEIN)
    ("the mucosal barrier" . SPARSER::PROTEIN) ("MALT" . SPARSER::PROTEIN)
    ("CHI3L1" . SPARSER::PROTEIN) ("Bcl- XL" . SPARSER::PROTEIN)
    ("TNFR2" . SPARSER::PROTEIN) ("chemokine receptor" . SPARSER::PROTEIN)
    ("envelope glycoproteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNFR superfamily" . SPARSER::PROTEIN)
    ("gp41" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sensitive to apoptosis" . SPARSER::PROTEIN) ("T-Cell" . SPARSER::PROTEIN)
    ("RU486" . SPARSER::DRUG) ("smad-3" . SPARSER::PROTEIN)
    ("NKG2D" . SPARSER::PROTEIN) ("caspase 1" . SPARSER::PROTEIN)
    ("virion-associated protein" . SPARSER::PROTEIN)
    ("T-cell growth factor" . SPARSER::PROTEIN)
    ("Fas ligand" . SPARSER::PROTEIN) ("IL-7" . SPARSER::PROTEIN)
    ("Erk-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Pyk2" . SPARSER::PROTEIN)
    ("apoptosis signal regulating kinase 1" . SPARSER::PROTEIN)
    ("DC-SIGN" . SPARSER::PROTEIN) ("MIP-1β" . SPARSER::PROTEIN)
    ("MIP-1α" . SPARSER::PROTEIN) ("Vav2" . SPARSER::PROTEIN)
    ("ELMO1" . SPARSER::PROTEIN) ("DOCK2" . SPARSER::PROTEIN)
    ("T-CELL" . SPARSER::PROTEIN) ("Siglec-1" . SPARSER::PROTEIN)
    ("T- cell" . SPARSER::PROTEIN) ("gp120" . SPARSER::PROTEIN)
    ("only six nucleotides" . SPARSER::NUCLEOTIDE)
    ("JAK2 and MPL" . SPARSER::COLLECTION) ("MPL" . SPARSER::PROTEIN)
    ("Exon" . SPARSER::PROTEIN) ("vera (PV)" . SPARSER::PROTEIN)
    ("MPN" . SPARSER::PROTEIN) ("PV" . SPARSER::PROTEIN)
    ("vera" . SPARSER::PROTEIN)
    ("CRS, TN, EM, NN and SAL" . SPARSER::COLLECTION)
    ("CRS, TN, SFC, EM, NN and SAL" . SPARSER::COLLECTION)
    ("CRS, TN, ER, MM, AA, SFC and TF-N" . SPARSER::COLLECTION)
    ("SFC" . SPARSER::PROTEIN) ("CRS, TN, NN and SAL" . SPARSER::COLLECTION)
    ("SAL" . SPARSER::PROTEIN) ("NN" . SPARSER::PROTEIN)
    ("TN" . SPARSER::PROTEIN) ("Paraquat" . SPARSER::MOLECULE)
    ("Maneb" . SPARSER::MOLECULE)
    ("a neuroprotective molecule" . SPARSER::MOLECULE)
    ("nitrogen" . SPARSER::MOLECULE) ("sporadic forms" . SPARSER::FORM)
    ("‘sporadic’ forms" . SPARSER::FORM)
    ("agricultural pesticides" . SPARSER::MOLECULE)
    ("exogenously-expressed parkin" . SPARSER::PROTEIN)
    ("p53, presenilin 1 and presenilin 2" . SPARSER::COLLECTION)
    ("SNO-parkin/parkin" . SPARSER::COLLECTION) ("flash" . SPARSER::PROTEIN)
    ("nNOS" . SPARSER::PROTEIN)
    ("these agricultural chemicals" . SPARSER::MOLECULE)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("the general neuronal markers NeuN and MAP2" . SPARSER::COLLECTION)
    ("NeuN and MAP2" . SPARSER::COLLECTION) ("NeuN" . SPARSER::PROTEIN)
    ("transporters (DAT)" . SPARSER::PROTEIN)
    ("ctrl-shRNA" . SPARSER::COLLECTION)
    ("GFP-p53-shRNA" . SPARSER::COLLECTION)
    ("the herbicide paraquat (PQ) and fungicide maneb (MB)"
     . SPARSER::COLLECTION)
    ("maneb (MB)" . SPARSER::MOLECULE) ("paraquat (PQ)" . SPARSER::MOLECULE)
    ("maneb" . SPARSER::MOLECULE) ("paraquat" . SPARSER::MOLECULE)
    ("Pesticide" . SPARSER::MOLECULE)
    ("pcDNA and non-targeting" . SPARSER::COLLECTION)
    ("ctrl-" . SPARSER::PROTEIN) ("ctrl" . SPARSER::PROTEIN)
    ("p53-shRNA" . SPARSER::COLLECTION) ("parkin-Pp53" . SPARSER::PROTEIN-PAIR)
    ("GSNO" . SPARSER::MOLECULE)
    ("transiently expressing parkin" . SPARSER::PROTEIN)
    ("expressing parkin" . SPARSER::PROTEIN) ("pesticides" . SPARSER::MOLECULE)
    ("pars" . SPARSER::PROTEIN) ("SNO-parkin" . SPARSER::COLLECTION)
    ("parkin and p53" . SPARSER::COLLECTION) ("SNO-" . SPARSER::PROTEIN)
    ("SNO" . SPARSER::PROTEIN) ("NOS" . SPARSER::PROTEIN)
    ("pesticide" . SPARSER::MOLECULE)
    ("environmental toxins" . SPARSER::MOLECULE) ("toxins" . SPARSER::MOLECULE)
    ("an E3 ubiquitin ligase and transcriptional repressor"
     . SPARSER::COLLECTION)
    ("a neuroprotective protein" . SPARSER::PROTEIN)
    ("S-nitrosothiol" . SPARSER::MOLECULE)
    ("Nitric oxide synthase" . SPARSER::PROTEIN)
    ("Nitric oxide" . SPARSER::MOLECULE) ("L-Arginine" . SPARSER::MOLECULE)
    ("GL3" . SPARSER::PROTEIN) ("S-Nitrosothiol" . SPARSER::MOLECULE)
    ("microtubule-associated protein 2" . SPARSER::PROTEIN)
    ("neuronal NOS" . SPARSER::PROTEIN) ("l -Arginine" . SPARSER::MOLECULE)
    ("S-nitrosoglutathione" . SPARSER::MOLECULE)
    ("l-glutamine" . SPARSER::MOLECULE) ("presenilin 2" . SPARSER::PROTEIN)
    ("presenilin 1" . SPARSER::PROTEIN) ("l-arginine" . SPARSER::MOLECULE)
    ("NO synthase" . SPARSER::PROTEIN)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("Arg/Gln" . SPARSER::COLLECTION)
    ("Hae III restriction enzyme" . SPARSER::PROTEIN) ("GA" . SPARSER::PROTEIN)
    ("Hpa II restriction enzyme" . SPARSER::PROTEIN)
    ("new HCC" . SPARSER::PROTEIN) ("Gln/Gln" . SPARSER::COLLECTION)
    ("Trp/Trp" . SPARSER::COLLECTION)
    ("the XRCC1 homozygous Gln allele" . SPARSER::ALLELE)
    ("XRCC1 genetic variants and the risk" . SPARSER::COLLECTION)
    ("Mae II restriction enzyme" . SPARSER::PROTEIN)
    ("AG (238,166 and 72bp) and GG (166 and 72bp, Table xref )"
     . SPARSER::COLLECTION)
    ("Hha" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NP" . SPARSER::PROTEIN)
    ("CRS" . SPARSER::PROTEIN) ("X-ray repair" . SPARSER::PROTEIN)
    ("PTEN and IR" . SPARSER::COLLECTION)
    ("IGF1/PI3K/Akt" . SPARSER::COLLECTION)
    ("lethal outcome regardless IGF1R" . SPARSER::PROTEIN)
    ("PHS and HPFS" . SPARSER::COLLECTION)
    ("IGF1 and its binding proteins" . SPARSER::COLLECTION)
    ("age and PSA" . SPARSER::COLLECTION)
    ("clinical prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("included demographic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cohorts" . SPARSER::MOLECULE) ("PHS" . SPARSER::PROTEIN)
    ("IGF1/IGF1R" . SPARSER::COLLECTION)
    ("PI3K/PTEN/Akt" . SPARSER::COLLECTION)
    ("IGF1 and IGF" . SPARSER::COLLECTION)
    ("independent prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Impact" . SPARSER::PROTEIN)
    ("demographic and clinical factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IGFBP3" . SPARSER::PROTEIN) ("B subunit" . SPARSER::PROTEIN)
    ("Insulin Receptor" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("CCL2/CCR2-STAT3-EMT" . SPARSER::COLLECTION)
    ("CCL2-STAT3" . SPARSER::COLLECTION) ("CCL2/EMT" . SPARSER::COLLECTION)
    ("orthotopic AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16/INK4A" . SPARSER::COLLECTION)
    ("Snail and MMP9" . SPARSER::COLLECTION) ("new light" . SPARSER::PROTEIN)
    ("CCL2 and PCa" . SPARSER::COLLECTION)
    ("CCL2/CCR2/EMT" . SPARSER::COLLECTION)
    ("PIAS3, and pSTAT3" . SPARSER::COLLECTION)
    ("CCL2/STAT3/Snail" . SPARSER::COLLECTION)
    ("mediators, STAT3 and Snail" . SPARSER::COLLECTION)
    ("macrophages and CCL2" . SPARSER::COLLECTION)
    ("CCL2/CCR2/STAT3/EMT" . SPARSER::COLLECTION)
    ("AR and CCL2" . SPARSER::COLLECTION)
    ("CCL2 and pSTAT3, and co-culture" . SPARSER::COLLECTION)
    ("CCL2 and pSTAT3" . SPARSER::COLLECTION)
    ("anti-CCL2/CCR2" . SPARSER::COLLECTION)
    ("CCL2 and macrophage" . SPARSER::COLLECTION)
    ("CCL2/STAT3/EMT" . SPARSER::COLLECTION)
    ("MARKO/TRAMP" . SPARSER::COLLECTION)
    ("pesARKO/TRAMP" . SPARSER::COLLECTION) ("TRAMP" . SPARSER::PROTEIN)
    ("CCL2/STAT3" . SPARSER::COLLECTION)
    ("antagonist, or STAT3" . SPARSER::COLLECTION)
    ("CCL2 and STAT3" . SPARSER::COLLECTION)
    ("AR silencing-induced chemotactic factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCL2/CCR2" . SPARSER::COLLECTION) ("cyclohexane" . SPARSER::MOLECULE)
    ("atg" . SPARSER::DRUG) ("CCL2/CCR2/STAT3" . SPARSER::COLLECTION)
    ("STAT3 and EMT" . SPARSER::COLLECTION)
    ("scr or siAR" . SPARSER::COLLECTION)
    ("macrophage or prostatic epithelial AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LNCaP and LAPC4 cells co-cultured" . SPARSER::COLLECTION)
    ("MMP9 and Snail" . SPARSER::COLLECTION)
    ("E-Cadherin, AR and PSA" . SPARSER::COLLECTION)
    ("EMT and STAT3" . SPARSER::COLLECTION)
    ("macrophages or PCa" . SPARSER::COLLECTION)
    ("PCa/macrophage" . SPARSER::COLLECTION)
    ("CCL2, IL-1ra, IL-16, CXCL11 and TNFα" . SPARSER::COLLECTION)
    ("CXCL10 (IP10) and C5a ( xref D)" . SPARSER::COLLECTION)
    ("cytokines/chemokines" . SPARSER::COLLECTION)
    ("scr and siAR" . SPARSER::COLLECTION)
    ("lentiviral AR-siRNA" . SPARSER::COLLECTION)
    ("AR-siRNA" . SPARSER::COLLECTION) ("scr" . SPARSER::PROTEIN)
    ("macrophages and PCa" . SPARSER::COLLECTION)
    ("PCa and macrophages" . SPARSER::COLLECTION)
    ("tumour-associated macrophages" . SPARSER::PROTEIN)
    ("androgen/AR" . SPARSER::COLLECTION)
    ("anti-CCL2/CCR2-STAT3" . SPARSER::COLLECTION)
    ("EMT and PCa" . SPARSER::COLLECTION)
    ("CCL2 and EMT" . SPARSER::COLLECTION)
    ("CCL2/CCR2-STAT3" . SPARSER::COLLECTION) ("AC-3" . SPARSER::PROTEIN)
    ("AR 2" . SPARSER::PROTEIN) ("LSD1" . SPARSER::PROTEIN)
    ("INK4A" . SPARSER::PROTEIN) ("CD68" . SPARSER::PROTEIN)
    ("THP1" . SPARSER::PROTEIN) ("anti-androgen" . SPARSER::DRUG)
    ("CXCL11" . SPARSER::PROTEIN) ("IL-16" . SPARSER::PROTEIN)
    ("IL-1ra" . SPARSER::PROTEIN) ("C5a" . SPARSER::PROTEIN)
    ("IP10" . SPARSER::PROTEIN) ("GRO-1" . SPARSER::PROTEIN)
    ("CCL4" . SPARSER::PROTEIN) ("CCL3" . SPARSER::PROTEIN)
    ("sphingomyelinase" . SPARSER::PROTEIN)
    ("PKB, ERK1/2 and p38" . SPARSER::COLLECTION)
    ("kinases and compound C" . SPARSER::COLLECTION)
    ("ERK and PKB" . SPARSER::COLLECTION) ("IKKb" . SPARSER::PROTEIN)
    ("COPD" . SPARSER::PROTEIN)
    ("pro- or anti-inflammatory" . SPARSER::COLLECTION)
    ("another systemic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("Neutrophil" . SPARSER::PROTEIN)
    ("PI3K, ERK 1/2 and p38" . SPARSER::COLLECTION)
    ("AICAR and compound C" . SPARSER::COLLECTION)
    ("PI3K, ERK 1/2 and p38 MAPKs" . SPARSER::COLLECTION)
    ("compound C [ xref ] and adiponectin" . SPARSER::COLLECTION)
    ("Ceramide" . SPARSER::MOLECULE)
    ("Adiponectin, AICAR and compound C" . SPARSER::COLLECTION)
    ("the pharmacological AMPK activator AICAR and its inhibitor compound C"
     . SPARSER::COLLECTION)
    ("ERK or p38" . SPARSER::COLLECTION)
    ("PKB, ERK 1/2 and p38 MAPK" . SPARSER::COLLECTION)
    ("PKB, ERK 1/2 and p38" . SPARSER::COLLECTION)
    ("AMPK, PKB, ERK 1/2 and p38 MAPK" . SPARSER::COLLECTION)
    ("Annexin V/PI" . SPARSER::COLLECTION)
    ("PKB, ERK 1/2 and p38 MAPKs" . SPARSER::COLLECTION)
    ("PKB and ERK 1/2" . SPARSER::COLLECTION)
    ("AMPK and p38 MAPK" . SPARSER::COLLECTION)
    ("PKB and the MAPKs ERK 1/2 and p38" . SPARSER::COLLECTION)
    ("AMPK, PKB and the MAPKs ERK 1/2 and p38" . SPARSER::COLLECTION)
    ("adiponectin-treated neutrophils" . SPARSER::PROTEIN)
    ("adiponectin or AMPK" . SPARSER::COLLECTION)
    ("survivin [ xref ] and proliferating cell nuclear antigen [ xref ]"
     . SPARSER::COLLECTION)
    ("mature neutrophils" . SPARSER::PROTEIN)
    ("LPS [ xref ] and hypoxia [ xref , xref ]" . SPARSER::COLLECTION)
    ("TLR agonists [ xref ] and granulocyte macrophage colony-stimulating factor (GM-CSF)"
     . SPARSER::COLLECTION)
    ("PI3K/PKB" . SPARSER::COLLECTION)
    ("apoptotic neutrophils" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines [ xref , xref ] and hypoxia [ xref ]"
     . SPARSER::COLLECTION)
    ("AICAR or adiponectin" . SPARSER::COLLECTION)
    ("ceramide" . SPARSER::MOLECULE) ("activator (AICAR)" . SPARSER::ACTIVATOR)
    ("AMPK, PKB and ERK 1/2" . SPARSER::COLLECTION)
    ("AICAR" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase (ERK 1/2) and p38 mitogen activated protein kinase (MAPK)"
     . SPARSER::COLLECTION)
    ("AMP-activated kinase (AMPK), protein kinase B (PKB), extracellular signal-regulated kinase (ERK 1/2) and p38 mitogen activated protein kinase (MAPK)"
     . SPARSER::COLLECTION)
    ("kinase (AMPK)" . SPARSER::KINASE) ("AMPK" . SPARSER::PROTEIN)
    ("adiponectin" . SPARSER::PROTEIN) ("adipokine" . SPARSER::PROTEIN-FAMILY)
    ("Adiponectin" . SPARSER::PROTEIN) ("Neutrophils" . SPARSER::PROTEIN)
    ("death receptor" . SPARSER::PROTEIN) ("Compound C" . SPARSER::MOLECULE)
    ("5-Aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("CXCL8" . SPARSER::PROTEIN)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("compound C" . SPARSER::MOLECULE) ("AMP-activated" . SPARSER::PROTEIN)
    ("vincristine or paclitaxel" . SPARSER::COLLECTION)
    ("wt and mutant" . SPARSER::COLLECTION) ("genomes" . SPARSER::PROTEIN)
    ("p21 and/or p27" . SPARSER::COLLECTION)
    ("p21 (SUDHL4 and U2932) or p27 (SUDHL8)" . SPARSER::COLLECTION)
    ("p21 or p27" . SPARSER::COLLECTION)
    ("cyclin D and cyclin E-containing cdk" . SPARSER::COLLECTION)
    ("both cyclin D- and cyclin E-containing cdk" . SPARSER::COLLECTION)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21, p57, and p16" . SPARSER::COLLECTION) ("p21-" . SPARSER::PROTEIN)
    ("Bcl-2 or Bcl-X" . SPARSER::COLLECTION)
    ("the clinic HDACi" . SPARSER::MOLECULE)
    ("cyclin E and cdk2" . SPARSER::COLLECTION) ("wt" . SPARSER::PROTEIN)
    ("OCI" . SPARSER::PROTEIN) ("p53-MDM2" . SPARSER::COLLECTION)
    ("PXD101, doxorubicin, or Nutlin-3A" . SPARSER::COLLECTION)
    ("p21, p27, and p57" . SPARSER::COLLECTION)
    ("CIP/KIP" . SPARSER::COLLECTION) ("KIP" . SPARSER::PROTEIN)
    ("CIP" . SPARSER::PROTEIN) ("antibody and histone" . SPARSER::COLLECTION)
    ("either cyclin D- or cyclin E-containing complexes" . SPARSER::COLLECTION)
    ("cyclin D-" . SPARSER::PROTEIN) ("BCL2 and MYC" . SPARSER::COLLECTION)
    ("MYC or BCL2" . SPARSER::COLLECTION)
    ("MYC, BCL2, and GAPDH" . SPARSER::COLLECTION)
    ("c-Myc ( MYC ) and BCL2" . SPARSER::COLLECTION) ("MTS" . SPARSER::PROTEIN)
    ("the hydroxamic acid class" . CLASS) ("GCB and ABC" . SPARSER::COLLECTION)
    ("inhibitors (CKI)" . SPARSER::INHIBITOR) ("belinostat" . SPARSER::DRUG)
    ("synergistic therapeutics" . SPARSER::THERAPEUTICS)
    ("These drugs target class I and II histone deacetylases (HDACs)"
     . SPARSER::COLLECTION)
    ("II histone deacetylases" . SPARSER::PROTEIN)
    ("ABC and GCB" . SPARSER::COLLECTION)
    ("HDACi, vorinostat and romidepsin" . SPARSER::COLLECTION)
    ("mitogens" . SPARSER::MITOGEN) ("MYC and BCL-2" . SPARSER::COLLECTION)
    ("two predominant subtypes" . SPARSER::PROTEIN)
    ("cyclophosphamide, doxorubicin, vincristine, and prednisone"
     . SPARSER::COLLECTION)
    ("vincristine" . SPARSER::DRUG) ("cyclophosphamide" . SPARSER::DRUG)
    ("rituximab" . SPARSER::DRUG) ("NHL" . SPARSER::PROTEIN)
    ("CKI" . SPARSER::PROTEIN) ("cyclin E/cdk2" . SPARSER::COLLECTION)
    ("CKIs" . SPARSER::PROTEIN) ("hydroxamate" . SPARSER::MOLECULE)
    ("HE12" . SPARSER::PROTEIN) ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nutlin3A" . SPARSER::DRUG) ("Nutlin-3A" . SPARSER::DRUG)
    ("suberoylanilide hydroxamic acid" . SPARSER::DRUG)
    ("cdk2" . SPARSER::PROTEIN) ("PXD101" . SPARSER::DRUG)
    ("Histone deacetylase" . SPARSER::PROTEIN)
    ("IL2 and IFNG" . SPARSER::COLLECTION)
    ("hyperglycemia and the O-GlcNAcylation" . SPARSER::COLLECTION)
    ("sugar" . SPARSER::MOLECULE)
    ("Pdx-1 ( xref ) and YY1 ( xref )" . SPARSER::COLLECTION)
    ("RHD" . SPARSER::PROTEIN)
    ("either wild-type c-Rel or the S350A mutant c-Rel" . SPARSER::COLLECTION)
    ("glucose and glucosamine" . SPARSER::COLLECTION)
    ("only c-Rel homodimers or c-Rel–p50 heterodimers" . SPARSER::COLLECTION)
    ("only c-Rel homodimers" . SPARSER::HOMODIMER)
    ("distinct c-Rel– and p65-containing complexes" . SPARSER::COLLECTION)
    ("distinct c-Rel–" . SPARSER::PROTEIN) ("c-Rel–" . SPARSER::PROTEIN)
    ("p65 and p50" . SPARSER::COLLECTION) ("Complexes" . SPARSER::BIO-COMPLEX)
    ("p65 or p50" . SPARSER::COLLECTION)
    ("the c-Rel homodimer and a c-Rel–p50 heterodimer" . SPARSER::COLLECTION)
    ("c-Rel–p50" . SPARSER::COLLECTION)
    ("the O-GlcNAcylated NF-κB protein" . SPARSER::PROTEIN)
    ("impaired anti-CD3–" . SPARSER::ANTIBODY) ("–type" . TYPE)
    ("OGT-" . SPARSER::PROTEIN) ("a TCRdependent cofactor" . SPARSER::MOLECULE)
    ("glucose- or GlcNAc-induced O-GlcNAcylation" . SPARSER::COLLECTION)
    ("glucose-" . SPARSER::PROTEIN)
    ("TNFAIP3 and NFKBIA" . SPARSER::COLLECTION)
    ("c-Rel and its O-GlcNAcylation" . SPARSER::COLLECTION)
    ("IL2 or CSF2" . SPARSER::COLLECTION)
    ("NFKBIA or TNFAIP3" . SPARSER::COLLECTION)
    ("c-Rel nor PUGNAc-enhanced O-GlcNAcylation" . SPARSER::COLLECTION)
    ("the anti-CD3–" . SPARSER::ANTIBODY)
    ("NFKBIA and TNFAIP3" . SPARSER::COLLECTION)
    ("IL2 , CSF2 , and IFNG" . SPARSER::COLLECTION)
    ("IL2 and CSF2" . SPARSER::COLLECTION) ("anti-CD3–" . SPARSER::ANTIBODY)
    ("FLAG–c-Rel" . SPARSER::COLLECTION) ("κB" . SPARSER::PROTEIN)
    ("IL2-κB" . SPARSER::PROTEIN-PAIR) ("NFAT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-norleucine" . SPARSER::MOLECULE) ("norleucine" . SPARSER::MOLECULE)
    ("diazo" . SPARSER::MOLECULE) ("the relevant proteins" . SPARSER::PROTEIN)
    ("inducibly expressed FLAG-tagged O-GlcNAcylated c-Rel" . SPARSER::PROTEIN)
    ("PMA and ionomycin" . SPARSER::COLLECTION)
    ("FLAG-tagged wild-type c-Rel or the S350A mutant c-Rel"
     . SPARSER::COLLECTION)
    ("overexpressed wild-type c-Rel and the S350A c-Rel mutant"
     . SPARSER::COLLECTION)
    ("exogenous c-Rel" . SPARSER::PROTEIN) ("alanines" . SPARSER::AMINO-ACID)
    ("glucose (30 mM) and PUGNAc ( xref )" . SPARSER::COLLECTION)
    ("nanoLC-MS/MS" . SPARSER::COLLECTION) ("chymotrypsin" . SPARSER::PROTEIN)
    ("GlcNAc-" . SPARSER::PROTEIN-FAMILY)
    ("c-Rel and p65" . SPARSER::COLLECTION)
    ("O-GlcNAcylated proteins showed O-GlcNAcylated c-Rel" . SPARSER::PROTEIN)
    ("GlcNAc and PUGNAc" . SPARSER::COLLECTION)
    ("agglutinin" . SPARSER::PROTEIN)
    ("the major O-GlcNAcylated protein" . SPARSER::PROTEIN)
    ("O-GlcNAcylated c-Rel" . SPARSER::PROTEIN)
    ("O-GlcNAcylated proteins" . SPARSER::PROTEIN) ("PUGNAc" . SPARSER::DRUG)
    ("acetamido" . SPARSER::MOLECULE)
    ("a major O-GlcNAcylated NF-κB protein" . SPARSER::PROTEIN)
    ("c-Rel and O-GlcNAcylation" . SPARSER::COLLECTION)
    ("CID-MS" . SPARSER::COLLECTION)
    ("the major O-GlcNAcylated NF-κB subunit" . SPARSER::FRAGMENT)
    ("the known O-GlcNAcylated proteins" . SPARSER::PROTEIN)
    ("NF-κB and O-GlcNAcylation" . SPARSER::COLLECTION)
    ("OGA" . SPARSER::PROTEIN) ("OGT" . SPARSER::PROTEIN)
    ("serine or threonine" . SPARSER::COLLECTION)
    ("-glucosamine" . SPARSER::MOLECULE) ("GlcNAc" . SPARSER::PROTEIN-FAMILY)
    ("glucosamine" . SPARSER::MOLECULE) ("monosaccharide" . SPARSER::MOLECULE)
    ("an essential and abundant form" . SPARSER::FORM)
    ("p105, p100, and p65" . SPARSER::COLLECTION)
    ("NFKBIA (which encodes IκBα) and TNFAIP3 (which encodes A20)"
     . SPARSER::COLLECTION)
    ("receptor (TCR)" . SPARSER::RECEPTOR)
    ("IL2 , IFNG , and CSF2" . SPARSER::COLLECTION) ("IFNG" . SPARSER::PROTEIN)
    ("O -linked β- N -acetylglucosamine" . SPARSER::MOLECULE)
    ("streptavidin-agarose" . SPARSER::DRUG) ("UBE2D2" . SPARSER::PROTEIN)
    ("CD32" . SPARSER::PROTEIN) ("CD16" . SPARSER::PROTEIN)
    ("CD271" . SPARSER::PROTEIN) ("bis-tris" . SPARSER::MOLECULE)
    ("sialic acid" . SPARSER::MOLECULE) ("O-GlcNAc" . SPARSER::PROTEIN)
    ("PLC-γ" . SPARSER::PROTEIN-FAMILY) ("C11" . SPARSER::PROTEIN)
    ("Pdx-1" . SPARSER::PROTEIN) ("activating protein" . SPARSER::PROTEIN)
    ("OCT1" . SPARSER::PROTEIN) ("interleukin-2" . SPARSER::PROTEIN)
    ("T-REx" . SPARSER::PROTEIN-FAMILY) ("p40" . SPARSER::PROTEIN)
    ("IL12" . SPARSER::PROTEIN-FAMILY) ("O -GlcNAcase" . SPARSER::PROTEIN)
    ("O -GlcNAc" . SPARSER::PROTEIN) ("p105" . SPARSER::PROTEIN)
    ("TNFAIP3" . SPARSER::PROTEIN) ("CSF2" . SPARSER::PROTEIN)
    ("IL2" . SPARSER::PROTEIN) ("N -acetylglucosamine" . SPARSER::MOLECULE)
    ("TRADD, and caspase 8" . SPARSER::COLLECTION)
    ("Trx-ASK1" . SPARSER::COLLECTION) ("Elk" . SPARSER::PROTEIN)
    ("a prosurvival kinase" . SPARSER::KINASE)
    ("ASK1 and FoxO3a" . SPARSER::COLLECTION)
    ("ASK1 and Akt" . SPARSER::COLLECTION)
    ("threonine and serine" . SPARSER::COLLECTION)
    ("available reagents" . SPARSER::MOLECULE)
    ("oxidative stress–activated ASK1" . SPARSER::PROTEIN)
    ("An oxidative stress–responsive kinase" . SPARSER::KINASE)
    ("kinases, or ASK1" . SPARSER::COLLECTION)
    ("sustained maternal hyperglycemia" . SPARSER::PROTEIN)
    ("STZ" . SPARSER::PROTEIN) ("streptozotocin" . SPARSER::DRUG)
    ("ASK1 and caspase 8" . SPARSER::COLLECTION)
    ("FoxO3a and TRADD" . SPARSER::COLLECTION) ("fetuses" . SPARSER::PROTEIN)
    ("the diabetic dams" . SPARSER::PROTEIN) ("hTrx" . SPARSER::PROTEIN)
    ("Thioredoxin" . SPARSER::PROTEIN)
    ("FoxO1 and FoxO4" . SPARSER::COLLECTION)
    ("both TRADD protein ( xref ) and mRNA ( xref )" . SPARSER::COLLECTION)
    ("dams or Ask1" . SPARSER::COLLECTION)
    ("diabetic Ask1  −/−" . SPARSER::PROTEIN)
    ("nondiabetic wild-type dams" . SPARSER::PROTEIN)
    ("diabetic wild-type dams" . SPARSER::PROTEIN)
    ("diabetic Ask1  −/− dams" . SPARSER::PROTEIN)
    ("Trx and ASK1" . SPARSER::COLLECTION)
    ("ASK1 or Trx" . SPARSER::COLLECTION) ("ASK1-Trx" . SPARSER::COLLECTION)
    ("nonactive ASK1" . SPARSER::PROTEIN)
    ("ASK1 and Trx" . SPARSER::COLLECTION)
    ("the related MAP3Ks TAK1 (transforming growth factor β–activated kinase) and MLK3"
     . SPARSER::COLLECTION)
    ("Trx" . SPARSER::PROTEIN)
    ("the Ask1 or the FoxO3a gene" . SPARSER::COLLECTION)
    ("the FoxO3a or the Casp8 gene" . SPARSER::COLLECTION)
    ("diabetic dams" . SPARSER::PROTEIN)
    ("the developing neural tube" . SPARSER::PROTEIN)
    ("ASK1, FoxO3a, and caspase 8" . SPARSER::COLLECTION)
    ("dams" . SPARSER::PROTEIN) ("Caspases" . SPARSER::PROTEIN)
    ("apoptosis-relevant target genes" . SPARSER::GENE)
    ("FoxO1, FoxO3a, and FoxO4" . SPARSER::COLLECTION)
    ("FoxO" . SPARSER::PROTEIN) ("Forkhead" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("one particular transcription factor" . SPARSER::PROTEIN)
    ("Maternal hyperglycemia" . SPARSER::PROTEIN)
    ("teratogen" . SPARSER::MOLECULE) ("the neural tube" . SPARSER::PROTEIN)
    ("ASK1–FoxO3a–TRADD–caspase 8" . SPARSER::COLLECTION)
    ("ASK1, FoxO3a, TRADD, and caspase 8" . SPARSER::COLLECTION)
    ("FoxO3a or Casp8" . SPARSER::COLLECTION)
    ("thioredoxin" . SPARSER::PROTEIN)
    ("maternal hyperglycemia" . SPARSER::PROTEIN)
    ("tube, and Ask1" . SPARSER::COLLECTION) ("Oct1" . SPARSER::PROTEIN)
    ("anti–phospho" . SPARSER::PROTEIN) ("of pregnancy" . SPARSER::PROTEIN)
    ("activating transcription factor 2" . SPARSER::PROTEIN)
    ("Ste20-like kinase" . SPARSER::PROTEIN) ("caspases 3" . SPARSER::PROTEIN)
    ("superoxide dismutase 1" . SPARSER::PROTEIN) ("SOD1" . SPARSER::PROTEIN)
    ("MLK3" . SPARSER::PROTEIN) ("MAP3Ks" . SPARSER::PROTEIN-FAMILY)
    ("FoxO4" . SPARSER::PROTEIN) ("FoxO1" . SPARSER::PROTEIN)
    ("MAPK kinase kinase" . SPARSER::PROTEIN) ("Casp8" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN) ("FoxO3a" . SPARSER::PROTEIN)
    ("Ask1" . SPARSER::PROTEIN) ("ASK1" . SPARSER::PROTEIN)
    ("apoptosis signal–regulating kinase 1" . SPARSER::PROTEIN)
    ("mutants of a tumor suppressor and a DNA mismatch repair gene"
     . SPARSER::COLLECTION)
    ("P53 and mismatch" . SPARSER::COLLECTION)
    ("both PMS2 R20Q and P53 V157D" . SPARSER::COLLECTION)
    ("these two mutants P53 V157D and PMS2 R20Q" . SPARSER::COLLECTION)
    ("the previously unreported P53 V157D" . SPARSER::PROTEIN)
    ("the germline mutants P53 V157D and PMS2 R20Q" . SPARSER::COLLECTION)
    ("disc" . SPARSER::BIO-COMPLEX) ("GMR" . SPARSER::PROTEIN)
    ("P53 and/or PMS2 mutants" . SPARSER::COLLECTION)
    ("the P53 V 157D and/or PMS2 R20Q" . SPARSER::COLLECTION)
    ("ofK-ras" . SPARSER::COLLECTION)
    ("P53 V157D and PMS2 R20Q" . SPARSER::COLLECTION)
    ("CRL" . SPARSER::PROTEIN)
    ("P53 V157D and/or PMS2 R20Q" . SPARSER::COLLECTION)
    ("P53 V 157D and/or PMS2 R 20Q" . SPARSER::COLLECTION)
    ("cyclindependent kinases" . SPARSER::KINASE)
    ("p53 and inhibitor" . SPARSER::COLLECTION)
    ("either P53 V157D or PMS2 R20Q" . SPARSER::COLLECTION)
    ("P53, PTEN , and DNA" . SPARSER::COLLECTION)
    ("PMS2, MSH2, MLH1 and MSH6" . SPARSER::COLLECTION)
    ("the upper lobe" . SPARSER::PROTEIN)
    ("MLH1 and PMS2" . SPARSER::COLLECTION)
    ("DNA polymerase and DNA ligase" . SPARSER::COLLECTION)
    ("MLH1" . SPARSER::PROTEIN) ("MSH2 and MSH6" . SPARSER::COLLECTION)
    ("LFS" . SPARSER::PROTEIN)
    ("either tumor suppressor genes or genome stability genes"
     . SPARSER::COLLECTION)
    ("P53 and PMS2" . SPARSER::COLLECTION)
    ("P53 V157D and/or PMS2 R20Q mutant" . SPARSER::COLLECTION)
    ("tumor suppressor gene P53 V157D and mismatch repair gene PMS2 R20Q"
     . SPARSER::COLLECTION)
    ("tumor suppressor genes or genome stability genes" . SPARSER::COLLECTION)
    ("β- actin" . SPARSER::PROTEIN)
    ("P53 family" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P73" . SPARSER::PROTEIN)
    ("MSH6" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("PMS2" . SPARSER::PROTEIN)
    ("growth factor receptor tyrosine kinase inhibitors and mechanistic target of rapamycin inhibitors [ xref ]"
     . SPARSER::COLLECTION)
    ("multiple mitotic genes" . SPARSER::GENE)
    ("an NFκB-regulated gene and its promoter" . SPARSER::COLLECTION)
    ("Erb" . SPARSER::PROTEIN) ("IKKβ and NFκB" . SPARSER::COLLECTION)
    ("growth factors and anti-apoptotic" . SPARSER::COLLECTION)
    ("miR-21-targeted PTEN" . SPARSER::PROTEIN)
    ("cancer directly targets mRNAs" . SPARSER::PROTEIN)
    ("mRNAs and protein" . SPARSER::COLLECTION)
    ("a haploinsufficient gene" . SPARSER::GENE)
    ("immunoreactive PTEN" . SPARSER::PROTEIN)
    ("SCF-βTrCP" . SPARSER::COLLECTION)
    ("the predominant NFκB isoforms" . SPARSER::ISOFORM)
    ("p65/p50" . SPARSER::COLLECTION) ("IKKα/IKKβ/IKKγ" . SPARSER::COLLECTION)
    ("PTEN-Akt-IKKβ" . SPARSER::COLLECTION)
    ("hyperglycemia and pro-fibrotic" . SPARSER::COLLECTION)
    ("hyperglycemia" . SPARSER::PROTEIN)
    ("proteins and growth factors" . SPARSER::COLLECTION)
    ("cyclin D1/CDK4" . SPARSER::COLLECTION)
    ("miR-21-regulated cyclin D1" . SPARSER::PROTEIN)
    ("Cyclin D1/CDK4" . SPARSER::COLLECTION)
    ("PTEN and Akt" . SPARSER::COLLECTION) ("PTEN-Akt" . SPARSER::COLLECTION)
    ("IKKβ and IκB" . SPARSER::COLLECTION) ("Myr" . SPARSER::MOLECULE)
    ("tris" . SPARSER::PROTEIN) ("protein and siPTEN" . SPARSER::COLLECTION)
    ("NFκB p65 subunit and its upstream regulator IKKβ" . SPARSER::COLLECTION)
    ("Pre" . SPARSER::PROTEIN) ("RNase" . SPARSER::PROTEIN)
    ("oligoribonucleotides" . SPARSER::MOLECULE)
    ("Oncogene" . SPARSER::ONCOGENE) ("VHL" . SPARSER::PROTEIN)
    ("PTEN/Akt/IKKβ" . SPARSER::COLLECTION)
    ("cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("IKKβ and p65" . SPARSER::COLLECTION)
    ("p65/IKKβ/IκB" . SPARSER::COLLECTION)
    ("p65, IKKβ, IκB and NFκB" . SPARSER::COLLECTION)
    ("NFκB, IKKβ and IκB" . SPARSER::COLLECTION) ("CDK4/6" . SPARSER::PROTEIN)
    ("cyclin family" . SPARSER::PROTEIN) ("PIP 3" . SPARSER::PIP3)
    ("PI 3 kinase" . SPARSER::PROTEIN) ("REX2" . SPARSER::PROTEIN)
    ("NEDD4-1" . SPARSER::PROTEIN) ("DJ-1" . SPARSER::PROTEIN)
    ("βTrCP" . SPARSER::PROTEIN) ("IKKα" . SPARSER::PROTEIN)
    ("TAK-1" . SPARSER::PROTEIN) ("p65 S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Argonaute 2" . SPARSER::PROTEIN) ("p25" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JAG, LR, RM, PTG and JSF" . SPARSER::COLLECTION)
    ("PTG" . SPARSER::PROTEIN) ("TP and LR" . SPARSER::COLLECTION)
    ("TP" . SPARSER::PROTEIN) ("JAG, RM and SD" . SPARSER::COLLECTION)
    ("RM" . SPARSER::PROTEIN) ("JAG" . SPARSER::PROTEIN)
    ("Stromelysin" . SPARSER::PROTEIN) ("Enzyme" . SPARSER::ENZYME)
    ("TB, MMP-1 and MMP-3" . SPARSER::COLLECTION)
    ("MMPs or p38 MAPK" . SPARSER::COLLECTION) ("TLR2" . SPARSER::PROTEIN)
    ("this latter cytokine" . SPARSER::PROTEIN)
    ("TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("the p38α and γ subunits" . SPARSER::COLLECTION)
    ("ERK-1/2 and AKT" . SPARSER::COLLECTION)
    ("ERK, p38, AKT, GSK, JNK and HSP-27" . SPARSER::COLLECTION)
    ("GSK" . SPARSER::PROTEIN) ("ERK and AKT" . SPARSER::COLLECTION)
    ("their associated TIMPs" . SPARSER::PROTEIN)
    ("IL-1β/MAP kinase/AP-1" . SPARSER::COLLECTION)
    ("pulmonary TB" . SPARSER::PROTEIN) ("MMP and TIMP" . SPARSER::COLLECTION)
    ("factors and microtubule-associated proteins" . SPARSER::COLLECTION)
    ("microtubule-associated proteins" . SPARSER::PROTEIN)
    ("prostaglandin" . SPARSER::PROTEIN) ("para" . SPARSER::PROTEIN-FAMILY)
    ("neutral pH, and MMP-3" . SPARSER::COLLECTION)
    ("aggrecan and collagen" . SPARSER::COLLECTION)
    ("pH, and MMP-3" . SPARSER::COLLECTION)
    ("fibronectin, laminin and type IV collagen" . SPARSER::COLLECTION)
    ("aggrecan" . SPARSER::PROTEIN) ("TIMP" . SPARSER::PROTEIN)
    ("MMP-1, MMP-3, MMP-8 and MMP-9" . SPARSER::COLLECTION)
    ("CSF" . SPARSER::PROTEIN) ("dystroglycan" . SPARSER::PROTEIN)
    ("defensins" . SPARSER::PROTEIN) ("neutral pH" . SPARSER::PROTEIN)
    ("fibrillar collagens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Monocytic cell-derived matrix metalloproteinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-1 and MMP-3" . SPARSER::COLLECTION)
    ("casein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tumour necrosis factor" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Activator protein" . SPARSER::PROTEIN) ("SB 203580" . SPARSER::DRUG)
    ("p38δ" . SPARSER::PROTEIN) ("p38γ" . SPARSER::PROTEIN)
    ("ERK-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HSP-27" . SPARSER::PROTEIN)
    ("TIMP-2" . SPARSER::PROTEIN) ("activator protein" . SPARSER::PROTEIN)
    ("type IV collagen" . SPARSER::PROTEIN) ("MMP-8" . SPARSER::PROTEIN)
    ("p38 mitogen activated protein kinase" . SPARSER::PROTEIN)
    ("MMP-3" . SPARSER::PROTEIN) ("proper integrin" . SPARSER::PROTEIN)
    ("insoluble vimentin filaments" . SPARSER::PROTEIN-FAMILY)
    ("TGN" . SPARSER::PROTEIN) ("sphingolipid" . SPARSER::MOLECULE)
    ("more heterogeneous filipin" . SPARSER::MOLECULE)
    ("Filipin" . SPARSER::MOLECULE)
    ("very little soluble vimentin" . SPARSER::PROTEIN)
    ("particular oleic acid" . SPARSER::MOLECULE)
    ("-cyclopropyl" . SPARSER::MOLECULE) ("cyclopropyl" . SPARSER::MOLECULE)
    ("DCP" . SPARSER::DRUG) ("significantly less filipin" . SPARSER::MOLECULE)
    ("PKCα, PKCε, or PKCβII" . SPARSER::COLLECTION)
    ("acyltransferase (ACAT)" . SPARSER::PROTEIN)
    ("PKC α or PKC ε" . SPARSER::COLLECTION) ("ACAT" . SPARSER::PROTEIN)
    ("acyltransferase" . SPARSER::PROTEIN)
    ("increased soluble vimentin" . SPARSER::PROTEIN)
    ("the insoluble vimentin fraction" . SPARSER::COMPONENT)
    ("almost no detectable soluble vimentin" . SPARSER::PROTEIN)
    ("insoluble vimentin" . SPARSER::PROTEIN)
    ("the soluble vimentin" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate (PMA)" . SPARSER::DRUG)
    ("Soluble Vimentin" . SPARSER::PROTEIN) ("filipin" . SPARSER::MOLECULE)
    ("LDL" . SPARSER::PROTEIN) ("atypical isoforms" . SPARSER::ISOFORM)
    ("diazoxide" . SPARSER::DRUG) ("PKC ζ" . SPARSER::PROTEIN)
    ("long chain" . SPARSER::PROTEIN) ("BODIPY-LacCer" . SPARSER::DRUG)
    ("oleic acid" . SPARSER::MOLECULE) ("acyl-CoA" . SPARSER::MOLECULE)
    ("PKC ε" . SPARSER::PROTEIN) ("PKC γ" . SPARSER::PROTEIN)
    ("Rab9" . SPARSER::PROTEIN) ("NPC1" . SPARSER::PROTEIN)
    ("Type C1" . SPARSER::PROTEIN)
    ("phase-specific cytotoxic drugs" . SPARSER::DRUG)
    ("IGF1 and other growth factors" . SPARSER::COLLECTION)
    ("protein or P–Rb" . SPARSER::COLLECTION)
    ("Rb and P–Rb" . SPARSER::COLLECTION)
    ("protein and P–Rb" . SPARSER::COLLECTION)
    ("Rb, cyclin D, and p21" . SPARSER::COLLECTION)
    ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("nutrient and GF" . SPARSER::COLLECTION)
    ("PI3K or mTORC2" . SPARSER::COLLECTION)
    ("p70-S6 kinase" . SPARSER::COLLECTION)
    ("phosphatidylinositol-3-kinase (PI3K) and Akt" . SPARSER::COLLECTION)
    ("the temporal map" . SPARSER::PROTEIN) ("-TdR" . SPARSER::COLLECTION)
    ("TdR" . SPARSER::PROTEIN) ("GF and nutrient" . SPARSER::COLLECTION)
    ("Growth factor and amino acids" . SPARSER::COLLECTION)
    ("essential amino acids (EAA)" . SPARSER::AMINO-ACID)
    ("TOR" . SPARSER::PROTEIN)
    ("growth factor (GF)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("task" . SPARSER::PROTEIN)
    ("the conditionally essential amino acid glutamine" . SPARSER::AMINO-ACID)
    ("essential amino acids" . SPARSER::AMINO-ACID)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("cell cycle regulatory protein" . SPARSER::PROTEIN)
    ("P–Rb" . SPARSER::PROTEIN) ("p70 S6" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("p70" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tissue Type" . SPARSER::PROTEIN) ("Torin1" . SPARSER::DRUG)
    ("IL-1alpha and EGFR" . SPARSER::COLLECTION) ("TLR-2" . SPARSER::PROTEIN)
    ("receptor (TLR)" . SPARSER::RECEPTOR)
    ("IL-1R or its ligands" . SPARSER::COLLECTION)
    ("IL-1R or its ligand IL-1alpha" . SPARSER::COLLECTION)
    ("factor-kappa" . SPARSER::COLLECTION)
    ("TACE, and TACE" . SPARSER::COLLECTION)
    ("release soluble ligands" . SPARSER::LIGAND)
    ("Metalloproteases" . SPARSER::PROTEIN)
    ("markedly more IL-1alpha" . SPARSER::PROTEIN) ("mcM" . SPARSER::PROTEIN)
    ("antibody or TAPI-1" . SPARSER::COLLECTION)
    ("markedly more IL-8" . SPARSER::PROTEIN)
    ("IL-1R-TACE-EGFR" . SPARSER::COLLECTION)
    ("TACE- and EGFR-dependently" . SPARSER::COLLECTION)
    ("EGFR, TACE, and IL-1alpha" . SPARSER::COLLECTION)
    ("IL-1R or IL-1alpha" . SPARSER::COLLECTION)
    ("IL-1alpha or IL-1beta" . SPARSER::COLLECTION)
    ("EGFR- and TACE-dependently" . SPARSER::COLLECTION)
    ("TACE-EGFR" . SPARSER::COLLECTION)
    ("the mature soluble ligand" . SPARSER::LIGAND)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("EGFR and its ligands" . SPARSER::COLLECTION)
    ("EGFR and EGFR" . SPARSER::COLLECTION)
    ("IL-8 and neutrophils" . SPARSER::COLLECTION)
    ("regulator (CFTR)" . SPARSER::REGULATOR)
    ("EGFR-, TACE-, and IL-1alpha/IL-1R-dependently" . SPARSER::COLLECTION)
    ("TACE-" . SPARSER::PROTEIN) ("TACE-EGFR-IL-8" . SPARSER::COLLECTION)
    ("TACE" . SPARSER::PROTEIN) ("normal CFTR" . SPARSER::PROTEIN)
    ("interleukin (IL)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neutrophil" . SPARSER::PROTEIN) ("CFTR" . SPARSER::PROTEIN)
    ("TGF-alpha" . SPARSER::PROTEIN) ("AG1295" . SPARSER::DRUG)
    ("converting enzyme" . SPARSER::PROTEIN) ("IL-1beta" . SPARSER::PROTEIN)
    ("IL-1alpha" . SPARSER::PROTEIN) ("IL-1R" . SPARSER::PROTEIN)
    ("cystic fibrosis transmembrane conductance regulator" . SPARSER::PROTEIN)
    ("the estrogen receptor or the TP53" . SPARSER::COLLECTION)
    ("TP53 and ER" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2, BRIP1, CHEK2, PALB2, PTEN, and TP53" . SPARSER::COLLECTION)
    ("NOTCH1" . SPARSER::PROTEIN) ("SNP 1" . SPARSER::PROTEIN)
    ("CHEK2" . SPARSER::PROTEIN) ("BRIP1" . SPARSER::PROTEIN)
    ("Brd4, P-TEFb and Plk1" . SPARSER::COLLECTION)
    ("an atypical kinase" . SPARSER::KINASE)
    ("Plk1 or other kinases" . SPARSER::COLLECTION)
    ("other mitotic components" . SPARSER::COMPONENT)
    ("Plk1 or other kinase" . SPARSER::COLLECTION)
    ("a cellular phosphoprotein" . SPARSER::PROTEIN)
    ("HEXIM 1 and 7SK" . SPARSER::COLLECTION) ("Granulin" . SPARSER::PROTEIN)
    ("the transcriptional elongation" . SPARSER::PROTEIN)
    ("tRNA and 5S rRNA transcription by phosphorylating Brf1 at Ser450 (the subunit of TFIIIB)"
     . SPARSER::COLLECTION)
    ("TFIIIB" . SPARSER::PROTEIN) ("tRNA" . SPARSER::RNA)
    ("Pol" . SPARSER::PROTEIN)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("Plk1, Plk2, Plk3 and Plk4" . SPARSER::COLLECTION)
    ("Plk" . SPARSER::PROTEIN) ("Plk1 and Plk1" . SPARSER::COLLECTION)
    ("TD or pCMV" . SPARSER::COLLECTION)
    ("phosphomimetic mutant cyclin T1 S564D" . SPARSER::PROTEIN)
    ("BI2536 or Nocodazole" . SPARSER::COLLECTION)
    ("both wild-type Plk1 and constitutive active Plk1 (Plk1 TD)"
     . SPARSER::COLLECTION)
    ("kinase defective Plk1" . SPARSER::PROTEIN)
    ("TD or Plk1" . SPARSER::COLLECTION)
    ("the wild type cyclin T1 and the phosphomimetic mutant cyclinT1 S564D"
     . SPARSER::COLLECTION)
    ("the phosphomimetic mutant cyclinT1 S564D" . SPARSER::PROTEIN)
    ("TD or His-Plk1" . SPARSER::COLLECTION)
    ("FLAG-Cdk9" . SPARSER::COLLECTION) ("mitotic kinases" . SPARSER::KINASE)
    ("FLAG-cyclinT1" . SPARSER::COLLECTION)
    ("FLAG-cyclin T1" . SPARSER::COLLECTION)
    ("full length GST-cyclin T1 S564A mutant and shorter form of GST-cyclin T1"
     . SPARSER::COLLECTION)
    ("shorter form" . SPARSER::FORM) ("GST-cyclinT1" . SPARSER::COLLECTION)
    ("cyclin T1 and Plk1" . SPARSER::COLLECTION)
    ("Cdk9 and/or cyclin T1" . SPARSER::COLLECTION)
    ("Histidine" . SPARSER::AMINO-ACID) ("GST-Plk1" . SPARSER::COLLECTION)
    ("FLAG-Plk1" . SPARSER::COLLECTION)
    ("FLAG-tagged Plk1 and the kinase-defective mutant FLAG-tagged Plk1 KD"
     . SPARSER::COLLECTION)
    ("the kinase-defective mutant FLAG-tagged Plk1 KD" . SPARSER::PROTEIN)
    ("Cdk9 and cyclin T1" . SPARSER::COLLECTION)
    ("GST-cyclin T1" . SPARSER::COLLECTION) ("GST-Cdk9" . SPARSER::COLLECTION)
    ("Cdk9, cyclin T1 or Plk1" . SPARSER::COLLECTION)
    ("Plk1 and P-TEFb" . SPARSER::COLLECTION) ("Nocodazole" . SPARSER::DRUG)
    ("cyclin H/Cdk7" . SPARSER::COLLECTION)
    ("an essential mitotic kinase" . SPARSER::KINASE)
    ("acetylated chromatin and the Mediator complex" . SPARSER::COLLECTION)
    ("the active cyclin T1/Cdk9 heterodimer and an inactive 7SK snRNP"
     . SPARSER::COLLECTION)
    ("an inactive 7SK snRNP" . SPARSER::BIO-COMPLEX)
    ("the active cyclin T1/Cdk9 heterodimer" . SPARSER::HETERODIMER)
    ("snRNA" . SPARSER::RNA) ("snRNP" . SPARSER::BIO-COMPLEX)
    ("Cdk9 and cyclin T1, or cyclin T2 and cyclin K" . SPARSER::COLLECTION)
    ("cyclin T1, or cyclin T2 and cyclin K" . SPARSER::COLLECTION)
    ("cyclin T2 and cyclin K" . SPARSER::COLLECTION)
    ("DSIF and NELF" . SPARSER::COLLECTION) ("NELF" . SPARSER::PROTEIN)
    ("DSIF" . SPARSER::PROTEIN) ("the largest subunit" . SPARSER::FRAGMENT)
    ("productive transcription elongation" . SPARSER::PROTEIN)
    ("the TFIIH-associated kinase" . SPARSER::KINASE)
    ("Cdk1/cyclin B1" . SPARSER::COLLECTION)
    ("the essential mitotic kinase" . SPARSER::KINASE)
    ("CDK1/cyclin B1" . SPARSER::COLLECTION)
    ("both wild type Plk1 and constitutively active form"
     . SPARSER::COLLECTION)
    ("cyclin T1/Cdk9" . SPARSER::COLLECTION) ("polo" . SPARSER::PROTEIN)
    ("HEXIM 1" . SPARSER::PROTEIN) ("PIE-1" . SPARSER::PROTEIN)
    ("Brf1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FoxM1" . SPARSER::PROTEIN)
    ("Plk3" . SPARSER::PROTEIN) ("Plk2" . SPARSER::PROTEIN)
    ("polo-like kinase" . SPARSER::PROTEIN) ("polo-like" . SPARSER::PROTEIN)
    ("Cyclin T1" . SPARSER::PROTEIN) ("cyclin H" . SPARSER::PROTEIN)
    ("G protein" . SPARSER::PROTEIN) ("cyclinT1" . SPARSER::PROTEIN)
    ("Brd4" . SPARSER::PROTEIN) ("HEXIM1" . SPARSER::PROTEIN)
    ("small nuclear RNA" . SPARSER::RNA) ("7SK" . SPARSER::RNA)
    ("Type 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cyclin K" . SPARSER::PROTEIN)
    ("cyclin T2" . SPARSER::PROTEIN) ("elongation factor" . SPARSER::PROTEIN)
    ("Pol II" . SPARSER::PROTEIN) ("Cdk7" . SPARSER::PROTEIN)
    ("cyclin B1" . SPARSER::PROTEIN) ("cyclin T1" . SPARSER::PROTEIN)
    ("Polo-like kinase 1" . SPARSER::PROTEIN)
    ("internal control housekeeping gene" . SPARSER::PROTEIN)
    ("the commercially available Bek antibody" . SPARSER::ANTIBODY)
    ("Bek" . SPARSER::PROTEIN) ("vs" . SPARSER::PROTEIN)
    ("FGFR-2-IIIb-specific monoclonal antibody" . SPARSER::DRUG)
    ("IIIc" . SPARSER::PROTEIN) ("FGFR-2-IIIc" . SPARSER::COLLECTION)
    ("KGFR" . SPARSER::PROTEIN) ("FGFs and FGFRs" . SPARSER::COLLECTION)
    ("FGFR-1 and FGFR-3" . SPARSER::COLLECTION)
    ("fibroblast growth factors (FGFs) and their receptors (FGFRs)"
     . SPARSER::COLLECTION)
    ("MET, PDGF and VEGF" . SPARSER::COLLECTION)
    ("different histological thyroid variants" . SPARSER::VARIANT)
    ("isoform, FGFR-2-IIIb and FGFR-2-IIIc" . SPARSER::COLLECTION)
    ("IIIb" . SPARSER::DRUG) ("FGFR-4" . SPARSER::PROTEIN)
    ("FGFR-3" . SPARSER::PROTEIN) ("FGFR-1" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor-2" . SPARSER::PROTEIN)
    ("PR, HER2, XRCC3 and RAD51" . SPARSER::COLLECTION)
    ("phospho-DNA-PKcs and –ATM repair foci, and RAD51 foci"
     . SPARSER::COLLECTION)
    ("dominant-negative EGFR" . SPARSER::PROTEIN)
    ("foci, and RAD51" . SPARSER::COLLECTION) ("–ATM" . SPARSER::COLLECTION)
    ("erbB" . SPARSER::PROTEIN)
    ("a strong poor prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a multimeric form" . SPARSER::FORM) ("III " . SPARSER::PROTEIN)
    ("II " . SPARSER::PROTEIN)
    ("some clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Clinicopathological Factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XRCC3 ( xref ) and RAD51 ( xref )" . SPARSER::COLLECTION)
    ("the central recombinase" . SPARSER::PROTEIN)
    ("recombinase" . SPARSER::PROTEIN)
    ("HER2, PR and RAD51" . SPARSER::COLLECTION)
    ("PR and HER2" . SPARSER::COLLECTION)
    ("XRCC3 and RAD51" . SPARSER::COLLECTION) ("Aims" . SPARSER::PROTEIN)
    ("homolog of" . SPARSER::PROTEIN) ("DNA repair protein" . SPARSER::PROTEIN)
    ("–3 " . SPARSER::PROTEIN) ("very low-penetrance SNPs" . SPARSER::PROTEIN)
    ("the non-muscle invasive type" . TYPE)
    ("identifying prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION) ("p50-p50" . SPARSER::COLLECTION)
    ("Homodimers" . SPARSER::HOMODIMER) ("muscle invasive types" . TYPE)
    ("promoter and cancer" . SPARSER::COLLECTION)
    ("promoter and bladder" . SPARSER::COLLECTION)
    ("ins/ins" . SPARSER::COLLECTION) ("GADD45" . SPARSER::PROTEIN)
    ("MEKK4" . SPARSER::PROTEIN) ("β-actin  " . SPARSER::PROTEIN)
    ("pT4" . SPARSER::PROTEIN) ("pT2" . SPARSER::PROTEIN)
    ("pT1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("factor-κB" . SPARSER::PROTEIN)
    ("NFKB1" . SPARSER::PROTEIN) ("PKCs, PKCα and PKCε" . SPARSER::COLLECTION)
    ("c-fos and MIP1β" . SPARSER::COLLECTION)
    ("Erk and CREB" . SPARSER::COLLECTION) ("staurosporine" . SPARSER::DRUG)
    ("activators and inhibitors" . SPARSER::COLLECTION)
    ("CysLT" . SPARSER::DRUG) ("pertinent mediators" . SPARSER::PROTEIN)
    ("kinases, PKCα and PKCε" . SPARSER::COLLECTION)
    ("LTD 4 and LTE 4 -induced c-fos expression or MIP1β generation"
     . SPARSER::COLLECTION)
    ("both LTD 4 and LTE 4 -induced c-fos expression ( xref ) and phosphorylation (data not shown)"
     . SPARSER::COLLECTION)
    ("PKCε and vice versa (data not shown)" . SPARSER::COLLECTION)
    ("expressed PKC isoforms" . SPARSER::ISOFORM)
    ("atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("classical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cys-LT-responsive PKC Isoforms" . SPARSER::ISOFORM)
    ("Isoforms" . SPARSER::ISOFORM) ("ERK and CREB" . SPARSER::COLLECTION)
    ("ERK, or CREB" . SPARSER::COLLECTION)
    ("both LTD 4 and LTE 4" . SPARSER::COLLECTION)
    ("potently activating inflammatory chemokine" . SPARSER::PROTEIN)
    ("either LTD 4 or LTE 4 ( xref )" . SPARSER::COLLECTION)
    ("RBL" . SPARSER::PROTEIN) ("MK" . SPARSER::PROTEIN)
    ("GFX" . SPARSER::DRUG) ("GF109203X (GFX)" . SPARSER::DRUG)
    ("a global PKC inhibitor" . SPARSER::INHIBITOR)
    ("CysLT 1 R or a CysLT 1 R-like GPCR" . SPARSER::COLLECTION)
    ("the specific PKC isoforms activated in MCs by cys-LTs and the role of each isoform in regulating cys-LT-induced MC responses"
     . SPARSER::COLLECTION)
    ("cytokines and GPCRs" . SPARSER::COLLECTION)
    ("human cord blood-derived MCs" . SPARSER::PROTEIN)
    ("hMCs" . SPARSER::PROTEIN) ("CysLT 1 R and CysLT 2" . SPARSER::COLLECTION)
    ("allergens" . SPARSER::MOLECULE)
    ("CysLT 1 R and a second GPCR" . SPARSER::COLLECTION)
    ("receptor (GPCR)" . SPARSER::RECEPTOR) ("GPCR" . SPARSER::PROTEIN)
    ("allergen" . SPARSER::MOLECULE) ("BAL" . SPARSER::PROTEIN)
    ("histamine" . SPARSER::PROTEIN) ("LTC 4 and LTD 4" . SPARSER::COLLECTION)
    ("LTD 4 and LTE 4" . SPARSER::COLLECTION)
    ("two distinct PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cys-LT" . SPARSER::COLLECTION) ("PKCα and PKCε" . SPARSER::COLLECTION)
    ("LTs" . SPARSER::PROTEIN) ("cys-LTs" . SPARSER::COLLECTION)
    ("LT" . SPARSER::PROTEIN)
    ("GPCRs, CysLT 1 R and CysLT 2" . SPARSER::COLLECTION)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("powerful inducers" . SPARSER::MOLECULE) ("cys" . SPARSER::PROTEIN)
    ("leukotrienes" . SPARSER::MOLECULE) ("CysLT 1" . SPARSER::PROTEIN)
    ("MRP1" . SPARSER::PROTEIN) ("PKC α" . SPARSER::PROTEIN)
    ("ι/λ" . SPARSER::PROTEIN) ("cysLT 1 R" . SPARSER::PROTEIN)
    ("GF109203X" . SPARSER::DRUG) ("Protein kinase" . SPARSER::PROTEIN)
    ("P2Y 12" . SPARSER::PROTEIN) ("c- kit" . SPARSER::PROTEIN)
    ("leukotriene C 4 synthase" . SPARSER::PROTEIN)
    ("c-kit" . SPARSER::PROTEIN) ("MK571" . SPARSER::DRUG)
    ("stem cell factor" . SPARSER::PROTEIN)
    ("G protein-coupled" . SPARSER::PROTEIN) ("LTC 4" . SPARSER::MOLECULE)
    ("MIP1β" . SPARSER::PROTEIN) ("LTD 4" . SPARSER::DRUG)
    ("CysLT 2" . SPARSER::PROTEIN) ("CysLT 1 R" . SPARSER::PROTEIN)
    ("stromal-specific targets" . SPARSER::TARGET-PROTEIN)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the conditional Ets2 allele" . SPARSER::ALLELE)
    ("a different Ets2 conditional allele" . SPARSER::ALLELE)
    ("opts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the exact genes" . SPARSER::GENE) ("Component" . SPARSER::COMPONENT)
    ("Mmp9" . SPARSER::PROTEIN) ("Mmp" . SPARSER::PROTEIN)
    ("driving factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ECM remodeling, cell adhesion and cell chemotaxis in tumor endothelial cells"
     . SPARSER::COLLECTION)
    ("PyMT or ErbB2" . SPARSER::COLLECTION)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("unique targets" . SPARSER::TARGET-PROTEIN) ("GO" . SPARSER::PROTEIN)
    ("cell growth-related genes and angiogenesis" . SPARSER::COLLECTION)
    ("only 4 genes" . SPARSER::GENE) ("only 22 genes" . SPARSER::GENE)
    ("NLP" . SPARSER::PROTEIN) ("TAFs" . SPARSER::PROTEIN)
    ("both vimentin and anti-phospho-Ets2 pT72 antibodies"
     . SPARSER::COLLECTION)
    ("anti-phospho" . SPARSER::PROTEIN)
    ("PyMT and ErbB2" . SPARSER::COLLECTION) ("PyMT" . SPARSER::PROTEIN)
    ("MMTV-ErbB2" . SPARSER::COLLECTION) ("stromal Ets2" . SPARSER::PROTEIN)
    ("andFsp-Cre" . SPARSER::COLLECTION)
    ("anti-phospho-Ets2" . SPARSER::COLLECTION)
    ("one conditionalEts2 loxP allele and a conventional Ets2 knockout allele"
     . SPARSER::COLLECTION)
    ("MMTV-Cre" . SPARSER::COLLECTION) ("MMTV-PyMT" . SPARSER::PROTEIN-PAIR)
    ("Pten" . SPARSER::PROTEIN)
    ("proteases and anti-apoptotic" . SPARSER::COLLECTION)
    ("Ras/Raf/MAPK" . SPARSER::COLLECTION) ("v-ets" . SPARSER::PROTEIN-PAIR)
    ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("molecules and signaling pathways" . SPARSER::COLLECTION)
    ("CAFs" . SPARSER::PROTEIN) ("Tgfbr2" . SPARSER::PROTEIN)
    ("Ets2-" . SPARSER::PROTEIN) ("ETS2" . SPARSER::PROTEIN)
    ("Protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase- 3" . SPARSER::PROTEIN) ("Ets2" . SPARSER::PROTEIN)
    ("cue" . SPARSER::PROTEIN-FAMILY) ("SMRT/HDAC" . SPARSER::COLLECTION)
    ("Nurr1 and the NAM-sensitive HDAC SIRT1" . SPARSER::COLLECTION)
    ("NSC and DA" . SPARSER::COLLECTION)
    ("class I and II inhibitors" . SPARSER::COLLECTION)
    ("II inhibitors" . SPARSER::INHIBITOR)
    ("TSA, NaB, or VPA" . SPARSER::COLLECTION)
    ("class I and II HDACs" . SPARSER::COLLECTION)
    ("II HDACs" . SPARSER::PROTEIN) ("Sp1 and CRE" . SPARSER::COLLECTION)
    ("TSA and NaB" . SPARSER::COLLECTION) ("aromatase" . SPARSER::PROTEIN)
    ("NR4" . SPARSER::PROTEIN) ("Lef-1 and SMRT" . SPARSER::COLLECTION)
    ("Lef-1" . SPARSER::PROTEIN) ("Nurr1 and SIRT1" . SPARSER::COLLECTION)
    ("NAM or TSA" . SPARSER::COLLECTION)
    ("all class I and II HDAC inhibitors" . SPARSER::COLLECTION)
    ("II HDAC inhibitors" . SPARSER::INHIBITOR)
    ("TSA, NaB, and VPA" . SPARSER::COLLECTION) ("SIRT" . SPARSER::PROTEIN)
    ("NaB" . SPARSER::PROTEIN) ("Inhibitor" . SPARSER::INHIBITOR)
    ("SWI" . SPARSER::PROTEIN) ("unexpectedly more active" . SPARSER::ACTIVE)
    ("Nu-va or Nu-vb" . SPARSER::COLLECTION)
    ("Nu-va and Nu-vb" . SPARSER::COLLECTION)
    ("a 455-amino-acid protein" . SPARSER::PROTEIN) ("va" . SPARSER::MOLECULE)
    ("a dual function transcription factor" . SPARSER::PROTEIN)
    ("endogenous Nurr1 or other protein(s)" . SPARSER::COLLECTION)
    ("each mutant’s" . SPARSER::MUTANT) ("the triple mutant" . SPARSER::MUTANT)
    ("SH-SY5Y and F3" . SPARSER::COLLECTION)
    ("a Dual Function Transcription Factor" . SPARSER::PROTEIN)
    ("mNBRE-A2" . SPARSER::PROTEIN-PAIR) ("pLPC-Nurr1" . SPARSER::COLLECTION)
    ("pLPC" . SPARSER::PROTEIN) ("Oligonucleotides" . SPARSER::MOLECULE)
    ("DR5 or a dimer" . SPARSER::COLLECTION)
    ("aromatic L-amino acid decarboxylase (AADC)" . SPARSER::PROTEIN)
    ("decarboxylase (AADC)" . SPARSER::PROTEIN) ("AADC" . SPARSER::PROTEIN)
    ("decarboxylase" . SPARSER::PROTEIN)
    ("the terminally differentiated neuronal marker neurofilament heavy polypeptide"
     . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein (GFAP)" . SPARSER::PROTEIN)
    ("the mesencephalic marker Wnt1" . SPARSER::PROTEIN)
    ("nestin and ATP-binding cassette" . SPARSER::COLLECTION)
    ("regulatory cofactors" . SPARSER::PROTEIN)
    ("retinoic acid (RA), phorbol-12-myristate-13-acetate (PMA),"
     . SPARSER::MOLECULE)
    ("retinoic acid (RA), phorbol-12-myristate-13-acetate (PMA), or forskolin xref"
     . SPARSER::COLLECTION)
    ("retinoic acid (RA)" . SPARSER::MOLECULE) ("forskolin" . SPARSER::PROTEIN)
    ("F3 and SH-SY5Y" . SPARSER::COLLECTION)
    ("a minimal impact" . SPARSER::PROTEIN)
    ("dual transcriptional complexes" . SPARSER::BIO-COMPLEX)
    ("hTH" . SPARSER::PROTEIN) ("CRIF1" . SPARSER::PROTEIN)
    ("Pitx3" . SPARSER::PROTEIN) ("DR5" . SPARSER::PROTEIN)
    ("retinoid X receptor" . SPARSER::PROTEIN)
    ("neurofilament heavy polypeptide" . SPARSER::PROTEIN)
    ("L protein" . SPARSER::PROTEIN) ("butyric acid" . SPARSER::MOLECULE)
    ("phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("HB1" . SPARSER::PROTEIN) ("Nurr1" . SPARSER::PROTEIN)
    ("Recently TRPC6 gene" . SPARSER::PROTEIN)
    ("p53-p300" . SPARSER::COLLECTION)
    ("several pro-apoptotic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER and mitochondria" . SPARSER::COLLECTION)
    ("calmodulin-dependent protein kinase and mitogen-activated protein kinase"
     . SPARSER::COLLECTION)
    ("TRPC" . SPARSER::PROTEIN) ("which lies 400 base" . SPARSER::PROTEIN)
    ("p53 RE" . SPARSER::PROTEIN)
    ("the pro-apoptotic TRPC6 calcium channel" . SPARSER::PROTEIN)
    ("annexin-V staining and the flow cytometry" . SPARSER::COLLECTION)
    ("HCT" . SPARSER::PROTEIN)
    ("the GaQ 3 -induced and p53-mediated rise" . SPARSER::COLLECTION)
    ("p53 and p53" . SPARSER::COLLECTION)
    ("p53 and p53RE" . SPARSER::COLLECTION) ("p53RE" . SPARSER::PROTEIN)
    ("TRPC6-p53RE" . SPARSER::COLLECTION)
    ("p53 and its response element" . SPARSER::COLLECTION)
    ("This TRPC6 minimal promoter" . SPARSER::PROMOTER)
    ("bar" . SPARSER::PROTEIN) ("AK" . SPARSER::PROTEIN)
    ("Mat" . SPARSER::PROTEIN)
    ("TRPC6 (chromosome 11q22.1, reverse strand) and p53"
     . SPARSER::COLLECTION)
    ("siRNA and TRPC6" . SPARSER::COLLECTION)
    ("p53 and TRPC6" . SPARSER::COLLECTION) ("SiRNA" . SPARSER::PROTEIN)
    ("Wt" . SPARSER::PROTEIN)
    ("Bcl-2, ROS and mitochondrial" . SPARSER::COLLECTION)
    ("RAF/MEK/ERK" . SPARSER::COLLECTION) ("pifithrin" . SPARSER::DRUG)
    ("a novel organic derivative" . SPARSER::DERIVATIVE)
    ("Wt-p53 or Mt-p53" . SPARSER::COLLECTION)
    ("Mt-p53" . SPARSER::PROTEIN-PAIR) ("Wt-p53" . SPARSER::PROTEIN-PAIR)
    ("KP" . SPARSER::PROTEIN) ("gallium" . SPARSER::MOLECULE)
    ("its organic derivatives" . SPARSER::DERIVATIVE)
    ("Gallium" . SPARSER::MOLECULE) ("p53 and calcium" . SPARSER::COLLECTION)
    ("calmodulin-dependent protein kinase" . SPARSER::PROTEIN)
    ("TMB-8" . SPARSER::DRUG) ("TMB–8" . SPARSER::DRUG)
    ("PGL3" . SPARSER::PROTEIN) ("GaQ3" . SPARSER::DRUG)
    ("Fluo- 3" . SPARSER::MOLECULE) ("si-RNA" . SPARSER::RNA)
    ("tris(8-quinolinolato)gallium(III)" . SPARSER::DRUG)
    ("TRPC6" . SPARSER::PROTEIN) ("GaQ 3" . SPARSER::DRUG)
    ("Polymerase" . SPARSER::PROTEIN) ("Trp-Trp" . SPARSER::COLLECTION)
    ("peptidyl-prolyl" . SPARSER::COLLECTION) ("parvulin" . SPARSER::PROTEIN)
    ("CIs" . SPARSER::PROTEIN)
    ("cis/trans isomerase NIMA-interacting 1" . SPARSER::COLLECTION)
    ("peptidylprolyl cis/trans isomerase, NIMA-interacting 1"
     . SPARSER::PROTEIN)
    ("Thr-Pro" . SPARSER::MOLECULE) ("PIN1" . SPARSER::PROTEIN)
    ("trans isomerase NIMA-interacting 1" . SPARSER::PROTEIN)
    ("miRs and PELP1-regulated miRs play" . SPARSER::COLLECTION)
    ("miR-200a and miR-141 mimetics" . SPARSER::COLLECTION)
    ("LIM" . SPARSER::PROTEIN)
    ("acetylases, deacetylases, methyltransferases, and demethylases"
     . SPARSER::COLLECTION)
    ("demethylases" . SPARSER::PROTEIN)
    ("methyltransferases" . SPARSER::PROTEIN) ("acetylases" . SPARSER::PROTEIN)
    ("ZEB1 and SIP1" . SPARSER::COLLECTION)
    ("PELP1-HDAC2" . SPARSER::COLLECTION) ("MCF7-PELP1" . SPARSER::COLLECTION)
    ("PELP1 regulated miRs" . SPARSER::MICRO-RNA) ("MDAMD" . SPARSER::DRUG)
    ("fluorescent foci" . SPARSER::PROTEIN)
    ("TSA or HDAC2" . SPARSER::COLLECTION)
    ("only HDAC2 siRNA" . SPARSER::PROTEIN)
    ("HDAC1 or HDAC3" . SPARSER::COLLECTION)
    ("HDAC3-siRNAs" . SPARSER::COLLECTION) ("HDAC1-" . SPARSER::PROTEIN)
    ("HDAC2-siRNA" . SPARSER::COLLECTION) ("Trichostatin" . SPARSER::MOLECULE)
    ("ZR-PELP1-shRNA" . SPARSER::COLLECTION) ("ZR" . SPARSER::PROTEIN)
    ("HDAC2 and PELP1" . SPARSER::COLLECTION)
    ("the proximal promoters" . SPARSER::PROMOTER)
    ("demethylase" . SPARSER::PROTEIN)
    ("proximal promoter" . SPARSER::PROMOTER)
    ("Src-, PI3K- and MAPK-pathways" . SPARSER::COLLECTION)
    ("PI3K-" . SPARSER::PROTEIN) ("Src-" . SPARSER::PROTEIN)
    ("Src, PI3K and MAPK" . SPARSER::COLLECTION)
    ("miR-200a and miR-141 expression" . SPARSER::COLLECTION)
    ("the miR-200a and miR-141 family members" . SPARSER::COLLECTION)
    ("MiR-200a and 141 mimetics" . SPARSER::COLLECTION)
    ("the expression miR-200a and miR-141" . SPARSER::COLLECTION)
    ("MCF7 and ZR75" . SPARSER::COLLECTION)
    ("two representative miRs" . SPARSER::MICRO-RNA)
    ("ZR-PELP1" . SPARSER::COLLECTION) ("PELP1-shRNA" . SPARSER::COLLECTION)
    ("miR-200a and miR-141" . SPARSER::COLLECTION)
    ("multiple hormonal receptors" . SPARSER::PROTEIN)
    ("Proline" . SPARSER::AMINO-ACID)
    ("nuclear receptor corepressor (NCoR) complex and its paralog"
     . SPARSER::COLLECTION)
    ("retinoid and thyroid hormone receptor (SMRT)" . SPARSER::COLLECTION)
    ("receptor (SMRT)" . SPARSER::RECEPTOR) ("/AIB1" . SPARSER::COLLECTION)
    ("retinoid" . SPARSER::PROTEIN) ("receptors (NR)" . SPARSER::RECEPTOR)
    ("MiRs" . SPARSER::MICRO-RNA)
    ("ER and growth factor receptors" . SPARSER::COLLECTION)
    ("ChIP, siRNA and HDAC" . SPARSER::COLLECTION) ("MiB-1" . SPARSER::PROTEIN)
    ("HDAC 1" . SPARSER::PROTEIN) ("n-cadherin" . SPARSER::PROTEIN)
    ("ILK1" . SPARSER::PROTEIN) ("SRC-1" . SPARSER::PROTEIN)
    ("PEA3" . SPARSER::PROTEIN) ("adhesion molecule" . SPARSER::PROTEIN)
    ("SIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("KDM1" . SPARSER::PROTEIN)
    ("MiR-200a" . SPARSER::MOLECULE)
    ("nuclear receptor corepressor" . SPARSER::PROTEIN)
    ("MTA1" . SPARSER::PROTEIN) ("tumor antigen" . SPARSER::DRUG)
    ("AIB1" . SPARSER::PROTEIN) ("SRC-3" . SPARSER::PROTEIN)
    ("miR -155" . SPARSER::PROTEIN) ("miR-200a" . SPARSER::MOLECULE)
    ("PELP1" . SPARSER::PROTEIN) ("LOX or SDC2" . SPARSER::COLLECTION)
    ("SDC2, RKIP and HMGA2" . SPARSER::COLLECTION)
    ("endothelin-1/NFkB" . SPARSER::COLLECTION)
    ("a transmembrane (type I) heparan sulfate proteoglycan"
     . SPARSER::PROTEIN)
    ("integral membrane protein and receptor" . SPARSER::COLLECTION)
    ("syndecan" . SPARSER::PROTEIN)
    ("collagen and elastin" . SPARSER::COLLECTION)
    ("aldehydes" . SPARSER::MOLECULE) ("ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("miR-200c and miR-141" . SPARSER::COLLECTION)
    ("microRNAs and proteins" . SPARSER::COLLECTION)
    ("RKIP, LOX and SDC2" . SPARSER::COLLECTION)
    ("LOX/SDC2" . SPARSER::COLLECTION) ("LOX nor SDC2" . SPARSER::COLLECTION)
    ("RKIP, LOX nor SDC2" . SPARSER::COLLECTION)
    ("HMGA2 and SDC2" . SPARSER::COLLECTION) ("Sdc2" . SPARSER::PROTEIN)
    ("Sdc" . SPARSER::PROTEIN) ("Lox" . SPARSER::PROTEIN)
    ("LOX-mut-UTR" . SPARSER::COLLECTION) ("Hmga2" . SPARSER::PROTEIN)
    ("Hmga" . SPARSER::PROTEIN-FAMILY) ("HMGA2 and LOX" . SPARSER::COLLECTION)
    ("mature RNA" . SPARSER::RNA) ("RKIP and LOX" . SPARSER::COLLECTION)
    ("elastin and collagen" . SPARSER::COLLECTION)
    ("LOX and SDC2" . SPARSER::COLLECTION)
    ("RKIP and miR-200b" . SPARSER::COLLECTION)
    ("RKIP and potential targets" . SPARSER::COLLECTION)
    ("GSA" . SPARSER::PROTEIN) ("PITA" . SPARSER::PROTEIN)
    ("a previously published 101 bone metastasis signature (BMS) genes"
     . SPARSER::GENE)
    ("bone-tropic derivative" . SPARSER::DERIVATIVE)
    ("gene and microRNA" . SPARSER::COLLECTION)
    ("microRNAs and genes" . SPARSER::COLLECTION)
    ("RKIP/LOX/SDC2" . SPARSER::COLLECTION)
    ("RKIP and HMGA2" . SPARSER::COLLECTION)
    ("osteopontin and CXCR4" . SPARSER::COLLECTION) ("PEBP" . SPARSER::PROTEIN)
    ("RKIP, LOX, and SDC2" . SPARSER::COLLECTION)
    ("MMTV-Wnt" . SPARSER::COLLECTION)
    ("the architectural transcription factor and oncogene"
     . SPARSER::COLLECTION)
    ("transcription factor and oncogene" . SPARSER::COLLECTION)
    ("RKIP/PEBP1" . SPARSER::COLLECTION) ("RKIP" . SPARSER::PROTEIN)
    ("Beta-galactosidase" . SPARSER::PROTEIN) ("BACH1" . SPARSER::PROTEIN)
    ("calpain-6" . SPARSER::PROTEIN) ("SDC1" . SPARSER::PROTEIN)
    ("heparan sulfate proteoglycan" . SPARSER::PROTEIN)
    ("MiR-200c" . SPARSER::MOLECULE) ("miR-200c" . SPARSER::MOLECULE)
    ("mir-200a" . SPARSER::MOLECULE) ("IL1R" . SPARSER::PROTEIN)
    ("Lysyl Oxidase" . SPARSER::PROTEIN) ("CXCR4" . SPARSER::PROTEIN)
    ("high mobility group AT-hook 2" . SPARSER::PROTEIN)
    ("SDC2" . SPARSER::PROTEIN) ("syndecan-2" . SPARSER::PROTEIN)
    ("PEBP1" . SPARSER::PROTEIN) ("survivin-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("survivin-2B" . SPARSER::COLLECTION)
    ("ChIP-reChIP" . SPARSER::PROTEIN-PAIR)
    ("SRp40 or SRp55" . SPARSER::COLLECTION)
    ("SRp55 (TGAGTA) and SC35 (GGTCTGAG) proteins" . SPARSER::COLLECTION)
    ("SRp40 (TGTCAGG) and SFD2 (GTCAGGA) proteins" . SPARSER::COLLECTION)
    ("SFD" . SPARSER::PROTEIN)
    ("competitively alternative pre-mRNA" . SPARSER::RNA)
    ("Notch3-BS2" . SPARSER::COLLECTION) ("Notch3-BS1" . SPARSER::COLLECTION)
    ("Notch3-BS" . SPARSER::COLLECTION) ("BS" . SPARSER::PROTEIN)
    ("pro-apoptotic Par-4/THAP1 and pro-survival Notch3" . SPARSER::PROTEIN)
    ("CCAR1 and truncated-CCAR1" . SPARSER::COLLECTION)
    ("protein and truncated-CCAR1" . SPARSER::COLLECTION)
    ("isoform or non-special" . SPARSER::COLLECTION)
    ("pcDNA3-Notch3-ICD" . SPARSER::COLLECTION)
    ("exogenous Notch3-ICD" . SPARSER::COLLECTION)
    ("Notch3-ICD" . SPARSER::COLLECTION) ("FLAG-THAP1" . SPARSER::COLLECTION)
    ("pcDNA3-FLAG-THAP1" . SPARSER::COLLECTION)
    ("pcDNA3-GFP-THAP1" . SPARSER::COLLECTION)
    ("THAP1 and Par-4" . SPARSER::COLLECTION)
    ("GST-THAP1" . SPARSER::COLLECTION) ("phenanthroline" . SPARSER::MOLECULE)
    ("multimolecular complex" . SPARSER::BIO-COMPLEX)
    ("antibody or anti-THAP1" . SPARSER::COLLECTION)
    ("Par-4–THAP1" . SPARSER::COLLECTION)
    ("pcDNA3-Par-4" . SPARSER::COLLECTION)
    ("protein and THAP-S2" . SPARSER::COLLECTION) ("pcDNA3" . SPARSER::PROTEIN)
    ("pcDNA3-THAP1" . SPARSER::COLLECTION) ("ATG" . SPARSER::DRUG)
    ("Par-4 and pcDNA" . SPARSER::COLLECTION)
    ("Par-4 or pcDNA" . SPARSER::COLLECTION) ("pcDNA" . SPARSER::PROTEIN)
    ("RACE" . SPARSER::PROTEIN) ("Par-4 or THAP1" . SPARSER::COLLECTION)
    ("lacZ" . SPARSER::PROTEIN) ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("some amino acids of the proapoptotic factor THAP1" . SPARSER::PROTEIN)
    ("a human T-ALL cell cDNA library using Par-4" . SPARSER::PROTEIN)
    ("a pro-apoptotic transcription factor and CCAR1" . SPARSER::COLLECTION)
    ("transcription factor and CCAR1" . SPARSER::COLLECTION)
    ("a shorter form" . SPARSER::FORM)
    ("SRp40 and SRp55" . SPARSER::COLLECTION)
    ("Par-4/THAP1" . SPARSER::COLLECTION)
    ("Par-4 and THAP1" . SPARSER::COLLECTION)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("non-small-cell" . SPARSER::PROTEIN)
    ("2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SC35" . SPARSER::PROTEIN)
    ("Splicing factor" . SPARSER::PROTEIN) ("BS2" . SPARSER::PROTEIN)
    ("BS1" . SPARSER::PROTEIN) ("chelating agent" . SPARSER::MOLECULE)
    ("anti-Par" . SPARSER::DRUG) ("par-4" . SPARSER::PROTEIN)
    ("CCAR1" . SPARSER::PROTEIN) ("THAP1" . SPARSER::PROTEIN)
    ("Par-4" . SPARSER::PROTEIN) ("NAR" . SPARSER::PROTEIN)
    ("GATA and COUP-TFII" . SPARSER::COLLECTION)
    ("NR cofactors and other gene regulatory proteins (see)"
     . SPARSER::COLLECTION)
    ("NRs, NR cofactors and other gene regulatory proteins (see)"
     . SPARSER::COLLECTION)
    ("‘repressive’ NRs" . SPARSER::PROTEIN)
    ("full length proteins or LXXLL peptides" . SPARSER::COLLECTION)
    ("MED1/TRAP220" . SPARSER::COLLECTION) ("RAR" . SPARSER::PROTEIN)
    ("corepressors and coactivators" . SPARSER::COLLECTION)
    ("this autoinhibitory conformation" . SPARSER::BIO-CONFORMATION)
    ("Both coactivator (LXXLL) peptides and repressor peptides"
     . SPARSER::COLLECTION)
    ("‘repressive’ conformations" . SPARSER::BIO-CONFORMATION)
    ("apo- and holo-receptor" . SPARSER::COLLECTION)
    ("holo-receptor" . SPARSER::PROTEIN-PAIR)
    ("PNR and TLX" . SPARSER::COLLECTION) ("TLX and PNR" . SPARSER::COLLECTION)
    ("Atrophin/RERE" . SPARSER::COLLECTION) ("Atrophin" . SPARSER::PROTEIN)
    ("BCL11B or other proteins" . SPARSER::COLLECTION)
    ("BCL11A and PNR" . SPARSER::COLLECTION) ("CoR" . SPARSER::PROTEIN-FAMILY)
    ("NRL" . SPARSER::PROTEIN) ("CRX" . SPARSER::PROTEIN)
    ("homeobox" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TLX/BCL11A" . SPARSER::COLLECTION)
    ("L isoforms in the hippocampus and cortex" . SPARSER::COLLECTION)
    ("NCoR" . SPARSER::PROTEIN) ("REST" . SPARSER::PROTEIN)
    ("exogenous BCL11A-XL" . SPARSER::COLLECTION)
    ("globins" . SPARSER::PROTEIN) ("COUP-TFII/GATA" . SPARSER::COLLECTION)
    ("SRC1 ( xref A) and MED1 (data not shown)" . SPARSER::COLLECTION)
    ("the developmental co-repressor BCL11A" . SPARSER::PROTEIN)
    ("ERα or LRH1" . SPARSER::COLLECTION)
    ("BCL11A and NSD1" . SPARSER::COLLECTION)
    ("NR1D2/Reverbβ" . SPARSER::COLLECTION) ("Dax-1" . SPARSER::PROTEIN)
    ("RXRα and PPARγ" . SPARSER::COLLECTION)
    ("SRC1 and MED1" . SPARSER::COLLECTION) ("LexA-NSD1" . SPARSER::COLLECTION)
    ("RARα, RXRα, ERα and TRα" . SPARSER::COLLECTION)
    ("RARs and other liganded NRs ( xref )" . SPARSER::COLLECTION)
    ("NCOR and SMRT" . SPARSER::COLLECTION) ("SMRT" . SPARSER::PROTEIN)
    ("NCOR" . SPARSER::PROTEIN)
    ("NSD1 and other proteins" . SPARSER::COLLECTION)
    ("the SANT domain repressor proteins Atrophin-1 (ATN1) and RERE/ATN2"
     . SPARSER::COLLECTION)
    ("TLX ( xref ) and PNR ( xref )" . SPARSER::COLLECTION)
    ("RERE" . SPARSER::PROTEIN) ("EAR2/NR2F6" . SPARSER::COLLECTION)
    ("AAD-COUP-TFII" . SPARSER::COLLECTION)
    ("PNR/BCL11A" . SPARSER::COLLECTION)
    ("TLX and BCL11A" . SPARSER::COLLECTION)
    ("CA1 and CA3" . SPARSER::COLLECTION) ("CA1" . SPARSER::PROTEIN)
    ("dentate" . SPARSER::PROTEIN)
    ("homodimer or heterodimer" . SPARSER::COLLECTION)
    ("RID1/RID2" . SPARSER::COLLECTION)
    ("COUP-TFII, TLX and PNR" . SPARSER::COLLECTION)
    ("RID2 mutant (Y656A/W659A) or a RID1/2 double mutant (L319A/Y656A/W659A)"
     . SPARSER::COLLECTION)
    ("TLX or PNR" . SPARSER::COLLECTION) ("FLAG-BCL11A" . SPARSER::COLLECTION)
    ("haemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the photonuclear-specific receptor NR2E3/PNR" . SPARSER::COLLECTION)
    ("RID2" . SPARSER::PROTEIN) ("NR4A2/NURR1" . SPARSER::COLLECTION)
    ("NR2F6/EAR2" . SPARSER::COLLECTION)
    ("NR2F2/COUP-TFII" . SPARSER::COLLECTION)
    ("NR2F1/COUP-TFI" . SPARSER::COLLECTION)
    ("NR2E3/PNR" . SPARSER::COLLECTION) ("NR2E1/TLX" . SPARSER::COLLECTION)
    ("NR2C2/TR4" . SPARSER::COLLECTION) ("NR2C1/TR2" . SPARSER::COLLECTION)
    ("NR0B2/SHP" . SPARSER::COLLECTION) ("NR0B1/DAX-1" . SPARSER::COLLECTION)
    ("erb" . SPARSER::PROTEIN) ("Rev" . SPARSER::PROTEIN-FAMILY)
    ("SHP" . SPARSER::PROTEIN) ("NR6A1/GCNF" . SPARSER::COLLECTION)
    ("NR5A2/LRH1" . SPARSER::COLLECTION) ("NR3B1/ERRα" . SPARSER::COLLECTION)
    ("NR2A2/HNF4γ" . SPARSER::COLLECTION) ("NR1F1/RORα" . SPARSER::COLLECTION)
    ("GCNF" . SPARSER::PROTEIN) ("NR3C4/AR" . SPARSER::COLLECTION)
    ("NR3A1/ERα" . SPARSER::COLLECTION) ("NR2B1/RXRα" . SPARSER::COLLECTION)
    ("NR1I1/VDR" . SPARSER::COLLECTION) ("NR1C3/PPARγ" . SPARSER::COLLECTION)
    ("NR1B1/RARα" . SPARSER::COLLECTION) ("NR1A2/TRβ" . SPARSER::COLLECTION)
    ("VDR" . SPARSER::PROTEIN) ("NID" . SPARSER::PROTEIN)
    ("AAD-NR" . SPARSER::COLLECTION) ("LexA-RID2" . SPARSER::PROTEIN-PAIR)
    ("LexA-RID1" . SPARSER::COLLECTION) ("LexA" . SPARSER::PROTEIN)
    ("GFP-BCL11A-XL" . SPARSER::COLLECTION)
    ("GFP-BCL11A" . SPARSER::COLLECTION)
    ("COUP-TFII/BCL11A" . SPARSER::COLLECTION) ("lncRNA" . SPARSER::RNA)
    ("BCL11A and COUP-TFII" . SPARSER::COLLECTION)
    ("HS2 and HS3" . SPARSER::COLLECTION) ("HS1-3" . SPARSER::COLLECTION)
    ("LCR" . SPARSER::PROTEIN) ("DNAse" . SPARSER::PROTEIN)
    ("BCL11A and COUPTFII" . SPARSER::COLLECTION)
    ("promyelocytic" . SPARSER::PROTEIN) ("HL60" . SPARSER::PROTEIN)
    ("the fetal-specific γ-globin genes" . SPARSER::GENE)
    ("globin" . SPARSER::PROTEIN)
    ("factors, COUP-TFII, SOX6 and NF-Y" . SPARSER::COLLECTION)
    ("GATA" . SPARSER::PROTEIN) ("COUP-TFII and BCL11A" . SPARSER::COLLECTION)
    ("γ-globin and Bgl3" . SPARSER::COLLECTION)
    ("RID1 or RID2" . SPARSER::COLLECTION)
    ("the RARβ2 proximal promoter" . SPARSER::PROMOTER)
    ("The RARβ2 gene proximal promoter" . SPARSER::PROMOTER)
    ("RARs and COUP-TFs" . SPARSER::COLLECTION) ("ATRA" . SPARSER::DRUG)
    ("COUP" . SPARSER::PROTEIN) ("RARs" . SPARSER::PROTEIN)
    ("COUP-TFII/BCL11A-XL" . SPARSER::COLLECTION)
    ("GST-PPARγ" . SPARSER::COLLECTION) ("LBD" . SPARSER::PROTEIN)
    ("GST-PNR" . SPARSER::COLLECTION) ("GST-TLX" . SPARSER::COLLECTION)
    ("GST-COUP-TFII" . SPARSER::COLLECTION)
    ("GST-COUP-TFI" . SPARSER::COLLECTION) ("LBDs" . SPARSER::PROTEIN)
    ("XL" . SPARSER::PROTEIN) ("PPARγ/NR1C3" . SPARSER::COLLECTION)
    ("GST-LBD" . SPARSER::PROTEIN-PAIR)
    ("COUP-TFI/NR2F1" . SPARSER::COLLECTION)
    ("BCL11A-XL" . SPARSER::COLLECTION)
    ("BCL11A/COUP-TFII" . SPARSER::COLLECTION)
    ("BCL11A and its homologue BCL11B" . SPARSER::COLLECTION)
    ("PNR/NR2E3" . SPARSER::COLLECTION) ("TLX/NR2E1" . SPARSER::COLLECTION)
    ("HNF4/NR2A" . SPARSER::COLLECTION) ("RXR/NR2B" . SPARSER::COLLECTION)
    ("RXR" . SPARSER::PROTEIN) ("COUP-TF" . SPARSER::PROTEIN-PAIR)
    ("FOG1 ( xref ) or the NuRD complex ( xref , xref )" . SPARSER::COLLECTION)
    ("BCL11B/CTIP2" . SPARSER::COLLECTION)
    ("GATA1 and SOX6" . SPARSER::COLLECTION)
    ("COUP-TFII/NR2F2" . SPARSER::COLLECTION)
    ("fetal haemoglobin" . SPARSER::MOLECULE)
    ("a developmental regulator" . SPARSER::PROTEIN)
    ("the orphan receptor COUP-TFII and the Krüppel zinc finger protein BCL11A (also known as CTIP1 and Evi9)"
     . SPARSER::COLLECTION)
    ("CTIP1 and Evi9" . SPARSER::COLLECTION) ("Evi" . SPARSER::PROTEIN)
    ("potentially several hundred cofactors" . SPARSER::PROTEIN)
    ("endogenous γ-globin gene and the regulatory non-coding transcript Bgl3"
     . SPARSER::COLLECTION)
    ("the regulatory non-coding transcript Bgl3" . SPARSER::PROTEIN)
    ("Bgl" . SPARSER::PROTEIN) ("BCL11A/TLX" . SPARSER::COLLECTION)
    ("RID1 and RID2" . SPARSER::COLLECTION) ("PNR" . SPARSER::PROTEIN)
    ("TLX" . SPARSER::PROTEIN) ("RID" . SPARSER::DRUG)
    ("the developmental regulator BCL11A" . SPARSER::PROTEIN)
    ("nuclear receptors (NRs) and their cofactors" . SPARSER::COLLECTION)
    ("FOG2" . SPARSER::PROTEIN) ("ID2" . SPARSER::PROTEIN)
    ("ID1" . SPARSER::PROTEIN) ("GAL4" . SPARSER::PROTEIN)
    ("Reverbβ" . SPARSER::PROTEIN) ("NR1D2" . SPARSER::PROTEIN)
    ("MED1" . SPARSER::PROTEIN) ("ATN1" . SPARSER::PROTEIN)
    ("Atrophin-1" . SPARSER::PROTEIN) ("AF2" . SPARSER::PROTEIN)
    ("H12" . SPARSER::PROTEIN) ("NR4A2" . SPARSER::PROTEIN)
    ("NR4A1" . SPARSER::PROTEIN) ("NR2C2" . SPARSER::PROTEIN)
    ("NR2C1" . SPARSER::PROTEIN) ("NR1D1" . SPARSER::PROTEIN)
    ("NR0B2" . SPARSER::PROTEIN) ("NR0B1" . SPARSER::PROTEIN)
    ("NR6A1" . SPARSER::PROTEIN) ("LRH1" . SPARSER::PROTEIN)
    ("NR5A2" . SPARSER::PROTEIN) ("NR3B1" . SPARSER::PROTEIN)
    ("NR2A2" . SPARSER::PROTEIN) ("NR1F2" . SPARSER::PROTEIN)
    ("NR1F1" . SPARSER::PROTEIN) ("NR3C4" . SPARSER::PROTEIN)
    ("NR3A1" . SPARSER::PROTEIN) ("NR2B1" . SPARSER::PROTEIN)
    ("NR1I1" . SPARSER::PROTEIN) ("NR1B1" . SPARSER::PROTEIN)
    ("HS1" . SPARSER::PROTEIN) ("HS2" . SPARSER::PROTEIN)
    ("HS3" . SPARSER::PROTEIN) ("RARβ" . SPARSER::PROTEIN)
    ("NR1C3" . SPARSER::PROTEIN) ("a 20 µ" . SPARSER::PROTEIN)
    ("β-estradiol" . SPARSER::MOLECULE) ("URA3" . SPARSER::PROTEIN)
    ("leu2" . SPARSER::PROTEIN) ("trp1" . SPARSER::PROTEIN)
    ("L40" . SPARSER::PROTEIN) ("RXRα" . SPARSER::PROTEIN)
    ("RARα" . SPARSER::PROTEIN) ("LRH-1" . SPARSER::PROTEIN)
    ("NURR1" . SPARSER::PROTEIN) ("Nur77" . SPARSER::PROTEIN)
    ("ERRα" . SPARSER::PROTEIN) ("EAR2" . SPARSER::PROTEIN)
    ("COUP-TFI" . SPARSER::PROTEIN) ("TR4" . SPARSER::PROTEIN)
    ("TR2" . SPARSER::PROTEIN) ("HNF4γ" . SPARSER::PROTEIN)
    ("RORα" . SPARSER::PROTEIN) ("DAX-1" . SPARSER::PROTEIN)
    ("SRC1" . SPARSER::PROTEIN) ("VP16" . SPARSER::DRUG)
    ("pTL1" . SPARSER::PROTEIN) ("NR2A" . SPARSER::PROTEIN)
    ("HNF4" . SPARSER::PROTEIN) ("FOG1" . SPARSER::PROTEIN)
    ("SUV39H1" . SPARSER::PROTEIN) ("CTIP2" . SPARSER::PROTEIN)
    ("BCL11B" . SPARSER::PROTEIN) ("SOX6" . SPARSER::PROTEIN)
    ("CTIP1" . SPARSER::PROTEIN) ("zinc finger protein" . SPARSER::PROTEIN)
    ("orphan receptor" . SPARSER::PROTEIN) ("RIP140" . SPARSER::PROTEIN)
    ("p160" . SPARSER::PROTEIN) ("NSD1" . SPARSER::PROTEIN)
    ("SET domain" . SPARSER::PROTEIN) ("COUP-TFII" . SPARSER::PROTEIN)
    ("γ-globin" . SPARSER::PROTEIN) ("NR2E3" . SPARSER::PROTEIN)
    ("NR2E1" . SPARSER::PROTEIN) ("NR2F6" . SPARSER::PROTEIN)
    ("NR2F1" . SPARSER::PROTEIN) ("RID1" . SPARSER::PROTEIN)
    ("BCL11A" . SPARSER::PROTEIN) ("GCB- and ABC-type" . SPARSER::COLLECTION)
    ("CREBBP or EP300" . SPARSER::COLLECTION) ("AICDA" . SPARSER::PROTEIN)
    ("the co-activator EP300 or its related acetyltransferase molecule CREBBP"
     . SPARSER::COLLECTION)
    ("transcriptional coactivators and corepressors" . SPARSER::COLLECTION)
    ("coactivators and corepressors" . SPARSER::COLLECTION)
    ("this broad MEF2B" . SPARSER::PROTEIN)
    ("a hierarchically relevant transcription factor" . SPARSER::PROTEIN)
    ("PKA-" . SPARSER::PROTEIN)
    ("lymphoma-associated mutant alleles" . SPARSER::ALLELE)
    ("the DLBCL-associated MEF2B mutants" . SPARSER::MUTANT)
    ("SUMO1-Ubc9" . SPARSER::COLLECTION)
    ("SUMO1 and Ubc9" . SPARSER::COLLECTION)
    ("SUMO1 and the E2" . SPARSER::COLLECTION) ("SUMO" . SPARSER::PROTEIN)
    ("The latter isoform" . SPARSER::PROTEIN)
    ("exogenous PKA" . SPARSER::PROTEIN) ("FSK" . SPARSER::PROTEIN)
    ("cyclase" . SPARSER::PROTEIN) ("Forskolin" . SPARSER::PROTEIN)
    ("MEF2B-CABIN1" . SPARSER::COLLECTION)
    ("MEF2B and HDAC9" . SPARSER::COLLECTION)
    ("MEF2B and CABIN1" . SPARSER::COLLECTION)
    ("lymphoma-associated MEF2B mutants" . SPARSER::MUTANT)
    ("NES" . SPARSER::PROTEIN) ("MEF2B and MEF2B" . SPARSER::COLLECTION)
    ("MEF2B-Bcl-6" . SPARSER::COLLECTION)
    ("MEF2B or Bcl-6" . SPARSER::COLLECTION) ("-shRNA" . SPARSER::COLLECTION)
    ("tRFP" . SPARSER::PROTEIN) ("VAL" . SPARSER::AMINO-ACID)
    ("protein or mRNA" . SPARSER::COLLECTION)
    ("HA-MEF2B" . SPARSER::COLLECTION) ("AT" . SPARSER::PROTEIN)
    ("Bcl-6 and ZMYND11" . SPARSER::COLLECTION)
    ("MEF2B and Bcl-6" . SPARSER::COLLECTION)
    ("∼19 kDa and ∼22 kDa" . SPARSER::COLLECTION)
    ("C-terminal truncated forms" . SPARSER::FORM)
    ("at least two protein isoforms" . SPARSER::ISOFORM)
    ("specific transcriptional co-factors" . SPARSER::MOLECULE)
    ("MADS" . SPARSER::PROTEIN) ("GCB- and ABC-DLBCLs" . SPARSER::COLLECTION)
    ("GCB-" . SPARSER::PROTEIN)
    ("three phenotypic subtypes" . SPARSER::PROTEIN) ("ABC" . SPARSER::PROTEIN)
    ("GCB" . SPARSER::PROTEIN) ("oncogene, and MEF2B" . SPARSER::COLLECTION)
    ("PAX5" . SPARSER::PROTEIN) ("P57" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("beta-glycerophosphate" . SPARSER::DRUG) ("FBXO11" . SPARSER::PROTEIN)
    ("K23" . SPARSER::PROTEIN) ("EP300" . SPARSER::PROTEIN)
    ("SUMO1" . SPARSER::PROTEIN) ("Ubc9" . SPARSER::PROTEIN)
    ("L38" . SPARSER::PROTEIN) ("ZMYND11" . SPARSER::PROTEIN)
    ("K5" . SPARSER::PROTEIN) ("K4" . SPARSER::PROTEIN)
    ("PRDM1" . SPARSER::PROTEIN) ("CABIN1" . SPARSER::PROTEIN)
    ("BCL6" . SPARSER::PROTEIN)
    ("a
considerable fraction"
     . SPARSER::COMPONENT)
    ("SE" . SPARSER::PROTEIN) ("GCTA" . SPARSER::PROTEIN)
    ("long intergenic non-coding RNAs" . SPARSER::RNA)
    ("lincRNAs" . SPARSER::RNA) ("VARS" . SPARSER::PROTEIN)
    ("TNXB" . SPARSER::PROTEIN)
    ("TRIM26 (tripartite
motif containing 26, chr6:30.1Mb) and the HLA-DRB9"
     . SPARSER::COLLECTION)
    ("HLA" . SPARSER::PROTEIN) ("antihypertensive" . SPARSER::DRUG)
    ("isradipine" . SPARSER::DRUG) ("verapamil" . SPARSER::DRUG)
    ("adjuvants" . SPARSER::DRUG) ("pimozide" . SPARSER::DRUG)
    ("antipsychotics" . SPARSER::DRUG)
    ("CALHM1, CALHM2 ,and CALHM3" . SPARSER::COLLECTION)
    ("centractin" . SPARSER::PROTEIN)
    ("MHC, C10orf26, DPYD-MIR137, SDCCAG8 , and MMP16" . SPARSER::COLLECTION)
    ("ITIH3-ITIH4" . SPARSER::COLLECTION) ("NCAN" . SPARSER::PROTEIN)
    ("DPYD" . SPARSER::PROTEIN) ("Sweden" . SPARSER::PROTEIN)
    ("Only
one MHC SNP"
     . SPARSER::PROTEIN)
    ("Sweden-PGC" . SPARSER::COLLECTION) ("PGC" . SPARSER::PROTEIN)
    ("C2orf60 , and TYW5" . SPARSER::COLLECTION) ("orf" . SPARSER::PROTEIN)
    ("9,871,789 high-quality polymorphic SNPs" . SPARSER::PROTEIN)
    ("Genomes" . SPARSER::PROTEIN)
    ("no compelling
Mendelian variants"
     . SPARSER::VARIANT)
    ("CACNA1C and CACNB2" . SPARSER::COLLECTION) ("beta)" . SPARSER::PROTEIN)
    ("PRKD3" . SPARSER::PROTEIN) ("SBNO1" . SPARSER::PROTEIN)
    ("PITPNM2" . SPARSER::PROTEIN) ("NT5DC2" . SPARSER::PROTEIN)
    ("TSSK6" . SPARSER::PROTEIN) ("HLA-DQA1" . SPARSER::PROTEIN)
    ("HLA-DRB5" . SPARSER::PROTEIN) ("HLA-DRA" . SPARSER::PROTEIN)
    ("tripartite
motif containing 26"
     . SPARSER::PROTEIN)
    ("TRIM26" . SPARSER::PROTEIN) ("CACNA2D1" . SPARSER::PROTEIN)
    ("CACNA1S" . SPARSER::PROTEIN) ("CACNA1H" . SPARSER::PROTEIN)
    ("CACNB4" . SPARSER::PROTEIN) ("CACNA1A" . SPARSER::PROTEIN)
    ("voltage-gated" . SPARSER::PROTEIN) ("CALHM1" . SPARSER::PROTEIN)
    ("TNNC1" . SPARSER::PROTEIN) ("ACTR1A" . SPARSER::PROTEIN)
    ("calcium channel" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ITIH4" . SPARSER::PROTEIN)
    ("ITIH3" . SPARSER::PROTEIN) ("MMP16" . SPARSER::PROTEIN)
    ("SDCCAG8" . SPARSER::PROTEIN) ("TRANK1" . SPARSER::PROTEIN)
    ("ZNF804A" . SPARSER::PROTEIN) ("chr5" . SPARSER::PROTEIN)
    ("chr1" . SPARSER::PROTEIN) ("neuroligin 4" . SPARSER::PROTEIN)
    ("NLGN4X" . SPARSER::PROTEIN) ("X chromosome" . SPARSER::PROTEIN)
    ("chr8" . SPARSER::PROTEIN) ("K2" . SPARSER::PROTEIN)
    ("RP11" . SPARSER::PROTEIN) ("MAD1L1" . SPARSER::PROTEIN)
    ("NT5C2" . SPARSER::PROTEIN) ("AS3MT" . SPARSER::PROTEIN)
    ("TYW5" . SPARSER::PROTEIN) ("C2orf60" . SPARSER::PROTEIN)
    ("chr2" . SPARSER::PROTEIN) ("chr6" . SPARSER::PROTEIN)
    ("CACNB2" . SPARSER::PROTEIN) ("CACNA1C" . SPARSER::PROTEIN)
    ("a drugable target" . SPARSER::TARGET-PROTEIN) ("ARS" . SPARSER::PROTEIN)
    ("a structural cofactor" . SPARSER::MOLECULE)
    ("AIMP2 and PARIS" . SPARSER::COLLECTION)
    ("CamKII-tTA/TetP-AIMP2" . SPARSER::COLLECTION)
    ("synuclein" . SPARSER::PROTEIN)
    ("LRRK2 or α-synuclein" . SPARSER::COLLECTION) ("tTA" . SPARSER::PROTEIN)
    ("CamKII-tTA" . SPARSER::PROTEIN-PAIR)
    ("PARIS or AIMP2" . SPARSER::COLLECTION)
    ("PARIS, FBP-1 and AIMP2" . SPARSER::COLLECTION) ("FBP" . SPARSER::PROTEIN)
    ("PARIS" . SPARSER::PROTEIN) ("Tet-AIMP2" . SPARSER::COLLECTION)
    ("amphetamine" . SPARSER::DRUG)
    ("theTetP-AIMP2/PARP1" . SPARSER::COLLECTION)
    ("versusTetP-AIMP2/PARP1" . SPARSER::COLLECTION)
    ("TheseTetP-AIMP2/PARP1" . SPARSER::COLLECTION)
    ("/PARP1" . SPARSER::COLLECTION)
    ("hydrogen peroxide or MNNG" . SPARSER::COLLECTION)
    ("hydrogen peroxide or N-methyl-N" . SPARSER::COLLECTION)
    ("reagent and strong PARP1 activator" . SPARSER::COLLECTION)
    ("strong PARP1 activator" . SPARSER::ACTIVATOR)
    ("AIMP2-PARP1" . SPARSER::COLLECTION)
    ("overexpressed AIMP2 and nuclear PARP1" . SPARSER::COLLECTION)
    ("PARP1 and MnSOD" . SPARSER::COLLECTION)
    ("GST-AIMP2" . SPARSER::COLLECTION)
    ("AIMP2 ( xref ) and AIMP2" . SPARSER::COLLECTION)
    ("AIMP2 and PARP1" . SPARSER::COLLECTION)
    ("AIMP2-FLAG" . SPARSER::COLLECTION) ("FLAG-AIMP2" . SPARSER::COLLECTION)
    ("H 2 O 2 , thapsigargin and MPP +" . SPARSER::COLLECTION)
    ("/dopamine" . SPARSER::COLLECTION)
    ("dopamine and its metabolites" . SPARSER::COLLECTION)
    ("HVA" . SPARSER::MOLECULE) ("SNpc and VTA" . SPARSER::COLLECTION)
    ("SNpc" . SPARSER::PROTEIN) ("AIMP2 and tyrosine" . SPARSER::COLLECTION)
    ("CamKII" . SPARSER::PROTEIN) ("TetP-AIMP2" . SPARSER::COLLECTION)
    ("AIF" . SPARSER::PROTEIN) ("a pathogenic substrate" . SPARSER::SUBSTRATE)
    ("a pathogenic parkin substrate" . SPARSER::SUBSTRATE)
    ("JTV-1 or P38" . SPARSER::COLLECTION)
    ("Aminoacyl-tRNA" . SPARSER::PROTEIN) ("MPTP" . SPARSER::PROTEIN)
    ("tetrahydropyridine" . SPARSER::MOLECULE)
    ("a multifunctional E3 ligase" . SPARSER::LIGASE)
    ("the more common sporadic form" . SPARSER::FORM)
    ("Parkin" . SPARSER::PROTEIN)
    ("brain permeable PARP inhibitors" . SPARSER::INHIBITOR)
    ("synthetase" . SPARSER::PROTEIN) ("aminoacyl-tRNA" . SPARSER::PROTEIN)
    ("pathogenic substrates" . SPARSER::SUBSTRATE)
    ("parkin" . SPARSER::PROTEIN) ("Z-VAD-FMK" . SPARSER::DRUG)
    ("PF-01367338" . SPARSER::DRUG) ("nM 3" . SPARSER::DRUG)
    ("C3F" . SPARSER::PROTEIN) ("GA5" . SPARSER::MOLECULE)
    ("α-synuclein" . SPARSER::PROTEIN) ("LRRK2" . SPARSER::PROTEIN)
    ("AG014699" . SPARSER::DRUG)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("MPP +" . SPARSER::MOLECULE) ("homovanillic acid" . SPARSER::MOLECULE)
    ("JTV-1" . SPARSER::PROTEIN) ("c-Abl" . SPARSER::PROTEIN)
    ("AIMP2" . SPARSER::PROTEIN) ("antisense or RNA" . SPARSER::COLLECTION)
    ("soluble vimentin" . SPARSER::PROTEIN)
    ("mature monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("Chemotactic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phorbol" . SPARSER::DRUG)
    ("the most widely expressed intermediate filament protein"
     . SPARSER::PROTEIN)
    ("expressed intermediate filament protein" . SPARSER::PROTEIN)
    ("PKCβ antisense ODN or a PKCβ inhibitor peptide" . SPARSER::COLLECTION)
    ("ProQ" . SPARSER::PROTEIN)
    ("both specific antisense ODN and the PKCβ inhibitor peptide"
     . SPARSER::COLLECTION)
    ("PKCβ and vimentin" . SPARSER::COLLECTION)
    ("MCP-1 and the PKCβ inhibitor peptide" . SPARSER::COLLECTION)
    ("-orthophosphate" . SPARSER::ORTHOPHOSPHATE)
    ("orthophosphate" . SPARSER::ORTHOPHOSPHATE)
    ("the PKCβ inhibitor peptide or AS-ODN" . SPARSER::COLLECTION)
    ("Phosphoproteins" . SPARSER::PROTEIN)
    ("phosphorylated proteins and all the proteins" . SPARSER::COLLECTION)
    ("antisense-ODN" . SPARSER::COLLECTION) ("lasp-1" . SPARSER::PROTEIN)
    ("lasp" . SPARSER::DRUG) ("transaldolase" . SPARSER::PROTEIN)
    ("gelsolin" . SPARSER::PROTEIN) ("Monocytes" . SPARSER::PROTEIN)
    ("the myristoylated PKCβ inhibitor peptide and our previously characterized PKCβ S- and AS-ODN"
     . SPARSER::COLLECTION)
    ("myristoylated" . SPARSER::PROTEIN) ("ruboxistaurin" . SPARSER::DRUG)
    ("apoE and PKCβ" . SPARSER::COLLECTION)
    ("PKCβ and other key molecules" . SPARSER::COLLECTION)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("a β-chemotactic cytokine" . SPARSER::PROTEIN)
    ("Monocyte chemotactic protein-1" . SPARSER::PROTEIN)
    ("inflammatory macrophages" . SPARSER::PROTEIN)
    ("MCP-1-treated monocytes" . SPARSER::PROTEIN)
    ("a major intermediate filament protein" . SPARSER::PROTEIN)
    ("AS-ODN" . SPARSER::COLLECTION) ("ODN" . SPARSER::PROTEIN)
    ("AS" . SPARSER::PROTEIN) ("GO6983" . SPARSER::DRUG)
    ("L-plastin" . SPARSER::PROTEIN) ("lamin B1" . SPARSER::PROTEIN)
    ("annexin 1" . SPARSER::PROTEIN) ("capping protein" . SPARSER::PROTEIN)
    ("PKCα" . SPARSER::PROTEIN) ("CCR2" . SPARSER::PROTEIN)
    ("Chemokine receptor" . SPARSER::PROTEIN) ("Dectin-1" . SPARSER::PROTEIN)
    ("intermediate filament protein" . SPARSER::PROTEIN)
    ("PKC β" . SPARSER::PROTEIN) ("HR, and NER" . SPARSER::COLLECTION)
    ("NER" . SPARSER::PROTEIN) ("TFIIH" . SPARSER::PROTEIN)
    ("accessory factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CtBP and HDAC1" . SPARSER::COLLECTION)
    ("heterochromatic chromatin" . SPARSER::PROTEIN)
    ("γH2AX and 53BP1" . SPARSER::COLLECTION)
    ("E2F-7-bound chromatin" . SPARSER::PROTEIN)
    ("DR-GFP" . SPARSER::COLLECTION) ("E2F-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gene, and repair" . SPARSER::COLLECTION)
    ("post-CPT" . SPARSER::COLLECTION)
    ("the most dangerous forms" . SPARSER::FORM)
    ("CtBP and HDAC" . SPARSER::COLLECTION) ("CtBP" . SPARSER::PROTEIN)
    ("Reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pE2" . SPARSER::PROTEIN) ("replication protein" . SPARSER::PROTEIN)
    ("Tumor suppressor p53" . SPARSER::PROTEIN)
    ("family member E" . SPARSER::PROTEIN)
    ("RAD51 recombinase" . SPARSER::PROTEIN) ("RAD50" . SPARSER::PROTEIN)
    ("H2A" . SPARSER::PROTEIN) ("EP" . SPARSER::PROTEIN)
    ("MEK, MAPK and RREB1" . SPARSER::COLLECTION)
    ("K-Ras and RREB1" . SPARSER::COLLECTION)
    ("GEF1 and GEF40" . SPARSER::COLLECTION)
    ("K-Ras in colon [ xref ] and ERK5 in prostate and colon [ xref ]"
     . SPARSER::COLLECTION)
    ("Ets-1 and Elk-1" . SPARSER::COLLECTION)
    ("UO126 or PD98059" . SPARSER::COLLECTION)
    ("U0126 or miR-143" . SPARSER::COLLECTION)
    ("PGE 2 , BxPC-3 and HPAF-II" . SPARSER::COLLECTION)
    ("U0126 and PD98059" . SPARSER::COLLECTION)
    ("p-MAPK" . SPARSER::COLLECTION) ("p-MEK" . SPARSER::COLLECTION)
    ("prostanoid" . SPARSER::MOLECULE)
    ("COX-2 and PGE 2" . SPARSER::COLLECTION)
    ("a constitutive COX-1 and an inducible COX-2" . SPARSER::COLLECTION)
    ("oncogenes or tumor suppressors" . SPARSER::COLLECTION)
    ("MEK/MAPK" . SPARSER::COLLECTION)
    ("U0126 or PD98059" . SPARSER::COLLECTION)
    ("kinase (MAPK)" . SPARSER::KINASE)
    ("cyclooxygenase (COX)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GEF1" . SPARSER::PROTEIN) ("Ets-1" . SPARSER::PROTEIN)
    ("Prostaglandin E 2" . SPARSER::MOLECULE)
    ("Actinomycin D" . SPARSER::MOLECULE) ("RREB1" . SPARSER::PROTEIN)
    ("element binding protein" . SPARSER::PROTEIN) ("EP 2" . SPARSER::PROTEIN)
    ("COX-1" . SPARSER::PROTEIN) ("MAPK kinase" . SPARSER::PROTEIN)
    ("COX-2" . SPARSER::PROTEIN) ("PGE 2" . SPARSER::DRUG)
    ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("RNF38 and p53" . SPARSER::COLLECTION)
    ("p53 and PML" . SPARSER::COLLECTION) ("PML and p53" . SPARSER::COLLECTION)
    ("possible RNF38" . SPARSER::PROTEIN)
    ("exogenous RNF38" . SPARSER::PROTEIN)
    ("HA-tagged ubiquitin and either GST" . SPARSER::COLLECTION)
    ("GST-RNF38" . SPARSER::COLLECTION) ("GST-p53" . SPARSER::COLLECTION)
    ("p53 and glutathione S-transferase (GST)" . SPARSER::COLLECTION)
    ("p53 and glutathione S-transferase" . SPARSER::COLLECTION)
    ("p53-RNF38" . SPARSER::COLLECTION) ("GFP-RNF38" . SPARSER::COLLECTION)
    ("two commercially available anti-RNF38 antibodies" . SPARSER::ANTIBODY)
    ("WWP1, Pirh2 and Cop1" . SPARSER::COLLECTION)
    ("Mdm2/Hdm2" . SPARSER::COLLECTION) ("interactors" . SPARSER::PROTEIN)
    ("Arf, Mdm2 and Pirh2" . SPARSER::COLLECTION)
    ("discrete foci" . SPARSER::PROTEIN) ("PML" . SPARSER::PROTEIN)
    ("bipartite" . SPARSER::PROTEIN)
    ("a functional ubiquitin protein ligase" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE) ("UbcH7" . SPARSER::PROTEIN)
    ("UbcH5b" . SPARSER::PROTEIN) ("E2s" . SPARSER::MOLECULE)
    ("Isoform 1" . SPARSER::PROTEIN) ("Cop1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WWP1" . SPARSER::PROTEIN) ("Hdm2" . SPARSER::PROTEIN)
    ("Pirh2" . SPARSER::PROTEIN) ("RING finger protein" . SPARSER::PROTEIN)
    ("RNF38" . SPARSER::PROTEIN) ("Hsp70/Stub1" . SPARSER::COLLECTION)
    ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("potentially other inflammation cues" . SPARSER::PROTEIN-FAMILY)
    ("LPS and IL-2" . SPARSER::COLLECTION)
    ("LPS and proinflammatory cytokines" . SPARSER::COLLECTION)
    ("Hsp60 and Hsp70" . SPARSER::COLLECTION)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("Suppressor" . SPARSER::SUPPRESSOR)
    ("the chaperone Hsp70 and its target Foxp3" . SPARSER::COLLECTION)
    ("Treg cell-associated genes" . SPARSER::GENE)
    ("IL-6 and other STAT3 signaling cytokines" . SPARSER::COLLECTION)
    ("IFN-γ and IL-17" . SPARSER::COLLECTION)
    ("sh-Stub1" . SPARSER::COLLECTION) ("LN, SPL and LP" . SPARSER::COLLECTION)
    ("Foxp3 and IL-2 and IFN-γ" . SPARSER::COLLECTION)
    ("LP" . SPARSER::PROTEIN) ("SPL" . SPARSER::PROTEIN)
    ("LV" . SPARSER::MOLECULE) ("CFSE" . SPARSER::DRUG)
    ("CD25, CTLA-4, GITR and IL-10" . SPARSER::COLLECTION)
    ("several Treg and T effector (Teff) cell-associated genes"
     . SPARSER::GENE)
    ("characteristic Treg gene" . SPARSER::PROTEIN)
    ("Foxp3, IFN-γ and IL-2" . SPARSER::COLLECTION)
    ("Hsp70 and Stub1" . SPARSER::COLLECTION)
    ("constitutively expressed Hsc70" . SPARSER::PROTEIN)
    ("expressed Hsc70" . SPARSER::PROTEIN)
    ("Stub1-Foxp3" . SPARSER::COLLECTION) ("MBP-Foxp3" . SPARSER::COLLECTION)
    ("Foxp3-Jurkat" . SPARSER::COLLECTION)
    ("Stub1 and Hsp70" . SPARSER::COLLECTION)
    ("Hsp70 and Foxp3" . SPARSER::COLLECTION)
    ("the biochemical stress indicator Hsp70" . SPARSER::PROTEIN)
    ("Foxp3-Stub1" . SPARSER::COLLECTION)
    ("wild type Foxp3 or the 4R mutant (marked by GFP)" . SPARSER::COLLECTION)
    ("dsRed" . SPARSER::PROTEIN) ("HA, Flag or Myc" . SPARSER::COLLECTION)
    ("the 20R mutant or the 4R mutant" . SPARSER::COLLECTION)
    ("HA-Ubi" . SPARSER::COLLECTION) ("Flag-Foxp3" . SPARSER::COLLECTION)
    ("ligase activity and chaperone" . SPARSER::COLLECTION)
    ("Ubi" . SPARSER::PROTEIN) ("cellular Foxp3" . SPARSER::PROTEIN)
    ("HA-Foxp3-Jurkat" . SPARSER::COLLECTION)
    ("Flag-Ubi" . SPARSER::COLLECTION)
    ("its subfamily member Foxp1" . SPARSER::PROTEIN)
    ("subdomains" . SPARSER::PROTEIN) ("Foxp3 or Foxp1" . SPARSER::COLLECTION)
    ("HA-Ubiquitin" . SPARSER::COLLECTION) ("N2 and N3" . SPARSER::COLLECTION)
    ("Foxp3 and Stub1" . SPARSER::COLLECTION)
    ("Myc-Stub1" . SPARSER::COLLECTION) ("HA-Foxp3" . SPARSER::COLLECTION)
    ("Foxp3 or Stub1" . SPARSER::COLLECTION) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("Both Hsp70 and the related Hsc70" . SPARSER::COLLECTION)
    ("a stress-activated E3 ubiquitin ligase" . SPARSER::PROTEIN)
    ("Hsp70 or HSPA1A" . SPARSER::COLLECTION)
    ("TAP-Foxp3" . SPARSER::COLLECTION) ("TAP" . SPARSER::PROTEIN)
    ("CTLA-4, GITR and CD25" . SPARSER::COLLECTION) ("GITR" . SPARSER::PROTEIN)
    ("mice given LPS" . SPARSER::PROTEIN)
    ("IL-1β and TNFα" . SPARSER::COLLECTION)
    ("LPS or inflammatory cytokines—the" . SPARSER::COLLECTION)
    ("Foxp3-GFP" . SPARSER::COLLECTION)
    ("IL-2 and IFN-γ" . SPARSER::COLLECTION)
    ("Stub1 and Foxp3" . SPARSER::COLLECTION)
    ("IL-4, IL-6, and IL-21" . SPARSER::COLLECTION)
    ("receptors (TLR)" . SPARSER::RECEPTOR) ("TLR" . SPARSER::PROTEIN)
    ("the stress-activated Stub1-Hsp70 complex" . SPARSER::BIO-COMPLEX)
    ("Stub1-Hsp70" . SPARSER::COLLECTION)
    ("Stub1 or Hsp70" . SPARSER::COLLECTION)
    ("proinflammatory cytokines and lipopolysaccharide" . SPARSER::COLLECTION)
    ("cytokines and lipopolysaccharide" . SPARSER::COLLECTION)
    ("Stub1" . SPARSER::PROTEIN) ("RAG2" . SPARSER::PROTEIN)
    ("Hsp60" . SPARSER::PROTEIN) ("Thy1" . SPARSER::PROTEIN)
    ("CD62L" . SPARSER::PROTEIN) ("Ubc5" . SPARSER::PROTEIN)
    ("Foxp1" . SPARSER::PROTEIN) ("Runx2" . SPARSER::PROTEIN)
    ("HIF-1α" . SPARSER::PROTEIN) ("HSPA1A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heat shock 70kDa protein 1A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CTLA-4" . SPARSER::PROTEIN) ("Myd88" . SPARSER::PROTEIN)
    ("CD127" . SPARSER::PROTEIN) ("IL-2" . SPARSER::PROTEIN)
    ("a nonphosphorylatable Cdh1 mutant" . SPARSER::MUTANT)
    ("roscovitine and BI2536" . SPARSER::COLLECTION)
    ("control Cdh1’s" . SPARSER::PROTEIN) ("tempo" . SPARSER::DRUG)
    ("the nondegradable S138A/S146A mutant" . SPARSER::MUTANT)
    ("S138A/S146A" . SPARSER::PROTEIN)
    ("nondegradable Cdh1 mutants" . SPARSER::MUTANT)
    ("4A-Cdh1 and S138A/S146A-Cdh1" . SPARSER::COLLECTION)
    ("S138A/S146A-Cdh1" . SPARSER::COLLECTION) ("Geminin" . SPARSER::PROTEIN)
    ("Cdk2 and Plk1" . SPARSER::COLLECTION)
    ("roscovitine and/or BI2536 ( xref )" . SPARSER::COLLECTION)
    ("both the Plk1 and cyclin A oncoproteins" . SPARSER::PROTEIN)
    ("Plk1 and cyclin" . SPARSER::COLLECTION)
    ("both the Cdk2 inhibitor roscovitine ( xref ) and the Plk1 inhibitor BI2536 ( xref )"
     . SPARSER::COLLECTION)
    ("either shRNA ( xref ) or the pharmacological Plk1 inhibitor"
     . SPARSER::COLLECTION)
    ("Plk1 and Cdh1" . SPARSER::COLLECTION) ("SpS/pTP" . SPARSER::COLLECTION)
    ("pTP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SpS" . SPARSER::PROTEIN)
    ("Polo" . SPARSER::PROTEIN)
    ("Gli3 ( xref ) and Mdm2 ( xref )" . SPARSER::COLLECTION)
    ("Cdh1 and Plk1" . SPARSER::COLLECTION) ("GST-Cdh1" . SPARSER::COLLECTION)
    ("the Cdk2/cyclin A complex" . SPARSER::BIO-COMPLEX)
    ("Cdh1 and β-TRCP1" . SPARSER::COLLECTION)
    ("Cdh1 and Cullin 1" . SPARSER::COLLECTION)
    ("other dominant-negative forms" . SPARSER::FORM)
    ("Cullins" . SPARSER::PROTEIN-FAMILY)
    ("a dominant-negative Cullin 1 mutant" . SPARSER::MUTANT)
    ("Cullin" . SPARSER::PROTEIN-FAMILY) ("-Cdh1" . SPARSER::COLLECTION)
    ("an as-yet-unidentified E3 ligase" . SPARSER::LIGASE)
    ("Cdk2/cyclin" . SPARSER::COLLECTION) ("cyclin-A-" . SPARSER::PROTEIN)
    ("Securin and cyclin" . SPARSER::COLLECTION) ("Securin" . SPARSER::PROTEIN)
    ("KEN" . SPARSER::PROTEIN) ("SCF and APC" . SPARSER::COLLECTION)
    ("APC/Cdh1" . SPARSER::COLLECTION) ("APC and SCF" . SPARSER::COLLECTION)
    ("the anaphase-promoting complex (APC) and Skp1-Cullin1-F-box (SCF) E3 ubiquitin ligase"
     . SPARSER::COLLECTION)
    ("anaphase-promoting complex (APC)" . SPARSER::PROTEIN)
    ("GL2" . SPARSER::PROTEIN) ("cyclin-B" . SPARSER::PROTEIN-FAMILY)
    ("Cdk1" . SPARSER::PROTEIN) ("BI2536" . SPARSER::DRUG)
    ("Gli3" . SPARSER::PROTEIN) ("Arg-Val" . SPARSER::MOLECULE)
    ("Cdc20" . SPARSER::PROTEIN) ("Cullin 2" . SPARSER::PROTEIN)
    ("Cullin family" . SPARSER::PROTEIN-FAMILY) ("Cullin 1" . SPARSER::PROTEIN)
    ("Emi-1" . SPARSER::PROTEIN) ("Cullin-1" . SPARSER::PROTEIN)
    ("cyclin-A" . SPARSER::PROTEIN) ("β-TRCP" . SPARSER::PROTEIN)
    ("Cdh1" . SPARSER::PROTEIN) ("Cullin1" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("RIP1-FADD-Caspase 8" . SPARSER::COLLECTION)
    ("EGFRvIII-RIP1-NF-κB" . SPARSER::COLLECTION)
    ("a trophic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a physical complex" . SPARSER::BIO-COMPLEX)
    ("Etoposide" . SPARSER::PROTEIN)
    ("both apoptotic and necrotic forms" . SPARSER::FORM)
    ("TNF-alpha, TLR3 and DNA" . SPARSER::COLLECTION)
    ("EGFRvIII-RIP1-pp65" . SPARSER::COLLECTION)
    ("EGFR, RIP1 and phospho-p65" . SPARSER::COLLECTION)
    ("RIP1 and Caspase-8" . SPARSER::COLLECTION)
    ("ligand and RIP1" . SPARSER::COLLECTION)
    ("RIP, FADD and Caspase 8" . SPARSER::COLLECTION)
    ("FADD-RIP1" . SPARSER::COLLECTION)
    ("NEMO and TAK1 and forms" . SPARSER::COLLECTION)
    ("TAK1 and forms" . SPARSER::COLLECTION)
    ("RIP1-FADD" . SPARSER::COLLECTION) ("NEMO and TAK1" . SPARSER::COLLECTION)
    ("Erlotinib and Necrostatin-1" . SPARSER::COLLECTION)
    ("NEMO-RIP1" . SPARSER::COLLECTION) ("RIP1-NEMO" . SPARSER::COLLECTION)
    ("RIP1-EGFRvIII" . SPARSER::COLLECTION) ("-EGFRvIII" . SPARSER::COLLECTION)
    ("cIAP1-RIP1" . SPARSER::COLLECTION)
    ("cIAP2 and TRAF2" . SPARSER::COLLECTION)
    ("c-IAP2 and TRAF2" . SPARSER::COLLECTION)
    ("c-IAP1" . SPARSER::PROTEIN-PAIR)
    ("RIP1 and EGFRvIII" . SPARSER::COLLECTION)
    ("silenced RIP1 or control shRNA" . SPARSER::COLLECTION)
    ("RIP1 or control shRNA" . SPARSER::COLLECTION)
    ("lentiviral shRNA" . SPARSER::PROTEIN)
    ("Necrostatin-1 and Erlotinib" . SPARSER::COLLECTION)
    ("EGFRvIII and EGFRwt" . SPARSER::COLLECTION) ("GBM9" . SPARSER::PROTEIN)
    ("GBM9-NS" . SPARSER::COLLECTION)
    ("EGFRvIII and NF-κB" . SPARSER::COLLECTION)
    ("EGFRvIII, NEMO and TAK1" . SPARSER::COLLECTION)
    ("EGFRvIII and RIP1" . SPARSER::COLLECTION)
    ("RIP1, NEMO and TAK1" . SPARSER::COLLECTION)
    ("ligases, TRAF2 and cIAP2" . SPARSER::COLLECTION)
    ("RIP1 and NF-κB" . SPARSER::COLLECTION)
    ("even focally distributed EGFRvIII" . SPARSER::PROTEIN)
    ("NFKBIA" . SPARSER::PROTEIN) ("SMAC" . SPARSER::PROTEIN)
    ("a prosurvival adaptor protein" . SPARSER::PROTEIN)
    ("RIP1, FADD and Caspase-8" . SPARSER::COLLECTION)
    ("TRADD and TAK1" . SPARSER::COLLECTION) ("TRADD" . SPARSER::PROTEIN)
    ("RIP" . SPARSER::PROTEIN) ("FADD and Caspase-8" . SPARSER::COLLECTION)
    ("FADD" . SPARSER::PROTEIN) ("TAK1 and NEMO" . SPARSER::COLLECTION)
    ("EGFRvIII-RIP1" . SPARSER::COLLECTION) ("signalosome" . SPARSER::PROTEIN)
    ("Annexin −V" . SPARSER::PROTEIN) ("AG-1478" . SPARSER::DRUG)
    ("Vitamin A" . SPARSER::MOLECULE) ("T-Rex" . SPARSER::PROTEIN-FAMILY)
    ("TLR3" . SPARSER::PROTEIN) ("pp65" . SPARSER::PROTEIN)
    ("Caspase 8" . SPARSER::PROTEIN) ("cIAP1" . SPARSER::PROTEIN)
    ("c-IAP2" . SPARSER::PROTEIN) ("IAP1" . SPARSER::PROTEIN)
    ("L11" . SPARSER::PROTEIN) ("1-L" . SPARSER::PROTEIN)
    ("U26" . SPARSER::PROTEIN) ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRAF2" . SPARSER::PROTEIN) ("IKKγ" . SPARSER::PROTEIN)
    ("RIPK1" . SPARSER::PROTEIN)
    ("receptor interacting protein" . SPARSER::PROTEIN)
    ("Caspase-8" . SPARSER::PROTEIN)
    ("the FGFR3K K650E pathogenic kinase" . SPARSER::KINASE)
    ("guanidinium" . SPARSER::MOLECULE)
    ("FGFR-invariant" . SPARSER::PROTEIN-PAIR)
    ("whereby one kinase molecule" . SPARSER::MOLECULE)
    ("amides" . SPARSER::MOLECULE)
    ("FGFR1 ( xref ; xref ) and FGFR2 ( xref , xref ) kinases"
     . SPARSER::COLLECTION)
    ("Conformation" . SPARSER::BIO-CONFORMATION)
    ("DFG and LPV" . SPARSER::COLLECTION) ("DFG" . SPARSER::PROTEIN)
    ("a nonhydrolyzable ATP analog" . SPARSER::ANALOG) ("AMP" . SPARSER::AMP)
    ("a previously reported kinase trans -phosphorylation complex"
     . SPARSER::BIO-COMPLEX)
    ("this pathogenic FGFR3 mutant" . SPARSER::MUTANT)
    ("STAT1 and Src" . SPARSER::COLLECTION) ("mannose" . SPARSER::MOLECULE)
    ("FGFR1 and FGFR2" . SPARSER::COLLECTION)
    ("the K650E mutation causes Thanatophoric Dysplasia type II"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cofactors or Klotho" . SPARSER::COLLECTION)
    ("ecto" . SPARSER::HUMAN-PROTEIN-FAMILY) ("coreceptors" . SPARSER::PROTEIN)
    ("Klotho" . SPARSER::PROTEIN) ("FGFs" . SPARSER::PROTEIN)
    ("this pathogenic FGFR3 kinase" . SPARSER::KINASE)
    ("FGF receptor 3 (FGFR3) causes Thanatophoric Dysplasia type II"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tail peptide" . SPARSER::PROTEIN) ("oxygen atom" . SPARSER::MOLECULE)
    ("Fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("FGFR3" . SPARSER::PROTEIN) ("Mst1/2 and Ras" . SPARSER::COLLECTION)
    ("inhibitors or activators" . SPARSER::COLLECTION)
    ("the activated Mst2 phosphorylated either Mob1 or myelin basic protein (MBP)"
     . SPARSER::COLLECTION)
    ("Mob1 or myelin basic protein (MBP)" . SPARSER::COLLECTION)
    ("Mob1 or myelin basic protein" . SPARSER::COLLECTION)
    ("MBP" . SPARSER::PROTEIN) ("Only Mst2 K473A" . SPARSER::PROTEIN)
    ("GST-RASSF5" . SPARSER::COLLECTION) ("HA-Mst2" . SPARSER::COLLECTION)
    ("Myc-Mst2" . SPARSER::COLLECTION) ("HA-" . SPARSER::PROTEIN)
    ("Mst2 and RASSF5" . SPARSER::COLLECTION)
    ("ion and AMP-PNP" . SPARSER::COLLECTION)
    ("the active Mst1 KD ( xref ) or inactive Mst2 KD" . SPARSER::COLLECTION)
    ("kinase and SARAH" . SPARSER::COLLECTION)
    ("Mst2-RASSF5" . SPARSER::COLLECTION) ("Myc-Lats1/2" . SPARSER::COLLECTION)
    ("HA-YAP" . SPARSER::COLLECTION) ("Flag-Mst2" . SPARSER::COLLECTION)
    ("a weak dimer" . SPARSER::DIMER) ("Substrates" . SPARSER::SUBSTRATE)
    ("inactive and active" . SPARSER::COLLECTION) ("-ATP" . SPARSER::ATP)
    ("lobes" . SPARSER::PROTEIN) ("PDB" . SPARSER::MOLECULE)
    ("asparagine" . SPARSER::AMINO-ACID) ("State" . SPARSER::BIO-STATE)
    ("Inactive" . SPARSER::INACTIVE)
    ("Mst1/2 and RASSFs" . SPARSER::COLLECTION)
    ("Raf1 and Mst2" . SPARSER::COLLECTION)
    ("Mst2-Lats1" . SPARSER::COLLECTION)
    ("RASSF1, RASSF5, and RASSF6" . SPARSER::COLLECTION)
    ("the only RASSF protein" . SPARSER::PROTEIN)
    ("RASSF1A or RASSF5" . SPARSER::COLLECTION)
    ("RASSFs and Sav1" . SPARSER::COLLECTION)
    ("Sav1 and RASSF" . SPARSER::COLLECTION)
    ("RASSF" . SPARSER::PROTEIN-FAMILY) ("Mst1 and Mst2" . SPARSER::COLLECTION)
    ("Mst1" . SPARSER::PROTEIN) ("SSF" . SPARSER::PROTEIN)
    ("Mst1/2" . SPARSER::PROTEIN) ("Mst1/2-Lats1/2" . SPARSER::PROTEIN-PAIR)
    ("Hippo-responsive genes" . SPARSER::GENE)
    ("YAP–TEAD" . SPARSER::COLLECTION)
    ("a functional hybrid transcription factor" . SPARSER::PROTEIN)
    ("Lats1/2" . SPARSER::PROTEIN) ("Lats1/2-Mob1" . SPARSER::PROTEIN-PAIR)
    ("NDR" . SPARSER::PROTEIN)
    ("an inhibitor or a potential positive regulator of Mst2"
     . SPARSER::COLLECTION)
    ("RASSFs" . SPARSER::PROTEIN-FAMILY) ("α-HA" . SPARSER::MOLECULE)
    ("Lats2" . SPARSER::PROTEIN) ("SO 4" . SPARSER::PROTEIN)
    ("myelin basic protein" . SPARSER::PROTEIN) ("AMP-PNP" . SPARSER::MOLECULE)
    ("K56" . SPARSER::PROTEIN) ("RASSF2" . SPARSER::PROTEIN)
    ("RASSF6" . SPARSER::PROTEIN) ("Mob1" . SPARSER::PROTEIN)
    ("Sav1" . SPARSER::PROTEIN) ("Ste20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RASSF5" . SPARSER::PROTEIN) ("Mst2" . SPARSER::PROTEIN)
    ("haematoxylin and eosin" . SPARSER::COLLECTION) ("no special type" . TYPE)
    ("UDG" . SPARSER::PROTEIN) ("mTORC" . SPARSER::PROTEIN)
    ("melt" . SPARSER::DRUG) ("cytokeratin" . SPARSER::PROTEIN)
    ("CK" . SPARSER::PROTEIN) ("sporadic and familial MBC" . SPARSER::PROTEIN)
    ("eIF4e" . SPARSER::PROTEIN) ("eIF" . SPARSER::PROTEIN)
    ("pS6 and p4EBP1 and pAKT" . SPARSER::COLLECTION)
    ("pAKT, p4EBP1 and pS6" . SPARSER::COLLECTION)
    ("BRCA1-" . SPARSER::PROTEIN)
    ("this particular cohort" . SPARSER::MOLECULE)
    ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("Further study correlating serum oestradiol" . SPARSER::MOLECULE)
    ("testosterone" . SPARSER::MOLECULE) ("oestradiol" . SPARSER::MOLECULE)
    ("alternate receptor" . SPARSER::PROTEIN)
    ("ERα and PgR" . SPARSER::COLLECTION) ("BRC" . SPARSER::PROTEIN)
    ("a strong inherent BRCA2" . SPARSER::PROTEIN)
    ("families and BRCA1" . SPARSER::COLLECTION)
    ("HRM and Sanger" . SPARSER::COLLECTION)
    ("a unique hot" . SPARSER::PROTEIN)
    ("a much larger cohort" . SPARSER::MOLECULE)
    ("AKT1 , KRAS and BRAF" . SPARSER::COLLECTION)
    ("pS6 and pAKT1" . SPARSER::COLLECTION)
    ("AKT1 , BRAF and KRAS" . SPARSER::COLLECTION)
    ("any clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIK3CA, AKT1, KRAS and BRAF" . SPARSER::COLLECTION)
    ("sporadic MBC" . SPARSER::PROTEIN)
    ("both tumour histological type and estrogen receptor (ERα) status [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("both tumour histological type" . TYPE)
    ("RAS/RAF/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("Several significant targetable oncogenes" . SPARSER::ONCOGENE)
    ("BRCA1 , BRCA2 and BRCAX" . SPARSER::COLLECTION)
    ("BRCAX" . SPARSER::PROTEIN) ("AKT1 , KRAS or BRAF" . SPARSER::COLLECTION)
    ("pAKT1, pS6 and p4EBP1" . SPARSER::COLLECTION)
    ("PIK3CA/mTOR" . SPARSER::COLLECTION)
    ("KRAS (exon 2) and BRAF (exon 15) genes" . SPARSER::COLLECTION)
    ("PIK3CA/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("MBC" . SPARSER::PROTEIN) ("CC1" . SPARSER::PROTEIN)
    ("Uracil-DNA glycosylase" . SPARSER::PROTEIN) ("A 20" . SPARSER::PROTEIN)
    ("CK5" . SPARSER::PROTEIN) ("alpha 9" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4,5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EBP1" . SPARSER::PROTEIN) ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LOXL2 and ErbB2" . SPARSER::COLLECTION)
    ("LOXL2 and TIMP-1" . SPARSER::COLLECTION)
    ("E-cadherin and SNAI1" . SPARSER::COLLECTION)
    ("vimentin, E-cadherin, N-cadherin, SNAI1, SNAI2, Twist, and α-SMA"
     . SPARSER::COLLECTION)
    ("ErbB2/ErbB3" . SPARSER::COLLECTION)
    ("Laminin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("either Herceptin (Figure xref ) or lapatinib (Figure xref )"
     . SPARSER::COLLECTION)
    ("Matrigel, and LOXL2" . SPARSER::COLLECTION)
    ("DMSO-treated 10A cont acini" . SPARSER::PROTEIN)
    ("aberrant mammary acini" . SPARSER::PROTEIN)
    ("caspase-3, Ki67, and GM130" . SPARSER::COLLECTION)
    ("a dual ErbB1/ErbB2 small-molecule inhibitor" . SPARSER::INHIBITOR)
    ("ErbB1/ErbB2" . SPARSER::COLLECTION)
    ("IgG-treated 10A cont acini" . SPARSER::PROTEIN)
    ("IgG-treated 10A L2 acini" . SPARSER::PROTEIN)
    ("acini and ErbB2" . SPARSER::COLLECTION)
    ("approximately 95 kDa and 65 kDa" . SPARSER::COLLECTION)
    ("approximately 95 kDa" . SPARSER::PROTEIN) ("cont" . SPARSER::PROTEIN)
    ("Normal acini" . SPARSER::PROTEIN)
    ("multiple mammary acini" . SPARSER::PROTEIN)
    ("an excellent drug target" . SPARSER::TARGET-PROTEIN)
    ("stromal collagens and elastin" . SPARSER::COLLECTION)
    ("collagens and elastin" . SPARSER::COLLECTION)
    ("Herceptin or lapatinib" . SPARSER::COLLECTION)
    ("acini" . SPARSER::PROTEIN)
    ("Clinically relevant inhibitors" . SPARSER::INHIBITOR)
    ("ErbB2, lapatinib and Herceptin" . SPARSER::COLLECTION)
    ("Herceptin" . SPARSER::DRUG) ("erbB-3" . SPARSER::PROTEIN)
    ("lysyl oxidase-like 2" . SPARSER::PROTEIN) ("TIMP1" . SPARSER::PROTEIN)
    ("TIMP-1" . SPARSER::PROTEIN) ("ErbB1" . SPARSER::PROTEIN)
    ("long form" . SPARSER::PROTEIN) ("GM130" . SPARSER::PROTEIN)
    ("Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hsc70" . SPARSER::PROTEIN) ("pErk1/2" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("lysyl oxidase" . SPARSER::PROTEIN)
    ("anti-ErbB2" . SPARSER::DRUG) ("LOXL2" . SPARSER::PROTEIN)
    ("Lysyl oxidase-like 2" . SPARSER::PROTEIN) ("NSPC" . SPARSER::PROTEIN)
    ("CBP-Smad1" . SPARSER::COLLECTION)
    ("the neurogenic period" . SPARSER::PROTEIN)
    ("Proneural bHLH proteins" . SPARSER::PROTEIN) ("NSC" . SPARSER::PROTEIN)
    ("Math1, Ngn3 and NeuroD" . SPARSER::COLLECTION)
    ("Hes5, Id2, and Id3" . SPARSER::COLLECTION) ("NeuroD" . SPARSER::PROTEIN)
    ("IL-1β or TNF-α" . SPARSER::COLLECTION) ("IL-1β-" . SPARSER::PROTEIN)
    ("IL-1 β or TNF-α" . SPARSER::COLLECTION)
    ("IL-1β (1 ng/ml) and TNF-α (20 ng/ml)" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines, IL-1β (1 ng/ml) and TNF-α (20 ng/ml)"
     . SPARSER::COLLECTION)
    ("siCon-treated NPCs" . SPARSER::MOLECULE)
    ("a STAT3-targeting siRNA (siSTAT3) or a negative control siRNA (siCon)"
     . SPARSER::COLLECTION)
    ("NB" . SPARSER::PROTEIN) ("the cytoskeletric protein" . SPARSER::PROTEIN)
    ("bFGF, EGF, and LIF" . SPARSER::COLLECTION)
    ("Nestin and Sox2" . SPARSER::COLLECTION)
    ("cytokines, IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("bFGF, EGF and LIF" . SPARSER::COLLECTION)
    ("cytokine-" . SPARSER::PROTEIN) ("resident microglia" . SPARSER::PROTEIN)
    ("HAD" . SPARSER::PROTEIN) ("proneural bHLH genes" . SPARSER::GENE)
    ("NPCs" . SPARSER::MOLECULE) ("IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("NPC" . SPARSER::MOLECULE) ("Smad1" . SPARSER::PROTEIN)
    ("Id3" . SPARSER::PROTEIN) ("Id2" . SPARSER::PROTEIN)
    ("Hes5" . SPARSER::PROTEIN) ("Ngn3" . SPARSER::PROTEIN)
    ("Math1" . SPARSER::PROTEIN) ("CREB binding protein" . SPARSER::PROTEIN)
    ("IL-1 β" . SPARSER::PROTEIN) ("Jak-STAT" . SPARSER::PROTEIN)
    ("β-Tubulin" . SPARSER::PROTEIN)
    ("sex determining region Y" . SPARSER::PROTEIN)
    ("Neurogenin2" . SPARSER::PROTEIN) ("Ngn2" . SPARSER::PROTEIN)
    ("Neurogenin 2" . SPARSER::PROTEIN) ("Ngn1" . SPARSER::PROTEIN)
    ("Neurogenin1" . SPARSER::PROTEIN) ("new biomarkers" . SPARSER::MOLECULE)
    ("membranous β -catenin" . SPARSER::PROTEIN)
    ("an oncofetal protein" . SPARSER::PROTEIN)
    ("Ras and Akt" . SPARSER::COLLECTION) ("Fan" . SPARSER::PROTEIN)
    ("molecules (CAM)" . SPARSER::MOLECULE)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("certain biological molecules" . SPARSER::MOLECULE)
    ("osteoblast cadherin" . SPARSER::PROTEIN)
    ("Cadherin-11" . SPARSER::PROTEIN) ("β -catenin" . SPARSER::PROTEIN)
    ("CDH11" . SPARSER::PROTEIN)
    ("available small molecule PDGFR inhibitors" . SPARSER::INHIBITOR)
    ("melanoma, or EGFR" . SPARSER::COLLECTION) ("imatinib" . SPARSER::DRUG)
    ("exogenous ligand" . SPARSER::LIGAND)
    ("the neonatal PMAs" . SPARSER::MOLECULE)
    ("the parental PMAs" . SPARSER::MOLECULE)
    ("the exogenous ligand" . SPARSER::LIGAND)
    ("expressed PDGFR" . SPARSER::PROTEIN)
    ("virally-transduced astrocytes" . SPARSER::PROTEIN)
    ("mutant PDGFRα-transformed PMAs" . SPARSER::MOLECULE)
    ("Ink4a/Arf" . SPARSER::COLLECTION) ("exogenous PDGF" . SPARSER::PROTEIN)
    ("receptor-receptor" . SPARSER::COLLECTION)
    ("c-Kit and other RTKs ( xref – xref )" . SPARSER::COLLECTION)
    ("PDGFRα and EGFRvIII" . SPARSER::COLLECTION)
    ("representative mutant" . SPARSER::MUTANT)
    ("SHP2 and Src" . SPARSER::COLLECTION) ("p-4E-BP1" . SPARSER::COLLECTION)
    ("Crenolanib and dasatinib" . SPARSER::COLLECTION)
    ("Crenolanib" . SPARSER::DRUG) ("IC" . SPARSER::PROTEIN)
    ("the only two mutants" . SPARSER::MUTANT)
    ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("wild type PDGFRα and all other mutants" . SPARSER::COLLECTION)
    ("crenolanib or dasatinib" . SPARSER::COLLECTION)
    ("PDGFRα and PDGFRβ" . SPARSER::COLLECTION)
    ("KIT, VEGFR-2, TIE-2, FGFR-2, EGFR, ERBB2, and SRC" . SPARSER::COLLECTION)
    ("CP" . SPARSER::PROTEIN) ("crenolanib" . SPARSER::DRUG)
    ("KIT and several other tyrosine kinases ( xref , xref )"
     . SPARSER::COLLECTION)
    ("PDGFRα, PDGFRβ, ABL, SRC family kinases, KIT and several other tyrosine kinases ( xref , xref )"
     . SPARSER::COLLECTION)
    ("multi-tyrosine kinase" . SPARSER::COLLECTION) ("ABL" . SPARSER::PROTEIN)
    ("Dasatinib" . SPARSER::DRUG)
    ("ribosomal protein and PRAS40" . SPARSER::COLLECTION)
    ("PMAs" . SPARSER::MOLECULE)
    ("wild-type PDGFRα or six selected PDGFRα mutants" . SPARSER::COLLECTION)
    ("intragenic mutations target PDGFRA" . SPARSER::PROTEIN)
    ("KDR-PDGFRA" . SPARSER::COLLECTION)
    ("PDGFRA and KDR" . SPARSER::COLLECTION) ("KDR" . SPARSER::PROTEIN)
    ("heterozygous alleles" . SPARSER::ALLELE)
    ("PLC/PKC" . SPARSER::COLLECTION) ("RAS/MAP kinase" . SPARSER::COLLECTION)
    ("PDGFRs" . SPARSER::PROTEIN) ("Ligand" . SPARSER::LIGAND)
    ("PDGF and its receptors" . SPARSER::COLLECTION)
    ("the predominant receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CNAs" . SPARSER::PROTEIN) ("Ink4a" . SPARSER::PROTEIN)
    ("c-Kit" . SPARSER::PROTEIN) ("FGFR-2" . SPARSER::PROTEIN)
    ("TIE-2" . SPARSER::PROTEIN) ("BMS-354825" . SPARSER::DRUG)
    ("del2" . SPARSER::PROTEIN) ("PRAS40" . SPARSER::PROTEIN)
    ("NDRG1" . SPARSER::PROTEIN) ("PDGFR-α" . SPARSER::PROTEIN)
    ("PDGF-AA" . SPARSER::PROTEIN)
    ("Platelet derived growth factor receptor alpha" . SPARSER::PROTEIN)
    ("PDGFRα" . SPARSER::PROTEIN)
    ("platelet derived growth factor receptor alpha" . SPARSER::PROTEIN)
    ("SMD" . SPARSER::PROTEIN) ("LMC" . SPARSER::PROTEIN)
    ("FC and HYX" . SPARSER::COLLECTION) ("FC" . SPARSER::PROTEIN)
    ("LZ and SSZ" . SPARSER::COLLECTION)
    ("an archetypal tumor suppressor" . SPARSER::SUPPRESSOR)
    ("CCNE1 and cdc25A" . SPARSER::COLLECTION)
    ("cdc2 and cyclin A genes" . SPARSER::GENE)
    ("cdc2 and cyclin" . SPARSER::COLLECTION)
    ("p15, p16 or CDK4" . SPARSER::COLLECTION)
    ("CDK4, CDK6, p15 and p16" . SPARSER::COLLECTION)
    ("Cyclin D3 and CDK6" . SPARSER::COLLECTION)
    ("siRNA duplex targeting either cyclin D3 or E2F3" . SPARSER::COLLECTION)
    ("cyclin D3 or E2F3" . SPARSER::COLLECTION) ("Mut" . SPARSER::PROTEIN)
    ("NC or miR-503" . SPARSER::COLLECTION)
    ("Cyclin D3 and E2F3" . SPARSER::COLLECTION)
    ("miR-503 inhibitor or respective NC" . SPARSER::COLLECTION)
    ("miR-503 inhibitor or respective NC using the CCK-8 cell viability assay"
     . SPARSER::COLLECTION)
    ("respective NC" . SPARSER::PROTEIN)
    ("tumor suppressor gene (TSG)" . SPARSER::PROTEIN)
    ("an independent and significant prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cirrhosis" . SPARSER::PROTEIN)
    ("factors and miR-503" . SPARSER::COLLECTION)
    ("cyclin D1, CDK6, and E2F3" . SPARSER::COLLECTION)
    ("CCND3, CCNE1 and CDK6" . SPARSER::COLLECTION)
    ("oncogenes or tumor suppressor genes" . SPARSER::COLLECTION)
    ("cyclin D3 and E2F3" . SPARSER::COLLECTION)
    ("Rb-E2F" . SPARSER::COLLECTION) ("AFP" . SPARSER::PROTEIN)
    ("cdc25A" . SPARSER::PROTEIN) ("cyclin-D" . SPARSER::PROTEIN)
    ("Cyclin D3" . SPARSER::PROTEIN) ("cyclinD3" . SPARSER::PROTEIN)
    ("CCNE1" . SPARSER::PROTEIN) ("CCND3" . SPARSER::PROTEIN)
    ("Etk" . SPARSER::PROTEIN) ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("RhoGDIα and Rho" . SPARSER::COLLECTION) ("GDF" . SPARSER::PROTEIN)
    ("simply Rho GTPase inhibitors" . SPARSER::INHIBITOR)
    ("axonal elongation" . SPARSER::PROTEIN)
    ("ezrin/radixin/moesin" . SPARSER::COLLECTION)
    ("at least three domains" . SPARSER::PROTEIN)
    ("only full-length FRMD7" . SPARSER::PROTEIN)
    ("RhoGDI and actin" . SPARSER::COLLECTION)
    ("RhoGDIα and release Rac1 ( xref )" . SPARSER::COLLECTION)
    ("FRMD7 and Rac1" . SPARSER::COLLECTION)
    ("FRMD7 or GFP" . SPARSER::COLLECTION) ("GFP-fused" . SPARSER::COLLECTION)
    ("Cdc42 and RhoA" . SPARSER::COLLECTION)
    ("RhoGDI-FLAG-tagged FRMD7" . SPARSER::PROTEIN)
    ("exogenous RhoGDI" . SPARSER::PROTEIN)
    ("Myc-RhoGDIα" . SPARSER::COLLECTION)
    ("RhoA or Cdc42" . SPARSER::COLLECTION)
    ("Rac1 and FRMD7" . SPARSER::COLLECTION)
    ("speciﬁcally precipitate GTP-bound Rac1 or Cdc42" . SPARSER::COLLECTION)
    ("GST-PAK2" . SPARSER::COLLECTION) ("Rac1/Cdc42" . SPARSER::COLLECTION)
    ("Rac1, RhoA and Cdc42" . SPARSER::COLLECTION)
    ("the anti-Myc" . SPARSER::ANTIBODY)
    ("FRMD7 and RhoGDIα" . SPARSER::COLLECTION)
    ("FRMD7 and Myc-tagged" . SPARSER::COLLECTION) ("ERM" . SPARSER::PROTEIN)
    ("This last complex" . SPARSER::BIO-COMPLEX)
    ("GDP/GTP" . SPARSER::PROTEIN-PAIR)
    ("inhibitor (GDI)" . SPARSER::INHIBITOR) ("GDI" . SPARSER::PROTEIN)
    ("the archetypal trio" . SPARSER::PROTEIN)
    ("RhoA, Cdc42 and Rac1" . SPARSER::COLLECTION) ("trio" . SPARSER::PROTEIN)
    ("FARP1 and FARP2" . SPARSER::COLLECTION)
    ("FARP1 (FERM, RhoGEF and pleckstrin domain protein 1; chondrocyte-derived ezrin-like protein; NM_005766) and FARP2 (FERM, RhoGEF and pleckstrin domain protein 2; NM_014808)"
     . SPARSER::COLLECTION)
    ("FERM, RhoGEF and pleckstrin" . SPARSER::COLLECTION)
    ("pleckstrin" . SPARSER::PROTEIN) ("RhoGEF" . SPARSER::PROTEIN)
    ("FERM" . SPARSER::PROTEIN) ("moesin" . SPARSER::PROTEIN)
    ("radixin" . SPARSER::PROTEIN) ("ezrin" . SPARSER::PROTEIN)
    ("FRMD7" . SPARSER::PROTEIN)
    ("the Rho GTPase regulators, RhoGDIα" . SPARSER::REGULATOR)
    ("the Rho subfamily member Rac1" . SPARSER::PROTEIN)
    ("RhoGDIα and release less Rac1" . SPARSER::COLLECTION)
    ("RhoGDIα" . SPARSER::PROTEIN) ("Rac1-RhoGDIα" . SPARSER::COLLECTION)
    ("p 75NTR" . SPARSER::PROTEIN) ("RhoGDI3" . SPARSER::PROTEIN)
    ("RhoGDI2" . SPARSER::PROTEIN) ("p75NTR" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN) ("Rho-GDIα" . SPARSER::PROTEIN)
    ("CDC42" . SPARSER::PROTEIN) ("N-Myc" . SPARSER::PROTEIN)
    ("FARP2" . SPARSER::PROTEIN)
    ("chondrocyte-derived ezrin-like protein" . SPARSER::PROTEIN)
    ("FARP1" . SPARSER::PROTEIN)
    ("Rho GDP dissociation inhibitor alpha" . SPARSER::PROTEIN)
    ("PI3K/Mdm2" . SPARSER::COLLECTION) ("-catenin" . SPARSER::COLLECTION)
    ("expressed proteins" . SPARSER::PROTEIN)
    ("Twist1 and slug" . SPARSER::COLLECTION)
    ("CTNNA1, CTNNB1, BECN1, DVL3, TP53, and GAB2" . SPARSER::COLLECTION)
    ("YWHAE, RPS6KB1, PTGS2, and BAK1" . SPARSER::COLLECTION)
    ("tumor-associated human mutp53 proteins" . SPARSER::PROTEIN)
    ("etoposide and cisplatin" . SPARSER::COLLECTION)
    ("SAM" . SPARSER::PROTEIN)
    ("BECN1, YWHAE, DVL3, TP53, RPS6KB1, GAB2, PTGS2, and BAK1"
     . SPARSER::COLLECTION)
    ("YWHAE" . SPARSER::PROTEIN) ("CTNNA1 and CTNNB1" . SPARSER::COLLECTION)
    ("GOF and NE-GOF" . SPARSER::COLLECTION)
    ("positions c469, c524, c527, c584, c659, c722, c733, c742, c743, c817, c818, and c844"
     . SPARSER::COLLECTION)
    ("c469, c524, c527, c584, c659, c722, c733, c742, c743, c817, c818, and c844"
     . SPARSER::COLLECTION)
    ("OvCa" . SPARSER::PROTEIN) ("p63 and p73" . SPARSER::COLLECTION)
    ("adenine" . SPARSER::NUCLEOBASE) ("cytosine" . SPARSER::MOLECULE)
    ("predominant type" . TYPE) ("RB, APC , or BRCA1" . SPARSER::COLLECTION)
    ("almost every type" . TYPE) ("HGS-OvCa" . SPARSER::COLLECTION)
    ("GOF or NE-GOF" . SPARSER::COLLECTION) ("FS" . SPARSER::PROTEIN)
    ("Genome" . SPARSER::PROTEIN) ("HGS" . SPARSER::PROTEIN)
    ("(beta" . SPARSER::PROTEIN) ("MDM2 protein" . SPARSER::PROTEIN)
    ("PTGS2" . SPARSER::PROTEIN) ("GAB2" . SPARSER::PROTEIN)
    ("RPS6KB1" . SPARSER::PROTEIN) ("DVL3" . SPARSER::PROTEIN)
    ("BECN1" . SPARSER::PROTEIN) ("CTNNB1" . SPARSER::PROTEIN)
    ("CTNNA1" . SPARSER::PROTEIN)
    ("other p53-induced genes and/or NF-κB-induced genes"
     . SPARSER::COLLECTION)
    ("corepressors/coactivators" . SPARSER::COLLECTION)
    ("corepressors" . SPARSER::PROTEIN)
    ("pro- or anti-apoptotic" . SPARSER::COLLECTION)
    ("NF-κB/p53" . SPARSER::COLLECTION) ("p100/p52" . SPARSER::COLLECTION)
    ("p53 and NF-κB" . SPARSER::COLLECTION)
    ("parthenolide and CAPE" . SPARSER::COLLECTION)
    ("caffeic acid phenethyl ester (CAPE) and quercetin" . SPARSER::COLLECTION)
    ("caffeic acid phenethyl ester (CAPE)" . SPARSER::MOLECULE)
    ("ester (CAPE)" . SPARSER::MOLECULE) ("CAPE" . SPARSER::PROTEIN)
    ("parthenolide" . SPARSER::MOLECULE)
    ("NF-κB and p53" . SPARSER::COLLECTION)
    ("p53 V143A and p53 R249S" . SPARSER::COLLECTION)
    ("aggressive subtypes" . SPARSER::PROTEIN) ("galectins" . SPARSER::PROTEIN)
    ("lectins" . SPARSER::PROTEIN) ("galectin" . SPARSER::PROTEIN)
    ("p100" . SPARSER::PROTEIN) ("NF-κB2" . SPARSER::PROTEIN)
    ("COX-IV" . SPARSER::PROTEIN) ("c-rel" . SPARSER::PROTEIN)
    ("TAT-3" . SPARSER::PROTEIN) ("C/EBPβ" . SPARSER::PROTEIN)
    ("galectin-3" . SPARSER::PROTEIN) ("G -3" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("galectin-7" . SPARSER::PROTEIN) ("Galectin-7" . SPARSER::PROTEIN)
    ("the histidine of the FOXO proteins" . SPARSER::PROTEIN)
    ("The first pivotal co-factor" . SPARSER::MOLECULE)
    ("histidine" . SPARSER::AMINO-ACID)
    ("transcriptional activators and repressors" . SPARSER::COLLECTION)
    ("proteins and PrP" . SPARSER::COLLECTION)
    ("peroxiredoxin" . SPARSER::PROTEIN)
    ("MnSOD and catalase" . SPARSER::COLLECTION)
    ("MnSOD, catalase, and peroxiredoxins" . SPARSER::COLLECTION)
    ("peroxiredoxins" . SPARSER::PROTEIN) ("catalase" . SPARSER::PROTEIN)
    ("MnSOD" . SPARSER::PROTEIN) ("cellular antioxidants" . SPARSER::DRUG)
    ("FOXO3a and IGF-1R" . SPARSER::COLLECTION)
    ("IGF-1 and insulin" . SPARSER::COLLECTION)
    ("DMSO, LY294002, U0126, or SP600125" . SPARSER::COLLECTION)
    ("PI3K-Akt-FOXO3a" . SPARSER::COLLECTION) ("AF" . SPARSER::PROTEIN)
    ("-ATGTTTAC-3" . SPARSER::COLLECTION) ("-CTGTTTAC-3" . SPARSER::COLLECTION)
    ("IGF-1 and LY294002" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO3a" . SPARSER::COLLECTION)
    ("FOXO1 (lane 2) and FOXO3a (lane 3)" . SPARSER::COLLECTION)
    ("90kDa" . SPARSER::PROTEIN) ("-FOXO3a" . SPARSER::COLLECTION)
    ("-FOXO1" . SPARSER::COLLECTION)
    ("YY1, Atox1, E4BP4, and p53" . SPARSER::COLLECTION)
    ("Atox1" . SPARSER::PROTEIN) ("mRNA and Protein" . SPARSER::COLLECTION)
    ("LY294002 and IGF-1" . SPARSER::COLLECTION)
    ("IGF-1 and U0126 or SP600125" . SPARSER::COLLECTION)
    ("U0126 or SP600125" . SPARSER::COLLECTION)
    ("IGF-1 and inhibitors" . SPARSER::COLLECTION)
    ("SP600125-" . SPARSER::PROTEIN) ("Protein and mRNA" . SPARSER::COLLECTION)
    ("Ras-MAPK" . SPARSER::COLLECTION) ("SH-SY5Y" . SPARSER::PROTEIN)
    ("IGF-1 or insulin" . SPARSER::COLLECTION)
    ("IGF-1/insulin" . SPARSER::COLLECTION)
    ("meaningful aim" . SPARSER::PROTEIN)
    ("IGF-1 and PRNP" . SPARSER::COLLECTION)
    ("a critical neurotropic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hyperbaric oxygen" . SPARSER::MOLECULE)
    ("some exogenous and endogenous stimulating factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("YY1 and Hes-1" . SPARSER::COLLECTION)
    ("E4BP4, Atox-1, SP1, MTF-1, and HSTF-1" . SPARSER::COLLECTION)
    ("promoter or intron" . SPARSER::COLLECTION)
    ("CJD and fatal familial insomnia" . SPARSER::COLLECTION)
    ("prions" . SPARSER::PROTEIN-FAMILY) ("cellular PrP" . SPARSER::PROTEIN)
    ("Prnp" . SPARSER::PROTEIN) ("CJD" . SPARSER::PROTEIN)
    ("IGF-1-PI3K-Akt-FOXO3a" . SPARSER::COLLECTION)
    ("the exogenous and endogenous stimulating factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PRNP" . SPARSER::PROTEIN)
    ("its β-sheet-rich scrapie isoform (PrP Sc ) causes fatal prion"
     . SPARSER::PROTEIN-FAMILY)
    ("the cellular prion protein" . SPARSER::PROTEIN)
    ("PrP" . SPARSER::PROTEIN) ("β-Catenin" . SPARSER::PROTEIN)
    ("co-factor" . SPARSER::MOLECULE)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("peroxiredoxin III" . SPARSER::PROTEIN) ("FOXO6" . SPARSER::PROTEIN)
    ("muscle and heart" . SPARSER::PROTEIN) ("170A" . SPARSER::PROTEIN)
    ("HSTF-1" . SPARSER::PROTEIN) ("E4BP4" . SPARSER::PROTEIN)
    ("Hes-1" . SPARSER::PROTEIN) ("fatal familial insomnia" . SPARSER::PROTEIN)
    ("IGF-1-" . SPARSER::PROTEIN) ("forkhead box O3" . SPARSER::PROTEIN)
    ("prion protein" . SPARSER::PROTEIN) ("osteoclasts" . SPARSER::PROTEIN)
    ("genistein" . SPARSER::PROTEIN) ("EGF and HB-EGF" . SPARSER::COLLECTION)
    ("EGFR, ErbB2 and ErbB3" . SPARSER::COLLECTION)
    ("Trigger" . SPARSER::PROTEIN) ("MEF2 and MyHC" . SPARSER::COLLECTION)
    ("Menadione" . SPARSER::DRUG) ("EGFR-EGFP" . SPARSER::COLLECTION)
    ("AG1478 and PD153035" . SPARSER::COLLECTION)
    ("p42/p44 MAPK" . SPARSER::COLLECTION) ("Cytometry" . SPARSER::PROTEIN)
    ("cesium" . SPARSER::MOLECULE)
    ("a late muscle-specific protein" . SPARSER::PROTEIN)
    ("the resting potential around −40 mV" . SPARSER::PROTEIN)
    ("thapsigargin" . SPARSER::MOLECULE)
    ("EGFR-silenced proliferating myoblasts" . SPARSER::PROTEIN)
    ("around −40 mV" . SPARSER::PROTEIN) ("Kir" . SPARSER::PROTEIN)
    ("pF" . SPARSER::PROTEIN) ("Myogenin and MEF2" . SPARSER::COLLECTION)
    ("human primary myoblasts" . SPARSER::PROTEIN) ("FGFRs" . SPARSER::PROTEIN)
    ("ErbB2 and ErbB3" . SPARSER::COLLECTION) ("mV" . SPARSER::PROTEIN)
    ("MyoD, Myf5, Myogenin and MRF4" . SPARSER::COLLECTION)
    ("MyoD" . SPARSER::PROTEIN) ("MRFs" . SPARSER::PROTEIN)
    ("Skeletal muscle" . SPARSER::PROTEIN)
    ("factors and muscle specific" . SPARSER::COLLECTION)
    ("MyHC" . SPARSER::PROTEIN) ("Myogenin" . SPARSER::PROTEIN)
    ("AG556" . SPARSER::DRUG) ("Kir2.3" . SPARSER::PROTEIN)
    ("HB-EGF" . SPARSER::PROTEIN) ("Ki67 " . SPARSER::PROTEIN)
    ("K3" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p44 MAPK" . SPARSER::PROTEIN) ("p42" . SPARSER::PROTEIN)
    ("S100" . SPARSER::PROTEIN) ("N -methyl-D-glucamine" . SPARSER::MOLECULE)
    ("β-Mercaptoethanol" . SPARSER::MOLECULE) ("CD56" . SPARSER::PROTEIN)
    ("PBS 2" . SPARSER::PROTEIN)
    ("Myosin heavy chain" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Serum Albumin" . SPARSER::PROTEIN)
    ("potassium channel" . SPARSER::PROTEIN)
    ("MEF2s" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MRF4" . SPARSER::PROTEIN)
    ("Myf5" . SPARSER::PROTEIN) ("cdk4" . SPARSER::PROTEIN)
    ("Myosin Heavy Chain" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Factor 2" . SPARSER::PROTEIN) ("muscle specific" . SPARSER::PROTEIN)
    ("Kir2.1" . SPARSER::PROTEIN) ("cMET/HGF" . SPARSER::COLLECTION)
    ("cMET" . SPARSER::PROTEIN) ("HTB" . SPARSER::DRUG)
    ("delta" . SPARSER::PROTEIN)
    ("EZH2 and the PRC2 complex" . SPARSER::COLLECTION)
    ("EZH2-PRC2" . SPARSER::COLLECTION) ("DNMT3a/b" . SPARSER::COLLECTION)
    ("repressive histone" . SPARSER::PROTEIN) ("tri" . SPARSER::PROTEIN)
    ("E2F and EZH2" . SPARSER::COLLECTION)
    ("E2F1, E2F2, and E2F3" . SPARSER::COLLECTION) ("ShRNA" . SPARSER::PROTEIN)
    ("E2F1 and E2F2" . SPARSER::COLLECTION)
    ("EZH2 and E2F1" . SPARSER::COLLECTION)
    ("EZH2 and E2F3" . SPARSER::COLLECTION) ("PcG" . SPARSER::PROTEIN-FAMILY)
    ("E2F and Rb1" . SPARSER::COLLECTION) ("Rb and E2F1" . SPARSER::COLLECTION)
    ("E2F/RB1" . SPARSER::COLLECTION) ("E2F1 and E2F3" . SPARSER::COLLECTION)
    ("methyltransferase" . SPARSER::PROTEIN) ("genes (TSG)" . SPARSER::GENE)
    ("Rb1/E2F" . SPARSER::COLLECTION) ("TSG" . SPARSER::PROTEIN)
    ("MLL" . SPARSER::PROTEIN) ("CREBBP" . SPARSER::PROTEIN)
    ("oncogene and core" . SPARSER::COLLECTION)
    ("E2F/Rb" . SPARSER::COLLECTION)
    ("Polycomb Repressive Complex 2" . SPARSER::PROTEIN)
    ("H3K27Me3" . SPARSER::MOLECULE) ("histone 3" . SPARSER::PROTEIN)
    ("WNT1" . SPARSER::PROTEIN) ("2 p " . SPARSER::PROTEIN)
    ("STMN1" . SPARSER::PROTEIN) ("log 2" . SPARSER::PROTEIN)
    ("PRC2" . SPARSER::PROTEIN)
    ("polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("EZH2" . SPARSER::PROTEIN) ("E6-p53-p300" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("E6 and p53" . SPARSER::COLLECTION) ("lys" . SPARSER::AMINO-ACID)
    ("NLS1 and NLS2" . SPARSER::COLLECTION)
    ("both ING4 and HPV16 E6" . SPARSER::COLLECTION)
    ("ING4 and HPV16 E6" . SPARSER::COLLECTION)
    ("Luciferase or siRNA" . SPARSER::COLLECTION)
    ("ING4 or ING4" . SPARSER::COLLECTION)
    ("ubiquitin-protein" . SPARSER::COLLECTION)
    ("p53 as well as ING4" . SPARSER::COLLECTION)
    ("p53, ING4, E6 and GAPDH" . SPARSER::COLLECTION)
    ("E6 and mutant" . SPARSER::COLLECTION)
    ("E6AP and p53" . SPARSER::COLLECTION)
    ("p53 and ING4" . SPARSER::COLLECTION) ("sh-E6" . SPARSER::COLLECTION)
    ("ING4-p53" . SPARSER::COLLECTION) ("p53-ING4" . SPARSER::COLLECTION)
    ("anti-Myc-p53" . SPARSER::COLLECTION) ("an anti-Myc" . SPARSER::ANTIBODY)
    ("Myc-p53" . SPARSER::COLLECTION) ("Mdm" . SPARSER::PROTEIN)
    ("E6, p53 and ING4" . SPARSER::COLLECTION)
    ("ING4 and p53" . SPARSER::COLLECTION) ("Flag-E6" . SPARSER::COLLECTION)
    ("PCDNA-ING4" . SPARSER::COLLECTION) ("PCDNA" . SPARSER::PROTEIN)
    ("E6 and ING4" . SPARSER::COLLECTION)
    ("both p53 and HPV16 E6" . SPARSER::COLLECTION)
    ("GST and GST-ING4 proteins" . SPARSER::COLLECTION)
    ("GST-ING4" . SPARSER::COLLECTION) ("pCDNA" . SPARSER::PROTEIN)
    ("E6 and pCDNA-ING4" . SPARSER::COLLECTION)
    ("pCDNA-ING4" . SPARSER::COLLECTION)
    ("Endogenously expressed HPV16 E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("expressed HPV16 E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ubiquitin–protein" . SPARSER::COLLECTION) ("Forms" . SPARSER::FORM)
    ("HIF" . SPARSER::PROTEIN) ("PHD" . SPARSER::PROTEIN)
    ("hDLG" . SPARSER::PROTEIN) ("TERT" . SPARSER::PROTEIN)
    ("the major oncoproteins" . SPARSER::PROTEIN)
    ("p53 and pRB" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("ING" . SPARSER::PROTEIN-FAMILY) ("NLS1" . SPARSER::PROTEIN)
    ("CIP1" . SPARSER::PROTEIN) ("ING1" . SPARSER::PROTEIN)
    ("E6BP" . SPARSER::PROTEIN) ("E6TP1" . SPARSER::PROTEIN)
    ("ubiquitin protein ligase" . SPARSER::PROTEIN) ("ING4" . SPARSER::PROTEIN)
    ("IL-6 and leukemia inhibitory factor (LIF)" . SPARSER::COLLECTION)
    ("IL-6 and leukemia inhibitory factor" . SPARSER::COLLECTION)
    ("STAT3 and ERK1/2" . SPARSER::COLLECTION)
    ("CCN2/CTGF" . SPARSER::COLLECTION) ("CTGF" . SPARSER::PROTEIN)
    ("a secretory endopeptidase" . SPARSER::PROTEIN)
    ("MMP3, or stromelysin-1" . SPARSER::COLLECTION)
    ("collagens, laminins, fibronectin, osteopontin and proteoglycans"
     . SPARSER::COLLECTION)
    ("proteoglycans" . SPARSER::PROTEIN) ("osteopontin" . SPARSER::PROTEIN)
    ("laminins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endopeptidase" . SPARSER::PROTEIN) ("SOCS" . SPARSER::PROTEIN)
    ("JAK2-STAT3" . SPARSER::COLLECTION)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("ischemic and pharmacological pre-" . SPARSER::PROTEIN)
    ("pre-" . SPARSER::PROTEIN)
    ("Heme-TLR4-JAK2-STAT3-CXCL10" . SPARSER::COLLECTION)
    ("MyD88/TRIF" . SPARSER::COLLECTION)
    ("TSP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thrombospondin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sulfate" . SPARSER::MOLECULE) ("chondroitin" . SPARSER::MOLECULE)
    ("a 90–115kDa transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("adipocytes, platelets, monocytes, and macrophages" . SPARSER::COLLECTION)
    ("CD36 or ICAM-1" . SPARSER::COLLECTION)
    ("Heme-STAT3" . SPARSER::COLLECTION)
    ("Heme, CXCL10 and HO-1" . SPARSER::COLLECTION) ("pY" . SPARSER::PROTEIN)
    ("Heme-STAT3-CXCL10" . SPARSER::COLLECTION)
    ("two adverse factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fatal CM" . SPARSER::PROTEIN) ("6B–c" . SPARSER::COLLECTION)
    ("STAT3 and its targeting gene MMP3" . SPARSER::COLLECTION)
    ("anti-phopho-STAT3" . SPARSER::COLLECTION)
    ("STAT3 (siSTAT3) and a control siRNA" . SPARSER::COLLECTION)
    ("GAS" . SPARSER::PROTEIN) ("Heme-STAT3-HO-1-CXCL10" . SPARSER::COLLECTION)
    ("JAK2-STAT3-MMP3" . SPARSER::COLLECTION) ("heat-map" . SPARSER::PROTEIN)
    ("proto-oncogene (JUNB)" . SPARSER::PROTO-ONCOGENE)
    ("regulated genes included STAT-induced gene matrix metallopeptidase 3"
     . SPARSER::PROTEIN)
    ("SOCS4 and STAT4" . SPARSER::COLLECTION) ("PAHS" . SPARSER::MOLECULE)
    ("indirect bilirubin" . SPARSER::MOLECULE)
    ("bilirubin" . SPARSER::MOLECULE)
    ("STAT3 and CXCL10-" . SPARSER::COLLECTION) ("JAKs" . SPARSER::PROTEIN)
    ("severe forms" . SPARSER::FORM)
    ("carbon monoxide (CO) and iron" . SPARSER::COLLECTION)
    ("iron" . SPARSER::MOLECULE) ("HO" . SPARSER::PROTEIN)
    ("ICAM-1 and CD36" . SPARSER::COLLECTION)
    ("NF-kappa" . SPARSER::COLLECTION)
    ("several TNF-superfamily genes and apoptosis-related genes"
     . SPARSER::COLLECTION)
    ("Bcl-w, Bik, and iNOS" . SPARSER::COLLECTION)
    ("DFF45/ICAD" . SPARSER::COLLECTION) ("Bik" . SPARSER::PROTEIN)
    ("ICAD" . SPARSER::PROTEIN) ("MMP3 and C/EBPb" . SPARSER::COLLECTION)
    ("CXCL10 and HO-1" . SPARSER::COLLECTION)
    ("JAK/STAT3" . SPARSER::COLLECTION)
    ("STAT3 and CXCL10" . SPARSER::COLLECTION) ("fatal ECM" . SPARSER::PROTEIN)
    ("Heme" . SPARSER::PROTEIN) ("set 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("set 1" . SPARSER::PROTEIN) ("3A1" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("PCR2" . SPARSER::PROTEIN) ("Oncostatin M" . SPARSER::PROTEIN)
    ("CCN2" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("stromelysin-1" . SPARSER::PROTEIN) ("PDK1" . SPARSER::PROTEIN)
    ("CCR5" . SPARSER::PROTEIN) ("MyD88" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("VCAM-1" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("E-selectin" . SPARSER::PROTEIN) ("hyaluronic acid" . SPARSER::MOLECULE)
    ("IL-15" . SPARSER::PROTEIN) ("Vascular endothelial" . SPARSER::PROTEIN)
    ("γ-interferon" . SPARSER::DRUG) ("OAS1" . SPARSER::PROTEIN)
    ("F2R" . SPARSER::PROTEIN) ("coagulation factor II" . SPARSER::PROTEIN)
    ("SOCS4" . SPARSER::PROTEIN) ("SOCS3" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("kappa light polypeptide gene enhancer in B-cells 1" . SPARSER::PROTEIN)
    ("FCGR1A" . SPARSER::PROTEIN) ("high affinity Ia" . SPARSER::PROTEIN)
    ("Fc fragment of IgG" . SPARSER::PROTEIN)
    ("CCAAT/enhancer binding protein" . SPARSER::PROTEIN)
    ("matrix metallopeptidase 3" . SPARSER::PROTEIN)
    ("carbon monoxide" . SPARSER::MOLECULE) ("Bcl-w" . SPARSER::PROTEIN)
    ("IFN-g" . SPARSER::PROTEIN) ("DFF45" . SPARSER::PROTEIN)
    ("SARP2" . SPARSER::PROTEIN) ("CD36" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule 1" . SPARSER::PROTEIN)
    ("MMP3" . SPARSER::PROTEIN) ("CXCL10" . SPARSER::PROTEIN)
    ("mesalamine" . SPARSER::DRUG) ("sporadic CRC" . SPARSER::PROTEIN)
    ("wnt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p-ANCA" . SPARSER::COLLECTION)
    ("ANCA" . SPARSER::PROTEIN) ("ASCA or pANCA" . SPARSER::COLLECTION)
    ("ASCA" . SPARSER::ANTIBODY)
    ("a negative perinuclear antineutrophil cytoplasmic antibodies"
     . SPARSER::ANTIBODY)
    ("antibodies ( ASCA )" . SPARSER::ANTIBODY)
    ("intestinal phospho-RB" . SPARSER::PROTEIN)
    ("kinase and PI3K" . SPARSER::COLLECTION) ("/AKT" . SPARSER::COLLECTION)
    ("mitogen activated protein kinase/extracellular signal-regulated kinase"
     . SPARSER::COLLECTION)
    ("phospho-RB and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and RB" . SPARSER::COLLECTION) ("DSS" . SPARSER::PROTEIN)
    ("dextran" . SPARSER::DEXTRAN)
    ("a strong and diffuse nucleocytoplasmic β-catenin" . SPARSER::PROTEIN)
    ("factor/T-cell" . SPARSER::COLLECTION)
    ("the adherent junction component" . SPARSER::COMPONENT)
    ("β-catenin and retinoblastoma protein" . SPARSER::COLLECTION)
    ("proteases and mucosal genes" . SPARSER::COLLECTION)
    ("mucosal genes" . SPARSER::GENE)
    ("oxidative stress inducers" . SPARSER::MOLECULE)
    ("anti-β-catenin" . SPARSER::COLLECTION)
    ("alpha-tubulin" . SPARSER::PROTEIN) ("alpha-Tubulin" . SPARSER::PROTEIN)
    ("sodium sulfate" . SPARSER::MOLECULE)
    ("an intriguing prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERα and Foxo3a" . SPARSER::COLLECTION)
    ("Foxo3a and positive ER" . SPARSER::COLLECTION)
    ("ER and Foxo3a" . SPARSER::COLLECTION)
    ("FOXO3a and ER" . SPARSER::COLLECTION)
    ("/protein kinase B" . SPARSER::COLLECTION) ("PKB" . SPARSER::PROTEIN)
    ("histological type" . TYPE)
    ("standard predictive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Foxo3a and age" . SPARSER::COLLECTION)
    ("Other Clinicopathological Factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Foxo3a and ER" . SPARSER::COLLECTION) ("ER−" . SPARSER::PROTEIN)
    ("FOXO3a and ERα" . SPARSER::COLLECTION)
    ("an exploitable target" . SPARSER::TARGET-PROTEIN)
    ("ERs" . SPARSER::PROTEIN) ("p27 Kip1 and Bim" . SPARSER::COLLECTION)
    ("14-3-3-FOXO" . SPARSER::COLLECTION)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("AFX" . SPARSER::PROTEIN)
    ("FKHR" . SPARSER::PROTEIN) ("forkhead" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a favorable independent prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Forkhead box" . SPARSER::PROTEIN) ("forkhead box M1" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG) ("FOXO4" . SPARSER::PROTEIN)
    ("FKHRL1" . SPARSER::PROTEIN) ("FOXO3a" . SPARSER::PROTEIN)
    ("Foxo3a" . SPARSER::PROTEIN) ("forkhead box" . SPARSER::PROTEIN)
    ("cell-matrix and cell-cell adhesion regulators" . SPARSER::COLLECTION)
    ("ZO-1/actin" . SPARSER::COLLECTION)
    ("actin-tubulin" . SPARSER::COLLECTION)
    ("tight junctions ZO-1" . SPARSER::PROTEIN)
    ("ZO-1 and α5-integrin" . SPARSER::COLLECTION)
    ("ZO-1-Flag" . SPARSER::COLLECTION)
    ("tubulin, Flag and dapi" . SPARSER::COLLECTION) ("dapi" . SPARSER::DRUG)
    ("homodimers" . SPARSER::HOMODIMER) ("ZO-1-PDZ2" . SPARSER::PROTEIN-PAIR)
    ("PIP2 and integrin" . SPARSER::COLLECTION)
    ("ZO-1 and ZO-2" . SPARSER::COLLECTION)
    ("integrin and PIP2" . SPARSER::COLLECTION)
    ("GST-ZO-1" . SPARSER::COLLECTION)
    ("that ZO-1 and α5β1-integrin" . SPARSER::COLLECTION)
    ("PLC" . SPARSER::PROTEIN) ("PH" . SPARSER::PROTEIN)
    ("‘TIRF’" . SPARSER::SUBSTRATE) ("TIRF" . SPARSER::SUBSTRATE)
    ("substrate (TIRF)" . SPARSER::SUBSTRATE)
    ("ligand binding competent β1-integrins" . SPARSER::COLLECTION)
    ("β1" . SPARSER::PROTEIN) ("ZO-1 and α5" . SPARSER::COLLECTION)
    ("tubulin and actin" . SPARSER::COLLECTION)
    ("tubulin and midbody marker Plk-1 antibodies" . SPARSER::COLLECTION)
    ("GFP-ZO-1" . SPARSER::COLLECTION) ("MRCK" . SPARSER::PROTEIN)
    ("α5β1-integrin" . SPARSER::COLLECTION)
    ("β1-integrins" . SPARSER::COLLECTION) ("α5" . SPARSER::PROTEIN)
    ("ZO-1/α5β1-integrin" . SPARSER::COLLECTION)
    ("α5-integrin" . SPARSER::COLLECTION) ("ZO-2" . SPARSER::PROTEIN)
    ("connexin43" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gap junction protein" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("β1-integrin" . SPARSER::PROTEIN)
    ("fibronectin receptor" . SPARSER::PROTEIN) ("Plk-1" . SPARSER::PROTEIN)
    ("ZO1" . SPARSER::PROTEIN) ("Rab21" . SPARSER::PROTEIN)
    ("PKCε" . SPARSER::PROTEIN) ("Zonula Occludens" . SPARSER::PROTEIN)
    ("tight junction" . SPARSER::PROTEIN)
    ("Sp1, SMAD3, NF-Y and YY1" . SPARSER::COLLECTION)
    ("ASPP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MYC and important developmental genes" . SPARSER::COLLECTION)
    ("important developmental genes" . SPARSER::GENE)
    ("many mitotic genes" . SPARSER::GENE)
    ("far best studied group" . SPARSER::MOLECULE)
    ("E2F7 and p21" . SPARSER::COLLECTION)
    ("E2F7 and CDKN1A" . SPARSER::COLLECTION)
    ("CDKN1A and E2F7" . SPARSER::COLLECTION)
    ("important pro-apoptotic genes and the repression of a large set of genes"
     . SPARSER::COLLECTION)
    ("important pro-apoptotic genes" . SPARSER::GENE)
    ("genes and oncogenes" . SPARSER::COLLECTION)
    ("distal enhancers" . SPARSER::PROTEIN)
    ("mitotic and developmental regulators" . SPARSER::REGULATOR)
    ("senescence-associated cytokines" . SPARSER::PROTEIN)
    ("MMTV-Wnt1" . SPARSER::COLLECTION) ("MMTV" . SPARSER::PROTEIN)
    ("p53 and the estrogen receptor" . SPARSER::COLLECTION)
    ("most prototypic cell cycle target genes" . SPARSER::GENE)
    ("many other functionally important pro-apoptotic genes" . SPARSER::GENE)
    ("biologically relevant response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("PIDD and APAF1" . SPARSER::COLLECTION) ("PIDD" . SPARSER::PROTEIN)
    ("a larger variety" . SPARSER::VARIETY) ("CTAG" . SPARSER::PROTEIN)
    ("common upstream regulators (YY1, FOXM1) as well as additional miRNAs (miR-34, miR-145, miR-200)"
     . SPARSER::COLLECTION)
    ("E2F8 and GJB2" . SPARSER::COLLECTION)
    ("MYC , E2F8 or GJB2" . SPARSER::COLLECTION)
    ("AURKA and BIRC5" . SPARSER::COLLECTION) ("E2F8" . SPARSER::PROTEIN)
    ("CDKN1A or E2F7" . SPARSER::COLLECTION)
    ("only three genes" . SPARSER::GENE) ("TGFβ and WNT" . SPARSER::COLLECTION)
    ("AURKB" . SPARSER::PROTEIN) ("AURKA" . SPARSER::PROTEIN)
    ("GSEA" . SPARSER::PROTEIN)
    ("actinomycin D or etoposide" . SPARSER::COLLECTION)
    ("RITA" . SPARSER::PROTEIN) ("BAX and PUMA/BBC3" . SPARSER::COLLECTION)
    ("PUMA/BBC3" . SPARSER::COLLECTION)
    ("critical pro-apoptotic genes" . SPARSER::GENE)
    ("CDKN1A and BTG2" . SPARSER::COLLECTION)
    ("highly cooperative p53" . SPARSER::PROTEIN) ("MH" . SPARSER::PROTEIN)
    ("Chip" . SPARSER::PROTEIN) ("homotetramers" . SPARSER::HOMOTETRAMER)
    ("EE and RR" . SPARSER::COLLECTION) ("EE/RR" . SPARSER::COLLECTION)
    ("RR" . SPARSER::PROTEIN) ("EE" . SPARSER::PROTEIN)
    ("highly cancer prone" . SPARSER::PROTEIN-FAMILY)
    ("salt" . SPARSER::MOLECULE) ("symmetric dimers" . SPARSER::DIMER)
    ("tetramer" . SPARSER::TETRAMER) ("CATG" . SPARSER::PROTEIN)
    ("lincRNA" . SPARSER::RNA) ("factors and components" . SPARSER::COLLECTION)
    ("PMAIP1/NOXA" . SPARSER::COLLECTION) ("p21/CDKN1A" . SPARSER::COLLECTION)
    ("PUMA" . SPARSER::PROTEIN) ("NOXA" . SPARSER::PROTEIN)
    ("SFN" . SPARSER::PROTEIN)
    ("a master regulatory transcription factor" . SPARSER::PROTEIN)
    ("apoptosis genes and repression of pro-survival genes which together triggers cell death"
     . SPARSER::COLLECTION)
    ("Cooperation increases p53's" . SPARSER::PROTEIN)
    ("CDKN1A, E2F7 and non-coding" . SPARSER::COLLECTION)
    ("log2" . SPARSER::PROTEIN) ("MAS 5" . SPARSER::PROTEIN)
    ("m 1" . SPARSER::MOLECULE) ("n 2" . SPARSER::PROTEIN)
    ("k 1" . SPARSER::PROTEIN) ("NUFIP1" . SPARSER::PROTEIN)
    ("ADRB1" . SPARSER::PROTEIN) ("Wnt1" . SPARSER::PROTEIN)
    ("VEGFR1" . SPARSER::PROTEIN) ("NF-Y" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN) ("GJB2" . SPARSER::PROTEIN)
    ("BIRC5" . SPARSER::PROTEIN) ("CCNB1" . SPARSER::PROTEIN)
    ("CDC20" . SPARSER::PROTEIN) ("UTP15" . SPARSER::PROTEIN)
    ("KLF6" . SPARSER::PROTEIN) ("PIG3" . SPARSER::PROTEIN)
    ("TP53I3" . SPARSER::PROTEIN) ("RAD54L2" . SPARSER::PROTEIN)
    ("5FU" . SPARSER::DRUG) ("BBC3" . SPARSER::PROTEIN)
    ("BTG2" . SPARSER::PROTEIN) ("nutlin-3a" . SPARSER::DRUG)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("PMAIP1" . SPARSER::PROTEIN)
    ("the differential fibronectin" . SPARSER::PROTEIN)
    ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("the insoluble ECM" . SPARSER::PROTEIN)
    ("LRDD and APAF1" . SPARSER::COLLECTION)
    ("an adequate matrix" . SPARSER::PROTEIN-FAMILY)
    ("the endometrial cell matrix" . SPARSER::PROTEIN-FAMILY)
    ("exogenous plasma fibronectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fibrillar FN matrix" . SPARSER::PROTEIN-FAMILY)
    ("exogenous plasma fibronectin (50 μg of pFN [EDA–]/35-mm dish) 3 d"
     . SPARSER::PROTEIN-FAMILY)
    ("commercially available plasma fibronectin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FN and EDA+" . SPARSER::COLLECTION)
    ("the insoluble matrix" . SPARSER::PROTEIN-FAMILY)
    ("deoxycholate" . SPARSER::MOLECULE)
    ("peptidase–activating factor" . SPARSER::COLLECTION)
    ("peptidase" . SPARSER::PROTEIN) ("LRDD" . SPARSER::PROTEIN)
    ("EDA, EDB, and IIICS" . SPARSER::COLLECTION)
    ("dermis fibroblasts release much more soluble fibronectin"
     . SPARSER::PROTEIN)
    ("proteins and ECM" . SPARSER::COLLECTION)
    ("fibronectin and collagen" . SPARSER::COLLECTION)
    ("ECM and adhesion proteins" . SPARSER::COLLECTION)
    ("vinculin and integrin" . SPARSER::COLLECTION)
    ("vinculin" . SPARSER::PROTEIN)
    ("adhesion molecules and ECM components" . SPARSER::COLLECTION)
    ("α1β1 and α5β1" . SPARSER::COLLECTION)
    ("their well-defined actin" . SPARSER::PROTEIN)
    ("the laminin/collagen receptor α1β1 and fibronectin-binding integrin α5β1 ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("laminin/collagen receptor" . SPARSER::COLLECTION)
    ("splicing factor/splicing factor" . SPARSER::COLLECTION)
    ("fetal fibronectin" . SPARSER::PROTEIN)
    ("insoluble matrix" . SPARSER::PROTEIN-FAMILY)
    ("cellular fibronectin" . SPARSER::PROTEIN)
    ("EDA and EDB" . SPARSER::COLLECTION)
    ("a unique fibronectin-encoding gene" . SPARSER::PROTEIN)
    ("EDB" . SPARSER::PROTEIN) ("noncollagenous molecules" . SPARSER::MOLECULE)
    ("collagen and fibronectin" . SPARSER::COLLECTION)
    ("Collagens and fibronectin" . SPARSER::COLLECTION)
    ("Collagens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fibrillar and nonfibrillar components" . SPARSER::COMPONENT)
    ("the interstitial matrix" . SPARSER::PROTEIN-FAMILY)
    ("EDA–" . SPARSER::PROTEIN)
    ("fibronectin (FN)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EDA" . SPARSER::PROTEIN) ("FN" . SPARSER::PROTEIN)
    ("SPF45" . SPARSER::PROTEIN) ("SRp40" . SPARSER::PROTEIN)
    ("SRSF5" . SPARSER::PROTEIN) ("9G8" . SPARSER::PROTEIN)
    ("SRSF7" . SPARSER::PROTEIN) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("p53-induced death domain protein" . SPARSER::PROTEIN)
    ("cytokeratin 7" . SPARSER::PROTEIN)
    ("collagen receptor" . SPARSER::PROTEIN)
    ("serine/arginine-rich splicing factor 1" . SPARSER::PROTEIN)
    ("any further regulatory proteins" . SPARSER::PROTEIN)
    ("E4 Orf6/E1B-55K" . SPARSER::COLLECTION)
    ("a model whereby cellular p53" . SPARSER::PROTEIN)
    ("L4-22K and/or L4-33K" . SPARSER::COLLECTION) ("DEF" . SPARSER::PROTEIN)
    ("E1B-55K/E4 Orf6" . SPARSER::COLLECTION) ("genome" . SPARSER::PROTEIN)
    ("the L3 hexon and L2 penton" . SPARSER::COLLECTION)
    ("MLP or L4P" . SPARSER::COLLECTION)
    ("any viral proteins" . SPARSER::PROTEIN)
    ("p53, IVa2, and E4 Orf3" . SPARSER::COLLECTION)
    ("viral factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FLAG and L4-33K" . SPARSER::COLLECTION)
    ("either L4-22K FLAG or the related L4-33K FLAG protein"
     . SPARSER::COLLECTION)
    ("p53 and E4 Orf3" . SPARSER::COLLECTION)
    ("RNA polymerase and its associated factors" . SPARSER::COLLECTION)
    ("its associated factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pVI" . SPARSER::PROTEIN) ("hpi, and by 16" . SPARSER::COLLECTION)
    ("hexon" . SPARSER::DRUG) ("DBP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hpi" . SPARSER::PROTEIN) ("a strong inducer" . SPARSER::PROTEIN)
    ("exogenous p53" . SPARSER::PROTEIN)
    ("wild-type p53 and no known endogenous adenovirus proteins"
     . SPARSER::COLLECTION)
    ("p53, E4 Orf3, and IVa2" . SPARSER::COLLECTION)
    ("p53, E4 Orf3 and IVa2" . SPARSER::COLLECTION)
    ("the previously defined L4P activators E4 Orf3 and IVa2"
     . SPARSER::COLLECTION)
    ("E4 Orf3 and IVa2" . SPARSER::COLLECTION)
    ("the cellular tumor suppressor p53" . SPARSER::PROTEIN)
    ("One possible factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenously and endogenously expressed p53" . SPARSER::PROTEIN)
    ("expressed p53" . SPARSER::PROTEIN)
    ("nuclear and potentially transcriptionally active" . SPARSER::COLLECTION)
    ("the viral E4 Orf3 protein" . SPARSER::PROTEIN)
    ("E4 Orf6 and cellular cullin 5" . SPARSER::COLLECTION)
    ("p53 and other cellular targets" . SPARSER::COLLECTION)
    ("cellular cullin 5" . SPARSER::PROTEIN)
    ("transcriptional activator or repressor" . SPARSER::COLLECTION)
    ("L4-22K-" . SPARSER::PROTEIN) ("nascent capsids" . SPARSER::PROTEIN)
    ("viral DNA" . SPARSER::DNA)
    ("MLP, L4-22K and L4-33K" . SPARSER::COLLECTION)
    ("promoter (MLP)" . SPARSER::PROMOTER) ("MLP" . SPARSER::PROTEIN)
    ("viral activators" . SPARSER::ACTIVATOR)
    ("early and intermediate viral factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("L4-22K and L4-33K" . SPARSER::COLLECTION) ("LT1" . SPARSER::PROTEIN)
    ("IgG2A" . SPARSER::PROTEIN) ("H3K9" . SPARSER::PROTEIN)
    ("cullin 5" . SPARSER::PROTEIN) ("E4 Orf6" . SPARSER::PROTEIN)
    ("E1B-55K" . SPARSER::PROTEIN) ("Orf3" . SPARSER::PROTEIN)
    ("Ad5" . SPARSER::PROTEIN) ("type 5" . SPARSER::PROTEIN)
    ("E4 Orf3" . SPARSER::PROTEIN) ("L4-33K" . SPARSER::PROTEIN)
    ("L4-22K" . SPARSER::PROTEIN)
    ("MEK and potentially JNK inhibitors" . SPARSER::COLLECTION)
    ("potentially JNK inhibitors" . SPARSER::INHIBITOR)
    ("EPCAM" . SPARSER::PROTEIN) ("PROCR" . SPARSER::PROTEIN)
    ("pINDUCER" . SPARSER::PROTEIN) ("Doxycycline" . SPARSER::DRUG)
    ("Recombinant IL-6 and/or IL-8 co-administered" . SPARSER::COLLECTION)
    ("pINDUCER-DUSP4" . SPARSER::PROTEIN-PAIR)
    ("CD44/CD24" . SPARSER::COLLECTION)
    ("ERCC6 , RRM2 and ABCG2" . SPARSER::COLLECTION)
    ("selumetinib and docetaxel" . SPARSER::COLLECTION)
    ("taxanes" . SPARSER::DRUG)
    ("selumetinib or the combination" . SPARSER::COLLECTION)
    ("Taxanes" . SPARSER::DRUG)
    ("the MEK inhibitors U0126 and CI1040 in SUM159PT cells ( xref )"
     . SPARSER::COLLECTION)
    ("Selumetinib" . SPARSER::DRUG) ("ETS-1 or cJUN" . SPARSER::COLLECTION)
    ("p-ETS-1" . SPARSER::COLLECTION) ("p-cJUN" . SPARSER::COLLECTION)
    ("cJUN and cFOS" . SPARSER::COLLECTION) ("cFOS" . SPARSER::PROTEIN)
    ("cJUN and P-cJUN" . SPARSER::COLLECTION)
    ("JNK and MEK" . SPARSER::COLLECTION) ("MEK or JNK" . SPARSER::COLLECTION)
    ("trypsinized, and re-plated" . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitor BEZ235" . SPARSER::DRUG)
    ("U0126 and CI-1040" . SPARSER::COLLECTION) ("selumetinib" . SPARSER::DRUG)
    ("MEK-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ETS-1 and cJUN" . SPARSER::COLLECTION)
    ("CD44:CD24" . SPARSER::BIO-COMPLEX) ("aggressive forms" . SPARSER::FORM)
    ("JNK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("cJUN and ETS-1" . SPARSER::COLLECTION) ("cJUN" . SPARSER::PROTEIN)
    ("ERK1/2 and JNK1/2" . SPARSER::COLLECTION)
    ("Ras and Raf" . SPARSER::COLLECTION) ("Ras/MEK/ERK" . SPARSER::COLLECTION)
    ("EMT and CSC" . SPARSER::COLLECTION)
    ("CD44 and CD24" . SPARSER::COLLECTION)
    ("HER-2/ERBB2" . SPARSER::COLLECTION) ("CD24-" . SPARSER::PROTEIN)
    ("claudin" . SPARSER::PROTEIN) ("ETS-1 and c-JUN" . SPARSER::COLLECTION)
    ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("MEK and JNK" . SPARSER::COLLECTION)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN) ("ABCG2" . SPARSER::PROTEIN)
    ("ERCC6" . SPARSER::PROTEIN) ("BEZ235" . SPARSER::DRUG)
    ("CI-1040" . SPARSER::DRUG) ("p11" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ETS1" . SPARSER::PROTEIN) ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dual Specificity Phosphatase" . SPARSER::PROTEIN)
    ("ETS-1" . SPARSER::PROTEIN) ("DUSP4" . SPARSER::PROTEIN)
    ("proliferative E2F1" . SPARSER::PROTEIN)
    ("cooperative targets" . SPARSER::TARGET-PROTEIN)
    ("multiple developmental genes" . SPARSER::GENE)
    ("normal and abnormal E2F1" . SPARSER::PROTEIN)
    ("Rb/E2F" . SPARSER::COLLECTION) ("PI3K and HDAC" . SPARSER::COLLECTION)
    ("HDAC inhibitors and PI3K inhibitors" . SPARSER::COLLECTION)
    ("FOXO1 or FOXO3" . SPARSER::COLLECTION)
    ("E2F1 and SAHA" . SPARSER::COLLECTION)
    ("vorinostat (SAHA) and scriptaid" . SPARSER::COLLECTION)
    ("scriptaid" . SPARSER::DRUG) ("HDACi" . SPARSER::MOLECULE)
    ("Map" . SPARSER::PROTEIN) ("E2F1 and FOXO3" . SPARSER::COLLECTION)
    ("signed-rank" . SPARSER::PROTEIN) ("FOXO and APAF1" . SPARSER::COLLECTION)
    ("FOXO3-AAA" . SPARSER::COLLECTION)
    ("two representative cooperative target genes" . SPARSER::GENE)
    ("APAF1 and CDKN1C" . SPARSER::COLLECTION)
    ("EGR4, APAF1, and CDKN1C" . SPARSER::COLLECTION)
    ("CDKN1C ( xref ) and several components" . SPARSER::COLLECTION)
    ("EGR1, EGR2, and EGR4" . SPARSER::COLLECTION)
    ("numerous developmental genes" . SPARSER::GENE)
    ("CTSB" . SPARSER::PROTEIN) ("EGR" . SPARSER::PROTEIN)
    ("Foxo" . SPARSER::PROTEIN-FAMILY)
    ("E2F1 apoptotic transcriptional cofactors" . SPARSER::PROTEIN)
    ("the apoptotic E2F1" . SPARSER::PROTEIN)
    ("factors, FOXO1 and FOXO3" . SPARSER::COLLECTION) ("OHT" . SPARSER::DRUG)
    ("E2F1 and FOXO" . SPARSER::COLLECTION)
    ("kinases and SIRT1" . SPARSER::COLLECTION)
    ("AKT and SGK" . SPARSER::COLLECTION) ("SGK" . SPARSER::PROTEIN)
    ("numerous proapoptotic genes and repression of survival genes ( xref – xref )"
     . SPARSER::COLLECTION)
    ("CDKs" . SPARSER::PROTEIN) ("HDAC and PI3K" . SPARSER::COLLECTION)
    ("cooperative targets genes" . SPARSER::GENE)
    ("FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("FOXO" . SPARSER::PROTEIN-FAMILY) ("GSK2126458" . SPARSER::DRUG)
    ("MCM4" . SPARSER::PROTEIN) ("EGR4" . SPARSER::PROTEIN)
    ("EGR2" . SPARSER::PROTEIN) ("EGR1" . SPARSER::PROTEIN)
    ("p57" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDKN1C" . SPARSER::PROTEIN)
    ("NR4A3" . SPARSER::PROTEIN) ("NLRP3" . SPARSER::PROTEIN)
    ("EPHA7" . SPARSER::PROTEIN) ("PTCH1" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("APAF1" . SPARSER::PROTEIN) ("GLO 3" . SPARSER::PROTEIN)
    ("DYRK1A" . SPARSER::PROTEIN) ("CK1" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("SNP and HTS" . SPARSER::COLLECTION)
    ("the face and other parts" . SPARSER::COLLECTION)
    ("PGT" . SPARSER::PROTEIN)
    ("associated genetic variants" . SPARSER::VARIANT)
    ("variant (CC)" . SPARSER::VARIANT) ("hoc" . SPARSER::PROTEIN)
    ("yrs" . SPARSER::PROTEIN) ("Itch" . SPARSER::PROTEIN)
    ("Factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("post-hoc" . SPARSER::COLLECTION) ("van" . SPARSER::PROTEIN)
    ("potentially yet-to-be-identified genetic variants" . SPARSER::VARIANT)
    ("itch" . SPARSER::PROTEIN) ("HTS" . SPARSER::PROTEIN)
    ("dominant and recessive" . SPARSER::PROTEIN)
    ("P27 kip1" . SPARSER::PROTEIN) ("kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nat" . SPARSER::PROTEIN) ("SRA" . SPARSER::PROTEIN)
    ("CTL" . SPARSER::PROTEIN) ("CTLs" . SPARSER::PROTEIN)
    ("class I, p53 and ERAP1" . SPARSER::COLLECTION)
    ("the genotoxic drug 5-FU" . SPARSER::PROTEIN)
    ("ERAP1 and MHC" . SPARSER::COLLECTION)
    ("possible p53-responsive genes" . SPARSER::GENE)
    ("siRNA and ERAP1a or ERAP1b" . SPARSER::COLLECTION)
    ("siRNAs and ERAP1" . SPARSER::COLLECTION)
    ("intense ERAP1" . SPARSER::PROTEIN)
    ("ERAP1 and p53" . SPARSER::COLLECTION)
    ("type I and type II" . SPARSER::COLLECTION)
    ("the viral NS1 protein" . SPARSER::PROTEIN)
    ("p53 and phosphor-p53" . SPARSER::COLLECTION)
    ("simultaneous antibody" . SPARSER::ANTIBODY)
    ("class I and p53" . SPARSER::COLLECTION)
    ("NS1 (non-structural protein 1) and HA (hemagglutinin)"
     . SPARSER::COLLECTION)
    ("viral genes" . SPARSER::GENE)
    ("a classical tumour suppressor" . SPARSER::SUPPRESSOR)
    ("two naturally occurring isoforms" . SPARSER::ISOFORM)
    ("ERAP1 , ERAP1a and ERAP1b" . SPARSER::COLLECTION)
    ("endogenous cellular p53" . SPARSER::PROTEIN)
    ("p53–ERAP1" . SPARSER::COLLECTION) ("Genotoxic drugs" . SPARSER::DRUG)
    ("ERAP1-RE2" . SPARSER::COLLECTION) ("RE2" . SPARSER::PROTEIN)
    ("REs" . SPARSER::PROTEIN)
    ("the SV40 minimal promoter" . SPARSER::PROMOTER)
    ("proteins and those specific DNA" . SPARSER::COLLECTION)
    ("p53 and ERAP1" . SPARSER::COLLECTION)
    ("the isogenic p53  +/+" . SPARSER::PROTEIN)
    ("p53-mdm2" . SPARSER::COLLECTION) ("TAP1 and ERAP1" . SPARSER::COLLECTION)
    ("PA28α and PSME2" . SPARSER::COLLECTION)
    ("BIP , CALR , CALR3 and CANX" . SPARSER::COLLECTION)
    ("ERAP1 and ERAP2" . SPARSER::COLLECTION)
    ("HLA-B and B2M" . SPARSER::COLLECTION) ("CANX" . SPARSER::PROTEIN)
    ("CALR" . SPARSER::PROTEIN) ("BIP" . SPARSER::PROTEIN)
    ("TAPBP" . SPARSER::PROTEIN)
    ("substantially more surface MHC Class I molecules" . SPARSER::MOLECULE)
    ("p53 and MHC" . SPARSER::COLLECTION)
    ("ERAP1 allelic variants" . SPARSER::VARIANT)
    ("aminopeptidase" . SPARSER::PROTEIN)
    ("which lacks p53" . SPARSER::PROTEIN) ("LASP1" . SPARSER::PROTEIN)
    ("Nutlin-3" . SPARSER::DRUG) ("4-1" . SPARSER::PROTEIN)
    ("Endoplasmic reticulum aminopeptidase 1" . SPARSER::PROTEIN)
    ("IFNγ" . SPARSER::PROTEIN) ("IFNβ" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN)
    ("non-structural protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mdm2" . SPARSER::PROTEIN) ("Nutlin 3" . SPARSER::DRUG)
    ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ERAP2" . SPARSER::PROTEIN)
    ("HSPA5" . SPARSER::PROTEIN) ("TAP2" . SPARSER::PROTEIN)
    ("TAP1" . SPARSER::PROTEIN) ("PA28β" . SPARSER::PROTEIN)
    ("PSME2" . SPARSER::PROTEIN) ("PA28α" . SPARSER::PROTEIN)
    ("PSME1" . SPARSER::PROTEIN) ("LMP2" . SPARSER::PROTEIN)
    ("PSMB9" . SPARSER::PROTEIN) ("LMP7" . SPARSER::PROTEIN)
    ("PSMB8" . SPARSER::PROTEIN) ("MECL1" . SPARSER::PROTEIN)
    ("PSMB10" . SPARSER::PROTEIN) ("MHC class I antigen" . SPARSER::PROTEIN)
    ("ERAP1" . SPARSER::PROTEIN)
    ("endoplasmic reticulum aminopeptidase 1" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("MYC and other pertinent proteins and genes" . SPARSER::COLLECTION)
    ("other pertinent proteins and genes" . SPARSER::COLLECTION)
    ("regulators and effectors" . SPARSER::COLLECTION)
    ("PTEN and IGF1R" . SPARSER::COLLECTION)
    ("proteins and genes" . SPARSER::COLLECTION)
    ("HER2 and MYC" . SPARSER::COLLECTION)
    ("sequential trastuzumab" . SPARSER::DRUG)
    ("oxygen and glucose" . SPARSER::COLLECTION)
    ("an overall null biomarker" . SPARSER::MOLECULE)
    ("disparate prognostic impact" . SPARSER::PROTEIN)
    ("type and number" . SPARSER::COLLECTION) ("arm" . SPARSER::PROTEIN)
    ("strong (3+) nuclear" . SPARSER::PROTEIN)
    ("genes and plays" . SPARSER::COLLECTION)
    ("the translational component" . SPARSER::COMPONENT)
    ("Group (NCCTG)" . SPARSER::MOLECULE) ("MYC/HER2" . SPARSER::COLLECTION)
    ("Adjuvant" . SPARSER::DRUG)
    ("a pleiotropic transcription factor and key regulator"
     . SPARSER::COLLECTION)
    ("a pleiotropic transcription factor" . SPARSER::PROTEIN)
    ("Trastuzumab" . SPARSER::DRUG) ("MYC-" . SPARSER::PROTEIN)
    ("WS" . SPARSER::PROTEIN) ("Arms" . SPARSER::PROTEIN)
    ("concurrent trastuzumab" . SPARSER::DRUG) ("Arm" . SPARSER::PROTEIN)
    ("2 p" . SPARSER::PROTEIN) ("Jag-1 or Notch2" . SPARSER::COLLECTION)
    ("Notch3 and Jag-1" . SPARSER::COLLECTION) ("SM" . SPARSER::PROTEIN)
    ("Notch1, Notch2 and p27 kip1" . SPARSER::COLLECTION)
    ("receptors and p27 kip1" . SPARSER::COLLECTION)
    ("Dll-1" . SPARSER::PROTEIN) ("Dll" . SPARSER::PROTEIN)
    ("mask" . SPARSER::PROTEIN)
    ("V5-tagged constitutively active forms" . SPARSER::FORM)
    ("S10 and Skp2" . SPARSER::COLLECTION)
    ("Skp2 and p27 kip1" . SPARSER::COLLECTION)
    ("significantly more p27 kip1" . SPARSER::PROTEIN)
    ("Fc and Jag-1" . SPARSER::COLLECTION)
    ("Notch1 or Notch3" . SPARSER::COLLECTION)
    ("total and phosphorylated forms" . SPARSER::FORM)
    ("total p27 kip1 and p-p27 kip1 S10" . SPARSER::COLLECTION)
    ("p-p27 kip1" . SPARSER::COLLECTION) ("si" . SPARSER::PROTEIN)
    ("si-p27 kip1" . SPARSER::COLLECTION) ("Fc or Fc" . SPARSER::COLLECTION)
    ("cyclin E1/CDK2" . SPARSER::COLLECTION)
    ("CDK2 and cyclin E1" . SPARSER::COLLECTION)
    ("cyclin E1 and its associated cyclin dependent kinase 2 (CDK2)"
     . SPARSER::COLLECTION)
    ("its associated cyclin dependent kinase 2" . SPARSER::PROTEIN)
    ("p21 cip1/waf1" . SPARSER::COLLECTION)
    ("Fc or Jag-1" . SPARSER::COLLECTION)
    ("Notch1 ( xref ) and Notch3 ( xref )" . SPARSER::COLLECTION)
    ("SM-actin" . SPARSER::COLLECTION)
    ("Notch1, Notch2 or Notch3" . SPARSER::COLLECTION)
    ("Notch1, Notch2 and Notch3" . SPARSER::COLLECTION)
    ("actin and SM22α" . SPARSER::COLLECTION)
    ("Notch1 and Notch2" . SPARSER::COLLECTION)
    ("Notch1, Notch2, or Notch3" . SPARSER::COLLECTION)
    ("Notch2 and Notch3" . SPARSER::COLLECTION)
    ("Notch2 and Notch1" . SPARSER::COLLECTION)
    ("myosin heavy chain and smoothelin" . SPARSER::COLLECTION)
    ("smoothelin" . SPARSER::PROTEIN)
    ("Notch2 and p27 kip1" . SPARSER::COLLECTION)
    ("Jag-1/Notch2" . SPARSER::COLLECTION) ("Jag-1" . SPARSER::PROTEIN)
    ("Notch1 and Notch3" . SPARSER::COLLECTION)
    ("gamma secretase" . SPARSER::PROTEIN) ("Dll1" . SPARSER::PROTEIN)
    ("CBF-1" . SPARSER::PROTEIN)
    ("cyclin dependent kinase 2" . SPARSER::PROTEIN)
    ("cyclin E1" . SPARSER::PROTEIN)
    ("p21 cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("18h" . SPARSER::PROTEIN)
    ("p-H3" . SPARSER::MOLECULE) ("Hes1" . SPARSER::PROTEIN)
    ("myosin heavy chain" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SM22α" . SPARSER::PROTEIN) ("calponin1" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("Skp2" . SPARSER::PROTEIN) ("p27 kip1" . SPARSER::PROTEIN)
    ("Jagged-1" . SPARSER::PROTEIN) ("Notch2" . SPARSER::PROTEIN)
    ("Notch3" . SPARSER::PROTEIN) ("Notch1" . SPARSER::PROTEIN)
    ("CHOP" . SPARSER::PROTEIN)
    ("NF-kB (transcriptionally) and mTOR (translationally)"
     . SPARSER::COLLECTION)
    ("13-197 principally targets IKKβ" . SPARSER::PROTEIN)
    ("Bcl-XL and Mcl-1" . SPARSER::COLLECTION)
    ("IκBα and p65" . SPARSER::COLLECTION)
    ("Mcl-1, Bcl-XL and cyclin D1" . SPARSER::COLLECTION)
    ("Bortezomib" . SPARSER::DRUG)
    ("NF-κB and PI3K-mTOR" . SPARSER::COLLECTION)
    ("IκB, S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("phosphorylated NF-kB (p-65) and mTOR (p-S6K) molecules"
     . SPARSER::COLLECTION)
    ("p-S6K" . SPARSER::PROTEIN) ("NF-kB and mTOR" . SPARSER::COLLECTION)
    ("Cyclin D1, Bcl-XL and Mcl-1" . SPARSER::COLLECTION)
    ("MCL as well as therapy-resistant MCL variants" . SPARSER::COLLECTION)
    ("both parental and therapy-resistant MCL" . SPARSER::PROTEIN)
    ("the principal molecules" . SPARSER::MOLECULE)
    ("Bcl-2 ant-apoptotic gene family" . SPARSER::PROTEIN-FAMILY)
    ("MCL, and Mcl-1" . SPARSER::COLLECTION)
    ("ant" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MCL and therapy-resistant-MCL" . SPARSER::COLLECTION)
    ("AnnexinV" . SPARSER::PROTEIN) ("GRK" . SPARSER::PROTEIN)
    ("GRL" . SPARSER::PROTEIN)
    ("MCL and therapy-resistant MCL cells growth/proliferation"
     . SPARSER::COLLECTION)
    ("-thymidine" . SPARSER::COLLECTION) ("malignant MCL" . SPARSER::PROTEIN)
    ("Parthenolide, Curcumin and Noscapine" . SPARSER::COLLECTION)
    ("Noscapine" . SPARSER::DRUG) ("Curcumin" . SPARSER::DRUG)
    ("Parthenolide" . SPARSER::MOLECULE) ("PI3K/mTOR" . SPARSER::COLLECTION)
    ("a characteristic chromosomal translocation t" . SPARSER::PROTEIN)
    ("cyclin D1, Bcl-XL and Mcl-1" . SPARSER::COLLECTION)
    ("NF-κB and mTOR" . SPARSER::COLLECTION) ("i.e. S" . SPARSER::MOLECULE)
    ("IkBα" . SPARSER::PROTEIN) ("p-S6" . SPARSER::PROTEIN)
    ("CD20" . SPARSER::PROTEIN) ("TPCA1" . SPARSER::DRUG)
    ("TSC1" . SPARSER::PROTEIN) ("tuberous sclerosis 1" . SPARSER::PROTEIN)
    ("IKKβ" . SPARSER::PROTEIN) ("Bcl-XL" . SPARSER::PROTEIN)
    ("cetuximab and afatinib" . SPARSER::COLLECTION)
    ("HER2/ERBB2" . SPARSER::COLLECTION)
    ("an ongoing PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR TKI's" . SPARSER::PROTEIN) ("PRs" . SPARSER::PROTEIN)
    ("PR or SD≥6 months" . SPARSER::COLLECTION)
    ("gefitinib and cetuximab" . SPARSER::COLLECTION)
    ("PR (n=2) or SD≥6 months (n=3)" . SPARSER::COLLECTION)
    ("a TKI (erlotinib/gefitinib) and an anti-EGFR antibody (cetuximab)"
     . SPARSER::COLLECTION)
    ("dual EGFR inhibitors" . SPARSER::INHIBITOR) ("MTD" . SPARSER::PROTEIN)
    ("troponins" . SPARSER::PROTEIN-FAMILY) ("three DLT's" . SPARSER::PROTEIN)
    ("DLT" . SPARSER::PROTEIN) ("NRAS" . SPARSER::PROTEIN)
    ("erlotinib and gefitinib-" . SPARSER::COLLECTION)
    ("gefitinib-" . SPARSER::DRUG) ("TTF" . SPARSER::PROTEIN)
    ("erlotinib and cetuximab" . SPARSER::COLLECTION)
    ("Liposomal complexes" . SPARSER::BIO-COMPLEX)
    ("MiR-27a" . SPARSER::PROTEIN)
    ("its respective targets EGFR, AKT1, and mTOR" . SPARSER::COLLECTION)
    ("mTOR-pGL3" . SPARSER::COLLECTION) ("AKT1-pGL3" . SPARSER::COLLECTION)
    ("E3908-pGL3 (WT) and miR-27a" . SPARSER::COLLECTION)
    ("CDS, and E160-pGL3" . SPARSER::COLLECTION)
    ("EGFR, AKT1 or mTOR" . SPARSER::COLLECTION)
    ("EGFR, AKT1, and mTOR" . SPARSER::COLLECTION)
    ("AKT1 or mTOR" . SPARSER::COLLECTION)
    ("AKT1 and mTOR" . SPARSER::COLLECTION)
    ("suppressor and oncogene" . SPARSER::COLLECTION)
    ("Components" . SPARSER::COMPONENT) ("IH" . SPARSER::MOLECULE)
    ("miR-27a" . SPARSER::PROTEIN) ("miR-27a-SL" . SPARSER::COLLECTION)
    ("alamarBlue" . SPARSER::DRUG)
    ("miR-7, −27a and −27a" . SPARSER::COLLECTION) ("CDS" . SPARSER::PROTEIN)
    ("oncogenes and tumor suppressors [ xref ]" . SPARSER::COLLECTION)
    ("EGFR and its downstream mediators" . SPARSER::COLLECTION)
    ("EGFR, AKT1 and mTOR" . SPARSER::COLLECTION)
    ("AKT1 (protein kinase B) and mTOR (mammalian target of rapamycin)"
     . SPARSER::COLLECTION)
    ("star" . SPARSER::HUMAN-PROTEIN-FAMILY) ("miR-7" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miR-27a-5p" . SPARSER::MOLECULE) ("miR-27a-3p" . SPARSER::MOLECULE)
    ("tubulin and tau" . SPARSER::COLLECTION)
    ("dynein and kinesin" . SPARSER::COLLECTION)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("dynein" . SPARSER::PROTEIN)
    ("acetyltransferase/deacetylase activity" . SPARSER::COLLECTION)
    ("MAP2 and MAP4" . SPARSER::COLLECTION)
    ("a dramatic impact" . SPARSER::PROTEIN) ("AB" . SPARSER::PROTEIN)
    ("the acetylation state of tau's" . SPARSER::BIO-STATE)
    ("the only commercially available recombinant MARK2" . SPARSER::PROTEIN)
    ("PKA" . SPARSER::PROTEIN) ("HSP" . SPARSER::PROTEIN)
    ("Par-1/MARK2" . SPARSER::COLLECTION)
    ("AGK2 (specific SIRT2 inhibitor) and nicotinamide (pan-SIRT inhibitor)"
     . SPARSER::COLLECTION)
    ("pan-SIRT" . SPARSER::PROTEIN-PAIR) ("tubacin" . SPARSER::DRUG)
    ("tau or mutant" . SPARSER::COLLECTION) ("ac" . SPARSER::PROTEIN)
    ("that tau's" . SPARSER::PROTEIN) ("HDAC6 and tau" . SPARSER::COLLECTION)
    ("preclinical AD" . SPARSER::PROTEIN) ("p-tau" . SPARSER::COLLECTION)
    ("beta-mercaptoethanol" . SPARSER::MOLECULE) ("Par1" . SPARSER::PROTEIN)
    ("MAP4" . SPARSER::PROTEIN) ("MAP2" . SPARSER::PROTEIN)
    ("PHF1" . SPARSER::PROTEIN) ("MARK2" . SPARSER::PROTEIN)
    ("Par-1" . SPARSER::PROTEIN) ("AGK2" . SPARSER::PROTEIN)
    ("EX527" . SPARSER::DRUG) ("MS275" . SPARSER::DRUG)
    ("F–H" . SPARSER::PROTEIN) ("CREB-binding protein" . SPARSER::PROTEIN)
    ("histone deacetylase 6" . SPARSER::PROTEIN)
    ("DAPK2 and CIDEC" . SPARSER::COLLECTION)
    ("PIAS3, CIDEC and DAPK2" . SPARSER::COLLECTION)
    ("the proteasome inhibitor bortezomib and the HDAC inhibitor vorinostat"
     . SPARSER::COLLECTION)
    ("many pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("Puma ( xref ) and p21 ( xref )" . SPARSER::COLLECTION)
    ("DNA fragmentation factor α--like effector (CIDE) family"
     . SPARSER::PROTEIN-FAMILY)
    ("CIDEC and DAPK2" . SPARSER::COLLECTION) ("CIDEC" . SPARSER::PROTEIN)
    ("PIAS3 and p53" . SPARSER::COLLECTION)
    ("pro-apoptotic Noxa proteins" . SPARSER::PROTEIN)
    ("caspase 3 and PARP" . SPARSER::COLLECTION) ("analog" . SPARSER::ANALOG)
    ("caspase 9 and caspase 3" . SPARSER::COLLECTION)
    ("VDAC" . SPARSER::PROTEIN) ("apoptosome" . SPARSER::BIO-COMPLEX)
    ("CCCP" . SPARSER::MOLECULE) ("trypan" . SPARSER::DRUG)
    ("death-associated protein kinase 2" . SPARSER::PROTEIN)
    ("DAPK2" . SPARSER::PROTEIN) ("AP21967" . SPARSER::DRUG)
    ("ZF2" . SPARSER::PROTEIN)
    ("terminal deoxyribonucleotidyl transferase" . SPARSER::PROTEIN)
    ("ABT-263" . SPARSER::DRUG) ("caspase 9" . SPARSER::PROTEIN)
    ("PIAS3" . SPARSER::PROTEIN)
    ("Protein inhibitor of activated STAT3" . SPARSER::PROTEIN)
    ("NCT" . SPARSER::PROTEIN)
    ("afatinib, erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("nail" . SPARSER::PROTEIN)
    ("erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("arms" . SPARSER::PROTEIN) ("-mutant" . SPARSER::MUTANT)
    ("LUX" . SPARSER::PROTEIN) ("Afatinib" . SPARSER::DRUG)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("afatinib" . SPARSER::DRUG)
    ("nucleocytoplasmic proteins" . SPARSER::PROTEIN)
    ("NCC" . SPARSER::PROTEIN)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("HSP70 and HSP27" . SPARSER::COLLECTION)
    ("MDM2 and CHIP" . SPARSER::COLLECTION) ("MOR" . SPARSER::PROTEIN)
    ("OST" . SPARSER::PROTEIN) ("oligosaccharide" . SPARSER::MOLECULE)
    ("Hedgehog" . SPARSER::PROTEIN) ("RPN2 and mtp53" . SPARSER::COLLECTION)
    ("anti-p53 and anti-GFP" . SPARSER::COLLECTION)
    ("RPN2/GSK3β" . SPARSER::COLLECTION) ("shRPN2" . SPARSER::PROTEIN)
    ("ectopically expressed RPN2-MF" . SPARSER::COLLECTION)
    ("expressed RPN2-MF" . SPARSER::COLLECTION)
    ("shRPN2-UTR" . SPARSER::COLLECTION)
    ("HSP70 and RPN2" . SPARSER::COLLECTION)
    ("HSP70 promoter-driven GFP" . SPARSER::PROTEIN)
    ("HSP70-GFP" . SPARSER::COLLECTION)
    ("SV40 promoter-driven secreted cypridina luciferase" . SPARSER::PROTEIN)
    ("HSP70-Cluc" . SPARSER::PROTEIN-PAIR)
    ("HSP70 promoter-driven secreted cypridina luciferase" . SPARSER::PROTEIN)
    ("Flag-HSF1" . SPARSER::COLLECTION) ("EMT and NF-κB" . SPARSER::COLLECTION)
    ("MDM2, CHIP, HSP90 and HSP70" . SPARSER::COLLECTION)
    ("Flag-Snail" . SPARSER::COLLECTION)
    ("expressing RPN2-MF" . SPARSER::COLLECTION)
    ("GSK3β-HA" . SPARSER::COLLECTION) ("the mammary fat" . SPARSER::PROTEIN)
    ("/GFP" . SPARSER::COLLECTION) ("HME-Snail" . SPARSER::COLLECTION)
    ("RPN2-MF" . SPARSER::COLLECTION) ("Myc-Flag" . SPARSER::COLLECTION)
    ("MF" . SPARSER::PROTEIN)
    ("Snail and a point mutant p53 (R280K)" . SPARSER::COLLECTION)
    ("HME" . SPARSER::PROTEIN) ("CH" . SPARSER::PROTEIN)
    ("GFP and a small hairpin RNA" . SPARSER::COLLECTION)
    ("RPN2 and E-cadherin" . SPARSER::COLLECTION) ("MM231" . SPARSER::PROTEIN)
    ("MM231-LN" . SPARSER::COLLECTION)
    ("essential factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSP70 and HSP90" . SPARSER::COLLECTION)
    ("RPN2 and GSK3β" . SPARSER::COLLECTION)
    ("Twist and Snail" . SPARSER::COLLECTION)
    ("protein (CHIP)" . SPARSER::PROTEIN)
    ("HSP90 and HSP70" . SPARSER::COLLECTION) ("CHIP" . SPARSER::PROTEIN)
    ("p63 and Mre11" . SPARSER::COLLECTION) ("GOF" . SPARSER::PROTEIN)
    ("thymidine kinase" . SPARSER::PROTEIN) ("site1" . SPARSER::PROTEIN)
    ("C-Myc" . SPARSER::PROTEIN) ("opioid receptor" . SPARSER::PROTEIN)
    ("RPN1" . SPARSER::PROTEIN) ("Ribophorin-1" . SPARSER::PROTEIN)
    ("14-3-3zeta" . SPARSER::PROTEIN) ("HSF1" . SPARSER::PROTEIN)
    ("heat shock transcription factor1" . SPARSER::PROTEIN)
    ("site2" . SPARSER::PROTEIN) ("ABCB1" . SPARSER::PROTEIN)
    ("MDM2" . SPARSER::PROTEIN) ("HSP70" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mre11" . SPARSER::PROTEIN)
    ("RPN2" . SPARSER::PROTEIN) ("ribophorin II" . SPARSER::PROTEIN)
    ("Pao" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("previously reported EGFR" . SPARSER::PROTEIN)
    ("-acrylamide" . SPARSER::MOLECULE) ("acrylamide" . SPARSER::MOLECULE)
    ("LSL-Kras" . SPARSER::COLLECTION) ("Kras" . SPARSER::PROTEIN)
    ("LSL" . SPARSER::PROTEIN) ("PDAC" . SPARSER::PROTEIN)
    ("dynamic PET" . SPARSER::PROTEIN) ("EGFRvIII" . SPARSER::PROTEIN)
    ("noninvasive PET" . SPARSER::PROTEIN)
    ("TBR and TMR" . SPARSER::COLLECTION) ("TMR" . SPARSER::PROTEIN)
    ("TBR" . SPARSER::PROTEIN)
    ("slightly decreased (L858R cells, xref ) (E746-A750 del cells, xref ) CMR"
     . SPARSER::PROTEIN)
    ("CMR" . SPARSER::PROTEIN) ("mL/min" . SPARSER::COLLECTION)
    ("acetonitrile" . SPARSER::MOLECULE) ("ethanol" . SPARSER::PROTEIN)
    ("kinases or EGFR" . SPARSER::COLLECTION) ("-amide" . SPARSER::MOLECULE)
    ("amide" . SPARSER::MOLECULE) ("quinazoline" . SPARSER::MOLECULE)
    ("a positive predictive biomarker" . SPARSER::MOLECULE)
    ("Leu-Arg-Glu-Ala" . SPARSER::COLLECTION)
    ("EGFR (i.e., cetuximab, panitumumab, matuzumab, nimotuzumab, etc.) and small molecular inhibitors"
     . SPARSER::COLLECTION)
    ("canertinib" . SPARSER::DRUG) ("nimotuzumab" . SPARSER::DRUG)
    ("matuzumab" . SPARSER::DRUG) ("panitumumab" . SPARSER::DRUG)
    ("epidermal growth factor receptor-tyrosine kinase" . SPARSER::COLLECTION)
    ("tumor type, size, and patient's" . SPARSER::COLLECTION)
    ("type, size, and patient" . SPARSER::COLLECTION)
    ("a 15 " . SPARSER::PROTEIN) ("sodium bicarbonate" . SPARSER::DRUG)
    ("PD153035" . SPARSER::DRUG) ("Spry4:c-Src" . SPARSER::BIO-COMPLEX)
    ("subcellular fractions" . SPARSER::COMPONENT)
    ("active or inactive" . SPARSER::COLLECTION)
    ("Spry1 and Spry2" . SPARSER::COLLECTION)
    ("Ras/MAPK" . SPARSER::COLLECTION)
    ("VEGF and the ECM [ xref , xref , xref ]" . SPARSER::COLLECTION)
    ("Conditional CAGGFP-Spry4" . SPARSER::COLLECTION)
    ("Tie2-Cre" . SPARSER::COLLECTION)
    ("conditional transgenic CAGGFP-Spry4" . SPARSER::COLLECTION)
    ("LM" . SPARSER::PROTEIN) ("PECAM" . SPARSER::PROTEIN)
    ("proteins, and DNSrc" . SPARSER::COLLECTION)
    ("VEGFR-2 or integrin" . SPARSER::COLLECTION)
    ("c-Src and integrin" . SPARSER::COLLECTION)
    ("VEGFR-2 and integrin" . SPARSER::COLLECTION)
    ("dominantly negative forms" . SPARSER::FORM)
    ("exogenous Spry4" . SPARSER::PROTEIN)
    ("Raf1 and TESK1" . SPARSER::COLLECTION)
    ("Spry4 and c-Src" . SPARSER::COLLECTION) ("Ras/ERK" . SPARSER::COLLECTION)
    ("Exogenously expressed Spry4 proteins" . SPARSER::PROTEIN)
    ("expressed Spry4 proteins" . SPARSER::PROTEIN)
    ("c-Src, AKT and ERK" . SPARSER::COLLECTION)
    ("CAGGFP-Spry4" . SPARSER::COLLECTION) ("retinas" . SPARSER::DRUG)
    ("Global gene" . SPARSER::GENE)
    ("the mouse embryonic vasculature" . SPARSER::PROTEIN)
    ("Spry2 and Spry4" . SPARSER::COLLECTION)
    ("Spry1, Spry2 and Spry4" . SPARSER::COLLECTION)
    ("Four mammalian Spry genes" . SPARSER::GENE)
    ("integrins and receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("αVβ3 and VEGFR-2" . SPARSER::COLLECTION)
    ("vitronectin (VTN)" . SPARSER::PROTEIN)
    ("antibodies or peptides" . SPARSER::COLLECTION)
    ("growth factor (VEGF)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("angiogenic growth factors" . SPARSER::GROWTH-FACTOR)
    ("sacs" . SPARSER::PROTEIN) ("VTN" . SPARSER::PROTEIN)
    ("vitronectin" . SPARSER::PROTEIN) ("Sprouty" . SPARSER::PROTEIN-FAMILY)
    ("Src family kinases and adhesion receptors" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases (RTKs), Src family kinases and adhesion receptors"
     . SPARSER::COLLECTION)
    ("Siah2" . SPARSER::PROTEIN) ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TESK1" . SPARSER::PROTEIN) ("Ly294002" . SPARSER::MOLECULE)
    ("Tie2" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("Raf1" . SPARSER::PROTEIN) ("Spry2" . SPARSER::PROTEIN)
    ("Spry1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("VEGFR-2" . SPARSER::PROTEIN) ("αVβ3" . SPARSER::PROTEIN)
    ("c-Src-" . SPARSER::PROTEIN) ("Spry4" . SPARSER::PROTEIN)
    ("flavopiridol and roscovitine" . SPARSER::COLLECTION)
    ("flavopiridol" . SPARSER::DRUG) ("CSC and non-CSC" . SPARSER::COLLECTION)
    ("doxorubicin and etoposide" . SPARSER::COLLECTION)
    ("kinases/proteins" . SPARSER::COLLECTION)
    ("the kinase as well as the substrate" . SPARSER::COLLECTION)
    ("PKK" . SPARSER::PROTEIN) ("Salinomycin" . SPARSER::DRUG)
    ("Doxorubicin" . SPARSER::PROTEIN) ("Fbw7" . SPARSER::PROTEIN)
    ("CD24/CD44" . SPARSER::COLLECTION) ("permanent red" . SPARSER::PROTEIN)
    ("Hbo1 and cyclin E" . SPARSER::COLLECTION)
    ("vimentin, twist and slug" . SPARSER::COLLECTION)
    ("cyclin E and the EMT marker genes E-cadherin, N-cadherin, vimentin, twist and slug"
     . SPARSER::COLLECTION)
    ("Hbo1, cyclin E and the EMT marker genes E-cadherin, N-cadherin, vimentin, twist and slug"
     . SPARSER::COLLECTION)
    ("E-cadherin, N-cadherin, vimentin, twist and slug" . SPARSER::COLLECTION)
    ("EL and LMW-E-expressing" . SPARSER::COLLECTION)
    ("CDK2, and Hbo1" . SPARSER::COLLECTION) ("antibiotic" . SPARSER::DRUG)
    ("Myc or FLAG" . SPARSER::COLLECTION) ("SFB-CDK2" . SPARSER::COLLECTION)
    ("-EL" . SPARSER::COLLECTION)
    ("streptavidin-flag-S protein" . SPARSER::COLLECTION)
    ("SFB" . SPARSER::PROTEIN) ("Cyclin E/CDK2" . SPARSER::COLLECTION)
    ("roscovitine" . SPARSER::DRUG) ("Myc and Flag" . SPARSER::COLLECTION)
    ("Myc-Hbo1" . SPARSER::COLLECTION) ("HA-CDK2" . SPARSER::COLLECTION)
    ("FLAG-EL" . SPARSER::COLLECTION)
    ("9000 unique human proteins" . SPARSER::PROTEIN)
    ("GST-Rb" . SPARSER::COLLECTION) ("EL/CDK2" . SPARSER::COLLECTION)
    ("EL, LMW-E, T1G2.2, T1G3.1, and T1G4.2" . SPARSER::COLLECTION)
    ("EL or LMW-E" . SPARSER::COLLECTION)
    ("CD24 and CD44" . SPARSER::COLLECTION)
    ("N-cadherin, twist, slug, and vimentin" . SPARSER::COLLECTION)
    ("slug" . SPARSER::PROTEIN) ("twist" . SPARSER::PROTEIN)
    ("the parental 76NE6 cells display strong membranous E-cadherin"
     . SPARSER::PROTEIN)
    ("EL and LMW-E" . SPARSER::COLLECTION)
    ("EL, and LMW-E" . SPARSER::COLLECTION) ("hMEC" . SPARSER::PROTEIN)
    ("b-Raf-ERK1/2-mTOR" . SPARSER::COLLECTION)
    ("cyclin E (EL)" . SPARSER::PROTEIN) ("p21 and p27" . SPARSER::COLLECTION)
    ("EL" . SPARSER::PROTEIN) ("pRb-E2F" . SPARSER::COLLECTION)
    ("doxorubicin and salinomycin" . SPARSER::COLLECTION)
    ("salinomycin" . SPARSER::DRUG) ("doxorubicin" . SPARSER::PROTEIN)
    ("cyclin E/CDK2" . SPARSER::COLLECTION) ("HAT" . SPARSER::PROTEIN)
    ("/CD24" . SPARSER::COLLECTION) ("ALDH" . SPARSER::PROTEIN)
    ("S protein" . SPARSER::PROTEIN) ("Plk1" . SPARSER::PROTEIN)
    ("polo-like kinase 1" . SPARSER::PROTEIN) ("CDK1" . SPARSER::PROTEIN)
    ("origin recognition complex" . SPARSER::PROTEIN)
    ("ORC1" . SPARSER::PROTEIN) ("b-Raf" . SPARSER::PROTEIN)
    ("Hbo1" . SPARSER::PROTEIN)
    ("histone acetyltransferase" . SPARSER::PROTEIN)
    ("neuroprotective factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("family and Cdk5" . SPARSER::COLLECTION)
    ("several other prosurvival factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pRb and p53" . SPARSER::COLLECTION)
    ("the phosphorylated form of Cdk5 and one" . SPARSER::COLLECTION)
    ("MEF2A and MEF2C" . SPARSER::COLLECTION)
    ("MEF2B or MEF2D" . SPARSER::COLLECTION)
    ("the transcription factor myocyte-specific enhancer factor 2"
     . SPARSER::PROTEIN)
    ("Inf" . SPARSER::PROTEIN)
    ("viral and cellular factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdk5 and its target MEF2" . SPARSER::COLLECTION)
    ("MEF2 and the state" . SPARSER::COLLECTION)
    ("the important prosurvival factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdk5 and MAPK" . SPARSER::COLLECTION)
    ("perchlorate (TMRE)" . SPARSER::MOLECULE) ("TMRE" . SPARSER::MOLECULE)
    ("perchlorate" . SPARSER::MOLECULE) ("ester" . SPARSER::MOLECULE)
    ("tetramethylrhodamine" . SPARSER::MOLECULE)
    ("the first 100 amino acids of the protein" . SPARSER::PROTEIN)
    ("smaller variants" . SPARSER::VARIANT) ("SOD" . SPARSER::PROTEIN)
    ("MTP" . SPARSER::PROTEIN) ("Glo" . SPARSER::PROTEIN)
    ("oxidoreductase" . SPARSER::PROTEIN) ("DING" . SPARSER::PROTEIN)
    ("myocyte-specific enhancer factor 2 also known as MEF2"
     . SPARSER::PROTEIN)
    ("MAPK and Cdk5" . SPARSER::COLLECTION)
    ("the viral regulatory proteins" . SPARSER::PROTEIN)
    ("these viral and cellular proteins" . SPARSER::PROTEIN)
    ("various cellular proinflammatory cytokines and chemokines"
     . SPARSER::COLLECTION)
    ("several viral regulatory and structural proteins" . SPARSER::PROTEIN)
    ("Cdk5 and MEF2" . SPARSER::COLLECTION)
    ("Cdk5 and their downstream target protein" . SPARSER::COLLECTION)
    ("MAPK, Cdk5 and their downstream target protein" . SPARSER::COLLECTION)
    ("its neurotoxic Tat protein" . SPARSER::PROTEIN)
    ("viral proteins" . SPARSER::PROTEIN)
    ("microglia, macrophages, and astrocytes" . SPARSER::COLLECTION)
    ("superoxide dismutase activity" . SPARSER::PROTEIN)
    ("MEF2D" . SPARSER::PROTEIN) ("MEF2B" . SPARSER::PROTEIN)
    ("MEF2C" . SPARSER::PROTEIN) ("MEF2A" . SPARSER::PROTEIN)
    ("Jak3" . SPARSER::PROTEIN) ("FGF-R" . SPARSER::PROTEIN)
    ("Phospho-kinase" . SPARSER::PROTEIN) ("bar 1" . SPARSER::PROTEIN)
    ("superoxide anion" . SPARSER::MOLECULE)
    ("superoxide anions" . SPARSER::MOLECULE)
    ("Xanthine Oxidase" . SPARSER::PROTEIN) ("Caspase 3" . SPARSER::PROTEIN)
    ("p24" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cytosine arabinoside" . SPARSER::DRUG) ("MEF2 family" . SPARSER::PROTEIN)
    ("Cdk5" . SPARSER::PROTEIN) ("pan-Bcl-2" . SPARSER::COLLECTION)
    ("siRNA or pharmaceutical drugs" . SPARSER::COLLECTION)
    ("pharmaceutical drugs" . SPARSER::DRUG)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("Mcl-1/Bcl-xL" . SPARSER::COLLECTION)
    ("BH3-mimetic molecules" . SPARSER::MOLECULE)
    ("anti-apoptotic proteins and the BH3-only proteins" . SPARSER::COLLECTION)
    ("activator BH3-only proteins as well as sensitizer BH3-only proteins"
     . SPARSER::COLLECTION)
    ("Cytotoxic" . SPARSER::PROTEIN)
    ("the pro-apoptotic multidomain protein Bak" . SPARSER::PROTEIN)
    ("ABT-737 and obatoclax" . SPARSER::COLLECTION)
    ("obatoclax" . SPARSER::DRUG)
    ("Bcl-xL and Mcl-1, and activator" . SPARSER::COLLECTION)
    ("Mcl-1, and activator" . SPARSER::COLLECTION)
    ("Bim and Bid" . SPARSER::COLLECTION)
    ("inactive monomer" . SPARSER::MONOMER)
    ("a strong multi-domain pro-apoptotic protein" . SPARSER::PROTEIN)
    ("pan-caspase" . SPARSER::COLLECTION)
    ("caspase-7 and PARP" . SPARSER::COLLECTION)
    ("total and cleaved PARP" . SPARSER::PROTEIN)
    ("Bcl-xL or Mcl-1" . SPARSER::COLLECTION)
    ("Bcl-xL and Bcl-2" . SPARSER::COLLECTION)
    ("Mcl-1 and Bcl-2" . SPARSER::COLLECTION)
    ("Mitochondrial and cytosolic fractions" . SPARSER::COLLECTION)
    ("Bcl-xL/Mcl-1" . SPARSER::COLLECTION) ("Bak or Bax" . SPARSER::COLLECTION)
    ("anti-apoptotic proteins (Bcl-2, Bcl-xL, and Mcl-1) and pro-apoptotic proteins"
     . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, and Mcl-1" . SPARSER::COLLECTION)
    ("Bak and Bax" . SPARSER::COLLECTION)
    ("Bad, Bid, Bim, Puma, and Noxa" . SPARSER::COLLECTION)
    ("Noxa" . SPARSER::PROTEIN) ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bid" . SPARSER::PROTEIN) ("baicalein" . SPARSER::DRUG)
    ("currently available chemotherapeutic drugs" . SPARSER::DRUG)
    ("Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("Mcl-1/Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-xL/Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-2 or Bcl-xL" . SPARSER::COLLECTION) ("PaCa" . SPARSER::PROTEIN)
    ("ABT-737" . SPARSER::DRUG) ("Mcl-1 protein" . SPARSER::PROTEIN)
    ("zVAD-fmk" . SPARSER::DRUG)
    ("cytochrome c oxidase subunit IV" . SPARSER::PROTEIN)
    ("APAF-1" . SPARSER::PROTEIN) ("activating factor" . SPARSER::PROTEIN)
    ("DNMT1 or HDAC3" . SPARSER::COLLECTION)
    ("enzymes, DNMT1 and HDAC3" . SPARSER::COLLECTION)
    ("some unknown relevant co-factors" . SPARSER::MOLECULE)
    ("the poorly-differentiated HCC" . SPARSER::PROTEIN)
    ("the traditional HDAC inhibitors TSA and VPA" . SPARSER::COLLECTION)
    ("the classic DNMT inhibitor, Zebu" . SPARSER::INHIBITOR)
    ("the classic DNMT inhibitor" . SPARSER::INHIBITOR)
    ("ZBP-89 and HDAC3" . SPARSER::COLLECTION) ("butyrate" . SPARSER::PROTEIN)
    ("pro-apoptotic Bak" . SPARSER::PROTEIN)
    ("siRNA and DNMT1" . SPARSER::COLLECTION) ("CpGs" . SPARSER::PROTEIN)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TSA and VPA" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein Bak" . SPARSER::PROTEIN)
    ("HDAC3 and DNMT1" . SPARSER::COLLECTION)
    ("TSA and 5-aza-dC" . SPARSER::COLLECTION) ("dC" . SPARSER::MOLECULE)
    ("poorly-differentiated HCC" . SPARSER::PROTEIN)
    ("Bak, ZBP-89, DNMT1 and HDAC3" . SPARSER::COLLECTION)
    ("ZBP-89 and DNMT1" . SPARSER::COLLECTION)
    ("ZBP-89 antibody as well as DNMT1/HDAC3 antibody ( xref )"
     . SPARSER::COLLECTION)
    ("DNMT1/HDAC3" . SPARSER::COLLECTION)
    ("DNMT1, DNMT3a, DNMT3b, HDAC1, HDAC3 and HDAC4" . SPARSER::COLLECTION)
    ("HDAC and DNA" . SPARSER::COLLECTION)
    ("GATA-1 and/or FOG-1" . SPARSER::COLLECTION)
    ("deacetylases (HDAC)" . SPARSER::PROTEIN)
    ("p16 and vimentin" . SPARSER::COLLECTION)
    ("a pro-apoptotic protein" . SPARSER::PROTEIN)
    ("ZBP-89 and the enzyme inhibitors" . SPARSER::COLLECTION)
    ("ZBP-89 or inhibitors" . SPARSER::COLLECTION)
    ("HDAC and DNMT" . SPARSER::COLLECTION) ("DNMT" . SPARSER::PROTEIN)
    ("DNMT1 and HDAC3" . SPARSER::COLLECTION) ("waf1" . SPARSER::PROTEIN)
    ("Valproic acid" . SPARSER::MOLECULE)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("DNMT3b" . SPARSER::PROTEIN) ("DNMT3a" . SPARSER::PROTEIN)
    ("HDAC4" . SPARSER::PROTEIN) ("MeCP2" . SPARSER::PROTEIN)
    ("FOG-1" . SPARSER::PROTEIN) ("GATA-1" . SPARSER::PROTEIN)
    ("methyl-CpG-binding protein 2" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("ZBP-89" . SPARSER::PROTEIN)
    ("dosage-sensitive co-regulated genes" . SPARSER::GENE)
    ("specific pro-apoptotic genes" . SPARSER::GENE)
    ("polymerases and enzymes" . SPARSER::COLLECTION)
    ("dNTPs" . SPARSER::MOLECULE) ("Rex" . SPARSER::PROTEIN)
    ("an essential gene" . SPARSER::GENE)
    ("E2F6 or E2F6" . SPARSER::COLLECTION)
    ("anti-gamma-H2AX" . SPARSER::COLLECTION)
    ("the checkpoint-insensitive E2F6 12/52 mutant" . SPARSER::MUTANT)
    ("E2F-regulated promoters and expression of E2F genes following HU treatment in synchronized cells expressing either ectopic wild-type E2F6"
     . SPARSER::COLLECTION)
    ("either ectopic wild-type E2F6" . SPARSER::PROTEIN-FAMILY)
    ("a phospho-Ser12-specific antibody" . SPARSER::ANTIBODY)
    ("E2F6 and E2F1" . SPARSER::COLLECTION)
    ("E2F6 or control siRNA" . SPARSER::COLLECTION)
    ("E2F6’s" . SPARSER::PROTEIN-FAMILY)
    ("RNA and protein" . SPARSER::COLLECTION)
    ("a representative activator E2F" . SPARSER::PROTEIN-FAMILY)
    ("Chemical" . SPARSER::MOLECULE)
    ("Cyclin E and E2F1" . SPARSER::COLLECTION)
    ("cyclin E, RRM2 and CDC6" . SPARSER::COLLECTION)
    ("camptothecin (CPT)" . SPARSER::DRUG) ("gamma-H2AX" . SPARSER::COLLECTION)
    ("CPT" . SPARSER::PROTEIN)
    ("the checkpoint protein kinase ATR and its downstream target Chk1"
     . SPARSER::COLLECTION)
    ("HU" . SPARSER::DRUG) ("hydroxyurea" . SPARSER::DRUG)
    ("DNA damage-inducible genes" . SPARSER::GENE)
    ("ATR and the downstream checkpoint protein kinase Chk1"
     . SPARSER::COLLECTION)
    ("ATM and Chk2" . SPARSER::COLLECTION)
    ("Chk1 and Chk2" . SPARSER::COLLECTION) ("ATM/ATR" . SPARSER::COLLECTION)
    ("ATR and Chk1" . SPARSER::COLLECTION) ("caspase 3" . SPARSER::PROTEIN)
    ("De-" . SPARSER::MOLECULE) ("UCN01" . SPARSER::DRUG)
    ("RRM2" . SPARSER::PROTEIN) ("ribonucleotide reductase" . SPARSER::PROTEIN)
    ("p130" . SPARSER::PROTEIN) ("p107" . SPARSER::PROTEIN)
    ("Rad51" . SPARSER::PROTEIN) ("Chk2" . SPARSER::PROTEIN)
    ("MEGF10 and helps form" . SPARSER::COLLECTION)
    ("proliferating myoblasts" . SPARSER::PROTEIN)
    ("MEGF11 (Y944) and MEGF12/PEAR1/Jedi-1 (Y925)" . SPARSER::COLLECTION)
    ("PY" . SPARSER::MOLECULE) ("MEGF10 and MEGF12" . SPARSER::COLLECTION)
    ("kinase-Syk" . SPARSER::COLLECTION) ("Syk" . SPARSER::PROTEIN)
    ("MEGF11 and MEGF12" . SPARSER::COLLECTION)
    ("homologues, MEGF11 and MEGF12" . SPARSER::COLLECTION)
    ("PEAR1 and Jedi-1" . SPARSER::COLLECTION) ("Jedi" . SPARSER::PROTEIN)
    ("myogenic" . SPARSER::PROTEIN) ("PEAR1" . SPARSER::PROTEIN)
    ("MEGF12" . SPARSER::PROTEIN) ("MEGF11" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN) ("c-Src" . SPARSER::PROTEIN)
    ("MEGF10" . SPARSER::PROTEIN)
    ("a much larger prospective cohort" . SPARSER::MOLECULE)
    ("healthy, precancerous, and cancerous states" . SPARSER::BIO-STATE)
    ("the precancerous state" . SPARSER::BIO-STATE) ("IBD" . SPARSER::PROTEIN)
    ("the major stimulant" . SPARSER::DRUG) ("stimulant" . SPARSER::DRUG)
    ("further enhanced CRT" . SPARSER::PROTEIN)
    ("E-cadherin/β-catenin" . SPARSER::COLLECTION) ("BFT" . SPARSER::PROTEIN)
    ("enterotoxin" . SPARSER::PROTEIN) ("NF kappa b2" . SPARSER::PROTEIN)
    ("a representative inflammatory gene" . SPARSER::GENE)
    ("a representative Wnt gene" . SPARSER::PROTEIN)
    ("the tumor growth genes and the inflammatory genes" . SPARSER::COLLECTION)
    ("FadA and Fn" . SPARSER::COLLECTION)
    ("Wnt or oncogenes" . SPARSER::COLLECTION)
    ("LEF/TCF" . SPARSER::COLLECTION)
    ("E-cadherin or other cellular components" . SPARSER::COLLECTION)
    ("Genistein" . SPARSER::PROTEIN) ("PTK" . SPARSER::PROTEIN)
    ("kappaB, and oncogenes" . SPARSER::COLLECTION)
    ("Myc and Cyclin D1" . SPARSER::COLLECTION)
    ("/T-cell" . SPARSER::COLLECTION) ("NF" . SPARSER::PROTEIN)
    ("LEF" . SPARSER::PROTEIN)
    ("EC5 and the inhibitory peptide ( xref )" . SPARSER::COLLECTION)
    ("peptide (ASANWTIQYND)" . SPARSER::PEPTIDE) ("EC5" . SPARSER::PROTEIN)
    ("GST-EC5" . SPARSER::PROTEIN-PAIR)
    ("NF-kappaB and cytokines" . SPARSER::COLLECTION)
    ("US1 and USF81" . SPARSER::COLLECTION)
    ("FadA and E-cadherin" . SPARSER::COLLECTION)
    ("glycoproteins" . SPARSER::PROTEIN) ("VE-cadherin" . SPARSER::COLLECTION)
    ("USF" . SPARSER::PROTEIN) ("fadA" . SPARSER::PROTEIN)
    ("DLD1" . SPARSER::PROTEIN) ("Wnt and oncogenes" . SPARSER::COLLECTION)
    ("CRC and non-CRC" . SPARSER::COLLECTION)
    ("heterogeneous filaments" . SPARSER::PROTEIN-FAMILY)
    ("pre" . SPARSER::PROTEIN) ("the secreted mature FadA" . SPARSER::PROTEIN)
    ("pre-FadA" . SPARSER::COLLECTION)
    ("anti-FadA monoclonal antibodies" . SPARSER::ANTIBODY)
    ("a potential diagnostic and therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("its unique FadA adhesin" . SPARSER::PROTEIN)
    ("adhesin" . SPARSER::PROTEIN) ("FadA" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN) ("TCF1" . SPARSER::PROTEIN)
    ("Wnt7b" . SPARSER::PROTEIN) ("NF-kappaB" . SPARSER::PROTEIN)
    ("E-cadherins" . SPARSER::PROTEIN) ("US1" . SPARSER::PROTEIN)
    ("CDH5" . SPARSER::PROTEIN) ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("active genes" . SPARSER::GENE) ("the SIRT1’s" . SPARSER::PROTEIN)
    ("PARP1 and SIRT1" . SPARSER::COLLECTION)
    ("ultraviolet light (UV)" . SPARSER::PROTEIN)
    ("histones and many non-histone proteins [ xref ]" . SPARSER::COLLECTION)
    ("Tdg" . SPARSER::PROTEIN) ("a chemotherapeutic drug" . SPARSER::DRUG)
    ("uracil and FU" . SPARSER::COLLECTION) ("uracil" . SPARSER::NUCLEOBASE)
    ("unacetylated TDG and Ac-TDG" . SPARSER::COLLECTION)
    ("GST-SIRT1" . SPARSER::COLLECTION) ("p300 and APE1" . SPARSER::COLLECTION)
    ("TDG and SIRT1" . SPARSER::COLLECTION)
    ("SIRT1 and SIRT6" . SPARSER::COLLECTION)
    ("TDG and p300" . SPARSER::COLLECTION)
    ("APE1 and PARP1" . SPARSER::COLLECTION)
    ("SIRT1/TDG" . SPARSER::COLLECTION) ("GFP-TDG" . SPARSER::COLLECTION)
    ("GST-hTDG" . SPARSER::COLLECTION) ("GST-TDG" . SPARSER::COLLECTION)
    ("CoA" . SPARSER::MOLECULE) ("Acetyl" . SPARSER::MOLECULE)
    ("formamide" . SPARSER::DRUG) ("NaOH" . SPARSER::MOLECULE)
    ("NAD + and SIRT1" . SPARSER::COLLECTION) ("DTT" . SPARSER::MOLECULE)
    ("mismatch and 28-mer" . SPARSER::COLLECTION)
    ("mismatch" . SPARSER::PROTEIN) ("mer" . SPARSER::PROTEIN)
    ("FLA" . SPARSER::PROTEIN) ("coupling solution" . SPARSER::MOLECULE)
    ("carbonate" . SPARSER::MOLECULE) ("runs" . SPARSER::PROTEIN-FAMILY)
    ("anti-rabbit or anti-mouse HRP-conjugated secondary antibody"
     . SPARSER::ANTIBODY)
    ("HRP" . SPARSER::PROTEIN) ("secondary antibodies" . SPARSER::ANTIBODY)
    ("polyacrylamide" . SPARSER::DRUG) ("bromophenol" . SPARSER::MOLECULE)
    ("glycerol" . SPARSER::PROTEIN) ("SDS" . SPARSER::PROTEIN)
    ("15% fetal bovine serum and 1" . SPARSER::PROTEIN)
    ("Sirt1  +/+ (Wild type, WT) and sirt1  −/− (knockout, KO) mouse embryonic fibroblast (MEF) cells"
     . SPARSER::COLLECTION)
    ("sirt1" . SPARSER::PROTEIN)
    ("10% fetal bovine serum and 1" . SPARSER::PROTEIN)
    ("Streptomycin" . SPARSER::DRUG) ("FLAG-SIRT1" . SPARSER::COLLECTION)
    ("Aldrich" . SPARSER::PROTEIN) ("NT" . SPARSER::PROTEIN)
    ("Ac" . SPARSER::PROTEIN) ("NaCl" . SPARSER::PROTEIN)
    ("PBS" . SPARSER::PROTEIN) ("coupled matrices" . SPARSER::PROTEIN-FAMILY)
    ("ethanolamine" . SPARSER::DRUG) ("sepharose" . SPARSER::MOLECULE)
    ("antisera" . SPARSER::PROTEIN) ("Sigma-Aldrich" . SPARSER::COLLECTION)
    ("Sigma" . SPARSER::PROTEIN)
    ("Reagents and antibodies" . SPARSER::COLLECTION)
    ("Reagents" . SPARSER::MOLECULE)
    ("a tumor promoter or a tumor suppressor in different tissue contexts [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("repetitive DNA and relocalizes" . SPARSER::COLLECTION)
    ("DNA and relocalizes" . SPARSER::COLLECTION)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("SIRT1, SIRT6, and SIRT7" . SPARSER::COLLECTION)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("histones and non-histone" . SPARSER::COLLECTION)
    ("histones" . SPARSER::PROTEIN) ("Histone" . SPARSER::PROTEIN)
    ("Ac-TDG" . SPARSER::COLLECTION)
    ("DNA-TDG-p300 ternary complex" . SPARSER::BIO-COMPLEX)
    ("developmental genes" . SPARSER::GENE) ("Tet1-3" . SPARSER::COLLECTION)
    ("Tet" . SPARSER::PROTEIN)
    ("estrogen receptors and p300/CBP histone/protein acetyltransferases (reviewed in [ xref ])"
     . SPARSER::COLLECTION)
    ("p300/CBP" . SPARSER::COLLECTION) ("mC" . SPARSER::PROTEIN)
    ("-methylguanine" . SPARSER::MOLECULE) ("MeG" . SPARSER::PROTEIN)
    ("methylguanine" . SPARSER::MOLECULE)
    ("a key multifunctional enzyme" . SPARSER::ENZYME)
    ("SIRT1 and TDG" . SPARSER::COLLECTION) ("Sirt1" . SPARSER::PROTEIN)
    ("hTDG" . SPARSER::PROTEIN) ("histone/protein" . SPARSER::COLLECTION)
    ("the predominant enzyme" . SPARSER::ENZYME)
    ("thymine" . SPARSER::NUCLEOBASE)
    ("an essential multifunctional enzyme" . SPARSER::ENZYME)
    ("DNA glycosylase (TDG)" . SPARSER::PROTEIN) ("TDG" . SPARSER::PROTEIN)
    ("Thymine" . SPARSER::NUCLEOBASE) ("9–1–1 complex" . SPARSER::|9-1-1|)
    ("EX-527" . SPARSER::DRUG) ("acetyl-coA" . SPARSER::MOLECULE)
    ("l Protein" . SPARSER::PROTEIN) ("hSIRT1" . SPARSER::PROTEIN)
    ("SIRT7" . SPARSER::PROTEIN) ("SIRT6" . SPARSER::PROTEIN)
    ("Rad9-Rad1-Hus1" . SPARSER::PROTEIN) ("Hus1" . SPARSER::PROTEIN)
    ("Tet1" . SPARSER::PROTEIN) ("retinoic acid" . SPARSER::MOLECULE)
    ("APE1" . SPARSER::PROTEIN) ("DNA glycosylase" . SPARSER::PROTEIN)
    ("hope" . SPARSER::PROTEIN) ("No prognostic impact" . SPARSER::PROTEIN)
    ("UGT2B15 A allele" . SPARSER::ALLELE) ("ER-protein" . SPARSER::COLLECTION)
    ("CGH" . SPARSER::PROTEIN) ("CISH" . SPARSER::PROTEIN)
    ("a negative prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stronger prognostic impact" . SPARSER::PROTEIN)
    ("the polymorphic (variant) alleles" . SPARSER::ALLELE)
    ("gen" . SPARSER::PROTEIN) ("1.91 and 1.93" . SPARSER::PROTEIN)
    ("ESR1 and APP" . SPARSER::COLLECTION)
    ("UGT2B15 *2 allele [ xref ] and CYP2C19 *2 allele [ xref ]"
     . SPARSER::COLLECTION)
    ("its active metabolites [ xref ] and certain polymorphisms"
     . SPARSER::COLLECTION)
    ("a well-established predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wt/wt and UGT2B15" . SPARSER::COLLECTION)
    ("wt/wt or wt/*2" . SPARSER::COLLECTION)
    ("at least one UGT2B15 wt allele" . SPARSER::ALLELE)
    ("clinico-pathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gene and genes" . SPARSER::COLLECTION)
    ("its prognostic impact" . SPARSER::PROTEIN) ("G-3" . SPARSER::PROTEIN)
    ("CA-3" . SPARSER::PROTEIN) ("polypeptide B15" . SPARSER::PROTEIN)
    ("UDP glucuronosyltransferase 2 family" . SPARSER::PROTEIN)
    ("wt/wt" . SPARSER::PROTEIN) ("UGT2B15" . SPARSER::PROTEIN)
    ("CYP2" . SPARSER::PROTEIN) ("the two larger cohorts" . SPARSER::MOLECULE)
    ("our largest cohort" . SPARSER::MOLECULE)
    ("at least part" . SPARSER::COMPONENT)
    ("tau and/or β-catenin" . SPARSER::COLLECTION)
    ("the minor A allele" . SPARSER::ALLELE)
    ("right inferior temporal gyrus" . SPARSER::PROTEIN)
    ("gyrus" . SPARSER::PROTEIN)
    ("the fix or random effects form" . SPARSER::COLLECTION)
    ("fix" . SPARSER::PROTEIN)
    ("Neither MAPT nor GSK3B rs334558" . SPARSER::COLLECTION)
    ("MAS" . SPARSER::PROTEIN) ("the A allele" . SPARSER::ALLELE)
    ("Oct-1 and Pbx-1" . SPARSER::COLLECTION)
    ("Given GSK-3β’s" . SPARSER::PROTEIN)
    ("an excellent candidate gene" . SPARSER::PROTEIN)
    ("Given GSK-3β" . SPARSER::PROTEIN) ("GM" . SPARSER::PROTEIN)
    ("GSK3B and MAPT" . SPARSER::COLLECTION)
    ("tau and β-catenin" . SPARSER::COLLECTION)
    ("Octamer transcription factor 1 (Oct-1) and Pre-B-cell leukemia transcription factor 1 (Pbx-1)"
     . SPARSER::COLLECTION)
    ("Pbx" . SPARSER::PROTEIN-FAMILY)
    ("MAPT and two functional promoter polymorphisms" . SPARSER::COLLECTION)
    ("gene ( MAPT )" . SPARSER::PROTEIN) ("MAPT" . SPARSER::PROTEIN)
    ("T-G" . SPARSER::PROTEIN) ("POU2F1" . SPARSER::PROTEIN)
    ("Glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("Microtubule-associated protein tau" . SPARSER::PROTEIN)
    ("Pre-B-cell leukemia transcription factor 1" . SPARSER::PROTEIN)
    ("Oct-1" . SPARSER::PROTEIN) ("transcription factor 1" . SPARSER::PROTEIN)
    ("GSK3B" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("microtubule-associated protein tau" . SPARSER::PROTEIN)
    ("caveolin" . SPARSER::PROTEIN)
    ("Ephrin A1, EphA2, EphB3 and EphB4" . SPARSER::COLLECTION)
    ("receptor and ephrin" . SPARSER::COLLECTION)
    ("receptors and ephrins" . SPARSER::COLLECTION) ("eph" . SPARSER::PROTEIN)
    ("exogenous bFGF and its neutralizing antibody" . SPARSER::COLLECTION)
    ("exogenous bFGF" . SPARSER::PROTEIN)
    ("PDGF, FGF and PlGF" . SPARSER::COLLECTION)
    ("an indirect target" . SPARSER::TARGET-PROTEIN)
    ("oxygen and nutrient" . SPARSER::COLLECTION)
    ("nonclassical receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a soluble activating form" . SPARSER::FORM)
    ("ephrin-A1" . SPARSER::PROTEIN)
    ("its main ligand ephrin-A1" . SPARSER::PROTEIN-FAMILY)
    ("factor or factors" . SPARSER::COLLECTION)
    ("media (CM)" . SPARSER::PROTEIN) ("CM" . SPARSER::PROTEIN)
    ("ephrin" . SPARSER::PROTEIN)
    ("at least 16 receptors and 9 ligands" . SPARSER::COLLECTION)
    ("at least 16 receptors" . SPARSER::RECEPTOR)
    ("insulin-like growth factor (IGF)" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor (VEGF)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("placental growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("derived growth factor (PDGF)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("These angiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PlGF" . SPARSER::PROTEIN)
    ("soluble angiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("local hypoxia" . SPARSER::PROTEIN)
    ("a metastasis-associated gene that is a transcriptional target of EWS/FLI1 as well as an important determinant"
     . SPARSER::COLLECTION)
    ("a metastasis-associated gene" . SPARSER::GENE)
    ("EWS/FLI1" . SPARSER::COLLECTION)
    ("a dominant-negative form" . SPARSER::FORM)
    ("EphA2 and CAV1" . SPARSER::COLLECTION) ("MVD" . SPARSER::PROTEIN)
    ("EphA2" . SPARSER::PROTEIN) ("EphA" . SPARSER::PROTEIN-FAMILY)
    ("EWS" . SPARSER::PROTEIN)
    ("Eph receptor tyrosine kinases and their membrane-anchored ligands"
     . SPARSER::COLLECTION)
    ("the largest receptor tyrosine kinase (RTK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ephrins" . SPARSER::PROTEIN)
    ("pro- and anti-angiogenic" . SPARSER::COLLECTION)
    ("PDGF-A" . SPARSER::PROTEIN) ("β-Actin" . SPARSER::PROTEIN)
    ("Ephrin-A" . SPARSER::PROTEIN-FAMILY) ("PECAM-1" . SPARSER::PROTEIN)
    ("Platelet Endothelial Cell Adhesion Molecule" . SPARSER::PROTEIN)
    ("g protein" . SPARSER::PROTEIN) ("ephrinA1" . SPARSER::PROTEIN)
    ("RH1" . SPARSER::PROTEIN) ("EphB4" . SPARSER::PROTEIN)
    ("EphB3" . SPARSER::PROTEIN) ("Ephrin A1" . SPARSER::PROTEIN)
    ("ephrin-A" . SPARSER::PROTEIN-FAMILY)
    ("neuronal migration" . SPARSER::PROTEIN) ("FLI1" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN) ("CAV1" . SPARSER::PROTEIN)
    ("MRLC and these 2 proteins (data not shown)" . SPARSER::COLLECTION)
    ("INCENP and MKLP2" . SPARSER::COLLECTION)
    ("2P-MRLC/Aurora" . SPARSER::COLLECTION)
    ("DAPK3/Dlk" . SPARSER::COLLECTION) ("Dlk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Clustal Omega" . SPARSER::PROTEIN) ("EMBL-EBI" . SPARSER::COLLECTION)
    ("EBI" . SPARSER::PROTEIN) ("Omega" . SPARSER::PROTEIN)
    ("RhoA and/or Rho-dependent kinases" . SPARSER::COLLECTION)
    ("ECT2-" . SPARSER::PROTEIN) ("MHC and F-actin" . SPARSER::COLLECTION)
    ("1P-MRLC and F-actin" . SPARSER::COLLECTION)
    ("GST-Aurora" . SPARSER::COLLECTION) ("-MRLC" . SPARSER::COLLECTION)
    ("INCENP and survivin" . SPARSER::COLLECTION)
    ("hesperadin" . SPARSER::DRUG) ("INCENP" . SPARSER::PROTEIN)
    ("the Rho-kinase inhibitor Y-27632 or the MLCK inhibitor ML-7"
     . SPARSER::COLLECTION)
    ("Rho or MLCK" . SPARSER::COLLECTION) ("MgcRacGAP-" . SPARSER::PROTEIN)
    ("proteins and RhoA" . SPARSER::COLLECTION)
    ("MKLP1 and MgcRacGAP" . SPARSER::COLLECTION)
    ("Rho kinase and citron" . SPARSER::COLLECTION)
    ("citron" . SPARSER::PROTEIN)
    ("MKLP1, MgcRacGAP, and ECT2" . SPARSER::COLLECTION)
    ("anti-2P-MRLC" . SPARSER::COLLECTION)
    ("Anti-2P-MRLC" . SPARSER::COLLECTION)
    ("centralspindlin" . SPARSER::PROTEIN)
    ("a mitotic kinase" . SPARSER::KINASE)
    ("and 2 regulatory light" . SPARSER::PROTEIN)
    ("2 essential light" . SPARSER::PROTEIN)
    ("filamentous myosin II" . SPARSER::PROTEIN) ("held" . SPARSER::PROTEIN)
    ("Rho/MLCK" . SPARSER::COLLECTION) ("Aurora" . SPARSER::PROTEIN)
    ("MKLP1, MgcRacGAP, or ECT2" . SPARSER::COLLECTION)
    ("MgcRacGAP" . SPARSER::PROTEIN) ("2P" . SPARSER::PROTEIN)
    ("2P-MRLC" . SPARSER::COLLECTION) ("MRLC" . SPARSER::PROTEIN)
    ("MRLC2" . SPARSER::PROTEIN) ("calyculin A" . SPARSER::MOLECULE)
    ("MKLP2" . SPARSER::PROTEIN) ("DAPK3" . SPARSER::PROTEIN)
    ("inner centromere protein" . SPARSER::PROTEIN)
    ("ML-7" . SPARSER::MOLECULE) ("Monoclonal Antibody" . SPARSER::DRUG)
    ("Rho guanine nucleotide exchange factor" . SPARSER::PROTEIN)
    ("kinesin-6" . SPARSER::PROTEIN)
    ("mitotic kinesin-like protein 1" . SPARSER::PROTEIN)
    ("myosin heavy chains" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ECT2" . SPARSER::PROTEIN) ("MKLP1" . SPARSER::PROTEIN)
    ("myosin II heavy chain" . SPARSER::PROTEIN)
    ("ATPase activity" . SPARSER::PROTEIN)
    ("αvβ3 and αvβ5" . SPARSER::COLLECTION) ("cilengitide" . SPARSER::DRUG)
    ("the particular integrin" . SPARSER::PROTEIN)
    ("Specific antibodies or small molecule inhibitors" . SPARSER::COLLECTION)
    ("cisplatin and gefitinib" . SPARSER::COLLECTION)
    ("integrins and EGFR" . SPARSER::COLLECTION)
    ("EGFR- and integrin" . SPARSER::COLLECTION)
    ("collagen and collagenase" . SPARSER::COLLECTION)
    ("collagenase" . SPARSER::PROTEIN)
    ("a human lung tumor-associated antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a fibrillar collagen matrix" . SPARSER::PROTEIN-FAMILY)
    ("EGFR and integrin" . SPARSER::COLLECTION)
    ("Akt and Erk1/2" . SPARSER::COLLECTION)
    ("Erk1/2 and PI3K" . SPARSER::COLLECTION)
    ("Erk1/2 and Akt" . SPARSER::COLLECTION)
    ("MEK/Erk1/2" . SPARSER::COLLECTION) ("BHA" . SPARSER::MOLECULE)
    ("α1β1 and α2β1" . SPARSER::COLLECTION)
    ("type I and fibronectin" . SPARSER::COLLECTION)
    ("α1β1, α2β1, α4β1, and α5β1" . SPARSER::COLLECTION)
    ("cell surface-adhesive receptors" . SPARSER::PROTEIN)
    ("Integrins" . SPARSER::PROTEIN)
    ("Collagen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Elongation" . SPARSER::PROTEIN)
    ("only phosphoinositide 3-kinase (PI3K)/Akt" . SPARSER::COLLECTION)
    ("kinase (FAK)" . SPARSER::KINASE) ("Integrin" . SPARSER::PROTEIN)
    ("integrins and growth factor receptors" . SPARSER::COLLECTION)
    ("integrins" . SPARSER::PROTEIN) ("αvβ5" . SPARSER::PROTEIN)
    ("α1β1" . SPARSER::PROTEIN) ("a 3D" . SPARSER::PROTEIN)
    ("p-p38" . SPARSER::PROTEIN) ("IGFR1" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("α5β1" . SPARSER::PROTEIN) ("αvβ3" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase-1" . SPARSER::PROTEIN)
    ("PD168393" . SPARSER::DRUG)
    ("EML4-ALK fusion gene and the variant" . SPARSER::COLLECTION)
    ("ALK and EGFR" . SPARSER::COLLECTION)
    ("Recently EML4-ALK variants" . SPARSER::VARIANT)
    ("Variant" . SPARSER::VARIANT) ("ALK or KRAS" . SPARSER::COLLECTION)
    ("ADC" . SPARSER::PROTEIN)
    ("reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("the Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("Crizotinib" . SPARSER::DRUG) ("ALK-TKI" . SPARSER::COLLECTION)
    ("TFG-ALK" . SPARSER::COLLECTION) ("KLC1-ALK" . SPARSER::COLLECTION)
    ("KIF5B-ALK" . SPARSER::COLLECTION) ("TFG" . SPARSER::PROTEIN)
    ("Nucleophosmin" . SPARSER::PROTEIN)
    ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("-tyrosine kinase" . SPARSER::COLLECTION)
    ("EML4-ALK fusion gene and their variant" . SPARSER::COLLECTION)
    ("Reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("Recently Echinoderm microtubule-associated protein-like 4- anaplastic lymphoma kinase ( EML4-ALK ) fusion gene"
     . SPARSER::PROTEIN)
    ("EGFR–TKI" . SPARSER::PROTEIN) ("KLC1" . SPARSER::PROTEIN)
    ("KIF5B" . SPARSER::PROTEIN) ("phosphoproteins" . SPARSER::PROTEIN)
    ("GALT" . SPARSER::PROTEIN) ("intestinal mDCs" . SPARSER::PROTEIN)
    ("pDCs or BDCA3+" . SPARSER::COLLECTION)
    ("IL-6 and IFN-α" . SPARSER::COLLECTION)
    ("The elevated systemic IL-6" . SPARSER::PROTEIN)
    ("IL-6 and pDCs" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("pDCs and CD1c+" . SPARSER::COLLECTION)
    ("blood-derived DCs" . SPARSER::PROTEIN)
    ("ICOS ligand, IDO, and programmed cell death 1 ligand 1"
     . SPARSER::COLLECTION)
    ("IDO" . SPARSER::PROTEIN) ("exogenous IL-6" . SPARSER::PROTEIN)
    ("pDC-growth factor" . SPARSER::COLLECTION)
    ("the respective cytokines" . SPARSER::PROTEIN)
    ("hyporesponsive IL-6-" . SPARSER::PROTEIN)
    ("IL-6 or IFN-α" . SPARSER::COLLECTION) ("INF" . SPARSER::PROTEIN)
    ("pDCs (4.01 vs. 5.74, P  = 0.006, xref ) and mDCs" . SPARSER::COLLECTION)
    ("both pDCs (1.92 vs. 2.44, P = 0.013, xref ) and mDCs (1.71 vs. 2.13, P  = 0.048, xref )"
     . SPARSER::COLLECTION)
    ("IL-10 and IFN-α" . SPARSER::COLLECTION)
    ("the elevated systemic IL-6" . SPARSER::PROTEIN)
    ("IFN-γ, IFN-α, IL-10, and IL-22" . SPARSER::COLLECTION)
    ("HLA-DR or CD86" . SPARSER::COLLECTION)
    ("CD86 or CD40" . SPARSER::COLLECTION) ("SES" . SPARSER::PROTEIN)
    ("IL-6-treated pDCs" . SPARSER::PROTEIN)
    ("IL-4 and IL-10" . SPARSER::COLLECTION)
    ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("blood-derived mDCs and pDCs" . SPARSER::COLLECTION)
    ("mDCs and pDCs" . SPARSER::COLLECTION) ("kinases (JAK)" . SPARSER::KINASE)
    ("Transducers and Activators" . SPARSER::COLLECTION)
    ("Activators" . SPARSER::ACTIVATOR) ("Transducers" . SPARSER::PROTEIN)
    ("MLN" . SPARSER::PROTEIN)
    ("myeloid (mDCs) and plasmacytoid DCs (pDCs)" . SPARSER::COLLECTION)
    ("healthy donor pDCs" . SPARSER::PROTEIN) ("pDC" . SPARSER::PROTEIN)
    ("pDCs and BDCA3+" . SPARSER::COLLECTION) ("mDCs" . SPARSER::PROTEIN)
    ("IL-6-" . SPARSER::PROTEIN) ("pDCs" . SPARSER::PROTEIN)
    ("CD-" . SPARSER::PROTEIN)
    ("programmed cell death 1 ligand 1" . SPARSER::PROTEIN)
    ("ICOS ligand" . SPARSER::PROTEIN) ("IL-6Rα" . SPARSER::PROTEIN)
    ("IL-22" . SPARSER::PROTEIN) ("IL-17A" . SPARSER::PROTEIN)
    ("CD80" . SPARSER::PROTEIN) ("CD86" . SPARSER::PROTEIN)
    ("HLA-DR" . SPARSER::PROTEIN) ("FLT3 ligand" . SPARSER::PROTEIN)
    ("PD-L1" . SPARSER::PROTEIN) ("FOXP3" . SPARSER::PROTEIN)
    ("type B" . SPARSER::PROTEIN) ("CD123" . SPARSER::PROTEIN)
    ("BDCA2" . SPARSER::PROTEIN) ("cytokine receptor" . SPARSER::PROTEIN)
    ("JAK-STAT" . SPARSER::PROTEIN) ("CD1c" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN)
    ("a PTEN suppressor and an Akt enhancer" . SPARSER::COLLECTION)
    ("ROS-Src" . SPARSER::COLLECTION)
    ("proteins and enzymes" . SPARSER::COLLECTION)
    ("oxidase and cytochromes" . SPARSER::COLLECTION)
    ("flavins" . SPARSER::MOLECULE) ("porphyrins" . SPARSER::MOLECULE)
    ("cytochromes c oxidase (red and near-infrared light region), NADH-dehydrogenase (blue spectral region), and cytochromes b"
     . SPARSER::COLLECTION)
    ("NADH" . SPARSER::MOLECULE) ("oxidase" . SPARSER::PROTEIN)
    ("GSI, and 186±8%" . SPARSER::COLLECTION) ("platelets" . SPARSER::PROTEIN)
    ("other novel drugs or treatments" . SPARSER::COLLECTION)
    ("GSIs" . SPARSER::PROTEIN) ("PTEN and Aβ" . SPARSER::COLLECTION)
    ("p-PTEN" . SPARSER::COLLECTION) ("p-Akt" . SPARSER::COLLECTION)
    ("inhibitor (GSI)" . SPARSER::INHIBITOR) ("GSI" . SPARSER::PROTEIN)
    ("Phosphatase and Tensin homolog" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("Amyloid beta" . SPARSER::PROTEIN) ("amyloid beta" . SPARSER::PROTEIN)
    ("γ-secretase" . SPARSER::PROTEIN) ("the unique miR" . SPARSER::MICRO-RNA)
    ("at least 200 miRs" . SPARSER::MICRO-RNA)
    ("functional exportin-5" . SPARSER::PROTEIN) ("Cdk4/6" . SPARSER::PROTEIN)
    ("Rb" . SPARSER::PROTEIN) ("CDK6 and miR-105" . SPARSER::COLLECTION)
    ("ST" . SPARSER::PROTEIN) ("relevant mRNA" . SPARSER::RNA)
    ("both PC3 ( xref ) and DU145 ( xref )" . SPARSER::COLLECTION)
    ("PC3 or DU145" . SPARSER::COLLECTION) ("agarose" . SPARSER::MOLECULE)
    ("cel" . SPARSER::PROTEIN) ("Hsa" . SPARSER::PROTEIN)
    ("expressed miRNA" . SPARSER::MICRO-RNA) ("chip" . SPARSER::PROTEIN)
    ("Drosha/DGCR8" . SPARSER::COLLECTION) ("Drosha" . SPARSER::PROTEIN)
    ("miRs" . SPARSER::MICRO-RNA) ("K-Ras and cyclinD1" . SPARSER::COLLECTION)
    ("the mature miR" . SPARSER::MICRO-RNA)
    ("the mature miRNA" . SPARSER::MICRO-RNA)
    ("Mature miRNA" . SPARSER::MICRO-RNA)
    ("Argonaute" . SPARSER::PROTEIN-FAMILY) ("Micro(mi) RNAs" . SPARSER::RNA)
    ("a novel therapeutically relevant cellular target"
     . SPARSER::TARGET-PROTEIN)
    ("micro (mi)RNA" . SPARSER::RNA) ("Exportin-5" . SPARSER::PROTEIN)
    ("exportin-5" . SPARSER::PROTEIN)
    ("promyelocytic leukemia" . SPARSER::PROTEIN) ("Panc1" . SPARSER::PROTEIN)
    ("ddH 2" . SPARSER::PROTEIN) ("FL2" . SPARSER::PROTEIN)
    ("DGCR8" . SPARSER::PROTEIN)
    ("successful Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRAF6 (Tumor necrosis factor receptor-associated factor 6) and DFFB (DNA fragmentation factor subunit beta)"
     . SPARSER::COLLECTION)
    ("pro-apoptotic gene BAX (Bcl-2 associated X), PDCD7 (Programmed cell death protein), TRAF6 (Tumor necrosis factor receptor-associated factor 6) and DFFB (DNA fragmentation factor subunit beta)"
     . SPARSER::COLLECTION)
    ("pro-apoptotic gene BAX" . SPARSER::PROTEIN)
    ("Rabl3 and myotilin" . SPARSER::COLLECTION)
    ("Myotilin" . SPARSER::PROTEIN) ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAK2 and MLCK" . SPARSER::COLLECTION) ("kinase (MLCK)" . SPARSER::KINASE)
    ("actin-myosin II" . SPARSER::COLLECTION) ("MLCK" . SPARSER::PROTEIN)
    ("MLC" . SPARSER::PROTEIN) ("PAK" . SPARSER::PROTEIN)
    ("CADM1, Ephrin and Arp2/3" . SPARSER::COLLECTION)
    ("Ephrin" . SPARSER::PROTEIN) ("Rac1 and cdc42" . SPARSER::COLLECTION)
    ("full length Tiam1 and C1199 Tiam1" . SPARSER::COLLECTION)
    ("two normal retina" . SPARSER::DRUG)
    ("DNA fragmentation factor (DFFB)" . SPARSER::PROTEIN)
    ("apoptotic genes- Homo sapiens BCL2-associated X protein (BAX)"
     . SPARSER::PROTEIN)
    ("protein (BAX)" . SPARSER::PROTEIN) ("BAX" . SPARSER::PROTEIN)
    ("Homo sapiens CD2-associated protein" . SPARSER::PROTEIN)
    ("genes-" . SPARSER::GENE) ("PDGFA" . SPARSER::PROTEIN)
    ("MYLK" . SPARSER::PROTEIN) ("MYOT" . SPARSER::PROTEIN)
    ("myotilin" . SPARSER::PROTEIN)
    ("The significantly de-regulated genes" . SPARSER::GENE)
    ("KDa" . SPARSER::PROTEIN) ("the normal retina" . SPARSER::DRUG)
    ("normal cadaveric human retina" . SPARSER::DRUG)
    ("retina" . SPARSER::DRUG)
    ("E-Cadherin and N-Cadherin" . SPARSER::COLLECTION)
    ("Rho, Rac, Cdc42 and Tiam1" . SPARSER::COLLECTION)
    ("DHR" . SPARSER::PROTEIN) ("PSD-95/DlgA/ZO-1" . SPARSER::COLLECTION)
    ("RhoA, Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factor (GEF)" . SPARSER::GEF)
    ("International Retinoblastoma" . SPARSER::PROTEIN)
    ("Retinoblastoma" . SPARSER::PROTEIN)
    ("tumorogenic potential targets" . SPARSER::TARGET-PROTEIN)
    ("Rb1" . SPARSER::PROTEIN)
    ("DNA fragmentation factor subunit beta" . SPARSER::PROTEIN)
    ("Tumor necrosis factor receptor" . SPARSER::PROTEIN)
    ("Rabl3" . SPARSER::PROTEIN)
    ("Microtubule-associated protein 1B" . SPARSER::PROTEIN)
    ("CADM1" . SPARSER::PROTEIN) ("cdc42" . SPARSER::PROTEIN)
    ("CALPAIN7" . SPARSER::PROTEIN) ("MLCK2" . SPARSER::PROTEIN)
    ("CDH15" . SPARSER::PROTEIN) ("cadherin 15" . SPARSER::PROTEIN)
    ("CLDN6" . SPARSER::PROTEIN) ("claudin 6" . SPARSER::PROTEIN)
    ("TPRG1L" . SPARSER::PROTEIN) ("tumor protein p63" . SPARSER::PROTEIN)
    ("ST7" . SPARSER::PROTEIN)
    ("suppression of tumorigenicity 7" . SPARSER::PROTEIN)
    ("ST5" . SPARSER::PROTEIN)
    ("suppression of tumorigenicity 5" . SPARSER::PROTEIN)
    ("COL7A1" . SPARSER::PROTEIN) ("alpha 1" . SPARSER::PROTEIN)
    ("type VII" . SPARSER::PROTEIN) ("MAP3K4" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase kinase 4" . SPARSER::PROTEIN)
    ("cAMP responsive element binding protein 1" . SPARSER::PROTEIN)
    ("ABCD1" . SPARSER::PROTEIN) ("sub-family D member 1" . SPARSER::PROTEIN)
    ("ABCG4" . SPARSER::PROTEIN) ("sub-family G member 4" . SPARSER::PROTEIN)
    ("ATP-binding cassette" . SPARSER::PROTEIN) ("RASGRP2" . SPARSER::PROTEIN)
    ("RAS guanyl releasing protein 2" . SPARSER::PROTEIN)
    ("RND2" . SPARSER::PROTEIN) ("Rho family GTPase 2" . SPARSER::PROTEIN)
    ("BCL2L12" . SPARSER::PROTEIN)
    ("TNF receptor-associated factor 6" . SPARSER::PROTEIN)
    ("DNA fragmentation factor" . SPARSER::PROTEIN)
    ("PDCD7" . SPARSER::PROTEIN) ("programmed cell death 7" . SPARSER::PROTEIN)
    ("CAPN7" . SPARSER::PROTEIN) ("calpain 7" . SPARSER::PROTEIN)
    ("GAB1" . SPARSER::PROTEIN) ("MMP28" . SPARSER::PROTEIN)
    ("matrix metallopeptidase 28" . SPARSER::PROTEIN)
    ("MMP27" . SPARSER::PROTEIN)
    ("matrix metallopeptidase 27" . SPARSER::PROTEIN)
    ("CRTC1" . SPARSER::PROTEIN)
    ("CREB regulated transcription coactivator 1" . SPARSER::PROTEIN)
    ("CTBP2" . SPARSER::PROTEIN)
    ("myosin light chain kinase" . SPARSER::PROTEIN)
    ("TUBD1" . SPARSER::PROTEIN) ("delta 1" . SPARSER::PROTEIN)
    ("MAP1B" . SPARSER::PROTEIN) ("FGF16" . SPARSER::PROTEIN)
    ("fibroblast growth factor 16" . SPARSER::PROTEIN)
    ("CD2AP" . SPARSER::PROTEIN) ("CD2" . SPARSER::PROTEIN)
    ("CDC42BPG" . SPARSER::PROTEIN)
    ("CDC42 binding protein kinase gamma" . SPARSER::PROTEIN)
    ("RABL3" . SPARSER::PROTEIN) ("RAB14" . SPARSER::PROTEIN)
    ("RAB3D" . SPARSER::PROTEIN) ("RHOT2" . SPARSER::PROTEIN)
    ("RAP2A" . SPARSER::PROTEIN) ("RAB8" . SPARSER::PROTEIN)
    ("β-2" . SPARSER::PROTEIN)
    ("3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("β2M" . SPARSER::PROTEIN) ("Tiam1" . SPARSER::PROTEIN)
    ("SNAIs" . SPARSER::PROTEIN-FAMILY)
    ("MEK-induced EMT-associated gene" . SPARSER::GENE)
    ("TWIST1, SNAI1 and SNAI2" . SPARSER::COLLECTION)
    ("enhanced EMT-associated gene" . SPARSER::GENE)
    ("MEK5/ERK5" . SPARSER::COLLECTION)
    ("fulvestrant and tamoxifen" . SPARSER::COLLECTION)
    ("ERK5 and ER-α" . SPARSER::COLLECTION) ("pERK5" . SPARSER::PROTEIN)
    ("pERK" . SPARSER::PROTEIN) ("MEK5-ERK5-shRNA" . SPARSER::COLLECTION)
    ("shRNA-ERK5" . SPARSER::COLLECTION) ("Blot" . SPARSER::PROTEIN)
    ("ER-α and PgR" . SPARSER::COLLECTION)
    ("ICI 182,780 and tamoxifen" . SPARSER::COLLECTION)
    ("fulvestrant" . SPARSER::DRUG)
    ("PgR, SDF-1, c-Myc, and Cathepsin-D" . SPARSER::COLLECTION)
    ("ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("classic estrogen responsive genes" . SPARSER::GENE)
    ("NCOA3 and GATA3" . SPARSER::COLLECTION) ("PRLR" . SPARSER::PROTEIN)
    ("FOXC2 or SNAI1" . SPARSER::COLLECTION) ("Twist" . SPARSER::PROTEIN)
    ("ZEB1, ZEB2 and SNAI2" . SPARSER::COLLECTION)
    ("vimentin, N-cadherin and FGF9" . SPARSER::COLLECTION)
    ("EMT-associated genes" . SPARSER::GENE) ("FGF-FGFR" . SPARSER::COLLECTION)
    ("Genes and Genomes" . SPARSER::COLLECTION)
    ("phopho-ERK5" . SPARSER::COLLECTION) ("MEK-ERK5" . SPARSER::COLLECTION)
    ("NF-κB and AP1" . SPARSER::COLLECTION) ("AP1" . SPARSER::PROTEIN)
    ("Sap1, c-FOS, c-MYC, and MEF2" . SPARSER::COLLECTION)
    ("Sap1" . SPARSER::PROTEIN) ("MEKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEK5 and ERK5" . SPARSER::COLLECTION)
    ("ERK1/2, JNK and p38" . SPARSER::COLLECTION)
    ("MEK5-ERK5" . SPARSER::COLLECTION) ("Endocrine" . SPARSER::PROTEIN)
    ("AP2 gamma" . SPARSER::PROTEIN) ("Cathepsin-D" . SPARSER::PROTEIN)
    ("SDF-1" . SPARSER::PROTEIN) ("prolactin receptor" . SPARSER::PROTEIN)
    ("GREB1" . SPARSER::PROTEIN) ("CXCL12" . SPARSER::PROTEIN)
    ("GATA3" . SPARSER::PROTEIN) ("NCOA3" . SPARSER::PROTEIN)
    ("Estrogen Receptor" . SPARSER::PROTEIN) ("FOXC2" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("LEF-1" . SPARSER::PROTEIN)
    ("FGF9" . SPARSER::PROTEIN) ("MAS5" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN) ("ERE2" . SPARSER::PROTEIN)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ICI 182, 780" . SPARSER::DRUG) ("4-Hydroxytamoxifen" . SPARSER::DRUG)
    ("17β-estradiol" . SPARSER::PROTEIN) ("ICI 182,780" . SPARSER::DRUG)
    ("HS 1" . SPARSER::PROTEIN) ("MEF2" . SPARSER::PROTEIN)
    ("c-FOS" . SPARSER::PROTEIN) ("ER-α" . SPARSER::PROTEIN)
    ("ER-β" . SPARSER::PROTEIN) ("ERK5" . SPARSER::PROTEIN)
    ("MEK5" . SPARSER::PROTEIN)
    ("mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K–Akt" . SPARSER::COLLECTION)
    ("phospho-Akt and total ERK1/2 and Akt" . SPARSER::COLLECTION)
    ("ERK1/2 and Akt" . SPARSER::COLLECTION)
    ("RL95-2–CON or RL95-2–NC" . SPARSER::COLLECTION)
    ("PI3K-Akt" . SPARSER::COLLECTION)
    ("Annexin-V and PI" . SPARSER::COLLECTION)
    ("RL95-2–CON and RL95-2–NC" . SPARSER::COLLECTION)
    ("IR and IR-A" . SPARSER::COLLECTION)
    ("RL95-2–CON and RL95-2–IR-A" . SPARSER::COLLECTION)
    ("RL95-2-con and RL95-2-IR-A" . SPARSER::COLLECTION)
    ("con" . SPARSER::PROTEIN) ("IR and IGF-2" . SPARSER::COLLECTION)
    ("CON" . SPARSER::PROTEIN) ("a classical IR" . SPARSER::PROTEIN)
    ("disulfide" . SPARSER::MOLECULE)
    ("the insulin-receptor-related receptor" . SPARSER::PROTEIN)
    ("insulin receptor (IR)" . SPARSER::PROTEIN) ("IGF-IR" . SPARSER::PROTEIN)
    ("IGF-1R" . SPARSER::PROTEIN) ("Insulin receptor" . SPARSER::PROTEIN)
    ("the cytoplasmic viral RNA sensor RIG-I" . SPARSER::PROTEIN)
    ("IPS-1, and RIG-I and TBK1" . SPARSER::COLLECTION)
    ("Riplet and IPS-1" . SPARSER::COLLECTION) ("C21A" . SPARSER::PROTEIN)
    ("RIG-I/Riplet" . SPARSER::COLLECTION)
    ("TRIM25 and full-length" . SPARSER::COLLECTION)
    ("RIG-I or RIG-I" . SPARSER::COLLECTION)
    ("Riplet-C21A" . SPARSER::PROTEIN-PAIR) ("Cys" . SPARSER::AMINO-ACID)
    ("TRIF" . SPARSER::PROTEIN) ("polypeptide" . SPARSER::PROTEIN)
    ("RING" . SPARSER::GENE) ("TRIM25 and IKK-ε" . SPARSER::COLLECTION)
    ("this protease's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-terminal FLAG-tagged Riplet or C-terminal HA-tagged Riplet"
     . SPARSER::COLLECTION)
    ("IFN, IP-10, and type III" . SPARSER::COLLECTION) ("IFNs" . SPARSER::DRUG)
    ("1b" . SPARSER::PROTEIN) ("viral protein" . SPARSER::PROTEIN)
    ("TBK1 as well as TRIM25" . SPARSER::COLLECTION)
    ("p-TBK1" . SPARSER::COLLECTION) ("RIG-I and TBK1" . SPARSER::COLLECTION)
    ("TBK1 or NEMO" . SPARSER::COLLECTION)
    ("RIG-I, TBK1, and IKK-ε" . SPARSER::COLLECTION)
    ("hetero-protein" . SPARSER::COLLECTION)
    ("TRIM25 and RIG-I" . SPARSER::COLLECTION)
    ("Riplet and RIG-I" . SPARSER::COLLECTION)
    ("RIG-I and Riplet" . SPARSER::COLLECTION)
    ("homo-oligomers" . SPARSER::PROTEIN)
    ("polyubiquitinated and non-ubiquitinated" . SPARSER::COLLECTION)
    ("streptavidin" . SPARSER::PROTEIN) ("RIG-I-" . SPARSER::PROTEIN)
    ("ectopically expressed Riplet" . SPARSER::PROTEIN)
    ("expressed Riplet" . SPARSER::PROTEIN)
    ("RIG-I and TRIM25" . SPARSER::COLLECTION)
    ("UTR dsRNA (a RIG-I ligand) or VSV infection" . SPARSER::COLLECTION)
    ("ectopically expressed TRIM25" . SPARSER::PROTEIN)
    ("expressed TRIM25" . SPARSER::PROTEIN)
    ("fragment or full-length" . SPARSER::COLLECTION)
    ("IFN-α2 and IFN-β" . SPARSER::COLLECTION) ("SeV" . SPARSER::PROTEIN)
    ("Chen DY and colleagues" . SPARSER::COLLECTION) ("DY" . SPARSER::MOLECULE)
    ("TBK1 and IKK-ε" . SPARSER::COLLECTION)
    ("TBK1, IKK-ε, and NEMO" . SPARSER::COLLECTION) ("NEMO" . SPARSER::PROTEIN)
    ("MAVS, Cardif, and VISA" . SPARSER::COLLECTION)
    ("VISA" . SPARSER::PROTEIN) ("Cardif" . SPARSER::PROTEIN)
    ("MAVS" . SPARSER::PROTEIN) ("dsRNA" . SPARSER::RNA)
    ("CTD and helicase" . SPARSER::COLLECTION) ("helicase" . SPARSER::PROTEIN)
    ("CTD" . SPARSER::PROTEIN) ("Repressor" . SPARSER::REPRESSOR)
    ("Caspase" . SPARSER::PROTEIN) ("Cytoplasmic viral RNA" . SPARSER::RNA)
    ("RIG-I and MDA5" . SPARSER::COLLECTION)
    ("TRIM25 and Riplet" . SPARSER::COLLECTION)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("The cytoplasmic viral RNA sensor RIG-I" . SPARSER::PROTEIN)
    ("RD" . SPARSER::PROTEIN) ("TRIM25 and TBK1" . SPARSER::COLLECTION)
    ("ubiquitin ligase and TBK1" . SPARSER::COLLECTION)
    ("Riplet and TRIM25" . SPARSER::COLLECTION) ("Riplet" . SPARSER::PROTEIN)
    ("RNF135" . SPARSER::PROTEIN) ("A11" . SPARSER::PROTEIN)
    ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("RNA polymerase" . SPARSER::PROTEIN) ("A-F" . SPARSER::PROTEIN)
    ("TRAF3" . SPARSER::PROTEIN) ("S3A" . SPARSER::PROTEIN)
    ("IP-10" . SPARSER::PROTEIN) ("NS1" . SPARSER::PROTEIN)
    ("G3BP" . SPARSER::PROTEIN) ("perinuclear region" . SPARSER::PROTEIN)
    ("p125" . SPARSER::PROTEIN) ("IFN-β" . SPARSER::PROTEIN)
    ("IFN-α2" . SPARSER::PROTEIN) ("TICAM-1" . SPARSER::PROTEIN)
    ("IRF-3" . SPARSER::PROTEIN)
    ("RNA helicase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MDA5" . SPARSER::PROTEIN) ("NS3" . SPARSER::PROTEIN)
    ("TBK1" . SPARSER::PROTEIN) ("IPS-1" . SPARSER::PROTEIN)
    ("TRIM25" . SPARSER::PROTEIN) ("RIG-I" . SPARSER::PROTEIN)
    ("YAP and its target genes" . SPARSER::COLLECTION)
    ("metastatic ILC" . SPARSER::PROTEIN) ("MRIP" . SPARSER::PROTEIN)
    ("both mILC and Trp53 ∆/" . SPARSER::COLLECTION)
    ("E-cadherin and p53" . SPARSER::COLLECTION) ("mILC" . SPARSER::PROTEIN)
    ("E-cadherin and/or p53" . SPARSER::COLLECTION)
    ("our invasive breast cancer cohort" . SPARSER::MOLECULE)
    ("odd" . SPARSER::PROTEIN) ("the histological type" . TYPE)
    ("YAP-IF" . SPARSER::COLLECTION) ("YAP1 and YAP2" . SPARSER::COLLECTION)
    ("called YAP (Yes Associated Protein) and TAZ (transcriptional coactivator with PDZ-binding motif, also known as WWTR1)"
     . SPARSER::COLLECTION)
    ("TAZ" . SPARSER::PROTEIN) ("Warts-Mats" . SPARSER::COLLECTION)
    ("Mats" . SPARSER::PROTEIN) ("Warts" . SPARSER::PROTEIN)
    ("Salvador" . SPARSER::PROTEIN) ("ILC" . SPARSER::PROTEIN)
    ("TEAD" . SPARSER::PROTEIN) ("–3 " . SPARSER::PROTEIN)
    ("TAF5" . SPARSER::PROTEIN) ("MgCL2" . SPARSER::MOLECULE)
    ("Ca2+" . SPARSER::CALCIUM-ION) ("Mg2+" . SPARSER::MOLECULE)
    ("SP3" . SPARSER::PROTEIN) ("Brca1" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE) ("α-catenin" . SPARSER::PROTEIN)
    ("αE-catenin" . SPARSER::PROTEIN) ("Lats1" . SPARSER::PROTEIN)
    ("Drosophila)" . SPARSER::PROTEIN) ("YAP2" . SPARSER::PROTEIN)
    ("WWTR1" . SPARSER::PROTEIN) ("Drosophila )" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("c-MYC and RAS" . SPARSER::COLLECTION)
    ("TWIST and ZEB1" . SPARSER::COLLECTION) ("TWIST" . SPARSER::PROTEIN)
    ("MIZ1" . SPARSER::PROTEIN) ("CDK2 and CDK4" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC3" . SPARSER::COLLECTION)
    ("ID-1 and BMI-1" . SPARSER::COLLECTION)
    ("p21, p53, caspase-3, cyclin D1, BCL-2 and BCL-xl" . SPARSER::COLLECTION)
    ("CDK/cyclin" . SPARSER::COLLECTION) ("CDK2/cyclin" . SPARSER::COLLECTION)
    ("c-MYC/RAS" . SPARSER::COLLECTION)
    ("MYC and mutant" . SPARSER::COLLECTION) ("p53-" . SPARSER::PROTEIN)
    ("AP4 or MYC" . SPARSER::COLLECTION) ("MYC or RAS" . SPARSER::COLLECTION)
    ("RAS or MYC" . SPARSER::COLLECTION) ("MYC and RAS" . SPARSER::COLLECTION)
    ("AP4 and RAS" . SPARSER::COLLECTION)
    ("MYC and RAS-expressing retroviruses" . SPARSER::COLLECTION)
    ("only AP4  +/+" . SPARSER::PROTEIN)
    ("AP4, MYC or RAS" . SPARSER::COLLECTION)
    ("at least two cooperating oncogenes" . SPARSER::ONCOGENE)
    ("MycER" . SPARSER::PROTEIN) ("c-MycER" . SPARSER::COLLECTION)
    ("p16 or p21" . SPARSER::COLLECTION) ("expressing AP4" . SPARSER::PROTEIN)
    ("a conditional AP4-ER (estrogen receptor) fusion protein"
     . SPARSER::PROTEIN)
    ("AP4-ER" . SPARSER::COLLECTION)
    ("the respective promoters" . SPARSER::PROMOTER)
    ("p15/INK4B/CDKN2B" . SPARSER::COLLECTION)
    ("p19/ARF" . SPARSER::COLLECTION) ("BrdU" . SPARSER::DRUG)
    ("bromo" . SPARSER::MOLECULE)
    ("AP4  +/− and AP4  −/− genotypes" . SPARSER::COLLECTION)
    ("htert/telomerase" . SPARSER::COLLECTION) ("WRN" . SPARSER::PROTEIN)
    ("bHLH-LZ" . SPARSER::COLLECTION) ("bHLH" . SPARSER::PROTEIN)
    ("p16 and p21" . SPARSER::COLLECTION)
    ("AP4 and mutant" . SPARSER::COLLECTION)
    ("c-MYC and mutant" . SPARSER::COLLECTION)
    ("p21 and p16" . SPARSER::COLLECTION)
    ("p16 and/or p21" . SPARSER::COLLECTION)
    ("a previously described target" . SPARSER::TARGET-PROTEIN)
    ("the c-MYC-inducible basic helix–loop–helix leucine-zipper transcription factor AP4"
     . SPARSER::PROTEIN)
    ("α -tubulin" . SPARSER::PROTEIN) ("K 4" . SPARSER::PROTEIN)
    ("K 3" . SPARSER::PROTEIN) ("X-gal" . SPARSER::MOLECULE)
    ("ZEB1" . SPARSER::PROTEIN) ("ID-1" . SPARSER::PROTEIN)
    ("BCL-2" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("4-OHT" . SPARSER::DRUG) ("CDKN2B" . SPARSER::PROTEIN)
    ("INK4B" . SPARSER::PROTEIN) ("p15" . SPARSER::PROTEIN)
    ("p19" . SPARSER::HUMAN-PROTEIN-FAMILY) ("β -gal" . SPARSER::PROTEIN)
    ("β -galactosidase" . SPARSER::PROTEIN) ("MAD2" . SPARSER::PROTEIN)
    ("c- MYC" . SPARSER::PROTEIN) ("AP4" . SPARSER::PROTEIN)
    ("c-MYC" . SPARSER::PROTEIN) ("mere" . SPARSER::PROTEIN-FAMILY)
    ("hnRNA" . SPARSER::RNA) ("hnRNP" . SPARSER::PROTEIN)
    ("a human T-cell leukaemia virus-1 accessory protein" . SPARSER::PROTEIN)
    ("myotube" . SPARSER::PROTEIN) ("MBNL1-exon" . SPARSER::COLLECTION)
    ("anti-Lyn and anti-P9" . SPARSER::COLLECTION)
    ("Lyn (570%, P< 0.02) and MBNL1" . SPARSER::COLLECTION)
    ("Ex5" . SPARSER::PROTEIN) ("Lyn and Tyr" . SPARSER::COLLECTION)
    ("GST-Lyn-SH3" . SPARSER::COLLECTION) ("MBNL1/Lyn" . SPARSER::COLLECTION)
    ("vo" . SPARSER::MOLECULE)
    ("293T cells co-overexpressing Lyn and one MBNL1 40–41–42–43 isoform"
     . SPARSER::COLLECTION)
    ("only MBNL1 43 isoform" . SPARSER::ISOFORM)
    ("the latter isoforms" . SPARSER::ISOFORM)
    ("anti-Lyn and anti-Src" . SPARSER::COLLECTION)
    ("Src and Lyn" . SPARSER::COLLECTION)
    ("peptide (KGGRSRLPLPPLPPPG)" . SPARSER::PEPTIDE)
    ("Lyn or Src" . SPARSER::COLLECTION) ("-Lyn" . SPARSER::COLLECTION)
    ("PRM" . SPARSER::PROTEIN) ("c-TNT" . SPARSER::COLLECTION)
    ("TNT" . SPARSER::PROTEIN) ("troponin" . SPARSER::PROTEIN)
    ("the ribonuclear foci" . SPARSER::PROTEIN) ("-P11" . SPARSER::COLLECTION)
    ("the MBNL1  40–41–42–43 major muscular MBNL1 isoforms" . SPARSER::ISOFORM)
    ("Ex5-MBNL1" . SPARSER::COLLECTION) ("MBNL" . SPARSER::PROTEIN)
    ("Mbnl1" . SPARSER::PROTEIN) ("Mbnl" . SPARSER::PROTEIN)
    ("MBNL1 and CUG-BP1" . SPARSER::COLLECTION)
    ("Lyn and MBNL1" . SPARSER::COLLECTION)
    ("the respective protein isoforms" . SPARSER::ISOFORM)
    ("muscleblind" . SPARSER::PROTEIN-FAMILY) ("RNA-dominant" . SPARSER::RNA)
    ("DMPK" . SPARSER::PROTEIN) ("cdc2" . SPARSER::PROTEIN)
    ("P20" . SPARSER::PROTEIN) ("M 2" . SPARSER::MOLECULE)
    ("M 1" . SPARSER::MOLECULE) ("pEF1" . SPARSER::PROTEIN)
    ("SH1" . SPARSER::PROTEIN) ("SH4" . SPARSER::PROTEIN)
    ("P11" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CUG-BP1" . SPARSER::PROTEIN)
    ("dystrophia myotonica protein kinase" . SPARSER::PROTEIN)
    ("Src-homology" . SPARSER::PROTEIN) ("MBNL1" . SPARSER::PROTEIN)
    ("pre-mRNAs" . SPARSER::RNA)
    ("the vacuolar type H(+)-ATPase" . SPARSER::COLLECTION)
    ("caspase and bafilomycin" . SPARSER::COLLECTION)
    ("-ATPase" . SPARSER::COLLECTION) ("ATPase" . SPARSER::PROTEIN)
    ("RB conditional knockout increases DNA" . SPARSER::DNA)
    ("cisplatin or camptothecin" . SPARSER::COLLECTION)
    ("DRAM" . SPARSER::PROTEIN) ("LAMP 1 and LC3" . SPARSER::COLLECTION)
    ("Electron" . SPARSER::MOLECULE) ("Neg" . SPARSER::PROTEIN)
    ("OB" . SPARSER::PROTEIN) ("refs" . SPARSER::PROTEIN)
    ("ethidium" . SPARSER::MOLECULE) ("siRNA-Neg" . SPARSER::COLLECTION)
    ("nick" . SPARSER::PROTEIN) ("dUTP" . SPARSER::MOLECULE)
    ("residual RB" . SPARSER::PROTEIN) ("siRNA-RB" . SPARSER::COLLECTION)
    ("U87 and GBM95" . SPARSER::COLLECTION) ("Type" . TYPE)
    ("VP-16 and tumor necrosis factor-" . SPARSER::COLLECTION)
    ("VP-16 and cisplatin" . SPARSER::COLLECTION)
    ("tumor necrosis factor-" . SPARSER::PROTEIN)
    ("cisplatin and VP-16" . SPARSER::COLLECTION)
    ("cisplatin and 5-fluoracil" . SPARSER::COLLECTION)
    ("a classical tumor suppressor" . SPARSER::SUPPRESSOR)
    ("RB" . SPARSER::PROTEIN) ("topoisomerase" . SPARSER::PROTEIN)
    ("Acridine orange" . SPARSER::MOLECULE)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("γ H2AX" . SPARSER::PROTEIN) ("mix 2 " . SPARSER::PROTEIN)
    ("α -Tubulin" . SPARSER::PROTEIN) ("P62" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("1A" . SPARSER::PROTEIN) ("NaHCO3" . SPARSER::DRUG)
    ("MgSO4" . SPARSER::DRUG) ("PO4" . SPARSER::PROTEIN)
    ("for 3 " . SPARSER::PROTEIN) ("VRK1" . SPARSER::PROTEIN)
    ("LAMP 1" . SPARSER::PROTEIN) ("LC-3" . SPARSER::PROTEIN)
    ("protein 1A" . SPARSER::PROTEIN) ("Beclin-1" . SPARSER::PROTEIN)
    ("γ -H2AX" . SPARSER::PROTEIN) ("SOX-2" . SPARSER::PROTEIN)
    ("OB1" . SPARSER::PROTEIN) ("U87 MG" . SPARSER::PROTEIN)
    ("TNF- α" . SPARSER::PROTEIN) ("arsenic trioxide" . SPARSER::MOLECULE)
    ("RB protein" . SPARSER::PROTEIN)
    ("Retinoblastoma protein" . SPARSER::PROTEIN) ("VP-16" . SPARSER::DRUG)
    ("CDK4/CDK6" . SPARSER::COLLECTION)
    ("angiogenic inhibitors" . SPARSER::INHIBITOR)
    ("CDK6-STAT-cyclin D" . SPARSER::COLLECTION)
    ("CDK6 and D-type" . SPARSER::COLLECTION)
    ("Cip and p27 Kip1" . SPARSER::COLLECTION)
    ("cyclin D/CDK6" . SPARSER::COLLECTION)
    ("cyclin D/CDK4" . SPARSER::COLLECTION) ("Cip" . SPARSER::PROTEIN)
    ("STAT3 and D-type" . SPARSER::COLLECTION)
    ("factors and D-type" . SPARSER::COLLECTION)
    ("the p16  INK4a and the Vegf-A promoters" . SPARSER::COLLECTION)
    ("cyclin D2 and CDK6" . SPARSER::COLLECTION)
    ("cyclin D2 and cyclin D3" . SPARSER::COLLECTION)
    ("c-JUN or STAT3" . SPARSER::COLLECTION)
    ("the proto-oncogene STAT3 and the AP-1 transcription factor c-JUN ( xref A and 7B; xref A)"
     . SPARSER::COLLECTION)
    ("STAT and AP-1" . SPARSER::COLLECTION)
    ("VEGF-A and CDK6" . SPARSER::COLLECTION)
    ("CDK6/CDK4" . SPARSER::COLLECTION) ("CDK6 and CDK4" . SPARSER::COLLECTION)
    ("pre-mRNA, mRNA, and protein" . SPARSER::COLLECTION)
    ("Vegf" . SPARSER::PROTEIN)
    ("CDK6, CDK6K43M or CDK6R31C" . SPARSER::COLLECTION)
    ("CDK6, CDK6K43M, or CDK6R31C" . SPARSER::COLLECTION)
    ("the angiogenic marker CD31" . SPARSER::PROTEIN)
    ("CDK6 protein in human and murine lymphoid cell lines side"
     . SPARSER::COLLECTION)
    ("NPM-ALK +" . SPARSER::COLLECTION) ("ALK +" . SPARSER::PROTEIN)
    ("ALK  +" . SPARSER::PROTEIN) ("NPM-ALK  +" . SPARSER::COLLECTION)
    ("CDK6-p16 INK4a" . SPARSER::COLLECTION) ("Lymphoid" . SPARSER::PROTEIN)
    ("p16 INK4a and CDK6" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("NPM-ALK" . SPARSER::COLLECTION) ("INK4a/ARF" . SPARSER::COLLECTION)
    ("/p19  ARF" . SPARSER::COLLECTION)
    ("CDK6 and p16 INK4a" . SPARSER::COLLECTION)
    ("Cdk6K43M" . SPARSER::PROTEIN) ("CDK6K43M" . SPARSER::PROTEIN)
    ("mRNA and pre-mRNA" . SPARSER::COLLECTION) ("bortezomib" . SPARSER::DRUG)
    ("p19 ARF as well as p21 CIP1 and p27 KIP1" . SPARSER::COLLECTION)
    ("inhibitor and tumor" . SPARSER::COLLECTION)
    ("p21 CIP1 and p27 KIP1" . SPARSER::COLLECTION)
    ("family " . SPARSER::PROTEIN-FAMILY) ("Promoter" . SPARSER::PROMOTER)
    ("methylcellulose" . SPARSER::DRUG)
    ("pMSCV-Cdk6-puro" . SPARSER::COLLECTION)
    ("pMSCV-puro" . SPARSER::COLLECTION) ("puro" . SPARSER::PROTEIN)
    ("c-neu" . SPARSER::PROTEIN-PAIR)
    ("an essential component" . SPARSER::COMPONENT)
    ("c-neu/ERBB-2" . SPARSER::COLLECTION)
    ("monomeric CDK4 and CDK6" . SPARSER::COLLECTION)
    ("cip and p27" . SPARSER::COLLECTION)
    ("CDK6-cyclin D" . SPARSER::COLLECTION) ("CDK4-" . SPARSER::PROTEIN)
    ("cip" . SPARSER::PROTEIN) ("Cdk4 and Cdk6" . SPARSER::COLLECTION)
    ("CDK4 and CDK6" . SPARSER::COLLECTION)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Available anticancer drugs" . SPARSER::DRUG)
    ("Part" . SPARSER::COMPONENT)
    ("the tumor suppressor p16 INK4a and the pro-angiogenic factor VEGF-A"
     . SPARSER::COLLECTION)
    ("Rag2" . SPARSER::PROTEIN) ("p27 Kip1" . SPARSER::PROTEIN)
    ("FOXM1" . SPARSER::PROTEIN) ("cyclin D2" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("PD0332991" . SPARSER::DRUG) ("S6E" . SPARSER::PROTEIN-FAMILY)
    ("S5B" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("AKT-induced" . SPARSER::PROTEIN) ("CD30" . SPARSER::PROTEIN)
    ("S2P" . SPARSER::PROTEIN) ("INK4a" . SPARSER::PROTEIN)
    ("H3K27me3" . SPARSER::MOLECULE) ("p19  ARF" . SPARSER::PROTEIN)
    ("pre-mRNA" . SPARSER::RNA) ("p27 KIP1" . SPARSER::PROTEIN)
    ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p19 ARF" . SPARSER::PROTEIN)
    ("p16  INK4a" . SPARSER::PROTEIN)
    ("Transcriptional Regulator" . SPARSER::PROTEIN-FAMILY)
    ("c-JUN" . SPARSER::PROTEIN)
    ("AP-1 transcription factor " . SPARSER::PROTEIN)
    ("ERBB-2" . SPARSER::PROTEIN) ("p19 INK4d" . SPARSER::PROTEIN)
    ("p18 INK4c" . SPARSER::PROTEIN) ("p15 INK4b" . SPARSER::PROTEIN)
    ("INK4" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("Cdk6" . SPARSER::PROTEIN)
    ("Cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCR-ABL" . SPARSER::PROTEIN) ("p185" . SPARSER::PROTEIN)
    ("GTPases and kinases" . SPARSER::COLLECTION)
    ("liposomes" . SPARSER::PROTEIN)
    ("dimeric Exo70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phospholipid" . SPARSER::PHOSPHOLIPID)
    ("expressing Exo70 mutants" . SPARSER::MUTANT)
    ("Arp3 and F-actin" . SPARSER::COLLECTION)
    ("stably expressing GFP-tagged rat Exo70 mutants Exo70(K571A/E572A) and Exo70(Δ1–75)"
     . SPARSER::COLLECTION)
    ("stably expressing GFP-tagged rat Exo70 mutants Exo70"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("expressing GFP-tagged rat Exo70 mutants Exo70"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VSV" . SPARSER::PROTEIN)
    ("The Exo70(K571A/E572A) and Exo70(Δ1–75) mutants" . SPARSER::COLLECTION)
    ("the physical step" . SPARSER::PROTEIN)
    ("Exo84 and Sec10" . SPARSER::COLLECTION)
    ("Sec8 or Sec15" . SPARSER::COLLECTION)
    ("Sec8 and Sec15" . SPARSER::COLLECTION) ("detergent" . SPARSER::MOLECULE)
    ("either empty or contained very few linear actin filaments"
     . SPARSER::PROTEIN-FAMILY)
    ("Exo70 and F-actin" . SPARSER::COLLECTION)
    ("GFP-Exo70" . SPARSER::COLLECTION) ("amphiphysin" . SPARSER::PROTEIN)
    ("the electrostatic map" . SPARSER::PROTEIN)
    ("its native planar state" . SPARSER::BIO-STATE)
    ("at least two linked Exo70 monomers" . SPARSER::MONOMER)
    ("protein and lipid" . SPARSER::COLLECTION)
    ("monomer or protein" . SPARSER::COLLECTION)
    ("Exo70(Δ1–75) monomer, Exo70(K571A/E572A) mutant dimers and no protein control in the system"
     . SPARSER::COLLECTION)
    ("DOPC" . SPARSER::DRUG)
    ("the minimal oligomerized state" . SPARSER::BIO-STATE)
    ("ENTH" . SPARSER::PROTEIN) ("PEG" . SPARSER::PROTEIN)
    ("low-MW chromatographic fractions" . SPARSER::COMPONENT)
    ("α-helical dimers" . SPARSER::DIMER) ("GST-Exo70" . SPARSER::COLLECTION)
    ("EM" . SPARSER::PROTEIN) ("rod" . SPARSER::PROTEIN)
    ("Arpc1" . SPARSER::PROTEIN)
    ("Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70 and Exo84"
     . SPARSER::COLLECTION)
    ("Sec10" . SPARSER::PROTEIN) ("Sec8" . SPARSER::PROTEIN)
    ("Sec6" . SPARSER::PROTEIN) ("Sec3" . SPARSER::PROTEIN)
    ("exocyst" . SPARSER::BIO-COMPLEX) ("PIP 2" . SPARSER::PROTEIN)
    ("alpha-" . SPARSER::PROTEIN) ("For 3" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("Arp3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("srGAP2" . SPARSER::PROTEIN)
    ("IRSp53" . SPARSER::PROTEIN) ("Arp2/3" . SPARSER::PROTEIN)
    ("Exo84" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sec15" . SPARSER::PROTEIN-FAMILY) ("Sec5" . SPARSER::PROTEIN)
    ("Exo70" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DL" . SPARSER::MOLECULE)
    ("GX" . SPARSER::PROTEIN) ("YL" . SPARSER::PROTEIN)
    ("quinone" . SPARSER::PROTEIN) ("Metallothionein" . SPARSER::PROTEIN)
    ("Nrf2 and its downstream genes" . SPARSER::COLLECTION)
    ("potentially toxic xenobiotics and xenobiotic" . SPARSER::COLLECTION)
    ("xenobiotics and xenobiotic" . SPARSER::COLLECTION)
    ("xenobiotic" . SPARSER::MOLECULE) ("xenobiotics" . SPARSER::MOLECULE)
    ("cytoprotective genes" . SPARSER::GENE) ("ia" . SPARSER::MOLECULE)
    ("diethylnitrosamine" . SPARSER::MOLECULE)
    ("type and stage" . SPARSER::COLLECTION)
    ("the NRF2-target genes NQO1 (15.84 ± 4.85 versus 9.67 ± 2.01) and GCLC (7.68 ± 1.41 versus 5.88 ± 0.85)"
     . SPARSER::COLLECTION)
    ("NRF2 and NRF2" . SPARSER::COLLECTION) ("HCC" . SPARSER::PROTEIN)
    ("the predominant forms" . SPARSER::FORM) ("MTs" . SPARSER::PROTEIN)
    ("Metallothioneins" . SPARSER::PROTEIN) ("MTF" . SPARSER::PROTEIN)
    ("Nrf2-targeted genes ( NQO1 and GCLC ) and the genes"
     . SPARSER::COLLECTION)
    ("NQO1 and GCLC" . SPARSER::COLLECTION) ("GCLC" . SPARSER::PROTEIN)
    ("metallothionein" . SPARSER::PROTEIN) ("MT-1G" . SPARSER::PROTEIN)
    ("MT-4" . SPARSER::PROTEIN) ("MTF1" . SPARSER::PROTEIN)
    ("MT-2" . SPARSER::PROTEIN) ("MT-1" . SPARSER::PROTEIN)
    ("Nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("SL and YS" . SPARSER::COLLECTION)
    ("ER, PR and P53" . SPARSER::COLLECTION)
    ("merely use CyclinD1" . SPARSER::PROTEIN)
    ("CDK4 or CDK6" . SPARSER::COLLECTION)
    ("parathyroid" . SPARSER::PROTEIN-FAMILY)
    ("the oncogenes and disorders of some genes
[ xref ]"
     . SPARSER::COLLECTION)
    ("pathogenic types" . TYPE)
    ("pathological types and invasion (p > 0.05 )" . SPARSER::COLLECTION)
    ("pathological types" . TYPE) ("pathological type" . TYPE)
    ("p " . SPARSER::PROTEIN) ("-p" . SPARSER::COLLECTION)
    ("5 different pathological types" . TYPE) ("BCL1" . SPARSER::PROTEIN)
    ("p  " . SPARSER::PROTEIN) ("ACH" . SPARSER::PROTEIN)
    ("regulator of cell cycle" . SPARSER::PROTEIN)
    ("cyclin-D1" . SPARSER::PROTEIN) ("CDK6" . SPARSER::PROTEIN)
    ("HR2" . SPARSER::PROTEIN) ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P53" . SPARSER::PROTEIN) ("CyclinD1" . SPARSER::PROTEIN)
    ("NC, PR and DNC" . SPARSER::COLLECTION) ("DNC" . SPARSER::PROTEIN)
    ("MU and PR" . SPARSER::COLLECTION) ("SEH" . SPARSER::PROTEIN)
    ("fragment and a 1-Mb fragment" . SPARSER::COLLECTION)
    ("the NF1 gene or the SPRED1 gene [ xref ]" . SPARSER::COLLECTION)
    ("p300 , c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("c-Fos (28,846,815–28,847,158) and c-Jun (28,846,819–28,847,094)"
     . SPARSER::COLLECTION)
    ("p300 (positions 28,846,840–28,847,158), c-Fos (28,846,815–28,847,158) and c-Jun (28,846,819–28,847,094)"
     . SPARSER::COLLECTION)
    ("Nco" . SPARSER::MOLECULE)
    ("A genome-wide matrix" . SPARSER::PROTEIN-FAMILY)
    ("intra-chromosomal interacting fragments" . SPARSER::FRAGMENT)
    ("orthologs" . SPARSER::PROTEIN)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("transcription factors TCF4 and/or TCF7L2" . SPARSER::COLLECTION)
    ("HBM" . SPARSER::PROTEIN)
    ("Far upstream polymorphic variants" . SPARSER::VARIANT)
    ("SHH" . SPARSER::PROTEIN) ("limb" . SPARSER::PROTEIN)
    ("GTPase-activating protein (GAP)" . SPARSER::PROTEIN)
    ("Neurofibromin" . SPARSER::PROTEIN) ("neurofibromin" . SPARSER::PROTEIN)
    ("NF1 or SPRED1" . SPARSER::COLLECTION) ("Histone H3K" . SPARSER::PROTEIN)
    ("TCF7L2" . SPARSER::PROTEIN) ("TCF4" . SPARSER::PROTEIN)
    ("GATA1" . SPARSER::PROTEIN) ("α-globin" . SPARSER::PROTEIN)
    ("AP-2α" . SPARSER::PROTEIN) ("IRF6" . SPARSER::PROTEIN)
    ("interferon regulatory factor 6" . SPARSER::PROTEIN)
    ("sonic hedgehog" . SPARSER::PROTEIN) ("Ras-GTP" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN) ("SPRED1" . SPARSER::PROTEIN)
    ("H3K27ac" . SPARSER::MOLECULE) ("NF1" . SPARSER::PROTEIN)
    ("DAB" . SPARSER::MOLECULE) ("TdT" . SPARSER::PROTEIN)
    ("DPX" . SPARSER::PROTEIN) ("haematoxylin" . SPARSER::MOLECULE)
    ("EDTA" . SPARSER::MOLECULE) ("Tris" . SPARSER::MOLECULE)
    ("xylene" . SPARSER::MOLECULE) ("archival formalin" . SPARSER::MOLECULE)
    ("Antibody" . SPARSER::ANTIBODY) ("sera and ELISA" . SPARSER::COLLECTION)
    ("SPF" . SPARSER::PROTEIN) ("antiandrogens" . SPARSER::DRUG)
    ("LHRH" . SPARSER::PROTEIN) ("MREC" . SPARSER::PROTEIN-FAMILY)
    ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("the stress-induced kinases p38α and JNK" . SPARSER::COLLECTION)
    ("p38α and JNK" . SPARSER::COLLECTION)
    ("using phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("cyclin D3/Cdk11" . SPARSER::COLLECTION) ("abiraterone" . SPARSER::DRUG)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("PI3K/Akt" . SPARSER::COLLECTION) ("serines" . SPARSER::AMINO-ACID)
    ("serine and tyrosine" . SPARSER::COLLECTION)
    ("dihydrotestosterone" . SPARSER::DRUG) ("GnRH" . SPARSER::PROTEIN)
    ("gonadotropin" . SPARSER::PROTEIN)
    ("testicular androgens" . SPARSER::DRUG) ("pAR" . SPARSER::PROTEIN)
    ("phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("MIB1" . SPARSER::PROTEIN) ("protein phosphatase 1" . SPARSER::PROTEIN)
    ("protein kinase A" . SPARSER::PROTEIN) ("Cdk11" . SPARSER::PROTEIN)
    ("cyclin D3" . SPARSER::PROTEIN) ("Cdk9" . SPARSER::PROTEIN)
    ("prostate specific antigen" . SPARSER::PROTEIN)
    ("Ku-70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Androgen receptor" . SPARSER::PROTEIN) ("EGFR TKI’s" . SPARSER::PROTEIN)
    ("MRI" . SPARSER::PROTEIN) ("PET" . SPARSER::PROTEIN)
    ("TTF-1 and CK7" . SPARSER::COLLECTION) ("CASE" . SPARSER::PROTEIN)
    ("CK20" . SPARSER::PROTEIN) ("CK7" . SPARSER::PROTEIN)
    ("Stat-1 (Tyr 701) and Stat-3 (Tyr 705)" . SPARSER::COLLECTION)
    ("diffusible angiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro- or anti-angiogenic" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::PROTEIN)
    ("VEGF as well as survivin, MMP-2, bFGF, iNOS and eNOS"
     . SPARSER::COLLECTION)
    ("survivin, MMP-2, bFGF, iNOS and eNOS" . SPARSER::COLLECTION)
    ("VEGF, iNOS, eNOS, survivin and MMP-2" . SPARSER::COLLECTION)
    ("angiogenic molecules" . SPARSER::MOLECULE)
    ("Stat-VEGF" . SPARSER::COLLECTION)
    ("Stat-1 (Tyr701) and Stat-3 (Tyr705)" . SPARSER::COLLECTION)
    ("various angiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("water" . SPARSER::MOLECULE)
    ("VEGF (50 ng/ml) and acacetin (25 or 50 mg/kg body weight)"
     . SPARSER::COLLECTION)
    ("ice" . SPARSER::PROTEIN)
    ("VEGF and other pro-angiogenic genes" . SPARSER::COLLECTION)
    ("VEGF, iNOS, eNOS and bFGF" . SPARSER::COLLECTION)
    ("VEGF, MMP-2 and survivin" . SPARSER::COLLECTION)
    ("acacetin or their combination" . SPARSER::COLLECTION)
    ("both Stat-1(Tyr701) and Stat-3(Tyr705)" . SPARSER::COLLECTION)
    ("Stat-1 and -3" . SPARSER::COLLECTION)
    ("VEGF, iNOS, eNOS, bFGF and survivin" . SPARSER::COLLECTION)
    ("VEGF, iNOS and survivin" . SPARSER::COLLECTION)
    ("survivin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Stats" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TCM" . SPARSER::PROTEIN)
    ("capillary-tube" . SPARSER::PROTEIN)
    ("a pre-requisite step" . SPARSER::PROTEIN)
    ("an essential and potent mitogen" . SPARSER::MITOGEN)
    ("FDA" . SPARSER::PROTEIN)
    ("the promising anti-angiogenic or angiopreventive strategies"
     . SPARSER::COLLECTION)
    ("new vasculature" . SPARSER::PROTEIN) ("Stat" . SPARSER::PROTEIN)
    ("Stat-1 and Stat-3" . SPARSER::COLLECTION) ("CAM" . SPARSER::PROTEIN)
    ("VEGF, eNOS, iNOS, MMP-2 and bFGF" . SPARSER::COLLECTION)
    ("bFGF" . SPARSER::PROTEIN) ("iNOS" . SPARSER::PROTEIN)
    ("Acacetin" . SPARSER::DRUG) ("flavone" . SPARSER::DRUG)
    ("acacetin" . SPARSER::DRUG) ("mitomycin C" . SPARSER::DRUG)
    ("Anti-VEGF" . SPARSER::DRUG) ("MMP-2" . SPARSER::PROTEIN)
    ("Stat-3" . SPARSER::PROTEIN) ("Stat-1" . SPARSER::PROTEIN)
    ("anti-angiogenic" . SPARSER::DRUG)
    ("type 1 and type 2 papillary RCC" . SPARSER::PROTEIN)
    ("different pathologic subtypes" . SPARSER::PROTEIN)
    ("type 1 and type 2" . SPARSER::COLLECTION)
    ("PRCC (47.6%) and CRCC (16.7%)" . SPARSER::COLLECTION)
    ("PRCC and CRCC" . SPARSER::COLLECTION)
    ("U0126 and BI-D1870" . SPARSER::COLLECTION)
    ("ERK and RSK4" . SPARSER::COLLECTION)
    ("the cell-cycle-related proteins p53, p21, and pRb" . SPARSER::COLLECTION)
    ("p53, p21, and pRb" . SPARSER::COLLECTION) ("beta" . SPARSER::PROTEIN)
    ("only one human RSK4 mRNA" . SPARSER::RNA)
    ("ERK1/2 and RSK4" . SPARSER::COLLECTION)
    ("CD44 and MMP-9" . SPARSER::COLLECTION)
    ("MMP-9 and CD44" . SPARSER::COLLECTION)
    ("neo-RSK4" . SPARSER::PROTEIN-PAIR) ("neo" . SPARSER::PROTEIN)
    ("Santa" . SPARSER::PROTEIN) ("ACHN" . SPARSER::PROTEIN)
    ("GRC" . SPARSER::PROTEIN) ("Log-rank" . SPARSER::COLLECTION)
    ("PRCC" . SPARSER::PROTEIN) ("hepatocytes" . SPARSER::PROTEIN)
    ("sunitinib" . SPARSER::DRUG) ("RSK" . SPARSER::PROTEIN)
    ("various histologic subtypes" . SPARSER::PROTEIN)
    ("a potential independent prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RCC" . SPARSER::PROTEIN) ("pT3" . SPARSER::PROTEIN)
    ("pT1-2" . SPARSER::PROTEIN) ("BI-D1870" . SPARSER::MOLECULE)
    ("MMP-9" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("cardiac muscle" . SPARSER::PROTEIN) ("X-linked" . SPARSER::PROTEIN)
    ("RSK4" . SPARSER::PROTEIN)
    ("only six potentially functional SNPs" . SPARSER::PROTEIN)
    ("etiological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SNPs and PCa" . SPARSER::COLLECTION)
    ("adipose-related proteins" . SPARSER::PROTEIN)
    ("the most noteworthy factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SNPs" . SPARSER::PROTEIN) ("multi-SNPs" . SPARSER::COLLECTION)
    ("disease-associated functional intronic variants" . SPARSER::VARIANT)
    ("variant or genotypes and cancer" . SPARSER::COLLECTION)
    ("Cao" . SPARSER::MOLECULE) ("Chen" . SPARSER::PROTEIN)
    ("gene and risk" . SPARSER::COLLECTION) ("FATC" . SPARSER::PROTEIN)
    ("FAT" . SPARSER::PROTEIN) ("gene and PCa" . SPARSER::COLLECTION)
    ("FPRP " . SPARSER::PROTEIN) ("FPRP" . SPARSER::PROTEIN)
    ("MDR" . SPARSER::PROTEIN) ("CCTG" . SPARSER::PROTEIN)
    ("GT/TT" . SPARSER::COLLECTION) ("TG" . SPARSER::PROTEIN)
    ("allele and genotype" . SPARSER::COLLECTION)
    ("other pivotal genes" . SPARSER::GENE)
    ("naturally occurring polymorphic genetic variants" . SPARSER::VARIANT)
    ("a possible driver gene" . SPARSER::PROTEIN)
    ("phosphoinositide-3 kinase-AKT-mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("three-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("one-factor" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GES-1" . SPARSER::PROTEIN)
    ("PtdIns 3-kinase" . SPARSER::PROTEIN) ("FKBP12" . SPARSER::PROTEIN)
    ("p36" . SPARSER::PROTEIN) ("beta 8" . SPARSER::PROTEIN)
    ("phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("this important cytoskeletal regulator" . SPARSER::PROTEIN)
    ("Pdk1" . SPARSER::PROTEIN) ("Phosphoinositide" . SPARSER::PROTEIN)
    ("insulin or a PI3K-activating transduction peptide" . SPARSER::COLLECTION)
    ("spine associated DBN" . SPARSER::MOLECULE) ("DRB" . SPARSER::PROTEIN)
    ("serine- and threonine-phosphorylated proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("a dual-specific protein phosphatase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serine-" . SPARSER::AMINO-ACID) ("tyrosine-" . SPARSER::AMINO-ACID)
    ("RFP-CRE" . SPARSER::COLLECTION) ("RFP" . SPARSER::PROTEIN)
    ("DIV" . SPARSER::PROTEIN) ("PTEN and DBN" . SPARSER::COLLECTION)
    ("flox/flox" . SPARSER::COLLECTION) ("Cre" . SPARSER::PROTEIN)
    ("flox" . SPARSER::PROTEIN) ("DBN and PTEN" . SPARSER::COLLECTION)
    ("D-loop" . SPARSER::PROTEIN) ("IPs" . SPARSER::PROTEIN)
    ("bacterially expressed (phosphorylation-deficient) DBN and a mutant version"
     . SPARSER::COLLECTION)
    ("YFP" . SPARSER::PROTEIN) ("approximately 110kD" . SPARSER::PROTEIN)
    ("an anti-DBN-S647 phospho-site-specific antibody" . SPARSER::ANTIBODY)
    ("PI3K/PTEN" . SPARSER::COLLECTION) ("Ant-D-loop" . SPARSER::PROTEIN-PAIR)
    ("Ant" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mCherry" . SPARSER::PROTEIN)
    ("FLIM" . SPARSER::PROTEIN) ("PTEN and PTENC2" . SPARSER::COLLECTION)
    ("aa" . SPARSER::MOLECULE) ("GFP-PTEN" . SPARSER::COLLECTION)
    ("Drebrin (DBN)" . SPARSER::PROTEIN)
    ("approximately 110 kD" . SPARSER::PROTEIN)
    ("the PTEN:DBN complex and de-represses S647-DBN phosphorylation leading to an increase in S647-phosphorylation"
     . SPARSER::COLLECTION)
    ("several important postsynaptic signaling proteins" . SPARSER::PROTEIN)
    ("protein–protein" . SPARSER::COLLECTION) ("seizures" . SPARSER::PROTEIN)
    ("PTEN and pS647-DBN" . SPARSER::COLLECTION)
    ("A salient candidate actin-binding protein" . SPARSER::PROTEIN)
    ("DBN" . SPARSER::MOLECULE) ("Drebrin" . SPARSER::PROTEIN)
    ("CA3" . SPARSER::PROTEIN) ("MgSO 4" . SPARSER::DRUG)
    ("D-glucose" . SPARSER::MOLECULE) ("1 L" . SPARSER::PROTEIN)
    ("Synapsin-1" . SPARSER::PROTEIN) ("P44" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("kinase-1" . SPARSER::PROTEIN)
    ("PI3K-mTOR" . SPARSER::PROTEIN) ("GSK-3" . SPARSER::PROTEIN)
    ("PI3Ks" . SPARSER::PROTEIN) ("110kD" . SPARSER::PROTEIN)
    ("110 kD" . SPARSER::PROTEIN) ("brain-specific" . SPARSER::PROTEIN)
    ("Postsynaptic density protein 95" . SPARSER::PROTEIN)
    ("PSD95" . SPARSER::PROTEIN) ("N-Methyl-D-aspartate" . SPARSER::MOLECULE)
    ("developmentally regulated brain protein" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("euchromatin" . SPARSER::BIO-COMPLEX) ("Sucrose" . SPARSER::MOLECULE)
    ("CBP/P/CAF" . SPARSER::COLLECTION) ("Cdk2/Cyclin A" . SPARSER::COLLECTION)
    ("Api5 and the E2F1 transcriptional activity E2F1 target genes"
     . SPARSER::COLLECTION)
    ("SKP2, cyclin E and E2F1" . SPARSER::COLLECTION)
    ("SKP2, E2F1 or cyclin E" . SPARSER::COLLECTION)
    ("SKP2, E2F1 and cyclin E" . SPARSER::COLLECTION)
    ("albumin" . SPARSER::PROTEIN) ("2F1 or HA-Api5" . SPARSER::COLLECTION)
    ("neither E2F1 nor its binding partner DP1" . SPARSER::COLLECTION)
    ("Promoters" . SPARSER::PROMOTER)
    ("the mutated cyclin E promoter" . SPARSER::PROMOTER)
    ("HA-Api5" . SPARSER::COLLECTION)
    ("a scrambled shRNA or a specific Api5 shRNA" . SPARSER::COLLECTION)
    ("E2F1 driven promoters" . SPARSER::PROMOTER)
    ("Api5 or both siRNAs" . SPARSER::COLLECTION)
    ("E2F1, Api5 or both siRNAs" . SPARSER::COLLECTION)
    ("Api5 or both siRNAs ( xref )" . SPARSER::COLLECTION)
    ("E2F1, Api5 or both siRNAs ( xref )" . SPARSER::COLLECTION)
    ("the mutated promoter" . SPARSER::PROMOTER)
    ("cyclin A protein" . SPARSER::PROTEIN)
    ("cyclin D1 or Cdk2" . SPARSER::COLLECTION)
    ("p16 INK4a and CDC25A" . SPARSER::COLLECTION)
    ("endogenous E2F1" . SPARSER::PROTEIN-FAMILY)
    ("Api5 or E2F1" . SPARSER::COLLECTION)
    ("E2F1 or Api5" . SPARSER::COLLECTION)
    ("E2F1 and Api5" . SPARSER::COLLECTION) ("Api5/E2F1" . SPARSER::COLLECTION)
    ("t " . SPARSER::PROTEIN) ("double-thymidine" . SPARSER::PROTEIN)
    ("Api5 and E2F1" . SPARSER::COLLECTION) ("Van" . SPARSER::PROTEIN)
    ("Acinus" . SPARSER::PROTEIN) ("Api5/aac11/FIF" . SPARSER::COLLECTION)
    ("FIF" . SPARSER::PROTEIN) ("Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA-bound E2F1" . SPARSER::PROTEIN-FAMILY)
    ("Cdk2, cdc25 or SKP2" . SPARSER::COLLECTION)
    ("retinoblastoma" . SPARSER::PROTEIN)
    ("Most E2Fs form active heterodimers" . SPARSER::HETERODIMER)
    ("DP1 or DP2" . SPARSER::COLLECTION)
    ("E2F1, E2F2, E2F3a and E2F3b" . SPARSER::COLLECTION)
    ("cell cycle-associated genes" . SPARSER::GENE)
    ("cyclin D1 and Cdk2" . SPARSER::COLLECTION)
    ("E2f" . SPARSER::PROTEIN-FAMILY) ("pGL2" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN) ("API5" . SPARSER::PROTEIN)
    ("CCL-2" . SPARSER::PROTEIN) ("SNF2" . SPARSER::PROTEIN)
    ("Cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ALC1" . SPARSER::PROTEIN)
    ("p73" . SPARSER::PROTEIN) ("P/CAF" . SPARSER::PROTEIN)
    ("Cyclin D" . SPARSER::PROTEIN) ("Cdk4" . SPARSER::PROTEIN)
    ("Fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("2F1" . SPARSER::PROTEIN) ("Cyclin A" . SPARSER::PROTEIN)
    ("p16 INK4a" . SPARSER::PROTEIN) ("CDC6" . SPARSER::PROTEIN)
    ("MCM2" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("OPA1" . SPARSER::PROTEIN) ("putative oncogene" . SPARSER::PROTEIN)
    ("aac11" . SPARSER::PROTEIN)
    ("Fibroblast Growth Factor-2" . SPARSER::PROTEIN)
    ("SKP2" . SPARSER::PROTEIN) ("cdc25" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("DP2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("E2Fs" . SPARSER::PROTEIN-FAMILY)
    ("E2F7" . SPARSER::PROTEIN) ("E2F6" . SPARSER::PROTEIN)
    ("E2F4" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE) ("Api5" . SPARSER::PROTEIN)
    ("a generally positive prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-deoxyguanosine" . SPARSER::MOLECULE)
    ("deoxyguanosine" . SPARSER::MOLECULE) ("longer PFS" . SPARSER::PROTEIN)
    ("significantly longer PFS" . SPARSER::PROTEIN)
    ("cisplatin-etoposide" . SPARSER::PROTEIN) ("docetaxel" . SPARSER::DRUG)
    ("vinorelbine" . SPARSER::DRUG) ("pemetrexed" . SPARSER::DRUG)
    ("Platinum" . SPARSER::MOLECULE) ("a good PS" . SPARSER::PROTEIN)
    ("ERCC1 and EGFR" . SPARSER::COLLECTION)
    ("an independent prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("carboplatin and paclitaxel" . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG) ("delE" . SPARSER::PROTEIN)
    ("a shorter PFS" . SPARSER::PROTEIN) ("a longer PFS" . SPARSER::PROTEIN)
    ("platinum" . SPARSER::MOLECULE) ("ERCC1" . SPARSER::PROTEIN)
    ("Sterile" . SPARSER::PROTEIN-FAMILY) ("Macrophage" . SPARSER::PROTEIN)
    ("a soluble form" . SPARSER::FORM) ("Proteins" . SPARSER::PROTEIN)
    ("the mature lysosomal" . SPARSER::PROTEIN) ("amyloid" . SPARSER::PROTEIN)
    ("his" . SPARSER::AMINO-ACID) ("form (MM)" . SPARSER::FORM)
    ("sucrose" . SPARSER::MOLECULE)
    ("samples present exosomal associated proteins" . SPARSER::PROTEIN)
    ("annexin V, Hsp70 and tubulin" . SPARSER::COLLECTION)
    ("Hsp 70, annexin V and c-src" . SPARSER::COLLECTION)
    ("the FLCs pelletable fraction" . SPARSER::COMPONENT)
    ("contained Phosphatidylcholine (PC) and Sphingomyelin (SFM) ( xref )"
     . SPARSER::COLLECTION)
    ("Sphingomyelin (SFM)" . SPARSER::MOLECULE)
    ("Phosphatidylcholine (PC)" . SPARSER::MOLECULE)
    ("Sphingomyelin" . SPARSER::MOLECULE)
    ("Phosphatidylcholine" . SPARSER::MOLECULE) ("TLC" . SPARSER::PROTEIN)
    ("Triton" . SPARSER::MOLECULE) ("pellettable proteins" . SPARSER::PROTEIN)
    ("actin and tubulin" . SPARSER::COLLECTION)
    ("no commercial anti FLCs antibodies" . SPARSER::ANTIBODY)
    ("anti" . SPARSER::PROTEIN) ("Lamp-1" . SPARSER::PROTEIN)
    ("Lamp" . SPARSER::PROTEIN) ("Lysosomal" . SPARSER::PROTEIN)
    ("annexin V and the Heat Shock Protein (Hsp)" . SPARSER::COLLECTION)
    ("sera" . SPARSER::PROTEIN) ("a vesicular form" . SPARSER::FORM)
    ("prion" . SPARSER::PROTEIN-FAMILY) ("a pelletable form" . SPARSER::FORM)
    ("the pelletable form" . SPARSER::FORM) ("homogenate" . SPARSER::PROTEIN)
    ("pellettable (P) form" . SPARSER::FORM) ("SN" . SPARSER::PROTEIN)
    ("nanotubes" . SPARSER::MOLECULE) ("microglia" . SPARSER::PROTEIN)
    ("Amyloid Precursor Protein (APP)" . SPARSER::PROTEIN)
    ("APP" . SPARSER::PROTEIN)
    ("a monoclonal component IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a single FLCs monoclonal component" . SPARSER::COMPONENT)
    ("potential amyloidogenic proteins" . SPARSER::PROTEIN)
    ("trypsin" . SPARSER::PROTEIN) ("HVEC" . SPARSER::PROTEIN)
    ("periumbilical fat" . SPARSER::PROTEIN) ("paraprotein" . SPARSER::PROTEIN)
    ("an IgGλ monoclonal component" . SPARSER::COMPONENT)
    ("kappa or lambda" . SPARSER::COLLECTION)
    ("cardiac myoblasts" . SPARSER::PROTEIN) ("myoblasts" . SPARSER::PROTEIN)
    ("a new potential diagnostic target" . SPARSER::TARGET-PROTEIN)
    ("p65, H 2 O 2 , and MCP-1" . SPARSER::COLLECTION)
    ("src-Tyrosine Kinase" . SPARSER::COLLECTION)
    ("Receptor" . SPARSER::RECEPTOR) ("LC" . SPARSER::PROTEIN)
    ("Kappa or lambda" . SPARSER::COLLECTION)
    ("Kappa" . SPARSER::PROTEIN-FAMILY) ("Paraproteins" . SPARSER::PROTEIN)
    ("monoclonal immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("paraproteins" . SPARSER::PROTEIN)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-src" . SPARSER::COLLECTION) ("src" . SPARSER::PROTEIN)
    ("kappa and lambda" . SPARSER::COLLECTION)
    ("Monoclonal immunoglobulin Free Light" . SPARSER::PROTEIN)
    ("FLC" . SPARSER::PROTEIN) ("neonatal Fc receptor" . SPARSER::PROTEIN)
    ("Hsp 70" . SPARSER::PROTEIN) ("caveolin1" . SPARSER::PROTEIN)
    ("integral membrane protein" . SPARSER::PROTEIN)
    ("Heat Shock Protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Amyloid Precursor Protein" . SPARSER::PROTEIN)
    ("CH 3" . SPARSER::MOLECULE) ("U 10" . SPARSER::PROTEIN)
    ("clathrin heavy chain" . SPARSER::PROTEIN)
    ("Tyrosine Kinase" . SPARSER::PROTEIN)
    ("trigger factor" . SPARSER::PROTEIN) ("Hsp70" . SPARSER::PROTEIN)
    ("The desmosomal cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAL and/or SRF" . SPARSER::COLLECTION)
    ("factors, p63 and grainyhead-like" . SPARSER::COLLECTION)
    ("grainyhead" . SPARSER::PROTEIN-FAMILY)
    ("suprabasal keratins, and loricrin" . SPARSER::COLLECTION)
    ("keratins, and loricrin" . SPARSER::COLLECTION)
    ("SRF and its cofactor MAL" . SPARSER::COLLECTION)
    ("suprabasal keratins" . SPARSER::PROTEIN)
    ("desmosomal cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("keratin 1 and keratin 10" . SPARSER::COLLECTION)
    ("GEF or GAPs" . SPARSER::COLLECTION)
    ("the ∼70 GEFs and 80 GAPs" . SPARSER::COLLECTION)
    ("GTPases, Bcr and Abr" . SPARSER::COLLECTION)
    ("RhoA, Rac, and Cdc42" . SPARSER::COLLECTION)
    ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("especially chronic myelogenous leukemia" . SPARSER::PROTEIN)
    ("GEFs or GAPs" . SPARSER::COLLECTION) ("RhoA/Rac1" . SPARSER::COLLECTION)
    ("Rnd3/RhoE" . SPARSER::COLLECTION) ("RhoE" . SPARSER::PROTEIN)
    ("ROCKI" . SPARSER::PROTEIN) ("RhoA/ROCK" . SPARSER::COLLECTION)
    ("Rho or ROCK" . SPARSER::COLLECTION)
    ("RhoA–SRF–Dsg1" . SPARSER::COLLECTION) ("GEFs/GAPs" . SPARSER::COLLECTION)
    ("Bcr/MAL" . SPARSER::COLLECTION)
    ("Dsg1, keratin 1, keratin 10, and loricrin" . SPARSER::COLLECTION)
    ("Dsg1, Dsc1, keratin 1, keratin 10, involucrin, loricrin, filaggrin, and suprabasin"
     . SPARSER::COLLECTION)
    ("JunB" . SPARSER::PROTEIN) ("suprabasin" . SPARSER::PROTEIN)
    ("filaggrin" . SPARSER::PROTEIN) ("JUP" . SPARSER::PROTEIN)
    ("junctional actin" . SPARSER::PROTEIN)
    ("response element (SRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("SRE-luciferase" . SPARSER::COLLECTION) ("SRE" . SPARSER::PROTEIN)
    ("Dsg1, Dsc1, keratin 1, keratin 10, and loricrin" . SPARSER::COLLECTION)
    ("E-cad, DP, or PG" . SPARSER::COLLECTION) ("CCG" . SPARSER::PROTEIN)
    ("Dsg1, Dsc1, and keratin 1" . SPARSER::COLLECTION)
    ("MAL and SRF" . SPARSER::COLLECTION)
    ("keratin 1 and loricrin" . SPARSER::COLLECTION)
    ("Dsg1, Dsc1, keratin 10, loricrin, and involucrin" . SPARSER::COLLECTION)
    ("E-cad and DP" . SPARSER::COLLECTION) ("involucrin" . SPARSER::PROTEIN)
    ("Dsc1 and loricrin" . SPARSER::COLLECTION)
    ("PKP2, DP, PG, E-cad, or β-catenin" . SPARSER::COLLECTION)
    ("PG" . SPARSER::PROTEIN) ("other junctional proteins" . SPARSER::PROTEIN)
    ("Dsg1 and Dsc1" . SPARSER::COLLECTION)
    ("the suprabasal keratins" . SPARSER::PROTEIN)
    ("Dsg1, Dsc1, and PKP1" . SPARSER::COLLECTION)
    ("keratins" . SPARSER::PROTEIN) ("RhoC and Rac1" . SPARSER::COLLECTION)
    ("RhoGDI" . SPARSER::PROTEIN)
    ("the desmosomal cadherins Dsg1 and desmocollin-1" . SPARSER::COLLECTION)
    ("Dsg1 and desmocollin-1" . SPARSER::COLLECTION)
    ("desmocollin" . SPARSER::PROTEIN) ("RhoC" . SPARSER::PROTEIN)
    ("RhoB" . SPARSER::PROTEIN)
    ("a previously described GEF-dead mutant" . SPARSER::MUTANT)
    ("NE" . SPARSER::PROTEIN) ("Successful (>80%) KD" . SPARSER::PROTEIN)
    ("Rhotekin" . SPARSER::PROTEIN)
    ("junctional complexes" . SPARSER::BIO-COMPLEX) ("DH" . SPARSER::PROTEIN)
    ("Bcr and MAL" . SPARSER::COLLECTION)
    ("Rac1 or Cdc42" . SPARSER::COLLECTION)
    ("RhoA or Rac1" . SPARSER::COLLECTION)
    ("Bcr and Abr" . SPARSER::COLLECTION) ("Rac/Cdc42" . SPARSER::COLLECTION)
    ("GEF/GAP" . SPARSER::COLLECTION) ("RhoGAP" . SPARSER::PROTEIN)
    ("RhoA and Rac1" . SPARSER::COLLECTION)
    ("SRF and MAL" . SPARSER::COLLECTION) ("Rho–ROCK" . SPARSER::COLLECTION)
    ("GTPases and SRF" . SPARSER::COLLECTION)
    ("MAL/MRTF-A" . SPARSER::COLLECTION) ("Myocardin" . SPARSER::PROTEIN)
    ("myocardin" . SPARSER::PROTEIN) ("GEFs and GAPs" . SPARSER::COLLECTION)
    ("an active GTP-bound form and an inactive GDP-bound form"
     . SPARSER::COLLECTION)
    ("RhoA, Rac1, and Cdc42" . SPARSER::COLLECTION)
    ("Multiple desmosomal proteins" . SPARSER::PROTEIN)
    ("plakophilin" . SPARSER::PROTEIN)
    ("the junctional complex" . SPARSER::BIO-COMPLEX)
    ("the cytoskeletal linker protein desmoplakin (DP)" . SPARSER::PROTEIN)
    ("desmoplakin (DP)" . SPARSER::PROTEIN)
    ("the transmembrane cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DP" . SPARSER::PROTEIN) ("desmoplakin" . SPARSER::PROTEIN)
    ("plakoglobin" . SPARSER::PROTEIN)
    ("desmosomal proteins" . SPARSER::PROTEIN)
    ("cues" . SPARSER::PROTEIN-FAMILY)
    ("the desmosomal cadherin Dsg1" . SPARSER::PROTEIN)
    ("RhoA/MAL" . SPARSER::COLLECTION) ("Bcr or MAL" . SPARSER::COLLECTION)
    ("keratin-1, and loricrin" . SPARSER::COLLECTION)
    ("loricrin" . SPARSER::PROTEIN) ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GEFs" . SPARSER::GEF) ("MAL/SRF" . SPARSER::COLLECTION)
    ("SRF" . SPARSER::PROTEIN) ("MAL" . SPARSER::PROTEIN)
    ("RhoA" . SPARSER::PROTEIN) ("Bcr" . SPARSER::PROTEIN)
    ("GEF" . SPARSER::PROTEIN) ("G10" . SPARSER::PROTEIN)
    ("anti–" . SPARSER::ANTIBODY) ("anti–β" . SPARSER::PROTEIN)
    ("Bcr–Abl" . SPARSER::PROTEIN) ("Rnd3" . SPARSER::PROTEIN)
    ("PRK2" . SPARSER::PROTEIN) ("ActG1" . SPARSER::PROTEIN)
    ("DSG1" . SPARSER::PROTEIN) ("keratin 1" . SPARSER::PROTEIN)
    ("keratin 10" . SPARSER::PROTEIN) ("E-cad" . SPARSER::PROTEIN)
    ("PKP2" . SPARSER::PROTEIN) ("envelope protein" . SPARSER::PROTEIN)
    ("Dsc1" . SPARSER::PROTEIN) ("DH-PH" . SPARSER::PROTEIN)
    ("ROCK-II" . SPARSER::PROTEIN) ("MRTF-A" . SPARSER::PROTEIN)
    ("serum response factor" . SPARSER::PROTEIN)
    ("Rho kinase" . SPARSER::PROTEIN) ("Rho GTPase" . SPARSER::PROTEIN)
    ("GTPase activating" . SPARSER::PROTEIN)
    ("Guanine nucleotide exchange factors" . SPARSER::GEF)
    ("Rac1" . SPARSER::PROTEIN) ("PKP1" . SPARSER::PROTEIN)
    ("linker protein" . SPARSER::PROTEIN)
    ("chemical products" . SPARSER::CHEMICAL-PRODUCT)
    ("keratin-1" . SPARSER::PROTEIN) ("Dsg1" . SPARSER::PROTEIN)
    ("breakpoint cluster region" . SPARSER::PROTEIN)
    ("desmoglein-1" . SPARSER::PROTEIN)
    ("ATM and other DNA repair genes" . SPARSER::COLLECTION)
    ("E2F1 and HDAC1/2" . SPARSER::COLLECTION)
    ("Only ATM mRNA and protein" . SPARSER::COLLECTION)
    ("p53R2" . SPARSER::PROTEIN) ("dNTP" . SPARSER::MOLECULE)
    ("deoxyribonucleoside" . SPARSER::MOLECULE)
    ("ATM, BRCA1, CHK2 and p53" . SPARSER::COLLECTION)
    ("poly (ADP-ribose) polymerase (PARP) and the CHK1/CHK2 proteins"
     . SPARSER::COLLECTION)
    ("CHK1/CHK2" . SPARSER::COLLECTION) ("ATM and CHK2" . SPARSER::COLLECTION)
    ("MRE11, Rad50 , or TP53" . SPARSER::COLLECTION)
    ("MRE11 and Rad50" . SPARSER::COLLECTION)
    ("ATM, BRCA1, and p53" . SPARSER::COLLECTION)
    ("Entinostat" . SPARSER::DRUG) ("Epirubicin" . SPARSER::DRUG)
    ("HDAC1-3" . SPARSER::COLLECTION) ("pan-HDAC" . SPARSER::COLLECTION)
    ("entinostat" . SPARSER::DRUG)
    ("pan- or class-specific HDAC inhibitors" . SPARSER::COLLECTION)
    ("pan-" . SPARSER::PROTEIN) ("Vorinostat" . SPARSER::DRUG)
    ("Serine" . SPARSER::AMINO-ACID) ("epirubicin" . SPARSER::DRUG)
    ("ATM, BRCA1, and CHK2" . SPARSER::COLLECTION)
    ("ATM and HDAC1/2" . SPARSER::COLLECTION)
    ("ataxia telangiectasia and Rad3-related" . SPARSER::COLLECTION)
    ("Ku70 and p53" . SPARSER::COLLECTION)
    ("anthracyclines" . SPARSER::MOLECULE)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("vorinostat and romidepsin" . SPARSER::COLLECTION)
    ("Food" . SPARSER::MOLECULE) ("romidepsin" . SPARSER::DRUG)
    ("vorinostat" . SPARSER::DRUG) ("IIb" . SPARSER::DRUG)
    ("histone and non-histone" . SPARSER::COLLECTION)
    ("ATM and HDAC1" . SPARSER::COLLECTION)
    ("defective ATM" . SPARSER::PROTEIN)
    ("MRE11, Rad50, and NBS1" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("BRCA1, CHK2, and p53" . SPARSER::COLLECTION)
    ("GADD45A and RRM2B" . SPARSER::COLLECTION) ("HDAC6" . SPARSER::PROTEIN)
    ("CHK1" . SPARSER::PROTEIN) ("HDAC9" . SPARSER::PROTEIN)
    ("HDAC8" . SPARSER::PROTEIN) ("HDAC3" . SPARSER::PROTEIN)
    ("topoisomerase II" . SPARSER::PROTEIN)
    ("β-glucuronidase" . SPARSER::PROTEIN) ("Histone H4" . SPARSER::PROTEIN)
    ("triton X-100" . SPARSER::MOLECULE) ("MS-275" . SPARSER::DRUG)
    ("ataxia telangiectasia" . SPARSER::PROTEIN) ("Mec1" . SPARSER::PROTEIN)
    ("SMC1" . SPARSER::PROTEIN) ("NBS1" . SPARSER::PROTEIN)
    ("Rad50" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("HDAC2" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("RRM2B" . SPARSER::PROTEIN) ("GADD45A" . SPARSER::PROTEIN)
    ("CDKN1A" . SPARSER::PROTEIN) ("CHK2" . SPARSER::PROTEIN)
    ("readily targetable molecules" . SPARSER::MOLECULE)
    ("EGFR or K-Ras" . SPARSER::COLLECTION)
    ("vimentin and Zeb-1" . SPARSER::COLLECTION) ("nodal" . SPARSER::PROTEIN)
    ("cetuximab or erlotinib" . SPARSER::COLLECTION)
    ("IHC using human-specific anti-vimentin antibody" . SPARSER::ANTIBODY)
    ("Cetuximab" . SPARSER::DRUG)
    ("currently used anti-EGFR drugs" . SPARSER::DRUG)
    ("dual IF" . SPARSER::PROTEIN) ("confocal IF" . SPARSER::PROTEIN)
    ("respective OCTT2 and LNT14 PDXs" . SPARSER::PROTEIN)
    ("Zeb1" . SPARSER::PROTEIN) ("LNT" . SPARSER::MOLECULE)
    ("Zeb" . SPARSER::PROTEIN) ("PDX" . SPARSER::PROTEIN)
    ("NSG" . SPARSER::PROTEIN-FAMILY) ("PDXs" . SPARSER::PROTEIN)
    ("cytotoxic and EGFR-targeted drugs ( xref , xref )" . SPARSER::COLLECTION)
    ("distinct invasive subtypes" . SPARSER::PROTEIN)
    ("erlotinib or cetuximab" . SPARSER::COLLECTION)
    ("Zeb-1" . SPARSER::PROTEIN) ("SP5" . SPARSER::PROTEIN)
    ("interleukin-2 receptor" . SPARSER::PROTEIN) ("HL" . SPARSER::PROTEIN)
    ("LZ" . SPARSER::PROTEIN) ("QS" . SPARSER::PROTEIN)
    ("Nrf2, BMI-1, Sox2 and cyclin E" . SPARSER::COLLECTION)
    ("FGF and Oct4" . SPARSER::COLLECTION)
    ("cytoprotective enzymes" . SPARSER::ENZYME)
    ("self-renewal-related molecules" . SPARSER::MOLECULE)
    ("chemotactic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdk2–cyclin E" . SPARSER::COLLECTION)
    ("a constitutively active Cdk2–cyclin-E complex" . SPARSER::BIO-COMPLEX)
    ("BMI-1, Sox2 and cyclin E" . SPARSER::COLLECTION)
    ("the sex-determining gene Sry and a regulator" . SPARSER::COLLECTION)
    ("Sry" . SPARSER::PROTEIN) ("Sox" . SPARSER::PROTEIN)
    ("a polycomb gene family transcriptional repressor and a proto-oncogene"
     . SPARSER::COLLECTION)
    ("polycomb" . SPARSER::PROTEIN) ("fetal hemoglobin" . SPARSER::PROTEIN)
    ("NRF2/antioxidant" . SPARSER::COLLECTION)
    ("a global regulator" . SPARSER::PROTEIN)
    ("enzymes and antioxidant" . SPARSER::COLLECTION)
    ("a basic redox-sensitive bZIP transcription factor" . SPARSER::PROTEIN)
    ("HO-1 and VEGF" . SPARSER::COLLECTION) ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("viable GSCs" . SPARSER::PROTEIN)
    ("pluripotency-associated genes" . SPARSER::GENE)
    ("Nrf2, Sox2, BMI-1 and Cyclin E" . SPARSER::COLLECTION)
    ("puromycin" . SPARSER::DRUG) ("Cdk2–cyclin-E" . SPARSER::COLLECTION)
    ("BMI-1, Sox2 and Cyclin E" . SPARSER::COLLECTION)
    ("Sox2, BMI-1 and Cyclin E" . SPARSER::COLLECTION)
    ("glutathione reductase and peroxidase" . SPARSER::COLLECTION)
    ("peroxidase" . SPARSER::PROTEIN)
    ("basic leucine zipper protein" . SPARSER::PROTEIN)
    ("Nuclear erythroid-2-related factor 2" . SPARSER::PROTEIN)
    ("CD133 and Nestin" . SPARSER::COLLECTION)
    ("BMI-1, Sox2 and CyclinE" . SPARSER::COLLECTION)
    ("CyclinE" . SPARSER::PROTEIN-FAMILY)
    ("Nestin, Nrf2, BMI-1, Sox2 and Cyclin E" . SPARSER::COLLECTION)
    ("Nestin" . SPARSER::PROTEIN)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Nuclear factor rythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("GSCs" . SPARSER::PROTEIN) ("G1–S" . SPARSER::PROTEIN)
    ("NRF2" . SPARSER::PROTEIN) ("cyclin-E" . SPARSER::PROTEIN-FAMILY)
    ("Cdk2" . SPARSER::PROTEIN) ("cyclin E" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("glutathione reductase" . SPARSER::PROTEIN)
    ("Cyclin E" . SPARSER::PROTEIN) ("BMI-1" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN) ("cytokine or VPA" . SPARSER::COLLECTION)
    ("total cellular STAT3" . SPARSER::PROTEIN)
    ("PKR and other ISGs [ xref ]" . SPARSER::COLLECTION)
    ("STAT1, PKR and other ISGs [ xref ]" . SPARSER::COLLECTION)
    ("the late viral promoter" . SPARSER::PROMOTER) ("ICP" . SPARSER::PROTEIN)
    ("the most aggressive forms" . SPARSER::FORM) ("OG" . SPARSER::PROTEIN)
    ("Cytokine" . SPARSER::PROTEIN) ("NFkB" . SPARSER::PROTEIN)
    ("VPA" . SPARSER::PROTEIN)
    ("FLAG-STAT3 expressing cells IFNalpha’s" . SPARSER::COLLECTION)
    ("receptor (IFNR)" . SPARSER::RECEPTOR) ("IFNR" . SPARSER::PROTEIN)
    ("IFNalpha" . SPARSER::PROTEIN)
    ("PKR, STAT1, IRF3 and IRF7" . SPARSER::COLLECTION)
    ("PKR, STAT1, IRF3, and IRF7" . SPARSER::COLLECTION)
    ("PKR" . SPARSER::PROTEIN) ("STAT3 or FLAG" . SPARSER::COLLECTION)
    ("transfectants" . SPARSER::PROTEIN) ("pCR" . SPARSER::PROTEIN)
    ("FLAG-STAT3" . SPARSER::COLLECTION) ("HA-STAT3" . SPARSER::COLLECTION)
    ("pharmacologic modulators or immunomodulators" . SPARSER::COLLECTION)
    ("modulators or immunomodulators" . SPARSER::COLLECTION)
    ("immunomodulators" . SPARSER::DRUG)
    ("subsequent biologic" . SPARSER::DRUG) ("OVs" . SPARSER::MOLECULE)
    ("LLL" . SPARSER::MOLECULE)
    ("oncolytic herpes simplex virus type 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OV" . SPARSER::MOLECULE) ("ICP34.5" . SPARSER::PROTEIN)
    ("valproic acid" . SPARSER::MOLECULE) ("IRF7" . SPARSER::PROTEIN)
    ("IRF3" . SPARSER::PROTEIN) ("IFNα" . SPARSER::PROTEIN)
    ("anti-Histone" . SPARSER::PROTEIN)
    ("trypsin inhibitor" . SPARSER::PROTEIN) ("hIL-6" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("Interleukin 6" . SPARSER::PROTEIN) ("Valproic Acid" . SPARSER::MOLECULE)
    ("type 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGX221 and AS252424" . SPARSER::COLLECTION)
    ("p110α and the E545K mutant" . SPARSER::COLLECTION)
    ("the exogenous substrate" . SPARSER::SUBSTRATE)
    ("cast" . SPARSER::PROTEIN)
    ("the correct conformation" . SPARSER::BIO-CONFORMATION)
    ("Divalent cations" . SPARSER::MOLECULE) ("cations" . SPARSER::MOLECULE)
    ("p110γ and the H1047R mutant" . SPARSER::COLLECTION)
    ("ATP-competitive" . SPARSER::ATP)
    ("all human class-1 PI 3-kinase isoforms as well as 2"
     . SPARSER::COLLECTION)
    ("LY294002 and A66 ( xref and xref )" . SPARSER::COLLECTION)
    ("protein kinase and lipid" . SPARSER::COLLECTION)
    ("p110α and the oncogenic mutants ( xref and xref )" . SPARSER::COLLECTION)
    ("p110 and p85" . SPARSER::COLLECTION) ("Wortmannin" . SPARSER::PROTEIN)
    ("first challenged all the isoforms and mutants" . SPARSER::COLLECTION)
    ("isoforms and mutants" . SPARSER::COLLECTION)
    ("LY294002 and wortmannin" . SPARSER::COLLECTION)
    ("mutant and wildtype" . SPARSER::COLLECTION)
    ("p110β and the oncogenic mutants" . SPARSER::COLLECTION)
    ("p110 γ and p110α" . SPARSER::COLLECTION)
    ("Mg 2+ or both ( xref )" . SPARSER::COLLECTION)
    ("all the isoforms and the two oncogenic mutants in the presence of Mn 2+"
     . SPARSER::COLLECTION)
    ("p110α and p110δ" . SPARSER::COLLECTION) ("Cation" . SPARSER::MOLECULE)
    ("p110α and p110β" . SPARSER::COLLECTION)
    ("all Class-I PI 3-kinases as well as two common oncogenic mutants"
     . SPARSER::COLLECTION)
    ("Class" . CLASS) ("an exogenous substrate" . SPARSER::SUBSTRATE)
    ("all the Class I PI 3-kinases as well as two common p110α oncogenic mutants (H1047R and E545K)"
     . SPARSER::COLLECTION)
    ("the most abundant divalent cation" . SPARSER::MOLECULE)
    ("cation" . SPARSER::MOLECULE) ("4EBP1 and H-Ras" . SPARSER::COLLECTION)
    ("Exogenous targets" . SPARSER::TARGET-PROTEIN)
    ("the lipid and protein kinase activities" . SPARSER::COLLECTION)
    ("Interestingly some small molecules" . SPARSER::MOLECULE)
    ("PtdIns" . SPARSER::PROTEIN)
    ("p101, p84 or p87PIKAP" . SPARSER::COLLECTION) ("b" . SPARSER::PROTEIN)
    ("p85β, p55α, p50α or p55γ" . SPARSER::COLLECTION)
    ("wortmannin and TGX221" . SPARSER::COLLECTION)
    ("lipid and protein" . SPARSER::COLLECTION)
    ("wortmannin" . SPARSER::PROTEIN) ("p110β and p110γ" . SPARSER::COLLECTION)
    ("p110α, p110β and p110γ" . SPARSER::COLLECTION)
    ("GM-CSF/IL-3" . SPARSER::COLLECTION)
    ("exogenous substrates" . SPARSER::SUBSTRATE) ("p110 γ" . SPARSER::PROTEIN)
    ("PP2A" . SPARSER::PROTEIN) ("Protein Kinase" . SPARSER::PROTEIN)
    ("AS252424" . SPARSER::DRUG) ("TGX-221" . SPARSER::DRUG)
    ("Class 1" . SPARSER::PROTEIN-FAMILY)
    ("PI 3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p110" . SPARSER::PROTEIN)
    ("Class I" . SPARSER::PROTEIN) ("magnesium dependent" . SPARSER::PROTEIN)
    ("H-Ras" . SPARSER::PROTEIN) ("PDE3B" . SPARSER::PROTEIN)
    ("MEK-1" . SPARSER::PROTEIN) ("IRS-1" . SPARSER::PROTEIN)
    ("protein phosphatase 2A" . SPARSER::PROTEIN) ("PI 3-K" . SPARSER::PROTEIN)
    ("p87PIKAP" . SPARSER::PROTEIN) ("p84" . SPARSER::PROTEIN)
    ("p101" . SPARSER::PROTEIN) ("PI3-K" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN) ("p55γ" . SPARSER::PROTEIN)
    ("p55" . SPARSER::PROTEIN) ("p85β" . SPARSER::PROTEIN)
    ("p85" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("class 1" . SPARSER::PROTEIN-FAMILY) ("TGX221" . SPARSER::DRUG)
    ("PIK-75" . SPARSER::DRUG) ("p110δ" . SPARSER::PROTEIN)
    ("p110γ" . SPARSER::PROTEIN) ("p110β" . SPARSER::PROTEIN)
    ("p110α" . SPARSER::PROTEIN)
    ("PI 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MSI" . SPARSER::PROTEIN)
    ("KRAS , TP53 , and let-7a" . SPARSER::COLLECTION)
    ("at least one wild-type allele" . SPARSER::ALLELE)
    ("homozygous wild-type TP53 alleles" . SPARSER::ALLELE)
    ("KO and mutant" . SPARSER::COLLECTION)
    ("at least one wild-type TP53 allele" . SPARSER::ALLELE)
    ("CRT and let-7a" . SPARSER::COLLECTION) ("Alleles" . SPARSER::ALLELE)
    ("TP53 and let-7a" . SPARSER::COLLECTION)
    ("mutant KRAS and various TP53 genotypes" . SPARSER::COLLECTION)
    ("TP53 and KRAS" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGFR)" . SPARSER::PROTEIN)
    ("CRCs" . SPARSER::PROTEIN) ("CRC" . SPARSER::PROTEIN)
    ("TP53 , KRAS , and let-7a" . SPARSER::COLLECTION)
    ("−/mut" . SPARSER::COLLECTION) ("CRT" . SPARSER::PROTEIN)
    ("KRAS, TP53 , and let-7a" . SPARSER::COLLECTION)
    ("KRAS and TP53" . SPARSER::COLLECTION) ("PIK3" . SPARSER::PROTEIN)
    ("micro-RNA" . SPARSER::MICRO-RNA) ("let-7" . SPARSER::RNA)
    ("Micro-RNAs" . SPARSER::MICRO-RNA) ("WNTs" . SPARSER::PROTEIN)
    ("Multi" . SPARSER::PROTEIN) ("TGF-β, EGF and TNF-α" . SPARSER::COLLECTION)
    ("TNF-α or EGF" . SPARSER::COLLECTION)
    ("TGF-β, TNF-α or EGF" . SPARSER::COLLECTION)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("/E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and catenin" . SPARSER::COLLECTION)
    ("catenins and E-cadherin" . SPARSER::COLLECTION)
    ("SCCs" . SPARSER::PROTEIN)
    ("isoform 3 and β-catenin" . SPARSER::COLLECTION)
    ("MNB" . SPARSER::PROTEIN) ("Catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("their pathological states" . SPARSER::BIO-STATE)
    ("E-cadherin, and E-cadherin" . SPARSER::COLLECTION)
    ("COOH" . SPARSER::PROTEIN) ("the shortest variants" . SPARSER::VARIANT)
    ("the longest variant" . SPARSER::VARIANT)
    ("filaments and microtubules" . SPARSER::COLLECTION)
    ("Catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGF or TNF-α" . SPARSER::COLLECTION)
    ("TGF-β, EGF or TNF-α" . SPARSER::COLLECTION)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("aggressive states" . SPARSER::BIO-STATE)
    ("p120-catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pp120" . SPARSER::PROTEIN)
    ("p120 catenin" . SPARSER::PROTEIN) ("HSC2" . SPARSER::PROTEIN)
    ("isoform 3" . SPARSER::PROTEIN) ("isoform 2" . SPARSER::PROTEIN)
    ("isoform 4" . SPARSER::PROTEIN) ("isoform 1" . SPARSER::PROTEIN)
    ("p120" . SPARSER::PROTEIN)
    ("Cyclin D1 and the hypo-phosphorylated retinoblastoma protein (p-pRb)"
     . SPARSER::COLLECTION)
    ("the hypo-phosphorylated retinoblastoma protein" . SPARSER::PROTEIN)
    ("BASP1 (brain acid-soluble protein 1) and WTIP (WT1 interacting protein)"
     . SPARSER::COLLECTION)
    ("WTIP" . SPARSER::PROTEIN)
    ("Snail, Slug and E-cadherin" . SPARSER::COLLECTION)
    ("the cell cycle regulators Cyclin D1 and p-pRb" . SPARSER::COLLECTION)
    ("WT1 and STAT3" . SPARSER::COLLECTION)
    ("Cyclin D1 and Bcl-xL" . SPARSER::COLLECTION)
    ("suppressor or oncogene" . SPARSER::COLLECTION)
    ("Cyclin D1 and cyclin-depended-kinase" . SPARSER::COLLECTION)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphoprotein" . SPARSER::PROTEIN)
    ("Cyclin D1, c-myc, and Bcl-xL" . SPARSER::COLLECTION)
    ("a tumor suppressor gene in Wilm’s" . SPARSER::PROTEIN)
    ("Case" . SPARSER::PROTEIN)
    ("STAT3 and p-STAT3 (S727 and Y705)" . SPARSER::COLLECTION)
    ("Cyclin D1 and p-pRb protein" . SPARSER::COLLECTION)
    ("Cyclin D1 and p-pRb" . SPARSER::COLLECTION)
    ("pLV-GFP" . SPARSER::COLLECTION) ("pLV-GFP-WT1" . SPARSER::COLLECTION)
    ("WT1-shRNA" . SPARSER::COLLECTION) ("IOD" . SPARSER::MOLECULE)
    ("cyclin D1 and Bcl-xL" . SPARSER::COLLECTION)
    ("Mcl-1 and Bcl-xL" . SPARSER::COLLECTION)
    ("Cyclin D1 and the phosphorylated retinoblastoma protein (p-pRb)"
     . SPARSER::COLLECTION)
    ("p-pRb" . SPARSER::COLLECTION) ("soluble protein 1" . SPARSER::PROTEIN)
    ("BASP1" . SPARSER::PROTEIN) ("co-factors" . SPARSER::MOLECULE)
    ("CDK4" . SPARSER::PROTEIN) ("CCK-8" . SPARSER::MOLECULE)
    ("Bcl-2L" . SPARSER::PROTEIN) ("F-H" . SPARSER::PROTEIN)
    ("Bcl-xL" . SPARSER::PROTEIN) ("Mcl-1" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN)
    ("PTEN (in this study) or other molecules" . SPARSER::COLLECTION)
    ("PTEN and other molecules" . SPARSER::COLLECTION)
    ("possible chaperone molecules" . SPARSER::MOLECULE)
    ("the traditional prostate cancer biomarker" . SPARSER::MOLECULE)
    ("PSA and exosomal-PTEN" . SPARSER::COLLECTION)
    ("the traditional biomarker" . SPARSER::MOLECULE)
    ("exosomal PSA" . SPARSER::PROTEIN) ("Simple" . SPARSER::PROTEIN)
    ("antibodies and Sepharose" . SPARSER::COLLECTION)
    ("previously documented elevated serum PSA" . SPARSER::PROTEIN)
    ("CHO-EGFR" . SPARSER::COLLECTION)
    ("Epidermal Growth Factor Receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Oncogenes" . SPARSER::ONCOGENE) ("Acceptor" . SPARSER::MOLECULE)
    ("pAKT" . SPARSER::PROTEIN-FAMILY) ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinase (AKT)" . SPARSER::KINASE) ("Active" . SPARSER::ACTIVE)
    ("PC-3" . SPARSER::COLLECTION) ("microvesicular PTEN" . SPARSER::PROTEIN)
    ("siRNA and DU145Kd" . SPARSER::COLLECTION)
    ("indolent and life-threatening forms" . SPARSER::FORM)
    ("relatively smaller type" . TYPE) ("cellular PIP-3" . SPARSER::MOLECULE)
    ("exosomal PTEN" . SPARSER::PROTEIN)
    ("prostate-specific antigen (PSA)" . SPARSER::PROTEIN)
    ("PSA" . SPARSER::PROTEIN) ("PIP2" . SPARSER::PROTEIN)
    ("Nedd4" . SPARSER::PROTEIN) ("Ndfip1" . SPARSER::PROTEIN)
    ("protein-G" . SPARSER::PROTEIN) ("CI-1033" . SPARSER::DRUG)
    ("Du145" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KIP1" . SPARSER::PROTEIN) ("PIP3" . SPARSER::PIP3)
    ("DiC8" . SPARSER::DRUG) ("U87" . SPARSER::PROTEIN)
    ("PIP-3" . SPARSER::MOLECULE)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("fasudil" . SPARSER::DRUG) ("ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("ROCKs" . SPARSER::PROTEIN-FAMILY)
    ("scaffolding proteins and actin-binding proteins (ABPs)"
     . SPARSER::COLLECTION)
    ("the incurable factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pCAG-myc" . SPARSER::COLLECTION)
    ("pCAG-myc-p160 ROCK" . SPARSER::COLLECTION) ("pCAG" . SPARSER::PROTEIN)
    ("thin" . SPARSER::PROTEIN) ("rhodamine" . SPARSER::PROTEIN)
    ("Rho/ROCK" . SPARSER::COLLECTION) ("FBS" . SPARSER::PROTEIN)
    ("U87MG and U251" . SPARSER::COLLECTION)
    ("gene, and ROCK1 protein" . SPARSER::COLLECTION)
    ("SLC16A1" . SPARSER::PROTEIN)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("approximately 21–23 nucleotides" . SPARSER::NUCLEOTIDE)
    ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("rho-associated coiled-coil" . SPARSER::PROTEIN)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("ROCK2" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ITGB1" . SPARSER::PROTEIN) ("LAMC1" . SPARSER::PROTEIN)
    ("IQGAP1" . SPARSER::PROTEIN)
    ("Ras GTPase activating protein 1" . SPARSER::PROTEIN)
    ("p160 ROCK" . SPARSER::PROTEIN) ("K+" . SPARSER::MOLECULE)
    ("ROCK1 protein" . SPARSER::PROTEIN) ("member 1" . SPARSER::PROTEIN)
    ("solute carrier family 16" . SPARSER::PROTEIN)
    ("SPHK1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("Y-27632" . SPARSER::MOLECULE) ("ROCK1" . SPARSER::PROTEIN)
    ("protein kinase 1" . SPARSER::PROTEIN) ("protoporphyrin" . SPARSER::DRUG)
    ("cobalt" . SPARSER::MOLECULE) ("eNOS" . SPARSER::PROTEIN)
    ("tetrahydrobiopterin" . SPARSER::DRUG)
    ("intima-media" . SPARSER::COLLECTION)
    ("fish oil-derived n-3 PUFAs" . SPARSER::MOLECULE)
    ("ischemia" . SPARSER::PROTEIN) ("Keap1-Nrf2" . SPARSER::COLLECTION)
    ("COX or PPARα" . SPARSER::COLLECTION)
    ("the COX- or lipoxygenase-mediated metabolites" . SPARSER::COLLECTION)
    ("PUFAs, or PPARs and GPR120" . SPARSER::COLLECTION)
    ("PPARs and GPR120" . SPARSER::COLLECTION) ("COX-" . SPARSER::PROTEIN)
    ("lipoxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("aldehyde" . SPARSER::MOLECULE) ("DHA or 4-HHE" . SPARSER::COLLECTION)
    ("COX1 or COX2" . SPARSER::COLLECTION) ("radical" . SPARSER::MOLECULE)
    ("antioxidants" . SPARSER::DRUG) ("COX" . SPARSER::PROTEIN)
    ("cyclooxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("either PPARα siRNA or control siRNA" . SPARSER::COLLECTION)
    ("Nrf2-HO-1" . SPARSER::COLLECTION)
    ("HO-1- or Nrf2-dependence" . SPARSER::COLLECTION)
    ("HO-1-" . SPARSER::PROTEIN) ("Antioxidant" . SPARSER::PROTEIN)
    ("GSSG" . SPARSER::DRUG) ("Redox" . SPARSER::PROTEIN)
    ("tBHP" . SPARSER::MOLECULE)
    ("DHA- as well as 4-HHE-induced" . SPARSER::COLLECTION)
    ("DHA-" . SPARSER::PROTEIN)
    ("either Nrf2 siRNA or control siRNA" . SPARSER::COLLECTION)
    ("HO-1, GCLM or p62" . SPARSER::COLLECTION)
    ("HO-1, GCLM and p62" . SPARSER::COLLECTION) ("GCLM" . SPARSER::PROTEIN)
    ("DHA, EPA and 4-HHE" . SPARSER::COLLECTION)
    ("DHA and EPA" . SPARSER::COLLECTION) ("HNE" . SPARSER::PROTEIN)
    ("ACh" . SPARSER::PROTEIN) ("fatty acid (NEFA)" . SPARSER::MOLECULE)
    ("NEFA" . SPARSER::PROTEIN) ("triglyceride" . SPARSER::MOLECULE)
    ("an important atheroprotective factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("J3 and D4 isoprostanes (as oxidation products of n-3 PUFAs)"
     . SPARSER::COLLECTION)
    ("EPA and DHA" . SPARSER::COLLECTION) ("hy" . SPARSER::MOLECULE)
    ("ligase (GCL)" . SPARSER::LIGASE) ("GCL" . SPARSER::PROTEIN)
    ("Electrophiles" . SPARSER::MOLECULE) ("redox" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptors" . SPARSER::PROTEIN)
    ("resolvins" . SPARSER::MOLECULE) ("oxidant" . SPARSER::PROTEIN)
    ("DHA and 4-HHE" . SPARSER::COLLECTION)
    ("DHA or EPA" . SPARSER::COLLECTION) ("EPA" . SPARSER::PROTEIN)
    ("DHA" . SPARSER::PROTEIN) ("PUFA" . SPARSER::PROTEIN)
    ("oxygenase" . SPARSER::PROTEIN) ("heme" . SPARSER::PROTEIN)
    ("Fish" . SPARSER::PROTEIN)
    ("antioxidant and anti-inflammatory" . SPARSER::COLLECTION)
    ("PUFAs" . SPARSER::MOLECULE) ("NADPH oxidase" . SPARSER::PROTEIN)
    ("vascular endothelial" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("COX1" . SPARSER::PROTEIN) ("RPS18" . SPARSER::PROTEIN)
    ("ribosomal protein S18" . SPARSER::PROTEIN)
    ("sequestosome 1" . SPARSER::PROTEIN) ("Fatty Acid" . SPARSER::MOLECULE)
    ("lamin A/C" . SPARSER::PROTEIN) ("Anti-β" . SPARSER::PROTEIN)
    ("α-tocopherol" . SPARSER::MOLECULE)
    ("tert -butyl hydroperoxide" . SPARSER::MOLECULE)
    ("NS-398" . SPARSER::DRUG) ("H2DCFDA" . SPARSER::DRUG)
    ("J3" . SPARSER::PROTEIN) ("NQO1" . SPARSER::PROTEIN)
    ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE) ("γ-glutamyl" . SPARSER::MOLECULE)
    ("Keap1" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("GPR120" . SPARSER::PROTEIN)
    ("G protein-coupled receptor 120" . SPARSER::PROTEIN)
    ("NFκB" . SPARSER::PROTEIN) ("docosahexaenoic acids" . SPARSER::MOLECULE)
    ("N-3" . SPARSER::PROTEIN) ("docosahexaenoic acid" . SPARSER::MOLECULE)
    ("HO-1" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("n-3" . SPARSER::PROTEIN) ("∼2.5E–11 new RBC" . SPARSER::PROTEIN)
    ("ID" . SPARSER::PROTEIN) ("MIM" . SPARSER::PROTEIN)
    ("increased LD and homogenous LD" . SPARSER::COLLECTION)
    ("homogenous LD" . SPARSER::PROTEIN) ("TFIID" . SPARSER::PROTEIN)
    ("TAF3 and TBP" . SPARSER::COLLECTION) ("Taf3" . SPARSER::PROTEIN)
    ("MEL" . SPARSER::PROTEIN) ("Taf" . SPARSER::PROTEIN)
    ("NS-shRNA" . SPARSER::COLLECTION) ("NS" . SPARSER::PROTEIN)
    ("shRNAs" . SPARSER::PROTEIN) ("proteins (TBP)" . SPARSER::PROTEIN)
    ("TBP" . SPARSER::PROTEIN)
    ("deacetylases and histone" . SPARSER::COLLECTION)
    ("TESS" . SPARSER::PROTEIN) ("erythroid" . SPARSER::PROTEIN)
    ("FHS" . SPARSER::PROTEIN) ("HET" . SPARSER::PROTEIN)
    ("SE  " . SPARSER::PROTEIN) ("any known gene A group" . SPARSER::MOLECULE)
    ("known gene" . SPARSER::GENE) ("GW" . SPARSER::PROTEIN)
    ("haemoglobin" . SPARSER::MOLECULE)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("acquired factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("corpuscular hemoglobin (MCH)" . SPARSER::PROTEIN)
    ("MCH" . SPARSER::PROTEIN) ("RBC" . SPARSER::PROTEIN)
    ("spectrin" . SPARSER::PROTEIN) ("hemoglobin" . SPARSER::PROTEIN)
    ("meta" . SPARSER::PROTEIN) ("SPTA 1" . SPARSER::PROTEIN)
    ("TRF3" . SPARSER::PROTEIN) ("YY1" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("(beta  " . SPARSER::PROTEIN)
    ("h12" . SPARSER::PROTEIN) ("e7" . SPARSER::PROTEIN-FAMILY)
    ("age 2" . SPARSER::PROTEIN)
    ("TATA box binding protein (TBP)-associated factor" . SPARSER::PROTEIN)
    ("PTA1" . SPARSER::PROTEIN) ("SPTA1" . SPARSER::PROTEIN)
    ("TAF3" . SPARSER::PROTEIN) ("β-catenin/T-cell" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION) ("TCF" . SPARSER::PROTEIN)
    ("NLK/c-Myb" . SPARSER::COLLECTION)
    ("potential prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Myb" . SPARSER::PROTEIN)
    ("a poor prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acute myelogenous leukemia" . SPARSER::PROTEIN)
    ("factors and cofactors" . SPARSER::COLLECTION)
    ("Bcl-2 and c-myc" . SPARSER::COLLECTION)
    ("HIPK2 and NLK" . SPARSER::COLLECTION)
    ("c-Myb, and NLK" . SPARSER::COLLECTION)
    ("TAK1, HIPK2, and NLK" . SPARSER::COLLECTION)
    ("c-myc and bcl-2" . SPARSER::COLLECTION)
    ("PI and Annexin V" . SPARSER::COLLECTION) ("PCNA" . SPARSER::PROTEIN)
    ("other prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER or PR" . SPARSER::COLLECTION) ("NLK-" . SPARSER::PROTEIN)
    ("NLK and c-Myb" . SPARSER::COLLECTION)
    ("NLK and c-MYB" . SPARSER::COLLECTION)
    ("Representative examples" . SPARSER::EXAMPLE)
    ("c-Myb and the proliferation index Ki-67" . SPARSER::COLLECTION)
    ("NLK, c-Myb and the proliferation index Ki-67" . SPARSER::COLLECTION)
    ("NLK, c-Myb and Ki-67" . SPARSER::COLLECTION)
    ("NLK and cytoplasmic c-Myb" . SPARSER::COLLECTION)
    ("HIPKs" . SPARSER::PROTEIN-FAMILY) ("nemo" . SPARSER::PROTEIN)
    ("MAPKKK or MAP3K" . SPARSER::COLLECTION) ("MAPKKK" . SPARSER::PROTEIN)
    ("Nemo-like kinase (NLK)" . SPARSER::PROTEIN)
    ("Erk/MAPK" . SPARSER::COLLECTION)
    ("extracellular-signal regulated kinase" . SPARSER::PROTEIN-PAIR)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-myc and Bcl2" . SPARSER::COLLECTION) ("NLK" . SPARSER::PROTEIN)
    ("c-myb" . SPARSER::PROTEIN) ("HIPK2" . SPARSER::PROTEIN)
    ("c-Myb protein" . SPARSER::PROTEIN) ("c-MYB" . SPARSER::PROTEIN)
    ("M/L" . SPARSER::PROTEIN) ("bcl-2" . SPARSER::PROTEIN)
    ("caspase3" . SPARSER::PROTEIN) ("Na3VO4" . SPARSER::MOLECULE)
    ("H2O2" . SPARSER::DRUG)
    ("homeodomain-interacting protein kinase 2" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Wnt-1" . SPARSER::PROTEIN)
    ("MAP3K" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAK1" . SPARSER::PROTEIN) ("signal regulated kinase" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("c-Myb" . SPARSER::PROTEIN)
    ("Nemo-like kinase" . SPARSER::PROTEIN) ("gefinitib" . SPARSER::DRUG)
    ("multiple growth factor receptors and their ligands"
     . SPARSER::COLLECTION)
    ("the only reliable predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the entire cohort" . SPARSER::MOLECULE)
    ("Log-Rank" . SPARSER::COLLECTION) ("Log" . SPARSER::PROTEIN)
    ("SD" . SPARSER::PROTEIN)
    ("the erlotinib-sensitive tumor PANC410" . SPARSER::PROTEIN)
    ("markedly higher Mig6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PANC" . SPARSER::PROTEIN)
    ("which lacks endogenous Mig6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HA-Mig6" . SPARSER::COLLECTION) ("cetuximab" . SPARSER::DRUG)
    ("PDGFR, FGFR,VEGRR, c-MET, FLT-3 and AXL" . SPARSER::COLLECTION)
    ("p-RTK" . SPARSER::COLLECTION) ("HN" . SPARSER::PROTEIN)
    ("p-ERK1/2 and Mig6" . SPARSER::COLLECTION) ("p-ERK1/2" . SPARSER::PROTEIN)
    ("p-AKT" . SPARSER::COLLECTION) ("fresh Mig6 antibody" . SPARSER::ANTIBODY)
    ("PI3K-AKT-mTOR" . SPARSER::COLLECTION)
    ("rapamycin, or U0126" . SPARSER::COLLECTION)
    ("an AKT1/2 kinase inhibitor (AKI, at 5 and 10 µM) or a MEK inhibitor (U0126, at 5 and 10 µM)"
     . SPARSER::COLLECTION)
    ("erlotinib or DMSO" . SPARSER::COLLECTION)
    ("EGFR and Mig6" . SPARSER::COLLECTION)
    ("Mig6 and EGFR" . SPARSER::COLLECTION) ("Errfi1" . SPARSER::PROTEIN)
    ("RALT, ERRFI1 or Gene" . SPARSER::COLLECTION)
    ("EGFR and ERBB2" . SPARSER::COLLECTION) ("RALT" . SPARSER::PROTEIN)
    ("a prospectively followed cohort" . SPARSER::MOLECULE)
    ("Mig6/EGFR" . SPARSER::COLLECTION) ("PI3K-AKT" . SPARSER::COLLECTION)
    ("TK" . SPARSER::PROTEIN) ("anti- EGFR" . SPARSER::PROTEIN)
    ("Receptor Tyrosine Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p44" . SPARSER::PROTEIN) ("OSI-774" . SPARSER::DRUG)
    ("anti-ERBB2" . SPARSER::DRUG) ("FLT-3" . SPARSER::PROTEIN)
    ("p-ERK1" . SPARSER::PROTEIN) ("LY294002" . SPARSER::MOLECULE)
    ("AKT1" . SPARSER::PROTEIN) ("ERRFI1" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("Mig6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIMPs and other proteases" . SPARSER::COLLECTION)
    ("stromelysin or plasmin" . SPARSER::COLLECTION)
    ("plasmin" . SPARSER::PROTEIN) ("stromelysin" . SPARSER::PROTEIN)
    ("neither other MMPs nor TIMPs" . SPARSER::COLLECTION)
    ("JAK1 and JAK3" . SPARSER::COLLECTION)
    ("IL-6 and soluble IL-6 receptor" . SPARSER::COLLECTION)
    ("soluble IL-6 receptor" . SPARSER::PROTEIN)
    ("chondrocytes" . SPARSER::PROTEIN)
    ("ERK 1/2 and p38" . SPARSER::COLLECTION)
    ("almost all MMPs" . SPARSER::PROTEIN)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("APMA" . SPARSER::PROTEIN)
    ("neither IL-6 nor MCP-1" . SPARSER::COLLECTION)
    ("cytokines or chemokines" . SPARSER::COLLECTION)
    ("type III and elastin" . SPARSER::COLLECTION)
    ("metalloproteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIMPs" . SPARSER::PROTEIN) ("elastin" . SPARSER::PROTEIN)
    ("collagen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CT-1, oncostatin M, IL-6 and leukemia inhibitory factor"
     . SPARSER::COLLECTION)
    ("oncostatin M and IL-6" . SPARSER::COLLECTION) ("luminal" . SPARSER::DRUG)
    ("AG490 and piceatannol" . SPARSER::COLLECTION)
    ("piceatannol" . SPARSER::DRUG)
    ("SB-203580 (p38 MAP kinase inhibitor) and PD-98059 (ERK1/2 inhibitor)"
     . SPARSER::COLLECTION)
    ("JAK1, JAK2, STAT1, STAT3, and JNK" . SPARSER::COLLECTION)
    ("monoclonal neutralizing antibody" . SPARSER::ANTIBODY)
    ("IL-6 and MCP-1" . SPARSER::COLLECTION)
    ("gp130, LIFR and CT-1" . SPARSER::COLLECTION) ("LIFR" . SPARSER::PROTEIN)
    ("endotoxin, IL-6 and MCP-1" . SPARSER::COLLECTION)
    ("endotoxin" . SPARSER::MOLECULE)
    ("normal IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("family and MMP-1" . SPARSER::COLLECTION)
    ("CT-1 and its receptor" . SPARSER::COLLECTION)
    ("glycoprotein" . SPARSER::PROTEIN)
    ("the proinflammatory cytokines" . SPARSER::PROTEIN)
    ("LIF" . SPARSER::PROTEIN)
    ("proinflammatory mediators or cytokines" . SPARSER::COLLECTION)
    ("mediators or cytokines" . SPARSER::COLLECTION)
    ("angiotensin II, C-reactive protein, vascular endothelial growth factor, tumor necrosis factor-α and interleukin"
     . SPARSER::COLLECTION)
    ("native fibrillar collagens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("collagens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endopeptidases" . SPARSER::PROTEIN) ("Matrix" . SPARSER::PROTEIN-FAMILY)
    ("matrices (ECM)" . SPARSER::PROTEIN-FAMILY)
    ("c-Jun N-terminal kinase (JNK) and Janus kinase/signal transducers and activators"
     . SPARSER::COLLECTION)
    ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("Casein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exclusively precursor form" . SPARSER::FORM)
    ("Ribonuclease" . SPARSER::PROTEIN)
    ("interleukin-6-type proinflammatory cytokines" . SPARSER::PROTEIN)
    ("CT-1" . SPARSER::PROTEIN) ("IL-6 receptor" . SPARSER::PROTEIN)
    ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JAK3" . SPARSER::PROTEIN)
    ("SP-600125" . SPARSER::DRUG) ("SB-203580" . SPARSER::DRUG)
    ("PD-98059" . SPARSER::DRUG) ("JAK1" . SPARSER::PROTEIN)
    ("LIF receptor" . SPARSER::PROTEIN) ("gp130" . SPARSER::PROTEIN)
    ("TLR4" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ciliary neurotrophic factor" . SPARSER::PROTEIN)
    ("oncostatin M" . SPARSER::PROTEIN)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("IL-11" . SPARSER::PROTEIN) ("C-reactive protein" . SPARSER::PROTEIN)
    ("angiotensin II" . SPARSER::PROTEIN)
    ("interstitial collagenase" . SPARSER::PROTEIN)
    ("Cardiotrophin-1" . SPARSER::PROTEIN) ("MMP-1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("IL8/CXCR1" . SPARSER::COLLECTION)
    ("untreated 3D and cytokine-treated 3D" . SPARSER::COLLECTION)
    ("cytokine-treated 3D" . SPARSER::PROTEIN-FAMILY)
    ("IL8 and IL6" . SPARSER::COLLECTION) ("IL6 and IL8" . SPARSER::COLLECTION)
    ("tumor-associated macrophages" . SPARSER::PROTEIN)
    ("TNF-" . SPARSER::PROTEIN)
    ("matrix and extracellular" . SPARSER::COLLECTION)
    ("EMT and CIC" . SPARSER::COLLECTION)
    ("highly reproducible EMT" . SPARSER::PROTEIN)
    ("IκBα(pS32) and RelA(pS536)" . SPARSER::COLLECTION)
    ("IL8 and BIRC3" . SPARSER::COLLECTION)
    ("IKK and NF-κB" . SPARSER::COLLECTION)
    ("KLF4 , SOX2 , POU5F1 , MYCN and KIT" . SPARSER::COLLECTION)
    ("factors, TWIST1 , SNAI1 , SNAI2 and ZEB2" . SPARSER::COLLECTION)
    ("N-Cadherin, Vimentin, and Fibronectin" . SPARSER::COLLECTION)
    ("SR-IκB" . SPARSER::COLLECTION)
    ("TWIST1 , ZEB2 and SNAI2" . SPARSER::COLLECTION)
    ("Vimentin, N-cadherin and Fibronectin" . SPARSER::COLLECTION)
    ("HPRT" . SPARSER::PROTEIN)
    ("IL8 and BIRC3/cIAP2 in A549" . SPARSER::COLLECTION)
    ("RelA-p50" . SPARSER::COLLECTION) ("SR-IκBα" . SPARSER::COLLECTION)
    ("IKK-regulated substrates and constitutive NF-κB transcriptional activation"
     . SPARSER::COLLECTION)
    ("NF-κB-regulated genes IL8 and BIRC3/cIAP2" . SPARSER::COLLECTION)
    ("mesenchymal 3D" . SPARSER::PROTEIN-FAMILY)
    ("BIRC3/cIAP2" . SPARSER::COLLECTION)
    ("E-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("MMP9 , LOX , and COL22A1" . SPARSER::COLLECTION)
    ("LOX" . SPARSER::PROTEIN) ("glass" . SPARSER::MOLECULE)
    ("trypsinized" . SPARSER::PROTEIN)
    ("mesenchymal markers VIM" . SPARSER::PROTEIN) ("VIM" . SPARSER::PROTEIN)
    ("CDH1/E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("N-cadherin and Fibronectin" . SPARSER::COLLECTION)
    ("N-cadherin, Vimentin, and Fibronectin" . SPARSER::COLLECTION)
    ("Fibronectin" . SPARSER::PROTEIN) ("Vimentin" . SPARSER::PROTEIN)
    ("HEMA" . SPARSER::PROTEIN) ("TNF and TGFβ" . SPARSER::COLLECTION)
    ("IκB/β-TrCP" . SPARSER::COLLECTION) ("RS" . SPARSER::PROTEIN)
    ("SCF" . SPARSER::PROTEIN) ("IKK" . SPARSER::PROTEIN)
    ("RelB, cRel, p50 and p52" . SPARSER::COLLECTION)
    ("RelA/p65" . SPARSER::COLLECTION) ("cRel" . SPARSER::PROTEIN)
    ("RelB" . SPARSER::PROTEIN) ("RelA" . SPARSER::PROTEIN)
    ("Rel" . SPARSER::PROTEIN) ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("SNAI1/Snail" . SPARSER::COLLECTION)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("growth factors, and cytokines" . SPARSER::COLLECTION)
    ("TWIST1 , SNAI2 , and ZEB2" . SPARSER::COLLECTION)
    ("The pleiotropic transcription factor" . SPARSER::PROTEIN)
    ("MYCN , and KIT" . SPARSER::COLLECTION)
    ("POU5F1/Oct4" . SPARSER::COLLECTION) ("KIT" . SPARSER::PROTEIN)
    ("MYCN" . SPARSER::PROTEIN) ("CIC" . SPARSER::PROTEIN)
    ("SNAI2/Slug" . SPARSER::COLLECTION) ("SNAI1/Snail1" . SPARSER::COLLECTION)
    ("Sip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Slug" . SPARSER::PROTEIN)
    ("Lin-28B" . SPARSER::PROTEIN) ("CXCR1" . SPARSER::PROTEIN)
    ("cIAP2" . SPARSER::PROTEIN) ("BIRC3" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("COL22A1" . SPARSER::PROTEIN)
    ("ERV3" . SPARSER::PROTEIN) ("E-Cadherin" . SPARSER::PROTEIN)
    ("Twist1" . SPARSER::PROTEIN) ("HMGA2" . SPARSER::PROTEIN)
    ("N-cadherin" . SPARSER::PROTEIN) ("IκBα" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("p50" . SPARSER::PROTEIN) ("POU5F1" . SPARSER::PROTEIN)
    ("ZEB2" . SPARSER::PROTEIN) ("SNAI2" . SPARSER::PROTEIN)
    ("Snail1" . SPARSER::PROTEIN) ("SNAI1" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN) ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transforming growth factor beta" . SPARSER::PROTEIN)
    ("the second exonic base" . SPARSER::PROTEIN)
    ("AG/GT" . SPARSER::COLLECTION) ("GT" . SPARSER::PROTEIN)
    ("AG" . SPARSER::PROTEIN) ("PALB2 and BRCA1" . SPARSER::COLLECTION)
    ("hereditary breast/pancreatic cancer families" . SPARSER::PROTEIN-FAMILY)
    ("cryptic" . SPARSER::PROTEIN) ("Variants" . SPARSER::VARIANT)
    ("Gln" . SPARSER::AMINO-ACID) ("Ala" . SPARSER::AMINO-ACID)
    ("another 21 different PALB2 variants and polymorphims ( xref )"
     . SPARSER::COLLECTION)
    ("progesterone receptor (PR) and HER2" . SPARSER::COLLECTION)
    ("estrogen receptor (ER), progesterone receptor (PR) and HER2"
     . SPARSER::COLLECTION)
    ("translation-stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA2 -negative breast/ovarian cancer families"
     . SPARSER::PROTEIN-FAMILY)
    ("hereditary breast cancer families" . SPARSER::PROTEIN-FAMILY)
    ("BRCA2/FANCD1" . SPARSER::COLLECTION)
    ("PALB2/FANCN" . SPARSER::COLLECTION) ("DNA-damage" . SPARSER::DNA)
    ("PALB2 and BRCA2" . SPARSER::COLLECTION) ("HNPCC" . SPARSER::PROTEIN)
    ("multiple melanoma, Peutz-Jeghers and Familial pancreatitis"
     . SPARSER::COLLECTION)
    ("STK11 , and PRSS1" . SPARSER::COLLECTION)
    ("p16/CDKN2A" . SPARSER::COLLECTION)
    ("other hereditary factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("moderate and low penetrance susceptibility genes" . SPARSER::GENE)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("TP53 and PTEN" . SPARSER::COLLECTION)
    ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA1/BRCA2" . SPARSER::COLLECTION) ("FANCN" . SPARSER::PROTEIN)
    ("FANCD1" . SPARSER::PROTEIN) ("Wilms tumor" . SPARSER::PROTEIN)
    ("Fanconi anemia" . SPARSER::PROTEIN)
    ("partner and localizer of BRCA2" . SPARSER::PROTEIN)
    ("PRSS1" . SPARSER::PROTEIN) ("STK11" . SPARSER::PROTEIN)
    ("CDKN2A" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN) ("cohesin" . SPARSER::PROTEIN)
    ("HP1α and KAP-1" . SPARSER::COLLECTION) ("camptothecin" . SPARSER::DRUG)
    ("HP1α or KAP-1" . SPARSER::COLLECTION)
    ("XRCC1 or DNA ligase I" . SPARSER::COLLECTION)
    ("PARP, XRCC1 and DNA ligase I/III" . SPARSER::COLLECTION)
    ("XRCC3-" . SPARSER::PROTEIN) ("BRCA2-" . SPARSER::PROTEIN)
    ("unphosphorylatable KAP-1" . SPARSER::PROTEIN)
    ("foci and chromatid" . SPARSER::COLLECTION)
    ("BRCA2 and/or KAP-1" . SPARSER::COLLECTION)
    ("HR and DSB" . SPARSER::COLLECTION)
    ("BRCA2 and KAP-1" . SPARSER::COLLECTION)
    ("functional GFP" . SPARSER::PROTEIN) ("endonuclease" . SPARSER::PROTEIN)
    ("SCE" . SPARSER::PROTEIN) ("S3B and S3C" . SPARSER::COLLECTION)
    ("mutants and cells" . SPARSER::COLLECTION)
    ("CtIP or BLM" . SPARSER::COLLECTION)
    ("DNA-PKcs and ATR" . SPARSER::COLLECTION) ("RPA" . SPARSER::PROTEIN)
    ("pATM" . SPARSER::PROTEIN) ("BRCA2 or RAD51" . SPARSER::COLLECTION)
    ("the fast and the slow component" . SPARSER::COLLECTION)
    ("HP" . SPARSER::PROTEIN) ("heterochromatin (HC)" . SPARSER::PROTEIN)
    ("EC" . SPARSER::PROTEIN) ("HC" . SPARSER::PROTEIN)
    ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("BRCA2, XRCC2, and XRCC3" . SPARSER::COLLECTION)
    ("BLM/DNA2" . SPARSER::COLLECTION) ("BLM" . SPARSER::PROTEIN)
    ("CtIP" . SPARSER::PROTEIN) ("homologous DNA" . SPARSER::DNA)
    ("XLF/Cernunnos" . SPARSER::COLLECTION) ("Cernunnos" . SPARSER::PROTEIN)
    ("holoenzyme" . SPARSER::PROTEIN)
    ("HR and instead repair heterochromatic DSBs" . SPARSER::COLLECTION)
    ("more open euchromatic DNA" . SPARSER::DNA)
    ("BRCA2, XRCC3 or RAD51" . SPARSER::COLLECTION) ("RPA2" . SPARSER::PROTEIN)
    ("Tween20" . SPARSER::MOLECULE) ("PJ34" . SPARSER::DRUG)
    ("NU7026" . SPARSER::DRUG) ("Nu7441" . SPARSER::MOLECULE)
    ("KU 60019" . SPARSER::DRUG) ("Lig III" . SPARSER::PROTEIN)
    ("HP1α" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("KU80" . SPARSER::PROTEIN) ("I-SceI" . SPARSER::PROTEIN)
    ("S3B" . SPARSER::PROTEIN) ("CHD3" . SPARSER::PROTEIN)
    ("HP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("XRCC1" . SPARSER::PROTEIN)
    ("DNA ligase I" . SPARSER::PROTEIN) ("ADP-ribose" . SPARSER::MOLECULE)
    ("RAD54" . SPARSER::PROTEIN) ("XRCC2" . SPARSER::PROTEIN)
    ("DNA2" . SPARSER::PROTEIN) ("EXO1" . SPARSER::PROTEIN)
    ("DNA ligase IV" . SPARSER::PROTEIN) ("KU70" . SPARSER::PROTEIN)
    ("RAD51" . SPARSER::PROTEIN) ("XRCC3" . SPARSER::PROTEIN)
    ("BRCA2" . SPARSER::PROTEIN) ("KAP-1" . SPARSER::PROTEIN)
    ("E6/E6-AP/p53" . SPARSER::COLLECTION)
    ("Persistent genital warts" . SPARSER::PROTEIN)
    ("heterochromatin" . SPARSER::PROTEIN) ("NAD" . SPARSER::MOLECULE)
    ("a central cytokine" . SPARSER::PROTEIN)
    ("essential components" . SPARSER::COMPONENT)
    ("one-step" . SPARSER::PROTEIN) ("accessory proteins" . SPARSER::PROTEIN)
    ("labile" . SPARSER::PROTEIN)
    ("the viral oncoprotein E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("deubiquitinases" . SPARSER::DEUBIQUITINASE) ("ligases" . SPARSER::LIGASE)
    ("proteins or cell organelles" . SPARSER::COLLECTION)
    ("viral oncoprotein" . SPARSER::PROTEIN)
    ("genital warts" . SPARSER::PROTEIN) ("two-step" . SPARSER::PROTEIN)
    ("the viral oncogenes" . SPARSER::ONCOGENE)
    ("viral capsids" . SPARSER::PROTEIN) ("capsids" . SPARSER::PROTEIN)
    ("five genital warts" . SPARSER::PROTEIN) ("warts" . SPARSER::PROTEIN)
    ("representative examples" . SPARSER::EXAMPLE)
    ("the mature form" . SPARSER::FORM) ("-HA" . SPARSER::COLLECTION)
    ("p53 and pro-IL-1β under our experimental conditions"
     . SPARSER::COLLECTION)
    ("p53 and E6-AP" . SPARSER::COLLECTION)
    ("p53 and HPV16 E6" . SPARSER::COLLECTION) ("E6/E7" . SPARSER::COLLECTION)
    ("Nigericin" . SPARSER::MOLECULE) ("ionophore" . SPARSER::MOLECULE)
    ("pro-IL1β" . SPARSER::COLLECTION) ("TUBE" . SPARSER::PROTEIN)
    ("IL-1β and p53" . SPARSER::COLLECTION)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("ultimately targets proteins" . SPARSER::PROTEIN)
    ("a trimeric complex" . SPARSER::BIO-COMPLEX) ("Pro" . SPARSER::AMINO-ACID)
    ("lysosomal and cathepsin B" . SPARSER::COLLECTION)
    ("intensely fluorescent fragments" . SPARSER::FRAGMENT)
    ("the bovine serum albumin" . SPARSER::PROTEIN) ("DQ" . SPARSER::MOLECULE)
    ("LysoTracker" . SPARSER::DRUG) ("punctae" . SPARSER::PROTEIN)
    ("LC3-punctae" . SPARSER::COLLECTION) ("lentiviral gene" . SPARSER::GENE)
    ("the cytoplasmic microtubule-associated protein 1 light chain 3"
     . SPARSER::PROTEIN)
    ("naturally occurring genetic variants" . SPARSER::VARIANT)
    ("IL-1α, IL-18 and IL-33" . SPARSER::COLLECTION)
    ("its mature form" . SPARSER::FORM)
    ("IL-6 and CCL-20" . SPARSER::COLLECTION) ("CCL" . SPARSER::DRUG)
    ("PK and immE7" . SPARSER::COLLECTION) ("immE6/E7" . SPARSER::COLLECTION)
    ("the E3 ubiquitin ligase E6-AP ( = E6-associated protein) and p53"
     . SPARSER::COLLECTION)
    ("mature IL-1β" . SPARSER::PROTEIN)
    ("E6- and E6/E7-" . SPARSER::COLLECTION) ("E7-" . SPARSER::PROTEIN-FAMILY)
    ("this central cytokine" . SPARSER::PROTEIN)
    ("neutrophils" . SPARSER::PROTEIN)
    ("NF-κB and the mitogen-activated protein (MAP) kinases p38 and JNK"
     . SPARSER::COLLECTION)
    ("p38 and JNK" . SPARSER::COLLECTION)
    ("Mature IL-1β and IL-1α" . SPARSER::COLLECTION)
    ("IL-1β and IL-1α" . SPARSER::COLLECTION) ("hyaluronan" . SPARSER::PROTEIN)
    ("inducer" . SPARSER::PROTEIN) ("pro-caspase-1" . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION)
    ("ASC" . SPARSER::HUMAN-PROTEIN-FAMILY) ("multi" . SPARSER::PROTEIN)
    ("pro-IL-1α" . SPARSER::COLLECTION) ("calpain" . SPARSER::PROTEIN)
    ("the IFN-stimulated gene factor 3 (ISGF3) trimeric complex"
     . SPARSER::BIO-COMPLEX)
    ("p48, STAT1 and STAT2" . SPARSER::COLLECTION)
    ("macrophage" . SPARSER::PROTEIN) ("leukocytes" . SPARSER::PROTEIN)
    ("chemokine" . SPARSER::PROTEIN) ("IFN" . SPARSER::PROTEIN)
    ("viral oncoproteins" . SPARSER::PROTEIN)
    ("the viral proteins E6 and E7" . SPARSER::COLLECTION)
    ("p53 and pRb" . SPARSER::COLLECTION) ("pRb" . SPARSER::PROTEIN)
    ("functional p53" . SPARSER::PROTEIN)
    ("E6- and E6/E7-immortalized" . SPARSER::COLLECTION)
    ("E6-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E6-AP and p53" . SPARSER::COLLECTION) ("pro-IL-1β" . SPARSER::COLLECTION)
    ("the HPV16 E6 and/or E7 oncogenes" . SPARSER::COLLECTION)
    ("immunomodulatory factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("P04406" . SPARSER::PROTEIN) ("P60709" . SPARSER::PROTEIN)
    ("P04637" . SPARSER::PROTEIN) ("Q05086" . SPARSER::PROTEIN)
    ("P20226" . SPARSER::PROTEIN) ("TBP-1" . SPARSER::PROTEIN)
    ("P29466" . SPARSER::PROTEIN) ("P01584" . SPARSER::PROTEIN)
    ("CIN1" . SPARSER::PROTEIN) ("UBE3A" . SPARSER::PROTEIN)
    ("Calpain inhibitor" . SPARSER::PROTEIN) ("mM 3" . SPARSER::PROTEIN)
    ("Cathepsin B" . SPARSER::PROTEIN)
    ("TATA-Box binding protein" . SPARSER::PROTEIN)
    ("Caspase-1" . SPARSER::PROTEIN)
    ("Reverse Transcriptase" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("LC3A" . SPARSER::PROTEIN) ("E6AP" . SPARSER::PROTEIN)
    ("IL-1b" . SPARSER::PROTEIN) ("IL-1 beta" . SPARSER::PROTEIN)
    ("IL-1B" . SPARSER::PROTEIN) ("steroid hormone" . SPARSER::MOLECULE)
    ("non-selective" . SPARSER::PROTEIN) ("decoy receptor" . SPARSER::PROTEIN)
    ("MCP-1" . SPARSER::PROTEIN) ("target cell" . SPARSER::PROTEIN)
    ("IL1β" . SPARSER::PROTEIN) ("cathepsin B" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IL-33" . SPARSER::PROTEIN)
    ("IL-18" . SPARSER::PROTEIN) ("ImmE6" . SPARSER::PROTEIN)
    ("immE7" . SPARSER::PROTEIN) ("immE6" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN) ("amyloid-β" . SPARSER::MOLECULE)
    ("P2X7" . SPARSER::PROTEIN) ("protein 3" . SPARSER::PROTEIN)
    ("leucine-rich repeat" . SPARSER::PROTEIN) ("caspase-1" . SPARSER::PROTEIN)
    ("IL-1α" . SPARSER::PROTEIN) ("precursor protein" . SPARSER::PROTEIN)
    ("interleukin-1β" . SPARSER::PROTEIN) ("STAT2" . SPARSER::PROTEIN)
    ("ISGF3" . SPARSER::PROTEIN) ("p48" . SPARSER::PROTEIN)
    ("IFN-κ" . SPARSER::PROTEIN) ("E6-AP" . SPARSER::PROTEIN)
    ("NALP3" . SPARSER::PROTEIN) ("IL-1β" . SPARSER::PROTEIN)
    ("knowledge-base" . SPARSER::PROTEIN) ("CHD" . SPARSER::PROTEIN)
    ("Given NAT8 ’s" . SPARSER::PROTEIN) ("Given NAT8" . SPARSER::PROTEIN)
    ("leucine or hydroperoxyleucines" . SPARSER::COLLECTION)
    ("Hydroxy-leucines" . SPARSER::COLLECTION)
    ("leucines" . SPARSER::AMINO-ACID)
    ("SLC36A2 and SLC6A20" . SPARSER::COLLECTION) ("imino" . SPARSER::MOLECULE)
    ("an electrogenic amino acid symporter" . SPARSER::PROTEIN)
    ("symporter" . SPARSER::PROTEIN)
    ("the three metabolites and the GRS" . SPARSER::COLLECTION)
    ("sentinel" . SPARSER::DRUG) ("Metabolites" . SPARSER::PROTEIN)
    ("biologic" . SPARSER::DRUG)
    ("previously reported HF-related metabolites" . SPARSER::MOLECULE)
    ("incident HF" . SPARSER::PROTEIN)
    ("hydroxy-isoleucine" . SPARSER::COLLECTION)
    ("hydroxy-leucine" . SPARSER::COLLECTION)
    ("metabolites" . SPARSER::PROTEIN) ("HF" . SPARSER::PROTEIN)
    ("NO 3" . SPARSER::PROTEIN) ("SLC6A20" . SPARSER::PROTEIN)
    ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("solute carrier family" . SPARSER::PROTEIN) ("SLC36A2" . SPARSER::PROTEIN)
    ("type 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NAT8" . SPARSER::PROTEIN)
    ("N-acetyltransferase 8" . SPARSER::PROTEIN) ("UK" . SPARSER::PROTEIN)
    ("ago" . SPARSER::PROTEIN) ("PNA-LNA" . SPARSER::COLLECTION)
    ("ARMS" . SPARSER::PROTEIN) ("HRM" . SPARSER::PROTEIN-FAMILY)
    ("wild-type DNA from tumor cells and wild-type DNA from non-malignant cells (normal epithelial cells, hematopoietic cells and stromal cells such as fibroblasts)"
     . SPARSER::COLLECTION)
    ("tyrosine kinase inhibitors (TKI) gefitinib 
( xref – xref )
and erlotinib 
( xref , xref )"
     . SPARSER::COLLECTION)
    ("transcription factor-1" . SPARSER::PROTEIN)
    ("plausible effectors" . SPARSER::EFFECTOR)
    ("Bcl2–Beclin1" . SPARSER::COLLECTION)
    ("Myc and its affected downstream targets" . SPARSER::COLLECTION)
    ("chloroquine" . SPARSER::PROTEIN)
    ("Beclin 1, PTEN and DAP" . SPARSER::COLLECTION) ("DAP" . SPARSER::PROTEIN)
    ("the autophagic substrates p62" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JNK1 and its downstream target Bcl2" . SPARSER::COLLECTION)
    ("JNK1 and Bcl2" . SPARSER::COLLECTION) ("MitoSOX" . SPARSER::DRUG)
    ("carboxy" . SPARSER::MOLECULE) ("menadione" . SPARSER::DRUG)
    ("superoxide" . SPARSER::MOLECULE) ("MAPK or ERK" . SPARSER::COLLECTION)
    ("MAPK and ERK" . SPARSER::COLLECTION)
    ("phospho-Bcl2 and phospho-JNK1" . SPARSER::COLLECTION)
    ("Bcl2 and Beclin 1" . SPARSER::COLLECTION)
    ("Bcl2-Beclin" . SPARSER::COLLECTION) ("Beclin" . SPARSER::PROTEIN)
    ("Bcl2–Beclin 1" . SPARSER::COLLECTION)
    ("p70S6 kinase (Fig.  xref A) and S6 ribosomal protein (Fig.  xref B)"
     . SPARSER::COLLECTION)
    ("p70S6 kinase or S6 ribosomal protein ( xref )" . SPARSER::COLLECTION)
    ("JNK1-Bcl2" . SPARSER::COLLECTION) ("Dendra" . SPARSER::PROTEIN)
    ("Dendra-tau" . SPARSER::COLLECTION)
    ("a photo-switchable fluorescent protein" . SPARSER::PROTEIN)
    ("tau" . SPARSER::PROTEIN) ("Myc or control siRNAs" . SPARSER::COLLECTION)
    ("GFP-p62" . SPARSER::COLLECTION) ("Halotag" . SPARSER::PROTEIN)
    ("a Halotag fluorescent ligand" . SPARSER::LIGAND)
    ("Halotag-p62" . SPARSER::COLLECTION) ("GFP-DFCP1" . SPARSER::COLLECTION)
    ("PIKfyve" . SPARSER::PROTEIN) ("puncta" . SPARSER::PROTEIN)
    ("MEFs" . SPARSER::PROTEIN) ("Max" . SPARSER::PROTEIN)
    ("Baf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("actin or tubulin" . SPARSER::COLLECTION)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("pro-LC3" . SPARSER::COLLECTION) ("repressors" . SPARSER::REPRESSOR)
    ("antisense oligonucleotides or phosphorodiamidate morpholino oligomers (PMOs)"
     . SPARSER::COLLECTION)
    ("macromolecules and organelles" . SPARSER::COLLECTION)
    ("macromolecules" . SPARSER::MOLECULE)
    ("ultraviolet radiation resistance-associated gene ( UVRAG ) and Atg4"
     . SPARSER::COLLECTION)
    ("ultraviolet radiation resistance-associated gene ( UVRAG )"
     . SPARSER::GENE)
    ("UVRAG" . SPARSER::PROTEIN) ("vacuolar protein" . SPARSER::PROTEIN)
    ("proteins, lipids and carbohydrates" . SPARSER::COLLECTION)
    ("catabolism" . SPARSER::PROTEIN)
    ("an attractive target" . SPARSER::TARGET-PROTEIN)
    ("many long-lived proteins and organelles" . SPARSER::COLLECTION)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("phenol red" . SPARSER::DRUG) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("sodium chloride" . SPARSER::DRUG) ("anti-S" . SPARSER::ANTIBODY)
    ("l -glutamine" . SPARSER::MOLECULE) ("Beclin1" . SPARSER::PROTEIN)
    ("A1 at" . SPARSER::DRUG) ("H 2 DCFDA" . SPARSER::DRUG)
    ("2’,7’-dichlorodihydrofluorescein diacetate" . SPARSER::DRUG)
    ("phospho-JNK" . SPARSER::PROTEIN) ("HA14-1" . SPARSER::DRUG)
    ("p70S6" . SPARSER::PROTEIN) ("SQSTM1" . SPARSER::PROTEIN)
    ("PI3" . SPARSER::PROTEIN) ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("DFCP1" . SPARSER::PROTEIN) ("EA1" . SPARSER::PROTEIN)
    ("GFP-LC3" . SPARSER::PROTEIN) ("Atg5" . SPARSER::PROTEIN)
    ("Bafilomycin A1" . SPARSER::DRUG)
    ("microtubule associated protein" . SPARSER::PROTEIN)
    ("anti-neoplastic" . SPARSER::DRUG) ("Atg4" . SPARSER::PROTEIN)
    ("Bif-1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-phosphate" . SPARSER::MOLECULE)
    ("Vps34" . SPARSER::PROTEIN) ("RAB5/RAB7" . SPARSER::COLLECTION)
    ("dominant negative canine RAB7" . SPARSER::PROTEIN)
    ("RAB" . SPARSER::PROTEIN) ("RAB7-" . SPARSER::PROTEIN)
    ("the fluorescent ligand" . SPARSER::LIGAND) ("mark" . SPARSER::PROTEIN)
    ("Liganded" . SPARSER::MOLECULE) ("TfnR and LAMP1" . SPARSER::COLLECTION)
    ("transferrin" . SPARSER::PROTEIN)
    ("antibody and kinase" . SPARSER::COLLECTION)
    ("the commercially available AG1478" . SPARSER::DRUG)
    ("the appropriate siRNA" . SPARSER::PROTEIN)
    ("naturally occurring EGFR ligands" . SPARSER::LIGAND)
    ("goat anti-mouse secondary antibody" . SPARSER::ANTIBODY)
    ("goat" . SPARSER::PROTEIN)
    ("RAB7, TSG101, or c-Cbl" . SPARSER::COLLECTION)
    ("more dense fractions" . SPARSER::COMPONENT) ("TFnR" . SPARSER::PROTEIN)
    ("TfnR" . SPARSER::PROTEIN) ("Percoll" . SPARSER::DRUG)
    ("LAMP-1 and EGFR" . SPARSER::COLLECTION)
    ("EGFR and EEA1" . SPARSER::COLLECTION)
    ("either EGFR (green) and EEA1(red)" . SPARSER::COLLECTION)
    ("EGFR (green) and LAMP-1(red)" . SPARSER::COLLECTION)
    ("Autoantigen" . SPARSER::DRUG) ("RAB7 or TSG101" . SPARSER::COLLECTION)
    ("control siRNA (siCON) or siRNA" . SPARSER::COLLECTION)
    ("RAB7, TSG101, or C-Cbl" . SPARSER::COLLECTION)
    ("RAB7 and TSG101" . SPARSER::COLLECTION)
    ("TSG101 and RAB7" . SPARSER::COLLECTION)
    ("TSG101 or RAB7" . SPARSER::COLLECTION)
    ("proteins, RAB7 and TSG101" . SPARSER::COLLECTION)
    ("EGFRs" . SPARSER::PROTEIN) ("clathrin" . SPARSER::PROTEIN)
    ("the receptor ( xref ) and ligands ( xref )" . SPARSER::COLLECTION)
    ("the prototypical receptor tyrosine kinase (RTK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGF:EGFR" . SPARSER::BIO-COMPLEX) ("RAB5" . SPARSER::PROTEIN)
    ("a 15" . SPARSER::PROTEIN) ("G-proteins" . SPARSER::PROTEIN)
    ("Membrane Protein" . SPARSER::PROTEIN)
    ("Transferrin receptor" . SPARSER::PROTEIN) ("C-Cbl" . SPARSER::PROTEIN)
    ("α-Tubulin" . SPARSER::PROTEIN) ("Citric Acid" . SPARSER::MOLECULE)
    ("Texas Red" . SPARSER::DRUG) ("Anti-EGFR" . SPARSER::PROTEIN)
    ("LAMP1" . SPARSER::PROTEIN) ("transferrin receptor" . SPARSER::PROTEIN)
    ("RAB11" . SPARSER::PROTEIN) ("LAMP-2" . SPARSER::PROTEIN)
    ("Transferrin Receptor" . SPARSER::PROTEIN) ("EEA1" . SPARSER::PROTEIN)
    ("LAMP-1" . SPARSER::PROTEIN) ("RAB7" . SPARSER::PROTEIN)
    ("TSG101" . SPARSER::PROTEIN) ("Tumor suppressor gene" . SPARSER::PROTEIN)
    ("b-actin" . SPARSER::PROTEIN-PAIR) ("chemicals" . SPARSER::MOLECULE)
    ("wild-type ACLY uptake significantly more phospholipids"
     . SPARSER::PHOSPHOLIPID)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("shRNA and the shRNA-resistant ACLY" . SPARSER::COLLECTION)
    ("Lipid" . SPARSER::LIPID) ("the primary deacetylase" . SPARSER::PROTEIN)
    ("SIRT2 and ACLY" . SPARSER::COLLECTION) ("MEF" . SPARSER::PROTEIN)
    ("ACLY and SIRT2" . SPARSER::COLLECTION)
    ("SIRT2-ACLY" . SPARSER::COLLECTION) ("salermide" . SPARSER::DRUG)
    ("SIRT1 ( xref ) or other SIRTs (data not shown)" . SPARSER::COLLECTION)
    ("inhibitor, and NAM" . SPARSER::COLLECTION) ("HDACs" . SPARSER::PROTEIN)
    ("ACLY and PCAF" . SPARSER::COLLECTION)
    ("cAMP response element-binding protein (CREB)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HEK" . SPARSER::PROTEIN) ("acetyltransferases" . SPARSER::PROTEIN)
    ("ACLY and UBR4" . SPARSER::COLLECTION) ("epsilon" . SPARSER::PROTEIN)
    ("high-glucose" . SPARSER::PROTEIN) ("low-glucose" . SPARSER::PROTEIN)
    ("Cycloheximide" . SPARSER::PROTEIN) ("BALB/c" . SPARSER::COLLECTION)
    ("NAM and TSA" . SPARSER::COLLECTION)
    ("antibody (α-Ac[3K]) antibody" . SPARSER::ANTIBODY)
    ("triple Q and R mutants" . SPARSER::MUTANT) ("KR" . SPARSER::PROTEIN)
    ("a glutamine (Q) or an arginine (R)" . SPARSER::COLLECTION)
    ("spec" . SPARSER::PROTEIN) ("TSA and NAM" . SPARSER::COLLECTION)
    ("deacetylases, and trichostatin" . SPARSER::COLLECTION)
    ("deacetylases" . SPARSER::PROTEIN) ("NAM" . SPARSER::PROTEIN-FAMILY)
    ("class I" . SPARSER::PROTEIN) ("Lysines" . SPARSER::AMINO-ACID)
    ("/Akt" . SPARSER::COLLECTION)
    ("ATP citrate lyase (ACLY)" . SPARSER::PROTEIN)
    ("coenzyme" . SPARSER::MOLECULE)
    ("primarily uptake lipids" . SPARSER::PROTEIN)
    ("P300/calcium-binding protein" . SPARSER::COLLECTION)
    ("acetyltransferase" . SPARSER::PROTEIN) ("PCAF" . SPARSER::PROTEIN)
    ("lyase (ACLY)" . SPARSER::PROTEIN) ("ATP-citrate" . SPARSER::ATP)
    ("ACLY" . SPARSER::PROTEIN) ("lyase" . SPARSER::PROTEIN)
    ("citrate" . SPARSER::MOLECULE) ("Sirt2" . SPARSER::PROTEIN)
    ("NAD(+)" . SPARSER::MOLECULE) ("KAT2A" . SPARSER::PROTEIN)
    ("GCN5" . SPARSER::PROTEIN) ("KAT2B" . SPARSER::PROTEIN)
    ("lysine acetyltransferase 2B" . SPARSER::PROTEIN)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("cAMP response element-binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("UBR4" . SPARSER::PROTEIN) ("2KR" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sterol regulatory element-binding protein 1" . SPARSER::PROTEIN)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("ATP citrate lyase" . SPARSER::PROTEIN)
    ("Fatty acid" . SPARSER::MOLECULE) ("SIRT2" . SPARSER::PROTEIN)
    ("sirtuin 2" . SPARSER::PROTEIN)
    ("calcium-binding protein" . SPARSER::PROTEIN) ("P300" . SPARSER::PROTEIN)
    ("the neuronal KIM-PTPs" . SPARSER::COLLECTION)
    ("PTPSL or HePTP" . SPARSER::COLLECTION)
    ("extra-synaptic glutamate receptors" . SPARSER::RECEPTOR)
    ("lobe" . SPARSER::PROTEIN) ("HePTP and PTPSL" . SPARSER::COLLECTION)
    ("p38α and the HePTP KIS" . SPARSER::COLLECTION)
    ("p38α and the PTPSL KIS ( xref )" . SPARSER::COLLECTION)
    ("NMR and SAXS" . SPARSER::COLLECTION)
    ("kinases, MKK3b and MKK6" . SPARSER::COLLECTION)
    ("KIM and HePTP" . SPARSER::COLLECTION)
    ("p38α and HePTP" . SPARSER::COLLECTION)
    ("p38α:PTPSL and p38α:STEP" . SPARSER::COLLECTION)
    ("CSP and ITC" . SPARSER::COLLECTION)
    ("MAPK:KIM-PTP" . SPARSER::BIO-COMPLEX)
    ("these essential signaling complexes" . SPARSER::BIO-COMPLEX)
    ("active-" . SPARSER::ACTIVE)
    ("the excellent fit" . SPARSER::PROTEIN-FAMILY)
    ("both STEP and the PSChimera" . SPARSER::COLLECTION)
    ("p38α and vice versa" . SPARSER::COLLECTION)
    ("STEP and p38α" . SPARSER::COLLECTION) ("apo-p38α" . SPARSER::COLLECTION)
    ("Ser/Thr" . SPARSER::COLLECTION) ("STEP and STEP" . SPARSER::COLLECTION)
    ("KIM and KIS" . SPARSER::COLLECTION) ("-STEP" . SPARSER::COLLECTION)
    ("PTPSL or STEP" . SPARSER::COLLECTION) ("Minor" . SPARSER::PROTEIN)
    ("SEC and a 2D" . SPARSER::COLLECTION) ("fused" . SPARSER::PROTEIN)
    ("SEC, and a 2D" . SPARSER::COLLECTION)
    ("full-length STEP and [ 2 H, 15 N]-p38α" . SPARSER::COLLECTION)
    ("PTPSL and HePTP" . SPARSER::COLLECTION)
    ("p38α:PTPSL and p38α:HePTP" . SPARSER::COLLECTION)
    ("PTPSL and p38α:HePTP" . SPARSER::COLLECTION)
    ("p38α:HePTP and ERK2:HePTP" . SPARSER::COLLECTION)
    ("p38α and PTPSL" . SPARSER::COLLECTION)
    ("SEC, and SAXS" . SPARSER::COLLECTION) ("Light" . SPARSER::PROTEIN)
    ("p38α or ERK2" . SPARSER::COLLECTION)
    ("the essential anchor" . SPARSER::ANCHOR) ("anchor" . SPARSER::ANCHOR)
    ("larger CSPs" . SPARSER::PROTEIN) ("KIS and HePTP" . SPARSER::COLLECTION)
    ("additional peaks experiencing larger CSPs" . SPARSER::PROTEIN)
    ("SEC" . SPARSER::PROTEIN) ("PTPSL and p38α" . SPARSER::COLLECTION)
    ("Met" . SPARSER::AMINO-ACID) ("CSP" . SPARSER::PROTEIN)
    ("KIM and STEP" . SPARSER::COLLECTION) ("CSPs" . SPARSER::PROTEIN)
    ("KIM and p38α:STEP" . SPARSER::COLLECTION)
    ("p38α:PTPSL" . SPARSER::BIO-COMPLEX) ("-p38α" . SPARSER::COLLECTION)
    ("KIM and PTPSL" . SPARSER::COLLECTION)
    ("ERK2 and HePTP" . SPARSER::COLLECTION)
    ("ERK2:HePTP" . SPARSER::BIO-COMPLEX)
    ("p38α:KIM-PTP" . SPARSER::BIO-COMPLEX) ("x-ray" . SPARSER::COLLECTION)
    ("HePTP and p38α" . SPARSER::COLLECTION) ("KIS" . SPARSER::PROTEIN)
    ("KIM" . SPARSER::PROTEIN) ("STEP and PTPSL" . SPARSER::COLLECTION)
    ("valine" . SPARSER::AMINO-ACID) ("methionine" . SPARSER::AMINO-ACID)
    ("KIMs" . SPARSER::PROTEIN) ("patch" . SPARSER::PROTEIN)
    ("ERK2 and p38" . SPARSER::COLLECTION) ("KIM-PTP" . SPARSER::COLLECTION)
    ("PTPSL/PTPBR7 (PTPRR)" . SPARSER::COLLECTION)
    ("KIM-PTPs" . SPARSER::COLLECTION) ("PTPs" . SPARSER::PROTEIN)
    ("p38, ERK and JNK" . SPARSER::COLLECTION)
    ("MAPKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NMR and small angle X-ray" . SPARSER::COLLECTION)
    ("p38α:STEP" . SPARSER::BIO-COMPLEX) ("ray" . SPARSER::PROTEIN)
    ("the previously described p38α:HePTP (PTPN7) complex"
     . SPARSER::BIO-COMPLEX)
    ("p38α:HePTP" . SPARSER::BIO-COMPLEX) ("HePTP" . SPARSER::PROTEIN)
    ("PTPSL and STEP" . SPARSER::COLLECTION)
    ("the two neuronal tyrosine phosphatases" . SPARSER::PHOSPHATASE)
    ("PTPSL/PTPBR7" . SPARSER::COLLECTION) ("STEP" . SPARSER::PROTEIN)
    ("PTPRR" . SPARSER::PROTEIN) ("PTPSL" . SPARSER::PROTEIN)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NH 4 Cl" . SPARSER::MOLECULE)
    ("DNA 2" . SPARSER::PROTEIN) ("MKK3" . SPARSER::PROTEIN)
    ("MKK6" . SPARSER::PROTEIN) ("α-2" . SPARSER::PROTEIN)
    ("CAT 2" . SPARSER::PROTEIN) ("V30" . SPARSER::PROTEIN)
    ("LC-PTP" . SPARSER::PROTEIN) ("PTPN7" . SPARSER::PROTEIN)
    ("PTPN5" . SPARSER::PROTEIN) ("PTPBR7" . SPARSER::PROTEIN)
    ("p38α" . SPARSER::PROTEIN)
    ("a clinically-relevant driver oncogene" . SPARSER::PROTEIN)
    ("RET" . SPARSER::PROTEIN)
    ("novel driver actionable oncogenes" . SPARSER::ONCOGENE)
    ("a targetable inhibitor" . SPARSER::INHIBITOR)
    ("metastatic ALK" . SPARSER::PROTEIN)
    ("Asian-based NSCLC never smoker cohorts" . SPARSER::MOLECULE)
    ("EGFR , KRAS and ALK" . SPARSER::COLLECTION)
    ("ALK ( xref ) and KRAS ( xref )" . SPARSER::COLLECTION)
    ("EGFR ( xref ), ALK ( xref ) and KRAS ( xref )" . SPARSER::COLLECTION)
    ("cigarettes" . SPARSER::DRUG)
    ("EGFR , ALK and KRAS" . SPARSER::COLLECTION)
    ("FISH and KRAS" . SPARSER::COLLECTION)
    ("The complete cohort" . SPARSER::MOLECULE)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("erlotinib and crizotinib" . SPARSER::COLLECTION)
    ("EGFR , KRAS, and ALK" . SPARSER::COLLECTION) ("ROS1" . SPARSER::PROTEIN)
    ("ki-ras" . SPARSER::PROTEIN)
    ("a larger patient cohort" . SPARSER::MOLECULE) ("melting" . SPARSER::DRUG)
    ("LN" . SPARSER::PROTEIN) ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("whose immunogen" . SPARSER::MOLECULE)
    ("a monoclonal mouse antibody" . SPARSER::ANTIBODY)
    ("immunogen" . SPARSER::MOLECULE)
    ("37 consecutive PTCs" . SPARSER::PROTEIN)
    ("PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR, KRAS , BRAF, and HER-2" . SPARSER::COLLECTION)
    ("El-Osta" . SPARSER::COLLECTION) ("Osta" . SPARSER::PROTEIN)
    ("Tie" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR, KRAS , BRAF , and HER-2" . SPARSER::COLLECTION)
    ("EGFR, KRAS, BRAF , and HER-2" . SPARSER::COLLECTION)
    ("BRAF or HER-2" . SPARSER::COLLECTION)
    ("mTOR and MEK" . SPARSER::COLLECTION)
    ("the sex-linked factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("technical art" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("art" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Sun" . SPARSER::PROTEIN)
    ("INCa" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KRAS, BRAF, and HER-2" . SPARSER::COLLECTION)
    ("The histological types" . TYPE)
    ("EGFR , KRAS , BRAF, and HER-2" . SPARSER::COLLECTION)
    ("BRAF, HER-2, MEK, and mTOR" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("BRAF and HER-2" . SPARSER::COLLECTION)
    ("v-erb-b2 erythroblastic leukemia viral oncogene homolog 2"
     . SPARSER::PROTEIN)
    ("serine-threonine" . SPARSER::COLLECTION)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("EGFR , KRAS , BRAF, and HER- 2" . SPARSER::COLLECTION)
    ("EGFR, KRAS , BRAF, and HER- 2" . SPARSER::COLLECTION)
    ("anti-EGFR" . SPARSER::PROTEIN) ("homolog 2" . SPARSER::PROTEIN)
    ("v-erb" . SPARSER::PROTEIN) ("HER- 2" . SPARSER::PROTEIN)
    ("Antibodies" . SPARSER::ANTIBODY)
    ("PRL-1, PRL-2 and PRL-3" . SPARSER::COLLECTION)
    ("PRLs" . SPARSER::PROTEIN)
    ("MEK/JNK inhibitors (U0126, SP600125) or AP-1 inhibitor (curcumin)"
     . SPARSER::COLLECTION)
    ("MEK/JNK" . SPARSER::COLLECTION) ("c-Jun/AP-1" . SPARSER::COLLECTION)
    ("FLT3 and its mutants" . SPARSER::COLLECTION)
    ("cytogenetic risk group" . SPARSER::MOLECULE) ("NPM" . SPARSER::PROTEIN)
    ("FAB" . SPARSER::PROTEIN)
    ("using Cohort 1 ( n = 221) and a publicly available dataset GSE12417 ( n = 163)"
     . SPARSER::COLLECTION)
    ("balb/c" . SPARSER::COLLECTION)
    ("IgG, PRL-3 or FLT3" . SPARSER::COLLECTION)
    ("Balb/c" . SPARSER::COLLECTION) ("sham" . SPARSER::DRUG)
    ("PRL-3 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Dao" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FLT3 and PRL-3" . SPARSER::COLLECTION)
    ("annexin-V and 7-AAD" . SPARSER::COLLECTION)
    ("annexin-V and 7-aminoactinomycin" . SPARSER::COLLECTION)
    ("AAD" . SPARSER::PROTEIN) ("TF-1-GFP" . SPARSER::COLLECTION)
    ("IL-3 or GM-CSF" . SPARSER::COLLECTION) ("media" . SPARSER::PROTEIN)
    ("Wang" . SPARSER::PROTEIN) ("curcumin" . SPARSER::DRUG)
    ("MEK-specific inhibitor (U0126, 5 µM) or JNK-specific inhibitor (SP600125, 5 µM)"
     . SPARSER::COLLECTION)
    ("PRL-3-ERK/JNK-c-Jun" . SPARSER::COLLECTION)
    ("either ERK ( xref C, c) or JNK ( xref C, d)" . SPARSER::COLLECTION)
    ("respective siRNA" . SPARSER::PROTEIN)
    ("ERK or JNK" . SPARSER::COLLECTION) ("JNK and ERK" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("SEAP" . SPARSER::PROTEIN-FAMILY) ("TF1-GFP" . SPARSER::COLLECTION)
    ("GFP-PRL-3" . SPARSER::COLLECTION) ("TF1-PRL-3" . SPARSER::COLLECTION)
    ("Guo" . SPARSER::MOLECULE) ("STAT5A or STAT5B" . SPARSER::COLLECTION)
    ("oligonucleotides" . SPARSER::MOLECULE) ("GAA" . SPARSER::PROTEIN)
    ("SU6656 and PP2" . SPARSER::COLLECTION)
    ("JAK or Src" . SPARSER::COLLECTION)
    ("The respective inhibitors" . SPARSER::INHIBITOR)
    ("FLT3 and STAT5" . SPARSER::COLLECTION)
    ("PKC412 or CEP-701" . SPARSER::COLLECTION)
    ("Src-STAT5" . SPARSER::COLLECTION)
    ("exogenous FLT3-ITD" . SPARSER::COLLECTION)
    ("TF1-ITD" . SPARSER::COLLECTION) ("TF1" . SPARSER::PROTEIN)
    ("TF-1" . SPARSER::PROTEIN)
    ("c-Jun proto-oncogene and cell growth" . SPARSER::COLLECTION)
    ("FLT3-Src-STAT5" . SPARSER::COLLECTION) ("Ren" . SPARSER::PROTEIN)
    ("Saha" . SPARSER::DRUG) ("CML" . SPARSER::PROTEIN)
    ("a possible downstream target" . SPARSER::TARGET-PROTEIN)
    ("SAHA" . SPARSER::DRUG) ("ABT" . SPARSER::PROTEIN)
    ("Linifanib" . SPARSER::DRUG) ("fms" . SPARSER::PROTEIN)
    ("Cohort" . SPARSER::MOLECULE) ("ERK and JNK" . SPARSER::COLLECTION)
    ("FLT3-STAT5" . SPARSER::COLLECTION) ("ITD" . SPARSER::PROTEIN)
    ("a metastasis-associated phosphatase" . SPARSER::PHOSPHATASE)
    ("FLT3-ITD" . SPARSER::COLLECTION) ("AML" . SPARSER::PROTEIN)
    ("PRL3" . SPARSER::PROTEIN) ("PRL-2" . SPARSER::PROTEIN)
    ("PRL-1" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("Group III" . SPARSER::PROTEIN) ("Group I" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("annexin-V" . SPARSER::PROTEIN)
    ("U0126" . SPARSER::DRUG) ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pAP1" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("S1b" . SPARSER::PROTEIN) ("STAT5B" . SPARSER::PROTEIN)
    ("STAT5A" . SPARSER::PROTEIN) ("streptavidin–agarose" . SPARSER::DRUG)
    ("Transcription Factor" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("SU6656" . SPARSER::PROTEIN) ("Src kinase" . SPARSER::PROTEIN)
    ("CEP-701" . SPARSER::DRUG) ("PKC412" . SPARSER::DRUG)
    ("tyrosine kinase-3" . SPARSER::PROTEIN) ("STAT5" . SPARSER::PROTEIN)
    ("PRL-3" . SPARSER::PROTEIN) ("FLT3" . SPARSER::PROTEIN)
    ("aims" . SPARSER::PROTEIN)
    ("account clinical prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CSC" . SPARSER::PROTEIN) ("K-ras and Akt" . SPARSER::COLLECTION)
    ("glial" . SPARSER::PROTEIN) ("Ago" . SPARSER::PROTEIN)
    ("argonaute" . SPARSER::PROTEIN-FAMILY) ("RISC" . SPARSER::PROTEIN)
    ("RNP" . SPARSER::PROTEIN) ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("strong homology" . SPARSER::PROTEIN)
    ("drosha and dicer" . SPARSER::COLLECTION) ("dicer" . SPARSER::PROTEIN)
    ("drosha" . SPARSER::PROTEIN) ("AKT and p38" . SPARSER::COLLECTION)
    ("MEK/ERK" . SPARSER::COLLECTION) ("UBE2L3-K-ras" . SPARSER::COLLECTION)
    ("multi-step" . SPARSER::COLLECTION)
    ("Neu as well as Bcr-Abl" . SPARSER::COLLECTION)
    ("relatively few targets" . SPARSER::TARGET-PROTEIN)
    ("biologically and clinically relevant step" . SPARSER::PROTEIN)
    ("toxic substances" . SPARSER::SUBSTANCE)
    ("substances" . SPARSER::SUBSTANCE)
    ("CD44 and the pro-growth effectors Akt and B-Raf" . SPARSER::COLLECTION)
    ("Akt and B-Raf" . SPARSER::COLLECTION) ("Raf-ERK" . SPARSER::COLLECTION)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pan-Ras" . SPARSER::COLLECTION)
    ("these chemically-engineered inhibitors and the increase in growth"
     . SPARSER::COLLECTION)
    ("these chemically-engineered inhibitors" . SPARSER::INHIBITOR)
    ("inhibitor or replacement" . SPARSER::COLLECTION)
    ("v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) 3"
     . SPARSER::PROTEIN)
    ("Chemically-engineered inhibitors" . SPARSER::INHIBITOR)
    ("TMZ or BCNU" . SPARSER::COLLECTION)
    ("temozolomide (TMZ) and carmustine (BCNU)" . SPARSER::COLLECTION)
    ("BCNU" . SPARSER::DRUG) ("carmustine" . SPARSER::DRUG)
    ("TMZ" . SPARSER::DRUG)
    ("chemically-engineered inhibitors" . SPARSER::INHIBITOR)
    ("AMO" . SPARSER::PROTEIN) ("pEZ" . SPARSER::PROTEIN)
    ("the stem cell self-renewal regulator BMI1" . SPARSER::PROTEIN)
    ("c" . SPARSER::PROTEIN) ("fibrillarin" . SPARSER::PROTEIN)
    ("previously published box C/D snoRNA and miRNA" . SPARSER::COLLECTION)
    ("snoRNA and miRNA" . SPARSER::COLLECTION) ("HBII" . SPARSER::PROTEIN)
    ("snoRNA" . SPARSER::RNA) ("-astrocytes" . SPARSER::COLLECTION)
    ("carbenoxolone (CBX)" . SPARSER::DRUG) ("CBX" . SPARSER::PROTEIN)
    ("carbenoxolone" . SPARSER::DRUG) ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PE" . SPARSER::PROTEIN)
    ("conditionally immortal astrocytes" . SPARSER::PROTEIN)
    ("tsA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the brain parenchyma release vascular endothelial growth factor and other cytokines"
     . SPARSER::COLLECTION)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("the K-ras protein and the downstream effectors ERK1/2 and B-Raf"
     . SPARSER::COLLECTION)
    ("ERK1/2 and B-Raf" . SPARSER::COLLECTION)
    ("a chemically-engineered miRNA-768-3p inhibitor" . SPARSER::INHIBITOR)
    ("homolog)" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("UBE2L3" . SPARSER::PROTEIN) ("Bcr-Abl" . SPARSER::PROTEIN)
    ("HER1" . SPARSER::PROTEIN)
    ("Growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("homolog) 3" . SPARSER::PROTEIN) ("Ki-ras" . SPARSER::PROTEIN)
    ("gene 3" . SPARSER::PROTEIN) ("BMI1" . SPARSER::PROTEIN)
    ("P-glycoprotein" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B-Raf" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("OCT4 and miR-125b-1" . SPARSER::COLLECTION)
    ("the pluripotent transcription factor OCT4" . SPARSER::PROTEIN)
    ("miR-125b and OCT4" . SPARSER::COLLECTION)
    ("Oct4/Tcl1/Akt1" . SPARSER::COLLECTION) ("Nam" . SPARSER::PROTEIN-FAMILY)
    ("exogenous OCT4" . SPARSER::PROTEIN)
    ("MRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("OCT4 and BAK1" . SPARSER::COLLECTION)
    ("HeLa-GFP and SiHa-GFP" . SPARSER::COLLECTION)
    ("response element (MRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Exogenous OCT4" . SPARSER::PROTEIN)
    ("the full-length miR-125b-1 promoter and the promoters"
     . SPARSER::COLLECTION)
    ("RR1 or both RR1 and RR2" . SPARSER::COLLECTION)
    ("RR1 and RR2" . SPARSER::COLLECTION)
    ("named RR1 (between −4280 nt and −4287 nt, pink oval) and RR2 (between −439 nt and −446 nt, red oval; xref )"
     . SPARSER::COLLECTION)
    ("pink" . SPARSER::PROTEIN) ("RRs" . SPARSER::MOLECULE)
    ("mature miR-125b" . SPARSER::MOLECULE) ("pri" . SPARSER::PROTEIN)
    ("hsa" . SPARSER::PROTEIN) ("the only unique gene" . SPARSER::GENE)
    ("HeLa-OCT4 and SiHa-OCT4" . SPARSER::COLLECTION)
    ("several apoptosis-related genes ( xref ) and microRNAs (miRNAs; xref ) in each cell line"
     . SPARSER::COLLECTION)
    ("OCT4 and Ki-67" . SPARSER::COLLECTION) ("IRS" . SPARSER::PROTEIN)
    ("the viral DNA" . SPARSER::DNA) ("IRSs" . SPARSER::PROTEIN)
    ("CIS" . SPARSER::PROTEIN) ("NC" . SPARSER::PROTEIN)
    ("directly targets BAK1" . SPARSER::PROTEIN)
    ("OCT4 and SOX2" . SPARSER::COLLECTION)
    ("Sox2 and Oct4" . SPARSER::COLLECTION)
    ("Oct4, Sox2, Klf4 and c-Myc" . SPARSER::COLLECTION)
    ("ESC" . SPARSER::PROTEIN) ("SOX2, NANOG and KLF4" . SPARSER::COLLECTION)
    ("NANOG" . SPARSER::PROTEIN) ("octamer" . SPARSER::PROTEIN)
    ("Pap" . SPARSER::PROTEIN) ("BAK1 and OCT4" . SPARSER::COLLECTION)
    ("OCT4 and miR-125b" . SPARSER::COLLECTION)
    ("Luciferase" . SPARSER::PROTEIN) ("MiRNA" . SPARSER::MICRO-RNA)
    ("Octamer" . SPARSER::PROTEIN) ("anti- β" . SPARSER::PROTEIN)
    ("GP6" . SPARSER::PROTEIN) ("CX31" . SPARSER::PROTEIN)
    ("citric acid" . SPARSER::MOLECULE) ("Stat3" . SPARSER::PROTEIN)
    ("Akt1" . SPARSER::PROTEIN) ("Tcl1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MiR-125b" . SPARSER::MOLECULE) ("RR2" . SPARSER::PROTEIN)
    ("RR1" . SPARSER::PROTEIN) ("GP5" . SPARSER::PROTEIN)
    ("Klf4" . SPARSER::PROTEIN) ("Oct4" . SPARSER::PROTEIN)
    ("Sox2" . SPARSER::PROTEIN) ("Fbx15" . SPARSER::PROTEIN)
    ("UTF1" . SPARSER::PROTEIN) ("FGF-4" . SPARSER::PROTEIN)
    ("KLF4" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("BAK1" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("OCT4" . SPARSER::PROTEIN) ("transcription factor 4" . SPARSER::PROTEIN)
    ("an operative step" . SPARSER::PROTEIN)
    ("the mature receptor" . SPARSER::PROTEIN)
    ("its respective ligand" . SPARSER::LIGAND)
    ("RTKs or their substrates" . SPARSER::COLLECTION)
    ("etc" . SPARSER::PROTEIN) ("other static biomarkers" . SPARSER::MOLECULE)
    ("high or low Pdgfrα and/or Igf1r" . SPARSER::COLLECTION)
    ("skeletal muscle" . SPARSER::PROTEIN)
    ("Sp1 and α-tubulin" . SPARSER::COLLECTION) ("NOD" . SPARSER::PROTEIN)
    ("Leg" . SPARSER::PROTEIN) ("p-Erk 1/2" . SPARSER::COLLECTION)
    ("Akt and Erk 1/2" . SPARSER::COLLECTION)
    ("Pdgfrα or Igf1r" . SPARSER::COLLECTION)
    ("Pdgfrα or Igf1R" . SPARSER::COLLECTION) ("/Igf1r" . SPARSER::COLLECTION)
    ("Igf1R" . SPARSER::PROTEIN)
    ("a Cy3.5 conjugated secondary antibody" . SPARSER::ANTIBODY)
    ("Pdgfrα (APC) and Igf1r (Cy3.5)" . SPARSER::COLLECTION)
    ("APC" . SPARSER::PROTEIN) ("Pax3:Fkhr" . SPARSER::BIO-COMPLEX)
    ("Fkhr" . SPARSER::PROTEIN) ("distinct RTK" . SPARSER::PROTEIN)
    ("FGFR, Igf1r, and ErbB4" . SPARSER::COLLECTION)
    ("FGFR" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Pdgfrα and Igf1r" . SPARSER::COLLECTION)
    ("RTKs, Pdgfrα and Igf1r" . SPARSER::COLLECTION)
    ("Igf1r" . SPARSER::PROTEIN) ("aRMS" . SPARSER::PROTEIN)
    ("CD24" . SPARSER::PROTEIN) ("CD133" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("Erk 1/2" . SPARSER::PROTEIN)
    ("Pax3" . SPARSER::PROTEIN) ("P40)" . SPARSER::PROTEIN)
    ("α-tubulin" . SPARSER::PROTEIN) ("CO2" . SPARSER::PROTEIN)
    ("Pdgfrα" . SPARSER::PROTEIN)
    ("the currently identified variants" . SPARSER::VARIANT)
    ("ErbB2 or ErB3" . SPARSER::COLLECTION) ("ErB" . SPARSER::PROTEIN)
    ("E6 and E7" . SPARSER::COLLECTION)
    ("Egfr and ErbB4" . SPARSER::COLLECTION)
    ("a highly polymorphic (CA) n" . SPARSER::PROTEIN)
    ("previously described sequence variants" . SPARSER::VARIANT)
    ("DNase" . SPARSER::PROTEIN)
    ("EGFR (rs2075112; rs845552) and ERBB4 (rs10497968; rs1978873; rs16847082)"
     . SPARSER::COLLECTION)
    ("SNP-SNP" . SPARSER::COLLECTION) ("EGFR and intron" . SPARSER::COLLECTION)
    ("EGFR and ERBB4" . SPARSER::COLLECTION)
    ("type, race, or stage" . SPARSER::COLLECTION)
    ("EGFR, ERBB2, ERBB3 , and ERBB4" . SPARSER::COLLECTION)
    ("Egfr, ErbB2, ErbB3, and ErbB4" . SPARSER::COLLECTION)
    ("Egfr" . SPARSER::PROTEIN) ("parental marker alleles" . SPARSER::ALLELE)
    ("host immunoregulatory and HPV-interacting genes" . SPARSER::GENE)
    ("intron 1 EGFR variants and intron 24 ERBB4 variants"
     . SPARSER::COLLECTION)
    ("EGFR and two SNPs" . SPARSER::COLLECTION)
    ("EGFR, ERBB2, ERBB3, and ERBB4" . SPARSER::COLLECTION)
    ("TDT" . SPARSER::PROTEIN) ("CIN2" . SPARSER::PROTEIN)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("CIN3" . SPARSER::PROTEIN)
    ("ErbB4" . SPARSER::PROTEIN) ("ErbB3" . SPARSER::PROTEIN)
    ("ErbB2" . SPARSER::PROTEIN) ("ERBB4" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN) ("HRK and JCL" . SPARSER::COLLECTION)
    ("HRK" . SPARSER::PROTEIN) ("SYK" . SPARSER::PROTEIN)
    ("CMC" . SPARSER::PROTEIN-FAMILY) ("MKL" . SPARSER::PROTEIN)
    ("DSH" . SPARSER::PROTEIN) ("SYL" . SPARSER::PROTEIN)
    ("CTC" . SPARSER::PROTEIN) ("an artificial polymer" . SPARSER::MOLECULE)
    ("polymer" . SPARSER::MOLECULE) ("Peptide" . SPARSER::PEPTIDE)
    ("IIIB" . SPARSER::DRUG) ("good PS" . SPARSER::PROTEIN)
    ("PS" . SPARSER::PROTEIN) ("second-line" . SPARSER::PROTEIN)
    ("first-line" . SPARSER::PROTEIN) ("Pan" . SPARSER::PROTEIN)
    ("Iressa" . SPARSER::DRUG) ("Gefitinib" . SPARSER::DRUG)
    ("the most reliable predictive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR-TKIs" . SPARSER::COLLECTION) ("other histologic types" . TYPE)
    ("Group (KMLCG)" . SPARSER::MOLECULE) ("PNA" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor ( EGFR )"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a 20" . SPARSER::PROTEIN) ("bromodomain" . SPARSER::PROTEIN)
    ("BET" . SPARSER::PROTEIN) ("MYC and BCL2" . SPARSER::COLLECTION)
    ("Green" . SPARSER::PROTEIN)
    ("technical factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gene and protein" . SPARSER::COLLECTION)
    ("a few blastic MCL" . SPARSER::PROTEIN)
    ("a new commercially available anti-MYC antibody" . SPARSER::ANTIBODY)
    ("shorter PFS" . SPARSER::PROTEIN) ("PFS" . SPARSER::PROTEIN)
    ("a dual color MYC" . SPARSER::PROTEIN)
    ("essentially all MCL" . SPARSER::PROTEIN) ("adriamycin" . SPARSER::DRUG)
    ("a commercially available anti-MYC antibody" . SPARSER::ANTIBODY)
    ("MYC-IgH" . SPARSER::COLLECTION) ("an aggressive form" . SPARSER::FORM)
    ("aid" . SPARSER::PROTEIN)
    ("a new monoclonal anti-MYC antibody" . SPARSER::ANTIBODY)
    ("lactate" . SPARSER::LACTATE) ("blastic MCL" . SPARSER::PROTEIN)
    ("MCL" . SPARSER::PROTEIN) ("Aim" . SPARSER::PROTEIN)
    ("BCL2" . SPARSER::PROTEIN) ("B2M" . SPARSER::PROTEIN)
    ("SP6" . SPARSER::PROTEIN) ("Mach 2" . SPARSER::DRUG)
    ("cyclinD1" . SPARSER::PROTEIN) ("– 3" . SPARSER::PROTEIN)
    ("MYC protein" . SPARSER::PROTEIN) ("MYC and HOXA9" . SPARSER::COLLECTION)
    ("SP1-ESR1" . SPARSER::COLLECTION) ("receptors (ER)" . SPARSER::RECEPTOR)
    ("siRNA and shRNA" . SPARSER::COLLECTION)
    ("cyclins and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SP1, ESR1 and E2F1" . SPARSER::COLLECTION)
    ("HOXA9 and NUP98" . SPARSER::COLLECTION)
    ("MYC and NF-κB" . SPARSER::COLLECTION)
    ("AP-1 and Sp1" . SPARSER::COLLECTION)
    ("whose target genes" . SPARSER::GENE)
    ("MYC, MYB, CREB1, E2F3 and USF2" . SPARSER::COLLECTION)
    ("MYB" . SPARSER::PROTEIN) ("TMX and TMP" . SPARSER::COLLECTION)
    ("tamoxifen (TMX)" . SPARSER::DRUG) ("TMX" . SPARSER::PROTEIN)
    ("TMP" . SPARSER::PROTEIN) ("Tamoxifen" . SPARSER::MOLECULE)
    ("SP1 or ESR1" . SPARSER::COLLECTION) ("c-SRC" . SPARSER::PROTEIN-PAIR)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("Step" . SPARSER::PROTEIN)
    ("ESR" . SPARSER::PROTEIN) ("TSS" . SPARSER::PROTEIN)
    ("SP1 and ESR1" . SPARSER::COLLECTION)
    ("alpha), SP1 and E2F1" . SPARSER::COLLECTION)
    ("MYC, NF-κB, MAPK and IL-6" . SPARSER::COLLECTION)
    ("RELA (p65, an NF-κB subunit, score=−138) and FOS (an IL-6 pathway member; score=−141)"
     . SPARSER::COLLECTION)
    ("FOS" . SPARSER::PROTEIN) ("RELA" . SPARSER::PROTEIN)
    ("CEBPB and STAT3" . SPARSER::COLLECTION)
    ("NF-κB, MYC and ATF2" . SPARSER::COLLECTION) ("CEBPB" . SPARSER::PROTEIN)
    ("HOXA9, MYC and NF-κB" . SPARSER::COLLECTION) ("REL" . SPARSER::PROTEIN)
    ("IL-6 and MAPK" . SPARSER::COLLECTION)
    ("the diagonal line" . SPARSER::PROTEIN)
    ("Differentially" . SPARSER::PROTEIN) ("SP1 or CDK2" . SPARSER::COLLECTION)
    ("SP1 and cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("NF-κB and MYC" . SPARSER::COLLECTION)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("HMM and NHMM" . SPARSER::COLLECTION)
    ("NF-κB, MYC and MAPK" . SPARSER::COLLECTION) ("IgH" . SPARSER::PROTEIN)
    ("MM" . SPARSER::PROTEIN) ("ESR1 and SP1" . SPARSER::COLLECTION)
    ("ESR1, SP1 and E2F1" . SPARSER::COLLECTION) ("SP1" . SPARSER::PROTEIN)
    ("MYC, NF-κB and HOXA9" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("HMM" . SPARSER::DRUG)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NUP98" . SPARSER::PROTEIN) ("USF2" . SPARSER::PROTEIN)
    ("CREB1" . SPARSER::PROTEIN) ("ERα" . SPARSER::PROTEIN)
    ("anti-estrogens" . SPARSER::DRUG) ("CCND1" . SPARSER::PROTEIN)
    ("alpha)" . SPARSER::PROTEIN) ("Estrogen receptor" . SPARSER::PROTEIN)
    ("p65" . SPARSER::PROTEIN) ("c-Rel" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN) ("MM1" . SPARSER::PROTEIN)
    ("E2F1" . SPARSER::PROTEIN) ("HOXA9" . SPARSER::PROTEIN)
    ("APCs" . SPARSER::PROTEIN)
    ("a complex and sequential process involving multiple signals"
     . SPARSER::COLLECTION)
    ("ICOS, IL-6 and IL-21" . SPARSER::COLLECTION) ("TCL" . SPARSER::PROTEIN)
    ("smaller GCs" . SPARSER::PROTEIN) ("ICOSL" . SPARSER::PROTEIN)
    ("IL-21 and STAT3" . SPARSER::COLLECTION) ("Ig" . SPARSER::MOLECULE)
    ("IgA" . SPARSER::PROTEIN) ("hyper" . SPARSER::PROTEIN)
    ("IL-6 or IL-21" . SPARSER::COLLECTION) ("TTN" . SPARSER::PROTEIN)
    ("EL4" . SPARSER::PROTEIN)
    ("the human proximal promoter" . SPARSER::PROMOTER)
    ("IL-6 and IL-12" . SPARSER::COLLECTION)
    ("ICOS/ICOS-L" . SPARSER::COLLECTION)
    ("soluble IL-21 receptor-Fc chimeric protein or ICOS-L-mIgFc protein"
     . SPARSER::PROTEIN)
    ("protein or ICOS-L-mIgFc" . SPARSER::COLLECTION)
    ("receptor-Fc" . SPARSER::COLLECTION)
    ("rIL-21 or rIL-27 also increased the membrane expression of ICOS ( xref )"
     . SPARSER::COLLECTION)
    ("IL-21 and IFN-γ" . SPARSER::COLLECTION)
    ("rIL-21 and rIL-27 induced a rapid and sustained activation of STAT3 ( xref )"
     . SPARSER::COLLECTION)
    ("superantigen" . SPARSER::MOLECULE)
    ("rIL-21 or rIL-27 (STAT3-activating cytokines) also markedly promoted the production of Igs"
     . SPARSER::COLLECTION)
    ("rIL" . SPARSER::PROTEIN) ("LPS or PolyI:C" . SPARSER::COLLECTION)
    ("IgG and IgM" . SPARSER::COLLECTION) ("IgM" . SPARSER::PROTEIN)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-CD3 and anti-CD28" . SPARSER::COLLECTION)
    ("LPS- or polyI:C-treated" . SPARSER::COLLECTION)
    ("LPS-" . SPARSER::PROTEIN) ("LPS" . SPARSER::PROTEIN)
    ("soluble factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-6, IL-12 and IL-27" . SPARSER::COLLECTION)
    ("IL-6, IL-21 and IL-27" . SPARSER::COLLECTION)
    ("IL-21/ICOS" . SPARSER::COLLECTION)
    ("IL-21 and ICOS" . SPARSER::COLLECTION)
    ("CD40L, and SLAM" . SPARSER::COLLECTION) ("SAP" . SPARSER::PROTEIN)
    ("SLAM" . SPARSER::PROTEIN) ("hyper-IgE" . SPARSER::COLLECTION)
    ("IL-6 and IL-21" . SPARSER::COLLECTION) ("GCs" . SPARSER::PROTEIN)
    ("FH" . SPARSER::PROTEIN) ("particular IL-4" . SPARSER::PROTEIN)
    ("ICOS and IL-21" . SPARSER::COLLECTION) ("ICOS" . SPARSER::PROTEIN)
    ("IL-6 and other STAT3" . SPARSER::COLLECTION)
    ("IL-21 and IL-27" . SPARSER::COLLECTION) ("Bcl6" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("NFATc2" . SPARSER::PROTEIN) ("STAT-3" . SPARSER::PROTEIN)
    ("T-bet" . SPARSER::PROTEIN) ("rIL-21" . SPARSER::DRUG)
    ("C20" . SPARSER::PROTEIN) ("and 1 µ" . SPARSER::PROTEIN)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("IL-21R" . SPARSER::PROTEIN)
    ("ICOS-L" . SPARSER::PROTEIN) ("IL-10" . SPARSER::PROTEIN)
    ("Bcl-6" . SPARSER::PROTEIN) ("CXCR5" . SPARSER::PROTEIN)
    ("CD69" . SPARSER::PROTEIN) ("IL-12p70" . SPARSER::PROTEIN)
    ("anti-CD28" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("CD14" . SPARSER::PROTEIN) ("CD45RA" . SPARSER::PROTEIN)
    ("CD40L" . SPARSER::PROTEIN) ("autosomal dominant" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("IL-12" . SPARSER::PROTEIN)
    ("IL-27" . SPARSER::PROTEIN) ("IL-21" . SPARSER::PROTEIN)
    ("an unequivocal prognostic impact" . SPARSER::PROTEIN)
    ("only ESR1 gene" . SPARSER::PROTEIN) ("RNAse" . SPARSER::PROTEIN)
    ("MLPA" . SPARSER::PROTEIN) ("functional ESR1" . SPARSER::PROTEIN)
    ("the prognostic impact" . SPARSER::PROTEIN)
    ("Prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Paclitaxel" . SPARSER::DRUG) ("The prognostic impact" . SPARSER::PROTEIN)
    ("distinct prognostic cohorts" . SPARSER::MOLECULE)
    ("prognostic impact" . SPARSER::PROTEIN) ("HR " . SPARSER::PROTEIN)
    ("Topoisomerase" . SPARSER::PROTEIN) ("cut" . SPARSER::PROTEIN)
    ("the relevant protein" . SPARSER::PROTEIN)
    ("Study biomarkers and correlations" . SPARSER::COLLECTION)
    ("ET" . SPARSER::PROTEIN) ("CMF" . SPARSER::PROTEIN)
    ("taxane" . SPARSER::DRUG) ("anthracycline" . SPARSER::MOLECULE)
    ("the Hellenic Cooperative Oncology Group" . SPARSER::MOLECULE)
    ("Group" . SPARSER::MOLECULE) ("tamoxifen" . SPARSER::MOLECULE)
    ("gold" . SPARSER::MOLECULE) ("protein and mRNA" . SPARSER::COLLECTION)
    ("CEP" . SPARSER::PROTEIN) ("Formalin" . SPARSER::MOLECULE)
    ("TOP2A" . SPARSER::PROTEIN) ("housekeeping gene" . SPARSER::PROTEIN)
    ("CALM2" . SPARSER::PROTEIN) ("Ki67" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("messenger RNA" . SPARSER::RNA)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Messenger RNA" . SPARSER::RNA) ("ER, PgR and HER2" . SPARSER::COLLECTION)
    ("T-STAR and BRK" . SPARSER::COLLECTION)
    ("breast tumor kinase (BRK)" . SPARSER::PROTEIN) ("BRK" . SPARSER::PROTEIN)
    ("Src, PI3K and PLCγ1" . SPARSER::COLLECTION)
    ("CD44, Bcl-X, mTOR and cyclin D1" . SPARSER::COLLECTION)
    ("MDA" . SPARSER::DRUG) ("A representative example" . SPARSER::EXAMPLE)
    ("reagent" . SPARSER::MOLECULE) ("RQ" . SPARSER::MOLECULE)
    ("the developed antibody" . SPARSER::ANTIBODY) ("wb" . SPARSER::PROTEIN)
    ("thymidine and WST-1" . SPARSER::COLLECTION) ("EX" . SPARSER::PROTEIN)
    ("fraction or intensity" . SPARSER::COLLECTION)
    ("invasive components" . SPARSER::COMPONENT) ("QKI" . SPARSER::PROTEIN)
    ("Examples" . SPARSER::EXAMPLE)
    ("fractions and intensities" . SPARSER::COLLECTION)
    ("Sam68 and SLM-1" . SPARSER::COLLECTION) ("KH" . SPARSER::PROTEIN)
    ("stabilizers and destabilizers" . SPARSER::COLLECTION)
    ("modifiers and chaperones" . SPARSER::COLLECTION)
    ("chaperones" . SPARSER::PROTEIN) ("modifiers" . SPARSER::MOLECULE)
    ("stabilizers" . SPARSER::MOLECULE)
    ("protein T-STAR" . SPARSER::COLLECTION) ("STAR" . SPARSER::PROTEIN)
    ("tumor-associated antigens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("study novel potentially clinical relevant antigens"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PgR" . SPARSER::PROTEIN) ("HER2 and ER" . SPARSER::COLLECTION)
    ("RFS" . SPARSER::PROTEIN) ("SH3" . SPARSER::PROTEIN)
    ("breast tumor kinase" . SPARSER::PROTEIN) ("Bcl-X" . SPARSER::PROTEIN)
    ("CD44" . SPARSER::PROTEIN) ("PLCγ1" . SPARSER::PROTEIN)
    ("and 1 " . SPARSER::PROTEIN) ("Bis-Tris" . SPARSER::MOLECULE)
    ("as 2" . SPARSER::PROTEIN) ("L-Glutamine" . SPARSER::MOLECULE)
    ("VEGFR2" . SPARSER::PROTEIN) ("VEGF-A" . SPARSER::PROTEIN)
    ("F11" . SPARSER::PROTEIN) ("MTA-1" . SPARSER::PROTEIN)
    ("SLM-1" . SPARSER::PROTEIN) ("Sam68" . SPARSER::PROTEIN)
    ("RNA binding" . SPARSER::PROTEIN) ("protein T" . SPARSER::PROTEIN)
    ("RNA binding protein" . SPARSER::PROTEIN) ("T-STAR" . SPARSER::PROTEIN)
    ("vascular smooth muscle" . SPARSER::PROTEIN)
    ("smooth muscle" . SPARSER::PROTEIN)
    ("SHP-2 and the phosphorylated forms" . SPARSER::COLLECTION)
    ("PTCA" . SPARSER::PROTEIN) ("PDGFBB" . SPARSER::PROTEIN)
    ("LRP1 and SHP-2" . SPARSER::COLLECTION) ("PGDF-BB" . SPARSER::COLLECTION)
    ("BB" . SPARSER::PROTEIN) ("KD or SHP-2" . SPARSER::COLLECTION)
    ("dimerized PDGF receptors" . SPARSER::RECEPTOR)
    ("SHP-2 or the structurally related SHP-1" . SPARSER::COLLECTION)
    ("ATP and phosphatase" . SPARSER::COLLECTION)
    ("phosphatase" . SPARSER::PROTEIN) ("p-PDGFRβ" . SPARSER::COLLECTION)
    ("pLRP-ICD" . SPARSER::COLLECTION) ("phosho-PDGFRβ" . SPARSER::COLLECTION)
    ("soluble forms" . SPARSER::FORM) ("GST:LRP-ICD" . SPARSER::BIO-COMPLEX)
    ("KD and SHP-2" . SPARSER::COLLECTION) ("Kinase" . SPARSER::KINASE)
    ("SHP-2 and the phosphorylated form" . SPARSER::COLLECTION)
    ("SPR" . SPARSER::PROTEIN) ("BSA" . SPARSER::PROTEIN)
    ("GST:LRP1-ICD" . SPARSER::BIO-COMPLEX) ("Sepharose" . SPARSER::MOLECULE)
    ("Glutathione" . SPARSER::DRUG) ("NRK" . SPARSER::PROTEIN)
    ("LRP1-ICD" . SPARSER::COLLECTION) ("KD" . SPARSER::PROTEIN)
    ("LRP1 and the PDGFRβ" . SPARSER::COLLECTION)
    ("phenylalanine" . SPARSER::AMINO-ACID)
    ("protein tyrosine phosphatase (PTP)" . SPARSER::PROTEIN)
    ("PTP" . SPARSER::PROTEIN) ("Shc" . SPARSER::PROTEIN)
    ("PTB" . SPARSER::PROTEIN) ("SH2" . SPARSER::PROTEIN)
    ("ICD" . SPARSER::PROTEIN) ("vasculature" . SPARSER::PROTEIN)
    ("Gleevec" . SPARSER::DRUG) ("Lrp1" . SPARSER::PROTEIN)
    ("vascular SMC" . SPARSER::PROTEIN) ("apoE" . SPARSER::PROTEIN)
    ("PDGF-B and the PDGFRβ" . SPARSER::COLLECTION)
    ("Pdgfb or Pdgfrb" . SPARSER::COLLECTION) ("Pdgfrb" . SPARSER::PROTEIN)
    ("Pdgfb" . SPARSER::PROTEIN) ("SMC" . SPARSER::PROTEIN)
    ("LRP1 and PDGFRβ" . SPARSER::COLLECTION)
    ("LRP1 and a specific SHP-2 inhibitor" . SPARSER::COLLECTION)
    ("LRP1 and phospho-SHP-2" . SPARSER::COLLECTION)
    ("dynasore" . SPARSER::MOLECULE) ("dynamin" . SPARSER::PROTEIN)
    ("chemotaxis" . SPARSER::PROTEIN) ("c-Cbl" . SPARSER::PROTEIN)
    ("SHP-1" . SPARSER::PROTEIN) ("Shp-2" . SPARSER::PROTEIN)
    ("LRP-ICD" . SPARSER::PROTEIN) ("tween 20" . SPARSER::MOLECULE)
    ("src kinase" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("Monoclonal antibody" . SPARSER::DRUG)
    ("phospho-tyrosine" . SPARSER::MOLECULE) ("PDGF-B" . SPARSER::PROTEIN)
    ("NSC-87877" . SPARSER::DRUG)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("SHP-2" . SPARSER::PROTEIN) ("PDGFRβ" . SPARSER::PROTEIN)
    ("PDGF receptor" . SPARSER::PROTEIN) ("LRP1" . SPARSER::PROTEIN)
    ("LDL receptor" . SPARSER::PROTEIN)
    ("unfavourable prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a possible target" . SPARSER::TARGET-PROTEIN)
    ("telomerase and Ku" . SPARSER::COLLECTION)
    ("undetectable telomerase activity" . SPARSER::PROTEIN)
    ("a telomerase-associated protein" . SPARSER::PROTEIN)
    ("CAB" . SPARSER::PROTEIN) ("Cajal" . SPARSER::PROTEIN)
    ("γ-H2AX and DNA" . SPARSER::COLLECTION) ("pDNA-PK" . SPARSER::COLLECTION)
    ("PK" . SPARSER::PROTEIN)
    ("DNA-PKcs or its DNA binding subunit" . SPARSER::COLLECTION)
    ("hTR-Ku" . SPARSER::COLLECTION) ("Ku" . SPARSER::PROTEIN)
    ("Ku-hTR" . SPARSER::COLLECTION)
    ("detectable basal telomerase activity" . SPARSER::PROTEIN)
    ("telomerase activity and Ku" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION) ("19a" . SPARSER::PROTEIN)
    ("both basal telomerase activity" . SPARSER::PROTEIN)
    ("p " . SPARSER::PROTEIN) ("Rai" . SPARSER::PROTEIN)
    ("phosphoramidate" . SPARSER::MOLECULE) ("GRN" . SPARSER::PROTEIN)
    ("a prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ku70 or Ku80" . SPARSER::COLLECTION)
    ("XRCC4-Ligase IV" . SPARSER::COLLECTION) ("XLF" . SPARSER::PROTEIN)
    ("nucleoside" . SPARSER::MOLECULE) ("purine" . SPARSER::DRUG)
    ("a catalytic reverse transcriptase (RT) subunit (hTERT) and an RNA subunit (hTR)"
     . SPARSER::COLLECTION)
    ("hTERT" . SPARSER::PROTEIN) ("RT" . SPARSER::PROTEIN)
    ("CLL several biological traits" . SPARSER::PROTEIN)
    ("FLU" . SPARSER::PROTEIN) ("Imetelstat and Ku80" . SPARSER::COLLECTION)
    ("Ku80 and Imetelstat" . SPARSER::COLLECTION)
    ("oligonucleotide" . SPARSER::MOLECULE) ("bad" . SPARSER::PROTEIN)
    ("fludarabine" . SPARSER::DRUG) ("hTR" . SPARSER::PROTEIN)
    ("telomerase" . SPARSER::PROTEIN) ("Imetelstat" . SPARSER::DRUG)
    ("TCAB1" . SPARSER::PROTEIN) ("γH2AX" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN) ("p21 protein" . SPARSER::PROTEIN)
    ("DNA-PK" . SPARSER::PROTEIN) ("α-actin" . SPARSER::PROTEIN)
    ("Telomerase Activity" . SPARSER::PROTEIN) ("BIBR1532" . SPARSER::DRUG)
    ("CD38" . SPARSER::PROTEIN) ("CD5" . SPARSER::PROTEIN)
    ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("N3" . SPARSER::PROTEIN)
    ("Ligase IV" . SPARSER::PROTEIN) ("XRCC4" . SPARSER::PROTEIN)
    ("DNA-PKcs" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase catalytic subunit" . SPARSER::PROTEIN)
    ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ku80" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN) ("ROR" . SPARSER::PROTEIN)
    ("gefitinib" . SPARSER::DRUG) ("p  " . SPARSER::PROTEIN)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("KRAS or EGFR" . SPARSER::COLLECTION) ("KRAS (WT)" . SPARSER::PROTEIN)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("EGFR/KRAS" . SPARSER::COLLECTION) ("EGFR and exon" . SPARSER::COLLECTION)
    ("TKI" . SPARSER::PROTEIN) ("HR 2" . SPARSER::PROTEIN)
    ("HR 1" . SPARSER::PROTEIN) ("L19" . SPARSER::PROTEIN)
    ("IL-8, TF, and caspase-7" . SPARSER::COLLECTION)
    ("IκB-α/NF-κB" . SPARSER::COLLECTION)
    ("SphK1 and sphingosine-1-phosphate" . SPARSER::COLLECTION)
    ("AC" . SPARSER::PROTEIN)
    ("cell surface-associated proteases" . SPARSER::PROTEIN)
    ("/Erk1" . SPARSER::COLLECTION)
    ("TMPRSS4 ( P  = 0.000) and Erk1 ( P  = 0.000)" . SPARSER::COLLECTION)
    ("prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TNM" . SPARSER::MOLECULE)
    ("TMPRSS4 and Erk1" . SPARSER::COLLECTION)
    ("transmembrane protease, serine 4(TMPRSS4) and extracellular signal-regulated kinases"
     . SPARSER::COLLECTION)
    ("caspase-7" . SPARSER::PROTEIN) ("IκB-α" . SPARSER::PROTEIN)
    ("sphingosine-1-phosphate" . SPARSER::DRUG) ("SphK1" . SPARSER::PROTEIN)
    ("sphingosine kinase 1" . SPARSER::PROTEIN)
    ("lysophosphatidic acid" . SPARSER::LPA) ("ERK1" . SPARSER::PROTEIN)
    ("Erk1/2" . SPARSER::PROTEIN)
    ("Hepatoma-derived growth factor" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hydrogen peroxide" . SPARSER::DRUG)
    ("Extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Transmembrane protease, serine 4" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Erk1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TMPRSS4" . SPARSER::PROTEIN)
    ("transmembrane protease, serine 4" . SPARSER::PROTEIN)
    ("Dr" . SPARSER::MOLECULE) ("TRβ1 or SIRT1" . SPARSER::COLLECTION)
    ("gluconeogenic genes" . SPARSER::GENE)
    ("TRβ1/PGC-1α/SIRT1" . SPARSER::COLLECTION)
    ("TRβ1 and/or SIRT1" . SPARSER::COLLECTION)
    ("TRβ/SIRT1" . SPARSER::COLLECTION) ("TRβ1/TRE" . SPARSER::COLLECTION)
    ("TRβ/TRE" . SPARSER::COLLECTION) ("cofactors" . SPARSER::PROTEIN)
    ("CBP/p300" . SPARSER::COLLECTION) ("CBP" . SPARSER::PROTEIN)
    ("HATs" . SPARSER::PROTEIN) ("-liganded" . SPARSER::MOLECULE)
    ("liganded" . SPARSER::MOLECULE) ("coactivators" . SPARSER::PROTEIN)
    ("CPT1a" . SPARSER::PROTEIN) ("palmitoyl" . SPARSER::PROTEIN)
    ("HR and other genes" . SPARSER::COLLECTION)
    ("SRCs and TRAP220" . SPARSER::COLLECTION) ("SRCs" . SPARSER::PROTEIN)
    ("PGC-1β or other TR" . SPARSER::COLLECTION)
    ("cofactor" . SPARSER::MOLECULE) ("exogenous PGC-1α" . SPARSER::PROTEIN)
    ("SIRT1 and TR" . SPARSER::COLLECTION)
    ("PCK1 and FGF21" . SPARSER::COLLECTION)
    ("an indirect activator" . SPARSER::ACTIVATOR)
    ("TRE and SIRT1" . SPARSER::COLLECTION)
    ("TRβ1 (using an antibody to the Flag-tag at the N-terminus of TRβ1 expressed in these cells) and SIRT1"
     . SPARSER::COLLECTION)
    ("hormone and SIRT1" . SPARSER::COLLECTION)
    ("TRβ1 and SIRT1" . SPARSER::COLLECTION)
    ("SLC16A6 and MYH6" . SPARSER::COLLECTION) ("SLC16A6" . SPARSER::PROTEIN)
    ("proximal promoters" . SPARSER::PROMOTER)
    ("the PCK1 downstream TRE ( xref ) and other native TREs (not shown)"
     . SPARSER::COLLECTION)
    ("the human PCK1 proximal promoter" . SPARSER::PROMOTER)
    ("functional TREs" . SPARSER::PROTEIN)
    ("the rodent PCK1 proximal promoter" . SPARSER::PROMOTER)
    ("LXRs" . SPARSER::PROTEIN) ("Nicotinamide" . SPARSER::MOLECULE)
    ("an essential step" . SPARSER::PROTEIN) ("Hormone" . SPARSER::PROTEIN)
    ("35 S-Methionine-labeled SIRT1 protein" . SPARSER::PROTEIN)
    ("GST-TRβ1" . SPARSER::COLLECTION) ("Methionine" . SPARSER::AMINO-ACID)
    ("SIRT1 (flag) and TRβ1 (myc)" . SPARSER::COLLECTION)
    ("SIRT1/TRβ1" . SPARSER::COLLECTION) ("myc" . SPARSER::PROTEIN)
    ("flag" . SPARSER::PROTEIN-FAMILY) ("TRβ1/PGC-1α" . SPARSER::COLLECTION)
    ("SIRT1 and PGC-1α" . SPARSER::COLLECTION)
    ("PGC-1α and SIRT1" . SPARSER::COLLECTION) ("DR" . SPARSER::PROTEIN)
    ("TRE" . SPARSER::PROTEIN) ("TRs and SIRT1" . SPARSER::COLLECTION)
    ("receptor (LXR)" . SPARSER::RECEPTOR) ("LXR" . SPARSER::PROTEIN)
    ("heterologous DNA" . SPARSER::DNA) ("TR/TF" . SPARSER::COLLECTION)
    ("TF" . SPARSER::PROTEIN) ("CTCF" . SPARSER::PROTEIN)
    ("chromatin and RNA polymerase II" . SPARSER::COLLECTION)
    ("TREs" . SPARSER::PROTEIN) ("NR" . SPARSER::PROTEIN)
    ("TRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dual TRβ1/SIRT1 target genes" . SPARSER::GENE)
    ("resveratrol and nicotinamide" . SPARSER::COLLECTION)
    ("TRβ1/SIRT1" . SPARSER::COLLECTION) ("nicotinamide" . SPARSER::MOLECULE)
    ("resveratrol" . SPARSER::PROTEIN) ("Drugs" . SPARSER::DRUG)
    ("triiodothyronine" . SPARSER::DRUG) ("NRs" . SPARSER::PROTEIN)
    ("peroxisome" . SPARSER::PROTEIN) ("deacetylase" . SPARSER::PROTEIN)
    ("AF-2" . SPARSER::PROTEIN) ("CPT1" . SPARSER::PROTEIN)
    ("PDK4" . SPARSER::PROTEIN)
    ("pyruvate dehydrogenase kinase 4" . SPARSER::PROTEIN)
    ("PGC-1β" . SPARSER::PROTEIN) ("FGF21" . SPARSER::PROTEIN)
    ("fibroblast growth factor 1" . SPARSER::PROTEIN)
    ("MG132" . SPARSER::PROTEIN)
    ("glutathione-S-transferase" . SPARSER::PROTEIN)
    ("myc-tagged" . SPARSER::PROTEIN) ("TRα1" . SPARSER::PROTEIN)
    ("TRβ" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("18 h" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("MYH6" . SPARSER::PROTEIN) ("16A" . SPARSER::PROTEIN)
    ("PCK1" . SPARSER::PROTEIN) ("pGL4" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE) ("coactivator 1" . SPARSER::PROTEIN)
    ("SREBP1" . SPARSER::PROTEIN) ("TRAP220" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("nuclear hormone receptor" . SPARSER::PROTEIN)
    ("glucose 6 phosphatase" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN) ("TRβ1" . SPARSER::PROTEIN)
    ("PGC-1α" . SPARSER::PROTEIN) ("NAD +" . SPARSER::MOLECULE)
    ("SIRT1" . SPARSER::PROTEIN) ("Sirtuin 1" . SPARSER::PROTEIN)
    ("homodimer" . SPARSER::HOMODIMER) ("MMP" . SPARSER::PROTEIN)
    ("metallopeptidase" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase/extracellular signal-regulated kinase"
     . SPARSER::COLLECTION)
    ("RhoU and GRB2" . SPARSER::COLLECTION) ("RhoU" . SPARSER::PROTEIN)
    ("MiRNAs" . SPARSER::MICRO-RNA) ("Nodal" . SPARSER::PROTEIN)
    ("activin" . SPARSER::PROTEIN) ("inosine" . SPARSER::MOLECULE)
    ("TSA" . SPARSER::PROTEIN) ("HDAC" . SPARSER::PROTEIN)
    ("dCR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AZA" . SPARSER::DRUG)
    ("bisulfite" . SPARSER::MOLECULE) ("VI" . SPARSER::PROTEIN)
    ("IL1B ( xref ) and MMP9 (to 52%, xref )" . SPARSER::COLLECTION)
    ("IL1B and MMP9" . SPARSER::COLLECTION)
    ("interleukin-1 beta ( IL1B ) and matrix metallopeptidase 9 ( MMP9 )"
     . SPARSER::COLLECTION)
    ("Base" . SPARSER::PROTEIN) ("IPA" . SPARSER::MOLECULE)
    ("siRNAs" . SPARSER::PROTEIN)
    ("both GRB2 protein ( xref ) and mRNA ( xref )" . SPARSER::COLLECTION)
    ("siRNA" . SPARSER::PROTEIN) ("Molecules" . SPARSER::MOLECULE)
    ("receptor (EGFR)" . SPARSER::RECEPTOR) ("pMIR-GRB2" . SPARSER::COLLECTION)
    ("Target" . SPARSER::TARGET-PROTEIN)
    ("only GRB2 protein" . SPARSER::PROTEIN)
    ("family and miR-205" . SPARSER::COLLECTION)
    ("inducers" . SPARSER::MOLECULE) ("ZEB" . SPARSER::PROTEIN)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("2–8 of the miRNAs ( i.e. , the seed sequences) and the 3"
     . SPARSER::COLLECTION)
    ("ncRNAs" . SPARSER::RNA) ("RNAs" . SPARSER::RNA)
    ("-deoxycytidine" . SPARSER::COLLECTION)
    ("trichostatin" . SPARSER::MOLECULE) ("deoxycytidine" . SPARSER::PROTEIN)
    ("Bisulfite" . SPARSER::MOLECULE)
    ("interleukin 1 beta and matrix metallopeptidase 9" . SPARSER::COLLECTION)
    ("ICC" . SPARSER::PROTEIN) ("MicroRNA" . SPARSER::MICRO-RNA)
    ("Ras homolog family member U" . SPARSER::PROTEIN)
    ("ALK7" . SPARSER::PROTEIN) ("interleukin-1 beta" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("IL1B" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("zinc finger" . SPARSER::PROTEIN) ("Let-7" . SPARSER::RNA)
    ("histone deacetylase" . SPARSER::PROTEIN)
    ("matrix metallopeptidase 9" . SPARSER::PROTEIN)
    ("interleukin 1 beta" . SPARSER::PROTEIN)
    ("growth factor and cytokine" . SPARSER::COLLECTION)
    ("pol ι-related error-prone TLS" . SPARSER::PROTEIN)
    ("MAPK/JNK/c-Jun" . SPARSER::COLLECTION)
    ("The pol ι-involved error-prone TLS" . SPARSER::PROTEIN)
    ("the cyclobutane pyrimidine dimer and 6-4 pyrimidine pyrimidone photoadduct xref"
     . SPARSER::COLLECTION)
    ("the predominant type" . TYPE)
    ("cigarette smoke and the uptake" . SPARSER::COLLECTION)
    ("cigarette" . SPARSER::DRUG) ("reagents" . SPARSER::MOLECULE)
    ("ATR-" . SPARSER::PROTEIN) ("p-MKK7" . SPARSER::COLLECTION)
    ("p-MKK4" . SPARSER::COLLECTION) ("MKK4 and MKK7" . SPARSER::COLLECTION)
    ("MAPKK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MKK4/SEK1" . SPARSER::COLLECTION)
    ("MAPKKs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("shRNA" . SPARSER::PROTEIN)
    ("siRNA-ATR or shRNA-XPC" . SPARSER::COLLECTION)
    ("shRNA-XPC" . SPARSER::PROTEIN-PAIR) ("siRNA-ATR" . SPARSER::PROTEIN-PAIR)
    ("XPC and ATR" . SPARSER::COLLECTION) ("ATR and XPC" . SPARSER::COLLECTION)
    ("p-JNK" . SPARSER::COLLECTION)
    ("PD98059 and SB203580" . SPARSER::COLLECTION)
    ("ERK and p38" . SPARSER::COLLECTION) ("p" . SPARSER::PROTEIN)
    ("p-c-Jun" . SPARSER::COLLECTION) ("c-Jun and JNK" . SPARSER::COLLECTION)
    ("the pol ι-mediated TLS" . SPARSER::PROTEIN)
    ("pyrimidone" . SPARSER::MOLECULE) ("pyrimidine" . SPARSER::DRUG)
    ("cyclobutane" . SPARSER::MOLECULE)
    ("cisplatin, bleomycin and etoposide" . SPARSER::COLLECTION)
    ("bleomycin" . SPARSER::DRUG) ("MU" . SPARSER::PROTEIN)
    ("the minimal POLI promoter" . SPARSER::PROMOTER)
    ("the basic promoter" . SPARSER::PROMOTER) ("POLI" . SPARSER::PROTEIN)
    ("proteins, XPC and ATR" . SPARSER::COLLECTION)
    ("TLS and DNA" . SPARSER::COLLECTION)
    ("cytokines and DNA" . SPARSER::COLLECTION)
    ("Jun, Fos and ATF" . SPARSER::COLLECTION)
    ("Targets" . SPARSER::TARGET-PROTEIN)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XPV" . SPARSER::PROTEIN) ("polymerases" . SPARSER::PROTEIN)
    ("TLS" . SPARSER::PROTEIN) ("JNK/c-Jun" . SPARSER::COLLECTION)
    ("protein (ATR)" . SPARSER::PROTEIN) ("protein (XPC)" . SPARSER::PROTEIN)
    ("ATR" . SPARSER::PROTEIN) ("XPC" . SPARSER::PROTEIN)
    ("kinase (JNK)" . SPARSER::KINASE) ("pol" . SPARSER::PROTEIN)
    ("−3" . SPARSER::PROTEIN) ("phosphatase-1" . SPARSER::PROTEIN)
    ("SEK1" . SPARSER::PROTEIN) ("β-gal" . SPARSER::PROTEIN)
    ("β-Galactosidase" . SPARSER::PROTEIN) ("MKP-1" . SPARSER::PROTEIN)
    ("MKK7" . SPARSER::PROTEIN) ("MKK4" . SPARSER::PROTEIN)
    ("SB203580" . SPARSER::DRUG) ("s 5A" . SPARSER::PROTEIN)
    ("activator protein 1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rev1" . SPARSER::PROTEIN) ("group C" . SPARSER::PROTEIN)
    ("DNA polymerase iota" . SPARSER::PROTEIN)
    ("Prolines" . SPARSER::AMINO-ACID)
    ("SCRIB and VANGL2" . SPARSER::COLLECTION)
    ("SCRIB and its mutants" . SPARSER::COLLECTION) ("PZD" . SPARSER::DRUG)
    ("GFP-SCRIB" . SPARSER::COLLECTION)
    ("the mouse pathogenic line- 90 mutant" . SPARSER::MUTANT)
    ("a highly conservative amino acid" . SPARSER::AMINO-ACID)
    ("EA" . SPARSER::PROTEIN) ("ESP" . SPARSER::PROTEIN)
    ("the most severe type" . TYPE) ("NTD" . SPARSER::PROTEIN)
    ("insC" . SPARSER::PROTEIN) ("LRR" . SPARSER::PROTEIN)
    ("leucine rich repeats and PSD-95/Discs" . SPARSER::COLLECTION)
    ("LAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CELSR" . SPARSER::PROTEIN)
    ("Celsr" . SPARSER::PROTEIN)
    ("all known planar cell polarity (PCP) genes" . SPARSER::GENE)
    ("the entire neural tube" . SPARSER::PROTEIN) ("line-" . SPARSER::PROTEIN)
    ("Scrib" . SPARSER::PROTEIN) ("a PCP-associated gene" . SPARSER::GENE)
    ("SCRIB" . SPARSER::PROTEIN)
    ("planar cell polarity (PCP) genes" . SPARSER::GENE)
    ("PCP" . SPARSER::PROTEIN) ("congenital malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("tube" . SPARSER::PROTEIN)
    ("PDZ1" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("PSD-95" . SPARSER::PROTEIN) ("leucine rich repeats" . SPARSER::PROTEIN)
    ("FZD6" . SPARSER::PROTEIN) ("VANGL2" . SPARSER::PROTEIN)
    ("1 D" . SPARSER::PROTEIN) ("Vangl2" . SPARSER::PROTEIN)
    ("the squamous components" . SPARSER::COMPONENT)
    ("p63 and TTF1" . SPARSER::COLLECTION) ("ALK-" . SPARSER::PROTEIN)
    ("other histological types" . TYPE) ("FISH and IHC" . SPARSER::COLLECTION)
    ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("EGFR, KRAS or BRAF" . SPARSER::COLLECTION) ("n " . SPARSER::PROTEIN)
    ("ALK1 and D5F3" . SPARSER::COLLECTION)
    ("A20 and E6a" . SPARSER::COLLECTION) ("ins" . SPARSER::PROTEIN)
    ("TTF-1 and p63" . SPARSER::COLLECTION) ("columnar goblet types" . TYPE)
    ("various predominant subtypes" . SPARSER::PROTEIN)
    ("EGFR , KRAS and BRAF" . SPARSER::COLLECTION)
    ("common driver mutation group (411 cases) and pan-negative group (117 cases)"
     . SPARSER::COLLECTION)
    ("named ALK -positive group (44 cases), common driver mutation group (411 cases) and pan-negative group (117 cases)"
     . SPARSER::COLLECTION)
    ("IV" . SPARSER::PROTEIN) ("formalin" . SPARSER::MOLECULE)
    ("EGFR or KRAS" . SPARSER::COLLECTION) ("EML4-ALK" . SPARSER::COLLECTION)
    ("the echinoderm microtubule-associated protein-like 4 ( EML4 ) gene"
     . SPARSER::PROTEIN)
    ("the optimal screening antibody" . SPARSER::ANTIBODY)
    ("additional focal squamous components" . SPARSER::COMPONENT)
    ("polymerase" . SPARSER::PROTEIN) ("FISH" . SPARSER::PROTEIN)
    ("crizotinib" . SPARSER::DRUG) ("ALK" . SPARSER::PROTEIN)
    ("TTF1" . SPARSER::PROTEIN) ("A20" . SPARSER::PROTEIN)
    ("3b" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TTF-1" . SPARSER::PROTEIN)
    ("p63" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p23" . SPARSER::PROTEIN)
    ("DNA polymerase" . SPARSER::PROTEIN) ("EML4" . SPARSER::PROTEIN)
    ("ALK1" . SPARSER::PROTEIN) ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("currently incurable form" . SPARSER::FORM)
    ("DU145 and PC3" . SPARSER::COLLECTION)
    ("the hereby confirmed miR-34c target MET and previously confirmed AR ( xref )"
     . SPARSER::COLLECTION)
    ("previously confirmed AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the benign and malignant parts" . SPARSER::COMPONENT)
    ("the benign parts" . SPARSER::COMPONENT) ("parts" . SPARSER::COMPONENT)
    ("subsequently targets MET" . SPARSER::PROTEIN)
    ("E2F3 and Bcl-2" . SPARSER::COLLECTION) ("run" . SPARSER::PROTEIN)
    ("ANOVA" . SPARSER::PROTEIN) ("prostatic" . SPARSER::PROTEIN)
    ("PC3 and DU145" . SPARSER::COLLECTION) ("LNCaP" . SPARSER::PROTEIN)
    ("MET and no miR-34c" . SPARSER::COLLECTION)
    ("exogenous MET" . SPARSER::PROTEIN) ("mut" . SPARSER::PROTEIN)
    ("LNA-antisense" . SPARSER::COLLECTION) ("antisense" . SPARSER::PROTEIN)
    ("LNA" . SPARSER::PROTEIN) ("-subunit" . SPARSER::FRAGMENT)
    ("CDC25A , E2F5 , NOTCH2 , RRAS , JAG1 , MET , and PDGFRA"
     . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN) ("RRAS" . SPARSER::PROTEIN)
    ("NF- κ B and hepatocyte growth factor" . SPARSER::COLLECTION)
    ("accession number GSE41322" . SPARSER::PROTEIN) ("GSE" . SPARSER::PROTEIN)
    ("androgen" . SPARSER::PROTEIN)
    ("well-documented PCa cohort" . SPARSER::MOLECULE)
    ("met" . SPARSER::PROTEIN) ("CRPC" . SPARSER::FORM)
    ("form (CRPC)" . SPARSER::FORM) ("Androgen" . SPARSER::PROTEIN)
    ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("androgens" . SPARSER::DRUG)
    ("PCa" . SPARSER::PROTEIN) ("microRNA" . SPARSER::MICRO-RNA)
    ("transcription factor Sp1" . SPARSER::PROTEIN) ("Sp1" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("E2F3" . SPARSER::PROTEIN)
    ("JAG1" . SPARSER::PROTEIN) ("NOTCH2" . SPARSER::PROTEIN)
    ("E2F5" . SPARSER::PROTEIN) ("CDC25A" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN) ("α -actinin" . SPARSER::PROTEIN)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PGK1" . SPARSER::PROTEIN)
    ("and 1 " . SPARSER::PROTEIN) ("DU145" . SPARSER::PROTEIN)
    ("loss of heterozygosity" . SPARSER::PROTEIN) ("HIF1 α" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTO-ONCOGENE)
    ("androgen receptor" . SPARSER::PROTEIN) ("PC3" . SPARSER::PROTEIN)
    ("particular GCA" . SPARSER::PROTEIN) ("gene-" . SPARSER::GENE)
    ("tobacco" . SPARSER::DRUG) ("PAK2 and CASP8AP2" . SPARSER::COLLECTION)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CHUK" . SPARSER::PROTEIN)
    ("a larger complex" . SPARSER::BIO-COMPLEX) ("IKKA" . SPARSER::PROTEIN)
    ("IkappaB" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("CASP8 and CASP10" . SPARSER::COLLECTION)
    ("TRAK" . SPARSER::PROTEIN-FAMILY) ("CR" . SPARSER::PROTEIN)
    ("protein or c-FLIP" . SPARSER::COLLECTION) ("FLICE" . SPARSER::PROTEIN)
    ("CFLAR, CASP10 and CASP8" . SPARSER::COLLECTION)
    ("max" . SPARSER::PROTEIN)
    ("GC ( P = 0.0185) and GCA (P = 0.0203)" . SPARSER::COLLECTION)
    ("soluble FasL" . SPARSER::PROTEIN) ("FasL" . SPARSER::PROTEIN)
    ("CASP10, CASP8, CFLAR and MAP2K1" . SPARSER::COLLECTION)
    ("CASP8, CASP10, CFLAR, and MAP2K1" . SPARSER::COLLECTION)
    ("MAP2K4 and IKBKB" . SPARSER::COLLECTION) ("Strong LD" . SPARSER::PROTEIN)
    ("strong LD" . SPARSER::PROTEIN)
    ("MAP2K4 and four SNPs" . SPARSER::COLLECTION)
    ("ARHGDIB, BID, CASP6, CASP7, CASP8, CASP8AP2, CASP10, CFLAR, CRADD, DFFB, FAF1, IKBKB, MAP2K1, MAP2K4, MAP3K5, MAPK8, NFKB2, PAK1, PAK2, PARP1, PRKDC, RAF1, RB1, and UBE2I"
     . SPARSER::COLLECTION)
    ("PRKDC" . SPARSER::PROTEIN) ("DFFB" . SPARSER::PROTEIN)
    ("CRADD" . SPARSER::PROTEIN) ("BID" . SPARSER::PROTEIN)
    ("ARHGDIB" . SPARSER::PROTEIN)
    ("PAK2 ( P = 0.0476) and IKKB ( P = 0.048)" . SPARSER::COLLECTION)
    ("MAP2K4 ( P = 0.0038), FAF1 ( P = 0.0039) MAPK8 (P = 0.0041), CASP10 ( P =0.011), CASP8 ( P = 0.012), CFLAR ( P = 0.015), MAP2K1 ( P = 0.0185), CASP8AP2 ( P = 0.02), PAK2 ( P = 0.0476) and IKKB ( P = 0.048)"
     . SPARSER::COLLECTION)
    ("IKKB" . SPARSER::PROTEIN) ("smoke" . SPARSER::MOLECULE)
    ("alcohol" . SPARSER::DRUG) ("NIT and Shanxi" . SPARSER::COLLECTION)
    ("NIT" . SPARSER::PROTEIN)
    ("initiator caspases and signal transduction effectors"
     . SPARSER::COLLECTION)
    ("Fas, initiator caspases and signal transduction effectors"
     . SPARSER::COLLECTION)
    ("‘caspases’" . SPARSER::PROTEIN) ("kappaB" . SPARSER::PROTEIN)
    ("CASP" . SPARSER::PROTEIN) ("TNFR" . SPARSER::PROTEIN)
    ("Han" . SPARSER::PROTEIN) ("GC and genome-wide" . SPARSER::COLLECTION)
    ("MAP2K4, FAF1, MAPK8, CASP10, CASP8, CFLAR, MAP2K1, CAP8AP2, PAK2 and IKBKB"
     . SPARSER::COLLECTION)
    ("FAF1 and MAPK8" . SPARSER::COLLECTION)
    ("GCA and GNCA" . SPARSER::COLLECTION) ("IKBKB" . SPARSER::PROTEIN)
    ("CFLAR" . SPARSER::PROTEIN)
    ("GC ( P = 5.5E-04) and GCA ( P = 6.3E-03)" . SPARSER::COLLECTION)
    ("Gene-" . SPARSER::GENE) ("Gene" . SPARSER::GENE)
    ("GC, GCA and GNCA" . SPARSER::COLLECTION) ("GCA" . SPARSER::PROTEIN)
    ("Fas" . SPARSER::PROTEIN) ("GC" . SPARSER::PROTEIN)
    ("FAF-1" . SPARSER::PROTEIN) ("CASP3" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("ALS2" . SPARSER::PROTEIN) ("RIP2" . SPARSER::PROTEIN)
    ("c-FLIP" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("JNK1" . SPARSER::PROTEIN) ("nuclear receptor" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN) ("JNKK1" . SPARSER::PROTEIN)
    ("map kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PLCE1" . SPARSER::PROTEIN)
    ("UBE2I" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("RAF1" . SPARSER::PROTEIN) ("PARP1" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NFKB2" . SPARSER::PROTEIN)
    ("MAP3K5" . SPARSER::PROTEIN) ("CASP7" . SPARSER::PROTEIN)
    ("CASP6" . SPARSER::PROTEIN) ("CASP8AP2" . SPARSER::PROTEIN)
    ("NF-kB" . SPARSER::PROTEIN) ("FasL-Fas" . SPARSER::PROTEIN)
    ("Tumor Necrosis Factor Receptor" . SPARSER::PROTEIN)
    ("p13" . SPARSER::PROTEIN) ("PAK2" . SPARSER::PROTEIN)
    ("AP2" . SPARSER::PROTEIN) ("MAP2K1" . SPARSER::PROTEIN)
    ("CASP8" . SPARSER::PROTEIN) ("CASP10" . SPARSER::PROTEIN)
    ("MAPK8" . SPARSER::PROTEIN) ("FAF1" . SPARSER::PROTEIN)
    ("MAP2K4" . SPARSER::PROTEIN) ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("a receptor’s" . SPARSER::RECEPTOR)
    ("AXL and c-MET" . SPARSER::COLLECTION)
    ("MET or AXL" . SPARSER::COLLECTION) ("AXL or MET" . SPARSER::COLLECTION)
    ("AXL and MET" . SPARSER::COLLECTION)
    ("AXL, and IGF1R" . SPARSER::COLLECTION)
    ("ErbB, MET, and AXL" . SPARSER::COLLECTION)
    ("associated EGFR" . SPARSER::PROTEIN)
    ("ErbB and AXL" . SPARSER::COLLECTION)
    ("erlotinib and lapatinib" . SPARSER::COLLECTION)
    ("synergizes" . SPARSER::PROTEIN) ("RTK/AXL" . SPARSER::COLLECTION)
    ("HRG and AXL" . SPARSER::COLLECTION) ("HBEGF" . SPARSER::PROTEIN)
    ("HER2 and HER3" . SPARSER::COLLECTION) ("HRG" . SPARSER::PROTEIN)
    ("heregulin" . SPARSER::PROTEIN) ("EGFR-AXL" . SPARSER::COLLECTION)
    ("ErbB, MET, and PDGFR" . SPARSER::COLLECTION)
    ("IGF1R or INSR" . SPARSER::COLLECTION)
    ("IGF1R and INSR" . SPARSER::COLLECTION) ("AXL/RTK" . SPARSER::COLLECTION)
    ("a particular RTK" . SPARSER::PROTEIN)
    ("AXL and each RTK" . SPARSER::COLLECTION)
    ("INSR and IGF1R" . SPARSER::COLLECTION)
    ("insulin receptor (INSR) or IGF1R ( xref and xref )"
     . SPARSER::COLLECTION)
    ("receptors, MET, and PDGFR" . SPARSER::COLLECTION)
    ("ErbB and MET" . SPARSER::COLLECTION)
    ("IGF1R or IR" . SPARSER::COLLECTION) ("IR" . SPARSER::PROTEIN)
    ("PCs" . SPARSER::PROTEIN) ("GSK3, STAT3, and Akt" . SPARSER::COLLECTION)
    ("simple" . SPARSER::PROTEIN) ("fit" . SPARSER::PROTEIN-FAMILY)
    ("EGFR and Akt" . SPARSER::COLLECTION) ("phos" . SPARSER::PROTEIN)
    ("the adaptor protein SHC and the CDC2 kinase" . SPARSER::COLLECTION)
    ("SHC" . SPARSER::PROTEIN) ("the former case" . SPARSER::PROTEIN)
    ("HGF and EGF" . SPARSER::COLLECTION)
    ("EGFR, HER2, or AXL" . SPARSER::COLLECTION)
    ("EGF and TGFα" . SPARSER::COLLECTION)
    ("Akt and GSK3" . SPARSER::COLLECTION)
    ("Principal component" . SPARSER::COMPONENT) ("PC2" . SPARSER::PROTEIN)
    ("PC1" . SPARSER::PROTEIN)
    ("GSK3 (glycogen synthase kinase 3) and Akt" . SPARSER::COLLECTION)
    ("EGF-" . SPARSER::PROTEIN) ("MET and AXL" . SPARSER::COLLECTION)
    ("AXL and other RTKs" . SPARSER::COLLECTION)
    ("the EGFR- and the AXL-targeted inhibitors" . SPARSER::COLLECTION)
    ("paclitaxel" . SPARSER::DRUG) ("erlotinib and R428" . SPARSER::COLLECTION)
    ("EGFR and AXL" . SPARSER::COLLECTION)
    ("EPHA1 and FGFR1" . SPARSER::COLLECTION)
    ("target MET [hepatocyte growth factor (HGF) receptor] and PDGFR (platelet-derived growth factor receptor)"
     . SPARSER::COLLECTION)
    ("HGF" . SPARSER::PROTEIN) ("IGFR" . SPARSER::PROTEIN)
    ("AXL and EGFR" . SPARSER::COLLECTION)
    ("Gas6 and protein" . SPARSER::COLLECTION)
    ("RTK and AXL" . SPARSER::COLLECTION)
    ("lapatinib and erlotinib" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG)
    ("all possible drug target RTK gene" . SPARSER::PROTEIN)
    ("particularly genes encoding proteins" . SPARSER::PROTEIN)
    ("those particular RTKs" . SPARSER::PROTEIN)
    ("both EGFR (epidermal growth factor receptor) and AXL"
     . SPARSER::COLLECTION)
    ("MERTK" . SPARSER::PROTEIN)
    ("EGFR- and AXL-targeted inhibitors" . SPARSER::COLLECTION)
    ("IGF1R (insulin-like growth factor 1 receptor) or INSR (insulin receptor)"
     . SPARSER::COLLECTION)
    ("INSR" . SPARSER::PROTEIN) ("PDGFR" . SPARSER::PROTEIN)
    ("MET" . SPARSER::PROTEIN)
    ("the epithelial-to-mesenchymal transition (EMT)–associated receptor tyrosine kinase (RTK) AXL"
     . SPARSER::PROTEIN)
    ("ErbB" . SPARSER::PROTEIN) ("AXL" . SPARSER::PROTEIN)
    ("Line" . SPARSER::PROTEIN) ("m  2" . SPARSER::MOLECULE)
    ("m  1" . SPARSER::MOLECULE) ("L15" . SPARSER::PROTEIN)
    ("Tyk2" . SPARSER::PROTEIN) ("pIRS1" . SPARSER::PROTEIN)
    ("HSP27" . SPARSER::PROTEIN) ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pP38" . SPARSER::PROTEIN) ("GSK3α" . SPARSER::PROTEIN)
    ("Cav1" . SPARSER::PROTEIN) ("α-actinin" . SPARSER::PROTEIN)
    ("extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdc2" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("PDGF-BB" . SPARSER::PROTEIN) ("c-MET" . SPARSER::PROTEIN)
    ("CDC2" . SPARSER::PROTEIN) ("adaptor protein" . SPARSER::PROTEIN)
    ("GSK3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FGFR1" . SPARSER::PROTEIN)
    ("EPHA1" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN) ("Gas6" . SPARSER::PROTEIN)
    ("TYRO3" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("Gemcitabine" . SPARSER::DRUG) ("guggulsterone" . SPARSER::DRUG)
    ("Mia" . SPARSER::PROTEIN)
    ("FAK (tyrosines 925 and 576/577) and Src (tyrosine 416)"
     . SPARSER::COLLECTION)
    ("tyrosines" . SPARSER::AMINO-ACID)
    ("FAK, Akt and ERK" . SPARSER::COLLECTION)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("ser" . SPARSER::AMINO-ACID)
    ("the pro-apoptotic proteins BAD and Bax" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Jak1and Jak2" . SPARSER::COLLECTION)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("particular STAT3" . SPARSER::PROTEIN)
    ("IL-4, IL-6, TNF-α and IFN-γ" . SPARSER::COLLECTION)
    ("JAK/STAT" . SPARSER::COLLECTION)
    ("mucins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("trastuzumab, and cisplatin" . SPARSER::COLLECTION)
    ("cisplatin" . SPARSER::DRUG) ("trastuzumab" . SPARSER::DRUG)
    ("TQ" . SPARSER::DRUG) ("MUC1 and MUC16" . SPARSER::COLLECTION)
    ("Src and FAK" . SPARSER::COLLECTION) ("FAK/Src" . SPARSER::COLLECTION)
    ("integrin" . SPARSER::PROTEIN)
    ("anti-STAT1 and -STAT3 antibodies" . SPARSER::COLLECTION)
    ("-STAT3" . SPARSER::COLLECTION) ("ChIP" . SPARSER::PROTEIN)
    ("kinases, pJak1 and pJak2" . SPARSER::COLLECTION)
    ("STAT1, STAT3, Jak1 and Jak2" . SPARSER::COLLECTION)
    ("Jak1" . SPARSER::PROTEIN) ("STATs" . SPARSER::PROTEIN)
    ("promoters" . SPARSER::PROMOTER) ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("which targets many extracellular proteins" . SPARSER::PROTEIN)
    ("matrigel" . SPARSER::PROTEIN)
    ("Cyclin D1, Abcl2 and Survivin" . SPARSER::COLLECTION)
    ("proteins-" . SPARSER::PROTEIN)
    ("Survivin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-apoptotic molecules BAD and Bax" . SPARSER::COLLECTION)
    ("BAD and Bax" . SPARSER::COLLECTION)
    ("xIAP, Bcl2 and Cyclin D1" . SPARSER::COLLECTION)
    ("Fluor" . SPARSER::MOLECULE) ("MTT" . SPARSER::MOLECULE)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("pregnane X receptor (PXR)" . SPARSER::PROTEIN) ("PXR" . SPARSER::PROTEIN)
    ("FXR" . SPARSER::PROTEIN) ("NF-κB and STAT3" . SPARSER::COLLECTION)
    ("gemcitabine" . SPARSER::DRUG) ("-pregnadiene- 3" . SPARSER::COLLECTION)
    ("phytochemicals" . SPARSER::DRUG) ("Jak/STAT" . SPARSER::COLLECTION)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mucin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAK and Src" . SPARSER::COLLECTION) ("FAK" . SPARSER::PROTEIN)
    ("Cyclin D1, Bcl-2 and xIAP" . SPARSER::COLLECTION)
    ("xIAP" . SPARSER::PROTEIN) ("Bad" . SPARSER::PROTEIN)
    ("GS" . SPARSER::DRUG) ("Guggulsterone" . SPARSER::DRUG)
    ("PC" . SPARSER::PROTEIN) ("PANC1" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN) ("TNF-α" . SPARSER::PROTEIN)
    ("membrane-bound" . SPARSER::PROTEIN) ("N-Cadherin" . SPARSER::PROTEIN)
    ("MUC16" . SPARSER::PROTEIN) ("MUC1" . SPARSER::PROTEIN)
    ("receptor protein-tyrosine kinase" . SPARSER::PROTEIN)
    ("Jak2" . SPARSER::PROTEIN) ("Muc4" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("Tom20" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Nonidet P-40" . SPARSER::DRUG)
    ("14-3-3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("STAT1" . SPARSER::PROTEIN)
    ("pregnane X receptor" . SPARSER::PROTEIN) ("Erα" . SPARSER::PROTEIN)
    ("Farnesoid X receptor" . SPARSER::PROTEIN) ("- 3" . SPARSER::PROTEIN)
    ("MUC4" . SPARSER::PROTEIN) ("MMP9" . SPARSER::PROTEIN)
    ("Annexin-V" . SPARSER::PROTEIN) ("CD18" . SPARSER::PROTEIN)
    ("ZIP6 and ELP2" . SPARSER::COLLECTION)
    ("ZIP4 [ xref ] and ZIP10 [ xref ]" . SPARSER::COLLECTION)
    ("subtilisin" . SPARSER::PROTEIN) ("‘ermelin’" . SPARSER::PROTEIN)
    ("ermelin" . SPARSER::PROTEIN) ("paralogue" . SPARSER::PROTEIN)
    ("our unique ZIP6 antibodies" . SPARSER::ANTIBODY)
    ("STAT3 or ZIP6" . SPARSER::COLLECTION)
    ("ZIP6 and E-cadherin" . SPARSER::COLLECTION)
    ("ZIP7 or ZIP14" . SPARSER::COLLECTION)
    ("ZIP7 and ZIP14" . SPARSER::COLLECTION)
    ("E2, EGF or TGFα" . SPARSER::COLLECTION)
    ("Extracellular" . SPARSER::PROTEIN) ("STAT3 and E2" . SPARSER::COLLECTION)
    ("fish" . SPARSER::PROTEIN) ("Zip6" . SPARSER::PROTEIN)
    ("anti-oestrogens FAS (Faslodex®) or TAM" . SPARSER::COLLECTION)
    ("E2, EGF and TGF" . SPARSER::COLLECTION) ("TAM" . SPARSER::PROTEIN)
    ("Faslodex" . SPARSER::DRUG) ("FAS" . SPARSER::PROTEIN)
    ("TGF" . SPARSER::PROTEIN) ("CHO" . SPARSER::PROTEIN)
    ("LacZ" . SPARSER::PROTEIN) ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("pSer" . SPARSER::PROTEIN)
    ("ZIP6 or other ZIP transporters" . SPARSER::COLLECTION)
    ("103 kDa and 35 kDa" . SPARSER::COLLECTION)
    ("103 kDa and 68 kDa" . SPARSER::COLLECTION)
    ("ZIP6-Y antibody (far N-terminus) and SC antibody (cytoplasmic loop between TM3 and TM4)"
     . SPARSER::COLLECTION)
    ("TM3 and TM4" . SPARSER::COLLECTION) ("SC" . SPARSER::PROTEIN)
    ("TM3" . SPARSER::PROTEIN) ("ZIP6 and Snail" . SPARSER::COLLECTION)
    ("STAT3 and oestrogen" . SPARSER::COLLECTION)
    ("STAT3 and ER" . SPARSER::COLLECTION) ("zip6" . SPARSER::PROTEIN)
    ("zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ELP2 (elongation protein 2) and E-cadherin" . SPARSER::COLLECTION)
    ("elongation" . SPARSER::PROTEIN) ("the respective genes" . SPARSER::GENE)
    ("ZIP6 or STAT3" . SPARSER::COLLECTION)
    ("STAT3 (6-fold) and Snail (5-fold)" . SPARSER::COLLECTION)
    ("ZIP6 (25-fold), STAT3 (6-fold) and Snail (5-fold)" . SPARSER::COLLECTION)
    ("ZIP6, STAT3, Snail and E-cadherin" . SPARSER::COLLECTION)
    ("ZIP6 and STAT3" . SPARSER::COLLECTION)
    ("plasma-membrane-located ZIP6" . SPARSER::PROTEIN)
    ("pro-protein" . SPARSER::COLLECTION)
    ("β-transducing repeat-containing protein" . SPARSER::PROTEIN)
    ("BTRC" . SPARSER::PROTEIN) ("mesenchymal character genes" . SPARSER::GENE)
    ("vimentin" . SPARSER::PROTEIN) ("STAT3 and ZIP6" . SPARSER::COLLECTION)
    ("STAT3 and Snail" . SPARSER::COLLECTION) ("cdh1" . SPARSER::PROTEIN)
    ("cdh" . SPARSER::PROTEIN) ("Zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the transcription factors STAT3 (signal transducer and activator of transcription 3) and Snail"
     . SPARSER::COLLECTION)
    ("clinical samples significantly places ZIP6 " . SPARSER::PROTEIN)
    ("ER- and lymph-node-positive" . SPARSER::COLLECTION)
    ("Luminal" . SPARSER::DRUG) ("metalloprotease" . SPARSER::PROTEIN)
    ("the prokaryotic homologue" . SPARSER::PROTEIN)
    ("homologue" . SPARSER::PROTEIN) ("SLC" . SPARSER::PROTEIN)
    ("ZIP" . SPARSER::PROTEIN) ("indicative genes" . SPARSER::GENE)
    ("a zinc uptake channel ZIP6 (also known as SLC39A6) and a transcription factor"
     . SPARSER::COLLECTION)
    ("underwent EMT" . SPARSER::PROTEIN) ("anoikis" . SPARSER::PROTEIN)
    ("monolayers" . SPARSER::PROTEIN) ("Akt or GSK-3β" . SPARSER::COLLECTION)
    ("transporters" . SPARSER::PROTEIN) ("Snail" . SPARSER::PROTEIN)
    ("an essential part" . SPARSER::COMPONENT) ("EMT" . SPARSER::PROTEIN)
    ("scaffold protein" . SPARSER::PROTEIN) ("ZIP4" . SPARSER::PROTEIN)
    ("interleukin 6" . SPARSER::PROTEIN) ("TGFα" . SPARSER::PROTEIN)
    ("G-protein" . SPARSER::PROTEIN) ("GPR39" . SPARSER::PROTEIN)
    ("anti-oestrogens" . SPARSER::DRUG) ("protein 2" . SPARSER::PROTEIN)
    ("for 3 " . SPARSER::PROTEIN) ("ELP2" . SPARSER::PROTEIN)
    ("P40" . SPARSER::PROTEIN) ("ZIP10" . SPARSER::PROTEIN)
    ("ZIP14" . SPARSER::PROTEIN) ("KE4" . SPARSER::PROTEIN)
    ("HKE4" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("4-hydroxytamoxifen" . SPARSER::DRUG) ("ZD1839" . SPARSER::DRUG)
    ("and 1 " . SPARSER::PROTEIN) ("STATIP1" . SPARSER::PROTEIN)
    ("GSK-3α" . SPARSER::PROTEIN) ("TM4" . SPARSER::PROTEIN)
    ("N-terminally" . SPARSER::PROTEIN)
    ("Zinc transporter ZIP6" . SPARSER::PROTEIN) ("β-TrCP" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN) ("CK2" . SPARSER::PROTEIN)
    ("protein kinase" . SPARSER::PROTEIN) ("ZIP7" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY) ("ZIP6 " . SPARSER::PROTEIN)
    ("CDH1" . SPARSER::PROTEIN) ("epithelial cadherin" . SPARSER::PROTEIN)
    ("E-cadherin" . SPARSER::PROTEIN) ("GSK-3β" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("LIV-1" . SPARSER::PROTEIN) ("member 6" . SPARSER::PROTEIN)
    ("solute carrier family 39 (zinc transporter)" . SPARSER::PROTEIN)
    ("SLC39A6" . SPARSER::PROTEIN) ("ZIP6" . SPARSER::PROTEIN)
    ("DM" . SPARSER::PROTEIN) ("JH, WM and MMH" . SPARSER::COLLECTION)
    ("MMH" . SPARSER::PROTEIN) ("JH" . SPARSER::PROTEIN)
    ("SL" . SPARSER::PROTEIN) ("BK and JK" . SPARSER::COLLECTION)
    ("JK" . SPARSER::PROTEIN) ("BK" . SPARSER::PROTEIN)
    ("GH/IGF-1" . SPARSER::COLLECTION) ("GH" . SPARSER::PROTEIN)
    ("BMPs and WNT" . SPARSER::COLLECTION)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BMPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRE or ARE" . SPARSER::COLLECTION)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT) ("CRE" . SPARSER::PROTEIN)
    ("Jun, ATF, MAF and Fos" . SPARSER::COLLECTION)
    ("ATF3/LRF1" . SPARSER::COLLECTION) ("FosB" . SPARSER::PROTEIN)
    ("Nrl" . SPARSER::PROTEIN) ("MafG" . SPARSER::PROTEIN)
    ("MafA" . SPARSER::PROTEIN) ("MafB" . SPARSER::PROTEIN)
    ("JUND" . SPARSER::PROTEIN) ("JUNB" . SPARSER::PROTEIN)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ATF" . SPARSER::PROTEIN)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY) ("homologues" . SPARSER::PROTEIN)
    ("PPARs or the SREBP family" . SPARSER::COLLECTION)
    ("SREBP" . SPARSER::PROTEIN-FAMILY) ("PPARs" . SPARSER::PROTEIN)
    ("Wnt5A, IL6, FGF-2, ODC-1, C/EBP, NR2F2, INHBB, SFRP1 or ITGA6"
     . SPARSER::COLLECTION)
    ("INHBB" . SPARSER::PROTEIN) ("ODC" . SPARSER::PROTEIN)
    ("masks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ubiquitous transcriptional repressor" . SPARSER::REPRESSOR)
    ("actin or nucleolin" . SPARSER::COLLECTION)
    ("nucleolin" . SPARSER::PROTEIN) ("HnRPs" . SPARSER::PROTEIN)
    ("no classical DNA" . SPARSER::DNA)
    ("proteins, and heat shock proteins" . SPARSER::COLLECTION)
    ("ribonucleoproteins" . SPARSER::PROTEIN)
    ("ATF4, PPARα, SREBP-1or-2 and CEBP" . SPARSER::COLLECTION)
    ("CEBP" . SPARSER::PROTEIN) ("differentially" . SPARSER::PROTEIN)
    ("preadipocytes" . SPARSER::PROTEIN)
    ("helicases or structural proteins (Table  xref )" . SPARSER::COLLECTION)
    ("helicases" . SPARSER::PROTEIN)
    ("at least 13 proteins" . SPARSER::PROTEIN)
    ("DNA-fragments" . SPARSER::DNA)
    ("a common heterozygous SNP" . SPARSER::PROTEIN)
    ("insulin and IGF-1" . SPARSER::COLLECTION)
    ("PDGF and EGF" . SPARSER::COLLECTION)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("the ternary complex factor Elk-1" . SPARSER::PROTEIN)
    ("a ternary transcription activation complex" . SPARSER::BIO-COMPLEX)
    ("the immediate-early genes c-fos" . SPARSER::PROTEIN)
    ("sre" . SPARSER::PROTEIN) ("ERK1/2-MAPK" . SPARSER::COLLECTION)
    ("Insulin" . SPARSER::PROTEIN) ("Glucose" . SPARSER::PROTEIN)
    ("triglycerides" . SPARSER::MOLECULE) ("dl" . SPARSER::MOLECULE)
    ("SREBP-1c or C/EBP" . SPARSER::COLLECTION) ("EBP" . SPARSER::PROTEIN)
    ("hot" . SPARSER::PROTEIN) ("the severe congenital forms" . SPARSER::FORM)
    ("fat" . SPARSER::PROTEIN) ("glycerophospholipid" . SPARSER::MOLECULE)
    ("PTRF" . SPARSER::PROTEIN) ("BSCL2/seipin" . SPARSER::COLLECTION)
    ("seipin" . SPARSER::PROTEIN) ("the most severe form" . SPARSER::FORM)
    ("one essential transcription factor" . SPARSER::PROTEIN)
    ("The immediate-early gene c-fos" . SPARSER::PROTEIN)
    ("adipocytes" . SPARSER::PROTEIN) ("BSCL" . SPARSER::PROTEIN)
    ("CGL" . SPARSER::PROTEIN)
    ("Berardinelli–Seip congenital lipodystrophy" . SPARSER::PROTEIN)
    ("Fra-2" . SPARSER::PROTEIN) ("Fra-1" . SPARSER::PROTEIN)
    ("c-Maf" . SPARSER::PROTEIN) ("JDP2" . SPARSER::PROTEIN)
    ("JDP1" . SPARSER::PROTEIN) ("LRF1" . SPARSER::PROTEIN)
    ("ATF3" . SPARSER::PROTEIN) ("ATF2" . SPARSER::PROTEIN)
    ("c-jun" . SPARSER::PROTEIN) ("ITGA6" . SPARSER::PROTEIN)
    ("SFRP1" . SPARSER::PROTEIN) ("NR2F2" . SPARSER::PROTEIN)
    ("FGF-2" . SPARSER::PROTEIN) ("IL6" . SPARSER::PROTEIN)
    ("Wnt5A" . SPARSER::PROTEIN) ("ATP dependent" . SPARSER::PROTEIN)
    ("heat shock proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SREBP-1" . SPARSER::PROTEIN) ("PPARα" . SPARSER::PROTEIN)
    ("ATF4" . SPARSER::PROTEIN) ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin receptor" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN) ("32P" . SPARSER::|32P|)
    ("32 P" . SPARSER::|32P|) ("β-galactosidase" . SPARSER::PROTEIN)
    ("aa 1" . SPARSER::PROTEIN) ("Elk-1" . SPARSER::PROTEIN)
    ("IGF-1" . SPARSER::PROTEIN) ("C-fos" . SPARSER::PROTEIN)
    ("SREBP-1c" . SPARSER::PROTEIN) ("PPARγ" . SPARSER::PROTEIN)
    ("lipid droplet" . SPARSER::PROTEIN) ("caveolin-1" . SPARSER::PROTEIN)
    ("BSCL2" . SPARSER::PROTEIN) ("AGPAT2" . SPARSER::PROTEIN)
    ("c-Fos" . SPARSER::PROTEIN) ("c-fos" . SPARSER::PROTEIN)
    ("the perinatal period" . SPARSER::PROTEIN)
    ("estradiol and progesterone" . SPARSER::COLLECTION)
    ("progesterone" . SPARSER::PROTEIN) ("Estrogen" . SPARSER::MOLECULE)
    ("antidepressants or psychotherapy" . SPARSER::COLLECTION)
    ("antidepressants" . SPARSER::DRUG) ("estradiol" . SPARSER::MOLECULE)
    ("estrogen" . SPARSER::MOLECULE)
    ("ESR1 and two SNPs" . SPARSER::COLLECTION)
    ("those encoding serotonergic signaling proteins" . SPARSER::PROTEIN)
    ("SERT and HTR2A" . SPARSER::COLLECTION)
    ("a synonymous SNP" . SPARSER::PROTEIN)
    ("dinucleotide" . SPARSER::MOLECULE)
    ("different variants and different regions of the gene (LD between the regions is low: R=0.07, D'=0.28)"
     . SPARSER::COLLECTION)
    ("those lacking at least one minor allele" . SPARSER::ALLELE)
    ("SS" . SPARSER::PROTEIN) ("LS" . SPARSER::PROTEIN)
    ("LL" . SPARSER::PROTEIN) ("ESR1-TA" . SPARSER::COLLECTION)
    ("SLC6A4 (SERT) and the serotonin receptor 2A (HTR2A)"
     . SPARSER::COLLECTION)
    ("a possible confounding factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Age" . SPARSER::PROTEIN)
    ("monoamine oxidase A ( MAOA ) and serotonin transporter ( SLC6A4 or SERT )"
     . SPARSER::COLLECTION)
    ("SLC6A4 or SERT" . SPARSER::COLLECTION)
    ("serotonin receptor 2A ( HTR2A) and dopamine transporter ( SLC6A3 or DAT )"
     . SPARSER::COLLECTION)
    ("tryptophan hydroxylase 2 ( TPH2 ), dopamine receptor D2 ( DRD2 ), serotonin receptor 2A ( HTR2A) and dopamine transporter ( SLC6A3 or DAT )"
     . SPARSER::COLLECTION)
    ("SLC6A3 or DAT" . SPARSER::COLLECTION) ("catechol" . SPARSER::PROTEIN)
    ("other candidate genes and gene-gene interactions with ESR1"
     . SPARSER::COLLECTION)
    ("TA-" . SPARSER::PROTEIN) ("SLC6A4 (SERT) and TPH2" . SPARSER::COLLECTION)
    ("SERT" . SPARSER::PROTEIN) ("DAT" . SPARSER::PROTEIN)
    ("MAOA" . SPARSER::PROTEIN) ("COMT" . SPARSER::PROTEIN)
    ("pilot" . SPARSER::PROTEIN) ("neurotransmitter" . SPARSER::MOLECULE)
    ("GABA" . SPARSER::MOLECULE) ("MDD" . SPARSER::PROTEIN)
    ("ESR1 and ESR2" . SPARSER::COLLECTION) ("Estrogens" . SPARSER::MOLECULE)
    ("hormonal factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("estrogens" . SPARSER::MOLECULE) ("transporter" . SPARSER::PROTEIN)
    ("serotonin" . SPARSER::MOLECULE) ("TA" . SPARSER::PROTEIN)
    ("PPD" . SPARSER::PROTEIN) ("monoamine oxidase A" . SPARSER::PROTEIN)
    ("dopamine transporter" . SPARSER::PROTEIN)
    ("serotonin receptor 2A" . SPARSER::PROTEIN)
    ("dopamine receptor D2" . SPARSER::PROTEIN)
    ("tryptophan hydroxylase 2" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TPH2" . SPARSER::PROTEIN)
    ("SLC6A4" . SPARSER::PROTEIN) ("SLC6A3" . SPARSER::PROTEIN)
    ("HTR2A" . SPARSER::PROTEIN) ("DRD2" . SPARSER::PROTEIN)
    ("ESR2" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("BLP, BP or FA" . SPARSER::COLLECTION)
    ("MP and BLP" . SPARSER::COLLECTION)
    ("strong diffuse p16" . SPARSER::PROTEIN) ("BLP/MP" . SPARSER::COLLECTION)
    ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("regulators" . SPARSER::REGULATOR)
    ("BLP, and BLP" . SPARSER::COLLECTION) ("BP and BLP" . SPARSER::COLLECTION)
    ("cellular FA" . SPARSER::PROTEIN) ("FA and MP" . SPARSER::COLLECTION)
    ("FA and phyllodes" . SPARSER::COLLECTION)
    ("BP, BLP, and MP" . SPARSER::COLLECTION) ("TMAs" . SPARSER::MOLECULE)
    ("t" . SPARSER::PROTEIN) ("BLP, BP, or FA" . SPARSER::COLLECTION)
    ("weak p16" . SPARSER::PROTEIN) ("TMA" . SPARSER::MOLECULE)
    ("FA" . SPARSER::PROTEIN) ("BLP" . SPARSER::PROTEIN)
    ("BP" . SPARSER::PROTEIN) ("MP" . SPARSER::PROTEIN)
    ("p16 or Rb" . SPARSER::COLLECTION) ("p16−" . SPARSER::PROTEIN)
    ("diffuse strong p16" . SPARSER::PROTEIN)
    ("p16, Rb, and Ki-67" . SPARSER::COLLECTION)
    ("p16 and Rb" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E2F" . SPARSER::PROTEIN-FAMILY)
    ("retinoblastoma protein" . SPARSER::PROTEIN) ("of 45" . SPARSER::PROTEIN)
    ("brain)" . SPARSER::PROTEIN) ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21" . SPARSER::PROTEIN) ("G1-S" . SPARSER::PROTEIN)
    ("p16" . SPARSER::PROTEIN) ("CG" . SPARSER::PROTEIN)
    ("DG" . SPARSER::PROTEIN) ("AI" . SPARSER::PROTEIN)
    ("phenylindole" . SPARSER::MOLECULE) ("DAPI" . SPARSER::DRUG)
    ("BFA" . SPARSER::MOLECULE) ("dinitrophenol" . SPARSER::MOLECULE)
    ("Sphingosine" . SPARSER::SPHINGOSINE) ("Chemokine" . SPARSER::PROTEIN)
    ("Phorbol" . SPARSER::DRUG) ("Mast cell" . SPARSER::PROTEIN)
    ("cytokinergic IgE" . SPARSER::PROTEIN)
    ("tumor-specific mouse monoclonal IgE antibodies" . SPARSER::ANTIBODY)
    ("fibronectin" . SPARSER::PROTEIN) ("IgE/Antigen" . SPARSER::COLLECTION)
    ("Antigen" . SPARSER::HUMAN-PROTEIN-FAMILY) ("tryptase" . SPARSER::PROTEIN)
    ("bevacizumab" . SPARSER::DRUG)
    ("monomeric IgE and hypoxia" . SPARSER::COLLECTION)
    ("IgE and hypoxia" . SPARSER::COLLECTION) ("brefeldin" . SPARSER::PROTEIN)
    ("nonspecific monomeric IgE" . SPARSER::PROTEIN)
    ("Bevacizumab" . SPARSER::DRUG) ("−IgE" . SPARSER::COLLECTION)
    ("HSA" . SPARSER::PROTEIN) ("DNP" . SPARSER::DRUG)
    ("Exogenous IgE" . SPARSER::PROTEIN)
    ("Non-specific monomeric IgE" . SPARSER::PROTEIN)
    ("pS6 and 4E-BP1" . SPARSER::COLLECTION)
    ("ribosome" . SPARSER::BIO-COMPLEX) ("CHX" . SPARSER::PROTEIN)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("cycloheximide" . SPARSER::PROTEIN)
    ("the predominant isoform" . SPARSER::PROTEIN)
    ("VEGF and GAPDH" . SPARSER::COLLECTION) ("GAPDH" . SPARSER::PROTEIN)
    ("BMMCS" . SPARSER::PROTEIN)
    ("Lyn −/− and Fyn −/− mice" . SPARSER::COLLECTION)
    ("toxin" . SPARSER::PROTEIN)
    ("actinomycin D (ActD) and brefeldin A (BFA)" . SPARSER::COLLECTION)
    ("ActD" . SPARSER::MOLECULE) ("pg" . SPARSER::MOLECULE)
    ("hypoxia, antigen or PMA" . SPARSER::COLLECTION)
    ("PMA" . SPARSER::PROTEIN)
    ("angiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IgEs" . SPARSER::PROTEIN) ("PI3K and leukotriene" . SPARSER::COLLECTION)
    ("leukotriene" . SPARSER::MOLECULE) ("Lyn and Fyn" . SPARSER::COLLECTION)
    ("Lyn" . SPARSER::PROTEIN) ("Fc" . SPARSER::PROTEIN)
    ("antigens" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RI" . SPARSER::PROTEIN)
    ("Proteases, cytokines, chemokines and growth factors"
     . SPARSER::COLLECTION)
    ("Interleukin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TNF" . SPARSER::PROTEIN)
    ("chemokines" . SPARSER::PROTEIN) ("Proteases" . SPARSER::PROTEIN)
    ("IgE/antigen" . SPARSER::COLLECTION) ("MCs" . SPARSER::PROTEIN)
    ("the translational regulator 4E-BP1" . SPARSER::PROTEIN)
    ("Monomeric IgE" . SPARSER::PROTEIN) ("Fyn" . SPARSER::PROTEIN)
    ("Rec" . SPARSER::PROTEIN) ("monomeric IgE" . SPARSER::PROTEIN)
    ("antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vascular Endothelial Growth Factor (VEGF)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immunomodulatory and angiogenic mediators" . SPARSER::PROTEIN)
    ("plasmatic IgE" . SPARSER::PROTEIN) ("IgE" . SPARSER::PROTEIN)
    ("Eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("Ribosomal protein S6" . SPARSER::PROTEIN)
    ("Tetanus Toxin" . SPARSER::PROTEIN) ("S1P" . SPARSER::PROTEIN)
    ("Vascular endothelial growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C-C motif" . SPARSER::PROTEIN) ("CCL2" . SPARSER::PROTEIN)
    ("Interleukin-3" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pH 1" . SPARSER::PROTEIN) ("6 B" . SPARSER::PROTEIN)
    ("Tetanus toxin" . SPARSER::PROTEIN) ("Brefeldin A" . SPARSER::MOLECULE)
    ("IL-3" . SPARSER::PROTEIN) ("β-hexosaminidase" . SPARSER::PROTEIN)
    ("anti-VEGF" . SPARSER::DRUG)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("ribosomal protein S6" . SPARSER::PROTEIN) ("PP2" . SPARSER::PROTEIN)
    ("VAMP-1" . SPARSER::PROTEIN) ("brefeldin A" . SPARSER::MOLECULE)
    ("actinomycin D" . SPARSER::MOLECULE) ("tetanus toxin" . SPARSER::PROTEIN)
    ("Tumor Necrosis Factor" . SPARSER::PROTEIN) ("B16" . SPARSER::PROTEIN)
    ("Vascular Endothelial Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NM" . SPARSER::PROTEIN) ("methotrexate" . SPARSER::DRUG)
    ("tumor-associated protein growth factor receptor-bound protein 2"
     . SPARSER::PROTEIN)
    ("a repressive regulator" . SPARSER::PROTEIN) ("FU" . SPARSER::PROTEIN)
    ("ACTB" . SPARSER::PROTEIN) ("MiR" . SPARSER::MICRO-RNA)
    ("MicroRNAs" . SPARSER::MICRO-RNA) ("fluoropyrimidine" . SPARSER::DRUG)
    ("intracellular enzyme" . SPARSER::ENZYME) ("thymidine" . SPARSER::PROTEIN)
    ("metabolite" . SPARSER::MOLECULE) ("dTMP" . SPARSER::MOLECULE)
    ("miRNA" . SPARSER::MICRO-RNA) ("miR" . SPARSER::MICRO-RNA)
    ("-UTR" . SPARSER::COLLECTION) ("miRNAs" . SPARSER::MICRO-RNA)
    ("microRNAs" . SPARSER::MICRO-RNA) ("fluorouracil" . SPARSER::DRUG)
    ("folate" . SPARSER::MOLECULE) ("TYMS" . SPARSER::PROTEIN)
    ("thymidylate synthase" . SPARSER::PROTEIN) ("GRB2" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("RNase H" . SPARSER::PROTEIN) ("pGL3 " . SPARSER::PROTEIN)
    ("pGL3" . SPARSER::PROTEIN) ("single-stranded RNAs" . SPARSER::RNA)
    ("thymidine monophosphate" . SPARSER::TMP)
    ("dual-luciferase" . SPARSER::PROTEIN) ("5-FU" . SPARSER::PROTEIN)
    ("Thymidylate synthase" . SPARSER::PROTEIN)
    ("AD, YS and YI" . SPARSER::COLLECTION) ("SK and YI" . SPARSER::COLLECTION)
    ("SK" . SPARSER::PROTEIN) ("MB" . SPARSER::PROTEIN)
    ("SH, JT, HG and SO" . SPARSER::COLLECTION) ("SO" . SPARSER::PROTEIN)
    ("HG" . SPARSER::MOLECULE) ("JT" . SPARSER::PROTEIN)
    ("YK" . SPARSER::MOLECULE) ("TD" . SPARSER::PROTEIN)
    ("SH" . SPARSER::PROTEIN) ("AD" . SPARSER::PROTEIN)
    ("MS" . SPARSER::PROTEIN) ("MT" . SPARSER::PROTEIN)
    ("food" . SPARSER::MOLECULE) ("PhIP" . SPARSER::PROTEIN)
    ("Vpr and Vpr" . SPARSER::COLLECTION) ("genetic traits" . SPARSER::PROTEIN)
    ("traits" . SPARSER::PROTEIN) ("these viral genes" . SPARSER::GENE)
    ("proteinuria" . SPARSER::PROTEIN) ("mediators" . SPARSER::PROTEIN)
    ("proximal RTECs" . SPARSER::PROTEIN-FAMILY)
    ("a soluble protein" . SPARSER::PROTEIN) ("latent foci" . SPARSER::PROTEIN)
    ("foci" . SPARSER::PROTEIN) ("autoantibodies" . SPARSER::PROTEIN)
    ("DNA and RNA" . SPARSER::COLLECTION) ("Vpr and AhR" . SPARSER::COLLECTION)
    ("nuclease" . SPARSER::PROTEIN)
    ("the exogenous hL1 gene" . SPARSER::PROTEIN)
    ("AhR and C/EBP-β" . SPARSER::COLLECTION)
    ("mRNAs, and MAPK" . SPARSER::COLLECTION)
    ("ORF1 and ARNT1" . SPARSER::COLLECTION)
    ("ORF1 and ORF2" . SPARSER::COLLECTION)
    ("ORF1 and AhR" . SPARSER::COLLECTION)
    ("ORF1 and EGFP" . SPARSER::COLLECTION)
    ("pORF1-EGFP" . SPARSER::COLLECTION) ("WB" . SPARSER::PROTEIN)
    ("a nucleic acid chaperone" . SPARSER::PROTEIN)
    ("chaperone" . SPARSER::PROTEIN) ("Chromatin" . SPARSER::PROTEIN)
    ("CREB and c-Jun" . SPARSER::COLLECTION) ("CREB" . SPARSER::PROTEIN)
    ("p38 and C/EBP-β" . SPARSER::COLLECTION) ("IP-WB" . SPARSER::COLLECTION)
    ("wild-type Vpr (WT Vpr) and the LA mutant" . SPARSER::COLLECTION)
    ("LAM" . SPARSER::PROTEIN) ("LA" . SPARSER::PROTEIN)
    ("tryptophan" . SPARSER::AMINO-ACID)
    ("AhR and ARNT1" . SPARSER::COLLECTION) ("AHR" . SPARSER::PROTEIN)
    ("heterodimer" . SPARSER::HETERODIMER) ("MNF" . SPARSER::PROTEIN)
    ("p300/histone" . SPARSER::COLLECTION) ("acetyl" . SPARSER::MOLECULE)
    ("AhR-p38-C/EBP-β" . SPARSER::COLLECTION) ("AhR" . SPARSER::PROTEIN)
    ("RTECs" . SPARSER::PROTEIN-FAMILY)
    ("aquaporin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hematoxylin" . SPARSER::MOLECULE) ("-Ed4T" . SPARSER::COLLECTION)
    ("-didehydro-3" . SPARSER::COLLECTION) ("Ed" . SPARSER::PROTEIN)
    ("stavudine (d4T) and tenofovir inhibited the rVpr activity"
     . SPARSER::COLLECTION)
    ("lamivudine (3TC) and azidothymidine (AZT)" . SPARSER::COLLECTION)
    ("AZT" . SPARSER::DRUG) ("azidothymidine" . SPARSER::DRUG)
    ("TC" . SPARSER::PROTEIN) ("lamivudine" . SPARSER::DRUG)
    ("stavudine" . SPARSER::DRUG) ("RTIs" . SPARSER::PROTEIN)
    ("IP" . SPARSER::PROTEIN) ("an irrelevant mAb" . SPARSER::DRUG)
    ("monoclonal antibodies" . SPARSER::ANTIBODY) ("SARS" . SPARSER::PROTEIN)
    ("spike" . SPARSER::PROTEIN) ("mAb" . SPARSER::DRUG)
    ("mAbs" . SPARSER::DRUG) ("EGFP" . SPARSER::PROTEIN)
    ("pEF" . SPARSER::MOLECULE) ("pL1-Neo" . SPARSER::COLLECTION)
    ("Neo" . SPARSER::PROTEIN) ("approximately 100 types" . TYPE)
    ("Alu and SVA" . SPARSER::COLLECTION)
    ("SINE-VNTR-Alu" . SPARSER::COLLECTION) ("SVA" . SPARSER::PROTEIN-FAMILY)
    ("Alu" . SPARSER::PROTEIN) ("LINE" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("monocytes" . SPARSER::PROTEIN) ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a virion-associated nuclear protein" . SPARSER::PROTEIN)
    ("an accessory gene" . SPARSER::GENE)
    ("a soluble factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCAAT" . SPARSER::PROTEIN) ("RTP" . SPARSER::PROTEIN)
    ("NP40" . SPARSER::MOLECULE) ("micrococcal nuclease" . SPARSER::PROTEIN)
    ("protein A" . SPARSER::PROTEIN) ("SP600125" . SPARSER::PROTEIN)
    ("SB202190" . SPARSER::DRUG) ("TCA-3" . SPARSER::PROTEIN)
    ("β-globin" . SPARSER::PROTEIN) ("TG-3" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate" . SPARSER::MOLECULE)
    ("AQP1" . SPARSER::PROTEIN) ("aquaporin 1" . SPARSER::PROTEIN)
    ("H2AX" . SPARSER::PROTEIN) ("PD98059" . SPARSER::MOLECULE)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("de-" . SPARSER::MOLECULE) ("S15" . SPARSER::PROTEIN)
    ("S15A" . SPARSER::PROTEIN) ("S14" . SPARSER::PROTEIN)
    ("S13" . SPARSER::PROTEIN) ("S12" . SPARSER::PROTEIN)
    ("pORF1" . SPARSER::PROTEIN) ("S11" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("ORF1" . SPARSER::PROTEIN) ("c-Jun" . SPARSER::PROTEIN)
    ("S10" . SPARSER::PROTEIN) ("CYP1A1" . SPARSER::PROTEIN)
    ("ARNT1" . SPARSER::PROTEIN) ("p300" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("d4T" . SPARSER::DRUG)
    ("ORF2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("S2" . SPARSER::MOLECULE) ("pL1" . SPARSER::PROTEIN)
    ("C/EBP-β" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-6" . SPARSER::PROTEIN) ("G 2 /M" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("IF and IHC" . SPARSER::COLLECTION) ("IF" . SPARSER::PROTEIN)
    ("ectopically-expressed RASSF1A" . SPARSER::PROTEIN)
    ("tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("matrix metalloproteinases (MMPs) or their inhibitors"
     . SPARSER::COLLECTION)
    ("MMPs" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RASSF1A and microtubules" . SPARSER::COLLECTION)
    ("punctate" . SPARSER::PROTEIN) ("A133S" . SPARSER::PROTEIN)
    ("microtubules" . SPARSER::PROTEIN) ("phalloidins" . SPARSER::MOLECULE)
    ("Matrigel" . SPARSER::PROTEIN) ("matrix (ECM)" . SPARSER::PROTEIN-FAMILY)
    ("ECM" . SPARSER::PROTEIN) ("matrix" . SPARSER::PROTEIN-FAMILY)
    ("RASSF1A (SW-13/A) and RASSF1A/A133S (SW-13/AM)" . SPARSER::COLLECTION)
    ("neomycin" . SPARSER::DRUG)
    ("RASSF1A and RASSF1A/A133S" . SPARSER::COLLECTION)
    ("RASSF1A (SW-13/A) or RASSF1A/A133S mutant (SW-13/AM)"
     . SPARSER::COLLECTION)
    ("AM" . SPARSER::PROTEIN)
    ("ectopic RASSF1A (Figure  xref A; b-d) and RASSF1A/A133S (Figure  xref A; f-h)"
     . SPARSER::COLLECTION)
    ("using anti-RASSF1A antibody (Figure  xref A; b & f) or anti-DDK antibody (Figure  xref A; c & g)"
     . SPARSER::COLLECTION)
    ("DDK" . SPARSER::BIO-COMPLEX) ("aza" . SPARSER::DRUG)
    ("ACT" . SPARSER::PROTEIN) ("the methylated fraction" . SPARSER::COMPONENT)
    ("normal and benign ACA" . SPARSER::PROTEIN)
    ("fraction" . SPARSER::COMPONENT) ("a larger cohort" . SPARSER::MOLECULE)
    ("consequent RASSF1A" . SPARSER::PROTEIN) ("n " . SPARSER::PROTEIN)
    ("ACC and ACA" . SPARSER::COLLECTION) ("ACA" . SPARSER::PROTEIN)
    ("K-Ras and TNF-alpha" . SPARSER::COLLECTION)
    ("MST1/MST2" . SPARSER::COLLECTION) ("SAPK-JNK" . SPARSER::COLLECTION)
    ("JNK" . SPARSER::PROTEIN) ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bp-CpG" . SPARSER::COLLECTION) ("CpG" . SPARSER::PROTEIN)
    ("protein-protein" . SPARSER::COLLECTION)
    ("cysteine" . SPARSER::AMINO-ACID) ("ATM" . SPARSER::PROTEIN)
    ("RA" . SPARSER::PROTEIN) ("kDa" . SPARSER::PROTEIN)
    ("germ-line" . SPARSER::PROTEIN)
    ("Several well-known tumor suppressor- and oncogene-signaling pathways"
     . SPARSER::COLLECTION)
    ("suppressor-" . SPARSER::SUPPRESSOR) ("genesis" . SPARSER::PROTEIN)
    ("TP53, IGF-2 and Wnt" . SPARSER::COLLECTION)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("endocrine" . SPARSER::PROTEIN)
    ("ACC" . SPARSER::PROTEIN) ("F-actin" . SPARSER::BIO-COMPLEX)
    ("beta-actin" . SPARSER::PROTEIN)
    ("filamentous actin" . SPARSER::BIO-COMPLEX) ("6B" . SPARSER::PROTEIN)
    ("a3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("apoptosis-inducing" . SPARSER::PROTEIN) ("f-h" . SPARSER::PROTEIN)
    ("2’-deoxycytidine" . SPARSER::MOLECULE) ("TNF-alpha" . SPARSER::PROTEIN)
    ("MST2" . SPARSER::PROTEIN) ("MST1" . SPARSER::PROTEIN)
    ("1C" . SPARSER::PROTEIN) ("Raf-1" . SPARSER::PROTEIN)
    ("RASSF1" . SPARSER::PROTEIN) ("a 37" . SPARSER::PROTEIN)
    ("Family 1" . SPARSER::PROTEIN) ("PRKAR1A" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN) ("RASSF1A" . SPARSER::PROTEIN)
    ("IGF-2" . SPARSER::PROTEIN) ("TP53" . SPARSER::PROTEIN)
    ("/Foxp3" . SPARSER::COLLECTION) ("cytokine" . SPARSER::PROTEIN)
    ("a pathogenetically relevant biomarker" . SPARSER::MOLECULE)
    ("anion" . SPARSER::MOLECULE) ("auto-antibodies" . SPARSER::ANTIBODY)
    ("rapamycin or NAC" . SPARSER::COLLECTION) ("IL17a" . SPARSER::PROTEIN)
    ("cytokines" . SPARSER::PROTEIN)
    ("3-dimensional PLS-DA" . SPARSER::MOLECULE)
    ("hydroxychloroquine" . SPARSER::DRUG) ("/CD3" . SPARSER::COLLECTION)
    ("the serological components" . SPARSER::COMPONENT)
    ("CD3/CD28" . SPARSER::COLLECTION)
    ("T-cell and B-cell subsets" . SPARSER::COLLECTION)
    ("mTOR and FoxP3" . SPARSER::COLLECTION)
    ("metabolic biomarkers" . SPARSER::MOLECULE)
    ("a discordant expression FoxP3 and CD25" . SPARSER::COLLECTION)
    ("FoxP3 and CD25" . SPARSER::COLLECTION) ("normal PBL" . SPARSER::PROTEIN)
    ("RP" . SPARSER::PROTEIN) ("FDR" . SPARSER::PROTEIN)
    ("212 metabolic biomarkers" . SPARSER::MOLECULE)
    ("matrices" . SPARSER::PROTEIN-FAMILY) ("biomarkers" . SPARSER::MOLECULE)
    ("DA" . SPARSER::MOLECULE) ("MTG" . SPARSER::PROTEIN)
    ("Mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("potentiometric dyes DiOC 6 and TMRM ( xref and xref )"
     . SPARSER::COLLECTION)
    ("potentiometric dyes DiOC 6" . SPARSER::DRUG)
    ("mechanistically relevant target" . SPARSER::TARGET-PROTEIN)
    ("/FoxP3" . SPARSER::COLLECTION) ("GSH" . SPARSER::DRUG)
    ("ROI" . SPARSER::PROTEIN) ("a key trigger" . SPARSER::PROTEIN)
    ("N-acetylcysteine (NAC)" . SPARSER::DRUG)
    ("immunosuppressants" . SPARSER::DRUG) ("prone" . SPARSER::PROTEIN-FAMILY)
    ("MRL" . SPARSER::PROTEIN) ("DCs" . SPARSER::PROTEIN)
    ("interferon" . SPARSER::PROTEIN) ("Mitochondria" . SPARSER::PROTEIN)
    ("nuclear" . SPARSER::PROTEIN)
    ("Systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("/CD19" . SPARSER::COLLECTION) ("/CD25" . SPARSER::COLLECTION)
    ("/CD8" . SPARSER::COLLECTION) ("/CD4" . SPARSER::COLLECTION)
    ("DN" . SPARSER::PROTEIN) ("SLE" . SPARSER::PROTEIN)
    ("PBL" . SPARSER::PROTEIN) ("Foxp3" . SPARSER::PROTEIN)
    ("antinuclear antibody" . SPARSER::PROTEIN) ("RIP1" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("Sle1" . SPARSER::PROTEIN) ("voltage-dependent" . SPARSER::PROTEIN)
    ("estrogen-related receptor gamma" . SPARSER::PROTEIN)
    ("necrostatin-1" . SPARSER::MOLECULE) ("IL4" . SPARSER::PROTEIN)
    ("IL17" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN) ("IL-17" . SPARSER::PROTEIN)
    ("IFN-γ" . SPARSER::PROTEIN) ("pS6" . SPARSER::PROTEIN)
    ("Necrostatin-1" . SPARSER::MOLECULE) ("Fluo-3" . SPARSER::MOLECULE)
    ("DCF-DA" . SPARSER::DRUG) ("H 2 O 2" . SPARSER::DRUG)
    ("acridine orange" . SPARSER::MOLECULE) ("DiOC 6" . SPARSER::DRUG)
    ("transcription factor" . SPARSER::PROTEIN)
    ("N-acetylcysteine" . SPARSER::DRUG) ("CD28" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("IFN-α" . SPARSER::PROTEIN) ("nitric oxide" . SPARSER::MOLECULE)
    ("CD19" . SPARSER::PROTEIN) ("IL-4" . SPARSER::PROTEIN)
    ("CD25" . SPARSER::PROTEIN) ("FoxP3" . SPARSER::PROTEIN)
    ("CD8" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("T-cell" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("adjuvant" . SPARSER::DRUG) ("biomarker" . SPARSER::MOLECULE)
    ("YAP" . SPARSER::PROTEIN)
    ("a Src pathway-associated protein" . SPARSER::PROTEIN)
    ("Yes-associated protein-1" . SPARSER::PROTEIN)
    ("dasatinib" . SPARSER::DRUG)
    ("Our studies shed new light" . SPARSER::PROTEIN)
    ("a complex and inefficient process" . SPARSER::COLLECTION)
    ("Src and HER2" . SPARSER::COLLECTION) ("EdU" . SPARSER::DRUG)
    ("pyruvate" . SPARSER::PROTEIN) ("histone" . SPARSER::PROTEIN)
    ("PARP" . SPARSER::PROTEIN) ("HER2 and Akt" . SPARSER::COLLECTION)
    ("Akt and Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER2, HER3 and Eph" . SPARSER::COLLECTION) ("Eph" . SPARSER::PROTEIN)
    ("lapatinib or saracatinib" . SPARSER::COLLECTION)
    ("log-rank" . SPARSER::COLLECTION) ("rank" . SPARSER::PROTEIN)
    ("log" . SPARSER::PROTEIN)
    ("lapatinib and saracatinib" . SPARSER::COLLECTION)
    ("Saracatinib" . SPARSER::DRUG)
    ("post-intracarotid" . SPARSER::PROTEIN-PAIR)
    ("saracatinib and lapatinib" . SPARSER::COLLECTION)
    ("saracatinib" . SPARSER::DRUG) ("EGFR and HER2" . SPARSER::COLLECTION)
    ("both small molecular weight BBB tracer (sodium fluorescein) and high molecular weight tracer (Evans blue)"
     . SPARSER::COLLECTION)
    ("fluorescein" . SPARSER::MOLECULE) ("tracer" . SPARSER::MOLECULE)
    ("tracers" . SPARSER::MOLECULE) ("red" . SPARSER::PROTEIN)
    ("Red" . SPARSER::PROTEIN) ("mixture" . SPARSER::MOLECULE)
    ("sh" . SPARSER::PROTEIN-FAMILY) ("astrocytes" . SPARSER::PROTEIN)
    ("either V5-tagged wild-type Src (Src-WT) or constitutively activated Src (Src-Y527F)"
     . SPARSER::COLLECTION)
    ("either V5-tagged wild-type Src" . SPARSER::PROTEIN)
    ("BBB" . SPARSER::PROTEIN) ("Paxillin" . SPARSER::PROTEIN)
    ("pSrc" . SPARSER::PROTEIN) ("subline" . SPARSER::PROTEIN)
    ("the parental line" . SPARSER::PROTEIN) ("RPPA" . SPARSER::PROTEIN)
    ("sub-line" . SPARSER::PROTEIN)
    ("Src and the EGFR/HER2 inhibitor lapatinib" . SPARSER::COLLECTION)
    ("HER" . SPARSER::PROTEIN)
    ("blood brain barrier (BBB)-permeable Src inhibitors" . SPARSER::INHIBITOR)
    ("barrier (BBB)" . SPARSER::PROTEIN) ("HER2:HER3" . SPARSER::BIO-COMPLEX)
    ("EGFR/HER2" . SPARSER::COLLECTION) ("lapatinib" . SPARSER::DRUG)
    ("barrier" . SPARSER::PROTEIN) ("Src" . SPARSER::PROTEIN)
    ("YAP1" . SPARSER::PROTEIN) ("protein-1" . SPARSER::PROTEIN)
    ("p27" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("β-catenin" . SPARSER::PROTEIN) ("PKM2" . SPARSER::PROTEIN)
    ("Cyclin D1" . SPARSER::PROTEIN) ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("m1" . SPARSER::MOLECULE) ("HER3" . SPARSER::PROTEIN)
    ("EGFR , ERBB2 , and PDGFB" . SPARSER::COLLECTION)
    ("EGFR , FGFR2 , and PDGFB" . SPARSER::COLLECTION)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("case" . SPARSER::PROTEIN)
    ("FGFR2 and PDGFB" . SPARSER::COLLECTION)
    ("PDGFB and the homozygote variant" . SPARSER::COLLECTION)
    ("variant" . SPARSER::VARIANT)
    ("ERBB2 and FGF1 and EGFR and NRG2" . SPARSER::COLLECTION)
    ("FGF1 and EGFR and NRG2" . SPARSER::COLLECTION)
    ("EGFR and NRG2" . SPARSER::COLLECTION)
    ("FGF1 and PDGFB" . SPARSER::COLLECTION)
    ("FGFR2, PDGFB, and NRG2" . SPARSER::COLLECTION) ("ER-" . SPARSER::PROTEIN)
    ("ER/PR" . SPARSER::COLLECTION)
    ("NRG2 (22 SNPs) and PDGFB (9 SNPs)" . SPARSER::COLLECTION)
    ("EGF (1 SNP), ERBB2 (3 SNPs), FGF1 (21 SNPs), FGF2 (16SNPs), FGFR2 (1 candidate SNP), NRG2 (22 SNPs) and PDGFB (9 SNPs)"
     . SPARSER::COLLECTION)
    ("call" . SPARSER::PROTEIN) ("San" . SPARSER::PROTEIN)
    ("SNP/LD" . SPARSER::COLLECTION) ("bin" . SPARSER::PROTEIN)
    ("age" . SPARSER::PROTEIN) ("hormone" . SPARSER::PROTEIN)
    ("ER and progesterone receptor" . SPARSER::COLLECTION)
    ("AIMs" . SPARSER::PROTEIN) ("States" . SPARSER::BIO-STATE)
    ("FGF1 , FGF2 , FGFR2 , NRG2 , EGF , ERBB2 , and PDGFB"
     . SPARSER::COLLECTION)
    ("mitogen" . SPARSER::MITOGEN)
    ("FGF [ xref ] and
VEGF [ xref ]"
     . SPARSER::COLLECTION)
    ("FGF" . SPARSER::PROTEIN) ("PDGF" . SPARSER::PROTEIN)
    ("neuregulin" . SPARSER::PROTEIN) ("ERBB" . SPARSER::PROTEIN)
    ("NRG" . SPARSER::PROTEIN) ("Neuregulins" . SPARSER::PROTEIN)
    ("Neu or ERBB2" . SPARSER::COLLECTION) ("Neu" . SPARSER::PROTEIN)
    ("EGF and its receptor" . SPARSER::COLLECTION)
    ("EGFR or ERBB1" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF) and IGF [ xref ]" . SPARSER::COLLECTION)
    ("heparin" . SPARSER::PROTEIN)
    ("growth factors (IGF)" . SPARSER::GROWTH-FACTOR)
    ("IGF" . SPARSER::PROTEIN)
    ("growth factors and their receptors" . SPARSER::COLLECTION)
    ("Genes" . SPARSER::GENE) ("polypeptides" . SPARSER::PROTEIN)
    ("ERBB2 and FGF1" . SPARSER::COLLECTION)
    ("FGF1 and ERBB2" . SPARSER::COLLECTION)
    ("FGF1, FGF2, and NRG2" . SPARSER::COLLECTION)
    ("EGFR , ERBB2 , FGFR2, and PDGFB" . SPARSER::COLLECTION)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Adaptive Rank" . SPARSER::PROTEIN) ("ARTP" . SPARSER::PROTEIN)
    ("Rank" . SPARSER::PROTEIN) ("FGF1 and FGF2" . SPARSER::COLLECTION)
    ("HER2/neu" . SPARSER::COLLECTION) ("PDGFB" . SPARSER::PROTEIN)
    ("neu" . SPARSER::PROTEIN) ("GF" . SPARSER::PROTEIN)
    ("growth
factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERRB2" . SPARSER::PROTEIN) ("progesterone receptor" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERBB1" . SPARSER::PROTEIN)
    ("Fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("fibroblast growth factor receptor 2" . SPARSER::PROTEIN)
    ("vascular endothelial growth
factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transforming growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CI 1" . SPARSER::PROTEIN) ("OR 1" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGFR2" . SPARSER::PROTEIN) ("its receptor" . SPARSER::PROTEIN)
    ("FGF2" . SPARSER::PROTEIN) ("FGF1" . SPARSER::PROTEIN)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("ERBB2" . SPARSER::PROTEIN) ("NRG2" . SPARSER::PROTEIN)
    ("neuregulin 2" . SPARSER::PROTEIN) ("RBPs" . SPARSER::PROTEIN)
    ("ribosomal proteins" . SPARSER::PROTEIN)
    ("RPL5, RPL7, RPL11, RPL23, and RPS27L" . SPARSER::COLLECTION)
    ("RNPC1 and Mdm2" . SPARSER::COLLECTION)
    ("the p53 and a negative regulator" . SPARSER::COLLECTION)
    ("p53 and Mdm2" . SPARSER::COLLECTION) ("p53-Mdm2" . SPARSER::COLLECTION)
    ("UTR" . SPARSER::PROTEIN) ("tetracycline" . SPARSER::MOLECULE)
    ("HuR and Musashi" . SPARSER::COLLECTION) ("Musashi" . SPARSER::PROTEIN)
    ("HuR" . SPARSER::PROTEIN)
    ("a key regulator of a variety of fundamental cellular processes [ xref ]"
     . SPARSER::REGULATOR)
    ("an E3 ligase and a key regulator" . SPARSER::COLLECTION)
    ("oncoprotein" . SPARSER::PROTEIN) ("RPS27L" . SPARSER::PROTEIN)
    ("RPL23" . SPARSER::PROTEIN) ("RPL11" . SPARSER::PROTEIN)
    ("RPL7" . SPARSER::PROTEIN) ("RPL5" . SPARSER::PROTEIN)
    ("RBM38" . SPARSER::PROTEIN) ("RNPC1" . SPARSER::PROTEIN)
    ("tumor suppressor p53" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("yet each oncogene" . SPARSER::PROTEIN)
    ("RAS-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EGFR-" . SPARSER::PROTEIN)
    ("growth factors, or EGFR-TKI" . SPARSER::COLLECTION)
    ("derivatives" . SPARSER::DERIVATIVE) ("analogs" . SPARSER::ANALOG)
    ("CCI-779, RAD001 and AP23573" . SPARSER::COLLECTION)
    ("active mTOR complexes" . SPARSER::BIO-COMPLEX)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAM83B or PLD1" . SPARSER::COLLECTION)
    ("ER and PR" . SPARSER::COLLECTION) ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER" . SPARSER::PROTEIN) ("EGFR-PLD-1" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("S6K, PI3K, and RAS" . SPARSER::COLLECTION)
    ("MAPK and mTOR" . SPARSER::COLLECTION) ("effectors" . SPARSER::EFFECTOR)
    ("ERK1/2 and AKT" . SPARSER::COLLECTION)
    ("oncoproteins" . SPARSER::PROTEIN) ("TKIs" . SPARSER::PROTEIN)
    ("PLD2-" . SPARSER::PROTEIN)
    ("GFP (G) or FAM83B (B)" . SPARSER::COLLECTION)
    ("exogenous PLD1, PLD2 or GFP" . SPARSER::COLLECTION)
    ("PLD1, PLD2 or GFP" . SPARSER::COLLECTION)
    ("RAS-HME1" . SPARSER::COLLECTION) ("derivative" . SPARSER::DERIVATIVE)
    ("GFP , PLD1 , or PLD2" . SPARSER::COLLECTION)
    ("PLD2 or FAM83B" . SPARSER::COLLECTION) ("lipase" . SPARSER::PROTEIN)
    ("Rac, Rho, and Cdc42" . SPARSER::COLLECTION)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ARF" . SPARSER::PROTEIN)
    ("ADP" . SPARSER::PROTEIN) ("PLD1 or PLD2" . SPARSER::COLLECTION)
    ("EGFR and FAM83B" . SPARSER::COLLECTION)
    ("Tyrosine" . SPARSER::AMINO-ACID) ("Erlotinib" . SPARSER::DRUG)
    ("EGFR-FAM83B" . SPARSER::COLLECTION) ("ERK or mTOR" . SPARSER::COLLECTION)
    ("S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("FAM83B-EGFR" . SPARSER::COLLECTION) ("FAM" . SPARSER::PROTEIN)
    ("FAM83B or EGFR" . SPARSER::COLLECTION)
    ("FLAG, or EGFR antibody" . SPARSER::COLLECTION)
    ("FLAG-FAM83B" . SPARSER::COLLECTION)
    ("FAM83B or GFP" . SPARSER::COLLECTION) ("GFP-" . SPARSER::PROTEIN)
    ("tyrosine" . SPARSER::AMINO-ACID)
    ("RAS, CRAF, and SRC" . SPARSER::COLLECTION) ("SRC" . SPARSER::PROTEIN)
    ("PLD1 and FAM83B" . SPARSER::COLLECTION) ("FAM83B-" . SPARSER::PROTEIN)
    ("PLD1 or FAM83B" . SPARSER::COLLECTION)
    ("GFP , PLD1 , or FAM83B" . SPARSER::COLLECTION)
    ("PLD1 or GFP" . SPARSER::COLLECTION)
    ("the dual PLD1/PLD2 inhibitor" . SPARSER::INHIBITOR)
    ("A dual PLD1/PLD2 inhibitor" . SPARSER::INHIBITOR)
    ("PLD1/PLD2" . SPARSER::COLLECTION) ("enzymes" . SPARSER::ENZYME)
    ("neither recombinant FAM83B nor FAM83B" . SPARSER::COLLECTION)
    ("a competitive nucleophile" . SPARSER::MOLECULE)
    ("nucleophile" . SPARSER::MOLECULE) ("PLD1-" . SPARSER::PROTEIN)
    ("GFP or FAM83B" . SPARSER::COLLECTION) ("trap" . SPARSER::PROTEIN)
    ("PLDs" . SPARSER::PROTEIN) ("phospholipase" . SPARSER::PROTEIN)
    ("EGFR and MAPK" . SPARSER::COLLECTION)
    ("phospholipase D (PLD)" . SPARSER::PROTEIN)
    ("EGFR or HER2" . SPARSER::COLLECTION) ("EGFR/RAS" . SPARSER::COLLECTION)
    ("PI3K, AKT, and mTOR" . SPARSER::COLLECTION)
    ("PI3K/AKT" . SPARSER::COLLECTION)
    ("ERK1/2, S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("Family" . SPARSER::PROTEIN-FAMILY) ("PA-BR" . SPARSER::COLLECTION)
    ("BR" . SPARSER::PROTEIN) ("the cells exogenous PA" . SPARSER::PROTEIN)
    ("RAS and EGFR" . SPARSER::COLLECTION)
    ("CRAF and mTOR" . SPARSER::COLLECTION) ("CRAF" . SPARSER::PROTEIN)
    ("PA" . SPARSER::PROTEIN) ("phosphatidylcholine" . SPARSER::MOLECULE)
    ("RAL" . SPARSER::PROTEIN) ("RalB" . SPARSER::PROTEIN)
    ("RalA" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor (EGF)" . SPARSER::PROTEIN)
    ("AKT (VDQ-002) and mTOR (Rapamycin, CCI-779, RAD001, and AP-23573)"
     . SPARSER::COLLECTION)
    ("EGFR, HER2 and VEGF" . SPARSER::COLLECTION)
    ("Tipifarnib and lonafarnib" . SPARSER::COLLECTION)
    ("Sorafenib, RAF265 and PLX4032" . SPARSER::COLLECTION)
    ("Rapamycin" . SPARSER::DRUG) ("Sorafenib" . SPARSER::DRUG)
    ("lonafarnib" . SPARSER::DRUG) ("Tipifarnib" . SPARSER::DRUG)
    ("VEGF" . SPARSER::PROTEIN) ("EGFR, MAPK, and mTOR" . SPARSER::COLLECTION)
    ("FAM83B/EGFR" . SPARSER::COLLECTION)
    ("MAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAM83B and EGFR" . SPARSER::COLLECTION) ("PLD" . SPARSER::PROTEIN)
    ("oncogenes" . SPARSER::ONCOGENE) ("or 2" . SPARSER::MOLECULE)
    ("P-ERK1/2" . SPARSER::PROTEIN) ("pMD2" . SPARSER::MOLECULE)
    ("DNA ligase" . SPARSER::PROTEIN) ("AP23573" . SPARSER::DRUG)
    ("ER-alpha" . SPARSER::PROTEIN) ("estrogen receptor" . SPARSER::PROTEIN)
    ("PLD-1" . SPARSER::PROTEIN) ("etc." . SPARSER::PROTEIN)
    ("growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR-TKI" . SPARSER::PROTEIN) ("AG1478" . SPARSER::DRUG)
    ("Cdc42" . SPARSER::PROTEIN) ("FAM83A" . SPARSER::PROTEIN)
    ("EGFR antibody" . SPARSER::PROTEIN) ("Grb2" . SPARSER::PROTEIN)
    ("VU0155069" . SPARSER::DRUG) ("PLD2" . SPARSER::PROTEIN)
    ("HME1" . SPARSER::PROTEIN) ("phospholipase D" . SPARSER::PROTEIN)
    ("4E-BP1" . SPARSER::PROTEIN)
    ("Mitogen Activated Protein Kinase" . SPARSER::PROTEIN)
    ("member B" . SPARSER::PROTEIN)
    ("mammalian Target of Rapamycin" . SPARSER::PROTEIN)
    ("growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K-RAS" . SPARSER::PROTEIN) ("H-RAS" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN) ("RAD001" . SPARSER::DRUG)
    ("CCI-779" . SPARSER::DRUG) ("ARRY-142886" . SPARSER::DRUG)
    ("AZD6244" . SPARSER::DRUG) ("PD0325901" . SPARSER::DRUG)
    ("PLX4032" . SPARSER::DRUG) ("RAF265" . SPARSER::DRUG)
    ("HER2" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLD1" . SPARSER::PROTEIN) ("Phospholipase D" . SPARSER::PROTEIN)
    ("FAM83B" . SPARSER::PROTEIN)
    ("towildtype/RAG1 −/− mice yet Von Frey filament"
     . SPARSER::PROTEIN-FAMILY)
    ("Thevpr/RAG1" . SPARSER::COLLECTION)
    ("therapeutics" . SPARSER::THERAPEUTICS) ("axon" . SPARSER::PROTEIN)
    ("axons" . SPARSER::PROTEIN)
    ("effectively treatvpr/RAG1 −/−" . SPARSER::COLLECTION)
    ("treatvpr/RAG1" . SPARSER::COLLECTION)
    ("NGF-axon" . SPARSER::PROTEIN-PAIR)
    ("that Vpr’s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TrkA and p75" . SPARSER::COLLECTION)
    ("the available TrkA receptor" . SPARSER::RECEPTOR)
    ("exogenous NGF" . SPARSER::PROTEIN)
    ("The second major aim" . SPARSER::PROTEIN)
    ("the cell soma or the proximal nerve ( xref , xref )"
     . SPARSER::COLLECTION)
    ("ourvpr/RAG1" . SPARSER::COLLECTION) ("wt/RAG1" . SPARSER::COLLECTION)
    ("a viral protein" . SPARSER::PROTEIN) ("mL" . SPARSER::PROTEIN)
    ("a functional TrkA agonist or REX" . SPARSER::COLLECTION)
    ("antiserum (RTA)" . SPARSER::PROTEIN) ("REX" . SPARSER::PROTEIN)
    ("RTA" . SPARSER::PROTEIN) ("antiserum" . SPARSER::PROTEIN)
    ("Ras/MAP" . SPARSER::COLLECTION) ("MAP" . SPARSER::PROTEIN)
    ("the TrkA receptor and the pan-neurotrophin receptor"
     . SPARSER::COLLECTION)
    ("pan-neurotrophin" . SPARSER::COLLECTION)
    ("neurotrophin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pan" . SPARSER::PROTEIN)
    ("dye" . SPARSER::MOLECULE)
    ("the pivotal signalling molecules" . SPARSER::MOLECULE)
    ("receptor and pGSK3β" . SPARSER::COLLECTION)
    ("TrkA and pGSK3β" . SPARSER::COLLECTION)
    ("showedvpr/RAG1" . SPARSER::COLLECTION)
    ("soluble recombinant Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("invpr/RAG1" . SPARSER::COLLECTION)
    ("correspondingwildtype/RAG1" . SPARSER::COLLECTION)
    ("thatvpr/RAG1" . SPARSER::COLLECTION) ("subtypes" . SPARSER::PROTEIN)
    ("forwildtype/RAG1" . SPARSER::COLLECTION)
    ("betweenwildtype/RAG1" . SPARSER::COLLECTION)
    ("myelin" . SPARSER::PROTEIN) ("thewildtype/RAG1" . SPARSER::COLLECTION)
    ("DRGs" . SPARSER::PROTEIN)
    ("small diameter (<20 μm) nociceptive DRG somas" . SPARSER::DRUG)
    ("andvpr/RAG1" . SPARSER::COLLECTION)
    ("ofwildtype/RAG1" . SPARSER::COLLECTION)
    ("an IB4-immunoreactive antibody" . SPARSER::ANTIBODY)
    ("andwildtype/RAG1" . SPARSER::COLLECTION)
    ("thesevpr/RAG1" . SPARSER::COLLECTION) ("somas" . SPARSER::DRUG)
    ("towildtype/RAG1" . SPARSER::COLLECTION)
    ("ofvpr/RAG1" . SPARSER::COLLECTION) ("Von" . SPARSER::PROTEIN)
    ("adultvpr/RAG1" . SPARSER::COLLECTION)
    ("thevpr/RAG1" . SPARSER::COLLECTION)
    ("all peripheral targets" . SPARSER::TARGET-PROTEIN)
    ("keratinocytes" . SPARSER::PROTEIN) ("II" . SPARSER::PROTEIN)
    ("the neuronal soma" . SPARSER::DRUG)
    ("viral protein R" . SPARSER::PROTEIN) ("soma" . SPARSER::DRUG)
    ("neuropathic pain" . SPARSER::PROTEIN) ("analgesics" . SPARSER::DRUG)
    ("HIV-associated DSP" . SPARSER::PROTEIN)
    ("pain, paresthesia and gait" . SPARSER::COLLECTION)
    ("NGF/TrkA" . SPARSER::COLLECTION)
    ("blocked Vpr’s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rat" . SPARSER::PROTEIN) ("TrkA" . SPARSER::PROTEIN)
    ("tropomyosin" . SPARSER::PROTEIN) ("wildtype/RAG1" . SPARSER::COLLECTION)
    ("vpr/RAG1" . SPARSER::COLLECTION) ("vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DSP-associated neuropathic pain" . SPARSER::PROTEIN)
    ("growth factor (NGF)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NGF" . SPARSER::PROTEIN) ("calcium and membrane" . SPARSER::COLLECTION)
    ("DRG" . SPARSER::PROTEIN) ("a neurotoxic protein" . SPARSER::PROTEIN)
    ("Viral protein R" . SPARSER::PROTEIN) ("macrophages" . SPARSER::PROTEIN)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("associated neuropathic pain" . SPARSER::PROTEIN)
    ("pain" . SPARSER::PROTEIN) ("DSP" . SPARSER::PROTEIN)
    ("substance P" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("neurotrophic factor" . SPARSER::PROTEIN) ("PI3K" . SPARSER::PROTEIN)
    ("Fluo-4" . SPARSER::DRUG) ("β-actin" . SPARSER::PROTEIN)
    ("per 1" . SPARSER::PROTEIN) ("GSK3β" . SPARSER::PROTEIN)
    ("GSK3-β" . SPARSER::PROTEIN) ("Sodium Bicarbonate" . SPARSER::DRUG)
    ("Magnesium Sulfate" . SPARSER::DRUG)
    ("Potassium Chloride" . SPARSER::MOLECULE)
    ("Sodium Chloride" . SPARSER::DRUG) ("Ara-C" . SPARSER::DRUG)
    ("N 2" . SPARSER::PROTEIN) ("for 3" . SPARSER::PROTEIN)
    ("p200" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RPLP0" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN) ("PGP9.5" . SPARSER::PROTEIN)
    ("serum albumin" . SPARSER::PROTEIN) ("Tween 20" . SPARSER::MOLECULE)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("M-CSF" . SPARSER::PROTEIN)
    ("c-fms" . SPARSER::PROTEIN) ("p75" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NGF receptor" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY) ("RAG1" . SPARSER::PROTEIN)
    ("protein R" . SPARSER::PROTEIN)
    ("peptides, or drugs" . SPARSER::COLLECTION)
    ("insulin and growth factors" . SPARSER::COLLECTION)
    ("Akt-TSC" . SPARSER::COLLECTION) ("TSC" . SPARSER::PROTEIN)
    ("AMBRA1-TRAF6" . SPARSER::COLLECTION)
    ("p62 and K63" . SPARSER::COLLECTION)
    ("TSC2, DEPTOR, REDD1, and IRS1" . SPARSER::COLLECTION)
    ("DEPTOR" . SPARSER::PROTEIN) ("examples" . SPARSER::EXAMPLE)
    ("PKCζ or PKCλ/ι" . SPARSER::COLLECTION)
    ("raptor and the Rags" . SPARSER::COLLECTION) ("Rags" . SPARSER::PROTEIN)
    ("a pivotal nutrient-sensitive kinase complex" . SPARSER::BIO-COMPLEX)
    ("growth factors, and amino acids" . SPARSER::COLLECTION)
    ("glucose" . SPARSER::MOLECULE) ("cre" . SPARSER::PROTEIN)
    ("ammonium chloride and leupeptin" . SPARSER::COLLECTION)
    ("leucine" . SPARSER::AMINO-ACID) ("leupeptin" . SPARSER::DRUG)
    ("Nutrients" . SPARSER::MOLECULE)
    ("amino acids and point" . SPARSER::COLLECTION)
    ("rapamycin or torin" . SPARSER::COLLECTION) ("torin" . SPARSER::PROTEIN)
    ("rapamycin" . SPARSER::DRUG)
    ("the mTOR ubiquitination-defective mutant" . SPARSER::MUTANT)
    ("lysines" . SPARSER::AMINO-ACID) ("TRAF6/p62" . SPARSER::COLLECTION)
    ("Polyubiquitination" . SPARSER::PROTEIN)
    ("the ubiquitin chain generally targets proteins" . SPARSER::PROTEIN)
    ("HA-ubiquitin" . SPARSER::COLLECTION)
    ("Ube1 (E1) and Ubch7 (E2)" . SPARSER::COLLECTION)
    ("a TRAF6 dominant-negative mutant" . SPARSER::MUTANT)
    ("TRAF6 and p62" . SPARSER::COLLECTION)
    ("a functionally relevant lysosomal mTORC1 complex" . SPARSER::BIO-COMPLEX)
    ("EFs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a cell-permeable peptide" . SPARSER::PEPTIDE)
    ("TRAF6 and mTOR" . SPARSER::COLLECTION)
    ("TB or TB-AAA mutant" . SPARSER::COLLECTION) ("RANK" . SPARSER::PROTEIN)
    ("TB-AAA" . SPARSER::COLLECTION) ("TRAF6-p62" . SPARSER::COLLECTION)
    ("GST-TB" . SPARSER::COLLECTION) ("AAA" . SPARSER::PROTEIN)
    ("TB" . SPARSER::PROTEIN) ("TRAF6 or p62" . SPARSER::COLLECTION)
    ("extracellular" . SPARSER::PROTEIN) ("insulin" . SPARSER::PROTEIN)
    ("S6K and 4EBP1" . SPARSER::COLLECTION)
    ("mTOR, raptor, and RagC" . SPARSER::COLLECTION)
    ("raptor and TRAF6" . SPARSER::COLLECTION)
    ("TRAF6 and raptor" . SPARSER::COLLECTION)
    ("Flag-TRAF6" . SPARSER::COLLECTION) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Complex" . SPARSER::BIO-COMPLEX) ("p62/TRAF6" . SPARSER::COLLECTION)
    ("neither PKCζ nor PKCλ/ι" . SPARSER::COLLECTION)
    ("microtubule-associated protein 1 light chain 3" . SPARSER::PROTEIN)
    ("PB1" . SPARSER::PROTEIN) ("p62, or sequestosome-1" . SPARSER::COLLECTION)
    ("a pentameric complex" . SPARSER::BIO-COMPLEX)
    ("HBXIP and C7orf59" . SPARSER::COLLECTION) ("HBXIP" . SPARSER::PROTEIN)
    ("vacuolar adenosine triphosphatase" . SPARSER::PROTEIN)
    ("anchors" . SPARSER::ANCHOR) ("triphosphatase" . SPARSER::PROTEIN)
    ("adenosine" . SPARSER::PROTEIN)
    ("MP1, p14, and p18" . SPARSER::COLLECTION)
    ("The active dimer" . SPARSER::DIMER)
    ("RagA or RagB and RagC or RagD" . SPARSER::COLLECTION)
    ("RagB and RagC or RagD" . SPARSER::COLLECTION)
    ("RagC or RagD" . SPARSER::COLLECTION)
    ("heterodimers" . SPARSER::HETERODIMER)
    ("RagA, RagB, RagC, and RagD" . SPARSER::COLLECTION)
    ("RagA and RagB" . SPARSER::COLLECTION)
    ("Gtr1, and RagC and RagD" . SPARSER::COLLECTION)
    ("RagC and RagD" . SPARSER::COLLECTION) ("RagD" . SPARSER::PROTEIN)
    ("RagC" . SPARSER::PROTEIN) ("RagB" . SPARSER::PROTEIN)
    ("RagA" . SPARSER::PROTEIN) ("lysosomal" . SPARSER::PROTEIN)
    ("triphosphatases" . SPARSER::PROTEIN) ("guanosine" . SPARSER::MOLECULE)
    ("Rag" . SPARSER::PROTEIN)
    ("raptor and mLST8/GβL ( xref )" . SPARSER::COLLECTION)
    ("mLST8/GβL" . SPARSER::COLLECTION)
    ("a paradigmatic example" . SPARSER::EXAMPLE) ("hub" . SPARSER::PROTEIN)
    ("example" . SPARSER::EXAMPLE) ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("complexes" . SPARSER::BIO-COMPLEX) ("p62-TRAF6" . SPARSER::COLLECTION)
    ("mTOR" . SPARSER::PROTEIN) ("raptor" . SPARSER::PROTEIN)
    ("nutrient" . SPARSER::MOLECULE) ("beclin 1" . SPARSER::PROTEIN)
    ("ULK1" . SPARSER::PROTEIN) ("AMBRA1" . SPARSER::PROTEIN)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("REDD1" . SPARSER::PROTEIN)
    ("TSC2" . SPARSER::PROTEIN) ("Skp1" . SPARSER::PROTEIN)
    ("Cul1" . SPARSER::PROTEIN) ("pS6K" . SPARSER::PROTEIN)
    ("bafilomycin A1" . SPARSER::DRUG) ("LC3-II" . SPARSER::PROTEIN)
    ("Cap2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CaP2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("K-Ras" . SPARSER::PROTEIN)
    ("E2" . SPARSER::MOLECULE) ("Ubch7" . SPARSER::PROTEIN)
    ("E1" . SPARSER::MOLECULE) ("Ube1" . SPARSER::PROTEIN)
    ("ligase activity" . SPARSER::PROTEIN)
    ("Amino Acids" . SPARSER::AMINO-ACID) ("LAMP2" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN)
    ("Amino Acid" . SPARSER::AMINO-ACID)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("S6K" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("NBR1" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("LC3" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sequestosome-1" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("C7orf59" . SPARSER::PROTEIN) ("V-ATPase" . SPARSER::PROTEIN-FAMILY)
    ("p18" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p14" . SPARSER::PROTEIN)
    ("MP1" . SPARSER::PROTEIN) ("Gtr2" . SPARSER::PROTEIN)
    ("Gtr1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GβL" . SPARSER::PROTEIN)
    ("mLST8" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("TRAF6" . SPARSER::PROTEIN)
    ("TNF receptor associated factor 6" . SPARSER::PROTEIN)
    ("p62" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mTORC1" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("Ligands" . SPARSER::LIGAND) ("fascin" . SPARSER::PROTEIN)
    ("bound cofilin and competitive ligands" . SPARSER::COLLECTION)
    ("NEM-treated myosin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pyrene" . SPARSER::PROTEIN)
    ("cofilin and myosin or phalloidin" . SPARSER::COLLECTION)
    ("myosin or phalloidin" . SPARSER::COLLECTION) ("classes" . CLASS)
    ("Phalloidin and cofilin" . SPARSER::COLLECTION)
    ("Myosin and cofilin" . SPARSER::COLLECTION)
    ("Refs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Myosin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phalloidin and myosin" . SPARSER::COLLECTION)
    ("Phalloidin" . SPARSER::MOLECULE)
    ("phalloidin or myosin" . SPARSER::COLLECTION) ("Actin" . SPARSER::PROTEIN)
    ("bare or saturated filaments" . SPARSER::PROTEIN-FAMILY)
    ("Filaments" . SPARSER::PROTEIN-FAMILY)
    ("an essential actin regulatory protein" . SPARSER::PROTEIN)
    ("competitive ligands" . SPARSER::LIGAND)
    ("phalloidin and myosin" . SPARSER::COLLECTION)
    ("myosin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phalloidin" . SPARSER::MOLECULE) ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("cofilin and actin" . SPARSER::COLLECTION)
    ("cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Filament" . SPARSER::PROTEIN-FAMILY)
    ("an essential actin filament" . SPARSER::PROTEIN-FAMILY)
    ("filament" . SPARSER::PROTEIN-FAMILY) ("actin" . SPARSER::PROTEIN)
    ("Cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Actin-interacting protein 1" . SPARSER::PROTEIN)
    ("glucose oxidase" . SPARSER::PROTEIN)
    ("N-ethylmaleimide" . SPARSER::MOLECULE) ("cofilin-1" . SPARSER::PROTEIN)
    ("mGluR, Homer1a and Pin1" . SPARSER::COLLECTION)
    ("Astrocytes" . SPARSER::PROTEIN) ("Dopa" . SPARSER::MOLECULE)
    ("Drug" . SPARSER::DRUG) ("mGluR-Pin1" . SPARSER::COLLECTION)
    ("synaptic Homer1c" . SPARSER::PROTEIN)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("NMDA and D1" . SPARSER::COLLECTION) ("-Pin1" . SPARSER::COLLECTION)
    ("modulators" . SPARSER::PROTEIN) ("Cocaine" . SPARSER::DRUG)
    ("Homer1c and Homer2" . SPARSER::COLLECTION)
    ("NMR and ITC" . SPARSER::COLLECTION)
    ("acute SKF38393" . SPARSER::MOLECULE)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("corticostriatal LTP" . SPARSER::PROTEIN) ("LTP" . SPARSER::PROTEIN)
    ("acute cocaine" . SPARSER::DRUG) ("heterozygotes" . SPARSER::PROTEIN)
    ("TS" . SPARSER::PROTEIN) ("n" . SPARSER::PROTEIN)
    ("striatum" . SPARSER::PROTEIN) ("mGluR5-Pin1" . SPARSER::COLLECTION)
    ("mGluR5 and mGluR5" . SPARSER::COLLECTION) ("pS" . SPARSER::PROTEIN)
    ("Pin1/Homer1" . SPARSER::COLLECTION) ("fractions" . SPARSER::COMPONENT)
    ("PSD" . SPARSER::PROTEIN)
    ("the mGluR5-pS or mGluR5-pTpS peptide" . SPARSER::COLLECTION)
    ("mGluR5-pTpS" . SPARSER::COLLECTION) ("mGluR5-pS" . SPARSER::PROTEIN-PAIR)
    ("pTpS" . SPARSER::PROTEIN) ("Homer triple KO" . SPARSER::PROTEIN)
    ("KO" . SPARSER::PROTEIN) ("Homer-mGluR5" . SPARSER::COLLECTION)
    ("WASP" . SPARSER::PROTEIN)
    ("a minimal Homer binding peptide TPPSPF" . SPARSER::PROTEIN-FAMILY)
    ("TPPSPF" . SPARSER::PROTEIN-FAMILY)
    ("the shorter peptide" . SPARSER::PEPTIDE)
    ("the conformational state" . SPARSER::BIO-STATE)
    ("Homer/Pin1" . SPARSER::COLLECTION) ("ligand" . SPARSER::LIGAND)
    ("cis and trans" . SPARSER::COLLECTION) ("cis/trans" . SPARSER::COLLECTION)
    ("trans" . SPARSER::PROTEIN-FAMILY) ("cis" . SPARSER::PROTEIN)
    ("Homer and Pin1" . SPARSER::COLLECTION)
    ("Homer, mGluR5, GluA1 and GluN1" . SPARSER::COLLECTION)
    ("Homer1c" . SPARSER::PROTEIN) ("FR" . SPARSER::PROTEIN)
    ("GST-Homer1c" . SPARSER::COLLECTION) ("NMDAR" . SPARSER::PROTEIN)
    ("Pin1C113S" . SPARSER::PROTEIN) ("GFP" . SPARSER::PROTEIN)
    ("KCl" . SPARSER::MOLECULE) ("Homer1aW24A" . SPARSER::PROTEIN)
    ("transgene" . SPARSER::PROTEIN)
    ("TrkB (K252a; 100 nM) or MEK (UO126; 20 μM)" . SPARSER::COLLECTION)
    ("Inhibitors" . SPARSER::INHIBITOR) ("min" . SPARSER::PROTEIN)
    ("BDNF-TrkB" . SPARSER::COLLECTION) ("Grm5" . SPARSER::PROTEIN)
    ("Grm1" . SPARSER::PROTEIN) ("external Mg 2+" . SPARSER::MOLECULE)
    ("ifenprodil and PPDA" . SPARSER::COLLECTION)
    ("NR2B and NR2C/D" . SPARSER::COLLECTION)
    ("ifenprodil (3 μM) and PPDA (0.2 μM, xref )" . SPARSER::COLLECTION)
    ("PPDA" . SPARSER::MOLECULE) ("ifenprodil" . SPARSER::DRUG)
    ("MPEP" . SPARSER::MOLECULE) ("AMPA" . SPARSER::PROTEIN)
    ("fast" . SPARSER::PROTEIN) ("voltage-clamp" . SPARSER::PROTEIN)
    ("DHPG" . SPARSER::DRUG) ("agonist" . SPARSER::AGONIST)
    ("clamp" . SPARSER::PROTEIN-FAMILY) ("IEG" . SPARSER::GENE)
    ("Homer3" . SPARSER::PROTEIN) ("GST-Pin1" . SPARSER::COLLECTION)
    ("GST" . SPARSER::PROTEIN) ("peptides" . SPARSER::PEPTIDE)
    ("receptors or BDNF" . SPARSER::COLLECTION) ("TrkB" . SPARSER::PROTEIN)
    ("BDNF" . SPARSER::PROTEIN) ("Mutant" . SPARSER::MUTANT)
    ("gene (IEG)" . SPARSER::PROTEIN) ("isomerase" . SPARSER::ISOMERASE)
    ("Homer (TPPSPF)" . SPARSER::PROTEIN-FAMILY)
    ("receptor and group I" . SPARSER::COLLECTION) ("mGluR" . SPARSER::PROTEIN)
    ("coiled-coil" . SPARSER::PROTEIN) ("Homer2" . SPARSER::PROTEIN)
    ("scaffold" . SPARSER::SCAFFOLD) ("Homer" . SPARSER::PROTEIN-FAMILY)
    ("postsynaptic ionotropic receptors" . SPARSER::PROTEIN)
    ("NMDA ionotropic receptors and group I metabotropic glutamate receptors"
     . SPARSER::RECEPTOR)
    ("receptors and group I" . SPARSER::COLLECTION)
    ("mGluR1 and mGluR5" . SPARSER::COLLECTION) ("Dopamine" . SPARSER::DRUG)
    ("a possible therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("NMDA" . SPARSER::MOLECULE) ("Pin1-mGluR5" . SPARSER::COLLECTION)
    ("prolyl" . SPARSER::PROTEIN) ("dopamine" . SPARSER::PROTEIN)
    ("cocaine and other drugs" . SPARSER::COLLECTION)
    ("cocaine" . SPARSER::DRUG) ("N-methyl-D-aspartate" . SPARSER::MOLECULE)
    ("NH 2" . SPARSER::MOLECULE) ("NaHCO 3" . SPARSER::DRUG)
    ("PO 4" . SPARSER::PROTEIN) ("MAPK2" . SPARSER::PROTEIN)
    ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TRPC1" . SPARSER::PROTEIN)
    ("GB1" . SPARSER::PROTEIN) ("NR1" . SPARSER::PROTEIN)
    ("GluA2" . SPARSER::PROTEIN) ("M1" . SPARSER::MOLECULE)
    ("pT-P" . SPARSER::PROTEIN) ("GluN1" . SPARSER::PROTEIN)
    ("GluA1" . SPARSER::PROTEIN) ("SKF38393" . SPARSER::MOLECULE)
    ("UO126" . SPARSER::DRUG) ("K252a" . SPARSER::MOLECULE)
    ("Mg 2+" . SPARSER::MOLECULE) ("MK-801" . SPARSER::MOLECULE)
    ("NR2C" . SPARSER::PROTEIN) ("NR2B" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p42/44" . SPARSER::PROTEIN) ("T-P" . SPARSER::PROTEIN)
    ("MAP Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immediate early" . SPARSER::PROTEIN) ("Homer1b" . SPARSER::PROTEIN)
    ("G-protein coupled" . SPARSER::PROTEIN) ("mGluR1" . SPARSER::PROTEIN)
    ("group I" . SPARSER::PROTEIN) ("Homer1" . SPARSER::PROTEIN)
    ("Pin1" . SPARSER::PROTEIN) ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mGluR5" . SPARSER::PROTEIN) ("glutamate receptor" . SPARSER::PROTEIN)
    ("the apo and Ca-bound states" . SPARSER::COLLECTION)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("significantly more active" . SPARSER::ACTIVE)
    ("cat and SOS" . SPARSER::COLLECTION)
    ("multiple oligomeric states" . SPARSER::BIO-STATE)
    ("monomers, dimers and tetramers" . SPARSER::COLLECTION)
    ("tetramers" . SPARSER::TETRAMER) ("monomers" . SPARSER::MONOMER)
    ("GTPases" . SPARSER::GTPASE) ("GTP or GDP" . SPARSER::COLLECTION)
    ("past" . SPARSER::PROTEIN) ("KRas or NRas" . SPARSER::COLLECTION)
    ("NRas" . SPARSER::PROTEIN) ("KRas" . SPARSER::PROTEIN)
    ("SOS and RasGRP1" . SPARSER::COLLECTION)
    ("either SOS or another protein" . SPARSER::COLLECTION)
    ("its conformational state" . SPARSER::BIO-STATE)
    ("a conformationally heterogeneous state" . SPARSER::BIO-STATE)
    ("DAG" . SPARSER::DAG) ("lab" . SPARSER::PROTEIN)
    ("Epac or Cdc25" . SPARSER::COLLECTION)
    ("the editorial decision letter and author response" . SPARSER::COLLECTION)
    ("the editorial decision letter" . SPARSER::MOLECULE)
    ("letter" . SPARSER::MOLECULE)
    ("variants and diseases" . SPARSER::COLLECTION)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("alleles" . SPARSER::ALLELE) ("classical EF" . SPARSER::PROTEIN)
    ("cAMP" . SPARSER::PROTEIN) ("Epac" . SPARSER::PROTEIN)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("dimeric RasGRP1" . SPARSER::PROTEIN)
    ("dimeric state" . SPARSER::BIO-STATE)
    ("diacylglycerol and calcium" . SPARSER::COLLECTION)
    ("proline" . SPARSER::AMINO-ACID) ("path" . SPARSER::PROTEIN)
    ("tip" . SPARSER::PROTEIN) ("apo-EF1" . SPARSER::COLLECTION)
    ("EF and Ca 2+" . SPARSER::COLLECTION) ("-RasGRP2" . SPARSER::COLLECTION)
    ("conformations" . SPARSER::BIO-CONFORMATION) ("RDCs" . SPARSER::DRUG)
    ("Nuclear" . SPARSER::PROTEIN)
    ("apo- and Ca-RasGRP2" . SPARSER::COLLECTION) ("apo-" . SPARSER::PROTEIN)
    ("apo-RasGRP1" . SPARSER::COLLECTION) ("apo-RasGRP2" . SPARSER::COLLECTION)
    ("detergents" . SPARSER::MOLECULE) ("pH" . SPARSER::PROTEIN)
    ("apo-calmodulin" . SPARSER::COLLECTION) ("apo" . SPARSER::PROTEIN)
    ("Calcium" . SPARSER::CALCIUM) ("MgCl 2 and GTP" . SPARSER::COLLECTION)
    ("inositol" . SPARSER::PROTEIN) ("ionomycin" . SPARSER::DRUG)
    ("metal-bound EF" . SPARSER::PROTEIN) ("aspartate" . SPARSER::MOLECULE)
    ("glycine" . SPARSER::AMINO-ACID)
    ("Classical Ca 2+" . SPARSER::CALCIUM-ION)
    ("calmodulin" . SPARSER::PROTEIN) ("ion" . SPARSER::MOLECULE)
    ("GTPase" . SPARSER::GTPASE) ("phosphatidylserine" . SPARSER::PROTEIN)
    ("lipids" . SPARSER::PROTEIN) ("maleimide" . SPARSER::DRUG)
    ("phosphatidyl" . SPARSER::MOLECULE) ("Asn" . SPARSER::AMINO-ACID)
    ("His" . SPARSER::AMINO-ACID) ("Ras-ERK" . SPARSER::COLLECTION)
    ("weaker" . SPARSER::PROTEIN) ("SOS cat , which is" . SPARSER::PROTEIN)
    ("only fourfold more active" . SPARSER::ACTIVE)
    ("exchange factor and Ras" . SPARSER::COLLECTION)
    ("significantly less active" . SPARSER::ACTIVE)
    ("the C1-mediated dimer" . SPARSER::DIMER) ("light" . SPARSER::PROTEIN)
    ("monomer" . SPARSER::MONOMER)
    ("the protein can form dimers and higher order oligomers in vitro ( xref )"
     . SPARSER::COLLECTION)
    ("the oligomeric state" . SPARSER::BIO-STATE)
    ("oligomers" . SPARSER::PROTEIN)
    ("the crystallographic dimer" . SPARSER::DIMER)
    ("nucleotide and diacylglycerol binding ( xref )" . SPARSER::COLLECTION)
    ("clamps" . SPARSER::PROTEIN-FAMILY) ("face" . SPARSER::PROTEIN)
    ("a crystallographic dimer" . SPARSER::DIMER) ("step" . SPARSER::PROTEIN)
    ("Asp" . SPARSER::AMINO-ACID)
    ("P-ERK- and Myc-antibodies" . SPARSER::COLLECTION)
    ("P-ERK-" . SPARSER::PROTEIN) ("Myc" . SPARSER::PROTEIN)
    ("FACS" . SPARSER::PROTEIN) ("solution" . SPARSER::MOLECULE)
    ("cat" . SPARSER::PROTEIN) ("soluble Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Trp" . SPARSER::AMINO-ACID) ("Val" . SPARSER::AMINO-ACID)
    ("Cdc25 and EF" . SPARSER::COLLECTION) ("peptide" . SPARSER::PEPTIDE)
    ("electron" . SPARSER::MOLECULE) ("Cdc25-EF" . SPARSER::COLLECTION)
    ("Glu" . SPARSER::AMINO-ACID)
    ("Leucine and isoleucine" . SPARSER::COLLECTION)
    ("glutamine" . SPARSER::AMINO-ACID) ("isoleucine" . SPARSER::AMINO-ACID)
    ("Leucine" . SPARSER::AMINO-ACID)
    ("dimeric coiled coil" . SPARSER::PROTEIN) ("subunit" . SPARSER::FRAGMENT)
    ("subunits" . SPARSER::FRAGMENT) ("dimer" . SPARSER::DIMER)
    ("canonical EF" . SPARSER::PROTEIN) ("side" . SPARSER::PROTEIN)
    ("The helical hairpin conformation" . SPARSER::BIO-CONFORMATION)
    ("Leu" . SPARSER::AMINO-ACID) ("Phe" . SPARSER::AMINO-ACID)
    ("Tyr" . SPARSER::AMINO-ACID) ("base" . SPARSER::PROTEIN)
    ("rest" . SPARSER::PROTEIN)
    ("an N-terminal fragment (residues 50–607, RasGRP1 CEC ) and a C-terminal fragment (residues 739–793, RasGRP1 CC )"
     . SPARSER::COLLECTION)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EF1 and EF2" . SPARSER::COLLECTION) ("coil" . SPARSER::PROTEIN)
    ("EF" . SPARSER::PROTEIN) ("ligands" . SPARSER::LIGAND)
    ("sharp" . SPARSER::PROTEIN) ("Jurkat" . SPARSER::PROTEIN)
    ("REM and Cdc25" . SPARSER::COLLECTION)
    ("SOS ( xref ; xref , xref ) and the Rap-specific exchange factor"
     . SPARSER::COLLECTION)
    ("the Rap-specific exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("REM" . SPARSER::PROTEIN) ("myeloid-" . SPARSER::PROTEIN)
    ("myeloid" . SPARSER::PROTEIN) ("RasGRP and Ras" . SPARSER::COLLECTION)
    ("RasGRF" . SPARSER::PROTEIN-FAMILY) ("guanine" . SPARSER::PROTEIN)
    ("families" . SPARSER::PROTEIN-FAMILY)
    ("an inactive GDP-bound form and an active GTP-bound form"
     . SPARSER::COLLECTION)
    ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("Ras guanine nucleotide releasing protein 1 (RasGRP1) and Son-of-Sevenless (SOS) ( xref )"
     . SPARSER::COLLECTION)
    ("Son-of-Sevenless (SOS)" . SPARSER::PROTEIN)
    ("diacylglycerol" . SPARSER::PROTEIN) ("ions" . SPARSER::MOLECULE)
    ("dimers" . SPARSER::DIMER) ("fragments" . SPARSER::FRAGMENT)
    ("lipid" . SPARSER::LIPID) ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("NMR" . SPARSER::PROTEIN) ("fragment" . SPARSER::FRAGMENT)
    ("RasGRP1 and Ras" . SPARSER::COLLECTION)
    ("RasGRP1 and SOS" . SPARSER::COLLECTION) ("RasGRP1" . SPARSER::PROTEIN)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SOS" . SPARSER::PROTEIN)
    ("RasGRP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RASGRP1" . SPARSER::PROTEIN)
    ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("hand 1" . SPARSER::PROTEIN)
    ("1  D" . SPARSER::PROTEIN) ("Pf1" . SPARSER::PROTEIN)
    ("A- V" . SPARSER::MOLECULE) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("-3" . SPARSER::PROTEIN) ("Zn 2+" . SPARSER::MOLECULE)
    ("CCP4" . SPARSER::PROTEIN) ("l protein" . SPARSER::PROTEIN)
    ("pH 3" . SPARSER::PROTEIN) ("MnCl 2" . SPARSER::DRUG)
    ("ULP1" . SPARSER::PROTEIN) ("and 1" . SPARSER::PROTEIN)
    ("β-mercaptoethanol" . SPARSER::MOLECULE)
    ("ammonium chloride" . SPARSER::MOLECULE)
    ("Nucleotide exchange factors" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("RasGRP3" . SPARSER::PROTEIN)
    ("RasGRP4" . SPARSER::PROTEIN) ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("polycystin-2" . SPARSER::PROTEIN) ("1 K" . SPARSER::PROTEIN)
    ("RasGRP2" . SPARSER::PROTEIN) ("EF-hand" . SPARSER::PROTEIN-FAMILY)
    ("Ca 2+ -calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("PLCγ" . SPARSER::PROTEIN-FAMILY) ("protein can" . SPARSER::PROTEIN)
    ("PKCβ" . SPARSER::PROTEIN) ("Myc-tagged" . SPARSER::PROTEIN)
    ("P-ERK" . SPARSER::PROTEIN) ("GCN4" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN) ("1 C" . SPARSER::PROTEIN)
    ("Rap1" . SPARSER::PROTEIN) ("E. coli )" . SPARSER::PROTEIN)
    ("full-length" . SPARSER::PROTEIN) ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("phospholipase C" . SPARSER::PROTEIN) ("EF2" . SPARSER::PROTEIN)
    ("EF1" . SPARSER::PROTEIN) ("Epac2" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR) ("Cdc25" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN) ("Son-of-Sevenless" . SPARSER::PROTEIN)
    ("guanine nucleotide releasing protein" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("nucleotide exchange factor" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("Ras family" . SPARSER::PROTEIN) ("Ras-binding" . SPARSER::PROTEIN)
    ("nucleotide exchange factors" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("BIM" . SPARSER::PROTEIN) ("variants" . SPARSER::VARIANT)
    ("complex and interaction between them" . SPARSER::COLLECTION)
    ("each prosurvival protein" . SPARSER::PROTEIN)
    ("seven" . SPARSER::PROTEIN)
    ("novel BH3 mimetic navitoclax" . SPARSER::DRUG)
    ("granzyme B and TRAIL" . SPARSER::COLLECTION) ("TRAIL" . SPARSER::PROTEIN)
    ("navitoclax" . SPARSER::DRUG) ("Mcl1/Bim" . SPARSER::COLLECTION)
    ("Gamma" . SPARSER::PROTEIN) ("enhancers" . SPARSER::PROTEIN)
    ("part" . SPARSER::COMPONENT) ("fate" . SPARSER::PROTEIN)
    ("variety" . SPARSER::VARIETY) ("regulator" . SPARSER::REGULATOR)
    ("typical prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cohorts" . SPARSER::MOLECULE) ("perfect LD" . SPARSER::PROTEIN)
    ("Bim/Mcl1" . SPARSER::COLLECTION)
    ("either total or major individual isoforms" . SPARSER::ISOFORM)
    ("BimS, BimL and BimEL" . SPARSER::COLLECTION)
    ("isoforms, or levels" . SPARSER::COLLECTION)
    ("serine and arginin" . SPARSER::COLLECTION) ("SNP" . SPARSER::PROTEIN)
    ("group" . SPARSER::MOLECULE)
    ("prednisone or dexamethasone" . SPARSER::COLLECTION)
    ("type and risk" . SPARSER::COLLECTION) ("SR" . SPARSER::PROTEIN)
    ("prednisone" . SPARSER::DRUG)
    ("typical prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cox" . SPARSER::PROTEIN) ("TT" . SPARSER::PROTEIN)
    ("CI" . SPARSER::PROTEIN) ("exon" . SPARSER::PROTEIN)
    ("Ile" . SPARSER::AMINO-ACID) ("EFS" . SPARSER::PROTEIN)
    ("LD" . SPARSER::PROTEIN) ("MAF" . SPARSER::PROTEIN)
    ("gene BCL2L11 and three major mRNA isoforms" . SPARSER::COLLECTION)
    ("BimEL, BimS, and BimL" . SPARSER::COLLECTION) ("BimL" . SPARSER::PROTEIN)
    ("BimS" . SPARSER::PROTEIN) ("BimEL" . SPARSER::PROTEIN)
    ("molecule" . SPARSER::MOLECULE) ("glucocorticoids" . SPARSER::PROTEIN)
    ("glucocorticoid" . SPARSER::PROTEIN)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("repressor" . SPARSER::REPRESSOR) ("activator" . SPARSER::ACTIVATOR)
    ("GR" . SPARSER::PROTEIN)
    ("childhood acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("Bim and Mcl1" . SPARSER::COLLECTION) ("Mcl1" . SPARSER::PROTEIN)
    ("pro" . SPARSER::PROTEIN) ("Mcl" . SPARSER::PROTEIN)
    ("factors" . SPARSER::HUMAN-PROTEIN-FAMILY) ("minor" . SPARSER::PROTEIN)
    ("isoforms" . SPARSER::ISOFORM) ("gamma" . SPARSER::PROTEIN)
    ("cohort" . SPARSER::MOLECULE) ("dexamethasone" . SPARSER::PROTEIN)
    ("HR" . SPARSER::PROTEIN) ("proapoptotic Bim" . SPARSER::PROTEIN)
    ("Bim" . SPARSER::PROTEIN)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("component" . SPARSER::COMPONENT) ("lymphoid" . SPARSER::PROTEIN)
    ("CS" . SPARSER::PROTEIN) ("granzyme B" . SPARSER::PROTEIN)
    ("SRSF1" . SPARSER::PROTEIN) ("SRSF6" . SPARSER::PROTEIN)
    ("splicing factor" . SPARSER::PROTEIN) ("gamma2" . SPARSER::PROTEIN)
    ("gamma isoform" . SPARSER::PROTEIN) ("SRp55" . SPARSER::PROTEIN)
    ("6.3" . SPARSER::PROTEIN) ("−3 µ" . SPARSER::PROTEIN)
    ("gamma 1" . SPARSER::PROTEIN) ("–3" . SPARSER::PROTEIN)
    ("4–1 µ" . SPARSER::PROTEIN) ("m 2" . SPARSER::MOLECULE)
    ("m2" . SPARSER::MOLECULE) ("BCL2L11" . SPARSER::PROTEIN)
    ("Bcl2" . SPARSER::PROTEIN) ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("gamma1" . SPARSER::PROTEIN) ("ligase" . SPARSER::LIGASE)
    ("EGF and BRAF" . SPARSER::COLLECTION)
    ("polyubiquitination and BRAF" . SPARSER::COLLECTION)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("effector" . SPARSER::EFFECTOR) ("HRAS" . SPARSER::PROTEIN)
    ("which increases KRAS GTP" . SPARSER::NUCLEOTIDE)
    ("polyubiquitination and ERK" . SPARSER::COLLECTION)
    ("EGFR/RAS-GTP" . SPARSER::COLLECTION) ("solvent" . SPARSER::MOLECULE)
    ("ED" . SPARSER::PROTEIN) ("impact" . SPARSER::PROTEIN)
    ("luciferase" . SPARSER::PROTEIN) ("AP-1" . SPARSER::PROTEIN)
    ("only K483R and K578R mutants" . SPARSER::MUTANT)
    ("Arg" . SPARSER::AMINO-ACID) ("Lysine" . SPARSER::AMINO-ACID)
    ("acceptor" . SPARSER::MOLECULE) ("map" . SPARSER::PROTEIN)
    ("BRAF-ED" . SPARSER::COLLECTION) ("AA" . SPARSER::MOLECULE)
    ("FLAG" . SPARSER::PROTEIN-FAMILY) ("Ub" . SPARSER::PROTEIN)
    ("polyubiquitinated" . SPARSER::PROTEIN) ("HA-Ub" . SPARSER::PROTEIN-PAIR)
    ("HA" . SPARSER::PROTEIN) ("RAS and BRAF" . SPARSER::COLLECTION)
    ("antibodies" . SPARSER::ANTIBODY) ("BRAF or RAS" . SPARSER::COLLECTION)
    ("KRAS" . SPARSER::PROTEIN)
    ("polyubiquitin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein/protein" . SPARSER::COLLECTION) ("DNA" . SPARSER::DNA)
    ("receptor" . SPARSER::RECEPTOR) ("ubiquitin" . SPARSER::PROTEIN)
    ("Ubiquitin" . SPARSER::PROTEIN) ("Protein" . SPARSER::PROTEIN)
    ("EGFR/RAS/RAF" . SPARSER::COLLECTION)
    ("proteins (GAP)" . SPARSER::PROTEIN)
    ("RAS and GTPase-activating" . SPARSER::COLLECTION)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Gly" . SPARSER::AMINO-ACID)
    ("a typical RTK" . SPARSER::PROTEIN) ("RTK" . SPARSER::PROTEIN)
    ("RAS/RAF/ERK" . SPARSER::COLLECTION) ("targets" . SPARSER::TARGET-PROTEIN)
    ("RAS-GTP and BRAF" . SPARSER::COLLECTION)
    ("serine/threonine" . SPARSER::COLLECTION)
    ("threonine" . SPARSER::AMINO-ACID) ("serine" . SPARSER::AMINO-ACID)
    ("Thr" . SPARSER::AMINO-ACID) ("GTP" . SPARSER::NUCLEOTIDE)
    ("GDP" . SPARSER::NUCLEOTIDE) ("inactive" . SPARSER::INACTIVE)
    ("RTKs" . SPARSER::PROTEIN) ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MCF7" . SPARSER::PROTEIN)
    ("arginine" . SPARSER::AMINO-ACID) ("EGF" . SPARSER::PROTEIN)
    ("lysine" . SPARSER::AMINO-ACID) ("polyubiquitination" . SPARSER::PROTEIN)
    ("Lys" . SPARSER::AMINO-ACID) ("BRAF" . SPARSER::PROTEIN)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("MgCl2" . SPARSER::MOLECULE)
    ("for 3 " . SPARSER::PROTEIN) ("Triton X-100" . SPARSER::MOLECULE)
    ("Protein A" . SPARSER::PROTEIN) ("anti-β" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN) ("F12" . SPARSER::PROTEIN)
    ("colon cancer" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("amino acids" . SPARSER::AMINO-ACID) ("amino acid" . SPARSER::AMINO-ACID)
    ("FLAG-BRAF" . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("SW480" . SPARSER::PROTEIN) ("NF-κB" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG) ("GTPase-activating" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RAS-GTP" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Growth factors" . SPARSER::GROWTH-FACTOR)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("partial" . SPARSER::PROTEIN)
    ("PTEN and PI 3-kinase" . SPARSER::COLLECTION)
    ("atypical PKC and Lgl" . SPARSER::COLLECTION)
    ("PKC and Lgl" . SPARSER::COLLECTION)
    ("Scribble and Discs" . SPARSER::COLLECTION)
    ("Discs" . SPARSER::BIO-COMPLEX) ("Scribble" . SPARSER::PROTEIN)
    ("suppressors" . SPARSER::SUPPRESSOR)
    ("PTEN/aPKC/Lgl1" . SPARSER::COLLECTION) ("aPKC" . SPARSER::PROTEIN)
    ("functional Lgl1" . SPARSER::PROTEIN) ("Partial" . SPARSER::PROTEIN)
    ("PKCι and Lgl3SA" . SPARSER::COLLECTION)
    ("PKCι and Lgl1" . SPARSER::COLLECTION)
    ("PTEN, Lgl1 and PKCι" . SPARSER::COLLECTION)
    ("PTEN, PKCι and Lgl1" . SPARSER::COLLECTION) ("GFAP" . SPARSER::PROTEIN)
    ("III" . SPARSER::PROTEIN) ("class" . CLASS) ("nestin" . SPARSER::PROTEIN)
    ("Lgl1 and PKCι" . SPARSER::COLLECTION)
    ("laminin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lgl and non-muscle" . SPARSER::COLLECTION)
    ("Lgl and Lgl3SA" . SPARSER::COLLECTION)
    ("Lgl or Lgl3SA" . SPARSER::COLLECTION) ("mutant" . SPARSER::MUTANT)
    ("Akt and PKCι" . SPARSER::COLLECTION)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("doxycycline" . SPARSER::DRUG)
    ("isoform" . SPARSER::PROTEIN) ("substrate" . SPARSER::SUBSTRATE)
    ("Ser" . SPARSER::AMINO-ACID) ("antibody" . SPARSER::ANTIBODY)
    ("Lgl1 and Lgl3SA" . SPARSER::COLLECTION) ("alanine" . SPARSER::AMINO-ACID)
    ("promoter" . SPARSER::PROMOTER) ("mRNA and protein" . SPARSER::COLLECTION)
    ("melanoma" . SPARSER::PROTEIN) ("mRNA" . SPARSER::RNA)
    ("mutants" . SPARSER::MUTANT)
    ("Atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("complex" . SPARSER::BIO-COMPLEX) ("homology" . SPARSER::PROTEIN)
    ("allele" . SPARSER::ALLELE)
    ("the atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("substrates" . SPARSER::SUBSTRATE) ("oncogene" . SPARSER::ONCOGENE)
    ("two atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCζ and PKCι" . SPARSER::COLLECTION)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PKC" . SPARSER::PROTEIN)
    ("EGFR , PIK3CA and PIK3R1" . SPARSER::COLLECTION)
    ("EGFR" . SPARSER::PROTEIN) ("kinase" . SPARSER::KINASE)
    ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("stem cell-associated genes" . SPARSER::GENE)
    ("states" . SPARSER::BIO-STATE) ("factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("temozolomide" . SPARSER::DRUG) ("an aggressive type" . TYPE)
    ("state" . SPARSER::BIO-STATE) ("form" . SPARSER::FORM)
    ("suppressor" . SPARSER::SUPPRESSOR) ("Lgl" . SPARSER::PROTEIN)
    ("active" . SPARSER::ACTIVE) ("PTEN" . SPARSER::PROTEIN)
    ("an aggressive and incurable type" . TYPE) ("G418" . SPARSER::MOLECULE)
    ("Sal1" . SPARSER::PROTEIN) ("Full-length" . SPARSER::PROTEIN)
    ("N2" . SPARSER::PROTEIN) ("B27" . SPARSER::PROTEIN)
    ("P-S" . SPARSER::PROTEIN)
    ("phospho-threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("monoclonal antibody" . SPARSER::DRUG) ("M2" . SPARSER::MOLECULE)
    ("Anti-" . SPARSER::ANTIBODY) ("cell membrane" . SPARSER::PROTEIN)
    ("BMP-4" . SPARSER::PROTEIN) ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) (NIL . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("U87MG" . SPARSER::PROTEIN) ("Par6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("scaffolding protein" . SPARSER::PROTEIN) ("myosin II" . SPARSER::PROTEIN)
    ("Lgl1" . SPARSER::PROTEIN) ("LGL2" . SPARSER::PROTEIN)
    ("LGL1" . SPARSER::PROTEIN) ("PKCι" . SPARSER::PROTEIN)
    ("PKCζ" . SPARSER::PROTEIN) ("Akt/PKB" . SPARSER::PROTEIN)
    ("PIK3R1" . SPARSER::PROTEIN) ("PIK3CA" . SPARSER::PROTEIN)
    ("tyrosine kinase" . SPARSER::PROTEIN)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphoinositide 3" . SPARSER::PROTEIN)
    ("alkylating agent" . SPARSER::MOLECULE)
    ("atypical protein kinase" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("signaling molecules (IL-8, IL-6) and proteins (JAK2, p-STAT3, Bax)"
     . SPARSER::COLLECTION)
    ("p-STAT3" . SPARSER::COLLECTION) ("molecules" . SPARSER::MOLECULE)
    ("Effective Bcl-2-specific antagonists or inhibitors"
     . SPARSER::COLLECTION)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("antagonists" . SPARSER::MOLECULE)
    ("cytotoxic" . SPARSER::PROTEIN) ("drugs" . SPARSER::DRUG)
    ("proteins and mitochondrial" . SPARSER::COLLECTION) ("RNA" . SPARSER::RNA)
    ("antiapoptotic genes and the downregulation of pro-apoptotic genes"
     . SPARSER::COLLECTION)
    ("pro-apoptotic genes" . SPARSER::GENE) ("genes" . SPARSER::GENE)
    ("kinases" . SPARSER::KINASE) ("inhibitors" . SPARSER::INHIBITOR)
    ("STAT" . SPARSER::PROTEIN) ("JAK" . SPARSER::PROTEIN)
    ("BAD" . SPARSER::PROTEIN) ("antagonist" . SPARSER::MOLECULE)
    ("line" . SPARSER::PROTEIN) ("gene" . SPARSER::PROTEIN)
    ("antioxidant" . SPARSER::PROTEIN) ("Bcl-2 and Bax" . SPARSER::COLLECTION)
    ("oligomer" . SPARSER::MOLECULE) ("forms" . SPARSER::FORM)
    ("particularly multidomain-type pro-apoptotic Bcl-2 family proteins"
     . SPARSER::PROTEIN)
    ("Pro-apoptotic Bcl-2 family proteins" . SPARSER::PROTEIN)
    ("Bax and Bak" . SPARSER::COLLECTION)
    ("Bax and Bcl-2" . SPARSER::COLLECTION) ("type" . TYPE)
    ("mitochondria" . SPARSER::PROTEIN) ("caspase" . SPARSER::PROTEIN)
    ("AG490 and QUE-NLs" . SPARSER::COLLECTION)
    ("IL-8 and IL-6" . SPARSER::COLLECTION) ("enzyme" . SPARSER::PROTEIN)
    ("IL" . SPARSER::PROTEIN) ("interleukin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STAT3 and phospho-STAT3" . SPARSER::COLLECTION)
    ("green" . SPARSER::PROTEIN) ("bright" . SPARSER::PROTEIN)
    ("N -acetyl-cysteine (NAC)" . SPARSER::DRUG) ("NAC" . SPARSER::PROTEIN)
    ("p53 and phospho-p53" . SPARSER::COLLECTION) ("blot" . SPARSER::PROTEIN)
    ("cytometry" . SPARSER::PROTEIN) ("iodide (PI)" . SPARSER::PROTEIN)
    ("PI" . SPARSER::PROTEIN) ("iodide" . SPARSER::PROTEIN)
    ("propidium" . SPARSER::MOLECULE) ("LDH" . SPARSER::PROTEIN)
    ("dehydrogenase" . SPARSER::PROTEIN) ("Lactate" . SPARSER::LACTATE)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("activators" . SPARSER::ACTIVATOR) ("post" . SPARSER::PROTEIN)
    ("period" . SPARSER::PROTEIN) ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("chromatin" . SPARSER::PROTEIN) ("Hematoxylin" . SPARSER::MOLECULE)
    ("dimethyl sulfoxide (DMSO)" . SPARSER::MOLECULE)
    ("DMSO" . SPARSER::MOLECULE) ("inhibitor" . SPARSER::INHIBITOR)
    ("caspases" . SPARSER::PROTEIN) ("trigger" . SPARSER::PROTEIN)
    ("aim" . SPARSER::PROTEIN) ("transducers" . SPARSER::PROTEIN)
    ("glutathione" . SPARSER::DRUG) ("QUE" . SPARSER::MOLECULE)
    ("Quercetin" . SPARSER::MOLECULE)
    ("the pro-apoptotic Bcl-2-associated X protein (Bax) or Bcl-2-associated killer (Bak)"
     . SPARSER::COLLECTION)
    ("Bcl-2-associated killer" . SPARSER::PROTEIN)
    ("the pro-apoptotic Bcl-2-associated X protein" . SPARSER::PROTEIN)
    ("hypoxia or etoposide" . SPARSER::COLLECTION) ("ATP" . SPARSER::ATP)
    ("calcium" . SPARSER::CALCIUM) ("etoposide" . SPARSER::PROTEIN)
    ("hypoxia" . SPARSER::PROTEIN) ("Bak" . SPARSER::PROTEIN)
    ("killer" . SPARSER::PROTEIN) ("protein" . SPARSER::PROTEIN)
    ("versa" . SPARSER::PROTEIN) ("leukemia" . SPARSER::PROTEIN)
    ("oxygen" . SPARSER::MOLECULE) ("receptors" . SPARSER::PROTEIN)
    ("drug" . SPARSER::DRUG) ("PCD" . SPARSER::PROTEIN) ("types" . TYPE)
    ("target" . SPARSER::TARGET-PROTEIN) ("chemical" . SPARSER::MOLECULE)
    ("agonists" . SPARSER::AGONIST) ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("ROS, mitochondrial, and Bcl-2" . SPARSER::COLLECTION)
    ("ROS" . SPARSER::PROTEIN) ("components" . SPARSER::COMPONENT)
    ("JAK2 and STAT3" . SPARSER::COLLECTION) ("mRNAs" . SPARSER::PROTEIN)
    ("proteins" . SPARSER::PROTEIN) ("Bax" . SPARSER::PROTEIN)
    ("family and mitochondrial" . SPARSER::COLLECTION)
    ("mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("family" . SPARSER::PROTEIN-FAMILY) ("quercetin" . SPARSER::MOLECULE)
    ("MgCl 2" . SPARSER::MOLECULE) ("β -actin" . SPARSER::PROTEIN)
    ("annexin V" . SPARSER::PROTEIN) ("NP-40" . SPARSER::DRUG)
    ("CO 2" . SPARSER::PROTEIN) ("caspase-9" . SPARSER::PROTEIN)
    ("Cytochrome c" . SPARSER::PROTEIN) ("L-glutamine" . SPARSER::MOLECULE)
    ("Indo-1" . SPARSER::MOLECULE) ("DiOC6" . SPARSER::DRUG)
    ("DCFH-DA" . SPARSER::DRUG) ("pro-oxidants" . SPARSER::MOLECULE)
    ("UCN-01" . SPARSER::DRUG) ("Chk1" . SPARSER::PROTEIN)
    ("Caspase-3" . SPARSER::PROTEIN) ("caspase-8" . SPARSER::PROTEIN)
    ("cytochrome c" . SPARSER::PROTEIN) ("caspase-3" . SPARSER::PROTEIN)
    ("IL-8" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("N -acetyl-cysteine" . SPARSER::DRUG) ("p53" . SPARSER::PROTEIN)
    ("Annexin V" . SPARSER::PROTEIN) ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("Janus kinase 2" . SPARSER::PROTEIN) ("AG490" . SPARSER::DRUG)
    ("pro-oxidant" . SPARSER::MOLECULE)
    ("adenosine triphosphate" . SPARSER::MOLECULE)
    ("Beclin 1" . SPARSER::PROTEIN) ("anti-" . SPARSER::ANTIBODY)
    ("JAK2" . SPARSER::PROTEIN) ("STAT3" . SPARSER::PROTEIN)
    ("Bcl-2" . SPARSER::PROTEIN)))